Publications
2024
Diabetes mellitus and adverse clinical events in patients with atrial fibrillation: A report from the GLORIA-AF registry phase III.
Liu, Y., Chen, Y., Lam, S. H. M., Huang, B., Romiti, G. F., Alam, U., . . . GLORIA‐AF Investigators. (2024). Diabetes mellitus and adverse clinical events in patients with atrial fibrillation: A report from the GLORIA-AF registry phase III.. Diabetes, obesity & metabolism, 26(12), 5795-5804. doi:10.1111/dom.15950
Relationship between systolic blood pressure and renal function on clinical outcomes in patients with atrial fibrillation: a report from the AF-GEN-UK registry
Shantsila, A., Lip, G. Y. H., & Lane, D. A. (2024). Relationship between systolic blood pressure and renal function on clinical outcomes in patients with atrial fibrillation: a report from the AF-GEN-UK registry. Journal of Hypertension. doi:10.1097/HJH.0000000000003856
Associations of ambient air pollution with incidence and dynamic progression of atrial fibrillation.
Zhang, J., Luo, L., Chen, G., Ai, B., Wu, G., Gao, Y., . . . Chen, Y. (2024). Associations of ambient air pollution with incidence and dynamic progression of atrial fibrillation.. The Science of the total environment, 951, 175710. doi:10.1016/j.scitotenv.2024.175710
Addressing methodological considerations in the assessment of the effect of SGLT2 inhibitors and GLP-1 receptor agonists on diabetic eye complications. Reply to Tsai Y-H, Hemphill NO, Kurth T.
Eleftheriadou, A., Riley, D., Zhao, S. S., Austin, P., Hernández, G., Lip, G. Y. H., . . . Alam, U. (2024). Addressing methodological considerations in the assessment of the effect of SGLT2 inhibitors and GLP-1 receptor agonists on diabetic eye complications. Reply to Tsai Y-H, Hemphill NO, Kurth T.. Diabetologia. doi:10.1007/s00125-024-06314-1
Machine learning for outcome prediction in patients with non-valvular atrial fibrillation from the GLORIA-AF registry.
Joddrell, M., El-Bouri, W., Harrison, S. L., Huisman, M. V., Lip, G. Y. H., Zheng, Y., & GLORIA-AFinvestigators. (2024). Machine learning for outcome prediction in patients with non-valvular atrial fibrillation from the GLORIA-AF registry.. Scientific reports, 14(1), 27088. doi:10.1038/s41598-024-78120-z
TARGET: A Major European Project Aiming to Advance the Personalised Management of Atrial Fibrillation-Related Stroke via the Development of Health Virtual Twins Technology and Artificial Intelligence.
Ortega-Martorell, S., Olier, I., Ohlsson, M., Lip, G. Y. H., & TARGET Consortium. (2024). TARGET: A Major European Project Aiming to Advance the Personalised Management of Atrial Fibrillation-Related Stroke via the Development of Health Virtual Twins Technology and Artificial Intelligence.. Thrombosis and haemostasis. doi:10.1055/a-2438-5671
Optimizing anticoagulant therapy: is pharmacist-led intervention the best.
Li, M., Bateman, J., & Lip, G. Y. H. (2024). Optimizing anticoagulant therapy: is pharmacist-led intervention the best.. European heart journal. Quality of care & clinical outcomes, 10(7), 563-564. doi:10.1093/ehjqcco/qcae047
Smoking Cessation and Incident Cardiovascular Disease.
Cho, J. H., Shin, S. Y., Kim, H., Kim, M., Byeon, K., Jung, M., . . . Lip, G. Y. H. (2024). Smoking Cessation and Incident Cardiovascular Disease.. JAMA network open, 7(11), e2442639. doi:10.1001/jamanetworkopen.2024.42639
Incident dementia in ischaemic stroke patients with early cardiac complications: A propensity-score matched cohort study.
Bucci, T., Choi, S. E., Tsang, C. T., Yiu, K. -H., Buckley, B. J., Pignatelli, P., . . . Abdul-Rahim, A. H. (2024). Incident dementia in ischaemic stroke patients with early cardiac complications: A propensity-score matched cohort study.. European stroke journal, 23969873241293573. doi:10.1177/23969873241293573
Clinical Outcomes of Patients with Atrial Fibrillation who Survived from Bleeding Event: The Results from COOL-AF Thailand Registry.
Winijkul, A., Kaewkumdee, P., Yindeengam, A., Lip, G. Y. H., & Krittayaphong, R. (2024). Clinical Outcomes of Patients with Atrial Fibrillation who Survived from Bleeding Event: The Results from COOL-AF Thailand Registry.. Thrombosis and haemostasis, 124(11), 991-1002. doi:10.1055/s-0044-1786028
Contemporary heart failure and comorbidity risk management.
Li, M., & Lip, G. Y. H. (2024). Contemporary heart failure and comorbidity risk management.. The Lancet. Public health, 9(11), e836-e837. doi:10.1016/s2468-2667(24)00229-9
Delaying Oral Anticoagulants: A False Economy?
Collins, B., & Lip, G. Y. H. (2024). Delaying Oral Anticoagulants: A False Economy?. PharmacoEconomics, 42(11), 1237-1239. doi:10.1007/s40273-024-01422-7
Global burden of metabolic diseases, 1990-2021.
Zhang, H., Zhou, X. -D., Shapiro, M. D., Lip, G. Y. H., Tilg, H., Valenti, L., . . . Zheng, M. -H. (2024). Global burden of metabolic diseases, 1990-2021.. Metabolism: clinical and experimental, 160, 155999. doi:10.1016/j.metabol.2024.155999
Metabolically 'extremely unhealthy' obese and non-obese patients with diabetes and the risk of cardiovascular events: a French nationwide cohort study.
Nabrdalik, K., Bisson, A., Irlik, K., Fauchier, G., Ducluzeau, P. H., Lip, G. Y. H., & Fauchier, L. (2024). Metabolically 'extremely unhealthy' obese and non-obese patients with diabetes and the risk of cardiovascular events: a French nationwide cohort study.. Clinical research in cardiology : official journal of the German Cardiac Society, 113(11), 1534-1543. doi:10.1007/s00392-023-02344-8
Editorial on incidence and outcomes of transient new onset atrial fibrillation complicating acute coronary syndromes: results from a systematic review and meta-analysis.
Balu, A., Welters, I., & Lip, G. Y. H. (2024). Editorial on incidence and outcomes of transient new onset atrial fibrillation complicating acute coronary syndromes: results from a systematic review and meta-analysis.. European heart journal. Cardiovascular pharmacotherapy, pvae067. doi:10.1093/ehjcvp/pvae067
Initial blood pressure and adverse cardiac events following acute ischaemic stroke: An individual patient data pooled analysis from the VISTA database.
Ishiguchi, H., Huang, B., El-Bouri, W. K., Dawson, J., Lip, G. Y. H., Abdul-Rahim, A. H., & VISTA Collaborators*. (2024). Initial blood pressure and adverse cardiac events following acute ischaemic stroke: An individual patient data pooled analysis from the VISTA database.. European stroke journal, 23969873241296391. doi:10.1177/23969873241296391
Novel Approaches to Atrial Fibrillation Screening: Debating the Clinical and Practical Implications.
Liu, H., Chen, Y., & Lip, G. Y. H. (2024). Novel Approaches to Atrial Fibrillation Screening: Debating the Clinical and Practical Implications.. European journal of preventive cardiology, zwae357. doi:10.1093/eurjpc/zwae357
Prognostic Impact and Prevalence of Cachexia in Patients With Heart Failure: A Systematic Review and Meta-Analysis.
Prokopidis, K., Irlik, K., Hendel, M., Piaśnik, J., Lip, G. Y. H., & Nabrdalik, K. (2024). Prognostic Impact and Prevalence of Cachexia in Patients With Heart Failure: A Systematic Review and Meta-Analysis.. Journal of cachexia, sarcopenia and muscle. doi:10.1002/jcsm.13596
Efficacy of the ABC Pathway for Integrated Care Across Phenotypes of Patients with Atrial Fibrillation: A Latent-Class Analysis Report from the mAFA-II Clinical Trial.
Corica, B., Romiti, G. F., Mei, D. A., Proietti, M., Zhang, H., Guo, Y., . . . mAF-App II trial investigators. (2024). Efficacy of the ABC Pathway for Integrated Care Across Phenotypes of Patients with Atrial Fibrillation: A Latent-Class Analysis Report from the mAFA-II Clinical Trial.. Journal of general internal medicine. doi:10.1007/s11606-024-09037-6
Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial.
Werring, D. J., Dehbi, H. -M., Ahmed, N., Arram, L., Best, J. G., Balogun, M., . . . OPTIMAS investigators. (2024). Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial.. Lancet (London, England), S0140-6736(24)02197-4. doi:10.1016/s0140-6736(24)02197-4
Impact of Educational Intervention on Anticoagulation Control Using SAMe-TT22R2 Score-Guided Strategy in Atrial Fibrillation
Phrommintikul, A., Nathisuwan, S., Wongcharoen, W., Krittayaphong, R., Gunaparn, S., Wongthanee, A., . . . Tipboonchu, W. (2024). Impact of Educational Intervention on Anticoagulation Control Using SAMe-TT22R2 Score-Guided Strategy in Atrial Fibrillation. JACC: Asia. doi:10.1016/j.jacasi.2024.08.011
Genetic Correlations and Causal Insights: Pathways to Precision Medicine in Patients with Obstructive Sleep Apnea and Cardiovascular Disease.
Chen, Y., Liu, H. Y., & Lip, G. Y. H. (2024). Genetic Correlations and Causal Insights: Pathways to Precision Medicine in Patients with Obstructive Sleep Apnea and Cardiovascular Disease.. European journal of preventive cardiology, zwae343. doi:10.1093/eurjpc/zwae343
Navigating the Efficacy and Safety of Oral Anticoagulation Use for Stroke Prevention in Very Elderly Patients With Atrial Fibrillation.
Shin, S. Y., Song, W. H., & Lip, G. Y. H. (2024). Navigating the Efficacy and Safety of Oral Anticoagulation Use for Stroke Prevention in Very Elderly Patients With Atrial Fibrillation.. Korean circulation journal. doi:10.4070/kcj.2024.0309
Variation in secondary prevention of coronary heart disease: the INTERASPIRE study.
McEvoy, J. W., Jennings, C., Kotseva, K., De Bacquer, D., De Backer, G., Erlund, I., . . . Wood, D. (2024). Variation in secondary prevention of coronary heart disease: the INTERASPIRE study.. European heart journal, 45(39), 4184-4196. doi:10.1093/eurheartj/ehae558
Reflections on World Thrombosis Day 2024.
Rigby, A., Albisetti, M., Favaloro, E. J., Koenen, R. R., Langer, F., Lip, G. Y. H., . . . Weber, C. (2024). Reflections on World Thrombosis Day 2024.. Thrombosis and haemostasis. doi:10.1055/s-0044-1791650
Stroke-heart syndrome and early mortality in patients with acute ischaemic stroke using hierarchical cluster analysis: An individual patient data pooled analysis from the VISTA database.
Ishiguchi, H., Huang, B., El-Bouri, W. K., Lip, G. Y. H., Abdul-Rahim, A. H., & VISTA Collaborators*. (2024). Stroke-heart syndrome and early mortality in patients with acute ischaemic stroke using hierarchical cluster analysis: An individual patient data pooled analysis from the VISTA database.. European stroke journal, 23969873241290440. doi:10.1177/23969873241290440
Clinical and subclinical acute brain injury caused by invasive cardiovascular procedures.
Lenarczyk, R., Proietti, M., Scheitz, J. F., Shah, D., Siebert, E., Gorog, D. A., . . . Lip, G. Y. H. (2024). Clinical and subclinical acute brain injury caused by invasive cardiovascular procedures.. Nature reviews. Cardiology. doi:10.1038/s41569-024-01076-0
Predicting future atrial fibrillation: risk factors, proteomics and beyond.
Mills, M. T., McDowell, G., & Lip, G. Y. H. (2024). Predicting future atrial fibrillation: risk factors, proteomics and beyond.. Heart (British Cardiac Society), 110(21), 1245-1246. doi:10.1136/heartjnl-2024-324954
Metabolomics: Implication in cardiovascular research and diseases.
Ajoolabady, A., Pratico, D., Dunn, W. B., Lip, G. Y. H., & Ren, J. (2024). Metabolomics: Implication in cardiovascular research and diseases.. Obesity reviews : an official journal of the International Association for the Study of Obesity, 25(12), e13825. doi:10.1111/obr.13825
Intima media thickness of the carotid artery in primary antiphospholipid syndrome: A systematic review and meta-analysis.
Bucci, T., Merashli, M., Pignatelli, P., Pastori, D., Delgado-Alves, J., Lip, G. Y. H., & Ames, P. R. J. (2024). Intima media thickness of the carotid artery in primary antiphospholipid syndrome: A systematic review and meta-analysis.. Autoimmunity reviews, 23(11), 103657. doi:10.1016/j.autrev.2024.103657
A Novel Model of Integrated Care of Older Patients With Atrial Fibrillation in Rural China.
Li, M., Chu, M., Shen, Y., Zhang, S., Yin, X., Yang, S., . . . MIRACLE-AF Trial Investigators. (2024). A Novel Model of Integrated Care of Older Patients With Atrial Fibrillation in Rural China.. JACC. Asia, 4(10), 764-773. doi:10.1016/j.jacasi.2024.07.006
Concurrent percutaneous left atrial appendage occlusion and catheter ablation for atrial fibrillation: State-of-the-art review.
Mills, M. T., Calvert, P., Velavan, P., Lip, G. Y. H., & Gupta, D. (2024). Concurrent percutaneous left atrial appendage occlusion and catheter ablation for atrial fibrillation: State-of-the-art review.. Trends in cardiovascular medicine, 34(7), 423-433. doi:10.1016/j.tcm.2023.11.003
Dynamic assessment of CHA<sub>2</sub>DS<sub>2</sub>-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patients.
Serna, M. J., Rivera-Caravaca, J. M., López-Gálvez, R., Soler-Espejo, E., Lip, G. Y. H., Marín, F., & Roldán, V. (2024). Dynamic assessment of CHA<sub>2</sub>DS<sub>2</sub>-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patients.. Revista espanola de cardiologia (English ed.), 77(10), 835-842. doi:10.1016/j.rec.2024.02.011
Global voices on atrial fibrillation care in China.
Li, M., Chen, M., Guo, Y., & Lip, G. Y. H. (2024). Global voices on atrial fibrillation care in China.. Heart rhythm O2, 5(10), 693-697. doi:10.1016/j.hroo.2024.08.004
Is it high time to leave the chronic disease care of rural older people to village doctors in China: Insights from a population-based atrial fibrillation screening study.
Li, M., Chu, M., Zhang, S., Shen, Y., Sun, X., Gong, J., . . . Chen, M. (2024). Is it high time to leave the chronic disease care of rural older people to village doctors in China: Insights from a population-based atrial fibrillation screening study.. Current problems in cardiology, 49(10), 102759. doi:10.1016/j.cpcardiol.2024.102759
Left Atrial Appendage Occlusion in Patients Without Atrial Fibrillation Undergoing Cardiac Surgery: The Evidence Is Mounting.
Mills, M. T., Kirmani, B. H., & Lip, G. Y. H. (2024). Left Atrial Appendage Occlusion in Patients Without Atrial Fibrillation Undergoing Cardiac Surgery: The Evidence Is Mounting.. Circulation. Cardiovascular interventions, 17(10), e014633. doi:10.1161/circinterventions.124.014633
Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry.
Mei, D. A., Imberti, J. F., Bonini, N., Romiti, G. F., Corica, B., Proietti, M., . . . Boriani, G. (2024). Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry.. European journal of internal medicine, 128, 63-70. doi:10.1016/j.ejim.2024.06.022
Real-world evidence of early rhythm control in patients with atrial fibrillation: A systematic review and meta-analysis.
Gu, Z., Guo, L., Liu, C., Lip, G. Y. H., & Zhu, W. (2024). Real-world evidence of early rhythm control in patients with atrial fibrillation: A systematic review and meta-analysis.. International journal of cardiology, 412, 132327. doi:10.1016/j.ijcard.2024.132327
Residual Stroke Risk in Patients With Atrial Fibrillation following Transcatheter Aortic Valve Implantation: What Else Can We Do to Mitigate Risk?
Li, M., Fauchier, L., & Lip, G. Y. H. (2024). Residual Stroke Risk in Patients With Atrial Fibrillation following Transcatheter Aortic Valve Implantation: What Else Can We Do to Mitigate Risk?. The American journal of cardiology, 228, 85-87. doi:10.1016/j.amjcard.2024.07.030
Reviewer Experience Detecting and Judging Human Versus Artificial Intelligence Content: The <i>Stroke</i> Journal Essay Contest.
Silva, G. S., Khera, R., & Schwamm, L. H. (2024). Reviewer Experience Detecting and Judging Human Versus Artificial Intelligence Content: The <i>Stroke</i> Journal Essay Contest.. Stroke, 55(10), 2573-2578. doi:10.1161/strokeaha.124.045012
Sex Differences in Frequency, Severity, and Distribution of Cerebral Microbleeds.
Fandler-Höfler, S., Eppinger, S., Ambler, G., Nash, P., Kneihsl, M., Lee, K. -J., . . . Microbleeds International Collaborative Network. (2024). Sex Differences in Frequency, Severity, and Distribution of Cerebral Microbleeds.. JAMA network open, 7(10), e2439571. doi:10.1001/jamanetworkopen.2024.39571
Stroke outcomes following cardiac and aortic surgery are improved by the involvement of a stroke team.
Harky, A., Chow, V. J., Voller, C., Goyal, K., Shaw, M., Bhawnani, A., . . . Kuduvalli, M. (2024). Stroke outcomes following cardiac and aortic surgery are improved by the involvement of a stroke team.. European journal of clinical investigation, 54(10), e14275. doi:10.1111/eci.14275
The global burden of atrial fibrillation: Voices from Asia and Brazil
Lip, G. Y. H., Srivatsa, U. N., & Poole, J. E. (2024). The global burden of atrial fibrillation: Voices from Asia and Brazil. Heart Rhythm O2, 5(10), 677-678. doi:10.1016/j.hroo.2024.08.007
Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: a systematic review and meta-analysis with meta-regression of observational studies.
Nabrdalik, K., Hendel, M., Irlik, K., Kwiendacz, H., Łoniewski, I., Bucci, T., . . . Skonieczna-Żydecka, K. (2024). Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: a systematic review and meta-analysis with meta-regression of observational studies.. BMC endocrine disorders, 24(1), 206. doi:10.1186/s12902-024-01727-w
CHA2DS2-VASc or a non-sex score (CHA2DS2-VA) for stroke risk prediction in atrial fibrillation: contemporary insights and clinical implications.
Lip, G. Y. H., Teppo, K., & Nielsen, P. B. (2024). CHA2DS2-VASc or a non-sex score (CHA2DS2-VA) for stroke risk prediction in atrial fibrillation: contemporary insights and clinical implications.. European heart journal, 45(36), 3718-3720. doi:10.1093/eurheartj/ehae540
Response to Xu et al: Time-to-event analysis, data variability, and consideration of model selection: Considerations in relation to stroke-heart syndrome.
Buckley, B. J., & Lip, G. Y. (2024). Response to Xu et al: Time-to-event analysis, data variability, and consideration of model selection: Considerations in relation to stroke-heart syndrome.. European stroke journal, 23969873241287131. doi:10.1177/23969873241287131
Atrial fibrillation after cardiac surgery: identifying candidate predictors through a Delphi process.
Bedford, J., Fields, K. G., Collins, G. S., Lip, G. Y. H., Clifton, D. A., O'Brien, B., . . . Redfern, O. C. (2024). Atrial fibrillation after cardiac surgery: identifying candidate predictors through a Delphi process.. BMJ open, 14(9), e086589. doi:10.1136/bmjopen-2024-086589
Residual Risks of Thrombotic Complications in Anticoagulated Patients with Atrial Fibrillation: A Cluster Analysis Approach from the GLORIA-AF Registry.
Ishiguchi, H., Abdul-Rahim, A. H., Huang, B., Lam, S. H. M., Liu, Y., Olshansky, B., . . . GLORIA-AF Investigators. (2024). Residual Risks of Thrombotic Complications in Anticoagulated Patients with Atrial Fibrillation: A Cluster Analysis Approach from the GLORIA-AF Registry.. Journal of general internal medicine. doi:10.1007/s11606-024-09045-6
How far are we from accurate sex-specific risk prediction of cardiovascular disease? One size may not fit all.
Huang, B., Dalakoti, M., & Lip, G. Y. H. (2024). How far are we from accurate sex-specific risk prediction of cardiovascular disease? One size may not fit all.. Cardiovascular research, 120(11), 1237-1238. doi:10.1093/cvr/cvae135
Exercise-based cardiac rehabilitation for adults with atrial fibrillation.
Buckley, B. J. R., Long, L., Risom, S. S., Lane, D. A., Berg, S. K., Gluud, C., . . . Taylor, R. S. (2024). Exercise-based cardiac rehabilitation for adults with atrial fibrillation.. The Cochrane database of systematic reviews, 9, CD011197. doi:10.1002/14651858.cd011197.pub3
SGLT2 Inhibitors vs GLP-1 Receptor Agonists and Clinical Outcomes in Patients With Diabetes With/Without Atrial Fibrillation.
Chan, Y. -H., Chao, T. -F., Chen, S. -W., Lee, H. -F., Li, P. -R., Yeh, Y. -H., . . . Lip, G. Y. H. (2024). SGLT2 Inhibitors vs GLP-1 Receptor Agonists and Clinical Outcomes in Patients With Diabetes With/Without Atrial Fibrillation.. The Journal of clinical endocrinology and metabolism, 109(10), 2617-2629. doi:10.1210/clinem/dgae157
Corrigendum to "Prevalence of mental health conditions and brain fog in people with long COVID: A systematic review and meta-analysis" [General Hospital Psychiatry volume 88 (2024)10-22 10.1016/j.genhosppsych.2024.02.009].
van der Feltz-Cornelis, C. M., Turk, F., Sweetman, J., Khunti, K., Gabbay, M., Shepherd, J., . . . Banerjee, A. (2024). Corrigendum to "Prevalence of mental health conditions and brain fog in people with long COVID: A systematic review and meta-analysis" [General Hospital Psychiatry volume 88 (2024)10-22 10.1016/j.genhosppsych.2024.02.009].. General hospital psychiatry, S0163-8343(24)00195-6. doi:10.1016/j.genhosppsych.2024.09.006
Remnant cholesterol and risk of premature mortality: an analysis from a nationwide prospective cohort study.
Li, L., Lai, J., Zhang, J., Van Spall, H. G. C., Thabane, L., Lip, G. Y. H., & Li, G. (2024). Remnant cholesterol and risk of premature mortality: an analysis from a nationwide prospective cohort study.. European heart journal. Quality of care & clinical outcomes, 10(6), 543-551. doi:10.1093/ehjqcco/qcad071
Early statin use is associated with improved survival and cardiovascular outcomes in patients with atrial fibrillation and recent ischaemic stroke: A propensity-matched analysis of a global federated health database.
Choi, S. E., Bucci, T., Huang, J. -Y., Yiu, K. -H., Tsang, C. T., Lau, K. K., . . . Abdul-Rahim, A. H. (2024). Early statin use is associated with improved survival and cardiovascular outcomes in patients with atrial fibrillation and recent ischaemic stroke: A propensity-matched analysis of a global federated health database.. European stroke journal, 23969873241274213. doi:10.1177/23969873241274213
Free fatty acids and mortality among adults in the United States: a report from US National Health and Nutrition Examination Survey (NHANES).
Li, M., Zhang, L., Huang, B., Liu, Y., Chen, Y., & Lip, G. Y. H. (2024). Free fatty acids and mortality among adults in the United States: a report from US National Health and Nutrition Examination Survey (NHANES).. Nutrition & metabolism, 21(1), 72. doi:10.1186/s12986-024-00844-6
Leveraging machine learning for enhanced mortality risk prediction in atrial fibrillation: A step towards precision medicine?
Chen, Y., Zheng, Y., & Lip, G. Y. H. (2024). Leveraging machine learning for enhanced mortality risk prediction in atrial fibrillation: A step towards precision medicine?. Kardiologia polska. doi:10.33963/v.phj.102455
Anticoagulation in Patients With Device-Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH-AFNET 6 Trial.
Diener, H. C., Becher, N., Sehner, S., Toennis, T., Bertaglia, E., Blomstrom-Lundqvist, C., . . . NOAH‐AFNET 6 investigators. (2024). Anticoagulation in Patients With Device-Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH-AFNET 6 Trial.. Journal of the American Heart Association, 13(17), e036429. doi:10.1161/jaha.124.036429
Metabolically "extremely unhealthy" obese and non-obese people with diabetes and the risk of cardiovascular adverse events: the Silesia Diabetes - Heart Project.
Janota, O., Mantovani, M., Kwiendacz, H., Irlik, K., Bucci, T., Lam, S. H. M., . . . Nabrdalik, K. (2024). Metabolically "extremely unhealthy" obese and non-obese people with diabetes and the risk of cardiovascular adverse events: the Silesia Diabetes - Heart Project.. Cardiovascular diabetology, 23(1), 326. doi:10.1186/s12933-024-02420-x
Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials.
Schnabel, R. B., Benezet-Mazuecos, J., Becher, N., McIntyre, W. F., Fierenz, A., Lee, S. F., . . . Kirchhof, P. (2024). Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials.. European heart journal, ehae596. doi:10.1093/eurheartj/ehae596
Association between cumulative uric acid exposure and the risk of incident cardiac conduction block.
Li, N., Cui, L., Korantzopoulos, P., Zhang, N., Shu, R., Song, H., . . . Liu, T. (2024). Association between cumulative uric acid exposure and the risk of incident cardiac conduction block.. Cardiovascular research, 120(10), 1104-1106. doi:10.1093/cvr/cvae115
AI-based derivation of atrial fibrillation phenotypes in the general and critical care populations.
Bellfield, R. A. A., Olier, I., Lotto, R., Jones, I., Dawson, E. A., Li, G., . . . Ortega-Martorell, S. (2024). AI-based derivation of atrial fibrillation phenotypes in the general and critical care populations.. EBioMedicine, 107, 105280. doi:10.1016/j.ebiom.2024.105280
Aspirin and Ticagrelor Versus Aspirin and Clopidogrel or Prasugrel and the Effect on Staphylococcal-associated Infections: A Real-world Study.
Essa, H., Ding, W. Y., Rana, F., Zhao, S. S., Anson, M., Austin, P., . . . Alam, U. (2024). Aspirin and Ticagrelor Versus Aspirin and Clopidogrel or Prasugrel and the Effect on Staphylococcal-associated Infections: A Real-world Study.. Clinical therapeutics, 46(9), 689-695. doi:10.1016/j.clinthera.2024.07.001
Asundexian versus Apixaban in Patients with Atrial Fibrillation.
Piccini, J. P., Patel, M. R., Steffel, J., Ferdinand, K., Van Gelder, I. C., Russo, A. M., . . . OCEANIC-AF Steering Committee and Investigators. (2024). Asundexian versus Apixaban in Patients with Atrial Fibrillation.. The New England journal of medicine. doi:10.1056/nejmoa2407105
Atrial Fibrillation and Stable Coronary Artery Disease.
Lip, G. Y. H. (2024). Atrial Fibrillation and Stable Coronary Artery Disease.. The New England journal of medicine. doi:10.1056/nejme2409696
Incidence of new onset type 2 diabetes in adults living with obesity treated with tirzepatide or semaglutide: real world evidence from an international retrospective cohort study.
Anson, M., Henney, A. E., Broadwell, N., Zhao, S. S., Ibarburu, G. H., Lip, G. Y. H., . . . Alam, U. (2024). Incidence of new onset type 2 diabetes in adults living with obesity treated with tirzepatide or semaglutide: real world evidence from an international retrospective cohort study.. EClinicalMedicine, 75, 102777. doi:10.1016/j.eclinm.2024.102777
Low-dose azithromycin prophylaxis in patients with atrial fibrillation and chronic obstructive pulmonary disease.
Bucci, T., Wat, D., Sibley, S., Wootton, D., Green, D., Pignatelli, P., . . . Frost, F. (2024). Low-dose azithromycin prophylaxis in patients with atrial fibrillation and chronic obstructive pulmonary disease.. Internal and emergency medicine. doi:10.1007/s11739-024-03653-0
Serum bile acid profiles are associated with heart failure with preserved ejection fraction in patients with metabolic dysfunction-associated fatty liver disease: An exploratory study.
Zhou, X. -D., Xu, C. -F., Chen, Q. -F., Shapiro, M. D., Lip, G. Y. H., Chen, L. -L., . . . Zheng, M. -H. (2024). Serum bile acid profiles are associated with heart failure with preserved ejection fraction in patients with metabolic dysfunction-associated fatty liver disease: An exploratory study.. Diabetes, obesity & metabolism, 26(9), 3684-3695. doi:10.1111/dom.15709
Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS).
Goette, A., Corradi, D., Dobrev, D., Aguinaga, L., Cabrera, J. -A., Chugh, S. S., . . . Teixeira, R. A. (2024). Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS).. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 26(9), euae204. doi:10.1093/europace/euae204
Clinical phenotypes and outcomes of patients with left ventricular thrombus: an unsupervised cluster analysis.
Leow, A. S. T., Goh, F. Q., Tan, B. Y. Q., Ho, J. S. Y., Kong, W. K. F., Foo, R. S. Y., . . . Sia, C. -H. (2024). Clinical phenotypes and outcomes of patients with left ventricular thrombus: an unsupervised cluster analysis.. Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese, S1109-9666(24)00178-7. doi:10.1016/j.hjc.2024.08.010
Components of the Atrial fibrillation Better Care pathway for holistic care of patients with atrial fibrillation: a win ratio analysis from the COOL-AF registry.
Krittayaphong, R., Treewaree, S., & Lip, G. Y. H. (2024). Components of the Atrial fibrillation Better Care pathway for holistic care of patients with atrial fibrillation: a win ratio analysis from the COOL-AF registry.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 26(9), euae237. doi:10.1093/europace/euae237
Validation of the NULL-EASE Score for Predicting Survival in a Multiethnic Asian Cohort of Out-of-Hospital Cardiac Arrest.
Lim, S. L., Chan, S. P., Shahidah, N., Woo, K. L., Lam, S. S. W., Leong, B. S. -H., . . . Singapore PAROS Investigators *. (2024). Validation of the NULL-EASE Score for Predicting Survival in a Multiethnic Asian Cohort of Out-of-Hospital Cardiac Arrest.. Journal of the American Heart Association, 13(16), e034133. doi:10.1161/jaha.123.034133
Prediabetes is associated with increased cardiac events in patients with cancer who are prescribed anthracyclines.
Cheang, I., Zhu, X., Huang, J. -Y., Tse, Y. -K., Li, H. -L., Ren, Q. -W., . . . Yiu, K. -H. (2024). Prediabetes is associated with increased cardiac events in patients with cancer who are prescribed anthracyclines.. Cancer, 130(16), 2795-2806. doi:10.1002/cncr.35322
Telehealth-aided outpatient management of acute heart failure in a specialist virtual ward compared with standard care.
Sankaranarayanan, R., Rasoul, D., Murphy, N., Kelly, A., Nyjo, S., Jackson, C., . . . Lip, G. Y. H. (2024). Telehealth-aided outpatient management of acute heart failure in a specialist virtual ward compared with standard care.. ESC heart failure. doi:10.1002/ehf2.15003
The impact of gestational diabetes and gestational hypertension on future cardiovascular events: A nationwide cross-sectional cohort study
Sharp, A., Bullough, S., & Lip, G. Y. H. (2024). The impact of gestational diabetes and gestational hypertension on future cardiovascular events: A nationwide cross-sectional cohort study. European Journal of Obstetrics & Gynecology and Reproductive Biology. doi:10.1016/j.ejogrb.2024.08.021
Cardio-reno-vascular protection in type 2 diabetes mellitus: new insights into pharmacotherapeutic management.
Janota, O., Kwiendacz, H., Olejarz, A., Włosowicz, A., Pabis, P., Gumprecht, J., . . . Nabrdalik, K. (2024). Cardio-reno-vascular protection in type 2 diabetes mellitus: new insights into pharmacotherapeutic management.. Expert opinion on pharmacotherapy, 25(12), 1605-1624. doi:10.1080/14656566.2024.2392017
Artificial intelligence-based classification of cardiac autonomic neuropathy from retinal fundus images in patients with diabetes: The Silesia Diabetes Heart Study.
Nabrdalik, K., Irlik, K., Meng, Y., Kwiendacz, H., Piaśnik, J., Hendel, M., . . . Alam, U. (2024). Artificial intelligence-based classification of cardiac autonomic neuropathy from retinal fundus images in patients with diabetes: The Silesia Diabetes Heart Study.. Cardiovascular diabetology, 23(1), 296. doi:10.1186/s12933-024-02367-z
Renal Outcomes of Rhythm Control in Patients Recently Diagnosed With Atrial Fibrillation.
Kim, D., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -H., Uhm, J. -S., . . . Joung, B. (2024). Renal Outcomes of Rhythm Control in Patients Recently Diagnosed With Atrial Fibrillation.. JACC. Clinical electrophysiology, S2405-500X(24)00664-9. doi:10.1016/j.jacep.2024.07.007
Risk of adverse cardiovascular events based on common genetic variants in 8-year follow-up of the LIPIDOGEN2015 population using the polygenic risk score (PRS) - study design and methodology.
Banach, M., Fronczek, M., Osadnik, T., Gach, A., Strapagiel, D., Słomka, M., . . . Jóźwiak, J. (n.d.). Risk of adverse cardiovascular events based on common genetic variants in 8-year follow-up of the LIPIDOGEN2015 population using the polygenic risk score (PRS) - study design and methodology.. Archives of Medical Science. doi:10.5114/aoms/192147
The burden of atrial fibrillation related to metabolic risks: different countries and territories, yet the same challenges.
Huang, B., Li, M., & Lip, G. Y. H. (2024). The burden of atrial fibrillation related to metabolic risks: different countries and territories, yet the same challenges.. European heart journal. Quality of care & clinical outcomes, 10(5), 379-380. doi:10.1093/ehjqcco/qcae037
Risk of stroke in male and female patients with atrial fibrillation in a nationwide cohort.
Nielsen, P. B., Brøndum, R. F., Nøhr, A. K., Overvad, T. F., & Lip, G. Y. H. (2024). Risk of stroke in male and female patients with atrial fibrillation in a nationwide cohort.. Nature communications, 15(1), 6728. doi:10.1038/s41467-024-51193-0
Accumulated β-catenin is associated with human atrial fibrosis and atrial fibrillation.
Bai, Y., Li, R., Hao, J. -F., Chen, L. -W., Liu, S. -T., Zhang, X. -L., . . . Wang, H. (2024). Accumulated β-catenin is associated with human atrial fibrosis and atrial fibrillation.. Journal of translational medicine, 22(1), 734. doi:10.1186/s12967-024-05558-0
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease.
Zhang, H., Targher, G., Byrne, C. D., Kim, S. U., Wong, V. W. -S., Valenti, L., . . . MAFLD ICD-11 coding collaborators. (2024). A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease.. Hepatology international, 18(4), 1178-1201. doi:10.1007/s12072-024-10702-5
Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper.
Harenberg, J., Gosselin, R. C., Cuker, A., Becattini, C., Pabinger, I., Poli, S., . . . Weiss, C. (2024). Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper.. Thrombosis and haemostasis, 124(8), 770-777. doi:10.1055/a-2261-1811
An international study to investigate and optimise the safety of discontinuing valproate in young men and women with epilepsy: Protocol.
Mbizvo, G. K., Martin, G. P., Sperrin, M., Bonnett, L. J., Schofield, P., Buchan, I., . . . Marson, A. G. (2024). An international study to investigate and optimise the safety of discontinuing valproate in young men and women with epilepsy: Protocol.. PloS one, 19(8), e0306226. doi:10.1371/journal.pone.0306226
Antiplatelet Agents and Oral Anticoagulant Use in Patients with Atrial Fibrillation and Carotid Artery Disease After First-Time Ischaemic Stroke
Harrison, S., Buckley, B., Lane, D., Fazio-Eynullayeva, E., Underhill, P., Hill, A., . . . Lip, G. (n.d.). Antiplatelet Agents and Oral Anticoagulant Use in Patients with Atrial Fibrillation and Carotid Artery Disease After First-Time Ischaemic Stroke. Cardiovascular Drugs and Therapy. doi:10.1007/s10557-023-07433-4
Combination therapy of beta-blockers and digoxin is associated with increased risk of major adverse cardiovascular events and all-cause mortality in patients with atrial fibrillation: a report from the GLORIA-AF registry.
Lam, S. H. M., Romiti, G. F., Olshansky, B., Chao, T. -F., Huisman, M. V., & Lip, G. Y. H. (2024). Combination therapy of beta-blockers and digoxin is associated with increased risk of major adverse cardiovascular events and all-cause mortality in patients with atrial fibrillation: a report from the GLORIA-AF registry.. Internal and emergency medicine. doi:10.1007/s11739-024-03629-0
Comparing CHA<sub>2</sub>DS<sub>2</sub>-VA and CHA<sub>2</sub>DS<sub>2</sub>-VASc scores for stroke risk stratification in patients with atrial fibrillation: a temporal trends analysis from the retrospective Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) cohort.
Teppo, K., Lip, G. Y. H., Airaksinen, K. E. J., Halminen, O., Haukka, J., Putaala, J., . . . Lehto, M. (2024). Comparing CHA<sub>2</sub>DS<sub>2</sub>-VA and CHA<sub>2</sub>DS<sub>2</sub>-VASc scores for stroke risk stratification in patients with atrial fibrillation: a temporal trends analysis from the retrospective Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) cohort.. The Lancet regional health. Europe, 43, 100967. doi:10.1016/j.lanepe.2024.100967
Effectiveness and safety in non-valvular atrial fibrillation patients switching from warfarin to direct oral anticoagulants in US healthcare claims.
Lip, G. Y. H., Noxon, V., Kang, A., Luo, X., Atreja, N., Han, S., . . . Deitelzweig, S. (2024). Effectiveness and safety in non-valvular atrial fibrillation patients switching from warfarin to direct oral anticoagulants in US healthcare claims.. Journal of thrombosis and thrombolysis, 57(6), 1092-1102. doi:10.1007/s11239-024-02976-1
Journal requirement for data sharing statements in clinical trials: a cross-sectional study.
Zhang, J., Liu, Y., Thabane, L., Li, J., Bai, X., Li, L., . . . Li, G. (2024). Journal requirement for data sharing statements in clinical trials: a cross-sectional study.. Journal of clinical epidemiology, 172, 111405. doi:10.1016/j.jclinepi.2024.111405
Novel stroke prevention strategies following catheter ablation for atrial fibrillation.
Ding, W. Y., Calvert, P., Lip, G. Y. H., & Gupta, D. (2024). Novel stroke prevention strategies following catheter ablation for atrial fibrillation.. Revista espanola de cardiologia (English ed.), 77(8), 690-696. doi:10.1016/j.rec.2024.02.008
One-year outcomes of rate versus rhythm control of atrial fibrillation in the Kerala-AF Registry.
Calvert, P., Chen, Y., Gue, Y., Gupta, D., Azariah, J. L., George Koshy, A., . . . Kerala AF Registry Investigators. (2024). One-year outcomes of rate versus rhythm control of atrial fibrillation in the Kerala-AF Registry.. Journal of arrhythmia, 40(4), 822-829. doi:10.1002/joa3.13059
Outcomes of vascular closure devices for femoral venous hemostasis following catheter ablation of atrial fibrillation.
Mills, M. T., Calvert, P., Lip, G. Y. H., Luther, V., & Gupta, D. (2024). Outcomes of vascular closure devices for femoral venous hemostasis following catheter ablation of atrial fibrillation.. Journal of cardiovascular electrophysiology, 35(8), 1656-1662. doi:10.1111/jce.16345
QRS detection in single-lead, telehealth electrocardiogram signals: Benchmarking open-source algorithms.
Kristof, F., Kapsecker, M., Nissen, L., Brimicombe, J., Cowie, M. R., Ding, Z., . . . SAFER Investigators. (2024). QRS detection in single-lead, telehealth electrocardiogram signals: Benchmarking open-source algorithms.. PLOS digital health, 3(8), e0000538. doi:10.1371/journal.pdig.0000538
Short and mid-term impact of ozone on myocardial infarction incidence in Poland.
Kuźma, Ł., Dąbrowski, E. J., Kurasz, A., Święczkowski, M., Jemielita, P., Dobrzycki, S., & Lip, G. Y. H. (2024). Short and mid-term impact of ozone on myocardial infarction incidence in Poland.. The Lancet regional health. Europe, 43, 100982. doi:10.1016/j.lanepe.2024.100982
The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regions.
Goh, R. S. J., Chong, B., Jayabaskaran, J., Jauhari, S. M., Chan, S. P., Kueh, M. T. W., . . . Chew, N. W. S. (2024). The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regions.. The Lancet regional health. Western Pacific, 49, 101138. doi:10.1016/j.lanwpc.2024.101138
Time to rethink post-resuscitation atrial fibrillation management?
Mills, M. T., Lim, S. L., & Lip, G. Y. H. (2024). Time to rethink post-resuscitation atrial fibrillation management?. Resuscitation, 201, 110287. doi:10.1016/j.resuscitation.2024.110287
Association between antithrombotic drug regimen changes and clinical outcomes after stroke in atrial fibrillation.
Liao, J. -N., Chan, Y. -H., Kuo, L., Tsai, C. -T., Liu, C. -M., Chen, T. -J., . . . Chao, T. -F. (2024). Association between antithrombotic drug regimen changes and clinical outcomes after stroke in atrial fibrillation.. Heart rhythm, S1547-5271(24)03094-7. doi:10.1016/j.hrthm.2024.07.115
Stroke-heart syndrome: Incidence and clinical outcomes of cardiac complications following intracerebral haemorrhage.
Hoad, K. L., Jones, H., Miller, G., Abdul-Rahim, A. H., Lip, G. Y., & Buckley, B. J. (2024). Stroke-heart syndrome: Incidence and clinical outcomes of cardiac complications following intracerebral haemorrhage.. European stroke journal, 23969873241264115. doi:10.1177/23969873241264115
Remote rhythm monitoring using a photoplethysmography smartphone application after cardioversion for atrial fibrillation.
Calvert, P., Mills, M. T., Howarth, K., Aykara, S., Lunt, L., Brewer, H., . . . Gupta, D. (2024). Remote rhythm monitoring using a photoplethysmography smartphone application after cardioversion for atrial fibrillation.. European heart journal. Digital health, 5(4), 461-468. doi:10.1093/ehjdh/ztae028
SGLT2 Inhibitors, but Not GLP-1 Receptor Agonists, Reduce Incidence of Gout in People Living With Type 2 Diabetes Across the Therapeutic Spectrum
Preston, F. G., Anson, M., Riley, D. R., Ibarburu, G. H., Henney, A., Lip, G. Y. H., . . . Zhao, S. S. (2024). SGLT2 Inhibitors, but Not GLP-1 Receptor Agonists, Reduce Incidence of Gout in People Living With Type 2 Diabetes Across the Therapeutic Spectrum. Clinical Therapeutics. doi:10.1016/j.clinthera.2024.06.021
Do non-dihydropyridine calcium channel blockers increase bleeding risk with direct oral anticoagulants?
Calvert, P., & Lip, G. Y. H. (2024). Do non-dihydropyridine calcium channel blockers increase bleeding risk with direct oral anticoagulants?. Heart rhythm, S1547-5271(24)03078-9. doi:10.1016/j.hrthm.2024.07.101
The Burden of Inpatient Hospitalizations with Cardiac and Cerebrovascular Diseases in Patients with Type 1 Diabetes: Insights from the National Inpatient Sample in the US.
Kwok, C. S., Qureshi, A. I., Phillips, A., Lip, G. Y. H., Hanif, W., & Borovac, J. A. (2024). The Burden of Inpatient Hospitalizations with Cardiac and Cerebrovascular Diseases in Patients with Type 1 Diabetes: Insights from the National Inpatient Sample in the US.. Diagnostics (Basel, Switzerland), 14(15), 1607. doi:10.3390/diagnostics14151607
Routine cardiac biomarkers for the prediction of incident major adverse cardiac events in patients with glomerulonephritis: a real-world analysis using a global federated database.
Davies, E. M., Buckley, B. J. R., Austin, P., Lip, G. Y. H., Oni, L., McDowell, G., & Rao, A. (2024). Routine cardiac biomarkers for the prediction of incident major adverse cardiac events in patients with glomerulonephritis: a real-world analysis using a global federated database.. BMC nephrology, 25(1), 233. doi:10.1186/s12882-024-03667-y
Outpatient treatment of decompensated heart failure: A systematic review and study level meta-analysis.
Bahar, J., Rahman, A., Wong, G. W. Y., Sankaranarayanan, R., Ahmed, F. Z., Taylor, R., . . . Wong, K. Y. K. (2024). Outpatient treatment of decompensated heart failure: A systematic review and study level meta-analysis.. ESC heart failure. doi:10.1002/ehf2.14841
Sex-specific comparative outcomes between oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis.
Chobanov, J. D., Wang, Z., Man, K. K. C., Dayib, E., Lip, G. Y. H., Hingorani, A. D., . . . Lau, W. C. Y. (2024). Sex-specific comparative outcomes between oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis.. Open heart, 11(2), e002792. doi:10.1136/openhrt-2024-002792
Cardiovascular and Renal Benefit of Sodium-Glucose Cotransporter Type 2 Inhibitors in Patients With Type 2 Diabetes.
Lam, S. H. M., Alam, U., & Lip, G. Y. H. (2024). Cardiovascular and Renal Benefit of Sodium-Glucose Cotransporter Type 2 Inhibitors in Patients With Type 2 Diabetes.. The American journal of cardiology, 223, 183-185. doi:10.1016/j.amjcard.2024.05.001
The Modified Risk of Paradoxical Embolism Score Is Associated with Patent Foramen Ovale in Patients with Ischemic Stroke: A Nationwide US Analysis.
Kwok, C. S., Alisiddiq, Z., Will, M., Schwarz, K., Khoo, C., Large, A., . . . Borovac, J. A. (2024). The Modified Risk of Paradoxical Embolism Score Is Associated with Patent Foramen Ovale in Patients with Ischemic Stroke: A Nationwide US Analysis.. Journal of cardiovascular development and disease, 11(7), 213. doi:10.3390/jcdd11070213
Atrial fibrillation accelerates functional decline in older adults: a 15-year follow-up population-based study.
Okoye, C., Qiu, C., Xia, X., Lip, G. Y. H., Bellelli, G., Welmer, A. -K., . . . Vetrano, D. L. (2024). Atrial fibrillation accelerates functional decline in older adults: a 15-year follow-up population-based study.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 26(7), euae173. doi:10.1093/europace/euae173
Atrial fibrillation accelerates functional decline in older adults: a 15-year follow-up population-based study.
Okoye, C., Qiu, C., Xia, X., Lip, G. Y. H., Bellelli, G., Welmer, A. -K., . . . Vetrano, D. L. (2024). Atrial fibrillation accelerates functional decline in older adults: a 15-year follow-up population-based study. . Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 26(7), euae173. doi:10.1093/europace/euae173
Reliability of single-lead electrocardiogram interpretation to detect atrial fibrillation: insights from the SAFER feasibility study.
Hibbitt, K., Brimicombe, J., Cowie, M. R., Dymond, A., Freedman, B., Griffin, S. J., . . . Charlton, P. H. (2024). Reliability of single-lead electrocardiogram interpretation to detect atrial fibrillation: insights from the SAFER feasibility study.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 26(7), euae181. doi:10.1093/europace/euae181
Reliability of single-lead electrocardiogram interpretation to detect atrial fibrillation: insights from the SAFER feasibility study.
Hibbitt, K., Brimicombe, J., Cowie, M. R., Dymond, A., Freedman, B., Griffin, S. J., . . . Charlton, P. H. (2024). Reliability of single-lead electrocardiogram interpretation to detect atrial fibrillation: insights from the SAFER feasibility study. . Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 26(7), euae181. doi:10.1093/europace/euae181
Early Rhythm Control and Incident Dementia in Patients With Atrial Fibrillation and Prior Stroke.
Lee, S. -R., Choi, E. -K., Lee, S. -W., Han, K. -D., Oh, S., & Lip, G. Y. H. (2024). Early Rhythm Control and Incident Dementia in Patients With Atrial Fibrillation and Prior Stroke.. JACC. Clinical electrophysiology, 10(7 Pt 1), 1409-1420. doi:10.1016/j.jacep.2024.03.007
Effect of combination pioglitazone with sodium-glucose cotransporter-2 inhibitors or glucagon-like peptide-1 receptor agonists on outcomes in type 2 diabetes: A systematic review, meta-analysis, and real-world study from an international federated database.
Anson, M., Henney, A. E., Zhao, S. S., Ibarburu, G. H., Lip, G. Y. H., Cuthbertson, D. J., . . . Alam, U. (2024). Effect of combination pioglitazone with sodium-glucose cotransporter-2 inhibitors or glucagon-like peptide-1 receptor agonists on outcomes in type 2 diabetes: A systematic review, meta-analysis, and real-world study from an international federated database.. Diabetes, obesity & metabolism, 26(7), 2606-2623. doi:10.1111/dom.15576
Calibration plots for multistate risk predictions models.
Pate, A., Sperrin, M., Riley, R. D., Peek, N., Van Staa, T., Sergeant, J. C., . . . Martin, G. P. (2024). Calibration plots for multistate risk predictions models.. Statistics in medicine, 43(14), 2830-2852. doi:10.1002/sim.10094
High initial heart rate score is an independent predictor of new atrial high-rate episodes in pacemaker patients with sinus node dysfunction.
Hayashi, K., Abe, H., Olshansky, B., Sharma, A. D., Jones, P. W., Wold, N., . . . Wilkoff, B. L. (2024). High initial heart rate score is an independent predictor of new atrial high-rate episodes in pacemaker patients with sinus node dysfunction.. Heart rhythm, S1547-5271(24)02820-0. doi:10.1016/j.hrthm.2024.06.046
Time to benefit and harm of direct oral anticoagulants in device-detected atrial fibrillation: A pooled analysis of the NOAH-AFNET 6 and ARTESiA trials.
Huang, C., Li, L., Liu, W., Fang, Y., Jiang, S., Li, Y., . . . Zhou, X. (2024). Time to benefit and harm of direct oral anticoagulants in device-detected atrial fibrillation: A pooled analysis of the NOAH-AFNET 6 and ARTESiA trials.. Heart rhythm, S1547-5271(24)02812-1. doi:10.1016/j.hrthm.2024.06.038
Estimating the impact of implementing an integrated care management approach with Atrial fibrillation Better Care (ABC) pathway for patients with atrial fibrillation in England from 2020 to 2040
Camacho, E. M., & Lip, G. Y. H. (2023). Estimating the impact of implementing an integrated care management approach with Atrial fibrillation Better Care (ABC) pathway for patients with atrial fibrillation in England from 2020 to 2040. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES. doi:10.1093/ehjqcco/qcad055
Systematic Review and Meta-Analysis of Prehospital Machine Learning Scores as Screening Tools for Early Detection of Large Vessel Occlusion in Patients With Suspected Stroke.
Alobaida, M., Joddrell, M., Zheng, Y., Lip, G. Y. H., Rowe, F. J., El-Bouri, W. K., . . . Harrison, S. L. (2024). Systematic Review and Meta-Analysis of Prehospital Machine Learning Scores as Screening Tools for Early Detection of Large Vessel Occlusion in Patients With Suspected Stroke.. Journal of the American Heart Association, e033298. doi:10.1161/jaha.123.033298
Five-year risk of all-cause death and cardiovascular events in women with gestational diabetes and hypertensive disorders of pregnancy.
Bucci, T., Meek, C. L., Awor, S., Lip, G. Y. H., & Merriel, A. (2024). Five-year risk of all-cause death and cardiovascular events in women with gestational diabetes and hypertensive disorders of pregnancy.. Current problems in cardiology, 102698. doi:10.1016/j.cpcardiol.2024.102698
Integrated care policy recommendations for complex multisystem long term conditions and long COVID.
van der Feltz-Cornelis, C. M., Sweetman, J., Turk, F., Allsopp, G., Gabbay, M., Khunti, K., . . . Banerjee, A. (2024). Integrated care policy recommendations for complex multisystem long term conditions and long COVID.. Scientific reports, 14(1), 13634. doi:10.1038/s41598-024-64060-1
Statin use is associated with a lower risk of all-cause death in patients with breast cancer treated with anthracycline containing regimens: a global federated health database analysis.
Bucci, T., Gue, Y., Dobson, R., Palmieri, C., Pignatelli, P., & Lip, G. Y. H. (2024). Statin use is associated with a lower risk of all-cause death in patients with breast cancer treated with anthracycline containing regimens: a global federated health database analysis.. Clinical and experimental medicine, 24(1), 124. doi:10.1007/s10238-024-01395-z
Natriuretic peptides and C-reactive protein in in heart failure and malnutrition: a systematic review and meta-analysis.
Prokopidis, K., Irlik, K., Ishiguchi, H., Rietsema, W., Lip, G. Y. H., Sankaranarayanan, R., . . . Nabrdalik, K. (2024). Natriuretic peptides and C-reactive protein in in heart failure and malnutrition: a systematic review and meta-analysis.. ESC heart failure. doi:10.1002/ehf2.14851
Phenotypes of Polish primary care patients using hierarchical clustering: Exploring the risk of mortality in the LIPIDOGEN2015 study cohort.
Chen, Y., Gue, Y., Banach, M., Mikhailidis, D., Toth, P. P., Gierlotka, M., . . . LIPIDOGRAM Investigators. (2024). Phenotypes of Polish primary care patients using hierarchical clustering: Exploring the risk of mortality in the LIPIDOGEN2015 study cohort.. European journal of clinical investigation, e14261. doi:10.1111/eci.14261
Cardiac resynchronization therapy (CRT) nonresponders in the contemporary era: A state-of-the-art review.
Gerra, L., Bonini, N., Mei, D. A., Imberti, J. F., Vitolo, M., Bucci, T., . . . Lip, G. Y. H. (2024). Cardiac resynchronization therapy (CRT) nonresponders in the contemporary era: A state-of-the-art review.. Heart rhythm, S1547-5271(24)02670-5. doi:10.1016/j.hrthm.2024.05.057
Social determinants of health and clinical outcomes among patients with atrial fibrillation: evidence from a global federated health research network.
Simoni, A. H., Bucci, T., Romiti, G. F., Frydenlund, J., Johnsen, S. P., Abdul-Rahim, A. H., & Lip, G. Y. H. (2024). Social determinants of health and clinical outcomes among patients with atrial fibrillation: evidence from a global federated health research network.. QJM : monthly journal of the Association of Physicians, 117(5), 353-359. doi:10.1093/qjmed/hcad275
Clinical Impact of Early Rhythm Control and Healthy Lifestyles in Patients With Atrial Fibrillation.
Lee, S. -R., Choi, E. -K., Lee, S. -W., Han, K. -D., Oh, S., & Lip, G. Y. H. (2024). Clinical Impact of Early Rhythm Control and Healthy Lifestyles in Patients With Atrial Fibrillation.. JACC. Clinical electrophysiology, 10(6), 1064-1074. doi:10.1016/j.jacep.2024.02.016
Clinical Outcomes in Metabolically Healthy and Unhealthy Obese and Overweight Patients With Atrial Fibrillation: Findings From the GLORIA-AF Registry.
Corica, B., Romiti, G. F., Proietti, M., Mei, D. A., Boriani, G., Chao, T. -F., . . . GLORIA-AF Investigators. (2024). Clinical Outcomes in Metabolically Healthy and Unhealthy Obese and Overweight Patients With Atrial Fibrillation: Findings From the GLORIA-AF Registry.. Mayo Clinic proceedings, 99(6), 927-939. doi:10.1016/j.mayocp.2023.07.013
Educational status and the risk of adverse outcomes in Asian patients with atrial fibrillation: a report from the prospective APHRS-AF Registry.
Bucci, T., Romiti, G. F., Corica, B., Shantsila, A., Teo, W. -S., Park, H. -W., . . . Asia-Pacific Heart Rhythm Society Atrial Fibrillation Registry Investigators. (2024). Educational status and the risk of adverse outcomes in Asian patients with atrial fibrillation: a report from the prospective APHRS-AF Registry.. Minerva medica, 115(3), 308-319. doi:10.23736/s0026-4806.24.09159-6
Effect of air pollution exposure on risk of acute coronary syndromes in Poland: a nationwide population-based study (EP-PARTICLES study).
Kuźma, Ł., Dąbrowski, E. J., Kurasz, A., Święczkowski, M., Jemielita, P., Kowalewski, M., . . . Lip, G. Y. H. (2024). Effect of air pollution exposure on risk of acute coronary syndromes in Poland: a nationwide population-based study (EP-PARTICLES study).. The Lancet regional health. Europe, 41, 100910. doi:10.1016/j.lanepe.2024.100910
For Debate: The 2023 European Society of Hypertension guidelines - cause for concern.
Shantsila, E., Beevers, D. G., & Lip, G. Y. H. (2024). For Debate: The 2023 European Society of Hypertension guidelines - cause for concern.. Journal of hypertension, 42(6), 948-950. doi:10.1097/hjh.0000000000003733
Impaired endogenous fibrinolysis status: a potential prognostic predictor in ischemic stroke.
Chen, Y., Gue, Y., McDowell, G., Gorog, D. A., & Lip, G. Y. H. (2024). Impaired endogenous fibrinolysis status: a potential prognostic predictor in ischemic stroke.. Minerva medica, 115(3), 364-379. doi:10.23736/s0026-4806.24.09133-x
Oral anticoagulants and cognitive impairment in patients with atrial fibrillation: A systematic review with meta-analysis and trial sequential analysis.
Lee, K. -H., Yeh, J. -T., Wu, M. -L., Yeh, W. -Y., Lip, G. Y. H., Chiang, C. -E., . . . Cheng, H. -M. (2024). Oral anticoagulants and cognitive impairment in patients with atrial fibrillation: A systematic review with meta-analysis and trial sequential analysis.. Thrombosis research, 238, 132-140. doi:10.1016/j.thromres.2024.04.032
Relationship between metabolic status, physical activity and cardiovascular disease in participants with obesity.
Liu, Y., Zhao, A., Sun, G., Wang, R., Zhang, J., Lip, G. Y. H., & Li, G. (2024). Relationship between metabolic status, physical activity and cardiovascular disease in participants with obesity.. International journal of obesity (2005), 48(6), 788-795. doi:10.1038/s41366-024-01469-8
Risk calculator for incident atrial fibrillation across a range of prediction horizons.
Wu, J., Nadarajah, R., Nakao, Y. M., Nakao, K., Arbel, R., Haim, M., . . . Gale, C. P. (2024). Risk calculator for incident atrial fibrillation across a range of prediction horizons.. American heart journal, 272, 1-10. doi:10.1016/j.ahj.2024.03.001
Risk of Cardiovascular Events after Acute Exacerbations of Chronic Obstructive Pulmonary Disease in Patients Receiving Long-Term Low-Dose Azithromycin.
Bucci, T., Wat, D., Nazareth, D., Sibley, S., Wootton, D., Lip, G. Y. H., & Frost, F. (2024). Risk of Cardiovascular Events after Acute Exacerbations of Chronic Obstructive Pulmonary Disease in Patients Receiving Long-Term Low-Dose Azithromycin.. American journal of respiratory and critical care medicine, 209(11), 1394-1396. doi:10.1164/rccm.202309-1699le
Risk of death, thrombotic and hemorrhagic events in anticoagulated patients with atrial fibrillation and systemic autoimmune diseases: an analysis from a global federated dataset.
Bucci, T., Cardamone, C., Triggiani, M., Ames, P. R. J., & Lip, G. Y. H. (2024). Risk of death, thrombotic and hemorrhagic events in anticoagulated patients with atrial fibrillation and systemic autoimmune diseases: an analysis from a global federated dataset.. Clinical research in cardiology : official journal of the German Cardiac Society, 113(6), 942-950. doi:10.1007/s00392-024-02426-1
The effect of hypertension on cerebrovascular carbon dioxide reactivity in atrial fibrillation patients.
Walsh, H. J., Junejo, R. T., Lip, G. Y. H., & Fisher, J. P. (2024). The effect of hypertension on cerebrovascular carbon dioxide reactivity in atrial fibrillation patients.. Hypertension research : official journal of the Japanese Society of Hypertension, 47(6), 1678-1687. doi:10.1038/s41440-024-01662-2
The impact of the site of myocardial infarction on in-hospital outcomes for patients with STEMI.
Kwok, C. S., Qureshi, A. I., & Lip, G. Y. H. (2024). The impact of the site of myocardial infarction on in-hospital outcomes for patients with STEMI.. Coronary artery disease, 35(4), 286-291. doi:10.1097/mca.0000000000001334
Ischaemic stroke in women with atrial fibrillation: temporal trends and clinical implications.
Teppo, K., Airaksinen, K. E. J., Jaakkola, J., Halminen, O., Salmela, B., Kouki, E., . . . Lehto, M. (2024). Ischaemic stroke in women with atrial fibrillation: temporal trends and clinical implications.. European heart journal, 45(20), 1819-1827. doi:10.1093/eurheartj/ehae198
Continuous infusion versus bolus injection of loop diuretics for acute heart failure.
Rasoul, D., Zhang, J., Farnell, E., Tsangarides, A. A., Chong, S. C., Fernando, R., . . . Sankaranarayanan, R. (2024). Continuous infusion versus bolus injection of loop diuretics for acute heart failure.. The Cochrane database of systematic reviews, 5, CD014811. doi:10.1002/14651858.cd014811.pub2
Early statin use is associated with improved survival and cardiovascular outcomes in patients with atrial fibrillation and recent ischaemic stroke
Association Between Remnant Cholesterol and Risk of Incident Atrial Fibrillation: Population-Based Evidence From a Large-Scale Prospective Cohort Study.
Li, L., Wang, C., Ye, Z., Van Spall, H. G. C., Zhang, J., Lip, G. Y. H., & Li, G. (2024). Association Between Remnant Cholesterol and Risk of Incident Atrial Fibrillation: Population-Based Evidence From a Large-Scale Prospective Cohort Study.. Journal of the American Heart Association, 13(10), e033840. doi:10.1161/jaha.123.033840
Embolic strokes of undetermined source: a clinical consensus statement of the ESC Council on Stroke, the European Association of Cardiovascular Imaging and the European Heart Rhythm Association of the ESC.
Ntaios, G., Baumgartner, H., Doehner, W., Donal, E., Edvardsen, T., Healey, J. S., . . . Lip, G. Y. H. (2024). Embolic strokes of undetermined source: a clinical consensus statement of the ESC Council on Stroke, the European Association of Cardiovascular Imaging and the European Heart Rhythm Association of the ESC.. European heart journal, 45(19), 1701-1715. doi:10.1093/eurheartj/ehae150
Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial.
Lip, G. Y. H., Nikorowitsch, J., Sehner, S., Becher, N., Bertaglia, E., Blomstrom-Lundqvist, C., . . . Kirchhof, P. (2024). Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial.. European heart journal, 45(19), 1733-1737. doi:10.1093/eurheartj/ehae225
Lipid-based insulin-resistance markers predict cardiovascular events in metabolic dysfunction associated steatotic liver disease.
Colantoni, A., Bucci, T., Cocomello, N., Angelico, F., Ettorre, E., Pastori, D., . . . Baratta, F. (2024). Lipid-based insulin-resistance markers predict cardiovascular events in metabolic dysfunction associated steatotic liver disease.. Cardiovascular diabetology, 23(1), 175. doi:10.1186/s12933-024-02263-6
Predicting multifaceted risks using machine learning in atrial fibrillation: insights from GLORIA-AF study.
Lu, J., Bisson, A., Bennamoun, M., Zheng, Y., Sanfilippo, F. M., Hung, J., . . . Lip, G. Y. H. (2024). Predicting multifaceted risks using machine learning in atrial fibrillation: insights from GLORIA-AF study.. European heart journal. Digital health, 5(3), 235-246. doi:10.1093/ehjdh/ztae010
Machine Learning Modeling to Predict Atrial Fibrillation Detection in Embolic Stroke of Undetermined Source Patients.
Ming, C., Lee, G. J. W., Teo, Y. H., Teo, Y. N., Toh, E. M. S., Li, T. Y. W., . . . Tan, B. Y. (2024). Machine Learning Modeling to Predict Atrial Fibrillation Detection in Embolic Stroke of Undetermined Source Patients.. Journal of personalized medicine, 14(5), 534. doi:10.3390/jpm14050534
Modifiable lifestyle factors and lifetime risk of atrial fibrillation: longitudinal data from the Korea NHIS-HealS and UK Biobank cohorts.
Park, H., Kim, D., Jang, E., Yu, H. T., Kim, T. -H., Kim, D. -M., . . . Joung, B. (2024). Modifiable lifestyle factors and lifetime risk of atrial fibrillation: longitudinal data from the Korea NHIS-HealS and UK Biobank cohorts.. BMC medicine, 22(1), 194. doi:10.1186/s12916-024-03400-4
Plasma Biomarkers for Hypertension-Mediated Organ Damage Detection: A Narrative Review.
Liu, X., Yang, M., Lip, G. Y. H., & McDowell, G. (2024). Plasma Biomarkers for Hypertension-Mediated Organ Damage Detection: A Narrative Review.. Biomedicines, 12(5), 1071. doi:10.3390/biomedicines12051071
Efficacy and safety of oral anticoagulants according to kidney function among patients with atrial fibrillation.
Binding, C., Blanche, P., Lip, G. Y. H., Kamper, A. -L., Lee, C. J. Y., Staerk, L., . . . Bonde, A. N. (2024). Efficacy and safety of oral anticoagulants according to kidney function among patients with atrial fibrillation.. European heart journal. Cardiovascular pharmacotherapy, 10(3), 210-218. doi:10.1093/ehjcvp/pvae016
Association of antiseizure medications and adverse cardiovascular events: A global health federated network analysis
Mayer, J., Mbizvo, G. K., Bucci, T., Marson, A., & Lip, G. Y. H. (n.d.). Association of antiseizure medications and adverse cardiovascular events: A global health federated network analysis. Epilepsia. doi:10.1111/epi.17922
Association of hospital-treated infectious diseases and infection burden with cardiovascular diseases and life expectancy.
Zheng, J., Ni, C., Lee, S. W. R., Li, F. -R., Huang, J., Zhou, R., . . . Tang, S. (2024). Association of hospital-treated infectious diseases and infection burden with cardiovascular diseases and life expectancy.. Journal of internal medicine, 295(5), 679-694. doi:10.1111/joim.13780
Diagnostic accuracy of digital technologies compared with 12-lead ECG in the diagnosis of atrial fibrillation in adults: A protocol for a systematic review.
Sheron, V. A., Surenthirakumaran, R., Gooden, T. E., Y H Lip, G., Thomas, G. N., J Moore, D., . . . NIHR Global Health Research Group on Atrial Fibrillation Management. (2024). Diagnostic accuracy of digital technologies compared with 12-lead ECG in the diagnosis of atrial fibrillation in adults: A protocol for a systematic review.. PloS one, 19(5), e0301729. doi:10.1371/journal.pone.0301729
Impact of ECG data format on the performance of machine learning models for the prediction of myocardial infarction.
Bellfield, R. A. A., Ortega-Martorell, S., Lip, G. Y. H., Oxborough, D., & Olier, I. (2024). Impact of ECG data format on the performance of machine learning models for the prediction of myocardial infarction.. Journal of electrocardiology, 84, 17-26. doi:10.1016/j.jelectrocard.2024.03.005
Prevalence of mental health conditions and brain fog in people with long COVID: A systematic review and meta-analysis.
van der Feltz-Cornelis, C., Turk, F., Sweetman, J., Khunti, K., Gabbay, M., Shepherd, J., . . . Banerjee, A. (2024). Prevalence of mental health conditions and brain fog in people with long COVID: A systematic review and meta-analysis.. General hospital psychiatry, 88, 10-22. doi:10.1016/j.genhosppsych.2024.02.009
Prognostic implications of heart failure stages among Chinese community populations: insight from a nationwide population-based study.
Zheng, C., Cai, A., Wang, X., Qiu, J., Song, Q., Gu, R., . . . Feng, Y. (2024). Prognostic implications of heart failure stages among Chinese community populations: insight from a nationwide population-based study.. The Lancet regional health. Western Pacific, 46, 101072. doi:10.1016/j.lanwpc.2024.101072
Subclinical atrial fibrillation patients, who are the best candidates for oral anticoagulant therapy?
Huang, B., Wright, D. J., & Lip, G. Y. H. (2024). Subclinical atrial fibrillation patients, who are the best candidates for oral anticoagulant therapy?. European journal of internal medicine, 123, 49-51. doi:10.1016/j.ejim.2024.03.015
When anticoagulation management in atrial fibrillation becomes difficult: Focus on chronic kidney disease, coagulation disorders, and cancer.
Papakonstantinou, P. E., Kalogera, V., Charitos, D., Polyzos, D., Benia, D., Batsouli, A., . . . Lip, G. Y. H. (2024). When anticoagulation management in atrial fibrillation becomes difficult: Focus on chronic kidney disease, coagulation disorders, and cancer.. Blood reviews, 65, 101171. doi:10.1016/j.blre.2024.101171
Antazoline for pharmacologic cardioversion of atrial fibrillation: teaching an old drug new tricks.
Lip, G. Y. H., & Mills, M. T. (2024). Antazoline for pharmacologic cardioversion of atrial fibrillation: teaching an old drug new tricks.. Polish archives of internal medicine, 134(4), 16741. doi:10.20452/pamw.16741
Randomised controlled trial of population screening for atrial fibrillation in people aged 70 years and over to reduce stroke: protocol for the SAFER trial.
Mant, J., Modi, R. N., Dymond, A., Armstrong, N., Burt, J., Calvert, P., . . . SAFER author group. (2024). Randomised controlled trial of population screening for atrial fibrillation in people aged 70 years and over to reduce stroke: protocol for the SAFER trial.. BMJ open, 14(4), e082047. doi:10.1136/bmjopen-2023-082047
Morbidity and mortality risks associated with valproate withdrawal in young men and women with epilepsy.
Mbizvo, G. K., Bucci, T., Lip, G. Y. H., & Marson, A. G. (2024). Morbidity and mortality risks associated with valproate withdrawal in young men and women with epilepsy.. Brain : a journal of neurology, awae128. doi:10.1093/brain/awae128
Fibrinaloid Microclots and Atrial Fibrillation
Kell, D. B., Lip, G. Y. H., & Pretorius, E. (2024). Fibrinaloid Microclots and Atrial Fibrillation. Biomedicines, 12(4), 891. doi:10.3390/biomedicines12040891
Cardiovascular Risk in Young Patients Diagnosed With Obstructive Sleep Apnea.
Albertsen, I. E., Bille, J., Piazza, G., Lip, G. Y. H., & Nielsen, P. B. (2024). Cardiovascular Risk in Young Patients Diagnosed With Obstructive Sleep Apnea.. Journal of the American Heart Association, 13(8), e033506. doi:10.1161/jaha.123.033506
Emergence of nephrocardiology: Integrating management of cardiovascular and kidney diseases for holistic patient care.
Dzeshka, M. S., Shantsila, A., Lip, G. Y. H., & Shantsila, E. (2024). Emergence of nephrocardiology: Integrating management of cardiovascular and kidney diseases for holistic patient care.. Trends in cardiovascular medicine, S1050-1738(24)00033-1. doi:10.1016/j.tcm.2024.04.002
Comparing the Real-World and Clinical Trial Bleeding Rates Associated with Oral Anticoagulation Treatment for Atrial Fibrillation.
Gue, Y., Bloomfield, D., Freedholm, D., & Lip, G. Y. H. (2024). Comparing the Real-World and Clinical Trial Bleeding Rates Associated with Oral Anticoagulation Treatment for Atrial Fibrillation.. Journal of clinical medicine, 13(8), 2277. doi:10.3390/jcm13082277
From HFpEF to "metabolic (dysfunction)-associated HFpEF": Time to act.
Zhou, X. -D., Lip, G. Y. H., & Zheng, M. -H. (2024). From HFpEF to "metabolic (dysfunction)-associated HFpEF": Time to act.. Science bulletin, 69(7), 850-852. doi:10.1016/j.scib.2024.01.006
Artificial intelligence-enhanced electrocardiogram analysis for identifying cardiac autonomic neuropathy in patients with diabetes
Irlik, K., Aldosari, H., Hendel, M., Piaśnik, J., Kulpa, J., Ignacy, P., . . . Nabrdalik, K. (2024). Artificial intelligence-enhanced electrocardiogram analysis for identifying cardiac autonomic neuropathy in patients with diabetes. Diabetes, Obesity and Metabolism: a journal of pharmacology and therapeutics.
Statin Therapy for Secondary Prevention in Ischemic Stroke Patients With Cerebral Microbleeds.
Prats-Sanchez, L., Camps-Renom, P., Nash, P. S., Wilson, D., Ambler, G., Best, J. G., . . . Microbleeds International Collaborative Network (MICON). (2024). Statin Therapy for Secondary Prevention in Ischemic Stroke Patients With Cerebral Microbleeds.. Neurology, 102(7), e209173. doi:10.1212/wnl.0000000000209173
Patterns of comorbidities in patients with atrial fibrillation and impact on management and long-term prognosis: an analysis from the Prospective Global GLORIA-AF Registry.
Romiti, G. F., Corica, B., Mei, D. A., Bisson, A., Boriani, G., Olshansky, B., . . . GLORIA-AF Investigators. (2024). Patterns of comorbidities in patients with atrial fibrillation and impact on management and long-term prognosis: an analysis from the Prospective Global GLORIA-AF Registry.. BMC medicine, 22(1), 151. doi:10.1186/s12916-024-03373-4
Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database.
Eleftheriadou, A., Riley, D., Zhao, S. S., Austin, P., Hernández, G., Lip, G. Y. H., . . . Alam, U. (2024). Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database.. Diabetologia. doi:10.1007/s00125-024-06132-5
Accelerometer-derived physical activity and the risk of death, heart failure, and stroke in patients with atrial fibrillation: a prospective study from UK Biobank.
Ahn, H. -J., Choi, E. -K., Rhee, T. -M., Choi, J., Lee, K. -Y., Kwon, S., . . . Lip, G. Y. H. (2024). Accelerometer-derived physical activity and the risk of death, heart failure, and stroke in patients with atrial fibrillation: a prospective study from UK Biobank.. British journal of sports medicine, 58(8), 427-434. doi:10.1136/bjsports-2023-106862
Risk of Death and Cardiovascular Events in Asian Patients With Atrial Fibrillation and Chronic Obstructive Pulmonary Disease: A Report From the Prospective APHRS Registry.
Bucci, T., Romiti, G. F., Shantsila, A., Teo, W. -S., Park, H. -W., Shimizu, W., . . . Asia‐Pacific Heart Rhythm Society Atrial Fibrillation Registry Investigators. (2024). Risk of Death and Cardiovascular Events in Asian Patients With Atrial Fibrillation and Chronic Obstructive Pulmonary Disease: A Report From the Prospective APHRS Registry.. Journal of the American Heart Association, 13(7), e032785. doi:10.1161/jaha.123.032785
Adherence to an integrated care pathway for stroke is associated with lower risk of major cardiovascular events: A report from the Athens Stroke Registry.
Sagris, D., Lip, G. Υ. Η., Korompoki, E., Ntaios, G., & Vemmos, K. (2024). Adherence to an integrated care pathway for stroke is associated with lower risk of major cardiovascular events: A report from the Athens Stroke Registry.. European journal of internal medicine, 122, 61-67. doi:10.1016/j.ejim.2023.12.010
Cardiovascular Outcomes with Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Patients with Diabetes: A Real-World Data Analysis.
Lai, J. Y. M., Riley, D. R., Anson, M., Henney, A., Cuthbertson, D. J., Hernadez, G., . . . Alam, U. (2024). Cardiovascular Outcomes with Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Patients with Diabetes: A Real-World Data Analysis.. Diabetes therapy : research, treatment and education of diabetes and related disorders, 15(4), 833-842. doi:10.1007/s13300-024-01544-3
The Cost of Atrial Fibrillation: A Systematic Review.
Buja, A., Rebba, V., Montecchio, L., Renzo, G., Baldo, V., Cocchio, S., . . . Lip, G. Y. H. (2024). The Cost of Atrial Fibrillation: A Systematic Review.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 27(4), 527-541. doi:10.1016/j.jval.2023.12.015
Efficacy and Safety of Combination Therapy with Low-Dose Rivaroxaban in Patients with Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Bucci, T., Del Sole, F., Menichelli, D., Galardo, G., Biccirè, F. G., Farcomeni, A., . . . Pastori, D. (2024). Efficacy and Safety of Combination Therapy with Low-Dose Rivaroxaban in Patients with Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. Journal of clinical medicine, 13(7), 2033. doi:10.3390/jcm13072033
Effect of physical activity on incident atrial fibrillation in individuals with varying duration of diabetes: a nationwide population study.
Choi, J., Lee, S. -R., Choi, E. -K., Lee, K. -Y., Ahn, H. -J., Kwon, S., . . . Lip, G. Y. H. (2024). Effect of physical activity on incident atrial fibrillation in individuals with varying duration of diabetes: a nationwide population study.. Cardiovascular diabetology, 23(1), 115. doi:10.1186/s12933-024-02194-2
Practical guide on left atrial appendage closure for the non-implanting physician: an international consensus paper.
Potpara, T., Grygier, M., Häusler, K. G., Nielsen-Kudsk, J. E., Berti, S., Genovesi, S., . . . Camm, A. J. (2024). Practical guide on left atrial appendage closure for the non-implanting physician: an international consensus paper.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 26(4), euae035. doi:10.1093/europace/euae035
Stroke-heart syndrome: mechanisms, risk factors, and adverse cardiovascular events
Buckley, B. J. R., Harrison, S. L., Lane, D. A., Hill, A., & Lip, G. Y. H. (2023). Stroke-heart syndrome: mechanisms, risk factors, and adverse cardiovascular events. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. doi:10.1093/eurjpc/zwad211
Effectiveness and cost-effectiveness of a web-based cardiac rehabilitation programme for people with chronic stable angina: protocol for the ACTIVATE (Angina Controlled Trial Investigating the Value of the 'Activate your heart' Therapeutic E-intervention) randomised controlled trial.
Williams, N. H., Collins, B., Comerford, T. J., Dodd, S., Fisher, M., Hardwick, B., . . . Singh, S. J. (2024). Effectiveness and cost-effectiveness of a web-based cardiac rehabilitation programme for people with chronic stable angina: protocol for the ACTIVATE (Angina Controlled Trial Investigating the Value of the 'Activate your heart' Therapeutic E-intervention) randomised controlled trial.. BMJ open, 14(3), e084509. doi:10.1136/bmjopen-2024-084509
The optimal antithrombotic strategy for post-stroke patients with atrial fibrillation and extracranial artery stenosis-a nationwide cohort study.
Tsai, C. -T., Chan, Y. -H., Liao, J. -N., Chen, T. -J., Lip, G. Y. H., Chen, S. -A., & Chao, T. -F. (2024). The optimal antithrombotic strategy for post-stroke patients with atrial fibrillation and extracranial artery stenosis-a nationwide cohort study.. BMC medicine, 22(1), 113. doi:10.1186/s12916-024-03338-7
Clinical trial evaluation: the EDOSURE clinical trial program.
Griffin, M., & Lip, G. Y. (2024). Clinical trial evaluation: the EDOSURE clinical trial program.. Future cardiology, 20(4), 171-177. doi:10.1080/14796678.2024.2354079
Sarcopenia is linked to higher levels of B-type natriuretic peptide and its N-terminal fragment in heart failure: a systematic review and meta-analysis.
Prokopidis, K., Morwani-Mangnani, J., McDowell, G., Lip, G. Y. H., Venturelli, M., Sankaranarayanan, R., & Isanejad, M. (2024). Sarcopenia is linked to higher levels of B-type natriuretic peptide and its N-terminal fragment in heart failure: a systematic review and meta-analysis.. European geriatric medicine. doi:10.1007/s41999-024-00950-x
Clonal haematopoiesis of indeterminate potential and atrial fibrillation: an east Asian cohort study.
Ahn, H. -J., An, H. Y., Ryu, G., Lim, J., Sun, C., Song, H., . . . Choi, E. -K. (2024). Clonal haematopoiesis of indeterminate potential and atrial fibrillation: an east Asian cohort study.. European heart journal, 45(10), 778-790. doi:10.1093/eurheartj/ehad869
Association between natriuretic peptides and C-reactive protein with frailty in heart failure: a systematic review and meta-analysis.
Prokopidis, K., Ishiguchi, H., Jordan, C., Irlik, K., Nabrdalik, K., Formiga, F., . . . Isanejad, M. (2024). Association between natriuretic peptides and C-reactive protein with frailty in heart failure: a systematic review and meta-analysis.. Aging clinical and experimental research, 36(1), 57. doi:10.1007/s40520-024-02713-x
Relationship of Warfarin and Apixaban with Vascular Function in Patients with Atrial Fibrillation.
Junejo, R. T., Gupta, D., Snowdon, R. L., Lip, G. Y. H., & Fisher, J. P. (2024). Relationship of Warfarin and Apixaban with Vascular Function in Patients with Atrial Fibrillation.. Journal of vascular research, 61(2), 59-67. doi:10.1159/000535618
Burden of intracerebral haemorrhage in Europe: forecasting incidence and mortality between 2019 and 2050.
Wafa, H. A., Marshall, I., Wolfe, C. D. A., Xie, W., Johnson, C. O., Veltkamp, R., . . . PRESTIGE-AF consortium. (2024). Burden of intracerebral haemorrhage in Europe: forecasting incidence and mortality between 2019 and 2050.. The Lancet regional health. Europe, 38, 100842. doi:10.1016/j.lanepe.2024.100842
Cardiorespiratory Multimorbidity in People Living With Chronic Lung Disease: Challenges, Opportunities, and a Concept for Optimization via an Integrated Care Approach.
Frost, F., & Lip, G. Y. H. (2024). Cardiorespiratory Multimorbidity in People Living With Chronic Lung Disease: Challenges, Opportunities, and a Concept for Optimization via an Integrated Care Approach.. Chest, 165(3), 500-502. doi:10.1016/j.chest.2023.11.009
Direct oral anticoagulants are associated with lower risk of dementia in patients with atrial fibrillation.
Sagris, D., Ntaios, G., Buckley, B. J. R., Harrison, S. L., Underhill, P., Lane, D. A., & Lip, G. Y. H. (2024). Direct oral anticoagulants are associated with lower risk of dementia in patients with atrial fibrillation.. European journal of internal medicine, 121, 114-120. doi:10.1016/j.ejim.2023.10.033
Mineralocorticoid receptor antagonist for chronic kidney disease, risk or benefit?
Huang, B., McDowell, G., Rao, A., & Lip, G. Y. H. (2024). Mineralocorticoid receptor antagonist for chronic kidney disease, risk or benefit?. Journal of hypertension, 42(3), 396-398. doi:10.1097/hjh.0000000000003643
The Reply.
Gue, Y., & Lip, G. Y. H. (2024). The Reply.. The American journal of medicine, 137(3), e61. doi:10.1016/j.amjmed.2023.11.024
The feasibility of population screening for paroxysmal atrial fibrillation using hand-held electrocardiogram devices.
Mant, J., Modi, R. N., Charlton, P., Dymond, A., Massou, E., Brimicombe, J., . . . Williams, K. (2024). The feasibility of population screening for paroxysmal atrial fibrillation using hand-held electrocardiogram devices.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 26(3), euae056. doi:10.1093/europace/euae056
Adverse Events and Clinical Correlates in Asian Patients with Atrial Fibrillation and Diabetes Mellitus: A Report from Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry
Bucci, T., Nabrdalik, K., Shantsila, A., Romiti, G. F., Teo, W. -S., Park, H. -W., . . . Lip, G. Y. H. (n.d.). Adverse Events and Clinical Correlates in Asian Patients with Atrial Fibrillation and Diabetes Mellitus: A Report from Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry. Journal of Clinical Medicine, 13(5), 1274. doi:10.3390/jcm13051274
Diabetes mellitus in patients with heart failure and reduced ejection fraction: a post hoc analysis from the WARCEF trial.
Romiti, G. F., Nabrdalik, K., Corica, B., Bucci, T., Proietti, M., Qian, M., . . . WARCEF Investigators. (2024). Diabetes mellitus in patients with heart failure and reduced ejection fraction: a post hoc analysis from the WARCEF trial.. Internal and emergency medicine. doi:10.1007/s11739-024-03544-4
New-onset syncope in diabetic patients treated with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors: a Chinese population-based cohort study.
Gao, X., Zhang, N., Lu, L., Gao, T., Chou, O. H. I., Wong, W. T., . . . Zhou, J. (2024). New-onset syncope in diabetic patients treated with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors: a Chinese population-based cohort study.. European heart journal. Cardiovascular pharmacotherapy, 10(2), 103-117. doi:10.1093/ehjcvp/pvad086
Supermarket/Hypermarket Opportunistic Screening for Atrial Fibrillation (SHOPS-AF) using sensors embedded in the handles of supermarket trolleys: A feasibility study.
Jones, I. D., Lane, D. A., Lotto, R. R., Oxborough, D., Neubeck, L., Penson, P. E., . . . Lip, G. Y. H. (2024). Supermarket/Hypermarket Opportunistic Screening for Atrial Fibrillation (SHOPS-AF) using sensors embedded in the handles of supermarket trolleys: A feasibility study.. American heart journal, S0002-8703(24)00038-3. doi:10.1016/j.ahj.2024.02.011
Hematologic Malignancies and Increased Cardiovascular Risk-Can More Be Done to Mitigate?
Gue, Y. X., & Lip, G. Y. H. (2024). Hematologic Malignancies and Increased Cardiovascular Risk-Can More Be Done to Mitigate?. The American journal of cardiology, 213, 182-183. doi:10.1016/j.amjcard.2023.12.039
Structural Complications Following ST-Elevation Myocardial Infarction: An Analysis of the National Inpatient Sample 2016 to 2020.
Kwok, C. S., Qureshi, A. I., Will, M., Schwarz, K., Lip, G. Y. H., & Borovac, J. A. (2024). Structural Complications Following ST-Elevation Myocardial Infarction: An Analysis of the National Inpatient Sample 2016 to 2020.. Journal of cardiovascular development and disease, 11(2), 59. doi:10.3390/jcdd11020059
Clinical Impact of Switching or Continuation of Apixaban or Rivaroxaban among Patients with Non-Valvular Atrial Fibrillation.
Deitelzweig, S., Kang, A., Jiang, J., Gao, C., Luo, X., Atreja, N., . . . Lip, G. Y. H. (2024). Clinical Impact of Switching or Continuation of Apixaban or Rivaroxaban among Patients with Non-Valvular Atrial Fibrillation.. Journal of clinical medicine, 13(4), 1073. doi:10.3390/jcm13041073
Predicting stroke in Asian patients with atrial fibrillation using machine learning: A report from the KERALA-AF registry, with external validation in the APHRS-AF registry.
Chen, Y., Gue, Y., Calvert, P., Gupta, D., McDowell, G., Azariah, J. L., . . . KERALA-AF Registry & APHRS-AF Registry Investigators joint senior authors. (2024). Predicting stroke in Asian patients with atrial fibrillation using machine learning: A report from the KERALA-AF registry, with external validation in the APHRS-AF registry.. Current problems in cardiology, 49(4), 102456. doi:10.1016/j.cpcardiol.2024.102456
The association between time-weighted remnant cholesterol and cardiovascular and non-cardiovascular mortality: A population-based cohort study
High Initial Heart Rate Score is an Independent Predictor of New Atrial High-Rate Episodes in Pacemaker Patients with Sinus Node Dysfunction
Albumin Levels and Risk of Early Cardiovascular Complications After Ischemic Stroke: A Propensity-Matched Analysis of a Global Federated Health Network.
Bucci, T., Pastori, D., Pignatelli, P., Ntaios, G., Abdul-Rahim, A. H., Violi, F., & Lip, G. Y. H. (2024). Albumin Levels and Risk of Early Cardiovascular Complications After Ischemic Stroke: A Propensity-Matched Analysis of a Global Federated Health Network.. Stroke. doi:10.1161/strokeaha.123.044248
High-Sensitivity C-Reactive Protein Is Associated With Heart Failure Hospitalization in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease and Normal Left Ventricular Ejection Fraction Undergoing Coronary Angiography.
Zhou, X. -D., Chen, Q. -F., Targher, G., Byrne, C. D., Shapiro, M. D., Tian, N., . . . Zheng, M. -H. (2024). High-Sensitivity C-Reactive Protein Is Associated With Heart Failure Hospitalization in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease and Normal Left Ventricular Ejection Fraction Undergoing Coronary Angiography.. Journal of the American Heart Association, 13(3), e032997. doi:10.1161/jaha.123.032997
Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulants in the Prevention of Ischaemic Stroke in Patients with Atrial Fibrillation.
Elsheikh, S., Alobaida, M., Bucci, T., Buckley, B. J. R., Gupta, D., Irving, G., . . . Abdul-Rahim, A. H. (2024). Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulants in the Prevention of Ischaemic Stroke in Patients with Atrial Fibrillation.. Cerebrovascular diseases (Basel, Switzerland). doi:10.1159/000536546
Relationship between trajectories of dietary iron intake and risk of type 2 diabetes mellitus: evidence from a prospective cohort study.
Wang, R., Liu, Y., Thabane, L., Olier, I., Li, L., Ortega-Martorell, S., . . . Li, G. (2024). Relationship between trajectories of dietary iron intake and risk of type 2 diabetes mellitus: evidence from a prospective cohort study.. Nutrition journal, 23(1), 15. doi:10.1186/s12937-024-00925-5
Adherence to the Atrial fibrillation Better Care pathway and the risk of adverse health outcomes in older care home residents with atrial fibrillation: a retrospective data linkage study 2003-18.
Ritchie, L. A., Harrison, S. L., Penson, P. E., Akbari, A., Torabi, F., Hollinghurst, J., . . . Lane, D. A. (2024). Adherence to the Atrial fibrillation Better Care pathway and the risk of adverse health outcomes in older care home residents with atrial fibrillation: a retrospective data linkage study 2003-18.. Age and ageing, 53(2), afae021. doi:10.1093/ageing/afae021
Association between antithrombotic therapy after stroke in patients with atrial fibrillation and the risk of net clinical outcome: an observational cohort study.
Ahn, H. -J., Lee, S. -R., Choi, J., Lee, K. -Y., Kwon, S., Choi, E. -K., . . . Lip, G. Y. H. (2024). Association between antithrombotic therapy after stroke in patients with atrial fibrillation and the risk of net clinical outcome: an observational cohort study.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 26(2), euae033. doi:10.1093/europace/euae033
Atrial fibrillation first detected after stroke: is timing and detection intensity relevant for stroke risk?
Sposato, L. A., Lip, G. Y. H., & Haeusler, K. G. (2024). Atrial fibrillation first detected after stroke: is timing and detection intensity relevant for stroke risk?. European heart journal, 45(5), 396-398. doi:10.1093/eurheartj/ehad744
Atrial fibrillation: comorbidities, lifestyle, and patient factors.
Shantsila, E., Choi, E. -K., Lane, D. A., Joung, B., & Lip, G. Y. H. (2024). Atrial fibrillation: comorbidities, lifestyle, and patient factors.. The Lancet regional health. Europe, 37, 100784. doi:10.1016/j.lanepe.2023.100784
Atrial fibrillation: epidemiology, screening and digital health.
Linz, D., Gawalko, M., Betz, K., Hendriks, J. M., Lip, G. Y. H., Vinter, N., . . . Johnsen, S. (2024). Atrial fibrillation: epidemiology, screening and digital health.. The Lancet regional health. Europe, 37, 100786. doi:10.1016/j.lanepe.2023.100786
Net Clinical Benefit of Oral Anticoagulation Among Frail Patients With Atrial Fibrillation: Nationwide Cohort Study.
Søgaard, M., Jensen, M., Højen, A. A., Larsen, T. B., Lip, G. Y. H., Ording, A. G., & Nielsen, P. B. (2024). Net Clinical Benefit of Oral Anticoagulation Among Frail Patients With Atrial Fibrillation: Nationwide Cohort Study.. Stroke, 55(2), 413-422. doi:10.1161/strokeaha.123.044407
Neuroticism and the Risk of Atrial Fibrillation: An Observational Epidemiologic and Mendelian Randomization Study.
Rhee, T. -M., Choi, J., Choi, E. -K., Lee, K. -Y., Ahn, H. -J., Kwon, S., . . . Lip, G. Y. H. (2024). Neuroticism and the Risk of Atrial Fibrillation: An Observational Epidemiologic and Mendelian Randomization Study.. JACC. Asia, 4(2), 138-147. doi:10.1016/j.jacasi.2023.09.010
The impact of sodium-glucose co-transporter-2 inhibitors on dementia and cardiovascular events in diabetic patients with atrial fibrillation.
Chen, Y. -Y., Chang, H. -C., Lin, Y. -J., Chien, K. -L., Hsieh, Y. -C., Chung, F. -P., . . . Chen, S. -A. (2024). The impact of sodium-glucose co-transporter-2 inhibitors on dementia and cardiovascular events in diabetic patients with atrial fibrillation.. Diabetes/metabolism research and reviews, 40(2), e3775. doi:10.1002/dmrr.3775
Which dose of apixaban is suitable for Asian patients with atrial fibrillation who have a serum creatinine < 1.5 mg/dL but an estimated glomerular filtration rate < 50 mL/min?
Tsai, C. -T., Liao, J. -N., Chan, Y. -H., Kuo, L., Liu, C. -M., Lip, G. Y. H., & Chao, T. -F. (2024). Which dose of apixaban is suitable for Asian patients with atrial fibrillation who have a serum creatinine < 1.5 mg/dL but an estimated glomerular filtration rate < 50 mL/min?. International journal of cardiology. Heart & vasculature, 50, 101333. doi:10.1016/j.ijcha.2023.101333
Relationship Between Lipoprotein(a), Renal Function Indicators, and Chronic Kidney Disease: Evidence From a Large Prospective Cohort Study.
Liu, Y., Wang, R., Li, S., Zhang, C., Lip, G. Y. H., Thabane, L., & Li, G. (2024). Relationship Between Lipoprotein(a), Renal Function Indicators, and Chronic Kidney Disease: Evidence From a Large Prospective Cohort Study.. JMIR public health and surveillance, 10, e50415. doi:10.2196/50415
Reliability of single-lead electrocardiogram interpretation to detect atrial fibrillation: insights from the SAFER Feasibility Study
Possible Role of Fibrinaloid Microclots in Postural Orthostatic Tachycardia Syndrome (POTS): Focus on Long COVID.
Kell, D. B., Khan, M. A., Kane, B., Lip, G. Y. H., & Pretorius, E. (2024). Possible Role of Fibrinaloid Microclots in Postural Orthostatic Tachycardia Syndrome (POTS): Focus on Long COVID.. Journal of personalized medicine, 14(2), 170. doi:10.3390/jpm14020170
Impact of chronic obstructive pulmonary disease in patients with atrial fibrillation: an analysis from the GLORIA-AF registry.
Romiti, G. F., Corica, B., Mei, D. A., Frost, F., Bisson, A., Boriani, G., . . . Lip, G. Y. H. (2024). Impact of chronic obstructive pulmonary disease in patients with atrial fibrillation: an analysis from the GLORIA-AF registry.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 26(1), euae021. doi:10.1093/europace/euae021
When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review.
Bejjani, A., Khairani, C. D., Assi, A., Piazza, G., Sadeghipour, P., Talasaz, A. H., . . . Bikdeli, B. (2024). When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review.. Journal of the American College of Cardiology, 83(3), 444-465. doi:10.1016/j.jacc.2023.10.038
Infective endocarditis: Five key developments.
Mills, M. T., Calvert, P., & Lip, G. Y. H. (2024). Infective endocarditis: Five key developments.. Trends in cardiovascular medicine, S1050-1738(24)00007-0. doi:10.1016/j.tcm.2024.01.007
Oral anti-coagulants use in Chinese hospitalized patients with atrial fibrillation.
Lin, J., Long, D., Jiang, C., Sang, C., Tang, R., Li, S., . . . CCC-AF investigators. (2024). Oral anti-coagulants use in Chinese hospitalized patients with atrial fibrillation.. Chinese medical journal, 137(2), 172-180. doi:10.1097/cm9.0000000000002915
Pharmacist-led intervention for older people with atrial fibrillation in long-term care (PIVOTALL study): a randomised pilot and feasibility study.
Ritchie, L. A., Penson, P. E., Akpan, A., Lip, G. Y. H., & Lane, D. A. (2024). Pharmacist-led intervention for older people with atrial fibrillation in long-term care (PIVOTALL study): a randomised pilot and feasibility study.. BMC geriatrics, 24(1), 64. doi:10.1186/s12877-023-04527-4
Educational status affects prognosis of patients with heart failure with reduced ejection fraction: A post-hoc analysis from the WARCEF trial.
Corica, B., Romiti, G. F., Simoni, A. H., Mei, D. A., Bucci, T., Thompson, J. L. P., . . . WARCEF Investigators. (2024). Educational status affects prognosis of patients with heart failure with reduced ejection fraction: A post-hoc analysis from the WARCEF trial.. European journal of clinical investigation, e14152. doi:10.1111/eci.14152
Clinical Associations and Prognostic Value of MRI-Visible Perivascular Spaces in Patients With Ischemic Stroke or TIA: A Pooled Analysis
Best, J. G., Ambler, G., Wilson, D., Du, H., Lee, K. -J., Lim, J. -S., . . . Werring, D. J. (2024). Clinical Associations and Prognostic Value of MRI-Visible Perivascular Spaces in Patients With Ischemic Stroke or TIA: A Pooled Analysis. Neurology, 102(1), e207795. doi:10.1212/wnl.0000000000207795
Epilepsy and the risk of adverse cardiovascular events: A nationwide cohort study.
Mayer, J., Fawzy, A. M., Bisson, A., Pasi, M., Bodin, A., Vigny, P., . . . Fauchier, L. (2024). Epilepsy and the risk of adverse cardiovascular events: A nationwide cohort study.. European journal of neurology. doi:10.1111/ene.16116
2024 Chinese Expert Consensus Guidelines on the Diagnosis and Treatment of Atrial Fibrillation in the Elderly, Endorsed by Geriatric Society of Chinese Medical Association (Cardiovascular Group) and Chinese Society of Geriatric Health Medicine (Cardiovascular Branch): Executive Summary.
Wang, Y., Guo, Y., Qin, M., Fan, J., Tang, M., Zhang, X., . . . Expert Reviewers. (2024). 2024 Chinese Expert Consensus Guidelines on the Diagnosis and Treatment of Atrial Fibrillation in the Elderly, Endorsed by Geriatric Society of Chinese Medical Association (Cardiovascular Group) and Chinese Society of Geriatric Health Medicine (Cardiovascular Branch): Executive Summary.. Thrombosis and haemostasis, 124(10), 897-911. doi:10.1055/a-2325-5923
A Happy New Year 2024 from Thrombosis and Haemostasis!
Lip, G. Y. H., Rigby, A., & Weber, C. (2024). A Happy New Year 2024 from Thrombosis and Haemostasis!. Thrombosis and haemostasis, 124(1), 1-3. doi:10.1055/s-0043-1778033
Association between changes in renal function and clinical outcomes in anticoagulated atrial fibrillation patients with marginal renal function. A nationwide observational cohort study.
Lee, K. -Y., Lee, S. -R., Choi, E. -K., Choi, J., Ahn, H. -J., Kwon, S., . . . Lip, G. Y. H. (2024). Association between changes in renal function and clinical outcomes in anticoagulated atrial fibrillation patients with marginal renal function. A nationwide observational cohort study.. Frontiers in cardiovascular medicine, 11, 1423336. doi:10.3389/fcvm.2024.1423336
Association between types of antihypertensive medication and the risk of atrial fibrillation: a nationwide population study.
Choi, J., Lee, S. -R., Choi, E. -K., Lee, K. -Y., Ahn, H. -J., Kwon, S., . . . Lip, G. Y. H. (2024). Association between types of antihypertensive medication and the risk of atrial fibrillation: a nationwide population study.. Frontiers in cardiovascular medicine, 11, 1372505. doi:10.3389/fcvm.2024.1372505
Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients.
Boriani, G., Bonini, N., Vitolo, M., Mei, D. A., Imberti, J. F., Gerra, L., . . . Lip, G. Y. (2024). Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients.. European journal of internal medicine, 119, 53-63. doi:10.1016/j.ejim.2023.09.009
Atrial fibrillation and stroke: State-of-the-art and future directions.
Elsheikh, S., Hill, A., Irving, G., Lip, G. Y. H., & Abdul-Rahim, A. H. (2024). Atrial fibrillation and stroke: State-of-the-art and future directions.. Current problems in cardiology, 49(1 Pt C), 102181. doi:10.1016/j.cpcardiol.2023.102181
Cardiac and renal outcomes of direct oral anticoagulants in patients with atrial fibrillation
Wang, Y. -T., Chen, J. -H., Liao, S. -F., Chen, Y. -J., Lip, G. Y. H., & Yeh, J. -S. (2023). Cardiac and renal outcomes of direct oral anticoagulants in patients with atrial fibrillation. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. doi:10.1111/eci.14086
Challenging anticoagulation decisions in atrial fibrillation: a narrative review.
Griffin, M., Proietti, R., Lip, G. Y. H., & Abdul-Rahim, A. H. (2024). Challenging anticoagulation decisions in atrial fibrillation: a narrative review.. Therapeutic advances in cardiovascular disease, 18, 17539447241290429. doi:10.1177/17539447241290429
Clinical characteristics of apixaban prescription in AF patients with single dose-reduction criterion: the ASPIRE (efficAcy and safety of aPixaban in rEal-world practice in Korean frail patients with atrial fibrillation) study.
Choi, J., Lee, S. -R., Kwon, S., Ahn, H. -J., Lee, K. -Y., Park, J. -S., . . . Choi, E. -K. (2024). Clinical characteristics of apixaban prescription in AF patients with single dose-reduction criterion: the ASPIRE (efficAcy and safety of aPixaban in rEal-world practice in Korean frail patients with atrial fibrillation) study.. Frontiers in cardiovascular medicine, 11, 1367623. doi:10.3389/fcvm.2024.1367623
Correction: Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry.
Ding, W. Y., Fawzy, A. M., Romiti, G. F., Proietti, M., Pastori, D., Huisman, M. V., . . . GLORIA-AF Investigators. (2024). Correction: Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry.. Journal of thrombosis and thrombolysis, 57(1), 178. doi:10.1007/s11239-023-02904-9
Development and Validation of a Predictive Model for Intracranial Haemorrhage in Patients on Direct Oral Anticoagulants.
Liu, Y., Li, L., Li, J., Liu, H., Geru, A., Wang, Y., . . . Zhou, X. (2024). Development and Validation of a Predictive Model for Intracranial Haemorrhage in Patients on Direct Oral Anticoagulants.. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 30, 10760296241271338. doi:10.1177/10760296241271338
Epidemiology of arrhythmogenic ventricular cardiomyopathy in China.
Liu, S. -T., Li, R., Zheng, J. -P., Lu, F., Sun, H. -N., Hua, L., . . . Bai, Y. (2024). Epidemiology of arrhythmogenic ventricular cardiomyopathy in China.. Clinical cardiology, 47(1), e24160. doi:10.1002/clc.24160
External Validation of COOL-AF Scores in the Asian Pacific Heart Rhythm Society Atrial Fibrillation Registry.
Bucci, T., Shantsila, A., Romiti, G. F., Teo, W. -S., Chao, T. -F., Shimizu, W., . . . Lip, G. Y. H. (2024). External Validation of COOL-AF Scores in the Asian Pacific Heart Rhythm Society Atrial Fibrillation Registry.. JACC. Asia, 4(1), 59-69. doi:10.1016/j.jacasi.2023.09.011
Impact of Unhealthy Lifestyles on Patients with Atrial Fibrillation at Low Risk of Stroke: A Nationwide Cohort Study.
Kwon, S., Lee, S. -R., Choi, E. -K., Lee, S. -W., Jung, J. -H., Han, K. -D., . . . Lip, G. Y. H. (2024). Impact of Unhealthy Lifestyles on Patients with Atrial Fibrillation at Low Risk of Stroke: A Nationwide Cohort Study.. The American journal of medicine, 137(1), 37-46.e6. doi:10.1016/j.amjmed.2023.09.012
Impact of bridging thrombolysis versus endovascular thrombectomy alone on outcomes in anticoagulated patients with atrial fibrillation and acute ischaemic stroke.
Alobaida, M., Harrison, S. L., Lane, D. A., Rowe, F., Austin, P., Abdul-Rahim, A. H., . . . Lip, G. Y. H. (2024). Impact of bridging thrombolysis versus endovascular thrombectomy alone on outcomes in anticoagulated patients with atrial fibrillation and acute ischaemic stroke.. European journal of neurology, e16453. doi:10.1111/ene.16453
Impact of prior oral anticoagulation therapies on post-discharge outcomes after COVID-19: Results from a global federated health network analysis.
Rivera-Caravaca, J. M., Frost, F., Marín, F., & Lip, G. Y. H. (2024). Impact of prior oral anticoagulation therapies on post-discharge outcomes after COVID-19: Results from a global federated health network analysis.. European journal of clinical investigation, e14299. doi:10.1111/eci.14299
In symptomatic AF, catheter ablation vs. medical therapy reduced depression and anxiety symptoms at 12 mo.
Ishiguchi, H., & Lip, G. Y. H. (2024). In symptomatic AF, catheter ablation vs. medical therapy reduced depression and anxiety symptoms at 12 mo.. Annals of internal medicine, 177(1), JC4. doi:10.7326/j23-0105
Incidence and Outcomes of Patients With Early Cardiac Complications After Intracerebral Hemorrhage: A Report From VISTA.
Ishiguchi, H., Huang, B., El-Bouri, W. K., Dawson, J., Lip, G. Y. H., Abdul-Rahim, A. H., & VISTA Collaborators. (2024). Incidence and Outcomes of Patients With Early Cardiac Complications After Intracerebral Hemorrhage: A Report From VISTA.. Stroke, 55(11), 2669-2676. doi:10.1161/strokeaha.124.048189
Initiation of warfarin is associated with decreased mortality in patients with infective endocarditis: A population-based cohort study.
Lee, T. T. L., Chan, S. C. L., Chou, O. H. I., Lee, S., Chan, J. S. K., Liu, T., . . . Tse, G. (2024). Initiation of warfarin is associated with decreased mortality in patients with infective endocarditis: A population-based cohort study.. Thrombosis research, 233, 1-9. doi:10.1016/j.thromres.2023.11.009
Management of Device Detected Subclinical Atrial Fibrillation
Salmon, T., Calvert, P., & Lip, G. Y. H. (n.d.). Management of Device Detected Subclinical Atrial Fibrillation. Current Cardiovascular Risk Reports. doi:10.1007/s12170-024-00748-3
Non-vitamin K Antagonist Oral Anticoagulant, Warfarin, and ABC Pathway Adherence on Hierarchical Outcomes: Win Ratio Analysis of the COOL-AF Registry.
Treewaree, S., Lip, G. Y. H., & Krittayaphong, R. (2024). Non-vitamin K Antagonist Oral Anticoagulant, Warfarin, and ABC Pathway Adherence on Hierarchical Outcomes: Win Ratio Analysis of the COOL-AF Registry.. Thrombosis and haemostasis, 124(1), 69-79. doi:10.1055/s-0043-1772773
Potentially inappropriate prescribing in polymedicated older adults with atrial fibrillation and multimorbidity: a Swedish national register-based cohort study.
Amrouch, C., Vetrano, D. L., Damiano, C., Dai, L., Calderón-Larrañaga, A., Grymonprez, M., . . . Petrovic, M. (2024). Potentially inappropriate prescribing in polymedicated older adults with atrial fibrillation and multimorbidity: a Swedish national register-based cohort study.. Frontiers in pharmacology, 15, 1476464. doi:10.3389/fphar.2024.1476464
Racial Differences in Bleeding Risk: An Ecological Epidemiological Study Comparing Korea and United Kingdom Subjects.
Kang, D. -S., Yang, P. -S., Kim, D., Jang, E., Yu, H. T., Kim, T. -H., . . . Joung, B. (2024). Racial Differences in Bleeding Risk: An Ecological Epidemiological Study Comparing Korea and United Kingdom Subjects.. Thrombosis and haemostasis, 124(9), 842-851. doi:10.1055/a-2269-1123
Risk of Atrial Fibrillation and Adverse Outcomes in Patients With Cardiac Implantable Electronic Devices.
Lee, S. -R., Lee, J. H., Choi, E. -K., Jung, E. -K., You, S. -J., Oh, S., & Lip, G. Y. (2024). Risk of Atrial Fibrillation and Adverse Outcomes in Patients With Cardiac Implantable Electronic Devices.. Korean circulation journal, 54(1), 13-27. doi:10.4070/kcj.2023.0084
Risk of Death From Various Causes According to Prevalent Atrial Fibrillation: A Nationwide Population-Based Study
Kim, Y. -K., Lee, S. -R., Choi, E. -K., Ahn, H. J., Bae, N. Y., Lee, K. -Y., . . . Lip, G. Y. H. (n.d.). Risk of Death From Various Causes According to Prevalent Atrial Fibrillation: A Nationwide Population-Based Study. Journal of Korean Medical Science, 39. doi:10.3346/jkms.2024.39.e306
Sex disparities for patients with atrial fibrillation in the direct oral anticoagulant era.
Ishiguchi, H., Liu, Y., & Lip, G. Y. H. (2024). Sex disparities for patients with atrial fibrillation in the direct oral anticoagulant era.. European journal of clinical investigation, 54(1), e14124. doi:10.1111/eci.14124
Single and 7-day handgrip and squat exercise prevents endothelial ischemia-reperfusion injury in individuals with cardiovascular disease risk factors.
Somani, Y. B., Boidin, M., Peggen, M. A. G., Wanders, I., Proctor, D. N., Low, D. A., . . . Thijssen, D. H. J. (2024). Single and 7-day handgrip and squat exercise prevents endothelial ischemia-reperfusion injury in individuals with cardiovascular disease risk factors.. American journal of physiology. Regulatory, integrative and comparative physiology, 326(1), R79-R87. doi:10.1152/ajpregu.00168.2023
The impact of COVID-19 and the COVID-19 pandemic on hospitalized patients with STEMI in the United States: insights from the National Inpatient Sample.
Kwok, C. S., Qureshi, A. I., Will, M., Schwartz, K., Borovac, J. A., Waters, D., . . . Lip, G. Y. H. (2024). The impact of COVID-19 and the COVID-19 pandemic on hospitalized patients with STEMI in the United States: insights from the National Inpatient Sample.. Coronary artery disease, 35(1), 23-30. doi:10.1097/mca.0000000000001280
Thrombosis and Haemostasis 2023 Editors' Choice Papers.
Weber, C., Rigby, A., & Lip, G. Y. H. (2024). Thrombosis and Haemostasis 2023 Editors' Choice Papers.. Thrombosis and haemostasis, 124(1), 80-87. doi:10.1055/s-0043-1778032
What Cannot be Missed: Important Publications on Electrophysiology in 2023.
Grace, A., Lip, G. Y., Lambiase, P. D., Narayan, S. M., Calkins, H., Guo, Y., . . . Katritsis, D. G. (2024). What Cannot be Missed: Important Publications on Electrophysiology in 2023.. Arrhythmia & electrophysiology review, 13, e04. doi:10.15420/aer.2024.03
2023
Generalisability of and lessons learned from a mixed-methods study conducted in three low- and middle-income countries to identify care pathways for atrial fibrillation
Gooden, T. E., Wang, J., Goulart, A. C., Varella, A. C., Tai, M., Sheron, V. A., . . . Manaseki-Holland, S. (2023). Generalisability of and lessons learned from a mixed-methods study conducted in three low- and middle-income countries to identify care pathways for atrial fibrillation. GLOBAL HEALTH ACTION, 16(1). doi:10.1080/16549716.2023.2231763
Correction: The impact of rate and rhythm control strategies on quality of life for patients with atrial fibrillation: a protocol for a systematic review.
Uruthirakumar, P., Surenthirakumaran, R., Gooden, T. E., Lip, G. Y. H., Thomas, G. N., Moore, D. J., . . . NIHR Global Health Research Group on Atrial Fibrillation Management. (2023). Correction: The impact of rate and rhythm control strategies on quality of life for patients with atrial fibrillation: a protocol for a systematic review.. Systematic reviews, 12(1), 241. doi:10.1186/s13643-023-02434-8
Better blood pressure control in patients with atrial fibrillation: overcoming barriers to improve outcomes
Dzeshka, M. S., Shantsila, A., Shantsila, E., & Lip, G. Y. H. (2023). Better blood pressure control in patients with atrial fibrillation: overcoming barriers to improve outcomes. HEART. doi:10.1136/heartjnl-2023-323028
Metabolic syndrome and ischaemic stroke in non-anticoagulated atrial fibrillation with low CHA<sub>2</sub>DS<sub>2</sub>-VASc scores.
Ahn, H. -J., Lee, S. -R., Choi, E. -K., Lee, S. -W., Han, K. -D., Kwon, S., . . . Lip, G. Y. H. (2023). Metabolic syndrome and ischaemic stroke in non-anticoagulated atrial fibrillation with low CHA<sub>2</sub>DS<sub>2</sub>-VASc scores.. Heart (British Cardiac Society), 110(2), 101-107. doi:10.1136/heartjnl-2022-322143
Subclinical thyroid dysfunction and the risk of incident atrial fibrillation: A systematic review and meta-analysis.
Singh, H., Shahid, M. Z., Harrison, S. L., Lane, D. A., Lip, G. Y. H., & Logantha, S. J. R. J. (2024). Subclinical thyroid dysfunction and the risk of incident atrial fibrillation: A systematic review and meta-analysis.. PloS one, 19(1), e0296413. doi:10.1371/journal.pone.0296413
Clinical outcomes in elderly atrial fibrillation patients at increased bleeding risk treated with very low dose vs. regular-dose non-vitamin K antagonist oral anticoagulants: a nationwide cohort study.
Chan, Y. -H., Chao, T. -F., Chen, S. -W., Lee, H. -F., Li, P. -R., Yeh, Y. -H., . . . Lip, G. Y. H. (2023). Clinical outcomes in elderly atrial fibrillation patients at increased bleeding risk treated with very low dose vs. regular-dose non-vitamin K antagonist oral anticoagulants: a nationwide cohort study.. European heart journal. Cardiovascular pharmacotherapy, 9(8), 681-691. doi:10.1093/ehjcvp/pvad058
Diurnal salivary cortisol and cortisone concentrations in girls with Turner syndrome and healthy controls: a preliminary report.
Jones, L., Park, J., Dliso, S., Hawcutt, D., Shantsila, A., Lip, G. Y. H., & Blair, J. C. (2023). Diurnal salivary cortisol and cortisone concentrations in girls with Turner syndrome and healthy controls: a preliminary report.. Archives of disease in childhood, archdischild-2023-326270. doi:10.1136/archdischild-2023-326270
Statin Therapy Is Associated With a Lower Risk of Heart Failure in Patients With Atrial Fibrillation: A Population-Based Study.
Huang, J. -Y., Chan, Y. -H., Tse, Y. -K., Yu, S. -Y., Li, H. -L., Chen, C., . . . Yiu, K. -H. (2023). Statin Therapy Is Associated With a Lower Risk of Heart Failure in Patients With Atrial Fibrillation: A Population-Based Study.. Journal of the American Heart Association, 12(23), e032378. doi:10.1161/jaha.123.032378
Augmentation of natriuretic peptide (NP) receptor A and B (NPR-A and NPR-B) and cyclic guanosine monophosphate (cGMP) signalling as a therapeutic strategy in heart failure.
Ajay, A., Rasoul, D., Abdullah, A., Lee Wei En, B., Mashida, K., Al-Munaer, M., . . . Sankaranarayanan, R. (2023). Augmentation of natriuretic peptide (NP) receptor A and B (NPR-A and NPR-B) and cyclic guanosine monophosphate (cGMP) signalling as a therapeutic strategy in heart failure.. Expert opinion on investigational drugs, 32(12), 1157-1170. doi:10.1080/13543784.2023.2290064
Managing older people with atrial fibrillation and preventing stroke: a review of anticoagulation approaches.
Verma, L. A., Penson, P. E., Akpan, A., Lip, G. Y. H., & Lane, D. A. (2023). Managing older people with atrial fibrillation and preventing stroke: a review of anticoagulation approaches.. Expert review of cardiovascular therapy, 21(12), 963-983. doi:10.1080/14779072.2023.2276892
Pharmacokinetics and pharmacodynamics of direct oral anticoagulants.
Hindley, B., Lip, G. Y. H., McCloskey, A. P., & Penson, P. E. (2023). Pharmacokinetics and pharmacodynamics of direct oral anticoagulants.. Expert opinion on drug metabolism & toxicology, 19(12), 911-923. doi:10.1080/17425255.2023.2287472
20 years on - the measurement of blood pressure and detection of hypertension in children and adolescents: a national descriptive survey
Jones, L., Park, J., Blair, J., Hawcutt, D. B. B., Lip, G. Y. H., & Shantsila, A. (2023). 20 years on - the measurement of blood pressure and detection of hypertension in children and adolescents: a national descriptive survey. JOURNAL OF HUMAN HYPERTENSION. doi:10.1038/s41371-023-00846-6
Antithrombotic Therapy in Arterial Thrombosis and Thromboembolism in COVID-19: An American College of Chest Physicians Expert Panel Report.
Potpara, T., Angiolillo, D. J., Bikdeli, B., Capodanno, D., Cole, O., Yataco, A. C., . . . Lip, G. Y. H. (2023). Antithrombotic Therapy in Arterial Thrombosis and Thromboembolism in COVID-19: An American College of Chest Physicians Expert Panel Report.. Chest, 164(6), 1531-1550. doi:10.1016/j.chest.2023.06.032
Association Between Atrial Fibrillation and Diabetes-Related Complications: A Nationwide Cohort Study.
Kwon, S., Lee, S. -R., Choi, E. -K., Ahn, H. -J., Lee, S. -W., Jung, J. -H., . . . Lip, G. Y. H. (2023). Association Between Atrial Fibrillation and Diabetes-Related Complications: A Nationwide Cohort Study.. Diabetes care, 46(12), 2240-2248. doi:10.2337/dc23-0931
De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis.
Gorog, D. A., Ferreiro, J. L., Ahrens, I., Ako, J., Geisler, T., Halvorsen, S., . . . Lip, G. Y. H. (2023). De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis.. Nature reviews. Cardiology, 20(12), 830-844. doi:10.1038/s41569-023-00901-2
Extracellular vesicles in cardiovascular diseases: From pathophysiology to diagnosis and therapy.
Du, Y., Wu, L., Wang, L., Reiter, R. J., Lip, G. Y. H., & Ren, J. (2023). Extracellular vesicles in cardiovascular diseases: From pathophysiology to diagnosis and therapy.. Cytokine & growth factor reviews, 74, 40-55. doi:10.1016/j.cytogfr.2023.09.006
Frailty predicts incident atrial fibrillation in women but not in men: The Kuopio Ischaemic Heart Disease Risk Factor Study
Tajik, B., Voutilainen, A., Lyytinen, A., Kauhanen, J., Lip, G. Y. H., Tuomainen, T. -P., & Isanejad, M. (2023). Frailty predicts incident atrial fibrillation in women but not in men: The Kuopio Ischaemic Heart Disease Risk Factor Study. CARDIOLOGY. doi:10.1159/000533361
Increased risk of venous thromboembolism in patients with gastrointestinal disorders
Gue, Y. X., & Lip, G. Y. H. (2023). Increased risk of venous thromboembolism in patients with gastrointestinal disorders. AMERICAN JOURNAL OF HEMATOLOGY. doi:10.1002/ajh.27140
Metformin and SGLT2i as First-line Combination Therapy in Type 2 Diabetes: A Real-world Study With a Focus on Ethnicity.
Anson, M., Zhao, S. S., Essa, H., Austin, P., Ibarburu, G. H., Lip, G. Y. H., & Alam, U. (2023). Metformin and SGLT2i as First-line Combination Therapy in Type 2 Diabetes: A Real-world Study With a Focus on Ethnicity.. Clinical therapeutics, 45(12), 1259-1265. doi:10.1016/j.clinthera.2023.07.026
Pathways to care for Long COVID and for long-term conditions from patients' and clinicians' perspective.
Turk, F., Sweetman, J., Allsopp, G., Crooks, M., Cuthbertson, D. J., Gabbay, M., . . . STIMULATE-ICP Consortium. (2023). Pathways to care for Long COVID and for long-term conditions from patients' and clinicians' perspective.. Journal of evidence-based medicine, 16(4), 435-437. doi:10.1111/jebm.12563
Potential Embolic Sources in Embolic Stroke of Undetermined Source in Patients with Patent Foramen Ovale: Look Harder
Elsheikh, S., Lip, G. Y. H., & Abdul-Rahim, A. H. H. (2023). Potential Embolic Sources in Embolic Stroke of Undetermined Source in Patients with Patent Foramen Ovale: Look Harder. CEREBROVASCULAR DISEASES. doi:10.1159/000529105
Predicting acute and long-term mortality in a cohort of pulmonary embolism patients using machine learning.
El-Bouri, W. K., Sanders, A., Lip, G. Y. H., & BBC-VTE investigators. (2023). Predicting acute and long-term mortality in a cohort of pulmonary embolism patients using machine learning.. European journal of internal medicine, 118, 42-48. doi:10.1016/j.ejim.2023.07.012
Complete revascularization in elderly patients with myocardial infarction-a safe, effective, and necessary strategy?
Gue, Y. X., & Lip, G. Y. H. (2023). Complete revascularization in elderly patients with myocardial infarction-a safe, effective, and necessary strategy?. Cell reports. Medicine, 4(11), 101284. doi:10.1016/j.xcrm.2023.101284
QRS detection in single-lead, telehealth electrocardiogram signals: benchmarking open-source algorithms
Balancing the risk of stroke and bleeding in atrial fibrillation patients with a history of falls.
Latt, N. K. Z., Calvert, P., & Lip, G. Y. H. (2023). Balancing the risk of stroke and bleeding in atrial fibrillation patients with a history of falls.. Expert opinion on drug safety, 22(11), 1041-1048. doi:10.1080/14740338.2023.2273333
Catheter ablation and lower risk of incident dementia and mortality in older adults with atrial fibrillation
Harrison, S. L., Buckley, B. J. R., Austin, P., Lane, D. A., & Lip, G. Y. H. (2023). Catheter ablation and lower risk of incident dementia and mortality in older adults with atrial fibrillation. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. doi:10.1111/jgs.18538
Electrical energy by electrode placement for cardioversion of atrial fibrillation: a systematic review and meta-analysis.
Vinter, N., Holst-Hansen, M. Z. B., Johnsen, S. P., Lip, G. Y. H., Frost, L., & Trinquart, L. (2023). Electrical energy by electrode placement for cardioversion of atrial fibrillation: a systematic review and meta-analysis.. Open heart, 10(2), e002456. doi:10.1136/openhrt-2023-002456
Machine Learning Predicting Atrial Fibrillation as an Adverse Event in the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial.
Gue, Y., Correa, E., Thompson, J. L. P., Homma, S., Qian, M., & Lip, G. Y. H. (2023). Machine Learning Predicting Atrial Fibrillation as an Adverse Event in the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial.. The American journal of medicine, 136(11), 1099-1108.e2. doi:10.1016/j.amjmed.2023.07.019
Interaction of Heart Failure and Stroke: A clinical consensus statement of the ESC Council on Stroke, the Heart Failure Association (HFA) and the ESC Working Group on Thrombosis.
Doehner, W., Böhm, M., Boriani, G., Christersson, C., Coats, A. J., Haeusler, K. G., . . . Rosano, G. (2023). Interaction of Heart Failure and Stroke: A clinical consensus statement of the ESC Council on Stroke, the Heart Failure Association (HFA) and the ESC Working Group on Thrombosis.. European journal of heart failure. doi:10.1002/ejhf.3071
Implications of new-onset atrial fibrillation on in-hospital and long-term prognosis of patients with acute myocardial infarction: A report from the CBD bank study
Yang, W. -Y., Lip, G. Y. H., Sun, Z. -J., Peng, H., Fawzy, A. M., & Li, H. -W. (2023). Implications of new-onset atrial fibrillation on in-hospital and long-term prognosis of patients with acute myocardial infarction: A report from the CBD bank study. Frontiers in Cardiovascular Medicine, 9. doi:10.3389/fcvm.2022.979546
Increased cardiovascular events in young patients with mental disorders: a nationwide cohort study.
Park, C. S., Choi, E. -K., Han, K. -D., Ahn, H. -J., Kwon, S., Lee, S. -R., . . . Lip, G. Y. H. (2023). Increased cardiovascular events in young patients with mental disorders: a nationwide cohort study.. European journal of preventive cardiology, 30(15), 1582-1592. doi:10.1093/eurjpc/zwad102
Relation of Life's Essential 8 to the genetic predisposition for cardiovascular outcomes and all-cause mortality: results from a national prospective cohort
Zhang, J., Chen, G., Habudele, Z., Wang, X., Cai, M., Li, H., . . . Lin, H. (2023). Relation of Life's Essential 8 to the genetic predisposition for cardiovascular outcomes and all-cause mortality: results from a national prospective cohort. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. doi:10.1093/eurjpc/zwad179
Sex-related differences in presentation, treatment, and outcomes of Asian patients with atrial fibrillation: a report from the prospective APHRS-AF Registry.
Bucci, T., Shantsila, A., Romiti, G. F., Teo, W. -S., Park, H. -W., Shimizu, W., . . . Asia-Pacific Heart Rhythm Society Atrial Fibrillation Registry Investigators. (2023). Sex-related differences in presentation, treatment, and outcomes of Asian patients with atrial fibrillation: a report from the prospective APHRS-AF Registry.. Scientific reports, 13(1), 18375. doi:10.1038/s41598-023-45345-3
Management of ischaemic stroke survivors in primary care setting: the road to holistic care
Ozdemir, H., Sagris, D., Abdul Rahim, A. H., Lip, G., & Shantsila, E. (2023). Management of ischaemic stroke survivors in primary care setting: the road to holistic care. Internal and Emergency Medicine.
The quest to refine atrial fibrillation-related stroke risk stratification: could the answer lie in left atrial appendage angiography?
Lip, G. Y. H., Mills, M. T., & Gupta, D. (2023). The quest to refine atrial fibrillation-related stroke risk stratification: could the answer lie in left atrial appendage angiography?. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 19(8), 625-627. doi:10.4244/eij-e-23-00038
Co-administered oral anticoagulants with nonsteroidal anti-inflammatory drugs and the risk of bleeding: A systematic review and meta-analysis.
Zheng, Y., Zhang, N., Tse, G., Li, G., Lip, G. Y. H., & Liu, T. (2023). Co-administered oral anticoagulants with nonsteroidal anti-inflammatory drugs and the risk of bleeding: A systematic review and meta-analysis.. Thrombosis research, 232, 15-26. doi:10.1016/j.thromres.2023.10.011
ABC-AF-Stroke score predicts thromboembolism in non-anticoagulated patients following successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry.
Wang, Y., Jiang, C., He, L., Du, X., Guo, X., Tang, R., . . . Ma, C. (2023). ABC-AF-Stroke score predicts thromboembolism in non-anticoagulated patients following successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry.. Chinese medical journal, 136(20), 2451-2458. doi:10.1097/cm9.0000000000002833
COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment.
Ortega-Paz, L., Talasaz, A. H., Sadeghipour, P., Potpara, T. S., Aronow, H. D., Jara-Palomares, L., . . . Bikdeli, B. (2023). COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment.. Seminars in thrombosis and hemostasis, 49(8), 816-832. doi:10.1055/s-0042-1757634
Machine Learning in Cardio-Oncology: New Insights from an Emerging Discipline.
Zheng, Y., Chen, Z., Huang, S., Zhang, N., Wang, Y., Hong, S., . . . Liu, T. (2023). Machine Learning in Cardio-Oncology: New Insights from an Emerging Discipline.. Reviews in cardiovascular medicine, 24(10), 296. doi:10.31083/j.rcm2410296
Impact of components of metabolic syndrome on the risk of adverse renal outcomes in patients with atrial fibrillation: a nationwide cohort study.
Kwon, S., Lee, S. -R., Choi, E. -K., Lee, S. -W., Jung, J. -H., Han, K. -D., . . . Lip, G. Y. H. (2023). Impact of components of metabolic syndrome on the risk of adverse renal outcomes in patients with atrial fibrillation: a nationwide cohort study.. Frontiers in cardiovascular medicine, 10, 1208979. doi:10.3389/fcvm.2023.1208979
Implications of Clinical Risk Phenotypes on the Management and Natural History of Atrial Fibrillation: A Report From the GLORIA-AF.
Romiti, G. F., Proietti, M., Corica, B., Bonini, N., Boriani, G., Huisman, M. V., . . . GLORIA‐AF Investigators. (2023). Implications of Clinical Risk Phenotypes on the Management and Natural History of Atrial Fibrillation: A Report From the GLORIA-AF.. Journal of the American Heart Association, 12(20), e030565. doi:10.1161/jaha.123.030565
Hs-CRP is associated with Heart Failure Hospitalization in Patients with MAFLD and Normal LVEF Undergoing Coronary Angiography
Low-grade endotoxemia and risk of recurrent thrombosis in primary antiphospholipid syndrome. The multicenter ATHERO-APS study.
Bucci, T., Ames, P. R. J., Cammisotto, V., Cardamone, C., Ciampa, A., Mangoni, B., . . . ATHERO-APS study group. (2023). Low-grade endotoxemia and risk of recurrent thrombosis in primary antiphospholipid syndrome. The multicenter ATHERO-APS study.. Thrombosis research, 231, 76-83. doi:10.1016/j.thromres.2023.10.006
Associations of Life's Essential 8 and fine particulate matter pollution with the incidence of atrial fibrillation
Zhang, J., Chen, G., Xia, H., Wang, X., Wang, C., Cai, M., . . . Lin, H. (2023). Associations of Life's Essential 8 and fine particulate matter pollution with the incidence of atrial fibrillation. JOURNAL OF HAZARDOUS MATERIALS, 459. doi:10.1016/j.jhazmat.2023.132114
Asymptomatic atrial fibrillation among hospitalized patients: clinical correlates and in-hospital outcomes in Improving Care for Cardiovascular Disease in China-Atrial Fibrillation
Lin, J., Wu, X. -Y., Long, D. -Y., Jiang, C. -X., Sang, C. -H., Tang, R. -B., . . . CCC, A. F. I. (2023). Asymptomatic atrial fibrillation among hospitalized patients: clinical correlates and in-hospital outcomes in Improving Care for Cardiovascular Disease in China-Atrial Fibrillation. EUROPACE, 25(10). doi:10.1093/europace/euad272
Comparisons of effectiveness and safety between on-label dosing, off-label underdosing, and off-label overdosing in Asian and non-Asian atrial fibrillation patients treated with rivaroxaban: a systematic review and meta-analysis of observational studies.
Chan, Y. -H., Chan, C. -Y., Chen, S. -W., Chao, T. -F., & Lip, G. Y. H. (2023). Comparisons of effectiveness and safety between on-label dosing, off-label underdosing, and off-label overdosing in Asian and non-Asian atrial fibrillation patients treated with rivaroxaban: a systematic review and meta-analysis of observational studies.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 25(10), euad288. doi:10.1093/europace/euad288
Effectiveness of out-patient based acute heart failure care: a pilot randomised controlled trial
Wong, K. Y. K., Hughes, D. A., Debski, M., Latt, N., Assaf, O., Abdelrahman, A., . . . Cleland, J. G. F. (2023). Effectiveness of out-patient based acute heart failure care: a pilot randomised controlled trial. ACTA CARDIOLOGICA, 78(7), 828-837. doi:10.1080/00015385.2023.2197834
All-cause mortality and cardiovascular outcomes with sodium-glucose Co-transporter 2 inhibitors, glucagon-like peptide-1 receptor agonists and with combination therapy in people with type 2 diabetes
Riley, D. R., Essa, H., Austin, P., Preston, F., Kargbo, I., Ibarburu, G. H., . . . Alam, U. (2023). All-cause mortality and cardiovascular outcomes with sodium-glucose Co-transporter 2 inhibitors, glucagon-like peptide-1 receptor agonists and with combination therapy in people with type 2 diabetes. DIABETES OBESITY & METABOLISM, 25(10), 2897-2909. doi:10.1111/dom.15185
Dementia Risk of Direct Oral Anticoagulants Versus Warfarin for Atrial Fibrillation: Systematic Review and Meta-Analysis.
Fong, K. Y., Chan, Y. H., Wang, Y., Yeo, C., Rosario, B. H., Lip, G. Y. H., & Tan, V. H. (2023). Dementia Risk of Direct Oral Anticoagulants Versus Warfarin for Atrial Fibrillation: Systematic Review and Meta-Analysis.. JACC. Asia, 3(5), 776-786. doi:10.1016/j.jacasi.2023.07.012
Identifying and understanding the care pathway of patients with atrial fibrillation in Brazil and the impact of the COVID-19 pandemic: A mixed-methods study.
Goulart, A. C., Varella, A. C., Gooden, T. E., Lip, G. Y. H., Jolly, K., Thomas, G. N., . . . NIHR Global Health Research Group on Atrial Fibrillation Management. (2023). Identifying and understanding the care pathway of patients with atrial fibrillation in Brazil and the impact of the COVID-19 pandemic: A mixed-methods study.. PloS one, 18(10), e0292463. doi:10.1371/journal.pone.0292463
Radiofrequency catheter ablation of atrial fibrillation: A review of techniques.
Calvert, P., Lip, G. Y. H., & Gupta, D. (2023). Radiofrequency catheter ablation of atrial fibrillation: A review of techniques.. Trends in cardiovascular medicine, 33(7), 405-415. doi:10.1016/j.tcm.2022.04.002
Systematic Review and Meta-Analysis of Direct Oral Anticoagulants Versus Warfarin in Atrial Fibrillation With Low Stroke Risk.
Fong, K. Y., Chan, Y. H., Yeo, C., Lip, G. Y. H., & Tan, V. H. (2023). Systematic Review and Meta-Analysis of Direct Oral Anticoagulants Versus Warfarin in Atrial Fibrillation With Low Stroke Risk.. The American journal of cardiology, 204, 366-376. doi:10.1016/j.amjcard.2023.07.108
The ABC-Death Score for Mortality Prediction in Patients With Atrial Fibrillation Undergoing Catheter Ablation.
Wang, Y. -F., Jiang, C., He, L., Du, X., Guo, X. -Y., Tang, R. -B., . . . Ma, C. -S. (2023). The ABC-Death Score for Mortality Prediction in Patients With Atrial Fibrillation Undergoing Catheter Ablation.. JACC. Asia, 3(5), 790-801. doi:10.1016/j.jacasi.2023.07.007
Use of historical remote monitoring data to determine predictors of CPAP non-compliance in patients with OSA.
Cowen, J., Harrison, S., Thom, L., Thomas, M., Sedano, J., Stephens, P., . . . Craig, S. (2023). Use of historical remote monitoring data to determine predictors of CPAP non-compliance in patients with OSA.. Sleep & breathing = Schlaf & Atmung, 27(5), 1899-1908. doi:10.1007/s11325-023-02806-3
Future Innovations in Novel Detection for Atrial Fibrillation (FIND-AF): pilot study of an electronic health record machine learning algorithm-guided intervention to identify undiagnosed atrial fibrillation
Nadarajah, R., Wahab, A., Reynolds, C., Raveendra, K., Askham, D., Dawson, R., . . . Gale, C. P. (2023). Future Innovations in Novel Detection for Atrial Fibrillation (FIND-AF): pilot study of an electronic health record machine learning algorithm-guided intervention to identify undiagnosed atrial fibrillation. OPEN HEART, 10(2). doi:10.1136/openhrt-2023-002447
Risk of Incident Atrial Fibrillation and Subsequent Use of Oral Anticoagulants in Patients with Dementia.
Tsai, C. -T., Chan, Y. -H., Liao, J. -N., Chen, T. -J., Lip, G. Y. H., Chen, S. -A., & Chao, T. -F. (2024). Risk of Incident Atrial Fibrillation and Subsequent Use of Oral Anticoagulants in Patients with Dementia.. Thrombosis and haemostasis, 124(3), 253-262. doi:10.1055/a-2184-7506
Prevalence of heart failure stages in the general population and implications for heart failure prevention: reports from the China Hypertension Survey 2012-15.
Cai, A., Zheng, C., Qiu, J., Fonarow, G. C., Lip, G. Y. H., Feng, Y., & Wang, Z. (2023). Prevalence of heart failure stages in the general population and implications for heart failure prevention: reports from the China Hypertension Survey 2012-15.. European journal of preventive cardiology, 30(13), 1391-1400. doi:10.1093/eurjpc/zwad223
Associations of renal function with cerebral small vessel disease and functional outcome in acute intracerebral haemorrhage: A hospital-based prospective cohort study.
Nash, P. S., Best, J. G., Ambler, G., Wilson, D., Banerjee, G., Hostettler, I. C., . . . CROMIS-2 collaborators. (2023). Associations of renal function with cerebral small vessel disease and functional outcome in acute intracerebral haemorrhage: A hospital-based prospective cohort study.. Journal of the neurological sciences, 452, 120743. doi:10.1016/j.jns.2023.120743
Left ventricular hypertrophy and mortality in ethnic minority groups in the UK: e-ECHOES study.
Shantsila, E., Shantsila, A., Williams, N., Lip, G. Y. H., & Gill, P. S. (2023). Left ventricular hypertrophy and mortality in ethnic minority groups in the UK: e-ECHOES study.. Journal of hypertension. doi:10.1097/hjh.0000000000003561
Social determinants of health and recurrence of atrial fibrillation after catheter ablation: a Danish nationwide cohort study
Vinter, N., Calvert, P., Kronborg, M. B., Cosedis-Nielsen, J., Gupta, D., Ding, W. Y., . . . Lip, G. Y. H. (2023). Social determinants of health and recurrence of atrial fibrillation after catheter ablation: a Danish nationwide cohort study. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 9(6), 632-638. doi:10.1093/ehjqcco/qcac071
Temporal trends of stroke severity and the association between antithrombotic drug regimen changes and clinical outcomes after stroke in atrial fibrillation
Metabolic syndrome is associated with similar long-term prognosis in those living with and without obesity: an analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 studies
Osadnik, K., Osadnik, T., Gierlotka, M., Windak, A., Tomasik, T., Mastej, M., . . . Jozwiak, J. (2023). Metabolic syndrome is associated with similar long-term prognosis in those living with and without obesity: an analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 studies. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. doi:10.1093/eurjpc/zwad101
Artificial Intelligence in the Image-Guided Care of Atrial Fibrillation
Lyu, Y., Bennamoun, M., Sharif, N., Lip, G. Y. H., & Dwivedi, G. (2023). Artificial Intelligence in the Image-Guided Care of Atrial Fibrillation. Life, 13(9). doi:10.3390/life13091870
Screening of atrial fibrillation in dental practices: a qualitative feasibility study.
Obaid Hassan, A., Moreno Lopez, R., Lane, D. A., Lip, G. Y. H., Harris, R. V., Mughal, A., & Weir, C. (2023). Screening of atrial fibrillation in dental practices: a qualitative feasibility study.. Expert review of cardiovascular therapy. doi:10.1080/14779072.2023.2254679
A Commentary on "Low Utility of Short-Term Rhythm Assessment Before Long-Term Rhythm Monitoring in Patients With Cryptogenic Stroke".
Griffin, M., & Lip, G. Y. H. (2023). A Commentary on "Low Utility of Short-Term Rhythm Assessment Before Long-Term Rhythm Monitoring in Patients With Cryptogenic Stroke".. The American journal of cardiology, 202, 239-240. doi:10.1016/j.amjcard.2023.07.015
Copper homeostasis and cuproptosis in cardiovascular disease therapeutics.
Yang, L., Yang, P., Lip, G. Y. H., & Ren, J. (2023). Copper homeostasis and cuproptosis in cardiovascular disease therapeutics.. Trends in pharmacological sciences, 44(9), 573-585. doi:10.1016/j.tips.2023.07.004
Long-term risk of cardiovascular implantable electronic device reinterventions following external cardioversion of atrial fibrillation and flutter: A nationwide cohort study.
Elgaard, A. F., Dinesen, P. T., Riahi, S., Hansen, J., Lundbye-Christensen, S., Johansen, J. B., . . . Larsen, J. M. (2023). Long-term risk of cardiovascular implantable electronic device reinterventions following external cardioversion of atrial fibrillation and flutter: A nationwide cohort study.. Heart rhythm, 20(9), 1227-1235. doi:10.1016/j.hrthm.2023.03.024
Machine-learning-derived heart and brain age are independently associated with cognition
Cameron, A. C. C., Lip, G. Y. H., & Abdul-Rahim, A. H. H. (2023). Machine-learning-derived heart and brain age are independently associated with cognition. EUROPEAN JOURNAL OF NEUROLOGY. doi:10.1111/ene.15953
Mobile health technology integrated care in atrial fibrillation patients with diabetes mellitus in China: A subgroup analysis of the mAFA‐II cluster randomized clinical trial
Guo, Y., Corica, B., Romiti, G. F., Proietti, M., Zhang, H., & Lip, G. Y. H. (n.d.). Mobile health technology integrated care in atrial fibrillation patients with diabetes mellitus in China: A subgroup analysis of the mAFA‐II cluster randomized clinical trial. European Journal of Clinical Investigation. doi:10.1111/eci.14031
Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry.
Romiti, G. F., Corica, B., Proietti, M., Mei, D. A., Frydenlund, J., Bisson, A., . . . GLORIA-AF Investigators. (2023). Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry.. EClinicalMedicine, 63, 102039. doi:10.1016/j.eclinm.2023.102039
Prediction of new onset atrial fibrillation in patients with acute coronary syndrome undergoing percutaneous coronary intervention using the C2HEST and mC2HEST scores: A report from the multicenter REALE-ACS registry.
Biccirè, F. G., Tanzilli, G., Prati, F., Sammartini, E., Gelfusa, M., Celeski, M., . . . Pastori, D. (2023). Prediction of new onset atrial fibrillation in patients with acute coronary syndrome undergoing percutaneous coronary intervention using the C2HEST and mC2HEST scores: A report from the multicenter REALE-ACS registry.. International journal of cardiology, 386, 45-49. doi:10.1016/j.ijcard.2023.05.023
Serum antinuclear autoantibodies are associated with measures of oxidative stress and lifestyle factors: analysis of LIPIDOGRAM2015 and LIPIDOGEN2015 studies.
Krzemień, P., Kasperczyk, S., Banach, M., Kasperczyk, A., Dobrakowski, M., Tomasik, T., . . . Jóźwiak, J. J. (2023). Serum antinuclear autoantibodies are associated with measures of oxidative stress and lifestyle factors: analysis of LIPIDOGRAM2015 and LIPIDOGEN2015 studies.. Archives of medical science : AMS, 19(5), 1214-1227. doi:10.5114/aoms/139313
Ventricular arrhythmias and cardiac arrest in atrial fibrillation patients with pacemakers and implantable cardioverter-defibrillators.
Fawzy, A. M., Bisson, A., Bentounes, S. A., Bodin, A., Herbert, J., Lip, G. Y. H., & Fauchier, L. (2023). Ventricular arrhythmias and cardiac arrest in atrial fibrillation patients with pacemakers and implantable cardioverter-defibrillators.. European journal of internal medicine, 115, 70-78. doi:10.1016/j.ejim.2023.05.014
Visit-to-Visit Heart Rate Variability in the Prediction of Clinical Outcomes of Patients with Atrial Fibrillation.
Krittayaphong, R., Boonyapisit, W., Sairat, P., & Lip, G. Y. H. (2023). Visit-to-Visit Heart Rate Variability in the Prediction of Clinical Outcomes of Patients with Atrial Fibrillation.. Thrombosis and haemostasis, 123(9), 920-929. doi:10.1055/s-0043-1768580
Neuroticism and sudden cardiac death: a prospective cohort study from UK biobank.
Rhee, T. -M., Lee, K. -Y., Choi, J., Choi, E. -K., Ahn, H. -J., Lee, S. -R., . . . Lip, G. Y. H. (2023). Neuroticism and sudden cardiac death: a prospective cohort study from UK biobank.. Clinical research in cardiology : official journal of the German Cardiac Society. doi:10.1007/s00392-023-02289-y
Machine learning profiles of cardiovascular risk in patients with diabetes mellitus: the Silesia Diabetes-Heart Project
Kwiendacz, H., Wijata, A. M., Nalepa, J., Piasnik, J., Kulpa, J., Herba, M., . . . Nabrdalik, K. (2023). Machine learning profiles of cardiovascular risk in patients with diabetes mellitus: the Silesia Diabetes-Heart Project. CARDIOVASCULAR DIABETOLOGY, 22(1). doi:10.1186/s12933-023-01938-w
Association between the accumulation of elevated serum γ-glutamyltransferase level and risk of atrial fibrillation: a nationwide cohort study.
Jeon, W. K., Lee, S. -R., Han, K. -D., Choi, E. -K., Oh, S., & Lip, G. Y. H. (2023). Association between the accumulation of elevated serum γ-glutamyltransferase level and risk of atrial fibrillation: a nationwide cohort study.. Scientific reports, 13(1), 13771. doi:10.1038/s41598-023-40689-2
Comparisons of new-onset peripheral arterial disease in Type 2 diabetes mellitus patients exposed to SGLT2I, DPP4I or GLP1a: a population-based cohort study
Prediction of early death after atrial fibrillation diagnosis using a machine learning approach: A French nationwide cohort study.
Bisson, A., Lemrini, Y., Romiti, G. F., Proietti, M., Angoulvant, D., Bentounes, S., . . . Fauchier, L. (2023). Prediction of early death after atrial fibrillation diagnosis using a machine learning approach: A French nationwide cohort study.. American heart journal, S0002-8703(23)00203-X. doi:10.1016/j.ahj.2023.08.006
Venous Thromboembolism in Patients With Atrial Fibrillation
Pastori, D., Gazzaniga, G., Farcomeni, A., Bucci, T., Menichelli, D., Franchino, G., . . . Lip, G. Y. H. (2023). Venous Thromboembolism in Patients With Atrial Fibrillation. JACC: Advances, 2(7), 100555. doi:10.1016/j.jacadv.2023.100555
Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry.
Ding, W. Y., Fawzy, A. M., Romiti, G. F., Proietti, M., Pastori, D., Huisman, M. V., . . . GLORIA-AF Investigators. (2023). Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry.. Journal of thrombosis and thrombolysis. doi:10.1007/s11239-023-02866-y
Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus
Wang, R., Gerstein, H. C., Van Spall, H. G. C., Lip, G. Y. H., Olier, I., Ortega-Martorell, S., . . . Li, G. (2023). Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 9(5), 537-545. doi:10.1093/ehjqcco/qcad030
Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus: Reply
Wang, R., Gerstein, H. C., Van Spall, H. G. C., Lip, G. Y. H., Olier, I., Ortega-Martorell, S., . . . Li, G. (2023). Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus: Reply. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 9(5), 547. doi:10.1093/ehjqcco/qcad038
Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal
Lip, G. Y. H., Proietti, M., Potpara, T., Mansour, M., Savelieva, I., Tse, H. F., . . . Boriani, G. (2023). Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal. EUROPACE, 25(9). doi:10.1093/europace/euad226
A randomized controlled trial to investigate the use of acute coronary syndrome therapy in patients hospitalized with COVID-19: the COVID-19 Acute Coronary Syndrome trial
Kanagaratnam, P., Francis, D. P., Chamie, D., Coyle, C., Marynina, A., Katritsis, G., . . . Shun-Shin, M. (2023). A randomized controlled trial to investigate the use of acute coronary syndrome therapy in patients hospitalized with COVID-19: the COVID-19 Acute Coronary Syndrome trial. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 21(8), 2213-2222. doi:10.1016/j.jtha.2023.04.045
An international multidisciplinary consensus statement on MAFLD and the risk of CVD.
Zhou, X. -D., Targher, G., Byrne, C. D., Somers, V., Kim, S. U., Chahal, C. A. A., . . . Zheng, M. -H. (2023). An international multidisciplinary consensus statement on MAFLD and the risk of CVD.. Hepatology international, 17(4), 773-791. doi:10.1007/s12072-023-10543-8
Association Between Glucosamine Use and the Risk of Incident Heart Failure: The UK Biobank Cohort Study and Mendelian Randomization Analysis.
Zheng, J., Hukportie, D. N., Zhang, Y., Huang, J., Ni, C., Lip, G. Y. H., & Tang, S. (2023). Association Between Glucosamine Use and the Risk of Incident Heart Failure: The UK Biobank Cohort Study and Mendelian Randomization Analysis.. Mayo Clinic proceedings, 98(8), 1177-1191. doi:10.1016/j.mayocp.2023.04.019
Cardiovascular disease (CVD) outcomes and associated risk factors in a medicare population without prior CVD history: an analysis using statistical and machine learning algorithms.
Lip, G. Y. H., Genaidy, A., & Estes, C. (2023). Cardiovascular disease (CVD) outcomes and associated risk factors in a medicare population without prior CVD history: an analysis using statistical and machine learning algorithms.. Internal and emergency medicine, 18(5), 1373-1383. doi:10.1007/s11739-023-03297-6
Cerebral infarction and in-hospital mortality for patients admitted to hospital with intracardiac thrombus: insights from the National Inpatient Sample
Kwok, C. S., Abbas, K. S., Qureshi, A. I., & Lip, G. Y. H. (2023). Cerebral infarction and in-hospital mortality for patients admitted to hospital with intracardiac thrombus: insights from the National Inpatient Sample. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 56(2), 342-350. doi:10.1007/s11239-023-02824-8
Comparative validation of HAS-BLED, GARFIELD-AF and ORBIT bleeding risk scores in Asian people with atrial fibrillation treated with oral anticoagulant: A report from the COOL-AF registry.
Chichareon, P., Winijkul, A., Lip, G. Y. H., & Krittayaphong, R. (2023). Comparative validation of HAS-BLED, GARFIELD-AF and ORBIT bleeding risk scores in Asian people with atrial fibrillation treated with oral anticoagulant: A report from the COOL-AF registry.. British journal of clinical pharmacology, 89(8), 2472-2482. doi:10.1111/bcp.15716
Diabetic Peripheral Neuropathy is Associated With Diabetic Kidney Disease and Cardiovascular Disease: The Silesia Diabetes-Heart Project
Nabrdalik, K., Kwiendacz, H., Moos, J., Moos, L., Kulpa, J., Brzoza, Z., . . . Lip, G. Y. H. (2023). Diabetic Peripheral Neuropathy is Associated With Diabetic Kidney Disease and Cardiovascular Disease: The Silesia Diabetes-Heart Project. CURRENT PROBLEMS IN CARDIOLOGY, 48(8). doi:10.1016/j.cpcardiol.2023.101726
Poststroke Cardiovascular Management: Current Concepts, Integrated Care, and Future Developments.
Lip, G. Y. H., Lenarczyk, R., Pastori, D., Ntaios, G., Doehner, W., & Schnabel, R. B. (2023). Poststroke Cardiovascular Management: Current Concepts, Integrated Care, and Future Developments.. Current problems in cardiology, 48(8), 101738. doi:10.1016/j.cpcardiol.2023.101738
Real world time trends in antithrombotic treatment for newly diagnosed atrial fibrillation in China: reports from the GLORIA-AF Phase III registry : Trends in antithrombotic therapy use in China.
Liu, X., Feng, G., Marler, S. V., Huisman, M. V., Lip, G. Y. H., & Ma, C. (2023). Real world time trends in antithrombotic treatment for newly diagnosed atrial fibrillation in China: reports from the GLORIA-AF Phase III registry : Trends in antithrombotic therapy use in China.. Thrombosis journal, 21(1), 83. doi:10.1186/s12959-023-00527-x
Beyond individual risk factors in atrial fibrillation: The interactions of hypertension and sex.
Shantsila, E., Shantsila, A., & Lip, G. Y. H. (2023). Beyond individual risk factors in atrial fibrillation: The interactions of hypertension and sex.. American journal of hypertension, hpad069. doi:10.1093/ajh/hpad069
Antidiabetic drugs and hypoglycaemia risk in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants
Nabrdalik, K., Kwiendacz, H., & Lip, G. Y. H. (2023). Antidiabetic drugs and hypoglycaemia risk in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 9(5), 435-436. doi:10.1093/ehjcvp/pvad042
Sex-based differences in risk of ischaemic stroke or systemic embolism after BNT162b2 or CoronaVac COVID-19 vaccination in patients with atrial fibrillation: a self-controlled case series and nested case-control study
Ye, X., Huang, C., Yan, V. K. C., Kang, W., Fan, M., Tsang, G. K. C., . . . Chan, E. W. Y. (2023). Sex-based differences in risk of ischaemic stroke or systemic embolism after BNT162b2 or CoronaVac COVID-19 vaccination in patients with atrial fibrillation: a self-controlled case series and nested case-control study. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 9(5), 403-412. doi:10.1093/ehjcvp/pvad015
The neurocognitive effects of atrial fibrillation: benefits of the ABC pathway
Calvert, P., Gupta, D., & Lip, G. Y. H. (2023). The neurocognitive effects of atrial fibrillation: benefits of the ABC pathway. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 9(5), 413-420. doi:10.1093/ehjcvp/pvad021
Long Covid active case finding study protocol: A co-produced community-based pilot within the STIMULATE-ICP study (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways)
Alwan, N., Clutterbuck, D., Pantelic, M., Hayer, J., Fisher, L., Hishmeh, L., . . . STIMULATE-ICP, C. (2023). Long Covid active case finding study protocol: A co-produced community-based pilot within the STIMULATE-ICP study (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways). PLOS ONE, 18(7). doi:10.1371/journal.pone.0284297
Prevalence, risk factors and outcomes of cardiac disease in cystic fibrosis: A multinational retrospective cohort study.
Frost, F., Nazareth, D., Fauchier, L., Wat, D., Shelley, J., Austin, P., . . . Lip, G. Y. H. (2023). Prevalence, risk factors and outcomes of cardiac disease in cystic fibrosis: A multinational retrospective cohort study.. The European respiratory journal, 2300174. doi:10.1183/13993003.00174-2023
The impact of frailty on the management of atrial fibrillation.
Harrison, S. L., Johnsen, S. P., & Lip, G. Y. H. (2023). The impact of frailty on the management of atrial fibrillation.. Aging, 15(14), 6622-6624. doi:10.18632/aging.204918
The influence of SGLT2 inhibitors on oxidative stress in heart failure and chronic kidney disease in patients with type 2 diabetes
Nabrdalik-Lesniak, D., Nabrdalik, K., Irlik, K., Janota, O., Kwiendacz, H., Szromek-Bialek, P., . . . Lip, G. Y. H. (2023). The influence of SGLT2 inhibitors on oxidative stress in heart failure and chronic kidney disease in patients with type 2 diabetes. ENDOKRYNOLOGIA POLSKA, 74(4), 349-362. doi:10.5603/EP.a2023.0039
Antihypertensive treatment in people of very old age with frailty: time for a paradigm shift?
Shantsila, E., Lip, G. Y. H., Shantsila, A., Kurpas, D., Beevers, G., Gill, P. S., & Williams, N. H. (2023). Antihypertensive treatment in people of very old age with frailty: time for a paradigm shift?. Journal of Hypertension, 4(10), 1502-1510. doi:10.1097/hjh.0000000000003495
Correct dosing, adherence and persistence of DOACs in atrial fibrillation and chronic kidney disease: a systematic review and meta-analysis.
Emanuel, S., Kaba, R. A., Delanerolle, G., Field, B. C. T., Lip, G. Y. H., & de Lusignan, S. (2023). Correct dosing, adherence and persistence of DOACs in atrial fibrillation and chronic kidney disease: a systematic review and meta-analysis.. Open heart, 10(2), e002340. doi:10.1136/openhrt-2023-002340
New-onset syncope in diabetic patients treated with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors: A Chinese population-based cohort study
Effect of Oral Anticoagulants in Atrial Fibrillation Patients with Polypharmacy: A Meta-analysis
Zheng, Y., Li, S., Liu, X., Lip, G. Y. H., Guo, L., & Zhu, W. (2023). Effect of Oral Anticoagulants in Atrial Fibrillation Patients with Polypharmacy: A Meta-analysis. THROMBOSIS AND HAEMOSTASIS. doi:10.1055/s-0043-1770724
Atrial Fibrillation Detected before or after Stroke: Role of Anticoagulation.
Lyrer, F., Zietz, A., Seiffge, D. J., Koga, M., Volbers, B., Wilson, D., . . . NOACISP-LONGTERM, Erlangen Registry, CROMIS-2, SAMURAI-NVAF and Verona Registry collaborators. (2023). Atrial Fibrillation Detected before or after Stroke: Role of Anticoagulation.. Annals of neurology, 94(1), 43-54. doi:10.1002/ana.26654
Early Rhythm Control in Patients With Incident Atrial Fibrillation Who Had a Prior Stroke.
Lee, S. -R., Choi, E. -K., Lee, S. -W., Han, K. -D., Oh, S., & Lip, G. Y. H. (2023). Early Rhythm Control in Patients With Incident Atrial Fibrillation Who Had a Prior Stroke.. JACC. Clinical electrophysiology, 9(7 Pt 2), 1121-1133. doi:10.1016/j.jacep.2022.11.021
Effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on cardiovascular and kidney outcomes in Asian versus White patients with type 2 diabetes mellitus.
Zhang, J., Van Spall, H. G., Li, L., Khan, M. S., Pandey, A., Thabane, L., . . . Li, G. (2023). Effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on cardiovascular and kidney outcomes in Asian versus White patients with type 2 diabetes mellitus.. Diabetes & metabolic syndrome, 17(7), 102804. doi:10.1016/j.dsx.2023.102804
Impact of Cerebral Microbleeds in Stroke Patients with Atrial Fibrillation
Soo, Y., Zietz, A., Yiu, B., Mok, V. C. T., Polymeris, A. A., Seiffge, D., . . . Peters, N. (2023). Impact of Cerebral Microbleeds in Stroke Patients with Atrial Fibrillation. ANNALS OF NEUROLOGY, 94(1), 61-74. doi:10.1002/ana.26642
Impact of particulate matter on the incidence of atrial fibrillation and the risk of adverse clinical outcomes: A review.
Mandaglio-Collados, D., López-Gálvez, R., Ruiz-Alcaraz, A. J., López-García, C., Roldán, V., Lip, G. Y. H., . . . Rivera-Caravaca, J. M. (2023). Impact of particulate matter on the incidence of atrial fibrillation and the risk of adverse clinical outcomes: A review.. The Science of the total environment, 880, 163352. doi:10.1016/j.scitotenv.2023.163352
Machine Learning Predicts Cardiovascular Events in Patients With Diabetes: The Silesia Diabetes-Heart Project
Nabrdalik, K., Kwiendacz, H., Drozdz, K., Irlik, K., Hendel, M., Wijata, A. M., . . . Lip, G. Y. H. (2023). Machine Learning Predicts Cardiovascular Events in Patients With Diabetes: The Silesia Diabetes-Heart Project. CURRENT PROBLEMS IN CARDIOLOGY, 48(7). doi:10.1016/j.cpcardiol.2023.101694
Using the 4S-AF scheme to characterize new-onset atrial fibrillation after myocardial infarction.
Dunlop, J., Potpara, T., & Lip, G. Y. H. (2023). Using the 4S-AF scheme to characterize new-onset atrial fibrillation after myocardial infarction.. European journal of internal medicine, 113, 20-21. doi:10.1016/j.ejim.2023.05.004
Integrated Care for Atrial Fibrillation Using the ABC Pathway in the Prospective APHRS-AF Registry
Bucci, T., Proietti, M., Shantsila, A., Romiti, G. F., Teo, W. -S., Park, H. -W., . . . Chao, T. -F. (2023). Integrated Care for Atrial Fibrillation Using the ABC Pathway in the Prospective APHRS-AF Registry. JACC: Asia, 3(4), 580-591. doi:10.1016/j.jacasi.2023.04.008
Phenotypes and outcomes in non-anticoagulated patients with atrial fibrillation: An unsupervised cluster analysis.
Bisson, A., M Fawzy, A., Romiti, G. F., Proietti, M., Angoulvant, D., El-Bouri, W., . . . Fauchier, L. (2023). Phenotypes and outcomes in non-anticoagulated patients with atrial fibrillation: An unsupervised cluster analysis.. Archives of cardiovascular diseases, S1875-2136(23)00120-1. doi:10.1016/j.acvd.2023.06.001
Hypertension and atrial fibrillation: Closing a virtuous circle
Gue, Y. X., & Lip, G. Y. H. (2023). Hypertension and atrial fibrillation: Closing a virtuous circle. In Advances in Surgical and Medical Specialties (pp. 191-195).
Relationship of vitamin D deficiency with cardiovascular disease and glycemic control in patients with type 2 diabetes mellitus: the Silesia Diabetes-Heart Project
Kwiendacz, H., Nabrdalik, K., Wijata, A. M., Bartman, W., Tabor, E., Olejarz, A., . . . Lip, G. Y. H. (2023). Relationship of vitamin D deficiency with cardiovascular disease and glycemic control in patients with type 2 diabetes mellitus: the Silesia Diabetes-Heart Project. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 133(6). doi:10.20452/pamw.16445
Social determinants of health and catheter ablation after an incident diagnosis of atrial fibrillation: a Danish nationwide cohort study
Vinter, N., Calvert, P., Kronborg, M. B., Cosedis-Nielsen, J., Gupta, D., Ding, W. Y., . . . Lip, G. Y. H. (2023). Social determinants of health and catheter ablation after an incident diagnosis of atrial fibrillation: a Danish nationwide cohort study. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 9(4), 389-396. doi:10.1093/ehjqcco/qcac038
Epilepsy-Heart Syndrome: Incidence and Clinical Outcomes of Cardiac Complications in patients with Epilepsy
Bucci, T., Mbizvo, G., Rivera-Caravaca, J. M., Mayer, J., Marson, A., Abdul Rahim, A. H., & Lip, G. (2023). Epilepsy-Heart Syndrome: Incidence and Clinical Outcomes of Cardiac Complications in patients with Epilepsy. Current Problems in Cardiology. doi:10.1016/j.cpcardiol.2023.101868
Racial differences in atrial fibrillation-related stroke: A patient-level comparative analysis of UK Biobank and Korean nationwide data
Risk of myocardial infarction and ischemic stroke in individuals with first-diagnosed paroxysmal vs. non-paroxysmal atrial fibrillation under anticoagulation
Ntaios, G., Sagris, D., Buckley, B. J. R., Harrison, S. L., Abdul-Rahim, A., Austin, P., & Lip, G. Y. H. (2023). Risk of myocardial infarction and ischemic stroke in individuals with first-diagnosed paroxysmal vs. non-paroxysmal atrial fibrillation under anticoagulation. EUROPACE, 25(6). doi:10.1093/europace/euad143
Silent cerebral lesions following catheter ablation for atrial fibrillation: a state-of-the-art review
Calvert, P., Kollias, G., Puererfellner, H., Narasimhan, C., Osorio, J., Lip, G. Y. H., & Gupta, D. (2023). Silent cerebral lesions following catheter ablation for atrial fibrillation: a state-of-the-art review. EUROPACE, 25(6). doi:10.1093/europace/euad151
Adherence levels and patterns for multiple cardiac medications prescribed to patients with incident atrial fibrillation events
Lip, G. Y. H., Genaidy, A., Jones, B., Tran, G., Marroquin, P., Estes, C., & Shnaiden, T. (2023). Adherence levels and patterns for multiple cardiac medications prescribed to patients with incident atrial fibrillation events. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 89(6), 1736-1746. doi:10.1111/bcp.15627
An evidence-based evaluation of left ventricular thrombus treatment, outcomes, and resolution: a systematic review, pooled analysis and meta-analysis
Kwok, C. S., Bennett, S., Borovac, J. A., Will, M., Schwarz, K., & Lip, G. Y. H. (2023). An evidence-based evaluation of left ventricular thrombus treatment, outcomes, and resolution: a systematic review, pooled analysis and meta-analysis. CORONARY ARTERY DISEASE, 34(4), 260-273. doi:10.1097/MCA.0000000000001230
Cardiovascular disease risk assessment using a deep-learning-based retinal biomarker: a comparison with existing risk scores.
Yi, J. K., Rim, T. H., Park, S., Kim, S. S., Kim, H. C., Lee, C. J., . . . Cheng, C. -Y. (2023). Cardiovascular disease risk assessment using a deep-learning-based retinal biomarker: a comparison with existing risk scores.. European heart journal. Digital health, 4(3), 236-244. doi:10.1093/ehjdh/ztad023
Clinical implications of different types of dementia in patients with atrial fibrillation: Insights from a global federated health network analysis
Proietti, R., Rivera-Caravaca, J. M., Lopez-Galvez, R., Harrison, S. L., Buckley, B. J. R., Marin, F., . . . Lip, G. Y. H. (2023). Clinical implications of different types of dementia in patients with atrial fibrillation: Insights from a global federated health network analysis. CLINICAL CARDIOLOGY, 46(6), 656-662. doi:10.1002/clc.24006
Effects of the ABC pathway on clinical outcomes in a secondary prevention population of Chinese patients with atrial fibrillation: A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry
Fawzy, A., Kotalczyk, A., Guo, Y., Wang, Y., Lip, G. Y. H., & ChiOTEAF, R. I. (2023). Effects of the ABC pathway on clinical outcomes in a secondary prevention population of Chinese patients with atrial fibrillation: A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry. JOURNAL OF ARRHYTHMIA, 39(3), 388-394. doi:10.1002/joa3.12862
Inflammaging: mechanisms and role in the cardiac and vasculature
Ajoolabady, A., Pratico, D., Vinciguerra, M., Lip, G. Y. H., Franceschi, C., & Ren, J. (2023). Inflammaging: mechanisms and role in the cardiac and vasculature. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 34(6), 373-387. doi:10.1016/j.tem.2023.03.005
Left Atrial Appendage Occlusion-A Choice or a Last Resort? How to Approach the Patient.
Ding, W. Y., Lip, G. Y. H., & Gupta, D. (2023). Left Atrial Appendage Occlusion-A Choice or a Last Resort? How to Approach the Patient.. Cardiac electrophysiology clinics, 15(2), 133-140. doi:10.1016/j.ccep.2023.01.006
Medication non-adherence patterns and profiles for patients with incident myocardial infarction: Observations from a large multi-morbid US population
Lip, G. Y. H., Genaidy, A., Jones, B., Tran, G., Estes, C., & Sloop, S. (2023). Medication non-adherence patterns and profiles for patients with incident myocardial infarction: Observations from a large multi-morbid US population. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. doi:10.1111/eci.13968
Molecular mechanisms of postoperative atrial fibrillation in patients with obstructive sleep apnea
Lopez-Galvez, R., Rivera-Caravaca, J. M., Mandaglio-Collados, D., Orenes-Pinero, E., Lahoz, A., Hernandez-Romero, D., . . . Marin, F. (2023). Molecular mechanisms of postoperative atrial fibrillation in patients with obstructive sleep apnea. FASEB JOURNAL, 37(6). doi:10.1096/fj.202201965RR
Net clinical benefit of oral anticoagulants in Korean atrial fibrillation patients with low to intermediate stroke risk: A report from the Clinical Survey on Stroke Prevention in patients with Atrial Fibrillation (CS-SPAF)
Jung, M., Byeon, K., Kang, K. -W., Lee, W. -S., Kim, S. W., Park, Y. M., . . . Shin, S. Y. (2023). Net clinical benefit of oral anticoagulants in Korean atrial fibrillation patients with low to intermediate stroke risk: A report from the Clinical Survey on Stroke Prevention in patients with Atrial Fibrillation (CS-SPAF). JOURNAL OF ARRHYTHMIA, 39(3), 376-387. doi:10.1002/joa3.12840
Predictors of left ventricular thrombus after acute myocardial infarction: a systematic review and meta-analysis
Kwok, C. S., Bennett, S., Borovac, J. A., Schwarz, K., & Lip, G. Y. H. (2023). Predictors of left ventricular thrombus after acute myocardial infarction: a systematic review and meta-analysis. CORONARY ARTERY DISEASE, 34(4), 250-259. doi:10.1097/MCA.0000000000001223
Associations of high-normal blood pressure and impaired fasting glucose with atrial fibrillation.
Kim, J., Kim, D., Jang, E., Kim, D., You, S. C., Yu, H. T., . . . Joung, B. (2023). Associations of high-normal blood pressure and impaired fasting glucose with atrial fibrillation.. Heart (British Cardiac Society), 109(12), 929-935. doi:10.1136/heartjnl-2022-322094
Developing prediction models to estimate the risk of two survival outcomes both occurring: A comparison of techniques
Pate, A., Sperrin, M., Riley, R. D., Sergeant, J. C., Van Staa, T., Peek, N., . . . Martin, G. P. (2023). Developing prediction models to estimate the risk of two survival outcomes both occurring: A comparison of techniques. STATISTICS IN MEDICINE, 42(18), 3184-3207. doi:10.1002/sim.9771
Incidence of clinical atrial fibrillation and related complications using a screening algorithm at a nationwide level
Roger, A., Cottin, Y., Bentounes, S. A., Bisson, A., Bodin, A., Herbert, J., . . . Fauchier, L. (2023). Incidence of clinical atrial fibrillation and related complications using a screening algorithm at a nationwide level. EUROPACE. doi:10.1093/europace/euad063
Frailty alone and interactively with obesity predicts heart failure: Kuopio Ischaemic Heart Disease Risk Factor Study
Tajik, B., Voutilainen, A., Sankaranarayanan, R., Lyytinen, A., Kauhanen, J., Lip, G. Y. H., . . . Isanejad, M. (2023). Frailty alone and interactively with obesity predicts heart failure: Kuopio Ischaemic Heart Disease Risk Factor Study. ESC HEART FAILURE. doi:10.1002/ehf2.14392
Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients without previous oral anticoagulants or stable under warfarin: a nationwide cohort study.
Liu, S. -H., Chao, T. -F., Chan, Y. -H., Liao, J. -N., Chen, T. -J., Lip, G. Y. H., & Chen, S. -A. (2023). Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients without previous oral anticoagulants or stable under warfarin: a nationwide cohort study.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, euad120. doi:10.1093/europace/euad120
In limb or pelvic fracture, aspirin was noninferior to enoxaparin for reducing all-cause death.
Griffin, M., & Lip, G. Y. H. (2023). In limb or pelvic fracture, aspirin was noninferior to enoxaparin for reducing all-cause death.. Annals of internal medicine, 176(5), JC56. doi:10.7326/j23-0024
Recommendation on the nomenclature for anticoagulants: updated communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Commitee on the Control of Anticoagulation.
Barnes, G. D., Ageno, W., Castellucci, L. A., Chiasakul, T., Eslick, R., Ferreiro, J. L., . . . Cuker, A. (2023). Recommendation on the nomenclature for anticoagulants: updated communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Commitee on the Control of Anticoagulation.. Journal of thrombosis and haemostasis : JTH, 21(5), 1381-1384. doi:10.1016/j.jtha.2023.02.008
Simplified Geleijnse score for identifying chest pain features associated with coronary ischemia
Ding, W. Y., Romero-Aniorte, A. I., Tello-Montoliu, A., Gil-Perez, P., Lopez-Garcia, C., Veliz-Martinez, A., . . . Marin, F. (2023). Simplified Geleijnse score for identifying chest pain features associated with coronary ischemia. HEART & LUNG, 59, 61-66. doi:10.1016/j.hrtlng.2023.01.010
C-reactive protein levels are associated with early cardiac complications or death in patients with acute ischemic stroke: a propensity-matched analysis of a global federated health from the TriNetX network.
Bucci, T., Sagris, D., Harrison, S. L., Underhill, P., Pastori, D., Ntaios, G., . . . Lip, G. Y. H. (2023). C-reactive protein levels are associated with early cardiac complications or death in patients with acute ischemic stroke: a propensity-matched analysis of a global federated health from the TriNetX network.. Internal and emergency medicine. doi:10.1007/s11739-023-03280-1
Development of Core Outcome Sets for trials on the management of Atrial fiBrillAtion in Critically Unwell patientS (COS-ABACUS): a protocol
Johnston, B., Hill, R. A., Blackwood, B., Lip, G. Y. H., & Welters, I. D. (2023). Development of Core Outcome Sets for trials on the management of Atrial fiBrillAtion in Critically Unwell patientS (COS-ABACUS): a protocol. BMJ open, 13(4), e067257. doi:10.1136/bmjopen-2022-067257
Features of Clinical Complexity in European Patients with Atrial Fibrillation: A Report from a European Observational Prospective AF Registry.
Proietti, M., Romiti, G. F., Corica, B., Mei, D. A., Bonini, N., Vitolo, M., . . . Lip, G. Y. H. (2023). Features of Clinical Complexity in European Patients with Atrial Fibrillation: A Report from a European Observational Prospective AF Registry.. Current problems in cardiology, 101752. doi:10.1016/j.cpcardiol.2023.101752
Pharmacotherapy for hypertension in very old people with frailty: A systematic review
EHRA expert consensus document on the management of arrhythmias in frailty syndrome, endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA)
Savelieva, I., Fumagalli, S., Kenny, R. A., Anker, S., Benetos, A., Boriani, G., . . . Grodzicki, T. (2023). EHRA expert consensus document on the management of arrhythmias in frailty syndrome, endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). EUROPACE, 25(4), 1249-1276. doi:10.1093/europace/euac123
Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis
Proietti, R., Rivera-Caravaza, J. M., Lopez-Galvez, R., Harrison, S. L., Marin, F., Underhill, P., . . . Lip, G. (n.d.). Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis. Journal of Clinical Medicine, 12(8). doi:10.3390/jcm12082814
Percutaneous left atrial appendage occlusion following successful treatment of large bi-atrial thrombi in a patient with atrial fibrillation: a case report
Ng, K. F., Calvert, P., Khalatbari, A., Lip, G. Y. H., Velavan, P., & Gupta, D. (2023). Percutaneous left atrial appendage occlusion following successful treatment of large bi-atrial thrombi in a patient with atrial fibrillation: a case report. EUROPEAN HEART JOURNAL-CASE REPORTS, 7(4). doi:10.1093/ehjcr/ytad165
Heightened risks of cardiovascular disease in South Asian populations: causes and consequences
Stefil, M., Bell, J., Calvert, P., & Lip, G. Y. H. (2023). Heightened risks of cardiovascular disease in South Asian populations: causes and consequences. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 21(4), 281-291. doi:10.1080/14779072.2023.2187780
Lessons learned from the influence of CYP2C9 genotype on warfarin dosing
Tidbury, N., Preston, J., & Lip, G. Y. H. (2023). Lessons learned from the influence of CYP2C9 genotype on warfarin dosing. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 19(4), 185-188. doi:10.1080/17425255.2023.2220961
Artificial intelligence in radiology: trainees want more.
Hashmi, O. -U., Chan, N., de Vries, C. F., Gangi, A., Jehanli, L., & Lip, G. (2023). Artificial intelligence in radiology: trainees want more.. Clinical radiology, 78(4), e336-e341. doi:10.1016/j.crad.2022.12.017
Cardiovascular considerations in management of patients with Turner syndrome
Stefil, M., Kotalczyk, A., Blair, J. C., & Lip, G. Y. H. (2023). Cardiovascular considerations in management of patients with Turner syndrome. TRENDS IN CARDIOVASCULAR MEDICINE, 33(3), 150-158. doi:10.1016/j.tcm.2021.12.002
Efficacy and safety of vitamin-K antagonists and direct oral anticoagulants for stroke prevention in patients with heart failure and sinus rhythm: An updated systematic review and meta-analysis of randomized clinical trials.
Li, W., Seo, J., Kokkinidis, D. G., Palaiodimos, L., Nagraj, S., Korompoki, E., . . . Ntaios, G. (2023). Efficacy and safety of vitamin-K antagonists and direct oral anticoagulants for stroke prevention in patients with heart failure and sinus rhythm: An updated systematic review and meta-analysis of randomized clinical trials.. International journal of stroke : official journal of the International Stroke Society, 18(4), 392-399. doi:10.1177/17474930221109149
Exercise-induced release of cardiac troponin is attenuated with repeated bouts of exercise: impact of cardiovascular disease and risk factors.
Somani, Y. B., Uthman, L., Aengevaeren, V. L., Rodwell, L., Lip, G. Y. H., Hopman, M. T. E., . . . Thijssen, D. H. J. (2023). Exercise-induced release of cardiac troponin is attenuated with repeated bouts of exercise: impact of cardiovascular disease and risk factors.. American journal of physiology. Heart and circulatory physiology, 324(4), H519-H524. doi:10.1152/ajpheart.00033.2023
Imaging in atrial fibrillation: A way to assess atrial fibrosis and remodeling to assist decision-making
Lopez-Galvez, R., Rivera-Caravaca, J. M., Roldan, V., Orenes-Pinero, E., Esteve-Pastor, M. A., Lopez-Garcia, C., . . . Marin, F. (2023). Imaging in atrial fibrillation: A way to assess atrial fibrosis and remodeling to assist decision-making. AMERICAN HEART JOURNAL, 258, 1-16. doi:10.1016/j.ahj.2022.12.007
Novel methodology for the evaluation of symptoms reported by patients with newly diagnosed atrial fibrillation: Application of natural language processing to electronic medical records data.
Reynolds, M. R., Bunch, T. J., Steinberg, B. A., Ronk, C. J., Kim, H., Wieloch, M., & Lip, G. Y. H. (2023). Novel methodology for the evaluation of symptoms reported by patients with newly diagnosed atrial fibrillation: Application of natural language processing to electronic medical records data.. Journal of cardiovascular electrophysiology, 34(4), 790-799. doi:10.1111/jce.15784
Preventing Recurrent Cardioembolic Stroke: Right Approach, Right Patient (PRECISE) Study Protocol
Cameron, A. C. C., Katsas, G., Arnold, M., Docherty, K., Campbell, R. T. T., Murdoch, D., . . . Dawson, J. (2023). Preventing Recurrent Cardioembolic Stroke: Right Approach, Right Patient (PRECISE) Study Protocol. CEREBROVASCULAR DISEASES, 52(2), 123-129. doi:10.1159/000525918
The association of epicardial adipose tissue volume and density with coronary calcium in HIV-positive and HIV-negative patients
Heseltine, T., Hughes, E., Mattew, J., Murray, S., Ortega-Martorell, S., Olier, I., . . . Khoo, S. (2023). The association of epicardial adipose tissue volume and density with coronary calcium in HIV-positive and HIV-negative patients. JOURNAL OF INFECTION, 86(4), 376-384. doi:10.1016/j.jinf.2023.02.020
Clinical Phenotypes and Atrial Fibrillation Recurrences after Catheter Ablation: An Unsupervised Cluster Analysis.
Bisson, A., Fawzy, A. M., El-Bouri, W., Angoulvant, D., Lip, G. Y. H., Fauchier, L., & Clementy, N. (2023). Clinical Phenotypes and Atrial Fibrillation Recurrences after Catheter Ablation: An Unsupervised Cluster Analysis.. Current problems in cardiology, 101732. doi:10.1016/j.cpcardiol.2023.101732
Frequent premature atrial contractions as a signalling marker of atrial cardiomyopathy, incident atrial fibrillation, and stroke
Farinha, J. M., Gupta, D., & Lip, G. Y. H. (2023). Frequent premature atrial contractions as a signalling marker of atrial cardiomyopathy, incident atrial fibrillation, and stroke. CARDIOVASCULAR RESEARCH, 119(2), 429-439. doi:10.1093/cvr/cvac054
Association of obesity with incident atrial fibrillation in Korea and the United Kingdom
Choi, S. H., Yang, P. -S., Kim, D., Sung, J. -H., Jang, E., Yu, H. T., . . . Joung, B. (2023). Association of obesity with incident atrial fibrillation in Korea and the United Kingdom. SCIENTIFIC REPORTS, 13(1). doi:10.1038/s41598-023-32229-9
Stroke in Atrial Fibrillation and Other Atrial Dysrhythmias
Ozdemir, H., Sagris, D., Lip, G., & Abdul Rahim, A. H. (2023). Stroke in Atrial Fibrillation and Other Atrial Dysrhythmias. Current Cardiology Reports.
Three-year outcomes of patients with non-valvular atrial fibrillation: the COOL-AF registry.
Krittayaphong, R., Pumprueg, S., Kaewkumdee, P., Yindeengam, A., & Lip, G. Y. (2023). Three-year outcomes of patients with non-valvular atrial fibrillation: the COOL-AF registry.. Journal of geriatric cardiology : JGC, 20(3), 163-173. doi:10.26599/1671-5411.2023.03.008
Initiation of Warfarin is associated with Decreased Mortality in Patients with Infective Endocarditis: A Population-Based Cohort Study
Predicting the Absolute Risk of Ischemic Stroke in Asian Patients with Atrial Fibrillation: Comparing the COOL-AF Risk Score with CARS/mCARS Models for Absolute Risk and the CHA2DS2-VASc Score.
Krittayaphong, R., Winijkul, A., Sairat, P., & Lip, G. Y. H. (2023). Predicting the Absolute Risk of Ischemic Stroke in Asian Patients with Atrial Fibrillation: Comparing the COOL-AF Risk Score with CARS/mCARS Models for Absolute Risk and the CHA2DS2-VASc Score.. Journal of clinical medicine, 12(7), 2449. doi:10.3390/jcm12072449
Stroke Risk and Antithrombotic Treatment During Follow-up of Patients With Ischemic Stroke and Cortical Superficial Siderosis
Marti-Fabregas, J., Camps-Renom, P. G., Best, J. G., Ramos-Pachon, A., Guasch-Jimenez, M., Martinez-Domeno, A., . . . Prats-Sanchez, L. (2023). Stroke Risk and Antithrombotic Treatment During Follow-up of Patients With Ischemic Stroke and Cortical Superficial Siderosis. NEUROLOGY, 100(12), E1267-E1281. doi:10.1212/WNL.0000000000201723
The impact of rate and rhythm control strategies on quality of life for patients with atrial fibrillation: a protocol for a systematic review
Uruthirakumar, P., Surenthirakumaran, R., Gooden, T., Lip, G. Y. H., Thomas, G. N., Moore, D., . . . Guruparan, M. (2023). The impact of rate and rhythm control strategies on quality of life for patients with atrial fibrillation: a protocol for a systematic review. SYSTEMATIC REVIEWS, 12(1). doi:10.1186/s13643-023-02197-2
Mobile health-technology integrated care in secondary prevention atrial fibrillation patients: a post-hoc analysis from the mAFA-II randomized clinical trial.
Guo, Y., Romiti, G. F., Sagris, D., Proietti, M., Bonini, N., Zhang, H., . . . mAF-App II trial investigators. (2023). Mobile health-technology integrated care in secondary prevention atrial fibrillation patients: a post-hoc analysis from the mAFA-II randomized clinical trial.. Internal and emergency medicine. doi:10.1007/s11739-023-03249-0
Mobile Health-Technology-Integrated Care for Atrial Fibrillation: A Win Ratio Analysis from the mAFA-II Randomized Clinical Trial
Romiti, G. F., Guo, Y., Corica, B., Proietti, M., Zhang, H., & Lip, G. Y. H. (2023). Mobile Health-Technology-Integrated Care for Atrial Fibrillation: A Win Ratio Analysis from the mAFA-II Randomized Clinical Trial. In THROMBOSIS AND HAEMOSTASIS. doi:10.1055/s-0043-1769612
Multivariable prediction models for atrial fibrillation after cardiac surgery: a systematic review protocol
Fields, K. G., Ma, J., Petrinic, T., Alhassan, H., Eze, A., Reddy, A., . . . Muehlschlegel, J. D. (2023). Multivariable prediction models for atrial fibrillation after cardiac surgery: a systematic review protocol. BMJ OPEN, 13(3). doi:10.1136/bmjopen-2022-067260
Associations of risk factor burden and genetic predisposition with the 10-year risk of atrial fibrillation: observations from a large prospective study of 348,904 participants
Zhang, J., Chen, G., Wang, C., Wang, X., Qian, Z. M., Cai, M., . . . Lin, H. (2023). Associations of risk factor burden and genetic predisposition with the 10-year risk of atrial fibrillation: observations from a large prospective study of 348,904 participants. BMC MEDICINE, 21(1). doi:10.1186/s12916-023-02798-7
Use of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Liver Disease
Hydes, T. J., Lip, G. Y. H., & Lane, D. A. (2023). Use of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Liver Disease. Circulation, 147(10), 795-797. doi:10.1161/circulationaha.122.063195
Single-lead VDD pacing: a literature review on short-term and long-term performance
Mei, D. A., Imberti, J. F., Vitolo, M., Bonini, N., Gerra, L., Romiti, G. F., . . . Boriani, G. (2023). Single-lead VDD pacing: a literature review on short-term and long-term performance. EXPERT REVIEW OF MEDICAL DEVICES, 20(3), 187-197. doi:10.1080/17434440.2023.2178901
Yield of diagnosis and risk of stroke with screening strategies for atrial fibrillation: a comprehensive review of current evidence.
Corica, B., Bonini, N., Imberti, J. F., Romiti, G. F., Vitolo, M., Attanasio, L., . . . Proietti, M. (2023). Yield of diagnosis and risk of stroke with screening strategies for atrial fibrillation: a comprehensive review of current evidence.. European heart journal open, 3(2), oead031. doi:10.1093/ehjopen/oead031
Alcohol and Atrial Fibrillation.
Surma, S., & Lip, G. Y. H. (2023). Alcohol and Atrial Fibrillation.. Reviews in cardiovascular medicine, 24(3), 73. doi:10.31083/j.rcm2403073
Altered cardiac and vascular stiffness in pregnancy after a hypertensive pregnancy
Castleman, J. S., Shantsila, A., Brown, R. A., Shantsila, E., & Lip, G. Y. H. (2023). Altered cardiac and vascular stiffness in pregnancy after a hypertensive pregnancy. JOURNAL OF HUMAN HYPERTENSION, 37(3), 189-196. doi:10.1038/s41371-022-00662-4
Bleeding and thrombotic events in atrial fibrillation patients with cancer: a systematic review and meta-analysis.
Pastori, D., Menichelli, D., Di Rocco, A., Farcomeni, A., Sciacqua, A., Pignatelli, P., . . . Lip, G. Y. H. (2023). Bleeding and thrombotic events in atrial fibrillation patients with cancer: a systematic review and meta-analysis.. Internal and emergency medicine, 18(2), 655-665. doi:10.1007/s11739-022-03156-w
Causes of death of patients with non-valvular atrial fibrillation in Asians.
Krittayaphong, R., Boonyapiphat, T., Aroonsiriwattana, S., Ngamjanyaporn, P., & Lip, G. Y. H. (2023). Causes of death of patients with non-valvular atrial fibrillation in Asians.. PloS one, 18(3), e0282455. doi:10.1371/journal.pone.0282455
Increased risk of incident atrial fibrillation in young adults with mental disorders: A nationwide population-based study.
Ahn, H. J., Lee, S. -R., Choi, E. -K., Bae, N. Y., Ahn, H. -J., Kwon, S., . . . Lip, G. Y. H. (2023). Increased risk of incident atrial fibrillation in young adults with mental disorders: A nationwide population-based study.. Heart rhythm, 20(3), 365-373. doi:10.1016/j.hrthm.2022.12.019
Long-term Management Considerations for Retinal Artery Occlusion and Cardiovascular and Cerebrovascular Mortality
Choi, S. E., Lip, G. Y. H., & Abdul-Rahim, A. H. (2023). Long-term Management Considerations for Retinal Artery Occlusion and Cardiovascular and Cerebrovascular Mortality. JAMA NETWORK OPEN, 6(3). doi:10.1001/jamanetworkopen.2023.3076
Men who live alone have worse anticoagulation control: A Danish registry study
Bonde, A. N., Bjerre, J., Proietti, M., Lip, G. Y. H., Gislason, G., & Hlatky, M. A. (2023). Men who live alone have worse anticoagulation control: A Danish registry study. AMERICAN HEART JOURNAL, 257, 30-32. doi:10.1016/j.ahj.2022.11.006
Molecular biomarkers predicting newly detected atrial fibrillation after ischaemic stroke or TIA: A systematic review
Ward, K., Vail, A., Cameron, A., Katan, M., Lip, G. Y. H., Dawson, J., . . . Kishore, A. K. (2023). Molecular biomarkers predicting newly detected atrial fibrillation after ischaemic stroke or TIA: A systematic review. EUROPEAN STROKE JOURNAL, 8(1), 125-131. doi:10.1177/23969873221136927
Outcomes for patients hospitalized with acute myocardial infarction and cerebral infarction in the United States: insights from the National Inpatient Sample
Kwok, C. S., Abbas, K. S., Qureshi, A. I., & Lip, G. Y. H. (2023). Outcomes for patients hospitalized with acute myocardial infarction and cerebral infarction in the United States: insights from the National Inpatient Sample. INTERNAL AND EMERGENCY MEDICINE. doi:10.1007/s11739-022-03172-w
Racial and Ethnic Disparities in Stroke Prevention for Atrial Fibrillation
Calvert, P., Tamirisa, K., Al-Ahmad, A., Lip, G. Y. H., & Gupta, D. (2023). Racial and Ethnic Disparities in Stroke Prevention for Atrial Fibrillation. AMERICAN JOURNAL OF MEDICINE, 136(3), 225-233. doi:10.1016/j.amjmed.2022.11.009
Relationship between obesity severity, metabolic status and cardiovascular disease in obese adults.
Liu, Y., Douglas, P. S., Lip, G. Y. H., Thabane, L., Li, L., Ye, Z., & Li, G. (2023). Relationship between obesity severity, metabolic status and cardiovascular disease in obese adults.. European journal of clinical investigation, 53(3), e13912. doi:10.1111/eci.13912
Response to 'Re. Comparison of open, standard, and complex endovascular aortic repair treatments for juxtarenal/short neck aneurysms: a systematic review and network meta-analysis'
Patel, S. R., Lip, G. Y. H., & Vallabhaneni, S. R. (2023). Response to 'Re. Comparison of open, standard, and complex endovascular aortic repair treatments for juxtarenal/short neck aneurysms: a systematic review and network meta-analysis'. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 65(3). doi:10.1016/j.ejvs.2022.11.018
Similarities and differences in systemic risk factors for retinal artery occlusion and retinal vein occlusion: A nationwide case-control study.
Ørskov, M., Vorum, H., Larsen, T. B., Lip, G. Y. H., Bek, T., & Skjøth, F. (2023). Similarities and differences in systemic risk factors for retinal artery occlusion and retinal vein occlusion: A nationwide case-control study.. International ophthalmology, 43(3), 817-824. doi:10.1007/s10792-022-02483-3
Therapeutic considerations for prevention and treatment of thrombotic events in COVID-19.
Khimani, F., Wolf, A. J., Yoon, B., Blancke, A., Gerhart, C., Endsley, D., . . . Sathyamoorthy, M. (2023). Therapeutic considerations for prevention and treatment of thrombotic events in COVID-19.. Thrombosis update, 10, 100126. doi:10.1016/j.tru.2022.100126
Thoracic aortic aneurysm and atrial fibrillation: clinical associations with the risk of stroke from a global federated health network analysis
Proietti, R., Rivera-Caravaca, J. M., Harrison, S. L., Buckley, B. J. R., Lopez-Galvez, R., Marin, F., . . . Lip, G. Y. H. (2023). Thoracic aortic aneurysm and atrial fibrillation: clinical associations with the risk of stroke from a global federated health network analysis. INTERNAL AND EMERGENCY MEDICINE. doi:10.1007/s11739-022-03184-6
Transient ischemic attack events and incident cardiovascular and non-cardiovascular complications: Observations from a large diversified multimorbid cohort.
Lip, G. Y., Genaidy, A., Estes, C., McKay, D., & Falks, T. (2023). Transient ischemic attack events and incident cardiovascular and non-cardiovascular complications: Observations from a large diversified multimorbid cohort.. European stroke journal, 8(1), 334-343. doi:10.1177/23969873221146044
Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the Global Burden of Disease Study 2019.
Chong, B., Jayabaskaran, J., Kong, G., Chan, Y. H., Chin, Y. H., Goh, R., . . . Chew, N. W. S. (2023). Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the Global Burden of Disease Study 2019.. EClinicalMedicine, 57, 101850. doi:10.1016/j.eclinm.2023.101850
Poor adherence to guideline-directed anticoagulation in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry.
Guo, Y., Kotalczyk, A., Imberti, J. F., Wang, Y., Lip, G. Y. H., & ChiOTEAF Registry Investigators. (2023). Poor adherence to guideline-directed anticoagulation in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry.. European heart journal. Quality of care & clinical outcomes, 9(2), 169-176. doi:10.1093/ehjqcco/qcab054
Cardiac abnormalities in Long COVID 1-year post-SARS-CoV-2 infection
Fernandez, A. R., Wamil, M., Telford, A., Carapella, V., Borlotti, A., Monteiro, D., . . . Banerjee, A. (2023). Cardiac abnormalities in Long COVID 1-year post-SARS-CoV-2 infection. OPEN HEART, 10(1). doi:10.1136/openhrt-2022-002241
Contemporary management of atrial fibrillation and the predicted vs. absolute risk of ischaemic stroke despite treatment: a report from ESC-EHRA EORP-AF Long-Term General Registry
Ding, W. Y., Blomstrom-Lundqvist, C., Fauchier, L., Marin, F., Potpara, T. S., Boriani, G., & Lip, G. Y. H. (2023). Contemporary management of atrial fibrillation and the predicted vs. absolute risk of ischaemic stroke despite treatment: a report from ESC-EHRA EORP-AF Long-Term General Registry. EUROPACE, 25(2), 277-282. doi:10.1093/europace/euac214
Contemporary management of atrial fibrillation in primary and secondary care in the UK: the prospective long-term AF-GEN-UK Registry
Shantsila, A., Lip, G. Y. H., & Lane, D. A. (2023). Contemporary management of atrial fibrillation in primary and secondary care in the UK: the prospective long-term AF-GEN-UK Registry. EUROPACE, 25(2), 308-317. doi:10.1093/europace/euac153
Corrigendum to: How to use digital devices to detect and manage arrhythmias: an EHRA practical guide.
Corrigendum to: How to use digital devices to detect and manage arrhythmias: an EHRA practical guide. (2023). Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 25(2), 486. doi:10.1093/europace/euac227
Erratum to: Worldwide trends in antithrombotic therapy prescribing for atrial fibrillation: observations on the 'transition era' to non-vitamin K antagonist oral anticoagulants.
Erratum to: Worldwide trends in antithrombotic therapy prescribing for atrial fibrillation: observations on the 'transition era' to non-vitamin K antagonist oral anticoagulants. (2023). Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 25(2), 505. doi:10.1093/europace/euac251
Impact of anti-arrhythmic drugs and catheter ablation on the survival of patients with atrial fibrillation: a population study based on 199 433 new-onset atrial fibrillation patients in the UK.
Chung, S. -C., Lai, A., Lip, G. Y. H., Lambiase, P. D., & Providencia, R. (2023). Impact of anti-arrhythmic drugs and catheter ablation on the survival of patients with atrial fibrillation: a population study based on 199 433 new-onset atrial fibrillation patients in the UK.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 25(2), 351-359. doi:10.1093/europace/euac155
Stereolithography 3D printing of Si3N4 cellular ceramics with ultrahigh strength by using highly viscous paste
Huang, Z., Liu, L. Y., Yuan, J., Guo, H., Wang, H., Ye, P., . . . Gan, C. L. (2023). Stereolithography 3D printing of Si3N4 cellular ceramics with ultrahigh strength by using highly viscous paste. Ceramics International, 49(4), 6984-6995. doi:10.1016/j.ceramint.2022.10.137
Endovascular treatment for ischaemic stroke patients with and without atrial fibrillation, and the effects of adjunctive pharmacotherapy: a narrative review.
Alobaida, M., Lip, G. Y. H., Lane, D. A., Sagris, D., Hill, A., & Harrison, S. L. (n.d.). Endovascular treatment for ischaemic stroke patients with and without atrial fibrillation, and the effects of adjunctive pharmacotherapy: a narrative review.. Expert Opin Pharmacother. doi:10.1080/14656566.2022.2161362
Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference.
Schnabel, R. B., Marinelli, E. A., Arbelo, E., Boriani, G., Boveda, S., Buckley, C. M., . . . Kirchhof, P. (2023). Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 25(1), 6-27. doi:10.1093/europace/euac062
Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper.
Kalarus, Z., Mairesse, G. H., Sokal, A., Boriani, G., Średniawa, B., Casado-Arroyo, R., . . . Eckardt, L. (2023). Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 25(1), 185-198. doi:10.1093/europace/euac144
Impact of Achieving Blood Pressure Targets and High Time in Therapeutic Range on Clinical Outcomes in Patients With Atrial Fibrillation Adherent to the Atrial Fibrillation Better Care Pathway: A Report From the COOL-AF Registry.
Krittayaphong, R., Winijkul, A., Methavigul, K., & Lip, G. Y. H. (2023). Impact of Achieving Blood Pressure Targets and High Time in Therapeutic Range on Clinical Outcomes in Patients With Atrial Fibrillation Adherent to the Atrial Fibrillation Better Care Pathway: A Report From the COOL-AF Registry.. Journal of the American Heart Association, 12(3), e028463. doi:10.1161/jaha.122.028463
Knowledge Gaps for Prophylactic Use of Antithrombotic Agents in Patients with COVID-19: Insights into New SARS-CoV-2 Variants, Vaccination Status, and Emerging Oral Antivirals.
Talasaz, A. H., Sadeghipour, P., Mehdizadeh, K., Khoshnam Rad, N., Bikdeli, B., Lip, G. Y. H., & Harenberg, J. (2023). Knowledge Gaps for Prophylactic Use of Antithrombotic Agents in Patients with COVID-19: Insights into New SARS-CoV-2 Variants, Vaccination Status, and Emerging Oral Antivirals.. Thrombosis and haemostasis, 123(2), 186-191. doi:10.1055/a-1956-9641
Pregnancy-Related Complications and Incidence of Atrial Fibrillation: A Systematic Review.
Al Bahhawi, T., Aqeeli, A., Harrison, S. L., Lane, D. A., Skjøth, F., Buchan, I., . . . Lip, G. Y. H. (2023). Pregnancy-Related Complications and Incidence of Atrial Fibrillation: A Systematic Review.. Journal of clinical medicine, 12(4), 1316. doi:10.3390/jcm12041316
Predicting Heart Failure in Patients with Atrial Fibrillation: A Report from the Prospective COOL-AF Registry.
Krittayaphong, R., Chichareon, P., Komoltri, C., Sairat, P., & Lip, G. Y. H. (2023). Predicting Heart Failure in Patients with Atrial Fibrillation: A Report from the Prospective COOL-AF Registry.. Journal of clinical medicine, 12(4), 1265. doi:10.3390/jcm12041265
Prevalence and Impact of Arrhythmia on Outcomes in Restrictive Cardiomyopathy-A Report from the Beijing Municipal Health Commission Information Center (BMHCIC) Database
Wang, H., Liu, S., Zhang, X., Zheng, J., Lu, F., Lip, G. Y. H., & Bai, Y. (2023). Prevalence and Impact of Arrhythmia on Outcomes in Restrictive Cardiomyopathy-A Report from the Beijing Municipal Health Commission Information Center (BMHCIC) Database. JOURNAL OF CLINICAL MEDICINE, 12(3). doi:10.3390/jcm12031236
Anticoagulation Control and Major Adverse Clinical Events in Patients with Operated Valvular Heart Disease with and without Atrial Fibrillation Receiving Vitamin K Antagonists
Zulkifly, H. H., Pastori, D., Lane, D. A., & Lip, G. Y. H. (2023). Anticoagulation Control and Major Adverse Clinical Events in Patients with Operated Valvular Heart Disease with and without Atrial Fibrillation Receiving Vitamin K Antagonists. In JOURNAL OF CLINICAL MEDICINE Vol. 12. doi:10.3390/jcm12031141
Anticoagulation Control and Major Adverse Clinical Events in Patients with Operated Valvular Heart Disease with and without Atrial Fibrillation Receiving Vitamin K Antagonists.
Zulkifly, H. H., Pastori, D., Lane, D. A., & Lip, G. Y. H. (2023). Anticoagulation Control and Major Adverse Clinical Events in Patients with Operated Valvular Heart Disease with and without Atrial Fibrillation Receiving Vitamin K Antagonists.. Journal of clinical medicine, 12(3), 1141. doi:10.3390/jcm12031141
Coronary artery calcium score and its association with stroke: A systematic review and meta-analysis
Kwok, C. S., Bennett, S., & Lip, G. Y. H. (2023). Coronary artery calcium score and its association with stroke: A systematic review and meta-analysis. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 53(2). doi:10.1111/eci.13892
Delaying clinical events among patients with non-valvular atrial fibrillation treated with oral anticoagulants: Insights from the ARISTOPHANES study
Deitelzweig, S., Keshishian, A., Kang, A., Jenkins, A., Atreja, N., Schuler, P., . . . Lip, G. Y. H. (2023). Delaying clinical events among patients with non-valvular atrial fibrillation treated with oral anticoagulants: Insights from the ARISTOPHANES study. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 108, 37-42. doi:10.1016/j.ejim.2022.10.021
Development and validation of a bleeding risk prediction score for patients with mitral valve stenosis and atrial fibrillation or mechanical heart valves receiving long-term warfarin therapy.
Phetroong, S., Nathisuwan, S., Chindavijak, B., Phrommintikul, A., Sapoo, U., Sookananchai, B., . . . Lip, G. Y. H. (2023). Development and validation of a bleeding risk prediction score for patients with mitral valve stenosis and atrial fibrillation or mechanical heart valves receiving long-term warfarin therapy.. British journal of clinical pharmacology, 89(2), 843-852. doi:10.1111/bcp.15540
Effects of different exercise types on quality of life for patients with atrial fibrillation: a systematic review and meta-analysis.
AbuElkhair, A., Boidin, M., Buckley, B. J. R., Lane, D. A., Williams, N. H., Thijssen, D., . . . Barraclough, D. L. (2023). Effects of different exercise types on quality of life for patients with atrial fibrillation: a systematic review and meta-analysis.. Journal of cardiovascular medicine (Hagerstown, Md.), 24(2), 87-95. doi:10.2459/jcm.0000000000001386
Heart failure in patients with atrial fibrillation: Insights from Polish part of the EORP-AF general long-term registry.
Budnik, M., Gawałko, M., Lodziński, P., Tymińska, A., Ozierański, K., Grabowski, M., . . . Balsam, P. (2023). Heart failure in patients with atrial fibrillation: Insights from Polish part of the EORP-AF general long-term registry.. ESC heart failure, 10(1), 637-649. doi:10.1002/ehf2.14130
Hypertension in Turner syndrome: a review of proposed mechanisms, management and new directions.
Jones, L., Blair, J., Hawcutt, D. B., Lip, G. Y. H., & Shantsila, A. (2023). Hypertension in Turner syndrome: a review of proposed mechanisms, management and new directions.. Journal of hypertension, 41(2), 203-211. doi:10.1097/hjh.0000000000003321
Ibrutinib use and adverse cardiovascular outcomes: A United States federated electronic medical records analysis
Gent, D. G., Rivera-Caravaca, J. M., Dobson, R., Liverpool, D. J., & Lip, G. Y. H. (2023). Ibrutinib use and adverse cardiovascular outcomes: A United States federated electronic medical records analysis. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 108, 117-119. doi:10.1016/j.ejim.2022.09.016
Improving risk prediction for death, stroke and bleeding in Asian patients with atrial fibrillation.
Krittayaphong, R., Kanjanarutjawiwat, W., Wisaratapong, T., & Lip, G. Y. H. (2023). Improving risk prediction for death, stroke and bleeding in Asian patients with atrial fibrillation.. European journal of clinical investigation, 53(2), e13886. doi:10.1111/eci.13886
Incident heart failure, arrhythmias and cardiovascular outcomes with sodium-glucose cotransporter 2 (SGLT2) inhibitor use in patients with diabetes: Insights from a global federated electronic medical record database
Fawzy, A. M., Miguel Rivera-Caravaca, J., Underhill, P., Fauchier, L., & Lip, G. Y. H. (2023). Incident heart failure, arrhythmias and cardiovascular outcomes with sodium-glucose cotransporter 2 (SGLT2) inhibitor use in patients with diabetes: Insights from a global federated electronic medical record database. DIABETES OBESITY & METABOLISM, 25(2), 602-610. doi:10.1111/dom.14854
Outcome of Femoral Angioplasty/Stenting Procedures in Different Ethnic Groups in England: A Retrospective Analysis of Hospital Episode Statistics and Review of Literature
Vitalis, A., Shantsila, A., Kay, M., Vohra, R. K., & Lip, G. Y. H. (2023). Outcome of Femoral Angioplasty/Stenting Procedures in Different Ethnic Groups in England: A Retrospective Analysis of Hospital Episode Statistics and Review of Literature. JOURNAL OF ENDOVASCULAR THERAPY, 30(1), 132-139. doi:10.1177/15266028211070967
Outcomes in patients with ischaemic stroke undergoing endovascular thrombectomy: Impact of atrial fibrillation
Alobaida, M., Harrison, S. L., Lane, D. A., Underhill, P., Hill, A., & Lip, G. Y. H. (2023). Outcomes in patients with ischaemic stroke undergoing endovascular thrombectomy: Impact of atrial fibrillation. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 32(2). doi:10.1016/j.jstrokecerebrovasdis.2022.106917
Physical Activity Changes and the Risk of Incident Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: A Nationwide Longitudinal Follow-up Cohort Study of 1.8 Million Subjects.
Park, C. S., Choi, E. -K., Kyung-DoHan., Yoo, J., Ahn, H. -J., Kwon, S., . . . Lip, G. Y. H. (2023). Physical Activity Changes and the Risk of Incident Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: A Nationwide Longitudinal Follow-up Cohort Study of 1.8 Million Subjects.. Diabetes care, 46(2), 434-440. doi:10.2337/dc22-1655
Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?
Martinez-Montesinos, L., Rivera-Caravaca, J. M., Agewall, S., Soler, E., Lip, G. Y. H., Marin, F., & Roldan, V. (2023). Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?. BIOMEDICINE & PHARMACOTHERAPY, 158. doi:10.1016/j.biopha.2022.114064
Pre-admission and In-Hospital Statin Use is Associated With Reduced Short-Term Mortality in Infective Endocarditis
Yu, S. -Y., Li, H. -L., Tse, Y. -K., Li, X., Ren, Q. -W., Wu, M. -Z., . . . Yiu, K. -H. (2023). Pre-admission and In-Hospital Statin Use is Associated With Reduced Short-Term Mortality in Infective Endocarditis. MAYO CLINIC PROCEEDINGS, 98(2), 252-265. doi:10.1016/j.mayocp.2022.06.006
Prognostic model for atrial fibrillation after cardiac surgery: a UK cohort study.
Chung, S. -C., O'Brien, B., Lip, G. Y. H., Fields, K. G., Muehlschlegel, J. D., Thakur, A., . . . Providencia, R. (2023). Prognostic model for atrial fibrillation after cardiac surgery: a UK cohort study.. Clinical research in cardiology : official journal of the German Cardiac Society, 112(2), 227-235. doi:10.1007/s00392-022-02068-1
Response to letter from Du et al. regarding article 'Sodium-glucose cotransporter-2 inhibitor use was associated with lower risks of stroke and cardiac arrest but not ventricular arrhythmias?'
Fawzy, A. M., Rivera-Caravaca, J. M., Fauchier, L., & Lip, G. Y. H. (2023). Response to letter from Du et al. regarding article 'Sodium-glucose cotransporter-2 inhibitor use was associated with lower risks of stroke and cardiac arrest but not ventricular arrhythmias?'. DIABETES OBESITY & METABOLISM, 25(2), 630-633. doi:10.1111/dom.14913
The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort
Miguel Rivera-Caravaca, J., Roldan, V., Martinez-Montesinos, L., Vicente, V., Lip, G. Y. H., & Marin, F. (2023). The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort. JOURNAL OF GENERAL INTERNAL MEDICINE, 38(2), 315-323. doi:10.1007/s11606-022-07567-5
Atrial Fibrillation and Stroke
Choi, S., Sagris, D., Hill, A., Lip, G., & Abdul Rahim, A. H. (2023). Atrial Fibrillation and Stroke. Expert Review of Cardiovascular Therapy, 21(1), 35-56. doi:10.1080/14779072.2023.2160319
Cumulative Alcohol Consumption Burden and the Risk of Stroke in Young Adults A Nationwide Population-Based Study
Chung, J. -W., Lee, S. -R., Choi, E. -K., Park, S. -H., Lee, H., Choi, J., . . . Lip, G. Y. H. (2023). Cumulative Alcohol Consumption Burden and the Risk of Stroke in Young Adults A Nationwide Population-Based Study. NEUROLOGY, 100(5), E505-E515. doi:10.1212/WNL.0000000000201473
Atrial Fibrillation and the Risk of Ventricular Arrhythmias and Cardiac Arrest: A Nationwide Population-Based Study
Fawzy, A. M. M., Bisson, A., Bodin, A., Herbert, J., Lip, G. Y. H., & Fauchier, L. (2023). Atrial Fibrillation and the Risk of Ventricular Arrhythmias and Cardiac Arrest: A Nationwide Population-Based Study. JOURNAL OF CLINICAL MEDICINE, 12(3). doi:10.3390/jcm12031075
Improved prognosis with integrated care management including early rhythm control and healthy lifestyle modification in patients with concurrent atrial fibrillation and diabetes mellitus: a nationwide cohort study
Lee, S. -R., Ahn, H. -J., Choi, E. -K., Lee, S. -W., Han, K. -D., Oh, S., & Lip, G. Y. H. (n.d.). Improved prognosis with integrated care management including early rhythm control and healthy lifestyle modification in patients with concurrent atrial fibrillation and diabetes mellitus: a nationwide cohort study. Cardiovascular Diabetology, 22(1). doi:10.1186/s12933-023-01749-z
What acute cardiac care physicians need to know from the latest 2022 ESC Guidelines for ventricular tachycardia and sudden cardiac death.
Goette, A., Lip, G. Y. H., & Gorenek, B. (2023). What acute cardiac care physicians need to know from the latest 2022 ESC Guidelines for ventricular tachycardia and sudden cardiac death.. European heart journal. Acute cardiovascular care, 12(1), 62-68. doi:10.1093/ehjacc/zuac149
Validation of a deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease: data from UK Biobank
Tseng, R. M. W. W., Rim, T. H., Shantsila, E., Yi, J. K., Park, S., Kim, S. S., . . . Cheng, C. -Y. (2023). Validation of a deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease: data from UK Biobank. In BMC MEDICINE Vol. 21. doi:10.1186/s12916-022-02684-8
Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on Thrombosis
Andreotti, F., Geisler, T., Collet, J. -P., Gigante, B., Gorog, D. A., Halvorsen, S., . . . Vilahur, G. (2023). Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on Thrombosis. European heart journal, 44(4), 262-279. doi:10.1093/eurheartj/ehac515
Accumulated hypertension burden on atrial fibrillation risk in diabetes mellitus: a nationwide population study
Choi, J., Lee, S. -R., Choi, E. -K., Lee, H., Han, M., Ahn, H. -J., . . . Lip, G. Y. H. (2023). Accumulated hypertension burden on atrial fibrillation risk in diabetes mellitus: a nationwide population study. CARDIOVASCULAR DIABETOLOGY, 22(1). doi:10.1186/s12933-023-01736-4
Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients
Vitolo, M., Proietti, M., Imberti, J. F., Bonini, N., Romiti, G. F., Mei, D. A., . . . Boriani, G. (2023). Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients. JOURNAL OF CLINICAL MEDICINE, 12(3). doi:10.3390/jcm12030768
Imaging and biophysical modelling of thrombogenic mechanisms in atrial fibrillation and stroke.
Qureshi, A., Lip, G. Y. H., Nordsletten, D. A., Williams, S. E., Aslanidi, O., & de Vecchi, A. (2022). Imaging and biophysical modelling of thrombogenic mechanisms in atrial fibrillation and stroke.. Frontiers in cardiovascular medicine, 9, 1074562. doi:10.3389/fcvm.2022.1074562
Development and validation of prediction models for incident atrial fibrillation in heart failure.
Vinter, N., Gerds, T. A., Cordsen, P., Valentin, J. B., Lip, G. Y. H., Benjamin, E. J. J., . . . Frost, L. (2023). Development and validation of prediction models for incident atrial fibrillation in heart failure.. Open heart, 10(1), e002169. doi:10.1136/openhrt-2022-002169
Efficacy of mobile health-technology integrated care based on the 'Atrial fibrillation Better Care' (ABC) pathway in relation to sex: a report from the mAFA-II randomized clinical trial
Guo, Y., Corica, B., Romiti, G. F., Proietti, M., Zhang, H., Lip, G. Y. H., & mAFApp, I. I. T. I. (2023). Efficacy of mobile health-technology integrated care based on the 'Atrial fibrillation Better Care' (ABC) pathway in relation to sex: a report from the mAFA-II randomized clinical trial. INTERNAL AND EMERGENCY MEDICINE. doi:10.1007/s11739-022-03188-2
Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial.
Talasaz, A. H., Sadeghipour, P., Bakhshandeh, H., Sharif-Kashani, B., Rashidi, F., Beigmohammadi, M. T., . . . Bikdeli, B. (2023). Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial.. Thrombosis and haemostasis, 123(7), 723-733. doi:10.1055/a-2059-4844
Impact of frailty on early rhythm control outcomes in older adults with atrial fibrillation: A nationwide cohort study
Yu, G. -I., Kim, D., Sung, J. -H., Jang, E., Yu, H. T., Kim, T. -H., . . . Joung, B. (2023). Impact of frailty on early rhythm control outcomes in older adults with atrial fibrillation: A nationwide cohort study. FRONTIERS IN CARDIOVASCULAR MEDICINE, 9. doi:10.3389/fcvm.2022.1050744
Low Quantitative Blush Evaluator score predicts larger infarct size and reduced left ventricular systolic function in patients with STEMI regardless of diabetes status
Nabrdalik, K., Tomasik, A., Irlik, K., Hendel, M., Kwiendacz, H., Radzik, E., . . . Lip, G. Y. H. (2023). Low Quantitative Blush Evaluator score predicts larger infarct size and reduced left ventricular systolic function in patients with STEMI regardless of diabetes status. SCIENTIFIC REPORTS, 13(1). doi:10.1038/s41598-022-24855-6
A review of emerging factor XI inhibitors
Elsheikh, S., Tidbury, N., & Lip, G. Y. H. (2023). A review of emerging factor XI inhibitors. EXPERT OPINION ON EMERGING DRUGS, 28(1), 43-53. doi:10.1080/14728214.2023.2192923
Dynamic changes of monocytes subsets predict major adverse cardiovascular events and left ventricular function after STEMI.
Boidin, M., Lip, G. Y. H., Shantsila, A., Thijssen, D., & Shantsila, E. (2023). Dynamic changes of monocytes subsets predict major adverse cardiovascular events and left ventricular function after STEMI.. Scientific reports, 13(1), 48. doi:10.1038/s41598-022-26688-9
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., . . . ESC/ERS Scientific Document Group. (2023). 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.. The European respiratory journal, 61(1), 2200879. doi:10.1183/13993003.00879-2022
A Happy New Year 2023 from Thrombosis and Haemostasis.
Lip, G. Y. H., Rigby, A., & Weber, C. (2023). A Happy New Year 2023 from Thrombosis and Haemostasis.. Thrombosis and haemostasis, 123(1), 1-5. doi:10.1055/s-0042-1760264
Adherence to the Atrial Fibrillation Better Care (ABC) pathway and the risk of major outcomes in patients with atrial fibrillation: A post-hoc analysis from the prospective GLORIA-AF Registry
Romiti, G. F., Proietti, M., Bonini, N., Ding, W. Y., Boriani, G., Huisman, M. V., & Lip, G. Y. H. (2023). Adherence to the Atrial Fibrillation Better Care (ABC) pathway and the risk of major outcomes in patients with atrial fibrillation: A post-hoc analysis from the prospective GLORIA-AF Registry. ECLINICALMEDICINE, 55. doi:10.1016/j.eclinm.2022.101757
Anticoagulation in older people with atrial fibrillation moving to care homes: a data linkage study
Ritchie, L. A., Harrison, S. L., Penson, P. E., Akbari, A., Torabi, F., Hollinghurst, J. P., . . . Lane, D. A. (n.d.). Anticoagulation in older people with atrial fibrillation moving to care homes: a data linkage study. British Journal of General Practice, BJGP.2022.0156. doi:10.3399/bjgp.2022.0156
Associations of Life's Essential 8 and Fine Particulate Pollution with Incidence of Atrial Fibrillation: Findings from a Prospective Cohort Study
At the heart of the matter: how mental stress and negative emotions affect atrial fibrillation
Leo, D. G., Ozdemir, H., Lane, D., Lip, G., Keller, S., & Proietti, R. (n.d.). At the heart of the matter: how mental stress and negative emotions affect atrial fibrillation. Frontiers in Cardiovascular Medicine. doi:10.3389/fcvm.2023.1171647
Cerebrovascular risk factors and their time-dependent effects on stroke survival in the EMMA cohort study.
Goulart, A. C., Varella, A. C., Tunes, G., Alencar, A. P., Santos, I. S., Romagnolli, C., . . . Bensenor, I. M. (2023). Cerebrovascular risk factors and their time-dependent effects on stroke survival in the EMMA cohort study.. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 56, e12895. doi:10.1590/1414-431x2023e12895
Characterising RR Intervals in Atrial Fibrillation Detected through Screening
Akande, R., Brimicombe, J., Cowie, M., Dymond, A., Clair Linden, H., Lip, G., . . . Charlton, P. (n.d.). Characterising RR Intervals in Atrial Fibrillation Detected through Screening. In Computing in Cardiology Conference (CinC). Computing in Cardiology. doi:10.22489/cinc.2023.270
Correction: Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation.
Correction: Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation. (2023). Annals of internal medicine, 176(1), 144. doi:10.7326/l22-0482
Early atrial fibrillation rhythm control after stroke
Calvert, P., Gupta, D., & Lip, G. Y. H. (2022). Early atrial fibrillation rhythm control after stroke. LANCET NEUROLOGY, 22(1), 3-4. Retrieved from https://www.webofscience.com/
Electrocardiogram Two-Dimensional Motifs: A Study Directed at Cardio Vascular Disease Classification
Aldosari, H., Coenen, F., Lip, G. Y. H., & Zheng, Y. (2023). Electrocardiogram Two-Dimensional Motifs: A Study Directed at Cardio Vascular Disease Classification. In Communications in Computer and Information Science (pp. 3-27). Springer Nature Switzerland. doi:10.1007/978-3-031-43471-6_1
Essen Stroke Risk Score Predicts Clinical Outcomes in Heart Failure Patients with Preserved Ejection Fraction: Evidence from the TOPCAT trial
Zhu, W., Cao, Y., Ye, M., Huang, H., Wu, Y., Ma, J., . . . Lip, G. Y. H. (2023). Essen Stroke Risk Score Predicts Clinical Outcomes in Heart Failure Patients with Preserved Ejection Fraction: Evidence from the TOPCAT trial. THROMBOSIS AND HAEMOSTASIS, 123(01), 85-96. doi:10.1055/a-1932-8854
Evaluation of the Paradoxical Association Between Lipid Levels and Incident Atrial Fibrillation According to Statin Usage: A Nationwide Cohort Study.
Ahn, H. -J., Lee, S. -R., Choi, E. -K., Lee, S. -W., Han, K. -D., Kwon, S., . . . Lip, G. Y. H. (2023). Evaluation of the Paradoxical Association Between Lipid Levels and Incident Atrial Fibrillation According to Statin Usage: A Nationwide Cohort Study.. Journal of lipid and atherosclerosis, 12(1), 73-86. doi:10.12997/jla.2023.12.1.73
Exercised-based cardiac rehabilitation associates with lower all-cause mortality in patients with primary pulmonary hypertension.
Kleinnibbelink, G., Buckley, B. J. R., Harrison, S. L., Williams, N., Fazio-Eynullayeva, E., Underhill, P., . . . Thijssen, D. H. J. (2023). Exercised-based cardiac rehabilitation associates with lower all-cause mortality in patients with primary pulmonary hypertension.. Frontiers in sports and active living, 5, 1247615. doi:10.3389/fspor.2023.1247615
Exploring the Technology Acceptance of Wearable Medical Devices Among the Younger Generation in Malaysia: The Role of Cognitive and Social Factors
Yap, W. Z., Sia, B. C., Goh, H. L., & Cham, T. H. (2023). Exploring the Technology Acceptance of Wearable Medical Devices Among the Younger Generation in Malaysia: The Role of Cognitive and Social Factors. In Unknown Conference (pp. 667-679). Springer International Publishing. doi:10.1007/978-3-031-20429-6_60
Impact of ABC (Atrial Fibrillation Better Care) pathway adherence in high-risk subgroups with atrial fibrillation: A report from the ESC-EHRA EORP-AF long-term general registry
Ding, W. Y., Proietti, M., Romiti, G. F., Vitolo, M., Fawzy, A. M., Boriani, G., . . . Lip, G. Y. H. (2023). Impact of ABC (Atrial Fibrillation Better Care) pathway adherence in high-risk subgroups with atrial fibrillation: A report from the ESC-EHRA EORP-AF long-term general registry. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 107, 60-65. doi:10.1016/j.ejim.2022.11.004
Impact of Pleural Effusion on Clinical Outcomes in Patients with Pulmonary Embolism: Insights from the National Inpatient Sample.
Abbas, K. S., Qureshi, A., Ahmad, S., Lip, G. Y. H., & Kwok, C. S. (2023). Impact of Pleural Effusion on Clinical Outcomes in Patients with Pulmonary Embolism: Insights from the National Inpatient Sample.. Acute medicine, 22(1), 24-32. doi:10.52964/amja.0930
Integrated Care Priorities for Complex, Multi-System, Long-Term Conditions and for Long COVID: Results of the STIMULATE-ICP-Delphi Study Among UK Patients and Healthcare Providers
MRI and CT imaging biomarkers of cerebral amyloid angiopathy in lobar intracerebral hemorrhage.
Schwarz, G., Banerjee, G., Hostettler, I. C., Ambler, G., Seiffge, D. J., Ozkan, H., . . . Werring, D. J. (2023). MRI and CT imaging biomarkers of cerebral amyloid angiopathy in lobar intracerebral hemorrhage.. International journal of stroke : official journal of the International Stroke Society, 18(1), 85-94. doi:10.1177/17474930211062478
Medium-term and long-term renal function changes with direct oral anticoagulants in elderly patients with atrial fibrillation.
Armentaro, G., D'Arrigo, G., Bo, M., Cassano, V., Miceli, S., Pitino, A., . . . Sciacqua, A. (2023). Medium-term and long-term renal function changes with direct oral anticoagulants in elderly patients with atrial fibrillation.. Frontiers in pharmacology, 14, 1210560. doi:10.3389/fphar.2023.1210560
Mobile health-technology integrated care in atrial fibrillation patients with heart failure: A report from the mAFA-II randomized clinical trial
Guo, Y., Romiti, G. F., Corica, B., Proietti, M., Bonini, N., Zhang, H., . . . mAF-App, I. I. T. I. (2023). Mobile health-technology integrated care in atrial fibrillation patients with heart failure: A report from the mAFA-II randomized clinical trial. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 107, 46-51. doi:10.1016/j.ejim.2022.11.002
Prediabetes Is Associated With Increased Risk of Heart Failure Among Patients With Atrial Fibrillation
Huang, J. -Y., Tse, Y. -K., Li, H. -L., Chen, C., Zhao, C. -T., Liu, M. -Y., . . . Yiu, K. -H. (2023). Prediabetes Is Associated With Increased Risk of Heart Failure Among Patients With Atrial Fibrillation. DIABETES CARE, 46(1), 190-196. doi:10.2337/dc22-1188
Prevalence of atrial fibrillation in the 65 or over Polish population. Report of cross-sectional NOMED-AF study.
Kalarus, Z., Średniawa, B., Mitręga, K., Wierucki, Ł., Sokal, A., Lip, G., . . . Zdrojewski, T. (2023). Prevalence of atrial fibrillation in the 65 or over Polish population. Report of cross-sectional NOMED-AF study.. Kardiologia polska, 81(1), 14-21. doi:10.33963/kp.a2022.0202
Prevalence of new-onset atrial fibrillation in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis
Corica, B., Tartaglia, F., Oliva, A., Raparelli, V., Cangemi, R., Basili, S., . . . Romiti, G. F. (2023). Prevalence of new-onset atrial fibrillation in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis. INTERNAL AND EMERGENCY MEDICINE, 18(1), 127-135. doi:10.1007/s11739-022-03135-1
Racial Differences in Ischemic and Hemorrhagic Stroke: An Ecological Epidemiological Study.
Kang, D. -S., Yang, P. -S., Kim, D., Jang, E., Yu, H. T., Kim, T. -H., . . . Joung, B. (2024). Racial Differences in Ischemic and Hemorrhagic Stroke: An Ecological Epidemiological Study.. Thrombosis and haemostasis, 124(9), 883-892. doi:10.1055/a-2278-8769
Relationship between Metabolic Status, Physical Activity and Cardiovascular Disease in Obese Adults
Renal outcomes of rivaroxaban compared with warfarin in Asian patients with nonvalvular atrial fibrillation: A nationwide population-based cohort study.
Lee, S. -R., Choi, E. -K., Park, S. -H., Han, K. -D., Oh, S., Abdelgawwad, K., & Lip, G. Y. H. (2023). Renal outcomes of rivaroxaban compared with warfarin in Asian patients with nonvalvular atrial fibrillation: A nationwide population-based cohort study.. Frontiers in cardiovascular medicine, 10, 1040834. doi:10.3389/fcvm.2023.1040834
Sex differences in pharmacological cardioversion among patients with atrial fibrillation.
Liu, Y., & Lip, G. Y. H. (2023). Sex differences in pharmacological cardioversion among patients with atrial fibrillation.. Kardiologia polska. doi:10.33963/v.kp.98206
Structured Rehabilitation for Patients with Atrial Fibrillation Based on an Integrated Care Approach: Protocol for a Prospective, Observational Cohort Study
Zhang, H., Jin, Z., Wang, H., Guo, Y., & Lip, G. Y. H. (2023). Structured Rehabilitation for Patients with Atrial Fibrillation Based on an Integrated Care Approach: Protocol for a Prospective, Observational Cohort Study. VASCULAR HEALTH AND RISK MANAGEMENT, 19, 485-494. doi:10.2147/VHRM.S407974
Temporal Trends of Stroke Severity and the Association between Antithrombotic Drug Regimen Changes and Clinical Outcomes after Stroke in Atrial Fibrillation
Thrombosis and Haemostasis 2022 Editors' Choice Papers.
Weber, C., Blanchet, X., & Lip, G. Y. H. (2023). Thrombosis and Haemostasis 2022 Editors' Choice Papers.. Thrombosis and haemostasis, 123(1), 123-130. doi:10.1055/s-0042-1760263
What People Post During the Movement Control Order (MCO): A Content Analysis of Intagram’s Top Posts
Goh, H. L., Foo, W. H., Cham, T. H., Sia, B. C., & Yap, W. Z. (2023). What People Post During the Movement Control Order (MCO): A Content Analysis of Intagram’s Top Posts. In Unknown Conference (pp. 84-94). Springer International Publishing. doi:10.1007/978-3-031-20429-6_9
2022
Prediction of postoperative atrial fibrillation with postoperative epicardial electrograms.
Feilberg Rasmussen, L., Andreasen, J. J., Riahi, S., Lip, G. Y. H., Lundbye-Christensen, S., Melgaard, J., & Graff, C. (2022). Prediction of postoperative atrial fibrillation with postoperative epicardial electrograms.. Scandinavian cardiovascular journal : SCJ, 56(1), 378-386. doi:10.1080/14017431.2022.2130421
Health care professionals’ perceptions about atrial fibrillation care in the Brazilian public primary care system: a mixed-methods study
Paschoal, E., Gooden, T. E., Olmos, R. D., Lotufo, P. A., Benseñor, I. M., Manaseki-Holland, S., . . . Zhong, J. (n.d.). Health care professionals’ perceptions about atrial fibrillation care in the Brazilian public primary care system: a mixed-methods study. BMC Cardiovascular Disorders, 22(1). doi:10.1186/s12872-022-02927-9
Anthropometric Measures and Risk of Cardiovascular Disease: Is there an Opportunity for Non-Traditional Anthropometric Assessment? A Review
Carrion-Martinez, A., Buckley, B. J. R., Orenes-Pinero, E., Marin, F., Lip, G. Y. H., & Miguel Rivera-Caravaca, J. (2022). Anthropometric Measures and Risk of Cardiovascular Disease: Is there an Opportunity for Non-Traditional Anthropometric Assessment? A Review. REVIEWS IN CARDIOVASCULAR MEDICINE, 23(12). doi:10.31083/j.rcm2312414
Impact of Socioeconomic Status on Emergency Department Visits in Patients With Atrial Fibrillation: A Nationwide Population-Based Cohort Study.
Lee, S. -Y., Lee, S. -R., Choi, E. -K., Han, K. -D., Oh, S., & Lip, G. Y. H. (2022). Impact of Socioeconomic Status on Emergency Department Visits in Patients With Atrial Fibrillation: A Nationwide Population-Based Cohort Study.. Journal of the American Heart Association, 11(24), e027192. doi:10.1161/jaha.122.027192
New use for an old drug : Metformin and atrial fibrillation
Vinciguerra, M., Olier, I., Ortega-Martorell, S., & Lip, G. Y. H. (2022). New use for an old drug : Metformin and atrial fibrillation. CELL REPORTS MEDICINE, 3(12). doi:10.1016/j.xcrm.2022.100875
Prediction of incident atrial fibrillation in post-stroke patients using machine learning: a French nationwide study
Bisson, A., Lemrini, Y., El-Bouri, W., Bodin, A., Angoulvant, D., Lip, G. Y. H., & Fauchier, L. (2022). Prediction of incident atrial fibrillation in post-stroke patients using machine learning: a French nationwide study. CLINICAL RESEARCH IN CARDIOLOGY. doi:10.1007/s00392-022-02140-w
Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry
Esteve-Pastor, M. A., Rivera-Caravaca, J. M., Roldan, V., Sanmartin Fernandez, M., Arribas, F., Masjuan, J., . . . Marin, F. (2022). Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 9(1), 38-46. doi:10.1093/ehjcvp/pvac060
Prothrombin Time-International Normalized Ratio Predicts the Outcome of Atrial Fibrillation Patients Taking Rivaroxaban.
Chao, T. -F., Chan, Y. -H., Tsai, P. -C., Lee, H. -F., Chang, S. -H., Kuo, C. -T., . . . Yeh, Y. -H. (2022). Prothrombin Time-International Normalized Ratio Predicts the Outcome of Atrial Fibrillation Patients Taking Rivaroxaban.. Biomedicines, 10(12), 3210. doi:10.3390/biomedicines10123210
AI in breast screening mammography: breast screening readers' perspectives.
de Vries, C. F., Colosimo, S. J., Boyle, M., Lip, G., Anderson, L. A., Staff, R. T., & iCAIRD Radiology Collaboration. (2022). AI in breast screening mammography: breast screening readers' perspectives.. Insights into imaging, 13(1), 186. doi:10.1186/s13244-022-01322-4
Prognosis and treatment of atrial fibrillation in Asian cities: 1-year review of the Asia-Pacific Heart Rhythm Society Atrial Fibrillation Registry.
Tse, H. -F., Teo, W. -S., Siu, C. -W., Chao, T. -F., Park, H. -W., Shimizu, W., . . . Lip, G. Y. H. (2022). Prognosis and treatment of atrial fibrillation in Asian cities: 1-year review of the Asia-Pacific Heart Rhythm Society Atrial Fibrillation Registry.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 24(12), 1889-1898. doi:10.1093/europace/euab327
Evaluation of Huawei Smart Wearables for Detection of Atrial Fibrillation in Patients Following Ischaemic Stroke: The Liverpool-Huawei Stroke Study
Harrison, S. L., Buckley, B. J. R., Zheng, Y., Hill, A., Hlaing, T., Davies, R., . . . Jones, I. (2022). Evaluation of Huawei Smart Wearables for Detection of Atrial Fibrillation in Patients Following Ischaemic Stroke: The Liverpool-Huawei Stroke Study. American Heart Journal. doi:10.1016/j.ahj.2022.12.004
Performance of the HAS-BLED, ORBIT, and ATRIA Bleeding Risk Scores on a Cohort of 399 344 Hospitalized Patients With Atrial Fibrillation and Cancer: Data From the French National Hospital Discharge Database
Pastori, D., Marang, A., Bisson, A., Herbert, J., Lip, G. Y. H., & Fauchier, L. (2022). Performance of the HAS-BLED, ORBIT, and ATRIA Bleeding Risk Scores on a Cohort of 399 344 Hospitalized Patients With Atrial Fibrillation and Cancer: Data From the French National Hospital Discharge Database. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 11(23). doi:10.1161/JAHA.121.026388
Prevalence and outcomes of atrial fibrillation in older people living in care homes in Wales: a routine data linkage study 2003-2018
Ritchie, L. A., Harrison, S. L., Penson, P. E., Akbari, A., Torabi, F., Hollinghurst, J., . . . Lane, D. A. (2022). Prevalence and outcomes of atrial fibrillation in older people living in care homes in Wales: a routine data linkage study 2003-2018. AGE AND AGEING, 51(12). doi:10.1093/ageing/afac252
Scanned ECG Arrhythmia Classification Using a Pre-trained Convolutional Neural Network as a Feature Extractor
Coenen, F., Aldosari, H., Lip, G., & Zheng, Y. (2022). Scanned ECG Arrhythmia Classification Using a Pre-trained Convolutional Neural Network as a Feature Extractor.
Clinical Complexity Domains, Anticoagulation, and Outcomes in Patients with Atrial Fibrillation: A Report from the GLORIA-AF Registry Phase II and III
Romiti, G. F., Proietti, M., Bonini, N., Ding, W. Y., Boriani, G., Huisman, M. V., & Lip, G. Y. H. (2022). Clinical Complexity Domains, Anticoagulation, and Outcomes in Patients with Atrial Fibrillation: A Report from the GLORIA-AF Registry Phase II and III. THROMBOSIS AND HAEMOSTASIS, 122(12), 2030-2041. doi:10.1055/s-0042-1756355
Integrated Care for Atrial Fibrillation Management: The Role of the Pharmacist
Ritchie, L. A., Penson, P. E., Akpan, A., Lip, G. Y. H., & Lane, D. A. (2022). Integrated Care for Atrial Fibrillation Management: The Role of the Pharmacist. AMERICAN JOURNAL OF MEDICINE, 135(12), 1410-1426. doi:10.1016/j.amjmed.2022.07.014
Microstructure and mechanical properties of electroplated Ni-Sn TLP bonded joints with different bonding and aging times
Yan, G., Gill, V., Gan, C. L., & Chen, Z. (2022). Microstructure and mechanical properties of electroplated Ni-Sn TLP bonded joints with different bonding and aging times. Materials Characterization, 194, 112452. doi:10.1016/j.matchar.2022.112452
Revisiting 'intensive' blood glucose control: A causal directed acyclic graph-guided systematic review of randomized controlled trials
Huang, C. -J., Wang, W. -T., Sung, S. -H., Chen, C. -H., Lip, G. Y. H., Cheng, H. -M., & Chiang, C. -E. (2022). Revisiting 'intensive' blood glucose control: A causal directed acyclic graph-guided systematic review of randomized controlled trials. DIABETES OBESITY & METABOLISM, 24(12), 2341-2352. doi:10.1111/dom.14819
Risk of stroke or systemic embolism in patients with degenerative mitral stenosis with or without atrial fibrillation: A cohort study.
Steiner, D. K., Søgaard, P., Jensen, M., Bjerregaard Larsen, T., Lip, G. Y. H., & Nielsen, P. B. (2022). Risk of stroke or systemic embolism in patients with degenerative mitral stenosis with or without atrial fibrillation: A cohort study.. International journal of cardiology. Heart & vasculature, 43, 101126. doi:10.1016/j.ijcha.2022.101126
Sinus rhythm restoration and improved outcomes in patients with acute ischemic stroke and in-hospital paroxysmal atrial fibrillation
Sagris, D., Korompoki, E., Ntaios, G., Tzeis, S., Manios, E., Kanakakis, J., . . . Vemmos, K. (2022). Sinus rhythm restoration and improved outcomes in patients with acute ischemic stroke and in-hospital paroxysmal atrial fibrillation. EUROPEAN STROKE JOURNAL, 7(4), 421-430. doi:10.1177/23969873221109405
Therapeutic<i> vs.</i> prophylactic anticoagulation in COVID-19 patients: a systematic review and meta-analysis of real-world studies
Vio, R., Giordani, A. S., Stefil, M., Alturki, A., Russo, V., China, P., . . . Proietti, R. (2022). Therapeutic<i> vs.</i> prophylactic anticoagulation in COVID-19 patients: a systematic review and meta-analysis of real-world studies. MINERVA CARDIOLOGY AND ANGIOLOGY, 70(6), 652-662. doi:10.23736/S2724-5683.22.06230-5
Ultrafast high-temperature sintering of dense and textured alumina
Behera, R. P., Reavley, M. J. -H., Du, Z., Gan, C. L., & Le Ferrand, H. (2022). Ultrafast high-temperature sintering of dense and textured alumina. Journal of the European Ceramic Society, 42(15), 7122-7133. doi:10.1016/j.jeurceramsoc.2022.08.014
The obesity paradox in patients with atrial fibrillation: an insight from the Gulf SAFE registry
Li, Y. G., Bai, J., Domek, M., Alsheikh-Ali, A., Almahmeed, W., Shehab, A., . . . Lip, G. Y. H. (2020). The obesity paradox in patients with atrial fibrillation: an insight from the Gulf SAFE registry. In EUROPEAN HEART JOURNAL Vol. 41 (pp. 354). Retrieved from https://www.webofscience.com/
Association between exercise habit changes and mortality following a cardiovascular event
Kang, D. -S., Sung, J. -H., Kim, D., Jin, M. -N., Jang, E., Yu, H. T., . . . Joung, B. (2022). Association between exercise habit changes and mortality following a cardiovascular event. HEART, 108(24), 1945-1951. doi:10.1136/heartjnl-2022-320882
Prevalence of atrial fibrillation in Northern Sri Lanka: a study protocol for a cross-sectional household survey.
Kanesamoorthy, S., Sheron, V. A., Uruthirakumar, P., Kodippily, C., Kumarendran, B., Gooden, T. E., . . . NIHR Global Health Research Group on Atrial Fibrillation Management. (2022). Prevalence of atrial fibrillation in Northern Sri Lanka: a study protocol for a cross-sectional household survey.. BMJ open, 12(11), e056480. doi:10.1136/bmjopen-2021-056480
Adverse Cardiovascular Events in Non-Traumatic Intracranial Hemorrhage and Ischemic Stroke Survivors
Pasi, M., Boulouis, G., Bisson, A., Herbert, J., Bodin, A., Cordonnier, C., . . . Fauchier, L. (2022). Adverse Cardiovascular Events in Non-Traumatic Intracranial Hemorrhage and Ischemic Stroke Survivors. JOURNAL OF CLINICAL MEDICINE, 11(23). doi:10.3390/jcm11236885
Evaluation of the atrial fibrillation better care pathway in the ENGAGE AF-TIMI 48 trial.
Patel, S. M., Palazzolo, M. G., Murphy, S. A., Antman, E. M., Braunwald, E., Lanz, H. -J., . . . Ruff, C. T. (2022). Evaluation of the atrial fibrillation better care pathway in the ENGAGE AF-TIMI 48 trial.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 24(11), 1730-1738. doi:10.1093/europace/euac082
Corrigendum to: Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week.
Corrigendum to: Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week. (2022). European heart journal, 43(44), 4634. doi:10.1093/eurheartj/ehac519
Impact of mental disorders on the risk of atrial fibrillation in patients with diabetes mellitus: a nationwide population-based study.
Bae, N. Y., Lee, S. -R., Choi, E. -K., Ahn, H. J., Ahn, H. -J., Kwon, S., . . . Lip, G. Y. H. (2022). Impact of mental disorders on the risk of atrial fibrillation in patients with diabetes mellitus: a nationwide population-based study.. Cardiovascular diabetology, 21(1), 251. doi:10.1186/s12933-022-01682-7
Safety and efficacy of direct oral anticoagulants in patients with anaemia and atrial fibrillation: an observational nationwide Danish cohort study.
Al-Hussainy, N., Kragholm, K. H., Lundbye-Christensen, S., Torp-Pedersen, C., Pareek, M., Therkelsen, S. K., . . . Riahi, S. (2022). Safety and efficacy of direct oral anticoagulants in patients with anaemia and atrial fibrillation: an observational nationwide Danish cohort study.. European heart journal. Quality of care & clinical outcomes, 8(8), 840-851. doi:10.1093/ehjqcco/qcab095
Targeted vs. full population screening costs for incident atrial fibrillation and AF-related stroke for a healthy population aged 65 years in the United Kingdom.
Burdett, P., & Lip, G. Y. H. (2022). Targeted vs. full population screening costs for incident atrial fibrillation and AF-related stroke for a healthy population aged 65 years in the United Kingdom.. European heart journal. Quality of care & clinical outcomes, 8(8), 892-898. doi:10.1093/ehjqcco/qcac005
The impact of socioeconomic deprivation on the risk of atrial fibrillation in patients with diabetes mellitus: A nationwide population-based study
Han, M., Lee, S. -R., Choi, E. -K., Park, S. -H., Lee, H., Chung, J., . . . Lip, G. Y. H. (2022). The impact of socioeconomic deprivation on the risk of atrial fibrillation in patients with diabetes mellitus: A nationwide population-based study. FRONTIERS IN CARDIOVASCULAR MEDICINE, 9. doi:10.3389/fcvm.2022.1008340
Screening of Atrial Fibrillation in Dental Practices: a qualitative feasibility study
Risk factors for cardiovascular disease in patients with metabolic-associated fatty liver disease: a machine learning approach
Drozdz, K., Nabrdalik, K., Kwiendacz, H., Hendel, M., Olejarz, A., Tomasik, A., . . . Lip, G. Y. H. (2022). Risk factors for cardiovascular disease in patients with metabolic-associated fatty liver disease: a machine learning approach. CARDIOVASCULAR DIABETOLOGY, 21(1). doi:10.1186/s12933-022-01672-9
Impact of anthropometric factors on outcomes in atrial fibrillation patients: analysis on 10 220 patients from the European Society of Cardiology (ESC)-European Heart Rhythm Association (EHRA) EurObservational Research Programme on Atrial Fibrillation (EORP-AF) general long-term registry
Boriani, G., Vitolo, M., Malavasi, V. L., Proietti, M., Fantecchi, E., Diemberger, I., . . . Lipand, G. Y. H. (2022). Impact of anthropometric factors on outcomes in atrial fibrillation patients: analysis on 10 220 patients from the European Society of Cardiology (ESC)-European Heart Rhythm Association (EHRA) EurObservational Research Programme on Atrial Fibrillation (EORP-AF) general long-term registry. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 29(15), 1967-1981. doi:10.1093/eurjpc/zwac115
The Athlete's Heart and Machine Learning: A Review of Current Implementations and Gaps for Future Research
Bellfield, R. A. A., Ortega-Martorell, S., Lip, G. Y. H., Oxborough, D., & Olier, I. (2022). The Athlete's Heart and Machine Learning: A Review of Current Implementations and Gaps for Future Research. JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 9(11). doi:10.3390/jcdd9110382
Trabectedin Cardiotoxicity in Soft Tissue Sarcoma: A Case Series and Clinical Insights
Gent, D. G., Ali, N., Olsson-Brown, A., Lip, G. Y. H., Wright, D. J., & Dobson, R. (2022). Trabectedin Cardiotoxicity in Soft Tissue Sarcoma: A Case Series and Clinical Insights. CASE REPORTS IN ONCOLOGY, 15(3), 950-959. doi:10.1159/000526256
Consumer-Led Screening for Atrial Fibrillation: Frontier Review of the AF-SCREEN International Collaboration.
Brandes, A., Stavrakis, S., Freedman, B., Antoniou, S., Boriani, G., Camm, A. J., . . . Turakhia, M. P. (2022). Consumer-Led Screening for Atrial Fibrillation: Frontier Review of the AF-SCREEN International Collaboration.. Circulation, 146(19), 1461-1474. doi:10.1161/circulationaha.121.058911
Stroke risk stratification in patients with heart failure and sinus rhythm
Sagris, D., Shantsila, E., & Lip, G. Y. H. (2022). Stroke risk stratification in patients with heart failure and sinus rhythm. EUROPEAN HEART JOURNAL, 43(42), 4480-4482. doi:10.1093/eurheartj/ehac493
Stroke and Myocardial Infarction in Patients with Abdominal Aortic Aneurysm and New-Onset Atrial Fibrillation.
Nicolajsen, C. W., Nielsen, P. B., Jensen, M., Eldrup, N., Larsen, T. B., Lip, G. Y. H., . . . Søgaard, M. (2023). Stroke and Myocardial Infarction in Patients with Abdominal Aortic Aneurysm and New-Onset Atrial Fibrillation.. Thrombosis and haemostasis, 123(5), 555-564. doi:10.1055/a-2009-8954
Prevalence, incidence and mortality of hypertrophic cardiomyopathy based on a population cohort of 21.9 million in China
Bai, Y., Zheng, J. -P., Lu, F., Zhang, X. -L., Sun, C. -P., Guo, W. -H., . . . Shi, X. -B. (2022). Prevalence, incidence and mortality of hypertrophic cardiomyopathy based on a population cohort of 21.9 million in China. SCIENTIFIC REPORTS, 12(1). doi:10.1038/s41598-022-20042-9
Interactive Remote Patient Monitoring Devices for Managing Chronic Health Conditions: Systematic Review and Meta-analysis
Leo, D. G., Buckley, B. J. R., Chowdhury, M., Harrison, S. L., Isanejad, M., Lip, G. Y. H., . . . Lane, D. A. (2022). Interactive Remote Patient Monitoring Devices for Managing Chronic Health Conditions: Systematic Review and Meta-analysis. JOURNAL OF MEDICAL INTERNET RESEARCH, 24(11). doi:10.2196/35508
Mobile health technology integrated care in older atrial fibrillation patients: a subgroup analysis of the mAFA-II randomised clinical trial
Guo, Y., Romiti, G. F., Proietti, M., Bonini, N., Zhang, H., & Lip, G. Y. H. (2022). Mobile health technology integrated care in older atrial fibrillation patients: a subgroup analysis of the mAFA-II randomised clinical trial. AGE AND AGEING, 51(11). doi:10.1093/ageing/afac245
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).
Lyon, A. R., López-Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., . . . ESC Scientific Document Group. (2022). 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).. European heart journal, 43(41), 4229-4361. doi:10.1093/eurheartj/ehac244
Adherence to the "Atrial fibrillation Better Care" (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry
Vitolo, M., Proietti, M., Malavasi, V. L., Bonini, N., Romiti, G. F., Imberti, J. F., . . . Boriani, G. (2022). Adherence to the "Atrial fibrillation Better Care" (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 105, 54-62. doi:10.1016/j.ejim.2022.08.004
Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation: A Multinational Population-Based Cohort Study
Lau, W. C. Y., Torre, C. O., Man, K. K. C., Stewart, H. M., Seager, S., Van Zandt, M., . . . Wong, I. C. K. (2022). Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation: A Multinational Population-Based Cohort Study. ANNALS OF INTERNAL MEDICINE, 175(11), 1515-+. doi:10.7326/M22-0511
Consumer-Led Screening for Atrial Fibrillation: A Report From the mAFA-II Trial Long-Term Extension Cohort.
Guo, Y., Zhang, H., Lip, G. Y. H., & mAF-App II Trial investigators. (2022). Consumer-Led Screening for Atrial Fibrillation: A Report From the mAFA-II Trial Long-Term Extension Cohort.. JACC. Asia, 2(6), 737-746. doi:10.1016/j.jacasi.2022.07.006
Development of Interstitial Lung Disease Among Patients With Atrial Fibrillation Receiving Oral Anticoagulants in Taiwan.
Chan, Y. -H., Chao, T. -F., Chen, S. -W., Lee, H. -F., Chen, W. -M., Li, P. -R., . . . Lip, G. Y. H. (2022). Development of Interstitial Lung Disease Among Patients With Atrial Fibrillation Receiving Oral Anticoagulants in Taiwan.. JAMA network open, 5(11), e2243307. doi:10.1001/jamanetworkopen.2022.43307
Effectiveness and safety of intracranial events associated with the use of direct oral anticoagulants for atrial fibrillation: A systematic review and meta-analysis of 92 studies.
Archontakis-Barakakis, P., Li, W., Kalaitzoglou, D., Tzelves, L., Manolopoulos, A., Giannopoulos, S., . . . Kokkinidis, D. G. (2022). Effectiveness and safety of intracranial events associated with the use of direct oral anticoagulants for atrial fibrillation: A systematic review and meta-analysis of 92 studies.. British journal of clinical pharmacology, 88(11), 4663-4675. doi:10.1111/bcp.15464
External validation of the simple NULL-PLEASE clinical score in predicting outcomes of out-of-hospital cardiac arrest in the Danish population - A nationwide registry-based study.
Byrne, C., Barcella, C. A., Krogager, M. L., Pareek, M., Ringgren, K. B., Andersen, M. P., . . . Lip, G. Y. H. (2022). External validation of the simple NULL-PLEASE clinical score in predicting outcomes of out-of-hospital cardiac arrest in the Danish population - A nationwide registry-based study.. Resuscitation, 180, 128-136. doi:10.1016/j.resuscitation.2022.08.009
Oral anticoagulant management of patients with mechanical heart valves at the Salam Centre of Khartoum: Observations on quality of anticoagulation and thrombotic risk.
Erba, N., Tosetto, A., Langer, M., Abdallah, S. A., Giovanella, E., Lentini, S., . . . Poli, D. (2022). Oral anticoagulant management of patients with mechanical heart valves at the Salam Centre of Khartoum: Observations on quality of anticoagulation and thrombotic risk.. Thrombosis research, 219, 155-161. doi:10.1016/j.thromres.2022.09.018
Protective effect of proton-pump inhibitor against gastrointestinal bleeding in patients receiving oral anticoagulants: A systematic review and meta-analysis.
Ahn, H. -J., Lee, S. -R., Choi, E. -K., Rhee, T. -M., Kwon, S., Oh, S., & Lip, G. Y. H. (2022). Protective effect of proton-pump inhibitor against gastrointestinal bleeding in patients receiving oral anticoagulants: A systematic review and meta-analysis.. British journal of clinical pharmacology, 88(11), 4676-4687. doi:10.1111/bcp.15478
STIMULATE-ICP-Delphi (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways Delphi): Study protocol
van der Feltz-Cornelis, C. M., Sweetman, J., Allsopp, G., Attree, E., Crooks, M. G., Cuthbertson, D. J., . . . STIMULATE-ICP, C. (2022). STIMULATE-ICP-Delphi (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways Delphi): Study protocol. PLOS ONE, 17(11). doi:10.1371/journal.pone.0277936
Social determinants of health and cardiovascular outcomes in patients with heart failure
Vinter, N., Fawzy, A. M., Gent, D., Ding, W. Y., Johnsen, S. P., Frost, L., . . . Lip, G. Y. H. (2022). Social determinants of health and cardiovascular outcomes in patients with heart failure. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 52(11). doi:10.1111/eci.13843
Stroke prevention in atrial fibrillation
Lip, G. Y. H., Gue, Y., Zhang, J., Chao, T. -F., Calkins, H., & Potpara, T. (2022). Stroke prevention in atrial fibrillation. TRENDS IN CARDIOVASCULAR MEDICINE, 32(8), 501-510. doi:10.1016/j.tcm.2021.10.001
Thromboembolic events and major bleeding with warfarin, non-vitamin K antagonist oral anticoagulants or antiplatelets following mitral valve repair: A systematic review and meta-analysis
Current Concepts: Comprehensive "Cardiovascular Health" Rehabilitation-An Integrated Approach to Improve Secondary Prevention and Rehabilitation of Cardiovascular Diseases
Buckley, B. J. R., & Lip, G. Y. H. (2022). Current Concepts: Comprehensive "Cardiovascular Health" Rehabilitation-An Integrated Approach to Improve Secondary Prevention and Rehabilitation of Cardiovascular Diseases. THROMBOSIS AND HAEMOSTASIS, 122(12), 1966-1968. doi:10.1055/s-0042-1757403
Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF General Long-Term Registry
Proietti, M., Romiti, G. F., Vitolo, M., Potpara, T. S., Boriani, G., & Lip, G. Y. H. (2022). Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF General Long-Term Registry. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 8(7), 778-786. doi:10.1093/ehjqcco/qcab069
Stroke prevention with non-vitamin K antagonist oral anticoagulants in high risk elderly atrial fibrillation patients at increased bleeding risk
Chao, T., Lip, G. Y. H., & Chen, S. A. (2021). Stroke prevention with non-vitamin K antagonist oral anticoagulants in high risk elderly atrial fibrillation patients at increased bleeding risk. In EUROPEAN HEART JOURNAL Vol. 42 (pp. 552). Retrieved from https://www.webofscience.com/
Habitual fish oil supplementation and the risk of incident atrial fibrillation: findings from a large prospective longitudinal cohort study
Zhang, J., Cai, A., Chen, G., Wang, X., Cai, M., Li, H., . . . Lin, H. (2022). Habitual fish oil supplementation and the risk of incident atrial fibrillation: findings from a large prospective longitudinal cohort study. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 29(14), 1911-1920. doi:10.1093/eurjpc/zwac192
Factor XIa Inhibition: Is It a Novel Alternative Antithrombotic Strategy for High-Risk ACS Patients?
Gue, Y. X., Gorog, D. A., & Lip, G. Y. H. (2022). Factor XIa Inhibition: Is It a Novel Alternative Antithrombotic Strategy for High-Risk ACS Patients?. CIRCULATION, 146(16), 1207-1209. doi:10.1161/CIRCULATIONAHA.122.061987
Editorial: New horizons in the management of patients with atrial fibrillation: Interactions with the gastrointestinal system
Rivera-Caravaca, J. M., Lip, G. Y. H., Roldan, V., & Marin, F. (2022). Editorial: New horizons in the management of patients with atrial fibrillation: Interactions with the gastrointestinal system. FRONTIERS IN CARDIOVASCULAR MEDICINE, 9. doi:10.3389/fcvm.2022.1042728
Association between metabolically healthy obesity and risk of atrial fibrillation: taking physical activity into consideration
Wang, R., Olier, I., Ortega-Martorell, S., Liu, Y., Ye, Z., Lip, G. Y. H., & Li, G. (2022). Association between metabolically healthy obesity and risk of atrial fibrillation: taking physical activity into consideration. CARDIOVASCULAR DIABETOLOGY, 21(1). doi:10.1186/s12933-022-01644-z
Effectiveness of early rhythm control in improving clinical outcomes in patients with atrial fibrillation: a systematic review and meta-analysis
Zhu, W., Wu, Z., Dong, Y., Lip, G. Y. H., & Liu, C. (2022). Effectiveness of early rhythm control in improving clinical outcomes in patients with atrial fibrillation: a systematic review and meta-analysis. BMC MEDICINE, 20(1). doi:10.1186/s12916-022-02545-4
Zero-burden atrial fibrillation: does stroke risk diminish the longer a person is free from atrial fibrillation?
Junarta, J., Dikdan, S. J., Weitz, H. H., Lip, G. Y. H., & Frisch, D. R. (2022). Zero-burden atrial fibrillation: does stroke risk diminish the longer a person is free from atrial fibrillation?. EUROPACE, 24(9), 1369-1371. doi:10.1093/europace/euac025
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., . . . ESC/ERS Scientific Document Group. (2022). 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.. European heart journal, 43(38), 3618-3731. doi:10.1093/eurheartj/ehac237
Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association
Levine, G. N., McEvoy, J. W., Fang, J. C., Ibeh, C., McCarthy, C. P., Misra, A., . . . Lip, G. Y. H. (2022). Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association. CIRCULATION, 146(15), E205-E223. doi:10.1161/CIR.0000000000001092
Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week
De Caterina, R., Agewall, S., Andreotti, F., Angiolillo, D. J., Bhatt, D. L., Byrne, R. A., . . . Potpara, T. (2022). Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week. EUROPEAN HEART JOURNAL, 43(37), 3512-3527. doi:10.1093/eurheartj/ehac294
Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper
Gorog, D. A., Gue, Y. X., Chao, T. -F., Fauchier, L., Ferreiro, J. L., Huber, K., . . . Lip, G. Y. H. (2022). Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper. THROMBOSIS AND HAEMOSTASIS, 122(10), 1625-1652. doi:10.1055/s-0042-1750385
Chemotherapy-Induced Arrhythmias
Essa, H., Dobson, R., & Lip, G. Y. H. (2022). Chemotherapy-Induced Arrhythmias. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 80(4), 531-539. doi:10.1097/FJC.0000000000001216
Clinical utility and prognostic implications of the 4S-AF scheme: Report from Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry.
Chao, T. -F., Tse, H. -F., Teo, W. -S., Park, H. -W., Shimizu, W., Chen, S. -A., . . . Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry Investigators. (2022). Clinical utility and prognostic implications of the 4S-AF scheme: Report from Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry.. European journal of clinical investigation, 52(10), e13825. doi:10.1111/eci.13825
Early Rhythm Control Therapy for Atrial Fibrillation in Low-Risk Patients A Nationwide Propensity Score-Weighted Study
Kim, D., Yang, P. -S., You, S. C., Jang, E., Yu, H. T., Kim, T. -H., . . . Joung, B. (2022). Early Rhythm Control Therapy for Atrial Fibrillation in Low-Risk Patients A Nationwide Propensity Score-Weighted Study. ANNALS OF INTERNAL MEDICINE, 175(10), 1356-+. doi:10.7326/M21-4798
Effectiveness and Safety of Antithrombotic Medication in Patients With Atrial Fibrillation and Intracranial Hemorrhage: Systematic Review and Meta-Analysis
Ivany, E., Ritchie, L. A., Lip, G. Y. H., Lotto, R. R., Werring, D. J., & Lane, D. A. (2022). Effectiveness and Safety of Antithrombotic Medication in Patients With Atrial Fibrillation and Intracranial Hemorrhage: Systematic Review and Meta-Analysis. STROKE, 53(10), 3035-3046. doi:10.1161/STROKEAHA.122.038752
Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program.
Beier, L., Lu, S., França, L. R., Marler, S., Lip, G. Y. H., Huisman, M. V., . . . Rothman, K. J. (2022). Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program.. PloS one, 17(10), e0274237. doi:10.1371/journal.pone.0274237
Sodium-glucose cotransporter 2 inhibitors: An additional management option for patients with atrial fibrillation?
Proietti, R., & Lip, G. Y. H. (2022). Sodium-glucose cotransporter 2 inhibitors: An additional management option for patients with atrial fibrillation?. DIABETES OBESITY & METABOLISM, 24(10), 1897-1900. doi:10.1111/dom.14818
Stroke Prevention in Atrial Fibrillation: A Scientific Statement of <i>JACC: Asia</i> (Part 2).
Chiang, C. -E., Chao, T. -F., Choi, E. -K., Lim, T. W., Krittayaphong, R., Li, M., . . . Lip, G. Y. H. (2022). Stroke Prevention in Atrial Fibrillation: A Scientific Statement of <i>JACC: Asia</i> (Part 2).. JACC. Asia, 2(5), 519-537. doi:10.1016/j.jacasi.2022.06.004
Thromboembolism and bleeding in patients with atrial fibrillation and liver disease - A nationwide register-based cohort study: Thromboembolism and bleeding in liver disease.
Steensig, K., Pareek, M., Krarup, A. L., Sogaard, P., Maeng, M., Tayal, B., . . . Kragholm, K. H. (2022). Thromboembolism and bleeding in patients with atrial fibrillation and liver disease - A nationwide register-based cohort study: Thromboembolism and bleeding in liver disease.. Clinics and research in hepatology and gastroenterology, 46(8), 101952. doi:10.1016/j.clinre.2022.101952
Using the C<sub>2</sub>HEST Score for Predicting Postoperative Atrial Fibrillation After Cardiac Surgery: A Report From the Western Denmark Heart Registry, the Danish National Patient Registry, and the Danish National Prescription Registry.
Rasmussen, L. F., Andreasen, J. J., Lundbye-Christensen, S., Riahi, S., Johnsen, S. P., & Lip, G. Y. H. (2022). Using the C<sub>2</sub>HEST Score for Predicting Postoperative Atrial Fibrillation After Cardiac Surgery: A Report From the Western Denmark Heart Registry, the Danish National Patient Registry, and the Danish National Prescription Registry.. Journal of cardiothoracic and vascular anesthesia, 36(10), 3730-3737. doi:10.1053/j.jvca.2022.03.037
Validation of Biomarker-Based ABCD Score in Atrial Fibrillation Patients with a Non-Gender CHA<sub>2</sub>DS<sub>2</sub>-VASc Score 0-1: A Korean Multi-Center Cohort
Jung, M., Byeon, K., Kang, K. -W., Park, Y. M., Hwang, Y. M., Lee, S. H., . . . Shin, S. Y. (2022). Validation of Biomarker-Based ABCD Score in Atrial Fibrillation Patients with a Non-Gender CHA<sub>2</sub>DS<sub>2</sub>-VASc Score 0-1: A Korean Multi-Center Cohort. YONSEI MEDICAL JOURNAL, 63(10), 892-901. doi:10.3349/ymj.2022.0157
Bond engineering of molecular ferroelectrics renders soft and high-performance piezoelectric energy harvesting materials.
Hu, Y., Parida, K., Zhang, H., Wang, X., Li, Y., Zhou, X., . . . Fan, H. J. (2022). Bond engineering of molecular ferroelectrics renders soft and high-performance piezoelectric energy harvesting materials.. Nature communications, 13(1), 5607. doi:10.1038/s41467-022-33325-6
Copper-Nanoparticle-Coated Fabrics for Rapid and Sustained Antibacterial Activity Applications
Gonçalves, R. A., Ku, J. W. K., Zhang, H., Salim, T., Oo, G., Zinn, A. A., . . . Lam, Y. M. (2022). Copper-Nanoparticle-Coated Fabrics for Rapid and Sustained Antibacterial Activity Applications. ACS Applied Nano Materials, 5(9), 12876-12886. doi:10.1021/acsanm.2c02736
<i>APOE</i> and Cerebral Small Vessel Disease Markers in Patients With Intracerebral Hemorrhage.
Hostettler, I. C., Seiffge, D., Wong, A., Ambler, G., Wilson, D., Shakeshaft, C., . . . Werring, D. J. (2022). <i>APOE</i> and Cerebral Small Vessel Disease Markers in Patients With Intracerebral Hemorrhage.. Neurology, 99(12), e1290-e1298. doi:10.1212/wnl.0000000000200851
Simultaneous Enhancement of Polymerization Kinetics and Properties of Phthalonitrile Using Alumina Fillers.
Tay, Y. S., Phua, E. J. R., Chen, Z., & Gan, C. L. (2022). Simultaneous Enhancement of Polymerization Kinetics and Properties of Phthalonitrile Using Alumina Fillers.. ACS omega, 7(37), 32996-33003. doi:10.1021/acsomega.2c02667
Efficacy and Safety of Anticoagulants in Patients with Atrial Fibrillation and History of Falls or Risk of Falls: A Systematic Review and Multilevel Meta-Analysis
Galvain, T., Hill, R., Donegan, S., Lisboa, P., Lip, G. Y. H., & Czanner, G. (2022). Efficacy and Safety of Anticoagulants in Patients with Atrial Fibrillation and History of Falls or Risk of Falls: A Systematic Review and Multilevel Meta-Analysis. DRUG SAFETY, 45(11), 1349-1362. doi:10.1007/s40264-022-01231-x
Should Audits Consider the Care Pathway Model? A New Approach to Benchmarking Real-World Activities
Kwok, C. S., Waters, D., Phan, T., Myint, P. K., & Lip, G. Y. H. (2022). Should Audits Consider the Care Pathway Model? A New Approach to Benchmarking Real-World Activities. HEALTHCARE, 10(9). doi:10.3390/healthcare10091798
Anticoagulation in Atrial Fibrillation and Rheumatic Heart Disease.
Lip, G. Y. H. (2022). Anticoagulation in Atrial Fibrillation and Rheumatic Heart Disease.. The New England journal of medicine, 387(11), 1036-1038. doi:10.1056/nejme2210187
Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials
Nabrdalik, K., Skonieczna-Zydecka, K., Irlik, K., Hendel, M., Kwiendacz, H., Loniewski, I., . . . Lip, G. Y. H. (2022). Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials. FRONTIERS IN ENDOCRINOLOGY, 13. doi:10.3389/fendo.2022.975912
Relationship between Renal Function, Fibrin Clot Properties and Lipoproteins in Anticoagulated Patients with Atrial Fibrillation
Ding, W. Y., Davies, I. G., Gupta, D., & Lip, G. Y. H. (2022). Relationship between Renal Function, Fibrin Clot Properties and Lipoproteins in Anticoagulated Patients with Atrial Fibrillation. BIOMEDICINES, 10(9). doi:10.3390/biomedicines10092270
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
Lyon, A. R., López-Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., . . . Srojidinova, N. (2022). 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). European Heart Journal - Cardiovascular Imaging, 23(10), e333-e465. doi:10.1093/ehjci/jeac106
Cluster randomised controlled trial of screening for atrial fibrillation in people aged 70 years and over to reduce stroke: protocol for the pilot study for the SAFER trial
Williams, K., Modi, R. N., Dymond, A., Hoare, S., Powell, A., Burt, J., . . . Mant, J. (2022). Cluster randomised controlled trial of screening for atrial fibrillation in people aged 70 years and over to reduce stroke: protocol for the pilot study for the SAFER trial. BMJ OPEN, 12(9). doi:10.1136/bmjopen-2022-065066
Quality indicators in the management of elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry.
Guo, Y., Kotalczyk, A., Imberti, J. F., Wang, Y., Lip, G. Y. H., & ChiOTEAF Registry Investigators. (2022). Quality indicators in the management of elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry.. European heart journal. Quality of care & clinical outcomes, 8(6), 651-658. doi:10.1093/ehjqcco/qcab057
A review of risk factors for retinal vein occlusions
Orskov, M., Vorum, H., Larsen, T. B., Vestergaard, N., Lip, G. Y. H., Bek, T., & Skjoth, F. (2022). A review of risk factors for retinal vein occlusions. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 20(9), 761-772. doi:10.1080/14779072.2022.2112667
Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry
Romiti, G. F., Proietti, M., Vitolo, M., Bonini, N., Fawzy, A. M., Ding, W. Y., . . . Lip, G. Y. H. (2022). Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry. BMC MEDICINE, 20(1). doi:10.1186/s12916-022-02526-7
Habitual Alcohol Intake and Risk of Atrial Fibrillation in Young Adults in Korea
Han, M., Lee, S. -R., Choi, E. -K., Choi, J., Chung, J., Park, S. -H., . . . Lip, G. Y. H. (2022). Habitual Alcohol Intake and Risk of Atrial Fibrillation in Young Adults in Korea. JAMA NETWORK OPEN, 5(9). doi:10.1001/jamanetworkopen.2022.29799
Arterial stiffness and atrial fibrillation: shared mechanisms, clinical implications and therapeutic options.
Vio, R., Giordani, A. S., Stefil, M., Madine, J., Fairbairn, T., Themistoclakis, S., . . . Proietti, R. (2022). Arterial stiffness and atrial fibrillation: shared mechanisms, clinical implications and therapeutic options.. Journal of hypertension, 40(9), 1639-1646. doi:10.1097/hjh.0000000000003223
Cardiovascular medications and long-term mortality among stroke survivors in the Brazilian Study of Stroke Mortality and Morbidity (EMMA).
Souza, K. A., Varella, A. C., Olmos, R. D., Romagnolli, C., Gooden, T. E., Thomas, G. N., . . . NIHR Global Health Research Group on Atrial Fibrillation Management. (2022). Cardiovascular medications and long-term mortality among stroke survivors in the Brazilian Study of Stroke Mortality and Morbidity (EMMA).. Geriatrics & gerontology international, 22(9), 715-722. doi:10.1111/ggi.14429
Durable functional limitation in patients with coronavirus disease-2019 admitted to intensive care and the effect of intermediate-dose vs standard-dose anticoagulation on functional outcomes.
INSPIRATION INVESTIGATORS. (2022). Durable functional limitation in patients with coronavirus disease-2019 admitted to intensive care and the effect of intermediate-dose vs standard-dose anticoagulation on functional outcomes.. European journal of internal medicine, 103, 76-83. doi:10.1016/j.ejim.2022.06.014
Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: A systematic review and meta-regression
Proietti, M., Romiti, G. F., Vitolo, M., Borgi, M., Di Rocco, A., Farcomeni, A., . . . Lip, G. Y. H. (2022). Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: A systematic review and meta-regression. In EUROPEAN JOURNAL OF INTERNAL MEDICINE Vol. 103 (pp. 84-94). doi:10.1016/j.ejim.2022.06.023
Impact of diabetes on the management and outcomes in atrial fibrillation: an analysis from the ESC-EHRA EORP-AF Long-Term General Registry
Ding, W. Y., Kotalczyk, A., Boriani, G., Marin, F., Blomstrom-Lundqvist, C., Potpara, T. S., . . . Lip, G. Y. H. (2022). Impact of diabetes on the management and outcomes in atrial fibrillation: an analysis from the ESC-EHRA EORP-AF Long-Term General Registry. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 103, 41-49. doi:10.1016/j.ejim.2022.04.026
Impact of early ablation of atrial fibrillation on long-term outcomes: results from phase II/III of the GLORIA-AF registry
Ding, W. Y., Calvert, P., Gupta, D., Huisman, M. V., & Lip, G. Y. H. (2022). Impact of early ablation of atrial fibrillation on long-term outcomes: results from phase II/III of the GLORIA-AF registry. CLINICAL RESEARCH IN CARDIOLOGY, 111(9), 1057-1068. doi:10.1007/s00392-022-02022-1
Long-Term Cardiac Monitoring After Embolic Stroke of Undetermined Source: Search Longer, Look Harder
Sagris, D., Harrison, S. L., Buckley, B. J. R., Ntaios, G., & Lip, G. Y. H. (2022). Long-Term Cardiac Monitoring After Embolic Stroke of Undetermined Source: Search Longer, Look Harder. AMERICAN JOURNAL OF MEDICINE, 135(9), E311-E317. doi:10.1016/j.amjmed.2022.04.030
Stroke in Older Adults Living in Care Homes: Results From a National Data Linkage Study in Wales
Harrison, S. L., Lip, G. Y. H., Akbari, A., Torabi, F., Ritchie, L. A., Akpan, A., . . . Lane, D. A. (2022). Stroke in Older Adults Living in Care Homes: Results From a National Data Linkage Study in Wales. JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 23(9), 1548-+. doi:10.1016/j.jamda.2022.05.003
Tensile behavior of tetragonal zirconia micro/nano‐fibers and beams in situ tested by push‐to‐pull devices
Zeng, X. M., Ye, P., Tan, H. T., Du, Z., & Gan, C. L. (2022). Tensile behavior of tetragonal zirconia micro/nano‐fibers and beams in situ tested by push‐to‐pull devices. Journal of the American Ceramic Society, 105(9), 5911-5920. doi:10.1111/jace.18555
Ultrafast high-temperature sintering of barium titanate ceramics with colossal dielectric constants
Reavley, M. J. -H., Guo, H., Yuan, J., Ng, A. Y. R., Ho, T. Y. K., Tan, H. T., . . . Gan, C. L. (2022). Ultrafast high-temperature sintering of barium titanate ceramics with colossal dielectric constants. Journal of the European Ceramic Society, 42(12), 4934-4943. doi:10.1016/j.jeurceramsoc.2022.04.056
Incidence and Complications of Atrial Fibrillation in a Low Socioeconomic and High Disability United States (US) Population: A Combined Statistical and Machine Learning Approach.
Lip, G. Y. H., Genaidy, A., Tran, G., Marroquin, P., & Estes, C. (2022). Incidence and Complications of Atrial Fibrillation in a Low Socioeconomic and High Disability United States (US) Population: A Combined Statistical and Machine Learning Approach.. International journal of clinical practice, 2022, 8649050. doi:10.1155/2022/8649050
Gender differences in antithrombotic treatment in patients with atrial fibrillation from Spain versus the rest of Western Europe. GLORIA-AF Program.
López-Sendón, J. L., Alonso-Rodríguez, D., Barón-Esquivias, G., Cosin-Sales, J., Marín, F., Galera-Llorca, J., . . . Spanish GLORIA-AF investigators. (2022). Gender differences in antithrombotic treatment in patients with atrial fibrillation from Spain versus the rest of Western Europe. GLORIA-AF Program.. Medicina clinica, 159(4), 177-182. doi:10.1016/j.medcli.2021.09.016
Healthcare provider and patient perspectives on access to and management of atrial fibrillation in the Northern Province, Sri Lanka: a rapid evaluation of barriers and facilitators to care
Sheron, V. A., Shanmugathas, S., Gooden, T. E., Guruparan, M., Kumarendran, B., Lip, G. Y. H., . . . Beane, A. (2022). Healthcare provider and patient perspectives on access to and management of atrial fibrillation in the Northern Province, Sri Lanka: a rapid evaluation of barriers and facilitators to care. BMC HEALTH SERVICES RESEARCH, 22(1). doi:10.1186/s12913-022-08440-1
Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease
Lee, S. -R., Jung, J. -H., Choi, E. -K., Lee, S. -W., Kwon, S., Park, J. -S., . . . Lip, G. Y. H. (2022). Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease. FRONTIERS IN CARDIOVASCULAR MEDICINE, 9. doi:10.3389/fcvm.2022.991293
Improving dynamic stroke risk prediction in non-anticoagulated patients with and without atrial fibrillation: comparing common clinical risk scores and machine learning algorithms.
Lip, G. Y. H., Tran, G., Genaidy, A., Marroquin, P., Estes, C., & Landsheft, J. (2022). Improving dynamic stroke risk prediction in non-anticoagulated patients with and without atrial fibrillation: comparing common clinical risk scores and machine learning algorithms.. European heart journal. Quality of care & clinical outcomes, 8(5), 548-556. doi:10.1093/ehjqcco/qcab037
Quality of care and risk of incident atrial fibrillation in patients with newly diagnosed heart failure: a nationwide cohort study.
Vinter, N., Cordsen, P., Fenger-Grøn, M., Lip, G. Y. H., Benjamin, E. J., Frost, L., & Johnsen, S. P. (2022). Quality of care and risk of incident atrial fibrillation in patients with newly diagnosed heart failure: a nationwide cohort study.. European heart journal. Quality of care & clinical outcomes, 8(5), 539-547. doi:10.1093/ehjqcco/qcab036
Should oral anticoagulants still be prescribed to patients with atrial fibrillation with a single stroke risk factor but at high bleeding risk? A nationwide cohort study.
Chao, T. -F., Chan, Y. -H., Tuan, T. -C., Liao, J. -N., Chen, T. -J., Lip, G. Y. H., & Chen, S. -A. (2022). Should oral anticoagulants still be prescribed to patients with atrial fibrillation with a single stroke risk factor but at high bleeding risk? A nationwide cohort study.. European heart journal. Quality of care & clinical outcomes, 8(5), 588-595. doi:10.1093/ehjqcco/qcab050
A multinational European network to implement integrated care in elderly multimorbid atrial fibrillation patients: the AFFIRMO Consortium
Johnsen, S. P., Proietti, M., Maggioni, A. P., & Lip, G. Y. H. (2022). A multinational European network to implement integrated care in elderly multimorbid atrial fibrillation patients: the AFFIRMO Consortium. EUROPEAN HEART JOURNAL, 43(31), 2916-2918. doi:10.1093/eurheartj/ehac265
A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry
Asuncion Esteve-Pastor, M., Miguel Rivera-Caravaca, J., Ruiz-Ortiz, M., Muniz, J., Roldan-Rabadan, I., Otero, D., . . . Marin, F. (2022). A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry. EXPERT OPINION ON PHARMACOTHERAPY, 23(12), 1457-1465. doi:10.1080/14656566.2022.2109961
Epidemiology and impact of frailty in patients with atrial fibrillation in Europe
Proietti, M., Romiti, G. F., Vitolo, M., Harrison, S. L., Lane, D. A., Fauchier, L., . . . Lip, G. Y. H. (2022). Epidemiology and impact of frailty in patients with atrial fibrillation in Europe. AGE AND AGEING, 51(8). doi:10.1093/ageing/afac192
Incidence and Risk Factors for Residual Adverse Events Despite Anticoagulation in Atrial Fibrillation: Results From Phase II/III of the GLORIA-AF Registry
Ding, W. Y., Lane, D. A., Gupta, D., Huisman, M. V., & Lip, G. Y. H. (2022). Incidence and Risk Factors for Residual Adverse Events Despite Anticoagulation in Atrial Fibrillation: Results From Phase II/III of the GLORIA-AF Registry. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 11(15). doi:10.1161/JAHA.122.026410
Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease Does Less Mean More?
Gue, Y. X., Gorog, D. A., & Lip, G. Y. H. (2022). Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease Does Less Mean More?. JAMA CARDIOLOGY, 7(8), 794-795. doi:10.1001/jamacardio.2022.1572
Associations between obesity parameters and the risk of incident atrial fibrillation and ischaemic stroke in the different age groups
Ahn, H. -J., Lee, S. -R., Choi, E. -K., Han, K. -D., Rhee, T. -M., Kwon, S., . . . Lip, G. Y. H. (2022). Associations between obesity parameters and the risk of incident atrial fibrillation and ischaemic stroke in the different age groups. FRONTIERS IN CARDIOVASCULAR MEDICINE, 9. doi:10.3389/fcvm.2022.906844
Atrial Fibrillation Better Care Pathway Adherent Care Improves Outcomes in Chinese Patients With Atrial Fibrillation.
Guo, Y., Imberti, J. F., Kotalczyk, A., Wang, Y., Lip, G. Y. H., & ChiOTEAF Registry Investigators. (2022). Atrial Fibrillation Better Care Pathway Adherent Care Improves Outcomes in Chinese Patients With Atrial Fibrillation.. JACC. Asia, 2(4), 422-429. doi:10.1016/j.jacasi.2022.01.007
Atrial fibrillation
Stefil, M., & Lip, G. Y. H. (2022). Atrial fibrillation. Medicine, 50(8), 516-521. doi:10.1016/j.mpmed.2022.05.007
Clinical risk factors for retinal artery occlusions: a nationwide case-control study.
Ørskov, M., Vorum, H., Larsen, T. B., Lip, G. Y. H., Bek, T., & Skjøth, F. (2022). Clinical risk factors for retinal artery occlusions: a nationwide case-control study.. International ophthalmology, 42(8), 2483-2491. doi:10.1007/s10792-022-02247-z
Disparities in oral anticoagulation initiation in patients with schizophrenia and atrial fibrillation: A nationwide cohort study.
Højen, A. A., Nielsen, P. B., Riahi, S., Jensen, M., Lip, G. Y. H., Larsen, T. B., & Søgaard, M. (2022). Disparities in oral anticoagulation initiation in patients with schizophrenia and atrial fibrillation: A nationwide cohort study.. British journal of clinical pharmacology, 88(8), 3847-3855. doi:10.1111/bcp.15337
Frailty prevalence and impact on outcomes in patients with atrial fibrillation: A systematic review and meta-analysis of 1,187,000 patients
Proietti, M., Romiti, G. F., Raparelli, V., Diemberger, I., Boriani, G., Vecchia, L. A. D., . . . Cesari, M. (2022). Frailty prevalence and impact on outcomes in patients with atrial fibrillation: A systematic review and meta-analysis of 1,187,000 patients. AGEING RESEARCH REVIEWS, 79. doi:10.1016/j.arr.2022.101652
Incident and recurrent myocardial infarction (MI) in relation to comorbidities: Prediction of outcomes using machine-learning algorithms.
Lip, G. Y. H., Genaidy, A., Tran, G., Marroquin, P., Estes, C., Shnaiden, T., & Bayewitz, A. (2022). Incident and recurrent myocardial infarction (MI) in relation to comorbidities: Prediction of outcomes using machine-learning algorithms.. European journal of clinical investigation, 52(8), e13777. doi:10.1111/eci.13777
Lipids and atrial fibrillation: New insights into a paradox.
Sagris, D., Harrison, S. L., & Lip, G. Y. H. (2022). Lipids and atrial fibrillation: New insights into a paradox.. PLoS medicine, 19(8), e1004067. doi:10.1371/journal.pmed.1004067
Oral Anticoagulant Use for Patients with Atrial Fibrillation with Concomitant Anemia and/or Thrombocytopenia.
Yeh, Y. -H., Chan, Y. -H., Chen, S. -W., Chang, S. -H., Wang, C. -L., Kuo, C. -T., . . . Chao, T. -F. (2022). Oral Anticoagulant Use for Patients with Atrial Fibrillation with Concomitant Anemia and/or Thrombocytopenia.. The American journal of medicine, 135(8), e248-e256. doi:10.1016/j.amjmed.2022.03.011
Outcomes in elderly Chinese patients with atrial fibrillation and coronary artery disease. A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry
Kotalczyk, A., Guo, Y., Fawzy, A. M., Wang, Y., & Lip, G. Y. H. (2022). Outcomes in elderly Chinese patients with atrial fibrillation and coronary artery disease. A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry. JOURNAL OF ARRHYTHMIA, 38(4), 580-588. doi:10.1002/joa3.12744
Proton Pump Inhibitor Co-Therapy in Patients with Atrial Fibrillation Treated with Oral Anticoagulants and a Prior History of Upper Gastrointestinal Tract Bleeding
Lee, S. -R., Kwon, S., Choi, E. -K., Jung, J. -H., Han, K. -D., Oh, S., & Lip, G. Y. H. (2022). Proton Pump Inhibitor Co-Therapy in Patients with Atrial Fibrillation Treated with Oral Anticoagulants and a Prior History of Upper Gastrointestinal Tract Bleeding. CARDIOVASCULAR DRUGS AND THERAPY, 36(4), 679-689. doi:10.1007/s10557-021-07170-6
Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants.
Lip, G. Y. H., Murphy, R. R., Sahiar, F., Ingall, T. J., Dhamane, A. D., Ferri, M., . . . Deitelzweig, S. (2022). Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants.. JAMA network open, 5(8), e2229333. doi:10.1001/jamanetworkopen.2022.29333
Risk of Cerebrovascular Events in Intracerebral Hemorrhage Survivors With Atrial Fibrillation: A Nationwide Cohort Study
Nielsen, P. B., Melgaard, L., Overvad, T. F., Jensen, M., Larsen, T. B., & Lip, G. Y. H. (2022). Risk of Cerebrovascular Events in Intracerebral Hemorrhage Survivors With Atrial Fibrillation: A Nationwide Cohort Study. STROKE, 53(8), 2559-2568. doi:10.1161/STROKEAHA.121.038331
STIMULATE-ICP-CAREINEQUAL (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways) study protocol: Defining usual care and examining inequalities in Long Covid support
Ramasawmy, M., Mu, Y., Clutterbuck, D., Pantelic, M., Lip, G. Y. H., van der Feltz-cornelis, C., . . . Lorgelly, P. (2022). STIMULATE-ICP-CAREINEQUAL (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways) study protocol: Defining usual care and examining inequalities in Long Covid support. PLOS ONE, 17(8). doi:10.1371/journal.pone.0271978
Similarities and Differences in Systemic Risk Factors for Retinal Artery Occlusion and Stroke: A Nationwide Case-Control Study.
Ørskov, M., Vorum, H., Larsen, T. B., Lip, G. Y. H., Bek, T., & Skjøth, F. (2022). Similarities and Differences in Systemic Risk Factors for Retinal Artery Occlusion and Stroke: A Nationwide Case-Control Study.. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 31(8), 106610. doi:10.1016/j.jstrokecerebrovasdis.2022.106610
Stroke Prevention in Atrial Fibrillation: A Scientific Statement of <i>JACC: Asia</i> (Part 1).
Chiang, C. -E., Chao, T. -F., Choi, E. -K., Lim, T. W., Krittayaphong, R., Li, M., . . . Lip, G. Y. H. (2022). Stroke Prevention in Atrial Fibrillation: A Scientific Statement of <i>JACC: Asia</i> (Part 1).. JACC. Asia, 2(4), 395-411. doi:10.1016/j.jacasi.2022.05.005
The mechanistic basis linking cytokine storm to thrombosis in COVID-19.
Wolf, A., Khimani, F., Yoon, B., Gerhart, C., Endsley, D., Ray, A. K., . . . Sathyamoorthy, M. (2022). The mechanistic basis linking cytokine storm to thrombosis in COVID-19.. Thrombosis update, 8, 100110. doi:10.1016/j.tru.2022.100110
Coffee and cardiac arrhythmias: Up-date review of the literature and clinical studies.
Surma, S., Romańczyk, M., Filipiak, K. J., & Lip, G. Y. H. (2022). Coffee and cardiac arrhythmias: Up-date review of the literature and clinical studies.. Cardiology journal, 30(4), 654-667. doi:10.5603/cj.a2022.0068
Antiplatelet agents and anticoagulants for hypertension.
Shantsila, E., Kozieł-Siołkowska, M., & Lip, G. Y. (2022). Antiplatelet agents and anticoagulants for hypertension.. The Cochrane database of systematic reviews, 7, CD003186. doi:10.1002/14651858.cd003186.pub4
Patient and Public Involvement and Engagement (PPIE): first steps in the process of the engagement in research projects in Brazil
Bensenor, I. M., Goulart, A. C., Thomas, G. N., Lip, G. Y. H., Arasalingam, A., Beane, A., . . . Fi, N. I. H. R. G. H. R. G. A. (2022). Patient and Public Involvement and Engagement (PPIE): first steps in the process of the engagement in research projects in Brazil. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 55(1). doi:10.1590/1414-431X2022e12369
A novel risk score to identify the need for triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a post hoc analysis of the RE-DUAL PCI trial.
Zwart, B., Bor, W. L., de Veer, A. J. W. M., Mahmoodi, B. K., Kelder, J. C., Lip, G. Y. H., . . . Ten Berg, J. M. (2022). A novel risk score to identify the need for triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a post hoc analysis of the RE-DUAL PCI trial.. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 18(4), e292-e302. doi:10.4244/eij-d-21-00165
Digoxin use and clinical outcomes in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry.
Guo, Y., Kotalczyk, A., Wang, Y., & Lip, G. Y. H. (2022). Digoxin use and clinical outcomes in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 24(7), 1076-1083. doi:10.1093/europace/euab319
Utilizing biomarkers in atrial fibrillation: the pros and cons
Ding, W. Y., McDowell, G., & Lip, G. Y. H. (2022). Utilizing biomarkers in atrial fibrillation: the pros and cons. CARDIOVASCULAR RESEARCH, 118(9), 2035-2036. doi:10.1093/cvr/cvab283
Associations between glycated hemoglobin and the risks of incident cardiovascular diseases in patients with gout
Li, L., Lip, G. Y. H., Li, S., Adachi, J. D., Thabane, L., & Li, G. (2022). Associations between glycated hemoglobin and the risks of incident cardiovascular diseases in patients with gout. CARDIOVASCULAR DIABETOLOGY, 21(1). doi:10.1186/s12933-022-01567-9
How to use digital devices to detect and manage arrhythmias: an EHRA practical guide
Svennberg, E., Tjong, F., Goette, A., Akoum, N., Di Biaise, L., Bordachar, P., . . . Sinner, M. (2022). How to use digital devices to detect and manage arrhythmias: an EHRA practical guide. EUROPACE. doi:10.1093/europace/euac038
Worldwide trends in antithrombotic therapy prescribing for atrial fibrillation: observations on the 'transition era' to non-vitamin K antagonist oral anticoagulants
Ritchie, L. A., Lane, D. A., & Lip, G. Y. H. (2022). Worldwide trends in antithrombotic therapy prescribing for atrial fibrillation: observations on the 'transition era' to non-vitamin K antagonist oral anticoagulants. EUROPACE, 24(6), 871-873. doi:10.1093/europace/euab313
Prioritising electrocardiograms for manual review to improve the efficiency of atrial fibrillation screening.
Adeniji, M., Brimicombe, J., Cowie, M. R., Dymond, A., Linden, H. C., Lip, G. Y. H., . . . Charlton, P. H. (2022). Prioritising electrocardiograms for manual review to improve the efficiency of atrial fibrillation screening.. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 2022, 3239-3242. doi:10.1109/embc48229.2022.9871092
Apolipoprotein E and Cerebral Small Vessel Disease Markers in Patients With Intracerebral Haemorrhage.
Hostettler, I. C., Seiffge, D., Wong, A., Ambler, G., Wilson, D., Shakeshaft, C., . . . Werring, D. (2022). Apolipoprotein E and Cerebral Small Vessel Disease Markers in Patients With Intracerebral Haemorrhage.. Neurology, 10.1212/WNL.0000000000200851. doi:10.1212/wnl.0000000000200851
Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: A systematic review and meta-regression
Proietti, M., Romiti, G. F., Vitolo, M., Borgi, M., Rocco, A. D., Farcomeni, A., . . . Lip, G. Y. H. (2022). Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: A systematic review and meta-regression. European Journal of Internal Medicine, 103, 84-94. doi:10.1016/j.ejim.2022.06.023
Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke
Lip, G. Y. H., Lane, D. A., Lenarczyk, R., Boriani, G., Doehner, W., Benjamin, L. A., . . . Potpara, T. (2022). Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke. EUROPEAN HEART JOURNAL, 43(26), 2442-2460. doi:10.1093/eurheartj/ehac245
Clustering of Unhealthy Lifestyle and the Risk of Adverse Events in Patients With Atrial Fibrillation.
Lee, S. -R., Choi, E. -K., Park, S. -H., Lee, S. -W., Han, K. -D., Oh, S., & Lip, G. Y. H. (2022). Clustering of Unhealthy Lifestyle and the Risk of Adverse Events in Patients With Atrial Fibrillation.. Frontiers in cardiovascular medicine, 9, 885016. doi:10.3389/fcvm.2022.885016
Analysis of the ESC/EACTS 2020 Atrial Fibrillation Guidelines With Perioperative Implications
Nelson, J. A., Gue, Y. X., Christensen, J. M., Lip, G. Y. H., & Ramakrishna, H. (2022). Analysis of the ESC/EACTS 2020 Atrial Fibrillation Guidelines With Perioperative Implications. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 36(7), 2177-2195. doi:10.1053/j.jvca.2021.05.011
Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations
Imberti, J. F., Mei, D. A., Vitolo, M., Bonini, N., Proietti, M., Potpara, T., . . . Boriani, G. (2022). Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 101, 1-7. doi:10.1016/j.ejim.2022.04.023
Editorial commentary: COVID-19 and COVID-19 vaccination: Observations on thrombosis and thrombocytopenia
Elsheikh, S., & Lip, G. Y. H. (2022). Editorial commentary: COVID-19 and COVID-19 vaccination: Observations on thrombosis and thrombocytopenia. TRENDS IN CARDIOVASCULAR MEDICINE, 32(5), 257-258. doi:10.1016/j.tcm.2022.03.002
Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative claims databases
Lip, G. Y. H., Keshishian, A., Kang, A., Luo, X., Atreja, N., Zhang, Y., . . . Deitelzweig, S. (2022). Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative claims databases. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 54(1), 33-46. doi:10.1007/s11239-022-02660-2
Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review.
Bikdeli, B., Zahedi Tajrishi, F., Sadeghipour, P., Talasaz, A. H., Fanikos, J., Lippi, G., . . . Lip, G. Y. H. (2022). Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review.. JAMA cardiology, 7(7), 747-759. doi:10.1001/jamacardio.2022.1292
Exercise-Based Cardiac Rehabilitation Associates with Lower Major Adverse Cardiovascular Events in People with Stroke
Buckley, B. J. R., Harrison, S. L., Fazio-Eynullayeva, E., Underhill, P., Lane, D. A., Thijssen, D. H. J., & Lip, G. Y. H. (2022). Exercise-Based Cardiac Rehabilitation Associates with Lower Major Adverse Cardiovascular Events in People with Stroke. CEREBROVASCULAR DISEASES, 51(4), 488-492. doi:10.1159/000521025
Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EURObservational research programme in atrial fibrillation general long-term registry
Malavasi, V. L., Vitolo, M., Proietti, M., Diemberger, I., Fauchier, L., Marin, F., . . . Boriani, G. (2022). Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EURObservational research programme in atrial fibrillation general long-term registry. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 52(7). doi:10.1111/eci.13773
Oral anticoagulation improves survival in very elderly Chinese patients with atrial fibrillation: A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry
Guo, Y., Kotalczyk, A., Imberti, J. F., Wang, Y., & Lip, G. Y. H. (2022). Oral anticoagulation improves survival in very elderly Chinese patients with atrial fibrillation: A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry. INTERNATIONAL JOURNAL OF STROKE, 17(6), 661-668. doi:10.1177/17474930211046743
Predictors of Adherence to Stroke Prevention in the BALKAN-AF Study: A Machine-Learning Approach.
Kozieł-Siołkowska, M., Siołkowski, S., Mihajlovic, M., Lip, G. Y. H., Potpara, T. S., & BALKAN-AF Investigators . (2022). Predictors of Adherence to Stroke Prevention in the BALKAN-AF Study: A Machine-Learning Approach.. TH open : companion journal to thrombosis and haemostasis, 6(3), e283-e290. doi:10.1055/s-0042-1755617
Relationship between temporal rhythm-based classification of atrial fibrillation and stroke: real-world vs. clinical trial
Ding, W. Y., Miguel Rivera-Caravaca, J., Marin, F., Roldan, V., & Lip, G. Y. H. (2022). Relationship between temporal rhythm-based classification of atrial fibrillation and stroke: real-world vs. clinical trial. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 54(1), 1-6. doi:10.1007/s11239-022-02638-0
Effectiveness and Safety of Apixaban in over 3.9 Million People with Atrial Fibrillation: A Systematic Review and Meta-Analysis
Buckley, B. J. R., Lane, D. A., Calvert, P., Zhang, J., Gent, D., Mullins, C. D., . . . Lip, G. Y. H. (2022). Effectiveness and Safety of Apixaban in over 3.9 Million People with Atrial Fibrillation: A Systematic Review and Meta-Analysis. JOURNAL OF CLINICAL MEDICINE, 11(13). doi:10.3390/jcm11133788
Antazoline: the Lazarus of antiarrhythmic drugs?
Calvert, P., Gupta, D., & Lip, G. Y. H. (2022). Antazoline: the Lazarus of antiarrhythmic drugs?. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 132(6). doi:10.20452/pamw.16264
Irisin is an Effector Molecule in Exercise Rehabilitation Following Myocardial Infarction (Review)
Qin, S., Tian, Z., Boidin, M., Buckley, B. J. R., Thijssen, D. H. J., & Lip, G. Y. H. (2022). Irisin is an Effector Molecule in Exercise Rehabilitation Following Myocardial Infarction (Review). FRONTIERS IN PHYSIOLOGY, 13. doi:10.3389/fphys.2022.935772
The risk of incident atrial fibrillation in patients with type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4 inhibitors: a nationwide cohort study.
Chan, Y. -H., Chao, T. -F., Chen, S. -W., Lee, H. -F., Li, P. -R., Chen, W. -M., . . . Lip, G. Y. H. (2022). The risk of incident atrial fibrillation in patients with type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4 inhibitors: a nationwide cohort study.. Cardiovascular diabetology, 21(1), 118. doi:10.1186/s12933-022-01549-x
Antithrombotic dilemmas in stroke medicine: new data, unsolved challenges.
Best, J. G., Cardus, B., Klijn, C. J. M., Lip, G., Seiffge, D. J., Smith, E. E., & Werring, D. J. (2022). Antithrombotic dilemmas in stroke medicine: new data, unsolved challenges.. Journal of neurology, neurosurgery, and psychiatry, jnnp-2020-325249. doi:10.1136/jnnp-2020-325249
Development and Validation of 3-Year Atrial Fibrillation Prediction Models Using Electronic Health Record With or Without Standardized Electrocardiogram Diagnosis and a Performance Comparison Among Models.
Yum, Y., Shin, S. Y., Yoo, H., Kim, Y. H., Kim, E. J., Lip, G. Y. H., & Joo, H. J. (2022). Development and Validation of 3-Year Atrial Fibrillation Prediction Models Using Electronic Health Record With or Without Standardized Electrocardiogram Diagnosis and a Performance Comparison Among Models.. Journal of the American Heart Association, 11(12), e024045. doi:10.1161/jaha.121.024045
Monocytes are increased in pregnancy after gestational hypertensive disease
Castleman, J. S., Lip, G. Y. H., & Shantsila, E. (2022). Monocytes are increased in pregnancy after gestational hypertensive disease. SCIENTIFIC REPORTS, 12(1). doi:10.1038/s41598-022-13606-2
Circulating Vitamin D Concentrations and Risk of Atrial Fibrillation: A Mendelian Randomization Study Using Non-deficient Range Summary Statistics
Zhang, N., Wang, Y., Chen, Z., Liu, D., Tse, G., Korantzopoulos, P., . . . Liu, T. (2022). Circulating Vitamin D Concentrations and Risk of Atrial Fibrillation: A Mendelian Randomization Study Using Non-deficient Range Summary Statistics. FRONTIERS IN NUTRITION, 9. doi:10.3389/fnut.2022.842392
Inflammasome Signaling in Atrial Fibrillation: JACC State-of-the-Art Review.
Ajoolabady, A., Nattel, S., Lip, G. Y. H., & Ren, J. (2022). Inflammasome Signaling in Atrial Fibrillation: JACC State-of-the-Art Review.. Journal of the American College of Cardiology, 79(23), 2349-2366. doi:10.1016/j.jacc.2022.03.379
Efficacy and Safety of Oral Anticoagulants in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis
Malhotra, K., Ishfaq, M. F., Goyal, N., Parissis, J., Alexandrov, A., Alexandrov, A., & Tsivgoulis, G. (2019). Efficacy and Safety of Oral Anticoagulants in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis. In STROKE Vol. 50. Retrieved from https://www.webofscience.com/
Discontinuation of direct oral anticoagulants among patients with atrial fibrillation according to gender and cohabitation status: a nationwide cohort study.
Binding, C., Olesen, J. B., Lee, C. J. -Y., Lip, G. Y. H., Sindet-Pedersen, C., Gislason, G., & Bonde, A. N. (2022). Discontinuation of direct oral anticoagulants among patients with atrial fibrillation according to gender and cohabitation status: a nationwide cohort study.. European heart journal. Cardiovascular pharmacotherapy, 8(4), 353-362. doi:10.1093/ehjcvp/pvab065
Dronedarone vs. placebo in patients with atrial fibrillation or atrial flutter across a range of renal function: a <i>post hoc</i> analysis of the ATHENA trial
Vamos, M., Oldgren, J., Nam, G. -B., Lip, G. Y. H., Calkins, H., Zhu, J., . . . Hohnloser, S. H. (2022). Dronedarone vs. placebo in patients with atrial fibrillation or atrial flutter across a range of renal function: a <i>post hoc</i> analysis of the ATHENA trial. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 8(4), 363-371. doi:10.1093/ehjcvp/pvab090
Outcomes of digoxin vs. beta blocker in atrial fibrillation: report from ESC-EHRA EORP AF Long-Term General Registry
Ding, W. Y., Boriani, G., Marin, F., Blomstrom-Lundqvist, C., Potpara, T. S., Fauchier, L., & Lip, G. Y. H. (2022). Outcomes of digoxin vs. beta blocker in atrial fibrillation: report from ESC-EHRA EORP AF Long-Term General Registry. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 8(4), 372-382. doi:10.1093/ehjcvp/pvab076
USPSTF found insufficient evidence on the benefits and harms of screening adults ≥50 y for AF.
Choi, S. E., & Lip, G. Y. H. (2022). USPSTF found insufficient evidence on the benefits and harms of screening adults ≥50 y for AF.. Annals of internal medicine, 175(6), JC62. doi:10.7326/j22-0036
Artificial intelligence to detect abnormal heart rhythm from scanned electrocardiogram tracings
Bridge, J., Fu, L., Lin, W., Xue, Y., Lip, G. Y. H., & Zheng, Y. (n.d.). Artificial intelligence to detect abnormal heart rhythm from scanned electrocardiogram tracings. Journal of Arrhythmia. doi:10.1002/joa3.12707
Assigning diagnosis codes using medication history.
Hansen, E. R., Sagi, T., Hose, K., Lip, G. Y. H., Larsen, T. B., & Skjøth, F. (2022). Assigning diagnosis codes using medication history.. Artificial intelligence in medicine, 128, 102307. doi:10.1016/j.artmed.2022.102307
Atrial fibrillation, a contemporary sign of multimorbidity and irregular social inequity
Sagris, D., & Lip, G. Y. H. (2022). Atrial fibrillation, a contemporary sign of multimorbidity and irregular social inequity. LANCET REGIONAL HEALTH-EUROPE, 17. doi:10.1016/j.lanepe.2022.100395
Breast cancer and incident cardiovascular events: A systematic analysis at the nationwide level
Gue, Y. X., Bisson, A., Bodin, A., Herbert, J., Lip, G. Y. H., & Fauchier, L. (2022). Breast cancer and incident cardiovascular events: A systematic analysis at the nationwide level. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 52(6). doi:10.1111/eci.13754
Comparative effectiveness and safety of edoxaban versus warfarin in patients with atrial fibrillation: A nationwide cohort study
Nielsen, P. B., Sogaard, M., Jensen, M., Ording, A. G., & Lip, G. Y. H. (2022). Comparative effectiveness and safety of edoxaban versus warfarin in patients with atrial fibrillation: A nationwide cohort study. INTERNATIONAL JOURNAL OF STROKE, 17(5), 536-544. doi:10.1177/17474930211029441
Drug Interactions Affecting Oral Anticoagulant Use.
Mar, P. L., Gopinathannair, R., Gengler, B. E., Chung, M. K., Perez, A., Dukes, J., . . . from the American Heart Association Electrocardiography & Arrhythmias Committee of the Council of Clinical Cardiology. (2022). Drug Interactions Affecting Oral Anticoagulant Use.. Circulation. Arrhythmia and electrophysiology, 15(6), e007956. doi:10.1161/circep.121.007956
Effect of 15-mg Edoxaban on Clinical Outcomes in 3 Age Strata in Older Patients With Atrial Fibrillation: A Prespecified Subanalysis of the ELDERCARE-AF Randomized Clinical Trial.
Kuroda, M., Tamiya, E., Nose, T., Ogimoto, A., Taura, J., Imamura, Y., . . . Okumura, K. (2022). Effect of 15-mg Edoxaban on Clinical Outcomes in 3 Age Strata in Older Patients With Atrial Fibrillation: A Prespecified Subanalysis of the ELDERCARE-AF Randomized Clinical Trial.. JAMA cardiology, 7(6), 583-590. doi:10.1001/jamacardio.2022.0480
Effectiveness and Safety of Anticoagulation Therapy in Frail Patients With Atrial Fibrillation
Kim, D., Yang, P. -S., Sung, J. -H., Jang, E., Yu, H. T., Kim, T. -H., . . . Joung, B. (2022). Effectiveness and Safety of Anticoagulation Therapy in Frail Patients With Atrial Fibrillation. STROKE, 53(6), 1873-1882. doi:10.1161/STROKEAHA.121.036757
Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): Protocol for a randomized controlled trial
Best, J. G., Arram, L., Ahmed, N., Balogun, M., Bennett, K., Bordea, E., . . . Werring, D. J. (2022). Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): Protocol for a randomized controlled trial. INTERNATIONAL JOURNAL OF STROKE, 17(5), 583-589. doi:10.1177/17474930211057722
Oral Anticoagulation Timing in Patients with Acute Ischemic Stroke and Atrial Fibrillation
Chang, P. -Y., Wang, W. -T., Wu, W. -L., Chang, H. -C., Chen, C. -H., Tsai, Y. -W., . . . Chiang, C. -E. (2022). Oral Anticoagulation Timing in Patients with Acute Ischemic Stroke and Atrial Fibrillation. THROMBOSIS AND HAEMOSTASIS, 122(06), 939-950. doi:10.1055/a-1669-4987
Rhythm- or rate-control strategies according to 4S-AF characterization scheme and long-term outcomes in atrial fibrillation patients: the FAMo (Fibrillazione Atriale in Modena) cohort
Malavasi, V. L., Vitolo, M., Colella, J., Montagnolo, F., Mantovani, M., Proietti, M., . . . Boriani, G. (2022). Rhythm- or rate-control strategies according to 4S-AF characterization scheme and long-term outcomes in atrial fibrillation patients: the FAMo (Fibrillazione Atriale in Modena) cohort. INTERNAL AND EMERGENCY MEDICINE, 17(4), 1001-1012. doi:10.1007/s11739-021-02890-x
Risk of Dementia After Smoking Cessation in Patients With Newly Diagnosed Atrial Fibrillation.
Lee, H. -J., Lee, S. -R., Choi, E. -K., Park, S. -H., Chung, J. -W., Choi, J. -M., . . . Lip, G. Y. H. (2022). Risk of Dementia After Smoking Cessation in Patients With Newly Diagnosed Atrial Fibrillation.. JAMA network open, 5(6), e2217132. doi:10.1001/jamanetworkopen.2022.17132
Statins to prevent pacing-induced cardiomyopathy: Evidence from the bench applied to clinical studies.
Lin, Y. -S., Lip, G. Y. H., Ho, W. -C., Shi, C. -S., Lin, M. -H., Kuo, T. -Y., . . . Chen, M. -C. (2022). Statins to prevent pacing-induced cardiomyopathy: Evidence from the bench applied to clinical studies.. Heart rhythm, 19(6), 960-968. doi:10.1016/j.hrthm.2022.01.029
The Patient Pathway Review for Atrial Fibrillation.
Kwok, C. S., & Lip, G. Y. H. (2022). The Patient Pathway Review for Atrial Fibrillation.. Critical pathways in cardiology, 21(2), 96-102. doi:10.1097/hpc.0000000000000280
Type and Severity of Migraine Determines Risk of Atrial Fibrillation in Women.
Rhee, T. -M., Choi, E. -K., Han, K. -D., Ahn, H. -J., Lee, S. -R., Oh, S., & Lip, G. Y. H. (2022). Type and Severity of Migraine Determines Risk of Atrial Fibrillation in Women.. Frontiers in cardiovascular medicine, 9, 910225. doi:10.3389/fcvm.2022.910225
Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry
Rivera-Caravaca, J. M., Nunez-Gil, I. J., Lip, G. Y. H., Uribarri, A., Viana-Llamas, M. C., Gonzalez, A., . . . Marin, F. (2022). Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2022. doi:10.1155/2022/7325060
Exercise-based cardiac rehabilitation vs. percutaneous coronary intervention for chronic coronary syndrome: impact on morbidity and mortality
Buckley, B. J. R., de Koning, I. A., Harrison, S. L., Fazio-Eynullayeva, E., Underhill, P., Kemps, H. M. C., . . . Thijssen, D. H. J. (2022). Exercise-based cardiac rehabilitation vs. percutaneous coronary intervention for chronic coronary syndrome: impact on morbidity and mortality. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 29(7), 1074-1080. doi:10.1093/eurjpc/zwab191
Oral anticoagulants and outcomes in adults >= 80 years with atrial fibrillation: A global federated health network analysis
Harrison, S. L., Buckley, B. J. R., Ritchie, L. A., Proietti, R., Underhill, P., Lane, D. A., & Lip, G. Y. H. (2022). Oral anticoagulants and outcomes in adults >= 80 years with atrial fibrillation: A global federated health network analysis. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. doi:10.1111/jgs.17884
Comparison Between the 24-hour Holter Test and 72-hour Single-Lead Electrocardiogram Monitoring With an Adhesive Patch-Type Device for Atrial Fibrillation Detection: Prospective Cohort Study.
Kwon, S., Lee, S. -R., Choi, E. -K., Ahn, H. -J., Song, H. -S., Lee, Y. -S., . . . Lip, G. Y. H. (2022). Comparison Between the 24-hour Holter Test and 72-hour Single-Lead Electrocardiogram Monitoring With an Adhesive Patch-Type Device for Atrial Fibrillation Detection: Prospective Cohort Study.. Journal of medical Internet research, 24(5), e37970. doi:10.2196/37970
Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCI.
Costa, F., Valgimigli, M., Steg, P. G., Bhatt, D. L., Hohnloser, S. H., Ten Berg, J. M., . . . Cannon, C. P. (2022). Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCI.. European heart journal. Cardiovascular pharmacotherapy, 8(3), 216-226. doi:10.1093/ehjcvp/pvaa135
Mental health and anticoagulant prescription in atrial fibrillation
Calvert, P., Lip, G. Y. H., & Lane, D. A. (2022). Mental health and anticoagulant prescription in atrial fibrillation. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 8(3), 235-237. doi:10.1093/ehjqcco/qcab085
Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry
Ding, W. Y., Proietti, M., Boriani, G., Fauchier, L., Blomstrom-Lundqvist, C., Marin, F., . . . Lip, G. Y. H. (2022). Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry. EUROPACE, 24(5), 721-728. doi:10.1093/europace/euab280
Impact of Integrated Care Management on Clinical Outcomes in Atrial Fibrillation Patients: A Report From the FANTASIIA Registry.
Esteve-Pastor, M. A., Ruiz-Ortiz, M., Muñiz, J., Roldán-Rabadán, I., Otero, D., Cequier, Á., . . . Marín, F. (2022). Impact of Integrated Care Management on Clinical Outcomes in Atrial Fibrillation Patients: A Report From the FANTASIIA Registry.. Frontiers in cardiovascular medicine, 9, 856222. doi:10.3389/fcvm.2022.856222
Relationship between Serum 25-Hydroxyvitamin D Level and Risk of Recurrent Stroke
Li, G., Li, L., Adachi, J. D., Wang, R., Ye, Z., Liu, X., . . . Lip, G. Y. H. (2022). Relationship between Serum 25-Hydroxyvitamin D Level and Risk of Recurrent Stroke. NUTRIENTS, 14(9). doi:10.3390/nu14091908
Thromboembolic Risk in Patients With Pneumonia and New-Onset Atrial Fibrillation Not Receiving Anticoagulation Therapy.
Søgaard, M., Skjøth, F., Nielsen, P. B., Smit, J., Dalager-Pedersen, M., Larsen, T. B., & Lip, G. Y. H. (2022). Thromboembolic Risk in Patients With Pneumonia and New-Onset Atrial Fibrillation Not Receiving Anticoagulation Therapy.. JAMA network open, 5(5), e2213945. doi:10.1001/jamanetworkopen.2022.13945
Age and Outcomes of Early Rhythm Control in Patients With Atrial Fibrillation Nationwide Cohort Study
Kim, D., Yang, P. -S., You, S. C., Jang, E., Yu, H. T., Kim, T. -H., . . . Joung, B. (2022). Age and Outcomes of Early Rhythm Control in Patients With Atrial Fibrillation Nationwide Cohort Study. JACC-CLINICAL ELECTROPHYSIOLOGY, 8(5), 619-632. doi:10.1016/j.jacep.2022.02.014
Appropriate dosing of the individual direct oral anticoagulants in atrial fibrillation: Differences in the questions to be answered.
Rubboli, A., Morici, N., & Lip, G. Y. H. (2022). Appropriate dosing of the individual direct oral anticoagulants in atrial fibrillation: Differences in the questions to be answered.. European journal of internal medicine, 99, 116-117. doi:10.1016/j.ejim.2022.01.014
Atrial Fibrillation in Heart Failure: Focus on Antithrombotic Management.
Obeidat, M., Burgess, M., & Lip, G. Y. H. (2022). Atrial Fibrillation in Heart Failure: Focus on Antithrombotic Management.. Cardiology clinics, 40(2), 245-258. doi:10.1016/j.ccl.2021.12.012
Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry.
Vitolo, M., Malavasi, V. L., Proietti, M., Diemberger, I., Fauchier, L., Marin, F., . . . ESC-EHRA EORP-AF Long-Term General Registry Investigators. (2022). Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry.. European journal of internal medicine, 99, 45-56. doi:10.1016/j.ejim.2022.01.025
Comparison of Open, Standard, and Complex Endovascular Aortic Repair Treatments for Juxtarenal/Short Neck Aneurysms: A Systematic Review and Network Meta-Analysis
Patel, S. R., Ormesher, D. C., Griffin, R., Jackson, R. J., Lip, G. Y. H., & Vallabhaneni, S. R. (2022). Comparison of Open, Standard, and Complex Endovascular Aortic Repair Treatments for Juxtarenal/Short Neck Aneurysms: A Systematic Review and Network Meta-Analysis. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 63(5), 696-706. doi:10.1016/j.ejvs.2021.12.042
Comparison of the HAS-BLED versus ORBIT scores in predicting major bleeding among Asians receiving direct-acting oral anticoagulants
Wattanaruengchai, P., Nathisuwan, S., Karaketklang, K., Wongcharoen, W., Phrommintikul, A., & Lip, G. Y. H. (2022). Comparison of the HAS-BLED versus ORBIT scores in predicting major bleeding among Asians receiving direct-acting oral anticoagulants. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 88(5), 2203-2212. doi:10.1111/bcp.15145
Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry.
Lip, G. Y. H., Kotalczyk, A., Teutsch, C., Diener, H. -C., Dubner, S. J., Halperin, J. L., . . . GLORIA-AF Investigators. (2022). Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry.. Clinical research in cardiology : official journal of the German Cardiac Society, 111(5), 593. doi:10.1007/s00392-022-02021-2
Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registry.
Huisman, M. V., Teutsch, C., Lu, S., Diener, H. -C., Dubner, S. J., Halperin, J. L., . . . GLORIA-AF Investigators. (2022). Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registry.. Clinical research in cardiology : official journal of the German Cardiac Society, 111(5), 548-559. doi:10.1007/s00392-021-01957-1
Drug Interactions Affecting Antiarrhythmic Drug Use
Mar, P. L., Horbal, P., Chung, M. K., Dukes, J. W., Ezekowitz, M., Lakkireddy, D., . . . Gopinathannair, R. (2022). Drug Interactions Affecting Antiarrhythmic Drug Use. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 15(5). doi:10.1161/CIRCEP.121.007955
Effects of multimorbidity on incident COVID-19 events and its interplay with COVID-19 event status on subsequent incident myocardial infarction (MI).
Lip, G. Y. H., Genaidy, A., Tran, G., Marroquin, P., Estes, C., & Sloop, S. (2022). Effects of multimorbidity on incident COVID-19 events and its interplay with COVID-19 event status on subsequent incident myocardial infarction (MI).. European journal of clinical investigation, 52(5), e13760. doi:10.1111/eci.13760
Mobile health solutions for atrial fibrillation detection and management: a systematic review
Hermans, A. N. L., Gawalko, M., Dohmen, L., van der Velden, R. M. J., Betz, K., Duncker, D., . . . Linz, D. (2022). Mobile health solutions for atrial fibrillation detection and management: a systematic review. CLINICAL RESEARCH IN CARDIOLOGY, 111(5), 479-491. doi:10.1007/s00392-021-01941-9
Stroke-Heart Syndrome: Incidence and Clinical Outcomes of Cardiac Complications Following Stroke
Buckley, B. J. R., Harrison, S. L., Hill, A., Underhill, P., Lane, D. A., & Lip, G. Y. H. (2022). Stroke-Heart Syndrome: Incidence and Clinical Outcomes of Cardiac Complications Following Stroke. STROKE, 53(5), 1759-1763. doi:10.1161/STROKEAHA.121.037316
Lipid levels, apolipoproteins, and risk of incident atrial fibrillation in men: A report from the Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD)
Tajik, B., Tuomainen, T. -P., Jarroch, R., Kauhanen, J., Lip, G. Y. H., & Isanejad, M. (2022). Lipid levels, apolipoproteins, and risk of incident atrial fibrillation in men: A report from the Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD). Journal of Clinical Lipidology. doi:10.1016/j.jacl.2022.04.003
Mobile health technology in atrial fibrillation
Bonini, N., Vitolo, M., Imberti, J. F., Proietti, M., Romiti, G. F., Boriani, G., . . . Lip, G. Y. H. (2022). Mobile health technology in atrial fibrillation. EXPERT REVIEW OF MEDICAL DEVICES. doi:10.1080/17434440.2022.2070005
Incidence of Cardiometabolic Diseases in People With and Without Human Immunodeficiency Virus in the United Kingdom: A Population-Based Matched Cohort Study
Gooden, T. E., Gardner, M., Wang, J., Jolly, K., Lane, D. A., Benjamin, L. A., . . . Thomas, G. N. (2022). Incidence of Cardiometabolic Diseases in People With and Without Human Immunodeficiency Virus in the United Kingdom: A Population-Based Matched Cohort Study. JOURNAL OF INFECTIOUS DISEASES, 225(8), 1348-1356. doi:10.1093/infdis/jiab420
Symptom Status, Clinical Subtypes, and Prognosis in Patients With Atrial Fibrillation from the Middle East Region (from the Gulf-SAFE Registry).
Xie, P. -X., Li, Y. -G., Alsheikh-Ali, A. A., AlMahmeed, W., Shehab, A., Sulaiman, K., . . . Lip, G. Y. H. (2022). Symptom Status, Clinical Subtypes, and Prognosis in Patients With Atrial Fibrillation from the Middle East Region (from the Gulf-SAFE Registry).. The American journal of cardiology, 169, 57-63. doi:10.1016/j.amjcard.2021.12.060
Atrial Fibrillation Specific Exercise Rehabilitation: Are We There Yet?
Buckley, B. J. R., Risom, S. S., Boidin, M., Lip, G. Y. H., & Thijssen, D. H. J. (2022). Atrial Fibrillation Specific Exercise Rehabilitation: Are We There Yet?. JOURNAL OF PERSONALIZED MEDICINE, 12(4). doi:10.3390/jpm12040610
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.
Piccini, J. P., Caso, V., Connolly, S. J., Fox, K. A. A., Oldgren, J., Jones, W. S., . . . PACIFIC-AF Investigators. (2022). Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.. Lancet (London, England), 399(10333), 1383-1390. doi:10.1016/s0140-6736(22)00456-1
The management of anticoagulants in patients with atrial fibrillation and history of falls or risk of falls: protocol for a systematic review and meta-analysis
Galvain, T., Hill, R., Donegan, S., Lisboa, P., Lip, G. Y. H., & Czanner, G. (2022). The management of anticoagulants in patients with atrial fibrillation and history of falls or risk of falls: protocol for a systematic review and meta-analysis. SYSTEMATIC REVIEWS, 11(1). doi:10.1186/s13643-022-01937-0
Atrial fibrillation.
Brundel, B. J. J. M., Ai, X., Hills, M. T., Kuipers, M. F., Lip, G. Y. H., & de Groot, N. M. S. (2022). Atrial fibrillation.. Nature reviews. Disease primers, 8(1), 21. doi:10.1038/s41572-022-00347-9
Effects of the Atrial Fibrillation Better Care Pathway on Outcomes Among Clinically Complex Chinese Patients With Atrial Fibrillation With Multimorbidity and Polypharmacy: A Report From the ChiOTEAF Registry
Kotalczyk, A., Guo, Y., Stefil, M., Wang, Y., & Lip, G. Y. H. (2022). Effects of the Atrial Fibrillation Better Care Pathway on Outcomes Among Clinically Complex Chinese Patients With Atrial Fibrillation With Multimorbidity and Polypharmacy: A Report From the ChiOTEAF Registry. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 11(7). doi:10.1161/JAHA.121.024319
Low Risk of Dementia in Patients With Newly Diagnosed Atrial Fibrillation and a Clustering of Healthy Lifestyle Behaviors: A Nationwide Population-Based Cohort Study
Park, S. -H., Lee, S. -R., Choi, E. -K., Lee, H., Chung, J., Choi, J., . . . Lip, G. Y. H. (2022). Low Risk of Dementia in Patients With Newly Diagnosed Atrial Fibrillation and a Clustering of Healthy Lifestyle Behaviors: A Nationwide Population-Based Cohort Study. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 11(7). doi:10.1161/JAHA.121.023739
Malignant Hypertension: Current Perspectives and Challenges
Boulestreau, R., van den Born, B. -J. H., Lip, G. Y. H., & Gupta, A. (2022). Malignant Hypertension: Current Perspectives and Challenges. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 11(7). doi:10.1161/JAHA.121.023397
Cardiac impairment in Long Covid 1-year post-SARS-CoV-2 infection
Supermarket/Hypermarket Opportunistic Screening for Atrial Fibrillation (SHOPS-AF): A Mixed Methods Feasibility Study Protocol
Jones, I. D., Lane, D. A., Lotto, R. R., Oxborough, D., Neubeck, L., Penson, P. E., . . . Lip, G. Y. H. (2022). Supermarket/Hypermarket Opportunistic Screening for Atrial Fibrillation (SHOPS-AF): A Mixed Methods Feasibility Study Protocol. JOURNAL OF PERSONALIZED MEDICINE, 12(4). doi:10.3390/jpm12040578
Add-on Therapy With Sacubitril/Valsartan and Clinical Outcomes in CRT-D Nonresponder Patients
Russo, V., Ammendola, E., Gasperetti, A., Bottino, R., Schiavone, M., Masarone, D., . . . Proietti, R. (2022). Add-on Therapy With Sacubitril/Valsartan and Clinical Outcomes in CRT-D Nonresponder Patients. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 79(4), 472-478. doi:10.1097/FJC.0000000000001202
Atrial high rate episodes as a marker of atrial cardiomyopathy: In the quest of the Holy Grail. Author's reply
Vitolo, M., Imberti, J. F., Proietti, M., Lip, G. Y. H., & Boriani, G. (2022). Atrial high rate episodes as a marker of atrial cardiomyopathy: In the quest of the Holy Grail. Author's reply. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 98, 115-116. doi:10.1016/j.ejim.2022.01.032
Bridging the Gap Between Artificial Intelligence Research and Clinical Practice in Cardiovascular Science: What the Clinician Needs to Know
Shipley, E., Joddrell, M., Lip, G. Y. H., & Zheng, Y. (n.d.). Bridging the Gap Between Artificial Intelligence Research and Clinical Practice in Cardiovascular Science: What the Clinician Needs to Know. Arrhythmia and Electrophysiology Review, 11. doi:10.15420/aer.2022.07
CHA<sub>2</sub>DS<sub>2</sub>-VASc impact on risk following percutaneous coronary intervention in atrial fibrillation
Jensen, T., Thrane, P. G., Olesen, K. K. W., Wurtz, M., Nielsen, J. C., Jensen, L. O., . . . Maeng, M. (2022). CHA<sub>2</sub>DS<sub>2</sub>-VASc impact on risk following percutaneous coronary intervention in atrial fibrillation. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 52(4). doi:10.1111/eci.13717
Left Atrial Appendage Occlusion-A Choice or a Last Resort? How to Approach the Patient.
Ding, W. Y., Lip, G. Y. H., & Gupta, D. (2022). Left Atrial Appendage Occlusion-A Choice or a Last Resort? How to Approach the Patient.. Interventional cardiology clinics, 11(2), 135-142. doi:10.1016/j.iccl.2021.11.006
Oral anti-coagulant treatment patterns in atrial fibrillation patients diagnosed with cancer: A Danish nationwide cohort study.
Ording, A. G., Søgaard, M., Nielsen, P. B., Lip, G. Y. H., Larsen, T. B., Grove, E. L., & Skjøth, F. (2022). Oral anti-coagulant treatment patterns in atrial fibrillation patients diagnosed with cancer: A Danish nationwide cohort study.. British journal of haematology, 197(2), 223-231. doi:10.1111/bjh.18060
Prediction of ischemic stroke in different populations: a comparison of absolute stroke risk and CHA2DS2-VASc in real-world and clinical trial patients
Miguel Rivera-Caravaca, J., Ding, W. Y., Marin, F., Roldan, V., Lip, G. Y. H., Lee, C. J. -Y., & Torp-Pedersen, C. (2022). Prediction of ischemic stroke in different populations: a comparison of absolute stroke risk and CHA2DS2-VASc in real-world and clinical trial patients. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 98, 122-124. doi:10.1016/j.ejim.2021.12.014
Prognosis of Atrial Fibrillation with or without Comorbidities: Analysis of Younger Adults from a Nationwide Database.
Mertz, V., Cottin, Y., Bentounes, S. A., Pastier-Debeaumarché, J., Didier, R., Herbert, J., . . . Fauchier, L. (2022). Prognosis of Atrial Fibrillation with or without Comorbidities: Analysis of Younger Adults from a Nationwide Database.. Journal of clinical medicine, 11(7), 1981. doi:10.3390/jcm11071981
The Impact of Atrial Fibrillation on Outcomes of Peripheral Arterial Disease: Analysis of Routinely Collected Primary Care Data
Vitalis, A., Nirantharakumar, K., Thayakaran, R., Vohra, R. K., Kay, M., Shantsila, A., & Lip, G. Y. H. (2022). The Impact of Atrial Fibrillation on Outcomes of Peripheral Arterial Disease: Analysis of Routinely Collected Primary Care Data. AMERICAN JOURNAL OF MEDICINE, 135(4), 488-492. doi:10.1016/j.amjmed.2021.10.021
What Cannot Be Missed: Important Publications on Electrophysiology in 2021.
Narayan, S. M., Calkins, H., Grace, A., Lip, G. Y., Ellenbogen, K., Lambiase, P. D., & Katritsis, D. G. (2022). What Cannot Be Missed: Important Publications on Electrophysiology in 2021.. Arrhythmia & electrophysiology review, 11, e01. doi:10.15420/aer.2022.04
Exercise-based cardiac rehabilitation for cardiac implantable electronic device recipients
Buckley, B. J. R., Harrison, S. L., Underhill, P., Wright, D. J., Thijssen, D. H. J., & Lip, G. Y. H. (2022). Exercise-based cardiac rehabilitation for cardiac implantable electronic device recipients. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 29(4), E153-E155. doi:10.1093/eurjpc/zwab103
Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes (vol 117, pg 1, 2021)
Boriani, G., Vitolo, M., Diemberger, I., Proietti, M., Valenti, A. C., Malavasi, V. L., & Lip, G. Y. H. (2022). Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes (vol 117, pg 1, 2021). CARDIOVASCULAR RESEARCH, 118(5), 1374. doi:10.1093/cvr/cvab361
Birth Weight and the Risk of Cardiovascular Outcomes: A Report From the Large Population-Based UK Biobank Cohort Study
Huang, X., Liu, J., Qi, L., Adachi, J. D., Wu, J., Li, Z., . . . Lip, G. Y. H. (2022). Birth Weight and the Risk of Cardiovascular Outcomes: A Report From the Large Population-Based UK Biobank Cohort Study. FRONTIERS IN CARDIOVASCULAR MEDICINE, 9. doi:10.3389/fcvm.2022.827491
Non-alcoholic Fatty Liver Disease and the Risk of Incident Atrial Fibrillation in Young Adults: A Nationwide Population-Based Cohort Study.
Choi, J., Lee, S. -R., Choi, E. -K., Ahn, H. -J., Kwon, S., Park, S. -H., . . . Lip, G. Y. H. (2022). Non-alcoholic Fatty Liver Disease and the Risk of Incident Atrial Fibrillation in Young Adults: A Nationwide Population-Based Cohort Study.. Frontiers in cardiovascular medicine, 9, 832023. doi:10.3389/fcvm.2022.832023
Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society
Gorog, D. A., Gue, Y. X., Chao, T. -F., Fauchier, L., Ferreiro, J. L., Huber, K., . . . Lip, G. Y. H. (2022). Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society. EUROPACE. doi:10.1093/europace/euac020
Early Rhythm Control and the Risks of Ischemic Stroke, Heart Failure, Mortality, and Adverse Events When Performed Early (<3 Months): A Nationwide Cohort Study of Newly Diagnosed Patients with Atrial Fibrillation.
Chao, T. -F., Chan, Y. -H., Chiang, C. -E., Tuan, T. -C., Liao, J. -N., Chen, T. -J., . . . Chen, S. -A. (2022). Early Rhythm Control and the Risks of Ischemic Stroke, Heart Failure, Mortality, and Adverse Events When Performed Early (<3 Months): A Nationwide Cohort Study of Newly Diagnosed Patients with Atrial Fibrillation.. Thrombosis and haemostasis, 122(11), 1899-1910. doi:10.1055/a-1807-0336
Relation of the 'Atrial Fibrillation Better Care (ABC) Pathway' to the Quality of Anticoagulation in Atrial Fibrillation Patients Taking Vitamin K Antagonists
Roldan, V., Martinez-Montesinos, L., Lopez-Galvez, R., Garcia-Tomas, L., Lip, G. Y. H., Miguel Rivera-Caravaca, J., & Marin, F. (2022). Relation of the 'Atrial Fibrillation Better Care (ABC) Pathway' to the Quality of Anticoagulation in Atrial Fibrillation Patients Taking Vitamin K Antagonists. JOURNAL OF PERSONALIZED MEDICINE, 12(3). doi:10.3390/jpm12030487
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry.
Lip, G. Y. H., Kotalczyk, A., Teutsch, C., Diener, H. -C., Dubner, S. J., Halperin, J. L., . . . GLORIA-AF Investigators. (2022). Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry.. Clinical research in cardiology : official journal of the German Cardiac Society. doi:10.1007/s00392-022-01996-2
Recommendations from the ICM-VTE: General.
ICM-VTE General Delegates. (2022). Recommendations from the ICM-VTE: General.. The Journal of bone and joint surgery. American volume, 104(Suppl 1), 4-162. doi:10.2106/jbjs.21.01531
Thoracic aortic aneurysms and atrial fibrillation: commonality in pathophysiological pathways
Proietti, R., Lip, G. Y. H., Akhtar, R., & Field, M. (2022). Thoracic aortic aneurysms and atrial fibrillation: commonality in pathophysiological pathways. CARDIOVASCULAR RESEARCH, 118(4), E32-E35. doi:10.1093/cvr/cvac016
Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation
Imberti, J. F., Bonini, N., Tosetti, A., Mei, D. A., Gerra, L., Malavasi, V. L., . . . Boriani, G. (2022). Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation. BIOLOGY-BASEL, 11(3). doi:10.3390/biology11030443
Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA-AF Phase III Registry.
Bayer, V., Kotalczyk, A., Kea, B., Teutsch, C., Larsen, P., Button, D., . . . Olshansky, B. (2022). Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA-AF Phase III Registry.. Journal of the American Heart Association, 11(6), e023907. doi:10.1161/jaha.121.023907
Magnetic resonance imaging-based scores of small vessel diseases: Associations with intracerebral haemorrhage location.
Schwarz, G., Banerjee, G., Hostettler, I. C., Ambler, G., Seiffge, D. J., Brookes, T. S., . . . CROMIS-2 investigators. (2022). Magnetic resonance imaging-based scores of small vessel diseases: Associations with intracerebral haemorrhage location.. Journal of the neurological sciences, 434, 120165. doi:10.1016/j.jns.2022.120165
A comparison of medical therapy and ablation for atrial fibrillation in patients with heart failure
Calvert, P., Farinha, J. M., Gupta, D., Kahn, M., Proietti, R., & Lip, G. Y. H. (2022). A comparison of medical therapy and ablation for atrial fibrillation in patients with heart failure. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 20(3), 169-183. doi:10.1080/14779072.2022.2050695
Managing uncertainty: Physicians' decision-making for stroke prevention for patients with atrial fibrillation and intracerebral haemorrhage.
Ivany, E., Lotto, R., Lip, G. Y., & Lane, D. (2022). Managing uncertainty: Physicians' decision-making for stroke prevention for patients with atrial fibrillation and intracerebral haemorrhage.. Thrombosis and haemostasis. doi:10.1055/a-1789-4824
Atrial fibrillation in the UK: predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs.
Burdett, P., & Lip, G. Y. H. (2022). Atrial fibrillation in the UK: predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs.. European heart journal. Quality of care & clinical outcomes, 8(2), 187-194. doi:10.1093/ehjqcco/qcaa093
Characteristics of patients with atrial high rate episodes detected by implanted defibrillator and resynchronization devices.
Miyazawa, K., Pastori, D., Martin, D. T., Choucair, W. K., Halperin, J. L., Lip, G. Y. H., & IMPACT Study Investigators. (2022). Characteristics of patients with atrial high rate episodes detected by implanted defibrillator and resynchronization devices.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 24(3), 375-383. doi:10.1093/europace/euab186
Impact of Multimorbidity and Polypharmacy on Clinical Outcomes of Elderly Chinese Patients with Atrial Fibrillation
Kotalczyk, A., Guo, Y., Wang, Y., & Lip, G. Y. H. (2022). Impact of Multimorbidity and Polypharmacy on Clinical Outcomes of Elderly Chinese Patients with Atrial Fibrillation. JOURNAL OF CLINICAL MEDICINE, 11(5). doi:10.3390/jcm11051370
"Novel Clinical Concepts in Thrombosis": Integrated Care for Stroke Management-Easy as ABC
Lip, G. Y. H., & Ntaios, G. (2022). "Novel Clinical Concepts in Thrombosis": Integrated Care for Stroke Management-Easy as ABC. THROMBOSIS AND HAEMOSTASIS, 122(03), 316-319. doi:10.1055/a-1632-1777
Adherence to the 'Atrial Fibrillation Better Care' Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes-A Systematic Review and Meta-Analysis of 285,000 Patients
Romiti, G. F., Pastori, D., Rivera-Caravaca, J. M., Ding, W. Y., Gue, Y. X., Menichelli, D., . . . Proietti, M. (2022). Adherence to the 'Atrial Fibrillation Better Care' Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes-A Systematic Review and Meta-Analysis of 285,000 Patients. THROMBOSIS AND HAEMOSTASIS, 122(03), 406-414. doi:10.1055/a-1515-9630
Atrial Fibrillation Diagnosed following Stroke: Dealing with a New Clinical Entity or Just a Matter of Definition?
Harrison, S. L., Buckley, B. J. R., Proietti, R., & Lip, G. Y. H. (2022). Atrial Fibrillation Diagnosed following Stroke: Dealing with a New Clinical Entity or Just a Matter of Definition?. CEREBROVASCULAR DISEASES, 51(2), 149-151. doi:10.1159/000520667
Clinical characteristics, time course, and outcomes of major bleeding according to bleeding site in patients with venous thromboembolism.
Bikdeli, B., Moustafa, F., Nieto, J. A., Lee, A. I., Ruíz-Giménez, N., Lorenzo, A., . . . RIETE Investigators. (2022). Clinical characteristics, time course, and outcomes of major bleeding according to bleeding site in patients with venous thromboembolism.. Thrombosis research, 211, 10-18. doi:10.1016/j.thromres.2022.01.007
Correction to: Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non‑Asian Patients with Atrial Fibrillation: A Systematic Review and Meta‑Analysis.
Escobar, C., Barrios, V., Lip, G. Y. H., Amin, A. N., Auladell-Rispau, A., Santero, M., . . . Requeijo, C. (2022). Correction to: Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non‑Asian Patients with Atrial Fibrillation: A Systematic Review and Meta‑Analysis.. Clinical drug investigation, 42(3), 279-280. doi:10.1007/s40261-022-01126-w
Hypertension control and end-stage renal disease in atrial fibrillation: a nationwide population-based cohort study
Kwon, S., Lee, S. -R., Choi, E. -K., Jung, J. -H., Han, K. -D., Oh, S., & Lip, G. Y. H. (2022). Hypertension control and end-stage renal disease in atrial fibrillation: a nationwide population-based cohort study. CLINICAL RESEARCH IN CARDIOLOGY, 111(3), 284-293. doi:10.1007/s00392-021-01899-8
Inconsistent Methodology as a Barrier to Meaningful Research Outputs From Studies of Atrial Fibrillation After Cardiac Surgery.
Campbell, N. G., Wollborn, J., Fields, K. G., Lip, G. Y. H., Ruetzler, K., Muehlschlegel, J. D., & O'Brien, B. (2022). Inconsistent Methodology as a Barrier to Meaningful Research Outputs From Studies of Atrial Fibrillation After Cardiac Surgery.. Journal of cardiothoracic and vascular anesthesia, 36(3), 739-745. doi:10.1053/j.jvca.2021.10.009
Lipid profile, lipid ratios, apolipoproteins, and risk of cardiometabolic multimorbidity in men: The Kuopio Ischaemic Heart Disease Risk Factor Study
Tajik, B., Voutilainen, A., Kauhanen, J., Mazidi, M., Lip, G. Y. H., Tuomainen, T. -P., & Isanejad, M. (2022). Lipid profile, lipid ratios, apolipoproteins, and risk of cardiometabolic multimorbidity in men: The Kuopio Ischaemic Heart Disease Risk Factor Study. LIPIDS, 57(2), 141-149. doi:10.1002/lipd.12337
Relationship between glucosamine use and the risk of lung cancer: data from a nationwide prospective cohort study
Li, G., Zhang, X., Liu, Y., Zhang, J., Li, L., Huang, X., . . . Lip, G. Y. H. (2022). Relationship between glucosamine use and the risk of lung cancer: data from a nationwide prospective cohort study. EUROPEAN RESPIRATORY JOURNAL, 59(3). doi:10.1183/13993003.01399-2021
The Birmingham and Black Country cohort of Venous Thromboembolism (BBC-VTE) registry: Rationale, design and preliminary results.
Sanders, A., El-Bouri, W. K., Lip, G. Y. H., & *BBC-VTE investigators. (2022). The Birmingham and Black Country cohort of Venous Thromboembolism (BBC-VTE) registry: Rationale, design and preliminary results.. European journal of internal medicine, 97, 50-55. doi:10.1016/j.ejim.2022.01.022
The role of adiposity, diet and inflammation on the discordance between LDL-C and apolipoprotein B.
Webb, R. J., Mazidi, M., Lip, G. Y. H., Kengne, A. P., Banach, M., & Davies, I. G. (2022). The role of adiposity, diet and inflammation on the discordance between LDL-C and apolipoprotein B.. Nutrition, metabolism, and cardiovascular diseases : NMCD, 32(3), 605-615. doi:10.1016/j.numecd.2021.12.004
Yearly Incidence of Stroke and Bleeding in Atrial Fibrillation with Concomitant Hyperthyroidism: A National Discharge Database Study
Zhang, J., Bisson, A., Fauchier, G., Bodin, A., Herbert, J., Ducluzeau, P. H., . . . Fauchier, L. (2022). Yearly Incidence of Stroke and Bleeding in Atrial Fibrillation with Concomitant Hyperthyroidism: A National Discharge Database Study. JOURNAL OF CLINICAL MEDICINE, 11(5). doi:10.3390/jcm11051342
Relationship between lipoproteins, thrombosis, and atrial fibrillation
Ding, W. Y., Protty, M. B., Davies, I. G., & Lip, G. Y. H. (2022). Relationship between lipoproteins, thrombosis, and atrial fibrillation. CARDIOVASCULAR RESEARCH, 118(3), 716-731. doi:10.1093/cvr/cvab017
Exercise rehabilitation associates with lower mortality and hospitalisation in cardiovascular disease patients with COVID-19
Buckley, B. J. R., Harrison, S. L., Fazio-Eynullayeva, E., Underhill, P., Jones, I. D., Williams, N., & Lip, G. Y. H. (2022). Exercise rehabilitation associates with lower mortality and hospitalisation in cardiovascular disease patients with COVID-19. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 29(1), E32-E34. doi:10.1093/eurjpc/zwaa135
Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation.
Farinha, J. M., Jones, I. D., & Lip, G. Y. H. (2022). Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation.. European heart journal supplements : journal of the European Society of Cardiology, 24(Suppl A), A42-A55. doi:10.1093/eurheartj/suab152
Kidney Function According to Different Equations in Patients Admitted to a Cardiology Unit and Impact on Outcome
Malavasi, V. L., Valenti, A. C., Ruggerini, S., Manicardi, M., Orlandi, C., Sgreccia, D., . . . Boriani, G. (2022). Kidney Function According to Different Equations in Patients Admitted to a Cardiology Unit and Impact on Outcome. JOURNAL OF CLINICAL MEDICINE, 11(3). doi:10.3390/jcm11030891
Impact of Physical Activity on All-Cause Mortality According to Specific Cardiovascular Disease
Kim, M. -H., Sung, J. -H., Jin, M. -N., Jang, E., Yu, H. T., Kim, T. -H., . . . Joung, B. (2022). Impact of Physical Activity on All-Cause Mortality According to Specific Cardiovascular Disease. FRONTIERS IN CARDIOVASCULAR MEDICINE, 9. doi:10.3389/fcvm.2022.811058
Effect of sodium-glucose cotransporter-2 inhibitors on cardiac remodelling: a systematic review and meta-analysis
Zhang, N., Wang, Y., Tse, G., Korantzopoulos, P., Letsas, K. P., Zhang, Q., . . . Liu, T. (2022). Effect of sodium-glucose cotransporter-2 inhibitors on cardiac remodelling: a systematic review and meta-analysis. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 28(17), 1961-1973. doi:10.1093/eurjpc/zwab173
Role of cardiorespiratory fitness in cancer development: time for an update
Boidin, M., Lip, G. Y. H., & Thijssen, D. (2022). Role of cardiorespiratory fitness in cancer development: time for an update. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 28(17), E14-E16. doi:10.1177/2047487320935228
Characterization of atrial fibrillation in real-world patients: testing the 4S-AF scheme in the Spanish and French cohorts of the EORP-AF Long-Term General Registry
Miguel Rivera-Caravaca, J., Piot, O., Roldan-Rabadan, I., Denis, A., Anguita, M., Mansourati, J., . . . Marin, F. (2022). Characterization of atrial fibrillation in real-world patients: testing the 4S-AF scheme in the Spanish and French cohorts of the EORP-AF Long-Term General Registry. EUROPACE, 24(2), 202-210. doi:10.1093/europace/euab202
Warfarin and increased fracture risk? Answering the big question
Fawzy, A. M., & Lip, G. Y. H. (2022). Warfarin and increased fracture risk? Answering the big question. AGE AND AGEING, 51(2). doi:10.1093/ageing/afab263
Analysis of the impact of sex and age on the variation in the prevalence of antinuclear autoantibodies in Polish population: a nationwide observational, cross-sectional study
Krzemien, P., Kasperczyk, S., Banach, M., Kasperczyk, A., Dobrakowski, M., Tomasik, T., . . . Jozwiak, J. J. (2022). Analysis of the impact of sex and age on the variation in the prevalence of antinuclear autoantibodies in Polish population: a nationwide observational, cross-sectional study. RHEUMATOLOGY INTERNATIONAL, 42(2), 261-271. doi:10.1007/s00296-021-05033-9
Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration
Rivard, L., Friberg, L., Conen, D., Healey, J. S., Berge, T., Boriani, G., . . . Freedman, B. (2022). Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration. CIRCULATION, 145(5), 392-409. doi:10.1161/CIRCULATIONAHA.121.055018
Comparison of early clinical outcomes between dual antiplatelet therapy and triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention
Park, J., Jung, J. -H., Choi, E. -K., Lee, S. -W., Kwon, S., Lee, S. -R., . . . Lip, G. Y. H. (2022). Comparison of early clinical outcomes between dual antiplatelet therapy and triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention. PLOS ONE, 17(2). doi:10.1371/journal.pone.0264538
Different Renal Function Equations and Dosing of Direct Oral Anticoagulants in Atrial Fibrillation.
Chan, Y. -H., Chao, T. -F., Lee, H. -F., Yeh, Y. -H., Chang, S. -H., Kuo, C. -T., . . . Chen, S. -A. (2022). Different Renal Function Equations and Dosing of Direct Oral Anticoagulants in Atrial Fibrillation.. JACC. Asia, 2(1), 46-58. doi:10.1016/j.jacasi.2021.11.006
ER stress in obesity pathogenesis and management.
Ajoolabady, A., Liu, S., Klionsky, D. J., Lip, G. Y. H., Tuomilehto, J., Kavalakatt, S., . . . Ren, J. (2022). ER stress in obesity pathogenesis and management.. Trends in pharmacological sciences, 43(2), 97-109. doi:10.1016/j.tips.2021.11.011
Integrated Care Systems and the Aortovascular Hub
Field, M., Kuduvalli, M., Torella, F., McKay, V., Khalatbari, A., & Lip, G. Y. H. (2022). Integrated Care Systems and the Aortovascular Hub. THROMBOSIS AND HAEMOSTASIS, 122(02), 177-180. doi:10.1055/a-1591-8033
Ischemic Stroke in Patients With Hypertrophic Cardiomyopathy According to Presence or Absence of Atrial Fibrillation
Fauchier, L., Bisson, A., Bodin, A., Herbert, J., Spiesser, P., Pierre, B., . . . Lip, G. Y. H. (2022). Ischemic Stroke in Patients With Hypertrophic Cardiomyopathy According to Presence or Absence of Atrial Fibrillation. STROKE, 53(2), 497-504. doi:10.1161/STROKEAHA.121.034213
Melatonin-based therapeutics for atherosclerotic lesions and beyond: Focusing on macrophage mitophagy
Ajoolabady, A., Bi, Y., McClements, D. J., Lip, G. Y. H., Richardson, D. R., Reiter, R. J., . . . Ren, J. (2022). Melatonin-based therapeutics for atherosclerotic lesions and beyond: Focusing on macrophage mitophagy. PHARMACOLOGICAL RESEARCH, 176. doi:10.1016/j.phrs.2022.106072
Not All Constipation is Created Equal Reply
Vitalis, A., Shantsila, A., & Lip, G. Y. H. (2022). Not All Constipation is Created Equal Reply. AMERICAN JOURNAL OF MEDICINE, 135(2), 59-60. doi:10.1016/j.amjmed.2021.09.019
Relationship between Chronic Kidney Disease, Time-in-Therapeutic Range, and Adverse Outcomes in Atrial Fibrillation: A post hoc Analysis from the AMADEUS Trial
Ding, W. Y., Lip, G. Y. H., & Shantsila, A. (2022). Relationship between Chronic Kidney Disease, Time-in-Therapeutic Range, and Adverse Outcomes in Atrial Fibrillation: A post hoc Analysis from the AMADEUS Trial. CEREBROVASCULAR DISEASES, 51(1), 29-35. doi:10.1159/000517608
Telemedical Monitoring Based on Implantable Devices-the Evolution Beyond the CardioMEMS™ Technology
Kotalczyk, A., Imberti, J. F., Lip, G. Y. H., & Wright, D. J. (2022). Telemedical Monitoring Based on Implantable Devices-the Evolution Beyond the CardioMEMS™ Technology. CURRENT HEART FAILURE REPORTS, 19(1), 7-14. doi:10.1007/s11897-021-00537-8
Anticoagulation Control in Older Atrial Fibrillation Patients Receiving Vitamin K Antagonist Therapy for Stroke Prevention
Zulkifly, H., Lip, G. Y. H., & Lane, D. A. (2022). Anticoagulation Control in Older Atrial Fibrillation Patients Receiving Vitamin K Antagonist Therapy for Stroke Prevention. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2022. doi:10.1155/2022/5951262
4S-AF scheme and ABC pathway guided management improves outcomes in atrial fibrillation patients.
Guo, Y., Imberti, J. F., Kotalczyk, A., Wang, Y., Lip, G. Y. H., & ChiOTEAF Registry Investigators. (2022). 4S-AF scheme and ABC pathway guided management improves outcomes in atrial fibrillation patients.. European journal of clinical investigation, e13751. doi:10.1111/eci.13751
Relationship between low-density lipoprotein cholesterol, lipid-lowering agents and risk of stroke: a meta-analysis of observational studies (<i>n</i> = 355,591) and randomized controlled trials (<i>n</i> = 165,988).
Banach, M., Shekoohi, N., Mikhailidis, D. P., Lip, G. Y. H., Hernandez, A. V., & Mazidi, M. (2022). Relationship between low-density lipoprotein cholesterol, lipid-lowering agents and risk of stroke: a meta-analysis of observational studies (<i>n</i> = 355,591) and randomized controlled trials (<i>n</i> = 165,988).. Archives of medical science : AMS, 18(4), 912-929. doi:10.5114/aoms/145970
Discordance between LDL-C and Apolipoprotein B Levels and Its Association with Renal Dysfunction: Insights from a Population-Based Study
Mazidi, M., Webb, R. J., Lip, G. Y. H., Kengne, A. P., Banach, M., & Davies, I. G. (2022). Discordance between LDL-C and Apolipoprotein B Levels and Its Association with Renal Dysfunction: Insights from a Population-Based Study. JOURNAL OF CLINICAL MEDICINE, 11(2). doi:10.3390/jcm11020313
Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry
Ding, W. Y., Potpara, T. S., Blomstrom-Lundqvist, C., Boriani, G., Marin, F., Fauchier, L., . . . Reg, E. S. C. -E. H. R. A. E. O. R. P. -A. F. L. -T. G. (2022). Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. doi:10.1111/eci.13745
Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial.
INSPIRATION-S Investigators. (2022). Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial.. BMJ (Clinical research ed.), 376, e068407. doi:10.1136/bmj-2021-068407
Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation
Ding, W. Y., Rivera-Caravaca, J. M., Fazio-Eynullayeva, E., Underhill, P., Gupta, D., Marin, F., & Lip, G. Y. H. (2022). Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation. CLINICAL RESEARCH IN CARDIOLOGY. doi:10.1007/s00392-021-01983-z
Association of rhythm control with incident dementia among patients with atrial fibrillation: a nationwide population-based cohort study
Kim, D., Yang, P. -S., You, S. C., Sung, J. -H., Jang, E., Yu, H. T., . . . Joung, B. (2022). Association of rhythm control with incident dementia among patients with atrial fibrillation: a nationwide population-based cohort study. AGE AND AGEING, 51(1). doi:10.1093/ageing/afab248
Association between sodium-glucose cotransporter-2 inhibitors and risk of sudden cardiac death or ventricular arrhythmias: a meta-analysis of randomized controlled trials
Sfairopoulos, D., Zhang, N., Wang, Y., Chen, Z., Letsas, K. P., Tse, G., . . . Korantzopoulos, P. (2022). Association between sodium-glucose cotransporter-2 inhibitors and risk of sudden cardiac death or ventricular arrhythmias: a meta-analysis of randomized controlled trials. EUROPACE, 24(1), 20-+. doi:10.1093/europace/euab177
Adherence to the 4S-AF Scheme in the Balkan region: Insights from the BALKAN-AF survey.
Kozieł-Siołkowska, M., Mihajlovic, M., Nedeljkovic, M., Pavlovic, N., Paparisto, V., Music, L., . . . Potpara, T. S. (2022). Adherence to the 4S-AF Scheme in the Balkan region: Insights from the BALKAN-AF survey.. Kardiologia polska, 80(4), 461-467. doi:10.33963/kp.a2022.0053
Association of proteinuria and hypertension with incident atrial fibrillation in an elderly population: nationwide data from a community-based elderly cohort
Park, Y. J., Yang, P. -S., Yu, H. T., Kim, T. -H., Jang, E., Uhm, J. -S., . . . Joung, B. (2022). Association of proteinuria and hypertension with incident atrial fibrillation in an elderly population: nationwide data from a community-based elderly cohort. JOURNAL OF HYPERTENSION, 40(1), 128-135. doi:10.1097/HJH.0000000000002987
Associations of anemia with death and major bleeding in patients with atrial fibrillation: A report from the Chinese Atrial Fibrillation Registry Study
Zhang, Z., Jiang, C., He, L., Bai, Y., Wu, J., Hu, R., . . . Ma, C. (2022). Associations of anemia with death and major bleeding in patients with atrial fibrillation: A report from the Chinese Atrial Fibrillation Registry Study. CLINICAL CARDIOLOGY, 45(1), 91-100. doi:10.1002/clc.23764
Atrial fibrillation ablation in heart failure: Findings from the ESC-EHRA EORP Atrial Fibrillation Ablation long-term (AFA LT) registry
Temporelli, P. L., Arbelo, E., Laroche, C., Blomstrom-Lundqvist, C., Kirchhof, P., Lip, G. Y. H., . . . Tavazzi, L. (2022). Atrial fibrillation ablation in heart failure: Findings from the ESC-EHRA EORP Atrial Fibrillation Ablation long-term (AFA LT) registry. INTERNATIONAL JOURNAL OF CARDIOLOGY, 346, 19-26. doi:10.1016/j.ijcard.2021.11.010
Cardiovascular Disorders
Shantsila, E., Shantsila, A., Dzeshka, M. S., & Lip, G. Y. H. (2022). Cardiovascular Disorders. In Textbook of Occupational Medicine Practice (pp. 463-504). WORLD SCIENTIFIC. doi:10.1142/9789811245657_0012
Clinical Features Associated with 'Normal Range' Fibrin D-Dimer Levels in Atrial Fibrillation Patients with Left Atrial Thrombus
Bai, Y., Luo, S. -Q., Liu, S. -T., Gong, L., Zhong, P., Wang, Z. -Z., . . . Guo, W. -H. (2022). Clinical Features Associated with 'Normal Range' Fibrin D-Dimer Levels in Atrial Fibrillation Patients with Left Atrial Thrombus. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 28. doi:10.1177/10760296221133380
Continuation or discontinuation of oral anticoagulants after HAS-BLED scores increase in patients with atrial fibrillation
Chao, T. -F., Chan, Y. -H., Chiang, C. -E., Tuan, T. -C., Liao, J. -N., Chen, T. -J., . . . Chen, S. -A. (2022). Continuation or discontinuation of oral anticoagulants after HAS-BLED scores increase in patients with atrial fibrillation. CLINICAL RESEARCH IN CARDIOLOGY, 111(1), 23-33. doi:10.1007/s00392-021-01816-z
Embedded-EEPROM descrambling via laser-based techniques – A case study on AVR MCU
Chef, S., Tah, C. C., Yun Tay, J., Cheah, J., & Gan, C. L. (2022). Embedded-EEPROM descrambling via laser-based techniques – A case study on AVR MCU. In 2022 Workshop on Fault Detection and Tolerance in Cryptography (FDTC) (pp. 1-8). IEEE. doi:10.1109/fdtc57191.2022.00010
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial.
Verma, S., Dhingra, N. K., Butler, J., Anker, S. D., Ferreira, J. P., Filippatos, G., . . . EMPEROR-Reduced trial committees and investigators. (2022). Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial.. The lancet. Diabetes & endocrinology, 10(1), 35-45. doi:10.1016/s2213-8587(21)00292-8
Hematuria in anticoagulated patients with atrial fibrillation and urologic cancer.
Ording, A. G., Søgaard, M., Skjøth, F., Grove, E. L., Lip, G. Y. H., Larsen, T. B., & Nielsen, P. B. (2022). Hematuria in anticoagulated patients with atrial fibrillation and urologic cancer.. Research and practice in thrombosis and haemostasis, 6(1), e12629. doi:10.1002/rth2.12629
Integrated Care of Atrial Fibrillation Using the ABC (Atrial fibrillation Better Care) Pathway Improves Clinical Outcomes in Chinese Population: An Analysis From the Chinese Atrial Fibrillation Registry
Wang, Y. -F., Jiang, C., He, L., Du, X., Sang, C. -H., Long, D. -Y., . . . Ma, C. -S. (2021). Integrated Care of Atrial Fibrillation Using the ABC (Atrial fibrillation Better Care) Pathway Improves Clinical Outcomes in Chinese Population: An Analysis From the Chinese Atrial Fibrillation Registry. FRONTIERS IN CARDIOVASCULAR MEDICINE, 8. doi:10.3389/fcvm.2021.762245
Life-Years Lost After Newly Diagnosed Atrial Fibrillation in Patients with Heart Failure.
Vinter, N., Cordsen, P., Lip, G. Y. H., Benjamin, E. J., Johnsen, S. P., Frost, L., & Trinquart, L. (2022). Life-Years Lost After Newly Diagnosed Atrial Fibrillation in Patients with Heart Failure.. Clinical epidemiology, 14, 711-720. doi:10.2147/clep.s365706
Management of cardiovascular complications of bruton tyrosine kinase inhibitors
Tang, C. P. S., Lip, G. Y. H., McCormack, T., Lyon, A. R., Hillmen, P., Iyengar, S., . . . Walewska, R. (2022). Management of cardiovascular complications of bruton tyrosine kinase inhibitors. BRITISH JOURNAL OF HAEMATOLOGY, 196(1), 70-78. doi:10.1111/bjh.17788
Modelling Virchow's Triad to Improve Stroke Risk Assessment in Atrial Fibrillation Patients
Qureshi, A., Balmus, M., E. Williams, S., Y. H. Lip, G., A. Nordsletten, D., Aslanidi, O., & de Vecchi", A. (n.d.). Modelling Virchow's Triad to Improve Stroke Risk Assessment in Atrial Fibrillation Patients. In Computing in Cardiology Conference (CinC). Computing in Cardiology. doi:10.22489/cinc.2022.378
Number needed to treat for net effect of anticoagulation in atrial fibrillation: Real-world <i>vs</i>. clinical-trial evidence
Ding, W. Y., Miguel Rivera-Caravaca, J., Marin, F., Li, G., Roldan, V., & Lip, G. Y. H. (2022). Number needed to treat for net effect of anticoagulation in atrial fibrillation: Real-world <i>vs</i>. clinical-trial evidence. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 88(1), 282-289. doi:10.1111/bcp.14961
Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation
Polymeris, A. A., Macha, K., Paciaroni, M., Wilson, D., Koga, M., Cappellari, M., . . . Engelter, S. T. (2022). Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation. ANNALS OF NEUROLOGY, 91(1), 78-88. doi:10.1002/ana.26267
Polypharmacy in Older People With Heart Failure: Roles of the Geriatrician and Pharmacist.
Stefil, M., Dixon, M., Bahar, J., Saied, S., Mashida, K., Heron, O., . . . Sankaranarayanan, R. (2022). Polypharmacy in Older People With Heart Failure: Roles of the Geriatrician and Pharmacist.. Cardiac failure review, 8, e34. doi:10.15420/cfr.2022.14
Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry
Proietti, M., Vitolo, M., Harrison, S. L., Lane, D. A., Fauchier, L., Marin, F., . . . Lip, G. Y. H. (2022). Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry. CLINICAL RESEARCH IN CARDIOLOGY, 111(1), 70-84. doi:10.1007/s00392-021-01914-y
Relationship Between Anti-DFS70 Autoantibodies and Oxidative Stress
Krzemien, P., Kasperczyk, S., Banach, M., Kasperczyk, A., Dobrakowski, M., Tomasik, T., . . . Jozwiak, J. J. (2022). Relationship Between Anti-DFS70 Autoantibodies and Oxidative Stress. BIOMARKER INSIGHTS, 17. doi:10.1177/11772719211066791
Reply to 'Digoxin and beta-blockers in patients with heart failure'. Letter regarding the article 'Clinical outcomes with digoxin vs. beta-blocker for heart rate control in permanent atrial fibrillation with heart failure'
Fauchier, L., Bisson, A., & Lip, G. Y. H. (2022). Reply to 'Digoxin and beta-blockers in patients with heart failure'. Letter regarding the article 'Clinical outcomes with digoxin vs. beta-blocker for heart rate control in permanent atrial fibrillation with heart failure'. EUROPEAN JOURNAL OF HEART FAILURE, 24(1), 239-241. doi:10.1002/ejhf.2389
Screening for Atrial Fibrillation by Village Doctors in Rural Areas of China: The Jiangsu Province Rural Community AF Project.
Li, M., Shi, J., Chu, M., Shen, Y., Zhang, S., Sun, X., . . . Chen, M. (2022). Screening for Atrial Fibrillation by Village Doctors in Rural Areas of China: The Jiangsu Province Rural Community AF Project.. Vascular health and risk management, 18, 757-766. doi:10.2147/vhrm.s379182
Selective Staining on Non-Volatile Memory Cells for Data Retrieval
Zeng, X. M., Liu, Q., Tay, J. Y., & Gan, C. L. (2022). Selective Staining on Non-Volatile Memory Cells for Data Retrieval. IEEE Transactions on Information Forensics and Security, 17, 1884-1892. doi:10.1109/tifs.2022.3172222
The Liverpool Heart And bRain Project (L-HARP): Protocol for an Observational Cohort Study of Cardiovascular Risk and Outcomes Following Stroke
Harrison, S. L., Lane, D. A., Buckley, B. J. R., Chatterjee, K., Alobaida, M., Shipley, E., & Lip, G. Y. H. (2022). The Liverpool Heart And bRain Project (L-HARP): Protocol for an Observational Cohort Study of Cardiovascular Risk and Outcomes Following Stroke. VASCULAR HEALTH AND RISK MANAGEMENT, 18, 313-318. doi:10.2147/VHRM.S357829
The impact of atrial fibrillation and long-term oral anticoagulant use on all-cause and cardiovascular mortality: A 12-year evaluation of the prospective Brazilian Study of Stroke Mortality and Morbidity
Goulart, A. C., Olmos, R. D., Santos, I. S., Tunes, G., Alencar, A. P., Thomas, N., . . . Bensenor, I. M. (2022). The impact of atrial fibrillation and long-term oral anticoagulant use on all-cause and cardiovascular mortality: A 12-year evaluation of the prospective Brazilian Study of Stroke Mortality and Morbidity. INTERNATIONAL JOURNAL OF STROKE, 17(1), 48-58. doi:10.1177/1747493021995592
Two-dimensional Motif Extraction from Images: A Study using an Electrocardiogram
Aldosari, H., Coenen, F., Lip, G., & Zheng, Y. (2022). Two-dimensional Motif Extraction from Images: A Study using an Electrocardiogram. In Proceedings of the 14th International Joint Conference on Knowledge Discovery, Knowledge Engineering and Knowledge Management (pp. 19-28). SCITEPRESS - Science and Technology Publications. doi:10.5220/0011380500003335
2021
Metabolic-Associated Fatty Liver Disease (MAFLD), Diabetes, and Cardiovascular Disease: Associations with Fructose Metabolism and Gut Microbiota
Drozdz, K., Nabrdalik, K., Hajzler, W., Kwiendacz, H., Gumprecht, J., & Lip, G. Y. H. (2022). Metabolic-Associated Fatty Liver Disease (MAFLD), Diabetes, and Cardiovascular Disease: Associations with Fructose Metabolism and Gut Microbiota. NUTRIENTS, 14(1). doi:10.3390/nu14010103
Comparative Effectiveness of Early Rhythm Control Versus Rate Control for Cardiovascular Outcomes in Patients With Atrial Fibrillation
Kim, D., Yang, P. -S., You, S. C., Jang, E., Yu, H. T., Kim, T. -H., . . . Joung, B. (2021). Comparative Effectiveness of Early Rhythm Control Versus Rate Control for Cardiovascular Outcomes in Patients With Atrial Fibrillation. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 10(24). doi:10.1161/JAHA.121.023055
Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic
Banerjee, A., Chen, S., Pasea, L., Lai, A. G., Katsoulis, M., Denaxas, S., . . . Hemingway, H. (2021). Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 28(14), 1599-1608. doi:10.1093/eurjpc/zwaa155
Modelling of longitudinal data to predict cardiovascular disease risk: a methodological review
Stevens, D., Lane, D. A., Harrison, S. L., Lip, G. Y. H., & Kolamunnage-Dona, R. (2021). Modelling of longitudinal data to predict cardiovascular disease risk: a methodological review. BMC MEDICAL RESEARCH METHODOLOGY, 21(1). doi:10.1186/s12874-021-01472-x
Season of Birth and Cardiovascular Mortality in Atrial Fibrillation: A Population-Based Cohort Study
Gue, Y. X., Bisson, A., Bodin, A., Herbert, J., Lip, G. Y. H., & Fauchier, L. (2021). Season of Birth and Cardiovascular Mortality in Atrial Fibrillation: A Population-Based Cohort Study. JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 8(12). doi:10.3390/jcdd8120177
Atrial Fibrillation in Patients With Cardiomyopathy: Prevalence and Clinical Outcomes From Real-World Data
Buckley, B. J. R., Harrison, S. L., Gupta, D., Fazio-Eynullayeva, E., Underhill, P., & Lip, G. Y. H. (2021). Atrial Fibrillation in Patients With Cardiomyopathy: Prevalence and Clinical Outcomes From Real-World Data. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 10(23). doi:10.1161/JAHA.121.021970
Effectiveness and Safety of NOAC Versus Warfarin in Patients With Atrial Fibrillation and Aortic Stenosis
Melgaard, L., Overvad, T. F., Jensen, M., Christensen, T. D., Lip, G. Y. H., Larsen, T. B., & Nielsen, P. B. (2021). Effectiveness and Safety of NOAC Versus Warfarin in Patients With Atrial Fibrillation and Aortic Stenosis. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 10(23). doi:10.1161/JAHA.121.022628
Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study
Lee, S. R., Choi, E. K., Jung, J. H., Han, K. D., Oh, S., & Lip, G. Y. H. (2021). Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study. EUROPEAN HEART JOURNAL, 42, 335. Retrieved from https://www.webofscience.com/
2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation.
Chao, T. -F., Joung, B., Takahashi, Y., Lim, T. W., Choi, E. -K., Chan, Y. -H., . . . Lip, G. Y. H. (2021). 2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation.. Journal of arrhythmia, 37(6), 1389-1426. doi:10.1002/joa3.12652
CMOS-Compatible Ti/TiN/Al Refractory Ohmic Contact for GaAs Heterojunction Bipolar Transistors Grown on Ge/Si Substrate
Wang, Y., Loke, W. K., Gao, Y., Lee, K. H., Kian Lee, K. E., Gan, C. L., . . . Yoon, S. F. (2021). CMOS-Compatible Ti/TiN/Al Refractory Ohmic Contact for GaAs Heterojunction Bipolar Transistors Grown on Ge/Si Substrate. IEEE Transactions on Electron Devices, 68(12), 6065-6068. doi:10.1109/ted.2021.3119557
Cardiovascular disease prevention: Risk factor modification at the heart of the matter
Fawzy, A. M., & Lip, G. Y. H. (2021). Cardiovascular disease prevention: Risk factor modification at the heart of the matter. LANCET REGIONAL HEALTH-WESTERN PACIFIC, 17. doi:10.1016/j.lanwpc.2021.100291
Crizanlizumab A CRITICAL Drug During a CRITICAL Time?
Gue, Y. X., Pula, G., & Lip, G. Y. H. (2021). Crizanlizumab A CRITICAL Drug During a CRITICAL Time?. JACC-BASIC TO TRANSLATIONAL SCIENCE, 6(12), 946-947. doi:10.1016/j.jacbts.2021.10.013
In ACS, de-escalation of DAPT reduces bleeding and does not increase ischemic events vs. other DAPT strategies
Fawzy, A. M., & Lip, G. Y. H. (2021). In ACS, de-escalation of DAPT reduces bleeding and does not increase ischemic events vs. other DAPT strategies. ANNALS OF INTERNAL MEDICINE, 174(12), JC138. doi:10.7326/ACPJ202112210-138
Increased 5-year risk of stroke, atrial fibrillation, acute coronary syndrome, and heart failure in out- of-hospital cardiac arrest survivors compared with population controls: A nationwide registry-based study
Byrne, C., Pareek, M., Krogager, M. L., Ringgren, K. B., Wissenberg, M., Folke, F., . . . Kragholm, K. (2021). Increased 5-year risk of stroke, atrial fibrillation, acute coronary syndrome, and heart failure in out- of-hospital cardiac arrest survivors compared with population controls: A nationwide registry-based study. RESUSCITATION, 169, 53-59. doi:10.1016/j.resuscitation.2021.10.024
Increased risk of ischemic stroke and systemic embolism in hyperthyroidism-related atrial fibrillation: A nationwide cohort study
Kim, K., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -H., Uhm, J. -S., . . . Joung, B. (2021). Increased risk of ischemic stroke and systemic embolism in hyperthyroidism-related atrial fibrillation: A nationwide cohort study. AMERICAN HEART JOURNAL, 242, 123-131. doi:10.1016/j.ahj.2021.08.018
Newly diagnosed atrial fibrillation and hospital utilization in heart failure: a nationwide cohort study
Vinter, N., Cordsen, P., Lip, G. Y. H., Benjamin, E. J., Trinquart, L., Johnsen, S. P., & Frost, L. (2021). Newly diagnosed atrial fibrillation and hospital utilization in heart failure: a nationwide cohort study. ESC HEART FAILURE, 8(6), 4808-4819. doi:10.1002/ehf2.13668
Photoplethysmography-Based Machine Learning Approaches for Atrial Fibrillation Prediction: A Report From the Huawei Heart Study.
Guo, Y., Wang, H., Zhang, H., Liu, T., Li, L., Liu, L., . . . Lip, G. Y. H. (2021). Photoplethysmography-Based Machine Learning Approaches for Atrial Fibrillation Prediction: A Report From the Huawei Heart Study.. JACC. Asia, 1(3), 399-408. doi:10.1016/j.jacasi.2021.09.004
The Effects of Implementing a Mobile Health-Technology Supported Pathway on Atrial Fibrillation-Related Adverse Events Among Patients With Multimorbidity The mAFA-II Randomized Clinical Trial
Yao, Y., Guo, Y., & Lip, G. Y. H. (2021). The Effects of Implementing a Mobile Health-Technology Supported Pathway on Atrial Fibrillation-Related Adverse Events Among Patients With Multimorbidity The mAFA-II Randomized Clinical Trial. JAMA NETWORK OPEN, 4(12). doi:10.1001/jamanetworkopen.2021.40071
Use of novel antithrombotic agents for COVID-19: Systematic summary of ongoing randomized controlled trials
Talasaz, A. H., Sadeghipour, P., Aghakouchakzadeh, M., Kakavand, H., Ariannejad, H., Connors, J. M., . . . Bikdeli, B. (2021). Use of novel antithrombotic agents for COVID-19: Systematic summary of ongoing randomized controlled trials. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 19(12), 3080-3089. doi:10.1111/jth.15533
The Differences in the Prevalence of Cardiovascular Disease, Its Risk Factors, and Achievement of Therapeutic Goals among Urban and Rural Primary Care Patients in Poland: Results from the LIPIDOGRAM 2015 Study
Studzinski, K., Tomasik, T., Windak, A., Banach, M., Wojtowicz, E., Mastej, M., . . . Jozwiak, J. J. (2021). The Differences in the Prevalence of Cardiovascular Disease, Its Risk Factors, and Achievement of Therapeutic Goals among Urban and Rural Primary Care Patients in Poland: Results from the LIPIDOGRAM 2015 Study. JOURNAL OF CLINICAL MEDICINE, 10(23). doi:10.3390/jcm10235656
Atrial High-Rate Episode Duration Thresholds and Thromboembolic Risk: A Systematic Review and Meta-Analysis
Sagris, D., Georgiopoulos, G., Pateras, K., Perlepe, K., Korompoki, E., Milionis, H., . . . Ntaios, G. (2021). Atrial High-Rate Episode Duration Thresholds and Thromboembolic Risk: A Systematic Review and Meta-Analysis. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 10(22). doi:10.1161/JAHA.121.022487
Atrial fibrillation and cognitive decline: it takes more than an irregular heart beat, to beat the brain
Sagris, D., & Lip, G. Y. H. (2021). Atrial fibrillation and cognitive decline: it takes more than an irregular heart beat, to beat the brain. AGE AND AGEING, 50(6), 1891-1893. doi:10.1093/ageing/afab158
Revisiting the diagnosis of 'resistant hypertension': what should we do nowadays'
Alsharari, R., Shantsila, E., Lip, G. Y. H., & Shantsila, A. (2021). Revisiting the diagnosis of 'resistant hypertension': what should we do nowadays'. JOURNAL OF HUMAN HYPERTENSION. doi:10.1038/s41371-021-00631-3
Biomarkers for Atrial Fibrillation Detection After Stroke Systematic Review and Meta-analysis
Cameron, A., Cheng, H. K., Lee, R. -P., Doherty, D., Hall, M., Khashayar, P., . . . Dawson, J. (2021). Biomarkers for Atrial Fibrillation Detection After Stroke Systematic Review and Meta-analysis. NEUROLOGY, 97(18), E1775-E1789. doi:10.1212/WNL.0000000000012769
Antithrombotic therapy in chronic liver disease: to clot or not to clot
Calvert, P., Gupta, D., & Lip, G. Y. H. (2021). Antithrombotic therapy in chronic liver disease: to clot or not to clot. LANCET REGIONAL HEALTH-EUROPE, 10. doi:10.1016/j.lanepe.2021.100226
Atrial fibrillation in the presence of chronic kidney disease: To ablation or not to ablate
Ding, W. Y., Gupta, D., Wong, C. F., & Lip, G. Y. H. (2021). Atrial fibrillation in the presence of chronic kidney disease: To ablation or not to ablate. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 75(11). doi:10.1111/ijcp.14723
Beyond atrial fibrillation detection: how digital tools impact the care of patients with atrial fibrillation
Guo, Y., & Lip, G. Y. H. (2021). Beyond atrial fibrillation detection: how digital tools impact the care of patients with atrial fibrillation. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 93, 117-118. doi:10.1016/j.ejim.2021.08.026
COVID-19 and ischemic stroke
Sagris, D., Papanikolaou, A., Kvernland, A., Korompoki, E., Frontera, J. A., Troxel, A. B., . . . Ntaios, G. (2021). COVID-19 and ischemic stroke. EUROPEAN JOURNAL OF NEUROLOGY, 28(11), 3826-3836. doi:10.1111/ene.15008
Comparing Warfarin and 4 Direct Oral Anticoagulants for the Risk of Dementia in Patients With Atrial Fibrillation
Lee, S. -R., Choi, E. -K., Park, S. -H., Jung, J. -H., Han, K. -D., Oh, S., & Lip, G. Y. H. (2021). Comparing Warfarin and 4 Direct Oral Anticoagulants for the Risk of Dementia in Patients With Atrial Fibrillation. STROKE, 52(11), 3459-3468. doi:10.1161/STROKEAHA.120.033338
Contemporary management of patients with atrial fibrillation in the Netherlands and Belgium: a report from the EORP-AF long-term general registry
Erkuner, O., van Eck, M., Xhaet, O., Verheij, H., Neefs, J., Duygun, A., . . . Mairesse, G. H. (2021). Contemporary management of patients with atrial fibrillation in the Netherlands and Belgium: a report from the EORP-AF long-term general registry. NETHERLANDS HEART JOURNAL, 29(11), 584-594. doi:10.1007/s12471-021-01634-y
Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non-Asian Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis
Escobar, C., Barrios, V., Lip, G. Y. H., Amin, A. N., Auladell-Rispau, A., Santero, M., . . . Requeijo, C. (2021). Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non-Asian Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis. CLINICAL DRUG INVESTIGATION, 41(11), 941-953. doi:10.1007/s40261-021-01091-w
Glucose-lowering drug use and new-onset atrial fibrillation in patients with diabetes mellitus
Fauchier, G., Bisson, A., Bodin, A., Herbert, J., Angoulvant, D., Ducluzeau, P. H., . . . Fauchier, L. (2021). Glucose-lowering drug use and new-onset atrial fibrillation in patients with diabetes mellitus. DIABETOLOGIA, 64(11), 2602-2605. doi:10.1007/s00125-021-05551-y
Metabolically healthy obesity and cardiovascular events: A nationwide cohort study
Fauchier, G., Bisson, A., Bodin, A., Herbert, J., Semaan, C., Angoulvant, D., . . . Fauchier, L. (2021). Metabolically healthy obesity and cardiovascular events: A nationwide cohort study. DIABETES OBESITY & METABOLISM, 23(11), 2492-2501. doi:10.1111/dom.14492
Response to Comment on Choi et al. Alcohol Abstinence and the Risk of Atrial Fibrillation in Patients With Newly Diagnosed Type 2 Diabetes Mellitus: a Nationwide Population-Based Study. Diabetes Care 2021;44:1393-1401.
Choi, Y. -J., Han, K. -D., Lee, S. -R., Choi, E. -K., Oh, S., & Lip, G. Y. H. (2021). Response to Comment on Choi et al. Alcohol Abstinence and the Risk of Atrial Fibrillation in Patients With Newly Diagnosed Type 2 Diabetes Mellitus: a Nationwide Population-Based Study. Diabetes Care 2021;44:1393-1401.. Diabetes care, 44(11), e199. doi:10.2337/dci21-0039
Review new concepts in pharmacotherapy for peripheral arterial disease
Kotalczyk, A., Vallabhaneni, S. R., & Lip, G. Y. H. (2021). Review new concepts in pharmacotherapy for peripheral arterial disease. CURRENT OPINION IN CARDIOLOGY, 36(6), 720-726. doi:10.1097/HCO.0000000000000883
Risk stratification of cardiac arrhythmias and sudden cardiac death in type 2 diabetes mellitus patients receiving insulin therapy: A population-based cohort study
Lee, S., Jeevaratnam, K., Liu, T., Chang, D., Chang, C., Wong, W. T., . . . Tse, G. (2021). Risk stratification of cardiac arrhythmias and sudden cardiac death in type 2 diabetes mellitus patients receiving insulin therapy: A population-based cohort study. CLINICAL CARDIOLOGY, 44(11), 1602-1612. doi:10.1002/clc.23728
Towards nationally curated data archives for clinical radiology image analysis at scale: Learnings from national data collection in response to a pandemic
Cushnan, D., Berka, R., Bertolli, O., Williams, P., Schofield, D., Joshi, I., . . . Collaborative, N. C. C. I. D. (2021). Towards nationally curated data archives for clinical radiology image analysis at scale: Learnings from national data collection in response to a pandemic. DIGITAL HEALTH, 7. doi:10.1177/20552076211048654
Quantitative Study of Photoelectric Laser Stimulation for Logic State Imaging in Embedded SRAM
Chef, S., Chua, C. T., Tay, J. Y., & Gan, C. L. (2021). Quantitative Study of Photoelectric Laser Stimulation for Logic State Imaging in Embedded SRAM. In International Symposium for Testing and Failure Analysis Vol. 84215 (pp. 154-162). ASM International. doi:10.31399/asm.cp.istfa2021p0154
Targeted atrial fibrillation detection in COVID-19 vaccination clinics
Ford, G. A., Hargroves, D., Lowe, D., Hicks, N., Lip, G. Y. H., Rooney, G., & Oatley, H. (2021). Targeted atrial fibrillation detection in COVID-19 vaccination clinics. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 7(6), 526-528. doi:10.1093/ehjqcco/qcab061
Predicting Mortality in Patients with Atrial Fibrillation and Obstructive Chronic Coronary Syndrome: The Bialystok Coronary Project
Kuzma, L., Tomaszuk-Kazberuk, A., Kurasz, A., Dobrzycki, S., Kozinski, M., Sobkowicz, B., & Lip, G. Y. H. (2021). Predicting Mortality in Patients with Atrial Fibrillation and Obstructive Chronic Coronary Syndrome: The Bialystok Coronary Project. JOURNAL OF CLINICAL MEDICINE, 10(21). doi:10.3390/jcm10214949
Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., . . . Watkins, C. L. (2021). Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.. European heart journal, 42(40), 4194. doi:10.1093/eurheartj/ehab648
Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry
Proietti, M., Vitolo, M., Harrison, S. L., Lane, D. A., Fauchier, L., Marin, F., . . . Lip, G. Y. H. (2021). Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry. BMC MEDICINE, 19(1). doi:10.1186/s12916-021-02120-3
Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19<i> JACC</i> State-of-the-Art Review
Talasaz, A. H., Sadeghipour, P., Aghakouchakzadeh, M., Dreyfus, I., Kakavand, H., Ariannejad, H., . . . Bikdeli, B. (2021). Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19<i> JACC</i> State-of-the-Art Review. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 78(16), 1635-1654. doi:10.1016/j.jacc.2021.08.021
Are low doses of non-vitamin K antagonists effective in Chinese patients with atrial fibrillation? A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry
Kotalczyk, A., Guo, Y., Wang, Y., & Lip, G. Y. H. (2022). Are low doses of non-vitamin K antagonists effective in Chinese patients with atrial fibrillation? A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry. INTERNATIONAL JOURNAL OF STROKE, 17(8), 848-854. doi:10.1177/17474930211053140
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
Anker, S. D., Butler, J., Filippatos, G., Ferreira, J. P., Bocchi, E., Böhm, M., . . . EMPEROR-Preserved Trial Investigators. (2021). Empagliflozin in Heart Failure with a Preserved Ejection Fraction.. The New England journal of medicine, 385(16), 1451-1461. doi:10.1056/nejmoa2107038
Low-dose rivaroxaban plus aspirin for elderly patients with symptomatic peripheral artery disease: is it worth the bleeding risk?
Zhang, J., Vallabhaneni, S. R., & Lip, G. Y. H. (2021). Low-dose rivaroxaban plus aspirin for elderly patients with symptomatic peripheral artery disease: is it worth the bleeding risk?. EUROPEAN HEART JOURNAL, 42(39), 4049-4052. doi:10.1093/eurheartj/ehab602
Prospective randomised trial examining the impact of an educational intervention versus usual care on anticoagulation therapy control based on an SAMe-TT<sub>2</sub>R<sub>2</sub> score-guided strategy in anticoagulant-naive Thai patients with atrial fibrillation (TREATS-AF): a study protocol
Phrommintikul, A., Nathisuwan, S., Gunaparn, S., Krittayaphong, R., Wongcharoen, W., Sehmi, S., . . . Lip, G. Y. H. (2021). Prospective randomised trial examining the impact of an educational intervention versus usual care on anticoagulation therapy control based on an SAMe-TT<sub>2</sub>R<sub>2</sub> score-guided strategy in anticoagulant-naive Thai patients with atrial fibrillation (TREATS-AF): a study protocol. BMJ OPEN, 11(10). doi:10.1136/bmjopen-2021-051987
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
Steffel, J., Collins, R., Antz, M., Cornu, P., Desteghe, L., Haeusler, K. G., . . . Field, M. (2021). 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. EUROPACE, 23(10), 1612-1676. doi:10.1093/europace/euab065
The Atrial Fibrillation Better Care pathway for managing atrial fibrillation: a review
Stevens, D., Harrison, S. L., Kolamunnage-Dona, R., Lip, G. Y. H., & Lane, D. A. (2021). The Atrial Fibrillation Better Care pathway for managing atrial fibrillation: a review. EUROPACE, 23(10), 1511-1527. doi:10.1093/europace/euab092
Aortovascular medicine: what is it?
Field, M. L., Kuduvalli, M., Torella, F., & Lip, G. Y. H. (2021). Aortovascular medicine: what is it?. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 114(10), 467-469. doi:10.1177/01410768211013436
Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis
Imberti, J. F., Ding, W. Y., Kotalczyk, A., Zhang, J., Boriani, G., Lip, G., . . . Gupta, D. (2021). Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis. HEART, 107(20), 1630-1636. doi:10.1136/heartjnl-2021-319496
Chemotherapy-Induced Arrhythmia - Underrecognized and Undertreated
Essa, H., Wright, D. J., Dobson, R., & Lip, G. Y. H. (2021). Chemotherapy-Induced Arrhythmia - Underrecognized and Undertreated. AMERICAN JOURNAL OF MEDICINE, 134(10), 1224-+. doi:10.1016/j.amjmed.2021.05.026
Clinical Outcomes in Atrial Fibrillation Patients With a History of Cancer Treated With Non-Vitamin K Antagonist Oral Anticoagulants A Nationwide Cohort Study
Chan, Y. -H., Chao, T. -F., Lee, H. -F., Chen, S. -W., Li, P. -R., Liu, J. -R., . . . Lip, G. Y. H. (2021). Clinical Outcomes in Atrial Fibrillation Patients With a History of Cancer Treated With Non-Vitamin K Antagonist Oral Anticoagulants A Nationwide Cohort Study. STROKE, 52(10), 3132-3141. doi:10.1161/STROKEAHA.120.033470
Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis
Vitolo, M., Imberti, J. F., Maisano, A., Albini, A., Bonini, N., Valenti, A. C., . . . Boriani, G. (2021). Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 92, 100-106. doi:10.1016/j.ejim.2021.05.038
Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis
See, L. -C., Lee, H. -F., Chao, T. -F., Li, P. -R., Liu, J. -R., Wu, L. -S., . . . Lip, G. Y. H. (2021). Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis. CARDIOVASCULAR DRUGS AND THERAPY, 35(5), 975-986. doi:10.1007/s10557-020-07108-4
Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage in the UK: a randomised, open-label, assessor-masked, pilot-phase, non-inferiority trial.
SoSTART Collaboration. (2021). Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage in the UK: a randomised, open-label, assessor-masked, pilot-phase, non-inferiority trial.. The Lancet. Neurology, 20(10), 842-853. doi:10.1016/s1474-4422(21)00264-7
Exploring the influence of rural residence on uptake of organized cancer screening - A systematic review of international literature.
Walji, L. T., Murchie, P., Lip, G., Speirs, V., & Iversen, L. (2021). Exploring the influence of rural residence on uptake of organized cancer screening - A systematic review of international literature.. Cancer epidemiology, 74, 101995. doi:10.1016/j.canep.2021.101995
Feasibility of a high-PRotein Mediterranean-style diet and resistance Exercise in cardiac Rehabilitation patients with sarcopenic obesity (PRiMER): Study protocol for a randomised control trial.
McCullough, D., Kirwan, R., Butler, T., Perez de Heredia, F., Thijssen, D., Lip, G. Y. H., . . . Davies, I. G. (2021). Feasibility of a high-PRotein Mediterranean-style diet and resistance Exercise in cardiac Rehabilitation patients with sarcopenic obesity (PRiMER): Study protocol for a randomised control trial.. Clinical nutrition ESPEN, 45, 492-498. doi:10.1016/j.clnesp.2021.08.001
Impact of abdominal obesity on outcomes of catheter ablation in Korean patients with atrial fibrillation
Ding, W. Y., Yang, P. -S., Jang, E., Gupta, D., Sung, J. -H., Joung, B., & Lip, G. Y. H. (2021). Impact of abdominal obesity on outcomes of catheter ablation in Korean patients with atrial fibrillation. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. doi:10.1111/ijcp.14696
Mortality associated with the use of non-vitamin K antagonist oral anticoagulants in cancer patients: Dabigatran versus rivaroxaban
Lin, Y. -S., Kuan, F. -C., Chao, T. -F., Wu, M., Chen, S. -W., Chen, M. -C., . . . Wu, V. C. -C. (2021). Mortality associated with the use of non-vitamin K antagonist oral anticoagulants in cancer patients: Dabigatran versus rivaroxaban. CANCER MEDICINE, 10(20), 7079-7088. doi:10.1002/cam4.4241
One-year Follow-up Results of the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry
Guo, Y., Wang, H., Kotalczyk, A., Wang, Y., & Lip, G. Y. H. (2021). One-year Follow-up Results of the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry. JOURNAL OF ARRHYTHMIA, 37(5), 1227-1239. doi:10.1002/joa3.12608
Outcome of Femoral-popliteal Bypass Procedures in Different Ethnic Groups in England: A Retrospective Analysis of Hospital Episode Statistics
Vitalis, A., Shantsila, A., Kay, M., Vohra, R. K., & Lip, G. Y. H. (2021). Outcome of Femoral-popliteal Bypass Procedures in Different Ethnic Groups in England: A Retrospective Analysis of Hospital Episode Statistics. ANNALS OF VASCULAR SURGERY, 76, 351-356. doi:10.1016/j.avsg.2021.04.018
Relationship between multimorbidity and outcomes in atrial fibrillation
Proietti, M., Esteve-Pastor, M. A., Rivera-Caravaca, J. M., Roldan, V., Rabadan, I. R., Muniz, J., . . . Marin, F. (2021). Relationship between multimorbidity and outcomes in atrial fibrillation. EXPERIMENTAL GERONTOLOGY, 153. doi:10.1016/j.exger.2021.111482
Photoplethysmography rhythm interpretation: an essential skill in an era of novel technologies.
Gue, Y. X., El-Bouri, W. K., & Lip, G. Y. H. (2021). Photoplethysmography rhythm interpretation: an essential skill in an era of novel technologies.. European heart journal. Digital health, 2(3), 361-362. doi:10.1093/ehjdh/ztab068
Secondary Stroke Prevention in Polish Adults: Results from the LIPIDOGRAM2015 Study
Labuz-Roszak, B., Banach, M., Skrzypek, M., Windak, A., Tomasik, T., Mastej, M., . . . Jozwiak, J. J. (2021). Secondary Stroke Prevention in Polish Adults: Results from the LIPIDOGRAM2015 Study. JOURNAL OF CLINICAL MEDICINE, 10(19). doi:10.3390/jcm10194472
How effective is pharmacotherapy for stroke and what more is needed? A focus on atrial fibrillation
Kotalczyk, A., Potpara, T. S., & Lip, G. Y. H. (2021). How effective is pharmacotherapy for stroke and what more is needed? A focus on atrial fibrillation. EXPERT OPINION ON PHARMACOTHERAPY, 22(14), 1807-1810. doi:10.1080/14656566.2021.1921738
Effectiveness and safety of oral anticoagulants among non-valvular atrial fibrillation patients with polypharmacy
Lip, G. Y. H., Keshishian, A., Kang, A., Dhamane, A. D., Luo, X., Klem, C., . . . Deitelzweig, S. (2021). Effectiveness and safety of oral anticoagulants among non-valvular atrial fibrillation patients with polypharmacy. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 7(5), 405-414. doi:10.1093/ehjcvp/pvaa117
Off-label underdosed apixaban use in Asian patients with non-valvular atrial fibrillation
Lee, S. -R., Choi, E. -K., Park, S. -H., Jung, J. -H., Han, K. -D., Oh, S., & Lip, G. Y. H. (2021). Off-label underdosed apixaban use in Asian patients with non-valvular atrial fibrillation. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 7(5), 415-423. doi:10.1093/ehjcvp/pvab004
Risk of Atrial Fibrillation in Young Adults With Isolated Diastolic, Isolated Systolic, and Systolic-Diastolic Hypertension
Lee, S. -R., Han, K. -D., Choi, E. -K., Ahn, H. -J., Oh, S., & Lip, G. Y. H. (2021). Risk of Atrial Fibrillation in Young Adults With Isolated Diastolic, Isolated Systolic, and Systolic-Diastolic Hypertension. HYPERTENSION, 78(5), 1248-1258. doi:10.1161/HYPERTENSIONAHA.121.17399
Procedural complications in patients undergoing catheter ablation for atrial fibrillation: let's talk about sex
Imberti, J. F., Boriani, G., Gupta, D., & Lip, G. Y. H. (2021). Procedural complications in patients undergoing catheter ablation for atrial fibrillation: let's talk about sex. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 7(5), 427-428. doi:10.1093/ehjqcco/qcab046
Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients
Romiti, G. F., Corica, B., Pipitone, E., Vitolo, M., Raparelli, V., Basili, S., . . . Group, A. F. -C. O. M. E. T. I. C. (2021). Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients. EUROPEAN HEART JOURNAL, 42(35), 3541-+. doi:10.1093/eurheartj/ehab453
Left Atrial Appendage Morphology Impacts Thrombus Formation Risks in Multi-Physics Atrial Models
Qureshi, A., Balmus, M., Nechipurenko, D., Ataullakhanov, F., Williams, S., Lip, G., . . . de Vecchi, A. (2021). Left Atrial Appendage Morphology Impacts Thrombus Formation Risks in Multi-Physics Atrial Models. In 2021 Computing in Cardiology (CinC) (pp. 1-4). IEEE. doi:10.23919/cinc53138.2021.9662901
Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID-19 patients
Buckley, B., Harrison, S., Fazio-Eynullayeva, E., Underhill, P., Lane, D., & Lip, G. (2021). Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID-19 patients. European Journal of Clinical Investigation.
Characteristics and clinical outcomes in atrial fibrillation patients classified using cluster analysis: the Fushimi AF Registry
Ogawa, H., An, Y., Nishi, H., Fukuda, S., Ishigami, K., Ikeda, S., . . . Akao, M. (2021). Characteristics and clinical outcomes in atrial fibrillation patients classified using cluster analysis: the Fushimi AF Registry. EUROPACE, 23(9), 1369-1379. doi:10.1093/europace/euab079
Association Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism
Bikdeli, B., Jimenez, D., del Toro, J., Piazza, G., Rivas, A., Fernandez-Reyes, J. L., . . . Monreal, M. (2021). Association Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 10(17). doi:10.1161/JAHA.121.021467
High resolution front-side visualization of charge stored in EEPROM with scanning nonlinear dielectric microscopy (SNDM).
Zeng, X. M., Liu, Q., Tay, J. Y., Chew, K. Y., Cheah, J., & Gan, C. L. (2021). High resolution front-side visualization of charge stored in EEPROM with scanning nonlinear dielectric microscopy (SNDM).. Nanotechnology, 32(48). doi:10.1088/1361-6528/ac1ebd
Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases
Rivera-Caravaca, J. M., Harrison, S. L., Buckley, B. J. R., Fazio-Eynullayeva, E., Underhill, P., Marin, F., & Lip, G. Y. H. (2021). Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases. CARDIOVASCULAR DIABETOLOGY, 20(1). doi:10.1186/s12933-021-01368-6
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis (vol 20, 100, 2021)
Li, H. -L., Lip, G. Y. H., Feng, Q., Fei, Y., Tse, Y. -K., Wu, M. -Z., . . . Yiu, K. -H. (2021). Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis (vol 20, 100, 2021). CARDIOVASCULAR DIABETOLOGY, 20(1). doi:10.1186/s12933-021-01371-x
Comparing Outcomes in Asymptomatic and Symptomatic Atrial Fibrillation: A Systematic Review and Meta-Analysis of 81,462 Patients
Sgreccia, D., Manicardi, M., Malavasi, V. L., Vitolo, M., Valenti, A. C., Proietti, M., . . . Boriani, G. (2021). Comparing Outcomes in Asymptomatic and Symptomatic Atrial Fibrillation: A Systematic Review and Meta-Analysis of 81,462 Patients. JOURNAL OF CLINICAL MEDICINE, 10(17). doi:10.3390/jcm10173979
The Prognosis of Baseline Mitral Regurgitation in Patients with Transcatheter Aortic Valve Implantation
Zhang, J., Bisson, A., Boumhidi, J., Herbert, J., Saint Etienne, C., Bernard, A., . . . Fauchier, L. (2021). The Prognosis of Baseline Mitral Regurgitation in Patients with Transcatheter Aortic Valve Implantation. JOURNAL OF CLINICAL MEDICINE, 10(17). doi:10.3390/jcm10173974
Age-Dependent Anticoagulant Therapy for Atrial Fibrillation Patients with Intermediate Risk of Ischemic Stroke: A Nationwide Population-Based Study
Choi, S. Y., Kim, M. H., Lee, K. M., Cho, Y. -R., Park, J. S., Yun, S. -C., & Lip, G. Y. H. (2021). Age-Dependent Anticoagulant Therapy for Atrial Fibrillation Patients with Intermediate Risk of Ischemic Stroke: A Nationwide Population-Based Study. THROMBOSIS AND HAEMOSTASIS, 121(09), 1151-1160. doi:10.1055/a-1336-0476
Clinical outcomes with digoxin vs. beta-blocker for heart rate control in permanent atrial fibrillation with heart failure
Bisson, A., Ding, W. Y., Bodin, A., Lip, G. Y. H., & Fauchier, L. (2021). Clinical outcomes with digoxin vs. beta-blocker for heart rate control in permanent atrial fibrillation with heart failure. EUROPEAN JOURNAL OF HEART FAILURE, 23(9), 1563-1565. doi:10.1002/ejhf.2292
Comparison among random forest, logistic regression, and existing clinical risk scores for predicting outcomes in patients with atrial fibrillation: A report from the J-RHYTHM registry
Watanabe, E., Noyama, S., Kiyono, K., Inoue, H., Atarashi, H., Okumura, K., . . . Origasa, H. (2021). Comparison among random forest, logistic regression, and existing clinical risk scores for predicting outcomes in patients with atrial fibrillation: A report from the J-RHYTHM registry. CLINICAL CARDIOLOGY, 44(9), 1305-1315. doi:10.1002/clc.23688
Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes
Rivera-Caravaca, J. M., Buckley, B. J. R., Harrison, S. L., Fazio-Eynullayeva, E., Underhill, P., Marin, F., & Lip, G. Y. H. (2021). Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes. THROMBOSIS RESEARCH, 205, 1-7. doi:10.1016/j.thromres.2021.06.014
Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients With Active Cancer
Deitelzweig, S., V. Keshishian, A., Zhang, Y., Kang, A., Dhamane, A. D., Luo, X., . . . Lip, G. Y. H. (2021). Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients With Active Cancer. JACC: CARDIOONCOLOGY, 3(3), 411-424. doi:10.1016/j.jaccao.2021.06.004
Improvements in the modulus and strength of multi-dimensional hybrid composites through synergistic reinforcement between 1D fiber and 0D particle fillers
Markandan, K., Kanaujia, P. K., Abhineet, J. P., Yap, X. Y., Gan, C. L., & Lai, C. Q. (2021). Improvements in the modulus and strength of multi-dimensional hybrid composites through synergistic reinforcement between 1D fiber and 0D particle fillers. Journal of Materials Science, 56(27), 15162-15179. doi:10.1007/s10853-021-06277-3
Incident atrial fibrillation and its risk prediction in patients developing COVID-19: A machine learning based algorithm approach
Lip, G. Y. H., Genaidy, A., Tran, G., Marroquin, P., & Estes, C. (2021). Incident atrial fibrillation and its risk prediction in patients developing COVID-19: A machine learning based algorithm approach. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 91, 53-58. doi:10.1016/j.ejim.2021.04.023
Low bleeding and thromboembolic risk with continued dabigatran during cardiovascular interventions: the GLORIA-AF study
van der Wall, S. J., Lip, G. Y. H., Teutsch, C., Kalejs, O., Lyrer, P., Hall, C., . . . Huisman, M. V. (2021). Low bleeding and thromboembolic risk with continued dabigatran during cardiovascular interventions: the GLORIA-AF study. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 91, 75-80. doi:10.1016/j.ejim.2021.05.020
Screening participants' attitudes to the introduction of artificial intelligence in breast screening.
de Vries, C. F., Morrissey, B. E., Duggan, D., Staff, R. T., & Lip, G. (2021). Screening participants' attitudes to the introduction of artificial intelligence in breast screening.. Journal of medical screening, 28(3), 221-222. doi:10.1177/09691413211001405
Association of proteinuria and incident atrial fibrillation in patients with diabetes mellitus: a population-based senior cohort study (vol 11, 17013, 2021)
Kim, J., Yang, P. -S., Park, B. -E., Kang, T. S., Lim, S. -H., Cho, S., . . . Joung, B. (2021). Association of proteinuria and incident atrial fibrillation in patients with diabetes mellitus: a population-based senior cohort study (vol 11, 17013, 2021). SCIENTIFIC REPORTS, 11(1). doi:10.1038/s41598-021-97510-1
Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the randomised RE-DUAL PCI trial
Zeymer, U., Leiva, O., Hohnloser, S. H., Steg, P. G., Oldgren, J., Nickenig, G., . . . Cannon, C. P. (2021). Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the randomised RE-DUAL PCI trial. EUROINTERVENTION, 17(6), 474-+. doi:10.4244/EIJ-D-20-00799
Continuous infusion versus bolus injection of loop diuretics for congestive heart failure
Zhang, J., Zhou, C., Ihsan, M., Tsangarides, A., Ahmed, S., Fernando, R., . . . Sankaranarayanan, R. (2021). Continuous infusion versus bolus injection of loop diuretics for congestive heart failure. The Cochrane database of systematic reviews, 2021(8).
Effect of Training on Peak Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction
Buckley, B. J. R., Lip, G. Y. H., & Thijssen, D. H. J. (2021). Effect of Training on Peak Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 326(8), 770-771. doi:10.1001/jama.2021.10055
Association of proteinuria and incident atrial fibrillation in patients with diabetes mellitus: a population-based senior cohort study
Kim, J., Yang, P. -S., Park, B. -E., Kang, T. S., Lim, S. -H., Cho, S., . . . Joung, B. (2021). Association of proteinuria and incident atrial fibrillation in patients with diabetes mellitus: a population-based senior cohort study. SCIENTIFIC REPORTS, 11(1). doi:10.1038/s41598-021-96483-5
INTERASPIRE: an International Survey of Coronary Patients; Their Cardiometabolic, Renal and Biomarker Status; and the Quality of Preventive Care Delivered in All WHO Regions In Partnership with the World Heart Federation, European Society of Cardiology, Asia Pacific Society of Cardiology, InterAmerican Society of Cardiology, and PanAfrican Society of Cardiology.
McEvoy, J. W., Jennings, C., Kotseva, K., De Backer, G., De Bacquer, D., Erlund, I., . . . Wood, D. A. (2021). INTERASPIRE: an International Survey of Coronary Patients; Their Cardiometabolic, Renal and Biomarker Status; and the Quality of Preventive Care Delivered in All WHO Regions In Partnership with the World Heart Federation, European Society of Cardiology, Asia Pacific Society of Cardiology, InterAmerican Society of Cardiology, and PanAfrican Society of Cardiology.. CURRENT CARDIOLOGY REPORTS, 23(10). doi:10.1007/s11886-021-01568-2
Association Between Change in Metabolic Syndrome Status and Risk of Incident Atrial Fibrillation: A Nationwide Population-Based Study
Lee, S. -Y., Lee, S. -R., Choi, E. -K., Kwon, S., Yang, S., Park, J., . . . Lip, G. Y. H. (2021). Association Between Change in Metabolic Syndrome Status and Risk of Incident Atrial Fibrillation: A Nationwide Population-Based Study. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 10(16). doi:10.1161/JAHA.121.020901
Associations of Hepatosteatosis With Cardiovascular Disease in HIV-Positive and HIV-Negative Patients: The Liverpool HIV-Heart Project
Heseltine, T., Murray, S., Ortega-Martorell, S., Olier, I., Lip, G. Y. H., & Khoo, S. (2021). Associations of Hepatosteatosis With Cardiovascular Disease in HIV-Positive and HIV-Negative Patients: The Liverpool HIV-Heart Project. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 87(5), 1221-1227. doi:10.1097/QAI.0000000000002721
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.
Schwartz, G. G., Szarek, M., Bittner, V. A., Diaz, R., Goodman, S. G., Jukema, J. W., . . . ODYSSEY Outcomes Committees and Investigators. (2021). Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.. Journal of the American College of Cardiology, 78(5), 421-433. doi:10.1016/j.jacc.2021.04.102
Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal Bleeding
Lip, G. Y. H., Keshishian, A. V., Zhang, Y., Kang, A., Dhamane, A. D., Luo, X., . . . Deitelzweig, S. (2021). Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal Bleeding. JAMA NETWORK OPEN, 4(8). doi:10.1001/jamanetworkopen.2021.20064
A greater burden of atrial fibrillation is associated with worse endothelial dysfunction in hypertension
Khan, A. A., Junejo, R. T., Alsharari, R., Thomas, G. N., Fisher, J. P., & Lip, G. Y. H. (n.d.). A greater burden of atrial fibrillation is associated with worse endothelial dysfunction in hypertension. Journal of Human Hypertension. doi:10.1038/s41371-020-0383-8
Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality
Violi, F., Ceccarelli, G., Cangemi, R., Cipollone, F., D'Ardes, D., Oliva, A., . . . Mastroianni, C. M. (2021). Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality. INTERNAL AND EMERGENCY MEDICINE, 16(5), 1231-1237. doi:10.1007/s11739-020-02621-8
Atrial Fibrillation in Patients with Chronic Kidney Disease
Kotalczyk, A., Ding, W. Y., Wong, C. F., Rao, A., Gupta, D., & Lip, G. Y. H. (2021). Atrial Fibrillation in Patients with Chronic Kidney Disease. CARDIOLOGY CLINICS, 39(3), 435-446. doi:10.1016/j.ccl.2021.04.005
Atrial fibrillation pattern and factors affecting the progression to permanent atrial fibrillation
Malavasi, V. L., Fantecchi, E., Tordoni, V., Melara, L., Barbieri, A., Vitolo, M., . . . Boriani, G. (2021). Atrial fibrillation pattern and factors affecting the progression to permanent atrial fibrillation. INTERNAL AND EMERGENCY MEDICINE, 16(5), 1131-1140. doi:10.1007/s11739-020-02551-5
Changes in anticoagulant prescription patterns over time for patients with atrial fibrillation around the world.
Kozieł, M., Teutsch, C., Bayer, V., Lu, S., Gurusamy, V. K., Halperin, J. L., . . . GLORIA‐AF Investigators. (2021). Changes in anticoagulant prescription patterns over time for patients with atrial fibrillation around the world.. Journal of arrhythmia, 37(4), 990-1006. doi:10.1002/joa3.12588
Clinical prediction of genotypes in hypertrophic cardiomyopathy: A systematic review
Aziz, A., Musiol, S. K., Moody, W. E., Pickup, L., Cooper, R., & Lip, G. Y. H. (2021). Clinical prediction of genotypes in hypertrophic cardiomyopathy: A systematic review. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 51(8). doi:10.1111/eci.13593
Comparative effectiveness and safety of direct acting oral anticoagulants in nonvalvular atrial fibrillation for stroke prevention: a systematic review and meta-analysis
Zhang, J., Wang, X., Liu, X., Larsen, T. B., Witt, D. M., Ye, Z., . . . Lip, G. Y. H. (2021). Comparative effectiveness and safety of direct acting oral anticoagulants in nonvalvular atrial fibrillation for stroke prevention: a systematic review and meta-analysis. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 36(8), 793-812. doi:10.1007/s10654-021-00751-7
Disparities in atrial fibrillation: a call for holistic care.
Kotalczyk, A., & Lip, G. Y. H. (2021). Disparities in atrial fibrillation: a call for holistic care.. The Lancet regional health. Europe, 7, 100160. doi:10.1016/j.lanepe.2021.100160
Heart Failure With Sinus Rhythm: Does Anticoagulation Reduce Stroke at All?
Zhang, J., Shantsila, E., & Lip, G. Y. H. (2021). Heart Failure With Sinus Rhythm: Does Anticoagulation Reduce Stroke at All?. JOURNAL OF CARDIAC FAILURE, 27(8), 865-868. doi:10.1016/j.cardfail.2021.03.008
Impalpable Breast Cancer and Service Delivery During the COVID-19 Pandemic – the Role of Radiofrequency Tag localization
Strickland, J., Elsberger, B., Lip, G., Fuller, M., & Masannat, Y. (n.d.). Impalpable Breast Cancer and Service Delivery During the COVID-19 Pandemic – the Role of Radiofrequency Tag localization. Archives of Breast Cancer, 247-250. doi:10.32768/abc.202183247-250
Importance of attributes and willingness to pay for oral anticoagulant therapy in patients with atrial fibrillation in China: A discrete choice experiment
Zhao, J., Wang, H., Li, X., Hu, Y., Yan, V. K. C., Wong, C. K. H., . . . Chan, E. W. (2021). Importance of attributes and willingness to pay for oral anticoagulant therapy in patients with atrial fibrillation in China: A discrete choice experiment. PLOS MEDICINE, 18(8). doi:10.1371/journal.pmed.1003730
Machine Learning for Time-Resolved Emission: Image Resolution Enhancement
Chef, S., Chua, C. T., & Gan, C. L. (2021). Machine Learning for Time-Resolved Emission: Image Resolution Enhancement. EDFA Technical Articles, 23(3), 24-31. doi:10.31399/asm.edfa.2021-3.p024
Revisiting the dynamic risk profile of cardiovascular/non-cardiovascular multimorbidity in incident atrial fibrillation patients and five cardiovascular/non-cardiovascular outcomes: A machine-learning approach.
Lip, G. Y. H., Tran, G., Genaidy, A., Marroquin, P., & Estes, C. (2021). Revisiting the dynamic risk profile of cardiovascular/non-cardiovascular multimorbidity in incident atrial fibrillation patients and five cardiovascular/non-cardiovascular outcomes: A machine-learning approach.. Journal of arrhythmia, 37(4), 931-941. doi:10.1002/joa3.12555
SARS-CoV-2 Vaccine and Thrombosis: An Expert Consensus on Vaccine-Induced Immune Thrombotic Thrombocytopenia.
Elalamy, I., Gerotziafas, G., Alamowitch, S., Laroche, J. -P., Van Dreden, P., Ageno, W., . . . Scientific Reviewer Committee. (2021). SARS-CoV-2 Vaccine and Thrombosis: An Expert Consensus on Vaccine-Induced Immune Thrombotic Thrombocytopenia.. Thrombosis and haemostasis, 121(8), 982-991. doi:10.1055/a-1499-0119
Stroke and Thromboembolism in Warfarin-Treated Patients with Atrial Fibrillation: Comparing the CHA <sub>2</sub> DS <sub>2</sub> -VASc and GARFIELD-AF Risk Scores
Proietti, M., Rivera-Caravaca, J. M., Asuncion Esteve-Pastor, M., Marin, F., & Lip, G. Y. H. (2021). Stroke and Thromboembolism in Warfarin-Treated Patients with Atrial Fibrillation: Comparing the CHA <sub>2</sub> DS <sub>2</sub> -VASc and GARFIELD-AF Risk Scores. THROMBOSIS AND HAEMOSTASIS, 121(08), 1107-1114. doi:10.1055/a-1333-4448
The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper.
Gerotziafas, G. T., Catalano, M., Theodorou, Y., Dreden, P. V., Marechal, V., Spyropoulos, A. C., . . . Scientific Reviewer Committee. (2021). The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper.. Thrombosis and haemostasis, 121(8), 992-1007. doi:10.1055/a-1535-8807
Updating a simple clinical score predicting incident atrial fibrillation: The C<sub>2</sub>HEST score or more (mC<sub>2</sub>HEST)?
Imberti, J. F., Boriani, G., & Lip, G. Y. H. (2021). Updating a simple clinical score predicting incident atrial fibrillation: The C<sub>2</sub>HEST score or more (mC<sub>2</sub>HEST)?. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 90, 27-29. doi:10.1016/j.ejim.2021.06.014
The Role of Acceptance and Commitment Therapy in Cardiovascular and Diabetes Healthcare: A Scoping Review
Rashidi, A., Whitehead, L., Newson, L., Astin, F., Gill, P., Lane, D. A., . . . Jones, I. D. (2021). The Role of Acceptance and Commitment Therapy in Cardiovascular and Diabetes Healthcare: A Scoping Review. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 18(15). doi:10.3390/ijerph18158126
Fusion of Higher Order Spectra and Texture Extraction Methods for Automated Stroke Severity Classification with MRI Images
Faust, O., Koh, J. E. W., Jahmunah, V., Sabut, S., Ciaccio, E. J., Majid, A., . . . Acharya, U. R. (2021). Fusion of Higher Order Spectra and Texture Extraction Methods for Automated Stroke Severity Classification with MRI Images. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 18(15). doi:10.3390/ijerph18158059
Prediction of Residual Stroke Risk in Anticoagulated Patients with Atrial Fibrillation: mCARS
Ding, W. Y., Rivera-Caravaca, J. M., Marin, F., Torp-Pedersen, C., Roldan, V., & Lip, G. Y. H. (2021). Prediction of Residual Stroke Risk in Anticoagulated Patients with Atrial Fibrillation: mCARS. JOURNAL OF CLINICAL MEDICINE, 10(15). doi:10.3390/jcm10153357
Next-generation Packaging Enabled by an Engineered Copper Nanomaterial
Stoltenberg, R. M., Capanzana, A., Vega, A., Ngo, N., Joven, R., Zhenggang, L., . . . Zinn, A. A. (2021). Next-generation Packaging Enabled by an Engineered Copper Nanomaterial. In 2021 IEEE 21st International Conference on Nanotechnology (NANO) (pp. 295-298). IEEE. doi:10.1109/nano51122.2021.9514346
Clinical Phenotype Classification of Atrial Fibrillation Patients Using Cluster Analysis and Associations with Trial-Adjudicated Outcomes
Vitolo, M., Proietti, M., Shantsila, A., Boriani, G., & Lip, G. Y. H. (2021). Clinical Phenotype Classification of Atrial Fibrillation Patients Using Cluster Analysis and Associations with Trial-Adjudicated Outcomes. BIOMEDICINES, 9(7). doi:10.3390/biomedicines9070843
'Rise of the machines': the next frontier in individualized medicine.
El-Bouri, W. K., Gue, Y., & Lip, G. Y. H. (2021). 'Rise of the machines': the next frontier in individualized medicine.. Cardiovascular research. doi:10.1093/cvr/cvab220
Exercise and the Risk of Dementia in Patients with Newly Diagnosed Atrial Fibrillation: A Nationwide Population-Based Study
Lim, J., Lee, S. -R., Choi, E. -K., Han, K. -D., Jung, J. -H., Ahn, H. -J., . . . Lip, G. Y. H. (2021). Exercise and the Risk of Dementia in Patients with Newly Diagnosed Atrial Fibrillation: A Nationwide Population-Based Study. JOURNAL OF CLINICAL MEDICINE, 10(14). doi:10.3390/jcm10143126
A new index to predict quality of anticoagulation control in patients on vitamin K antagonists: the DAFNE score.
Barrios, V., Escobar, C., Prieto, L., Polo, J., Muñiz, J., Anguita, M., & H Lip, G. Y. (2021). A new index to predict quality of anticoagulation control in patients on vitamin K antagonists: the DAFNE score.. Future cardiology, 17(4), 685-692. doi:10.2217/fca-2020-0122
A randomized prospective multicenter trial for stroke prevention by prophylactic surgical closure of the left atrial appendage in patients undergoing bioprosthetic aortic valve surgery--LAA-CLOSURE trial protocol
Kiviniemi, T., Bustamante-Munguira, J., Olsson, C., Jeppsson, A., Halfwerk, F. R., Hartikainen, J., . . . van Putte, B. (2021). A randomized prospective multicenter trial for stroke prevention by prophylactic surgical closure of the left atrial appendage in patients undergoing bioprosthetic aortic valve surgery--LAA-CLOSURE trial protocol. AMERICAN HEART JOURNAL, 237, 127-134. doi:10.1016/j.ahj.2021.03.014
Bleeding complications in patients with gastrointestinal cancer and atrial fibrillation treated with oral anticoagulants
Ording, A. G., Sogaard, M., Skjoth, F., Grove, E. L., Lip, G. Y. H., Larsen, T. B., & Nielsen, P. B. (2021). Bleeding complications in patients with gastrointestinal cancer and atrial fibrillation treated with oral anticoagulants. CANCER MEDICINE, 10(13), 4405-4414. doi:10.1002/cam4.4012
Central and peripheral arterial diseases in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Johansen, K. L., Garimella, P. S., Hicks, C. W., Kalra, P. A., Kelly, D. M., Martens, S., . . . Conference Participants. (2021). Central and peripheral arterial diseases in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.. In Kidney international Vol. 100 (pp. 35-48). doi:10.1016/j.kint.2021.04.029
Chronic Kidney Disease and Cerebrovascular Disease Consensus and Guidance From a KDIGO Controversies Conference
Kelly, D. M., Ademi, Z., Doehner, W., Lip, G. Y. H., Mark, P., Toyoda, K., . . . Sood, M. M. (2021). Chronic Kidney Disease and Cerebrovascular Disease Consensus and Guidance From a KDIGO Controversies Conference. STROKE, 52(7), E328-E346. doi:10.1161/STROKEAHA.120.029680
Ferritinophagy and ferroptosis in the management of metabolic diseases
Ajoolabady, A., Aslkhodapasandhokmabad, H., Libby, P., Tuomeilehto, J., Lip, G. Y. H., Penninger, J. M., . . . Ren, J. (2021). Ferritinophagy and ferroptosis in the management of metabolic diseases. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 32(7), 444-462. doi:10.1016/j.tem.2021.04.010
Frailty and cognitive impairment are not reasons to withhold anticoagulation in people with atrial fibrillation but screening could guide management
Harrison, S. L., Akpan, A., & Lip, G. Y. H. (2021). Frailty and cognitive impairment are not reasons to withhold anticoagulation in people with atrial fibrillation but screening could guide management. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 69(7), 1807-1810. doi:10.1111/jgs.17142
Response to a letter by Jolobe: ARISTOPHANES subgroup analysis of frail and older patients with NVAF receiving low doses of novel oral anticoagulants
Lip, G. Y. H., & Deitelzweig, S. B. (2021). Response to a letter by Jolobe: ARISTOPHANES subgroup analysis of frail and older patients with NVAF receiving low doses of novel oral anticoagulants. JOURNAL OF INTERNAL MEDICINE, 290(1), 221-222. doi:10.1111/joim.13296
The 2020 ESC Guidelines on the Diagnosis and Management of Atrial Fibrillation.
Kotalczyk, A., Lip, G. Y., & Calkins, H. (2021). The 2020 ESC Guidelines on the Diagnosis and Management of Atrial Fibrillation.. Arrhythmia & electrophysiology review, 10(2), 65-67. doi:10.15420/aer.2021.07
The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE-DUAL PCI subgroup analysis and comparison to other dual antithrombotic therapy trials)
Eccleston, D. S., Kim, J. M., ten Berg, J. M., Steg, P. G., Bhatt, D. L., Hohnloser, S. H., . . . Cannon, C. P. (2021). The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE-DUAL PCI subgroup analysis and comparison to other dual antithrombotic therapy trials). CLINICAL CARDIOLOGY, 44(7), 1002-1010. doi:10.1002/clc.23649
Acute Dental Periapical Abscess and New-Onset Atrial Fibrillation: A Nationwide, Population-Based Cohort Study
Hassan, A. O., Lip, G. Y. H., Bisson, A., Herbert, J., Bodin, A., Fauchier, L., & Harris, R. V. (2021). Acute Dental Periapical Abscess and New-Onset Atrial Fibrillation: A Nationwide, Population-Based Cohort Study. JOURNAL OF CLINICAL MEDICINE, 10(13). doi:10.3390/jcm10132927
Atrial fibrillation occurring initially during acute medical illness: the heterogeneous nature of disease, outcomes and management strategies
Li, Y. -G., Borgi, M., & Lip, G. Y. H. (2021). Atrial fibrillation occurring initially during acute medical illness: the heterogeneous nature of disease, outcomes and management strategies. EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 10(5), 567-569. doi:10.1177/2048872618801763
Relationship between diabetes mellitus and atrial fibrillation prevalence in the Polish population: a report from the Non-invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) prospective cross-sectional observational study
Gumprecht, J., Lip, G. Y. H., Sokal, A., Sredniawa, B., Mitrega, K., Stokwiszewski, J., . . . Kalarus, Z. (2021). Relationship between diabetes mellitus and atrial fibrillation prevalence in the Polish population: a report from the Non-invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) prospective cross-sectional observational study. CARDIOVASCULAR DIABETOLOGY, 20(1). doi:10.1186/s12933-021-01318-2
Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies
Awad, K., Mohammed, M., Zaki, M. M., Abushouk, A. I., Lip, G. Y. H., Blaha, M. J., . . . Banach, M. (2021). Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies. BMC MEDICINE, 19(1). doi:10.1186/s12916-021-02009-1
Challenges and opportunities in improving the management of atrial fibrillation: recent research advances and their clinical translation
Nattel, S., Lip, G. Y. H., Filgueiras-Rama, D., & Dobrev, D. (2021). Challenges and opportunities in improving the management of atrial fibrillation: recent research advances and their clinical translation. CARDIOVASCULAR RESEARCH, 117(7), 1609-1611. doi:10.1093/cvr/cvab170
How machine learning is impacting research in atrial fibrillation: implications for risk prediction and future management
Olier, I., Ortega-Martorell, S., Pieroni, M., & Lip, G. Y. H. (2021). How machine learning is impacting research in atrial fibrillation: implications for risk prediction and future management. CARDIOVASCULAR RESEARCH, 117(7), 1700-1717. doi:10.1093/cvr/cvab169
Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atria fibrillation severity, risk and outcomes
Boriani, G., Vitolo, M., Diemberger, I., Proietti, M., Valenti, A. C., Malavasi, V. L., & Lip, G. Y. H. (2021). Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atria fibrillation severity, risk and outcomes. CARDIOVASCULAR RESEARCH, 117(7), 1-21. doi:10.1093/cvr/cvab147
Quality indicators in the management of atrial fibrillation: the BALKAN-AF survey
Koziel, M., Mihajlovic, M., Nedeljkovic, M., Pavlovic, N., Paparisto, V., Music, L., . . . Potpara, T. S. (2021). Quality indicators in the management of atrial fibrillation: the BALKAN-AF survey. INTERNATIONAL JOURNAL OF CARDIOLOGY, 333, 105-109. doi:10.1016/j.ijcard.2021.02.041
Thromboembolism, mortality, and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: A nationwide cohort study
Pastori, D., Marang, A., Bisson, A., Menichelli, D., Herbert, J., Lip, G. Y. H., & Fauchier, L. (2021). Thromboembolism, mortality, and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: A nationwide cohort study. CANCER, 127(12), 2122-2129. doi:10.1002/cncr.33470
Associations of hypertension burden on subsequent dementia: a population-based cohort study
Jung, H., Yang, P. -S., Kim, D., Jang, E., Yu, H. T., Kim, T. -H., . . . Joung, B. (2021). Associations of hypertension burden on subsequent dementia: a population-based cohort study. SCIENTIFIC REPORTS, 11(1). doi:10.1038/s41598-021-91923-8
Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews
Harrison, S., Buckley, B., Rivera-Caravaca, J. M., Zhang, J., & Lip, G. (2021). Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews. European Heart Journal - Quality of Care and Clinical Outcomes. doi:10.1093/ehjqcco/qcab029
Prediction of thromboembolic events and mortality by the CHADS<sub>2</sub> and the CHA<sub>2</sub>DS<sub>2</sub>-VASc in COVID-19
Caro-Codon, J., Lip, G. Y. H., Rey, J. R., Iniesta, A. M., Rosillo, S. O., Castrejon-Castrejon, S., . . . Merino, J. L. (2021). Prediction of thromboembolic events and mortality by the CHADS<sub>2</sub> and the CHA<sub>2</sub>DS<sub>2</sub>-VASc in COVID-19. EUROPACE, 23(6), 937-947. doi:10.1093/europace/euab015
Should we make the risk stratification process more complex in patients with atrial fibrillation?
Miguel Rivera-Caravaca, J., Nielsen, P. B., & Lip, G. Y. H. (2021). Should we make the risk stratification process more complex in patients with atrial fibrillation?. EUROPACE, 23(6), 978. doi:10.1093/europace/euab007
Prevalence and Impact of Atrial Fibrillation in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis
Romiti, G. F., Corica, B., Lip, G. Y. H., & Proietti, M. (2021). Prevalence and Impact of Atrial Fibrillation in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis. JOURNAL OF CLINICAL MEDICINE, 10(11). doi:10.3390/jcm10112490
Alcohol Abstinence and the Risk of Atrial Fibrillation in Patients With Newly Diagnosed Type 2 Diabetes Mellitus: A Nationwide Population-Based Study
Choi, Y. -J., Han, K. -D., Choi, E. -K., Jung, J. -H., Lee, S. -R., Oh, S., & Lip, G. Y. H. (2021). Alcohol Abstinence and the Risk of Atrial Fibrillation in Patients With Newly Diagnosed Type 2 Diabetes Mellitus: A Nationwide Population-Based Study. DIABETES CARE, 44(6), 1393-1401. doi:10.2337/dc20-2607
Antithrombotic treatment pattern in newly diagnosed atrial fibrillation patients and 2-year follow-up results for dabigatran-treated patients in the Africa/Middle-East Region: Phase II results from the GLORIA-AF registry program.
Azar, R. R., Ragy, H. I., Kozan, O., El Khuri, M., Bazergani, N., Marler, S., . . . Huisman, M. V. (2021). Antithrombotic treatment pattern in newly diagnosed atrial fibrillation patients and 2-year follow-up results for dabigatran-treated patients in the Africa/Middle-East Region: Phase II results from the GLORIA-AF registry program.. International journal of cardiology. Heart & vasculature, 34, 100763. doi:10.1016/j.ijcha.2021.100763
Association between exercise habits and stroke, heart failure, and mortality in Korean patients with incident atrial fibrillation: A nationwide population-based cohort study
Ahn, H. -J., Lee, S. -R., Choi, E. -K., Han, K. -D., Jung, J. -H., Lim, J. -H., . . . Lip, G. Y. H. (2021). Association between exercise habits and stroke, heart failure, and mortality in Korean patients with incident atrial fibrillation: A nationwide population-based cohort study. PLOS MEDICINE, 18(6). doi:10.1371/journal.pmed.1003659
Hypertension and atrial fibrillation: Closing a virtuous circle
Gue, Y. X., & Lip, G. Y. H. (2021). Hypertension and atrial fibrillation: Closing a virtuous circle. PLOS MEDICINE, 18(6). doi:10.1371/journal.pmed.1003598
Improving the diagnosis of heart failure in patients with atrial fibrillation
Bunting, K. V., Gill, S. K., Sitch, A., Mehta, S., O'Connor, K., Lip, G. Y. H., . . . Kotecha, D. (2021). Improving the diagnosis of heart failure in patients with atrial fibrillation. HEART, 107(11), 902-908. doi:10.1136/heartjnl-2020-318557
Integrated care and outcomes in patients with atrial fibrillation and comorbidities
Proietti, M., Vitolo, M., & Lip, G. Y. H. (2021). Integrated care and outcomes in patients with atrial fibrillation and comorbidities. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 51(6). doi:10.1111/eci.13498
Oral anticoagulants in extremely-high-risk, very elderly (>90 years) patients with atrial fibrillation
Chao, T. -F., Chiang, C. -E., Chan, Y. -H., Liao, J. -N., Chen, T. -J., Lip, G. Y. H., & Chen, S. -A. (2021). Oral anticoagulants in extremely-high-risk, very elderly (>90 years) patients with atrial fibrillation. In HEART RHYTHM Vol. 18 (pp. 871-877). doi:10.1016/j.hrthm.2021.02.018
Restart TICrH: An Adaptive Randomized Trial of Time Intervals to Restart Direct Oral Anticoagulants after Traumatic Intracranial Hemorrhage
Milling, T. J. J., Warach, S., Johnston, S. C., Gajewski, B., Costantini, T., Price, M., . . . Lip, G. Y. H. (2021). Restart TICrH: An Adaptive Randomized Trial of Time Intervals to Restart Direct Oral Anticoagulants after Traumatic Intracranial Hemorrhage. JOURNAL OF NEUROTRAUMA, 38(13), 1791-1798. doi:10.1089/neu.2020.7535
Symptom management strategies: Rhythm vs rate control in patients with atrial fibrillation in the Balkan region: Data from the BALKAN-AF survey
Koziel, M., Mihajlovic, M., Nedeljkovic, M., Pavlovic, N., Paparisto, V., Music, L., . . . Potpara, T. S. (2021). Symptom management strategies: Rhythm vs rate control in patients with atrial fibrillation in the Balkan region: Data from the BALKAN-AF survey. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 75(6). doi:10.1111/ijcp.14080
Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity
Deitelzweig, S., Keshishian, A., Kang, A., Dhamane, A. D., Luo, X., Klem, C., . . . Lip, G. Y. H. (2021). Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity. ADVANCES IN THERAPY, 38(6), 3166-3184. doi:10.1007/s12325-021-01724-8
Socioeconomic inequality in oral anticoagulation therapy initiation in patients with atrial fibrillation with high risk of stroke: a register-based observational study
Lunde, E. D., Joensen, A. M., Fonager, K., Lundbye-Christensen, S., Johnsen, S. P., Larsen, M. L., . . . Riahi, S. (2021). Socioeconomic inequality in oral anticoagulation therapy initiation in patients with atrial fibrillation with high risk of stroke: a register-based observational study. BMJ OPEN, 11(5). doi:10.1136/bmjopen-2021-048839
Cryoablation as Initial Therapy for Atrial Fibrillation
Proietti, R., Vio, R., & Lip, G. Y. H. (2021). Cryoablation as Initial Therapy for Atrial Fibrillation. NEW ENGLAND JOURNAL OF MEDICINE, 384(21). doi:10.1056/NEJMc2103408
Predicting Silent Atrial Fibrillation in the Elderly: A Report from the NOMED-AF Cross-Sectional Study
Mitrega, K., Lip, G. Y. H., Sredniawa, B., Sokal, A., Streb, W., Przyludzki, K., . . . Kalarus, Z. (2021). Predicting Silent Atrial Fibrillation in the Elderly: A Report from the NOMED-AF Cross-Sectional Study. JOURNAL OF CLINICAL MEDICINE, 10(11). doi:10.3390/jcm10112321
Understanding the global burden of atrial fibrillation and regional variations: we need improvement
Vitolo, M., & Lip, G. Y. H. (2021). Understanding the global burden of atrial fibrillation and regional variations: we need improvement. CARDIOVASCULAR RESEARCH, 117(6), 1420-1422. doi:10.1093/cvr/cvaa330
Current trends in the use of anticoagulant pharmacotherapy in the United Kingdom are changes on the horizon?
Kotalczyk, A., Gue, Y. X., Potpara, T. S., & Lip, G. Y. H. (2021). Current trends in the use of anticoagulant pharmacotherapy in the United Kingdom are changes on the horizon?. EXPERT OPINION ON PHARMACOTHERAPY, 22(8), 1061-1070. doi:10.1080/14656566.2021.1879050
Smoking Cessation after Diagnosis of New-Onset Atrial Fibrillation and the Risk of Stroke and Death
Lee, S. -R., Choi, E. -K., Jung, J. -H., Han, K. -D., Oh, S., & Lip, G. Y. H. (2021). Smoking Cessation after Diagnosis of New-Onset Atrial Fibrillation and the Risk of Stroke and Death. JOURNAL OF CLINICAL MEDICINE, 10(11). doi:10.3390/jcm10112238
Anticoagulation versus placebo for heart failure in sinus rhythm
Shantsila, E., Koziel, M., & Lip, G. Y. H. (2021). Anticoagulation versus placebo for heart failure in sinus rhythm. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (5). doi:10.1002/14651858.CD003336.pub4
Disparities in atrial fibrillation management: Is race to blame?
Olshansky, B., & Lip, G. Y. H. (2021). Disparities in atrial fibrillation management: Is race to blame?. INTERNATIONAL JOURNAL OF CARDIOLOGY, 331, 118-119. doi:10.1016/j.ijcard.2021.01.020
Cardiac rehabilitation and all-cause mortality in patients with heart failure: A retrospective cohort study
Buckley, B., Harrison, S., Fazio-Eynullayeva, E., Underhill, P., Sankaranarayanan, R., Wright, D., . . . Lip, G. (2021). Cardiac rehabilitation and all-cause mortality in patients with heart failure: A retrospective cohort study. European Journal of Preventive Cardiology. doi:10.1093/eurjpc/zwab061.328
Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation: nationwide cohort study
Kim, D., Yang, P. -S., You, S. C., Sung, J. -H., Jang, E., Yu, H. T., . . . Joung, B. (2021). Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation: nationwide cohort study. BMJ-BRITISH MEDICAL JOURNAL, 373. doi:10.1136/bmj.n991
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis
Li, H. -L., Lip, G. -Y. H., Feng, Q., Fei, Y., Tse, Y. -K., Wu, M. -Z., . . . Yiu, K. -H. (2021). Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis. CARDIOVASCULAR DIABETOLOGY, 20(1). doi:10.1186/s12933-021-01293-8
A prospective survey of atrial fibrillation management in Iran: Baseline results of the Iranian Registry of Atrial Fibrillation (IRAF)
Heidarali, M., Bakhshandeh, H., Golpira, R., Fazelifar, A., Alizadeh-Diz, A., Emkanjoo, Z., . . . Haghjoo, M. (2021). A prospective survey of atrial fibrillation management in Iran: Baseline results of the Iranian Registry of Atrial Fibrillation (IRAF). INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 75(8). doi:10.1111/ijcp.14313
Myocardial Strain Imaging in Resistant Hypertension
Alsharari, R., Oxborough, D., Lip, G. Y. H., & Shantsila, A. (2021). Myocardial Strain Imaging in Resistant Hypertension. CURRENT HYPERTENSION REPORTS, 23(5). doi:10.1007/s11906-021-01148-3
Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials.
Talasaz, A. H., Sadeghipour, P., Aghakouchakzadeh, M., Dreyfus, I., Kakavand, H., Ariannejad, H., . . . Bikdeli, B. (2021). Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials.. medRxiv. doi:10.1101/2021.05.03.21256468
Cohort profile: the ESC EURObservational Research Programme Atrial Fibrillation III (AF III) Registry
Potpara, T. S., Lip, G. Y. H., Dagres, N., Crijns, H. J. M. G., Boriani, G., Kirchhof, P., . . . Gale, C. P. (2021). Cohort profile: the ESC EURObservational Research Programme Atrial Fibrillation III (AF III) Registry. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 7(3), 229-237. doi:10.1093/ehjqcco/qcaa050
Intracerebral Hemorrhage and Exposure to Antithrombotic Drugs
Nielsen, P. B., Milling, T. J., & Lip, G. Y. H. (2021). Intracerebral Hemorrhage and Exposure to Antithrombotic Drugs. JAMA NETWORK OPEN, 4(5). doi:10.1001/jamanetworkopen.2021.9175
Alterations in atrial electrogram amplitude as steady sinus rhythm transitions to paroxysmal atrial fibrillation during continuous monitoring in patients with implantable cardiac devices: Insights from the IMPACT study
Kantharia, B. K., Lip, G. Y. H., & Martin, D. T. (2021). Alterations in atrial electrogram amplitude as steady sinus rhythm transitions to paroxysmal atrial fibrillation during continuous monitoring in patients with implantable cardiac devices: Insights from the IMPACT study. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 32(5), 1357-1363. doi:10.1111/jce.14997
Assessment of endogenous fibrinolysis in clinical practice using novel tests: ready for clinical roll-out?
Gue, Y. X., Ding, W. Y., Lip, G. Y. H., & Gorog, D. A. (2021). Assessment of endogenous fibrinolysis in clinical practice using novel tests: ready for clinical roll-out?. SN APPLIED SCIENCES, 3(5). doi:10.1007/s42452-021-04517-4
Associations between COVID-19 and 30-day thromboembolic events and mortality in people with dementia receiving antipsychotic medications
Harrison, S. L., Buckley, B. J. R., Lane, D. A., Underhill, P., & Lip, G. Y. H. (2021). Associations between COVID-19 and 30-day thromboembolic events and mortality in people with dementia receiving antipsychotic medications. PHARMACOLOGICAL RESEARCH, 167. doi:10.1016/j.phrs.2021.105534
Atrial fibrillation and cardiac arrhythmia associated with acute dental infection: A systematic literature review and case report
Hassan, A., Lip, G. Y. H., & Harris, R. V. (2021). Atrial fibrillation and cardiac arrhythmia associated with acute dental infection: A systematic literature review and case report. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 75(5). doi:10.1111/ijcp.13875
Clinical Practice Guide Guide ESC 2020 on the diagnosis and treatment of atrial fibrillation, developed in collaboration with the <i>European Association for Cardio-Thoracic Surgery (EACTS)</i>
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomstrom-Lundqvist, C., . . . Watkins, C. L. (2021). Clinical Practice Guide Guide ESC 2020 on the diagnosis and treatment of atrial fibrillation, developed in collaboration with the <i>European Association for Cardio-Thoracic Surgery (EACTS)</i>. REVISTA ESPANOLA DE CARDIOLOGIA, 74(5). doi:10.1016/j.recesp.2020.10.022
Comments on the Pathophysiological Basis and Rationale for Early Treatment of COVID-19 Reply
Vitalis, A., Shantsila, A., & Lip, G. Y. H. (2021). Comments on the Pathophysiological Basis and Rationale for Early Treatment of COVID-19 Reply. AMERICAN JOURNAL OF MEDICINE, 134(5), E354-E355. doi:10.1016/j.amjmed.2020.11.033
Endothelial dysfunction and vascular maladaptation in atrial fibrillation
Qin, S., Boidin, M., Buckley, B. J. R., Lip, G. Y. H., & Thijssen, D. H. J. (2021). Endothelial dysfunction and vascular maladaptation in atrial fibrillation. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 51(5). doi:10.1111/eci.13477
Higher Mortality of Ischaemic Stroke Patients Hospitalized with COVID-19 Compared to Historical Controls
Harrison, S. L., Fazio-Eynullayeva, E., Lane, D. A., Underhill, P., & Lip, G. Y. H. (2021). Higher Mortality of Ischaemic Stroke Patients Hospitalized with COVID-19 Compared to Historical Controls. CEREBROVASCULAR DISEASES, 50(3), 326-331. doi:10.1159/000514137
Impact of Non-Vitamin K Antagonist Oral Anticoagulants on the Change of Antithrombotic Regimens in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
Kwon, S., Jung, J. H., Choi, E. K., Lee, S. W., Park, J., Lee, S. R., . . . Lip, G. Y. H. (2021). Impact of Non-Vitamin K Antagonist Oral Anticoagulants on the Change of Antithrombotic Regimens in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. KOREAN CIRCULATION JOURNAL, 51(5), 409-422. doi:10.4070/kcj.2020.0407
Long-term outcomes of left atrial appendage occlusion in high-risk atrial fibrillation patients: 4-year follow up data
Ding, W. Y., Lip, G. Y. H., Bartoletti, S., Morrison, L., Khalatbari, A., Aggarwal, S., . . . Gupta, D. (2021). Long-term outcomes of left atrial appendage occlusion in high-risk atrial fibrillation patients: 4-year follow up data. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 51(4), 1090-1093. doi:10.1007/s11239-020-02333-y
Predictors of ischemic stroke for low-risk patients with atrial fibrillation: A matched case-control study
Kwon, S., Kim, T. J., Choi, E. -K., Ahn, H. -J., Lee, E., Lee, S. -R., . . . Lip, G. Y. H. (2021). Predictors of ischemic stroke for low-risk patients with atrial fibrillation: A matched case-control study. HEART RHYTHM, 18(5), 702-708. doi:10.1016/j.hrthm.2021.01.016
Prevalence/incidence of atrial fibrillation based on integrated medical/pharmacy claims, and association with co-morbidity profiles/multi-morbidity in a large US adult cohort
Lip, G. Y. H., Tran, G., Genaidy, A., Marroquin, P., Estes, C., & Harrelll, T. (2021). Prevalence/incidence of atrial fibrillation based on integrated medical/pharmacy claims, and association with co-morbidity profiles/multi-morbidity in a large US adult cohort. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 75(5). doi:10.1111/ijcp.14042
Real-World Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in a Developing Country
Mitsuntisuk, P., Nathisuwan, S., Junpanichjaroen, A., Wongcharoen, W., Phrommintikul, A., Wattanaruengchai, P., . . . Lip, G. Y. H. (2021). Real-World Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in a Developing Country. CLINICAL PHARMACOLOGY & THERAPEUTICS, 109(5), 1282-1292. doi:10.1002/cpt.2090
Stroke Care during the COVID-19 Pandemic: International Expert Panel Review
Venketasubramanian, N., Anderson, C., Ay, H., Aybek, S., Brinjikji, W., de Freitas, G. R., . . . Hennerici, M. G. (2021). Stroke Care during the COVID-19 Pandemic: International Expert Panel Review. CEREBROVASCULAR DISEASES, 50(3), 245-261. doi:10.1159/000514155
The heart in hypertension
Nadar, S. K., & Lip, G. Y. H. (2021). The heart in hypertension. JOURNAL OF HUMAN HYPERTENSION, 35(5), 383-386. doi:10.1038/s41371-020-00427-x
Incident atrial fibrillation in patients with differentiated thyroid cancer: a meta-analysis
Kostopoulos, G., Doundoulakis, I., Antza, C., Bouras, E., Nirantharakumar, K., Tsiachris, D., . . . Toulis, K. A. (2021). Incident atrial fibrillation in patients with differentiated thyroid cancer: a meta-analysis. ENDOCRINE-RELATED CANCER, 28(5), 325-335. doi:10.1530/ERC-20-0496
Catheter ablation for atrial fibrillation in heart failure: untying the Gordian knot
Javed, S., Koniari, I., Fox, D., Skene, C., Lip, G. Y. H., & Gupta, D. (2021). Catheter ablation for atrial fibrillation in heart failure: untying the Gordian knot. JOURNAL OF GERIATRIC CARDIOLOGY, 18(4), 297-306. doi:10.11909/j.issn.1671-5411.2021.04.002
Sensitivity and specificity of blood-fluid levels for oral anticoagulant-associated intracerebral haemorrhage (vol 10, 15529, 2020)
Almarzouki, A., Wilson, D., Ambler, G., Shakeshaft, C., Cohen, H., Yousry, T., . . . Werring, D. J. (2021). Sensitivity and specificity of blood-fluid levels for oral anticoagulant-associated intracerebral haemorrhage (vol 10, 15529, 2020). SCIENTIFIC REPORTS, 11(1). doi:10.1038/s41598-021-88890-5
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit The INSPIRATION Randomized Clinical Trial
Sadeghipour, P., Talasaz, A. H., Rashidi, F., Sharif-Kashani, B., Beigmohammadi, M. T., Farrokhpour, M., . . . Bikdeli, B. (2021). Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit The INSPIRATION Randomized Clinical Trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 325(16), 1620-1630. doi:10.1001/jama.2021.4152
Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19
Talasaz, A. H., Sadeghipour, P., Kakavand, H., Aghakouchakzadeh, M., Kordzadeh-Kermani, E., Van Tassell, B. W., . . . Bikdeli, B. (2021). Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 77(15), 1903-1921. doi:10.1016/j.jacc.2021.02.035
Mechanical properties and failure behaviour of architected alumina microlattices fabricated by stereolithography 3D printing
Yap, X. Y., Seetoh, I., Goh, W. L., Ye, P., Zhao, Y., Du, Z., . . . Gan, C. L. (2021). Mechanical properties and failure behaviour of architected alumina microlattices fabricated by stereolithography 3D printing. International Journal of Mechanical Sciences, 196, 106285. doi:10.1016/j.ijmecsci.2021.106285
Cerebral Small Vessel Disease and Functional Outcome Prediction After Intracerebral Hemorrhage
Hostettler, I. C., Schwarz, G., Ambler, G., Wilson, D., Banerjee, G., Seiffge, D. J., . . . Werring, D. J. (2021). Cerebral Small Vessel Disease and Functional Outcome Prediction After Intracerebral Hemorrhage. NEUROLOGY, 96(15), E1954-E1965. doi:10.1212/WNL.0000000000011746
Atrial Fibrillation and Oral Health
Hassan, A., Lip, G. Y. H., Fauchier, L., & Harris, R. V. (2021). Atrial Fibrillation and Oral Health. ARRHYTHMIA & ELECTROPHYSIOLOGY REVIEW, 10(1), 7-9. doi:10.15420/aer.2021.09
Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial
Peterson, B. E., Bhatt, D. L., Steg, P. G., Oldgren, J., Maeng, M., Zeymer, U., . . . Cannon, C. P. (2021). Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial. JACC-CARDIOVASCULAR INTERVENTIONS, 14(7), 768-780. doi:10.1016/j.jcin.2021.02.022
What Cannot Be Missed: Important Publications on Electrophysiology in 2020.
Narayan, S. M., Calkins, H., Grace, A., Ellenbogen, K., Lip, G. Y., Lambiase, P. D., & Katritsis, D. G. (2021). What Cannot Be Missed: Important Publications on Electrophysiology in 2020.. Arrhythmia & electrophysiology review, 10(1), 5-6. doi:10.15420/aer.2021.02
Assessing absolute stroke risk in patients with atrial fibrillation using a risk factor-based approach
Lee, C. J. -Y., Toft-Petersen, A. P., Ozenne, B., Phelps, M., Olesen, J. B., Ellinor, P. T., . . . Gerds, T. A. (2021). Assessing absolute stroke risk in patients with atrial fibrillation using a risk factor-based approach. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 7(F11), F3-F10. doi:10.1093/ehjcvp/pvaa063
Impact of liver disease on oral anticoagulant prescription and major adverse events in patients with atrial fibrillation: analysis from a population-based cohort study
Proietti, M., Marzona, I., Vannini, T., Colacioppo, P., Tettamanti, M., Foresta, A., . . . Roncaglioni, M. C. (2021). Impact of liver disease on oral anticoagulant prescription and major adverse events in patients with atrial fibrillation: analysis from a population-based cohort study. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 7(F11), F84-F92. doi:10.1093/ehjcvp/pvaa015
Real-world safety and efficacy of direct oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of 605 771 patients
Menichelli, D., Del Sole, F., Di Rocco, A., Farcomeni, A., Vestri, A., Violi, F., . . . Pastori, D. (2021). Real-world safety and efficacy of direct oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of 605 771 patients. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 7(F11), F11-F19. doi:10.1093/ehjcvp/pvab002
The importance of adherence and persistence with oral anticoagulation treatment in patients with atrial fibrillation
Vitolo, M., Lane, D. A., Boriani, G., & Lip, G. Y. H. (2021). The importance of adherence and persistence with oral anticoagulation treatment in patients with atrial fibrillation. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 7(F11), F81-F83. doi:10.1093/ehjcvp/pvaa020
Thromboembolism and bleeding complications in anticoagulated patients with atrial fibrillation and native aortic or mitral valvular heart disease: a descriptive nationwide cohort study
Melgaard, L., Overvad, T. F., Jensen, M., Lip, G. Y. H., Larsen, T. B., & Nielsen, P. B. (2021). Thromboembolism and bleeding complications in anticoagulated patients with atrial fibrillation and native aortic or mitral valvular heart disease: a descriptive nationwide cohort study. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 7(F11), F101-F110. doi:10.1093/ehjcvp/pvaa008
Longitudinal Patterns in Antithrombotic Therapy in Patients with Atrial Fibrillation after Percutaneous Coronary Intervention in the Non-Vitamin K Oral Anticoagulant Era: A Nationwide Population-Based Study
Park, J., Jung, J. -H., Choi, E. -K., Lee, S. -W., Kwon, S., Lee, S. -R., . . . Lip, G. Y. H. (2021). Longitudinal Patterns in Antithrombotic Therapy in Patients with Atrial Fibrillation after Percutaneous Coronary Intervention in the Non-Vitamin K Oral Anticoagulant Era: A Nationwide Population-Based Study. JOURNAL OF CLINICAL MEDICINE, 10(7). doi:10.3390/jcm10071505
Clinical outcomes following rhythm control for atrial fibrillation: is early better?
Kotalczyk, A., Ding, W. Y., Gupta, D., Wright, D. J., & Lip, G. Y. H. (2021). Clinical outcomes following rhythm control for atrial fibrillation: is early better?. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 19(4), 277-287. doi:10.1080/14779072.2021.1902307
3D Printing of Transparent Spinel Ceramics with Transmittance Approaching the Theoretical Limit.
Wang, H., Liu, L. Y., Ye, P., Huang, Z., Ng, A. Y. R., Du, Z., . . . Gan, C. L. (2021). 3D Printing of Transparent Spinel Ceramics with Transmittance Approaching the Theoretical Limit.. Advanced materials (Deerfield Beach, Fla.), 33(15), e2007072. doi:10.1002/adma.202007072
Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF
Koziel, M., Teutsch, C., Halperin, J. L., Rothman, K. J., Diener, H. -C., Ma, C. -S., . . . Lip, G. Y. H. (2021). Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF. PLOS ONE, 16(4). doi:10.1371/journal.pone.0249524
Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID-19 patients: A multicenter retrospective study
Li, J. -Y., Wang, H. -F., Yin, P., Li, D., Wang, D. -L., Peng, P., . . . Lip, G. Y. H. (2021). Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID-19 patients: A multicenter retrospective study. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 19(4), 1038-1048. doi:10.1111/jth.15261
Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients
Zhu, W., Ye, Z., Chen, S., Wu, D., He, J., Dong, Y., . . . Liu, C. (2021). Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients. STROKE, 52(4), 1225-1233. doi:10.1161/STROKEAHA.120.031007
Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies
Best, J. G., Ambler, G., Wilson, D., Lee, K. -J., Lim, J. -S., Shiozawa, M., . . . Werring, D. J. (2021). Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies. LANCET NEUROLOGY, 20(4), 294-303. doi:10.1016/S1474-4422(21)00024-7
Effects of antithrombotic drugs on the prothrombotic state in patients with atrial fibrillation: The west Birmingham atrial fibrillation project
Voukalis, C., Lip, G. Y. H., & Shantsila, E. (2021). Effects of antithrombotic drugs on the prothrombotic state in patients with atrial fibrillation: The west Birmingham atrial fibrillation project. THROMBOSIS RESEARCH, 200, 149-155. doi:10.1016/j.thromres.2021.02.005
Hypertension and sleep health: a multidimensional puzzle
Shantsila, A., Shantsila, E., & Lip, G. Y. H. (2021). Hypertension and sleep health: a multidimensional puzzle. JOURNAL OF HYPERTENSION, 39(4), 600-601. doi:10.1097/HJH.0000000000002743
In patients with AF and a bioprosthetic mitral valve, rivaroxaban was noninferior to warfarin for time to clinical events
Gue, Y. X., & Lip, G. Y. H. (2021). In patients with AF and a bioprosthetic mitral valve, rivaroxaban was noninferior to warfarin for time to clinical events. ANNALS OF INTERNAL MEDICINE, 174(4), JC43. doi:10.7326/ACPJ202104200-043
Out-of-hospital cardiac arrest: A systematic review of current risk scores to predict survival
GUE, Y. X., ADATIA, K., KANJI, R., POTPARA, T., LIP, G. Y. H., & GOROG, D. A. (2021). Out-of-hospital cardiac arrest: A systematic review of current risk scores to predict survival. AMERICAN HEART JOURNAL, 234, 31-41. doi:10.1016/j.ahj.2020.12.011
Outcomes in VKA-treated patients with atrial fibrillation and chronic kidney disease: Clinical trials vs 'real-world'
Ding, W. Y., Rivera-Caravaca, J. M., Shantsila, A., Marin, F., Gupta, D., Roldan, V., & Lip, G. Y. H. (2021). Outcomes in VKA-treated patients with atrial fibrillation and chronic kidney disease: Clinical trials vs 'real-world'. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 75(4). doi:10.1111/ijcp.13888
Peripheral Arterial Disease in Patients with Atrial Fibrillation: The AFFIRM Study
Vitalis, A., Shantsila, A., Proietti, M., Vohra, R. K., Kay, M., Olshansky, B., & Lip, G. Y. H. (2021). Peripheral Arterial Disease in Patients with Atrial Fibrillation: The AFFIRM Study. AMERICAN JOURNAL OF MEDICINE, 134(4), 514-518. doi:10.1016/j.amjmed.2020.08.026
Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A report from the FANTASIIA registry
Bertomeu-Gonzalez, V., Moreno-Arribas, J., Esteve-Pastor, M. A., Roldan-Rabadan, I., Muniz, J., Otero Garcia, D., . . . Marin, F. (2021). Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A report from the FANTASIIA registry. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 51(4). doi:10.1111/eci.13431
Stroke prevention strategies in high-risk patients with atrial fibrillation
Kotalczyk, A., Mazurek, M., Kalarus, Z., Potpara, T. S., & Lip, G. Y. H. (2021). Stroke prevention strategies in high-risk patients with atrial fibrillation. NATURE REVIEWS CARDIOLOGY, 18(4), 276-290. doi:10.1038/s41569-020-00459-3
The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease
Kim, H. K., Tantry, U. S., Smith, S. C. J., Jeong, M. H., Park, S. -J., Kim, M. H., . . . Jeong, Y. -H. (2021). The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease. THROMBOSIS AND HAEMOSTASIS, 121(04), 422-432. doi:10.1055/s-0040-1718729
Treatment with direct oral anticoagulants or warfarin and the risk for incident diabetes among patients with atrial fibrillation: a population-based cohort study
Cheung, C. -L., Sing, C. -W., Lau, W. C. Y., Li, G. H. Y., Lip, G. Y. H., Tan, K. C. B., . . . Wong, I. C. K. (2021). Treatment with direct oral anticoagulants or warfarin and the risk for incident diabetes among patients with atrial fibrillation: a population-based cohort study. CARDIOVASCULAR DIABETOLOGY, 20(1). doi:10.1186/s12933-021-01263-0
Pathophysiology of atrial fibrillation and chronic kidney disease
Ding, W. Y., Gupta, D., Wong, C. F., & Lip, G. Y. H. (2021). Pathophysiology of atrial fibrillation and chronic kidney disease. CARDIOVASCULAR RESEARCH, 117(4), 1046-1059. doi:10.1093/cvr/cvaa258
Small vessel disease burden and intracerebral haemorrhage in patients taking oral anticoagulants
Seiffge, D. J., Wilson, D., Ambler, G., Banerjee, G., Hostettler, I. C., Houlden, H., . . . Werring, D. J. (2021). Small vessel disease burden and intracerebral haemorrhage in patients taking oral anticoagulants. In JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Vol. 92 (pp. 805-814). doi:10.1136/jnnp-2020-325299
Identifying At-Risk Patients for Sustained Atrial High-Rate Episodes Using the C<sub>2</sub>HEST Score: The West Birmingham Atrial Fibrillation Project
Li, Y. -G., Pastori, D., Miyazawa, K., Shahid, F., & Lip, G. Y. H. (2021). Identifying At-Risk Patients for Sustained Atrial High-Rate Episodes Using the C<sub>2</sub>HEST Score: The West Birmingham Atrial Fibrillation Project. In JOURNAL OF THE AMERICAN HEART ASSOCIATION Vol. 10. doi:10.1161/JAHA.120.017519
Drugs in phase I and II clinical development for the prevention of stroke in patients with atrial fibrillation
Bentley, R., Hardy, L. J., Scott, L. J., Sharma, P., Philippou, H., & Lip, G. Y. H. (2021). Drugs in phase I and II clinical development for the prevention of stroke in patients with atrial fibrillation. Expert Opinion on Investigational Drugs. doi:10.1080/13543784.2021.1897786
Long-term clinical outcomes after major bleeding in patients with atrial fibrillation: the Fushimi AF registry
Ogawa, H., An, Y., Ishigami, K., Ikeda, S., Doi, K., Hamatani, Y., . . . Akao, M. (2021). Long-term clinical outcomes after major bleeding in patients with atrial fibrillation: the Fushimi AF registry. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 7(2), 163-171. doi:10.1093/ehjqcco/qcaa082
Optimization of atrial fibrillation care: management strategies and quality measures
Ritchie, L. A., Lip, G. Y. H., & Lane, D. A. (2021). Optimization of atrial fibrillation care: management strategies and quality measures. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 7(2), 121-133. doi:10.1093/ehjqcco/qcaa063
Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference
Fabritz, L., Crijns, H. J. G. M., Guasch, E., Goette, A., Hausler, K. G., Kotecha, D., . . . Kirchhof, P. (2021). Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference. EUROPACE, 23(3), 329-344. doi:10.1093/europace/euaa279
Hypertension Burden and the Risk of New-Onset Atrial Fibrillation A Nationwide Population-Based Study
Lee, S. -R., Park, C. S., Choi, E. -K., Ahn, H. -J., Han, K. -D., Oh, S., & Lip, G. Y. H. (2021). Hypertension Burden and the Risk of New-Onset Atrial Fibrillation A Nationwide Population-Based Study. HYPERTENSION, 77(3), 919-928. doi:10.1161/HYPERTENSIONAHA.120.16659
Anticoagulant selection in relation to the SAMe-TT<sub>2</sub>R<sub>2</sub> score in patients with atrial fibrillation: The GLORIA-AF registry
Ntaios, G., Huisman, M. V., Diener, H. -C., Halperin, J. L., Teutsch, C., Marler, S., . . . Olshansky, B. (2021). Anticoagulant selection in relation to the SAMe-TT<sub>2</sub>R<sub>2</sub> score in patients with atrial fibrillation: The GLORIA-AF registry. HELLENIC JOURNAL OF CARDIOLOGY, 62(2), 152-157. doi:10.1016/j.hjc.2020.11.009
Atrial Fibrillation and Stroke.
Essa, H., Hill, A. M., & Lip, G. Y. H. (2021). Atrial Fibrillation and Stroke.. Cardiac electrophysiology clinics, 13(1), 243-255. doi:10.1016/j.ccep.2020.11.003
Atrial fibrillation and vascular disease: Coronary artery disease and/or peripheral artery disease?
Essa, H., & Lip, G. Y. H. (2021). Atrial fibrillation and vascular disease: Coronary artery disease and/or peripheral artery disease?. ARCHIVES OF CARDIOVASCULAR DISEASES, 114(3), 173-175. doi:10.1016/j.acvd.2021.02.002
Compliance of atrial fibrillation treatment with the ABC pathway in patients with concomitant diabetes mellitus in the Middle East based on the Gulf SAFE registry
Lip, G. (n.d.). Compliance of atrial fibrillation treatment with the ABC pathway in patients with concomitant diabetes mellitus in the Middle East based on the Gulf SAFE registry. European Journal of Clinical Investigation. doi:10.1111/eci.13385
Embolic Stroke of Undetermined Source: The Need for an Integrated and Holistic Approach to Care
Guo, Y., Zhang, J., & Lip, G. Y. H. (2021). Embolic Stroke of Undetermined Source: The Need for an Integrated and Holistic Approach to Care. THROMBOSIS AND HAEMOSTASIS, 121(03), 251-254. doi:10.1055/a-1336-0576
Epidemiology of Atrial Fibrillation: Geographic/Ecological Risk Factors, Age, Sex, Genetics.
Zhang, J., Johnsen, S. P., Guo, Y., & Lip, G. Y. H. (2021). Epidemiology of Atrial Fibrillation: Geographic/Ecological Risk Factors, Age, Sex, Genetics.. Cardiac Electrophysiology Clinics, 13(1), 1-23. doi:10.1016/j.ccep.2020.10.010
How to Manage Atrial Fibrillation Secondary to Ibrutinib
Essa, H., Lodhi, T., Dobson, R., Wright, D., & Lip, G. Y. H. (2021). How to Manage Atrial Fibrillation Secondary to Ibrutinib. JACC: CARDIOONCOLOGY, 3(1), 140-144. doi:10.1016/j.jaccao.2020.11.016
Inter-device reproducibility of transcutaneous bilirubin meters.
Dam-Vervloet, A. J., van Erk, M. D., Doorn, N., Lip, S. G. J., Timmermans, N. A., Vanwinsen, L., . . . Bosschaart, N. (2021). Inter-device reproducibility of transcutaneous bilirubin meters.. Pediatric research, 89(4), 770-775. doi:10.1038/s41390-020-01118-6
Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: A systematic review and metanalysis
Albini, A., Malavasi, V. L., Vitolo, M., Imberti, J. F., Marietta, M., Lip, G. Y. H., & Boriani, G. (2021). Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: A systematic review and metanalysis. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 85, 27-33. doi:10.1016/j.ejim.2020.12.018
Nonatrial Fibrillation Patients With Complete P Wave Disappearance An Overlooked Population With High Stroke Risk
Liu, H., Li, M., Li, C., Wang, Z., Lu, Q., Gu, Z., . . . Chen, M. (2021). Nonatrial Fibrillation Patients With Complete P Wave Disappearance An Overlooked Population With High Stroke Risk. STROKE, 52(3), 1074-1078. doi:10.1161/STROKEAHA.120.031666
Prescriber compliance to direct oral anticoagulant labels and impact on outcomes in Thailand
Wattanaruengchai, P., Nathisuwan, S., Rattanavipanon, W., Chulavatnatol, S., Kongwatcharapong, J., Mitsuntisuk, P., . . . Lip, G. Y. H. (2021). Prescriber compliance to direct oral anticoagulant labels and impact on outcomes in Thailand. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 87(3), 1390-1400. doi:10.1111/bcp.14535
Renal Disease and Atrial Fibrillation.
Stefil, M., Nabrdalik, K., & Lip, G. Y. H. (2021). Renal Disease and Atrial Fibrillation.. Cardiac electrophysiology clinics, 13(1), 95-112. doi:10.1016/j.ccep.2020.11.001
Statin use and mortality in atrial fibrillation: A systematic review and meta-analysis of 100,287 patients
Pastori, D., Baratta, F., Di Rocco, A., Farcomeni, A., Del Ben, M., Angelico, F., . . . Lip, G. Y. H. (2021). Statin use and mortality in atrial fibrillation: A systematic review and meta-analysis of 100,287 patients. PHARMACOLOGICAL RESEARCH, 165. doi:10.1016/j.phrs.2021.105418
The Atrial fibrillation Better Care (ABC) pathway and cardiac complications in atrial fibrillation: a potential sex-based difference. The ATHERO-AF study
Pastori, D., Menichelli, D., Violi, F., Pignatelli, P., & Lip, G. Y. H. (2021). The Atrial fibrillation Better Care (ABC) pathway and cardiac complications in atrial fibrillation: a potential sex-based difference. The ATHERO-AF study. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 85, 80-85. doi:10.1016/j.ejim.2020.12.011
Relationship Between Body Mass Index and Incidence of Atrial Fibrillation in Young Japanese Men -The Nishimura Health Survey-
Senoo, K., Nakata, M., Teramukai, S., Kumagai, M., Yamamoto, T., Nishimura, H., . . . Matoba, S. (2021). Relationship Between Body Mass Index and Incidence of Atrial Fibrillation in Young Japanese Men -The Nishimura Health Survey-. CIRCULATION JOURNAL, 85(3), 243-+. doi:10.1253/circj.CJ-20-0864
Pathophysiological insights into atrial fibrillation: revisiting the electrophysiological substrate, anatomical substrate, and possible insights from proteomics
Bentley, R., Logantha, S. J. R. J., Sharma, P., Rainbow, R. R., & Lip, G. Y. H. (2021). Pathophysiological insights into atrial fibrillation: revisiting the electrophysiological substrate, anatomical substrate, and possible insights from proteomics. CARDIOVASCULAR RESEARCH, 117(3), E41-E45. doi:10.1093/cvr/cvaa276
C<sub>2</sub>HEST score predicts clinical outcomes in heart failure with preserved ejection fraction: a secondary analysis of the TOPCAT trial
Liang, W., Wu, Y., Xue, R., Wu, Z., Wu, D., He, J., . . . Liu, C. (2021). C<sub>2</sub>HEST score predicts clinical outcomes in heart failure with preserved ejection fraction: a secondary analysis of the TOPCAT trial. BMC MEDICINE, 19(1). doi:10.1186/s12916-021-01921-w
Fat, Sugar or Gut Microbiota in Reducing Cardiometabolic Risk: Does Diet Type Really Matter?
Nabrdalik, K., Krzyzak, K., Hajzler, W., Drozdz, K., Kwiendacz, H., Gumprecht, J., & Lip, G. Y. H. (2021). Fat, Sugar or Gut Microbiota in Reducing Cardiometabolic Risk: Does Diet Type Really Matter?. NUTRIENTS, 13(2). doi:10.3390/nu13020639
Relation of Atrial Fibrillation to Angiographic Characteristics and Coronary Artery Disease Severity in Patients Undergoing Percutaneous Coronary Intervention
Pastori, D., Biccire, F. G., Lip, G. Y. H., Menichelli, D., Pignatelli, P., Barilla, F., . . . Tanzilli, G. (2021). Relation of Atrial Fibrillation to Angiographic Characteristics and Coronary Artery Disease Severity in Patients Undergoing Percutaneous Coronary Intervention. AMERICAN JOURNAL OF CARDIOLOGY, 141, 1-6. doi:10.1016/j.amjcard.2020.11.006
Nonalcoholic fatty liver disease and the risk of atrial fibrillation stratified by body mass index: a nationwide population-based study
Lee, S. -R., Han, K. -D., Choi, E. -K., Oh, S., & Lip, G. Y. H. (2021). Nonalcoholic fatty liver disease and the risk of atrial fibrillation stratified by body mass index: a nationwide population-based study. SCIENTIFIC REPORTS, 11(1). doi:10.1038/s41598-021-83367-x
Gut Microbiota and the Quality of Oral Anticoagulation in Vitamin K Antagonists Users: A Review of Potential Implications
Camelo-Castillo, A., Rivera-Caravaca, J. M., Orenes-Pinero, E., Ramirez-Macias, I., Roldan, V., Lip, G. Y. H., & Marin, F. (2021). Gut Microbiota and the Quality of Oral Anticoagulation in Vitamin K Antagonists Users: A Review of Potential Implications. JOURNAL OF CLINICAL MEDICINE, 10(4). doi:10.3390/jcm10040715
Association of anticoagulant therapy with risk of dementia among patients with atrial fibrillation
Kim, D., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -H., Uhm, J. -S., . . . Joung, B. (2021). Association of anticoagulant therapy with risk of dementia among patients with atrial fibrillation. EUROPACE, 23(2), 184-195. doi:10.1093/europace/euaa192
Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis fromthe ESC-EHRA EORPAtrial Fibrillation General Long-Term (AFGen LT) Registry
Proietti, M., Lip, G. Y. H., Laroche, C., Fauchier, L., Marin, F., Nabauer, M., . . . Boriani, G. (2021). Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis fromthe ESC-EHRA EORPAtrial Fibrillation General Long-Term (AFGen LT) Registry. EUROPACE, 23(2), 174-183. doi:10.1093/europace/euaa274
The interpretation of CHA<sub>2</sub>DS<sub>2</sub>-VASc score components in clinical practice: a joint survey by the European Heart Rhythm Association (EHRA) Scientific Initiatives Committee, the EHRA Young Electrophysiologists, the Association of Cardiovascular Nursing and Allied Professionals, and the European Society of Cardiology Council on Stroke
Zhang, J., Lenarczyk, R., Marin, F., Malaczynska-Rajpold, K., Kosiuk, J., Doehner, W., . . . Potpara, T. S. (2021). The interpretation of CHA<sub>2</sub>DS<sub>2</sub>-VASc score components in clinical practice: a joint survey by the European Heart Rhythm Association (EHRA) Scientific Initiatives Committee, the EHRA Young Electrophysiologists, the Association of Cardiovascular Nursing and Allied Professionals, and the European Society of Cardiology Council on Stroke. EUROPACE, 23(2), 314-322. doi:10.1093/europace/euaa358
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC (vol 42, pg 373, 2021)
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomstroem-Lundqvist, C., . . . Watkins, C. L. (2021). 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC (vol 42, pg 373, 2021). EUROPEAN HEART JOURNAL, 42(40), 4194. doi:10.1093/eurheartj/ehab648
Associations of atrial fibrillation progression with clinical risk factors and clinical prognosis: A report from the Chinese Atrial Fibrillation Registry study
Yang, W. -Y., Du, X., Fawzy, A. M., He, L., Li, H. -W., Dong, J. -Z., . . . Ma, C. -S. (2021). Associations of atrial fibrillation progression with clinical risk factors and clinical prognosis: A report from the Chinese Atrial Fibrillation Registry study. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 32(2), 333-341. doi:10.1111/jce.14826
Effect of Diabetes Mellitus and Left Ventricular Perfusion on Frequency of Development of Heart Failure and/or All-cause Mortality Late After Acute Myocardial Infarction
Tomasik, A., Nabrdalik, K., Kwiendacz, H., Radzik, E., Pigon, K., Mlynczak, T., . . . Lip, G. Y. H. (2021). Effect of Diabetes Mellitus and Left Ventricular Perfusion on Frequency of Development of Heart Failure and/or All-cause Mortality Late After Acute Myocardial Infarction. AMERICAN JOURNAL OF CARDIOLOGY, 140, 25-32. doi:10.1016/j.amjcard.2020.10.051
From the CHA<sub>2</sub>DS<sub>2</sub>-VASc score to inflammation: a path leading to frailty? An update of the PURE-Rhythm Trial
Fumagalli, S., Di Serio, C., Ricciardi, G., Lip, G. Y. H., & Marchionni, N. (2021). From the CHA<sub>2</sub>DS<sub>2</sub>-VASc score to inflammation: a path leading to frailty? An update of the PURE-Rhythm Trial. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 84, 118-120. doi:10.1016/j.ejim.2020.12.001
Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology
Boriani, G., Vitolo, M., Lane, D. A., Potpara, T. S., & Lip, G. Y. H. (2021). Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 86, 1-11. doi:10.1016/j.ejim.2021.01.006
Association of Exercise-Based Cardiac Rehabilitation with Progression of Paroxysmal to Sustained Atrial Fibrillation
Buckley, B. J. R., Harrison, S. L., Fazio-Eynullayeva, E., Underhill, P., Lane, D. A., Thijssen, D. H. J., & Lip, G. Y. H. (2021). Association of Exercise-Based Cardiac Rehabilitation with Progression of Paroxysmal to Sustained Atrial Fibrillation. JOURNAL OF CLINICAL MEDICINE, 10(3). doi:10.3390/jcm10030435
Sex, age, type of diabetes and incidence of atrial fibrillation in patients with diabetes mellitus: a nationwide analysis
Bisson, A., Bodin, A., Fauchier, G., Herbert, J., Angoulvant, D., Ducluzeau, P. H., . . . Fauchier, L. (2021). Sex, age, type of diabetes and incidence of atrial fibrillation in patients with diabetes mellitus: a nationwide analysis. CARDIOVASCULAR DIABETOLOGY, 20(1). doi:10.1186/s12933-021-01216-7
Cumulative burden of metabolic syndrome and its components on the risk of atrial fibrillation: a nationwide population-based study
Ahn, H. -J., Han, K. -D., Choi, E. -K., Jung, J. -H., Kwon, S., Lee, S. -R., . . . Lip, G. Y. H. (2021). Cumulative burden of metabolic syndrome and its components on the risk of atrial fibrillation: a nationwide population-based study. CARDIOVASCULAR DIABETOLOGY, 20(1). doi:10.1186/s12933-021-01215-8
Choices in antithrombotic management for patients with atrial fibrillation undergoing percutaneous coronary intervention: questions (and answers) in chronological sequence
Rubboli, A., Valgimigli, M., Capodanno, D., & Lip, G. Y. H. (2021). Choices in antithrombotic management for patients with atrial fibrillation undergoing percutaneous coronary intervention: questions (and answers) in chronological sequence. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 7(1), 68-73. doi:10.1093/ehjcvp/pvaa047
Effectiveness and safety of edoxaban in patients with atrial fibrillation:data from the Danish Nationwide Cohort
Nielsen, P. B., Larsen, T. B., Skjoth, F., Sogaard, M., & Lip, G. Y. H. (2021). Effectiveness and safety of edoxaban in patients with atrial fibrillation:data from the Danish Nationwide Cohort. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 7(1), 31-39. doi:10.1093/ehjcvp/pvz070
Non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation patients with concomitant peripheral artery disease
Lee, H. -F., See, L. -C., Li, P. -R., Liu, J. -R., Chao, T. -F., Chang, S. -H., . . . Lip, G. Y. H. (2021). Non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation patients with concomitant peripheral artery disease. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 7(1), 50-58. doi:10.1093/ehjcvp/pvz072
Obesity and atrial fibrillation: making inroads through fat
Javed, S., Gupta, D., & Lip, G. Y. H. (2021). Obesity and atrial fibrillation: making inroads through fat. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 7(1), 59-67. doi:10.1093/ehjcvp/pvaa013
Body Mass Index and Clinical Outcomes in Asian Patients With Atrial Fibrillation Receiving Oral Anticoagulation.
Lee, S. -R., Choi, E. -K., Jung, J. -H., Park, S. -H., Han, K. -D., Oh, S., & Lip, G. Y. H. (2021). Body Mass Index and Clinical Outcomes in Asian Patients With Atrial Fibrillation Receiving Oral Anticoagulation.. Stroke, 52(2), 521-530. doi:10.1161/strokeaha.120.030356
Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Prior Gastrointestinal Bleeding.
Kwon, S., Lee, S. -R., Choi, E. -K., Lee, E., Jung, J. -H., Han, K. -D., . . . Lip, G. Y. H. (2021). Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Prior Gastrointestinal Bleeding.. Stroke, 52(2), 511-520. doi:10.1161/strokeaha.120.030761
Antithrombotic Therapy in COVID-19: Systematic Summary of Ongoing or Completed Randomized Trials
Acute ischemic stroke management: concepts and controversies.A narrative review
Li, K. H. C., Jesuthasan, A., Kui, C., Davies, R., Tse, G., & Lip, G. Y. H. (2021). Acute ischemic stroke management: concepts and controversies.A narrative review. EXPERT REVIEW OF NEUROTHERAPEUTICS, 21(1), 65-79. doi:10.1080/14737175.2021.1836963
<i>Thrombosis and Haemostasis</i> 2020 Editors' Choice Papers
Weber, C., Rigby, A., & Lip, G. Y. H. (2021). <i>Thrombosis and Haemostasis</i> 2020 Editors' Choice Papers. THROMBOSIS AND HAEMOSTASIS, 121(01), 109-114. doi:10.1055/s-0040-1722171
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomstrӧm-Lundqvist, C., . . . Watkins, C. L. (n.d.). 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Russian Journal of Cardiology, 26(9), 4701. doi:10.15829/1560-4071-2021-4701
2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary *
Chao, T. -F., Joung, B., Takahashi, Y., Lim, T. W., Choi, E. -K., Chan, Y. -H., . . . Lip, G. Y. H. (2022). 2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary *. THROMBOSIS AND HAEMOSTASIS, 122(01), 20-47. doi:10.1055/s-0041-1739411
A Rollercoaster Plunge into 2022.
Lip, G. Y. H., Rigby, A., & Weber, C. (2022). A Rollercoaster Plunge into 2022.. Thrombosis and haemostasis, 122(1), 1-4. doi:10.1055/s-0041-1741073
Addressing the Challenge of Data Heterogeneity Using a Homogeneous Feature Vector Representation: A Study Using Time Series and Cardiovascular Disease Classification
Aldosari, H., Coenen, F., Lip, G. Y. H., & Zheng, Y. (2021). Addressing the Challenge of Data Heterogeneity Using a Homogeneous Feature Vector Representation: A Study Using Time Series and Cardiovascular Disease Classification. In ARTIFICIAL INTELLIGENCE XXXVIII Vol. 13101 (pp. 254-266). doi:10.1007/978-3-030-91100-3_21
Anticoagulation Prescription and Outcomes in Relation to Renal Function in Patients with Atrial Fibrillation: Results from GLORIA-AF.
van der Wall, S. J., Teutsch, C., Dubner, S. J., Diener, H. -C., Halperin, J. L., Ma, C. S., . . . GLORIA-AF Investigators . (2021). Anticoagulation Prescription and Outcomes in Relation to Renal Function in Patients with Atrial Fibrillation: Results from GLORIA-AF.. TH open : companion journal to thrombosis and haemostasis, 5(1), e35-e42. doi:10.1055/s-0040-1722706
Atrial Fibrillation Diagnosis using ECG Records and Self-Report in the Community: Cross-Sectional Analysis from ELSA-Brasil
Santos, I. S., Lotufo, P. A., Brant, L., Pinto, M. M., Pereira, A. D. C., Barreto, S. M., . . . Bensenor, I. M. (2021). Atrial Fibrillation Diagnosis using ECG Records and Self-Report in the Community: Cross-Sectional Analysis from ELSA-Brasil. ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 117(3), 426-434. doi:10.36660/abc.20190873
Average Systolic Blood Pressure and Clinical Outcomes in Patients with Atrial Fibrillation: Prospective Data from COOL-AF Registry
Krittayaphong, R., Pumprueg, S., Ratanasumawong, K., Sairat, P., & Lip, G. Y. H. (2021). Average Systolic Blood Pressure and Clinical Outcomes in Patients with Atrial Fibrillation: Prospective Data from COOL-AF Registry. CLINICAL INTERVENTIONS IN AGING, 16, 1835-1846. doi:10.2147/CIA.S335321
Blood pressure measurement in atrial fibrillation: goodbye mercury? (vol 29, pg 638, 2020)
Watson, T., & Lip, G. Y. H. (2021). Blood pressure measurement in atrial fibrillation: goodbye mercury? (vol 29, pg 638, 2020). JOURNAL OF HUMAN HYPERTENSION, 35(1), 107. doi:10.1038/s41371-020-0315-7
Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients
Deitelzweig, S., Keshishian, A., Kang, A., Dhamane, A. D., Luo, X., Balachander, N., . . . Lip, G. Y. H. (2021). Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 14. doi:10.1177/1756284821997352
Diabetes mellitus and atrial fibrillation—Untying the Gordian Knot
Domek, M., Javed, S., Gumprecht, J., & Lip, G. Y. H. (2021). Diabetes mellitus and atrial fibrillation—Untying the Gordian Knot. In Diabetes and Cardiovascular Disease (pp. 95-121). Elsevier. doi:10.1016/b978-0-12-817428-9.00004-8
Differential Presentations of Arterial Thromboembolic Events Between Venous Thromboembolism and Atrial Fibrillation Patients
Lin, Y. -S., Lin, M. -S., Wu, V. C. -C., Chen, Y. -L., Chang, J. -J., Chu, P. -H., . . . Chen, M. -C. (2021). Differential Presentations of Arterial Thromboembolic Events Between Venous Thromboembolism and Atrial Fibrillation Patients. FRONTIERS IN CARDIOVASCULAR MEDICINE, 8. doi:10.3389/fcvm.2021.775564
FIRST-TIME HOMEBUYERS’ INTERESTS IN USING PROPERTY CROWDFUNDING AS AN ALTERNATIVE FINANCING OPTION
Hon, C. C., Sivanathan, S., Goh, H. L., & Low, C. W. (n.d.). FIRST-TIME HOMEBUYERS’ INTERESTS IN USING PROPERTY CROWDFUNDING AS AN ALTERNATIVE FINANCING OPTION. PLANNING MALAYSIA, 19. doi:10.21837/pm.v19i17.989
Grupul de lucru pentru diagnosticul şi tratamentul fi brilaţiei atriale al societăţii europene de cardiologie (Esc)
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomstrom-Lundqvist, C., . . . Watkins, C. L. (2021). Grupul de lucru pentru diagnosticul şi tratamentul fi brilaţiei atriale al societăţii europene de cardiologie (Esc). Revista Romana de Cardiologie, 31(3), 641-791.
Heart rate variability in patients with atrial fibrillation and hypertension
Khan, A. A., Junejo, R. T., Thomas, G. N., Fisher, J. P., & Lip, G. Y. H. (2021). Heart rate variability in patients with atrial fibrillation and hypertension. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 51(1). doi:10.1111/eci.13361
Impact of multimorbidity and polypharmacy on the management of patients with atrial fibrillation: insights from the BALKAN-AF survey
Koziel, M., Simovic, S., Pavlovic, N., Kocijancic, A., Paparisto, V., Music, L., . . . Investigators, B. A. L. K. A. N. -A. F. (n.d.). Impact of multimorbidity and polypharmacy on the management of patients with atrial fibrillation: insights from the BALKAN-AF survey. ANNALS OF MEDICINE. doi:10.1080/07853890.2020.1799241
Improving Stroke Risk Prediction in the General Population: A Comparative Assessment of Common Clinical Rules, a New Multimorbid Index, and Machine-Learning-Based Algorithms
Lip, G. Y. H., Genaidy, A., Tran, G., Marroquin, P., Estes, C., & Sloop, S. (2022). Improving Stroke Risk Prediction in the General Population: A Comparative Assessment of Common Clinical Rules, a New Multimorbid Index, and Machine-Learning-Based Algorithms. THROMBOSIS AND HAEMOSTASIS, 122(01), 142-150. doi:10.1055/a-1467-2993
Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial
Bikdeli, B., Talasaz, A. H., Rashidi, F., Bakhshandeh, H., Rafiee, F., Rezaeifar, P., . . . Sadeghipour, P. (2022). Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial. THROMBOSIS AND HAEMOSTASIS, 122(01), 131-141. doi:10.1055/a-1485-2372
Looking Back on 2020, Looking Forward to 2021
Lip, G. Y. H., Rigby, A., & Weber, C. (2021). Looking Back on 2020, Looking Forward to 2021. THROMBOSIS AND HAEMOSTASIS, 121(01), 1-3. doi:10.1055/s-0040-1722198
Motif Based Feature Vectors: Towards a Homogeneous Data Representation for Cardiovascular Diseases Classification
Aldosari, H., Coenen, F., Lip, G. Y. H., & Zheng, Y. (2021). Motif Based Feature Vectors: Towards a Homogeneous Data Representation for Cardiovascular Diseases Classification. In BIG DATA ANALYTICS AND KNOWLEDGE DISCOVERY (DAWAK 2021) Vol. 12925 (pp. 235-241). doi:10.1007/978-3-030-86534-4_22
Non-Vitamin K Antagonist Oral Anticoagulants in Elderly (≥85 years) Patients With Newly Diagnosed Atrial Fibrillation: Changing Clinical Practice and Outcomes for Stroke Prevention in a Nationwide Cohort Study
Cheng, W. -H., Chiang, C. -E., Lin, Y. -J., Chang, S. -L., Lo, L. -W., Hu, Y. -F., . . . Chao, T. -F. (2021). Non-Vitamin K Antagonist Oral Anticoagulants in Elderly (≥85 years) Patients With Newly Diagnosed Atrial Fibrillation: Changing Clinical Practice and Outcomes for Stroke Prevention in a Nationwide Cohort Study. MAYO CLINIC PROCEEDINGS, 96(1), 52-65. doi:10.1016/j.mayocp.2020.08.042
Observations on clot properties in atrial fibrillation: Relation to renal function and choice of anticoagulant
Khan, A. A., Hardy, L. J., Shantsila, E., Lau, Y. C., Philippou, H., & Lip, G. Y. H. (2021). Observations on clot properties in atrial fibrillation: Relation to renal function and choice of anticoagulant. THROMBOSIS RESEARCH, 197, 69-76. doi:10.1016/j.thromres.2020.10.039
One-year clinical outcome of patients with nonvalvular atrial fibrillation: Insights from KERALA-AF registry
Bahuleyan, C. G., Namboodiri, N., Jabir, A., Lip, G. Y. H., Koshy, G., Shifas, B. M., . . . Lordson, A. J. (2021). One-year clinical outcome of patients with nonvalvular atrial fibrillation: Insights from KERALA-AF registry. INDIAN HEART JOURNAL, 73(1), 56-62. doi:10.1016/j.ihj.2020.11.152
Oral anticoagulants for nonvalvular atrial fibrillation in frail elderly patients: insights from the ARISTOPHANES study
Lip, G. Y. H., Keshishian, A. V., Kang, A. L., Dhamane, A. D., Luo, X., Li, X., . . . Deitelzweig, S. (n.d.). Oral anticoagulants for nonvalvular atrial fibrillation in frail elderly patients: insights from the ARISTOPHANES study. Journal of Internal Medicine. doi:10.1111/joim.13140
Palpitations in the Cancer Patient
Essa, H., & Lip, G. Y. H. (2021). Palpitations in the Cancer Patient. EUROPEAN CARDIOLOGY REVIEW, 16. doi:10.15420/ecr.2021.44
Small Vessel Disease and Ischemic Stroke Risk During Anticoagulation for Atrial Fibrillation After Cerebral Ischemia
Du, H., Wilson, D., Ambler, G., Banerjee, G., Shakeshaft, C., Cohen, H., . . . Werring, D. J. (2021). Small Vessel Disease and Ischemic Stroke Risk During Anticoagulation for Atrial Fibrillation After Cerebral Ischemia. STROKE, 52(1), 91-99. doi:10.1161/STROKEAHA.120.029474
Thrombosis and Haemostasis 2021 Editors' Choice Papers.
Weber, C., Rigby, A., & Lip, G. Y. H. (2022). Thrombosis and Haemostasis 2021 Editors' Choice Papers.. Thrombosis and haemostasis, 122(1), 163-170. doi:10.1055/s-0041-1741072
TransBridge: A Lightweight Transformer for Left Ventricle Segmentation in Echocardiography
Deng, K., Meng, Y., Gao, D., Bridge, J., Shen, Y., Lip, G., . . . Zheng, Y. (2021). TransBridge: A Lightweight Transformer for Left Ventricle Segmentation in Echocardiography. In SIMPLIFYING MEDICAL ULTRASOUND Vol. 12967 (pp. 63-72). doi:10.1007/978-3-030-87583-1_7
2020
Prevalence of atrial fibrillation and outcomes in older long-term care residents: a systematic review.
Ritchie, L. A., Oke, O. B., Harrison, S. L., Rodgers, S. E., Lip, G. Y. H., & Lane, D. A. (2021). Prevalence of atrial fibrillation and outcomes in older long-term care residents: a systematic review.. Age and Ageing, 50(3), 744-757. doi:10.1093/ageing/afaa268
Why Is Atrial Fibrillation So Frequent in Hypertensive Patients?
Vitolo, M., Lip, G. Y. H., & Shantsila, A. (2020). Why Is Atrial Fibrillation So Frequent in Hypertensive Patients?. AMERICAN JOURNAL OF HYPERTENSION, 33(12), 1067-1070. doi:10.1093/ajh/hpaa157
Atrial fibrillation in low- and middle-income countries: a narrative review
Santos, I. S., Goulart, A. C., Olmos, R. D., Thomas, G. N., Lip, G. Y. H., Lotufo, P. A., & Bensenor, I. M. (2020). Atrial fibrillation in low- and middle-income countries: a narrative review. EUROPEAN HEART JOURNAL SUPPLEMENTS, 22(O), 61-77. doi:10.1093/eurheartj/suaa181
Atrial fibrillation is more frequently associated with nonobstructive coronary lesions: the Bialystok Coronary Project
Tomaszuk-Kazberuk, A., Kozinski, M., Kuzma, L., Bujno, E., Lopatowska, P., Rogalska, E., . . . Lip, G. Y. H. (2020). Atrial fibrillation is more frequently associated with nonobstructive coronary lesions: the Bialystok Coronary Project. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 130(12), 1029-1036. doi:10.20452/pamw.15635
Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial
Kotecha, D., Bunting, K. V., Gill, S. K., Mehta, S., Stanbury, M., Jones, J. C., . . . Kirchhof, P. (2020). Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 324(24), 2497-2508. doi:10.1001/jama.2020.23138
Relationship between coronary artery disease and atrial fibrillation still unclear Reply
Kuzma, L., Tomaszuk-Kazberuk, A., Kozinski, M., & Lip, G. Y. H. (2020). Relationship between coronary artery disease and atrial fibrillation still unclear Reply. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 130(12), 1123. doi:10.20452/pamw.15726
Stroke and bleeding risk stratification in atrial fibrillation: a critical appraisal
Lane, D. A., & Lip, G. Y. H. (2020). Stroke and bleeding risk stratification in atrial fibrillation: a critical appraisal. EUROPEAN HEART JOURNAL SUPPLEMENTS, 22(O), 14-27. doi:10.1093/eurheartj/suaa178
What do we do about atrial high rate episodes?
Boriani, G., Vitolo, M., Imberti, J. F., Potpara, T. S., & Lip, G. Y. H. (2020). What do we do about atrial high rate episodes?. EUROPEAN HEART JOURNAL SUPPLEMENTS, 22(O), 42-52. doi:10.1093/eurheartj/suaa179
Less dementia after catheter ablation for atrial fibrillation: a nationwide cohort study
Kim, D., Yang, P. -S., Sung, J. -H., Jang, E., Yu, H. T., Kim, T. -H., . . . Joung, B. (2020). Less dementia after catheter ablation for atrial fibrillation: a nationwide cohort study. EUROPEAN HEART JOURNAL, 41(47), 4483-4493. doi:10.1093/eurheartj/ehaa726
Thromboembolic Risk in Nonanticoagulated Patients With Atrial Fibrillation and Valvular Heart Disease
Melgaard, L., Overvad, T. F., Jensen, M., Lip, G. Y. H., Larsen, T. B., & Nielsen, P. B. (2020). Thromboembolic Risk in Nonanticoagulated Patients With Atrial Fibrillation and Valvular Heart Disease. JACC-CLINICAL ELECTROPHYSIOLOGY, 6(13), 1672-1682. doi:10.1016/j.jacep.2020.07.005
Atrial fibrillation and the risk of 30-day incident thromboembolic events and mortality in adults ≥50 years with COVID-19
Harrison, S., Fazio-Eynullayeva, E., Lane, D., Underhill, P., & Lip, G. (2020). Atrial fibrillation and the risk of 30-day incident thromboembolic events and mortality in adults ≥50 years with COVID-19. Journal of Arrhythmia.
A nurse-led atrial fibrillation clinic: Impact on anticoagulation therapy and clinical outcomes
Miguel Rivera-Caravaca, J., Gil-Perez, P., Lopez-Garcia, C., Veliz-Martinez, A., Quintana-Giner, M., Isabel Romero-Aniorte, A., . . . Marin, F. (2020). A nurse-led atrial fibrillation clinic: Impact on anticoagulation therapy and clinical outcomes. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 74(12). doi:10.1111/ijcp.13634
Association of different oral anticoagulants use with renal function worsening in patients with atrial fibrillation: A multicentre cohort study
Pastori, D., Ettorre, E., Lip, G. Y. H., Sciacqua, A., Perticone, F., Melillo, F., . . . Pignatelli, P. (2020). Association of different oral anticoagulants use with renal function worsening in patients with atrial fibrillation: A multicentre cohort study. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 86(12), 2455-2463. doi:10.1111/bcp.14350
Cardiac rehabilitation meta-analysis of trials in patients with coronary heart disease using individual participant data (CaReMATCH): Project protocol
Buckley, B. J. R., Kleinnibbelink, G., Lip, G. Y. H., Taylor, R. S., & Thijssen, D. H. J. (2020). Cardiac rehabilitation meta-analysis of trials in patients with coronary heart disease using individual participant data (CaReMATCH): Project protocol. IJC Heart & Vasculature, 31, 100616. doi:10.1016/j.ijcha.2020.100616
Detection of Atrial Fibrillation on Stroke Units: Look Harder, Look Longer, Look in More Sophisticated Ways
Gue, Y. X., Potpara, T. S., & Lip, G. Y. H. (2020). Detection of Atrial Fibrillation on Stroke Units: Look Harder, Look Longer, Look in More Sophisticated Ways. CEREBROVASCULAR DISEASES, 49(6), 656-658. doi:10.1159/000512205
Effectiveness and safety of dabigatran in Latin American patients with atrial fibrillation: Two years follow up results from GLORIA-AF registry.
Dubner, S., Saraiva, J. F. K., Fragoso, J. C. N., Barón-Esquivias, G., Teutsch, C., Gurusamy, V. K., . . . Zeballos, C. (2020). Effectiveness and safety of dabigatran in Latin American patients with atrial fibrillation: Two years follow up results from GLORIA-AF registry.. International journal of cardiology. Heart & vasculature, 31, 100666. doi:10.1016/j.ijcha.2020.100666
Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine.
Gerotziafas, G. T., Catalano, M., Colgan, M. -P., Pecsvarady, Z., Wautrecht, J. C., Fazeli, B., . . . Scientific Reviewer Committee. (2020). Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine.. Thrombosis and haemostasis, 120(12), 1597-1628. doi:10.1055/s-0040-1715798
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies
Bikdeli, B., Talasaz, A. H., Rashidi, F., Sharif-Kashani, B., Farrokhpour, M., Bakhshandeh, H., . . . Sadeghipour, P. (2020). Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies. THROMBOSIS RESEARCH, 196, 382-394. doi:10.1016/j.thromres.2020.09.027
Letter by Ding et al Regarding Article, "Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation"
Ding, W. Y., Rivera-Caravaca, J. M., & Lip, G. Y. H. (2020). Letter by Ding et al Regarding Article, "Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation". STROKE, 51(12), E361-E362. doi:10.1161/STROKEAHA.120.031780
Mobile health technology-supported atrial fibrillation screening and integrated care: A report from the mAFA-II trial Long-term Extension Cohort
Guo, Y., Guo, J., Shi, X., Yao, Y., Sun, Y., Xia, Y., . . . Investigators, M. -A. I. I. T. (2020). Mobile health technology-supported atrial fibrillation screening and integrated care: A report from the mAFA-II trial Long-term Extension Cohort. European Journal of Internal Medicine, 82, 105-111. doi:10.1016/j.ejim.2020.09.024
Off-label dosing of non-vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation
Chan, Y. -H., Chao, T. -F., Chen, S. -W., Lee, H. -F., Yeh, Y. -H., Huang, Y. -C., . . . Chen, S. -A. (2020). Off-label dosing of non-vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation. HEART RHYTHM, 17(12), 2102-2110. doi:10.1016/j.hrthm.2020.07.022
Physical activity or fitness as medicine for your arteries?
Buckley, B. J. R., Thijssen, D. H. J., & Lip, G. Y. H. (2020). Physical activity or fitness as medicine for your arteries?. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 74(12). doi:10.1111/ijcp.13688
The CHA(2)DS(2)-VASc score and Geriatric Multidimensional Assessment tools in elderly patients with persistent atrial fibrillation undergoing electrical cardioversion. A link with arrhythmia relapse?
Fumagalli, S., Pelagalli, G., Montorzi, R. F., Marozzi, I., Migliorini, M., D'Andria, M. F., . . . Marchionni, N. (2020). The CHA(2)DS(2)-VASc score and Geriatric Multidimensional Assessment tools in elderly patients with persistent atrial fibrillation undergoing electrical cardioversion. A link with arrhythmia relapse?. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 82, 56-61. doi:10.1016/j.ejim.2020.07.010
The prevalence of cardiovascular risk factors and cardiovascular disease among primary care patients in Poland: results from the LIPIDOGRAM2015 study
Jozwiak, J. J., Studzinski, K., Tomasik, T., Windak, A., Mastej, M., Catapano, A. L., . . . Banach, M. (2020). The prevalence of cardiovascular risk factors and cardiovascular disease among primary care patients in Poland: results from the LIPIDOGRAM2015 study. ATHEROSCLEROSIS SUPPLEMENTS, 42, E15-E24. doi:10.1016/j.atherosclerosissup.2021.01.004
Heart-type fatty acid-binding protein: an overlooked cardiac biomarker
Goel, H., Melot, J., Krinock, M. D., Kumar, A., Nadar, S. K., & Lip, G. Y. H. (n.d.). Heart-type fatty acid-binding protein: an overlooked cardiac biomarker. Annals of Medicine. doi:10.1080/07853890.2020.1800075
Association between critical care admission and 6-month functional outcome after spontaneous intracerebral haemorrhage
Mc Lernon, S., Schwarz, G., Wilson, D., Ambler, G., Goodwin, R., Shakeshaft, C., . . . Werring, D. J. (2020). Association between critical care admission and 6-month functional outcome after spontaneous intracerebral haemorrhage. JOURNAL OF THE NEUROLOGICAL SCIENCES, 418. doi:10.1016/j.jns.2020.117141
Atrial Fibrillation Increases the Risk of Early-Onset Dementia in the General Population: Data from a Population-Based Cohort
Kim, D., Yang, P. -S., Lip, G. Y. H., & Joung, B. (2020). Atrial Fibrillation Increases the Risk of Early-Onset Dementia in the General Population: Data from a Population-Based Cohort. JOURNAL OF CLINICAL MEDICINE, 9(11). doi:10.3390/jcm9113665
End-Stage Renal Disease and 30-day Mortality for Adults with and without COVID-19
Harrison, S. L., Buckley, B. J. R., Fazio-Eynullayeva, E., Underhill, P., Lane, D. A., & Lip, G. Y. H. (2020). End-Stage Renal Disease and 30-day Mortality for Adults with and without COVID-19. European Journal of Internal Medicine. doi:10.1016/j.ejim.2020.11.003
Association between clustering of unhealthy lifestyle factors and risk of new-onset atrial fibrillation: a nationwide population-based study
Lee, S. -R., Choi, E. -K., Ahn, H. -J., Han, K. -D., Oh, S., & Lip, G. Y. H. (2020). Association between clustering of unhealthy lifestyle factors and risk of new-onset atrial fibrillation: a nationwide population-based study. SCIENTIFIC REPORTS, 10(1). doi:10.1038/s41598-020-75822-y
Atrial fibrillation: Can it be as easy as CC to ABC?
Ding, W. Y., Lip, G. Y. H., & Potpara, T. S. (2020). Atrial fibrillation: Can it be as easy as CC to ABC?. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 50(11). doi:10.1111/eci.13413
Cardiovascular Events and Mortality in Patients With Atrial Fibrillation and Anemia (from the Fushimi AF Registry)
An, Y., Ogawa, H., Esato, M., Ishii, M., Iguchi, M., Masunaga, N., . . . Akao, M. (2020). Cardiovascular Events and Mortality in Patients With Atrial Fibrillation and Anemia (from the Fushimi AF Registry). AMERICAN JOURNAL OF CARDIOLOGY, 134, 74-82. doi:10.1016/j.amjcard.2020.08.009
Comparison of Dabigatran Plus a P2Y<sub>12</sub> Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCI
De Caterina, R., Procopio, A., Lopez Sendon, J. -L., Raev, D., Mehta, S. R., Opolski, G., . . . Cannon, C. P. (2020). Comparison of Dabigatran Plus a P2Y<sub>12</sub> Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCI. AMERICAN JOURNAL OF MEDICINE, 133(11), 1302-1312. doi:10.1016/j.amjmed.2020.03.045
Effect of concomitant antiplatelet agents on clinical outcomes in the edoxaban vs warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial
Goette, A., Merino, J. L., De Caterina, R., Huber, K., Heidbuchel, H., Jin, J., & Lip, G. Y. H. (2020). Effect of concomitant antiplatelet agents on clinical outcomes in the edoxaban vs warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial. CLINICAL RESEARCH IN CARDIOLOGY, 109(11), 1374-1380. doi:10.1007/s00392-020-01635-8
Impact of atrial fibrillation in critically ill patients admitted to a stepdown unit
Falsetti, L., Proietti, M., Zaccone, V., Guerra, F., Nitti, C., Salvi, A., . . . Capucci, A. (2020). Impact of atrial fibrillation in critically ill patients admitted to a stepdown unit. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 50(11). doi:10.1111/eci.13317
Non-vitamin K antagonist oral anticoagulants in very elderly east Asians with atrial fibrillation: A nationwide population-based study
Kwon, S., Lee, S. -R., Choi, E. -K., Choe, W. -S., Lee, E., Jung, J. -H., . . . Lip, G. Y. H. (2020). Non-vitamin K antagonist oral anticoagulants in very elderly east Asians with atrial fibrillation: A nationwide population-based study. AMERICAN HEART JOURNAL, 229, 81-91. doi:10.1016/j.ahj.2020.08.006
Particulate Matter and Temperature: Increased Risk of Adverse Clinical Outcomes in Patients With Atrial Fibrillation
Rivera-Caravaca, J. M., Roldan, V., Vicente, V., Lip, G. Y. H., & Marin, F. (2020). Particulate Matter and Temperature: Increased Risk of Adverse Clinical Outcomes in Patients With Atrial Fibrillation. MAYO CLINIC PROCEEDINGS, 95(11), 2360-2369. doi:10.1016/j.mayocp.2020.05.046
Relative skeletal muscle mass and incident hypertension: associations, caveats, and future perspectives
Buckley, B. J. R., Thijssen, D., & Lip, G. Y. H. (2020). Relative skeletal muscle mass and incident hypertension: associations, caveats, and future perspectives. JOURNAL OF HYPERTENSION, 38(11), 2150-2151. doi:10.1097/HJH.0000000000002548
Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysis.
Sambola, A., Rello, P., Soriano, T., Bhatt, D. L., Pasupuleti, V., Cannon, C. P., . . . Hernandez, A. V. (2020). Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysis.. Thrombosis research, 195, 128-135. doi:10.1016/j.thromres.2020.07.010
Stroke-Related Visual Impairment; is There an Association with Atrial Fibrillation?
Rowe, F. J., Hepworth, L. R., Howard, C., Cullen, C., Sturgess, B., Griffiths, N., & Lip, G. Y. H. (2020). Stroke-Related Visual Impairment; is There an Association with Atrial Fibrillation?. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 29(11). doi:10.1016/j.jstrokecerebrovasdis.2020.105186
Usefulness of the NULL-PLEASE Score to Predict Survival in Out-of-Hospital Cardiac Arrest
Gue, Y. X., Sayers, M., Whitby, B. T., Kanji, R., Adatia, K., Smith, R., . . . Gorog, D. A. (2020). Usefulness of the NULL-PLEASE Score to Predict Survival in Out-of-Hospital Cardiac Arrest. AMERICAN JOURNAL OF MEDICINE, 133(11), 1328-1335. doi:10.1016/j.amjmed.2020.03.046
Vernakalant hydrochloride for the treatment of atrial fibrillation: evaluation of its place in clinical practice
Ritchie, L. A., Qin, S., Penson, P. E., Henney, N. C., & Lip, G. Y. H. (2020). Vernakalant hydrochloride for the treatment of atrial fibrillation: evaluation of its place in clinical practice. FUTURE CARDIOLOGY, 16(6), 585-596. doi:10.2217/fca-2020-0039
Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation
Okumura, K., Akao, M., Yoshida, T., Kawata, M., Okazaki, O., Akashi, S., . . . Yamashita, T. (2020). Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation. NEW ENGLAND JOURNAL OF MEDICINE, 383(18), 1735-1745. doi:10.1056/NEJMoa2012883
Optimal INR level in elderly and non-elderly patients with atrial fibrillation receiving warfarin: a report from the COOL-AF nationwide registry in Thailand
Krittayaphong, R., Kunjara-Na-Ayudhya, R., Ngamjanyaporn, P., Boonyaratavej, S., Komoltri, C., Yindeengam, A., . . . Lip, G. Y. H. (2020). Optimal INR level in elderly and non-elderly patients with atrial fibrillation receiving warfarin: a report from the COOL-AF nationwide registry in Thailand. JOURNAL OF GERIATRIC CARDIOLOGY, 17(10), 612-620. doi:10.11909/j.issn.1671-5411.2020.10.004
ACE Inhibitors and Angiotensin II Receptor Blockers May Have Different Impact on Prognosis of COVID-19
Wang, Y., Tse, G., Li, G., Lip, G. Y. H., & Liu, T. (2020). ACE Inhibitors and Angiotensin II Receptor Blockers May Have Different Impact on Prognosis of COVID-19. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 76(17), 2041. doi:10.1016/j.jacc.2020.07.068
Association of enlarged perivascular spaces and anticoagulant-related intracranial hemorrhage
Best, J. G., Barbato, C., Ambler, G., Du, H., Banerjee, G., Wilson, D., . . . Werring, D. J. (2020). Association of enlarged perivascular spaces and anticoagulant-related intracranial hemorrhage. NEUROLOGY, 95(16), E2192-E2199. doi:10.1212/WNL.0000000000010788
Impacts of Different Renal Function Estimation Formulas on Dosing of DOACs and Clinical Outcomes
Chan, Y. -H., Chao, T. -F., Lee, H. -F., Yeh, Y. -H., Yeh, C. -H., Huang, Y. -C., . . . Chen, S. -A. (2020). Impacts of Different Renal Function Estimation Formulas on Dosing of DOACs and Clinical Outcomes. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 76(15), 1808-1810. doi:10.1016/j.jacc.2020.08.025
Treatment strategies for patients with atrial fibrillation and anticoagulant-associated intracranial hemorrhage: an overview of the pharmacotherapy
Rivera-Caravaca, J. M., Esteve-Pastor, M. A., Camelo-Castillo, A., Ramirez-Macias, I., Lip, G. Y. H., Roldan, V., & Marin, F. (n.d.). Treatment strategies for patients with atrial fibrillation and anticoagulant-associated intracranial hemorrhage: an overview of the pharmacotherapy. Expert Opinion on Pharmacotherapy. doi:10.1080/14656566.2020.1789099
Ag–Sn Transient Liquid Phase Bonding for High Temperature Electronic Packaging: Effect of Ag Content
Singh Nobeen, N., Yan, G., Gan, C. L., & Chen, Z. (2020). Ag–Sn Transient Liquid Phase Bonding for High Temperature Electronic Packaging: Effect of Ag Content. IEEE Transactions on Components, Packaging and Manufacturing Technology, 10(10), 1604-1610. doi:10.1109/tcpmt.2020.3009515
Association of relative wall thickness of left ventricle with incidence of thromboembolism in patients with non-valvular atrial fibrillation: The Fushimi AF Registry
Tezuka, Y., Iguchi, M., Hamatani, Y., Ogawa, H., Esato, M., Tsuji, H., . . . Akao, M. (2020). Association of relative wall thickness of left ventricle with incidence of thromboembolism in patients with non-valvular atrial fibrillation: The Fushimi AF Registry. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 6(4), 273-283. doi:10.1093/ehjqcco/qcaa003
Atrial fibrillation and the prothrombotic state: revisiting Virchow's triad in 2020
Ding, W. Y., Gupta, D., & Lip, G. Y. H. (2020). Atrial fibrillation and the prothrombotic state: revisiting Virchow's triad in 2020. HEART, 106(19), 1463-1468. doi:10.1136/heartjnl-2020-316977
Atrial fibrillation in obesity: Weighing up the evidence for catheter ablation
Javed, S., Gupta, D., & Lip, G. Y. H. (2020). Atrial fibrillation in obesity: Weighing up the evidence for catheter ablation. CLINICAL CARDIOLOGY, 43(10), 1064-1066. doi:10.1002/clc.23416
Cardiac arrhythmias in patients with COVID-19
Wang, Y., Wang, Z., Tse, G., Zhang, L., Wan, E. Y., Guo, Y., . . . Liu, T. (2020). Cardiac arrhythmias in patients with COVID-19. JOURNAL OF ARRHYTHMIA, 36(5), 827-836. doi:10.1002/joa3.12405
Characteristics and 2-year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation: GLORIA-AF
Dubner, S. J., Teutsch, C., Huisman, M. V., Diener, H. -C., Halperin, J., Rothman, K. J., . . . Lip, G. Y. H. (2020). Characteristics and 2-year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation: GLORIA-AF. ESC HEART FAILURE, 7(5), 2679-2689. doi:10.1002/ehf2.12857
Influence of BMI and geographical region on prescription of oral anticoagulants in newly diagnosed atrial fibrillation: The GLORIA-AF Registry Program
Boriani, G., Huisman, M. V., Teutsch, C., Marler, S., Franca, L. R., Lu, S., & Lip, G. Y. H. (2020). Influence of BMI and geographical region on prescription of oral anticoagulants in newly diagnosed atrial fibrillation: The GLORIA-AF Registry Program. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 80, 35-44. doi:10.1016/j.ejim.2020.04.032
Outcomes in relation to antithrombotic therapy among patients with atrial fibrillation after percutaneous coronary intervention
Park, J., Choi, E. -K., Han, K. -D., Kim, B., Choi, Y. -J., Lee, S. -R., . . . Lip, G. Y. H. (2020). Outcomes in relation to antithrombotic therapy among patients with atrial fibrillation after percutaneous coronary intervention. PLOS ONE, 15(10). doi:10.1371/journal.pone.0240161
Regular Bleeding Risk Assessment Associated with Reduction in Bleeding Outcomes: The mAFA-II Randomized Trial
Guo, Y., Lane, D. A., Chen, Y., & Lip, G. Y. H. (2020). Regular Bleeding Risk Assessment Associated with Reduction in Bleeding Outcomes: The mAFA-II Randomized Trial. AMERICAN JOURNAL OF MEDICINE, 133(10), 1195-+. doi:10.1016/j.amjmed.2020.03.019
Risks and outcomes of gastrointestinal malignancies in anticoagulated atrial fibrillation patients experiencing gastrointestinal bleeding: A nationwide cohort study
Chang, T. -Y., Chan, Y. -H., Chiang, C. -E., Lin, Y. -J., Chang, S. -L., Lo, L. -W., . . . Chao, T. -F. (2020). Risks and outcomes of gastrointestinal malignancies in anticoagulated atrial fibrillation patients experiencing gastrointestinal bleeding: A nationwide cohort study. Heart Rhythm, 17(10), 1745-1751. doi:10.1016/j.hrthm.2020.05.026
Short-Term Apixaban for Documented Left Atrial Appendage Thrombus in High-Risk Atrial Fibrillation Patients Undergoing Left Atrial Appendage Occlusion.
Ding, W. Y., Lip, G. Y. H., Fairbairn, T., Binukrishnan, S., Khalatbari, A., Velavan, P., & Gupta, D. (2020). Short-Term Apixaban for Documented Left Atrial Appendage Thrombus in High-Risk Atrial Fibrillation Patients Undergoing Left Atrial Appendage Occlusion.. TH open : companion journal to thrombosis and haemostasis, 4(4), e351-e353. doi:10.1055/s-0040-1718585
Temporal trends of catheter ablation for patients with atrial fibrillation: A Korean nationwide population-based study
Lee, E., Lee, S. -R., Choi, E. -K., Han, K. -D., Cha, M. -J., Lip, G. Y. H., & Oh, S. (2020). Temporal trends of catheter ablation for patients with atrial fibrillation: A Korean nationwide population-based study. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 31(10), 2616-2625. doi:10.1111/jce.14737
The Euro Heart Survey and EURObservational Research Programme (EORP) in atrial fibrillation registries: contribution to epidemiology, clinical management and therapy of atrial fibrillation patients over the last 20 years
Vitolo, M., Proietti, M., Harrison, S., Lane, D. A., Potpara, T. S., Boriani, G., & Lip, G. Y. H. (2020). The Euro Heart Survey and EURObservational Research Programme (EORP) in atrial fibrillation registries: contribution to epidemiology, clinical management and therapy of atrial fibrillation patients over the last 20 years. INTERNAL AND EMERGENCY MEDICINE, 15(7), 1183-1192. doi:10.1007/s11739-020-02405-0
Thromboembolic and bleeding outcomes in patients with atrial fibrillation and valvular heart disease: A descriptive nationwide cohort study.
Melgaard, L., Jensen, M., Overvad, T. F., Larsen, T. B., Lip, G. Y. H., & Nielsen, P. B. (n.d.). Thromboembolic and bleeding outcomes in patients with atrial fibrillation and valvular heart disease: A descriptive nationwide cohort study.. International Journal of Clinical Practice. doi:10.1111/ijcp.13589
Treatment implications of renal disease in patients with atrial fibrillation: The BALKAN‐AF survey
Kozieł, M., Simovic, S., Pavlovic, N., Nedeljkovic, M., Kocijancic, A., Paparisto, V., . . . Potpara, T. S. (n.d.). Treatment implications of renal disease in patients with atrial fibrillation: The BALKAN‐AF survey. Journal of Arrhythmia. doi:10.1002/joa3.12404
Wearable cardioverter-defibrillator to reduce the transient risk of sudden cardiac death in coronary artery disease: Authors' reply
Tfelt-Hansen, J., Svendsen, J. H., Kalarus, Z., Capodanno, D., Dan, G. -A., De Maria, E., . . . Lip, G. Y. H. (2020). Wearable cardioverter-defibrillator to reduce the transient risk of sudden cardiac death in coronary artery disease: Authors' reply. EUROPACE, 22(10), 1600-1601. doi:10.1093/europace/euaa052
Cardiac Electronic Devices: Future Directions and Challenges.
Kotalczyk, A., Kalarus, Z., Wright, D. J., Boriani, G., & Lip, G. Y. H. (2020). Cardiac Electronic Devices: Future Directions and Challenges.. Medical devices (Auckland, N.Z.), 13, 325-338. doi:10.2147/mder.s245625
Sensitivity and specificity of blood-fluid levels for oral anticoagulant-associated intracerebral haemorrhage
Almarzouki, A., Wilson, D., Ambler, G., Shakeshaft, C., Cohen, H., Yousry, T., . . . Werring, D. J. (2020). Sensitivity and specificity of blood-fluid levels for oral anticoagulant-associated intracerebral haemorrhage. SCIENTIFIC REPORTS, 10(1). doi:10.1038/s41598-020-72504-7
Vascular disease in patients with atrial fibrillation. A report from Polish participants in the EORP-AF General Long-Term Registry
Gawalko, M., Lodzinski, P., Budnik, M., Tyminska, A., Wancerz, A., Ozieranski, K., . . . Balsam, P. (2020). Vascular disease in patients with atrial fibrillation. A report from Polish participants in the EORP-AF General Long-Term Registry. International Journal of Clinical Practice. doi:10.1111/ijcp.13701
The counterintuitive role of exercise in the prevention and cause of atrial fibrillation.
Buckley, B., Lip, G., & Thijssen, D. H. J. (2020). The counterintuitive role of exercise in the prevention and cause of atrial fibrillation.. American journal of physiology. Heart and circulatory physiology. doi:10.1152/ajpheart.00509.2020
What Is the Ideal Blood Pressure Threshold for the Prevention of Atrial Fibrillation in Elderly General Population?
Park, Y. J., Yang, P. -S., Yu, H. T., Kim, T. -H., Jang, E., Uhm, J. -S., . . . Joung, B. (2020). What Is the Ideal Blood Pressure Threshold for the Prevention of Atrial Fibrillation in Elderly General Population?. JOURNAL OF CLINICAL MEDICINE, 9(9). doi:10.3390/jcm9092988
A Novel Model for Prediction of Thromboembolic and Cardiovascular Events in Patients Without Atrial Fibrillation
Steensig, K., Olesen, K. K. W., Madsen, M., Thim, T., Jensen, L. O., Wurtz, M., . . . Maeng, M. (2020). A Novel Model for Prediction of Thromboembolic and Cardiovascular Events in Patients Without Atrial Fibrillation. AMERICAN JOURNAL OF CARDIOLOGY, 131, 40-48. doi:10.1016/j.amjcard.2020.06.031
Differences in Thromboembolic Complications Between Paroxysmal and Persistent Atrial Fibrillation Patients Following Electrical Cardioversion (From the ENSURE-AF Study)
Goette, A., Lip, G. Y. H., Jin, J., Heidbuchel, H., Cohen, A. -A., Ezekowitz, M., & Luis Merino, J. (2020). Differences in Thromboembolic Complications Between Paroxysmal and Persistent Atrial Fibrillation Patients Following Electrical Cardioversion (From the ENSURE-AF Study). AMERICAN JOURNAL OF CARDIOLOGY, 131, 27-32. doi:10.1016/j.amjcard.2020.06.046
Spironolactone in Atrial Fibrillation With Preserved Cardiac Fraction: The IMPRESS-AF Trial
Shantsila, E., Shahid, F., Sun, Y., Deeks, J., Calvert, M., Fisher, J. P., . . . Lip, G. Y. H. (2020). Spironolactone in Atrial Fibrillation With Preserved Cardiac Fraction: The IMPRESS-AF Trial. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 9(18). doi:10.1161/JAHA.119.016239
Feasibility of weight loss in obese atrial fibrillation patients attending a specialist arrhythmia clinic and its impact on ablation outcomes
Yew Ding, W., Kozhuharov, N., Hao Chin, S., Shaw, M., Snowdon, R., Lip, G. Y. H., & Gupta, D. (2020). Feasibility of weight loss in obese atrial fibrillation patients attending a specialist arrhythmia clinic and its impact on ablation outcomes. Journal of Arrhythmia. doi:10.1002/joa3.12432
Cerebrovascular Dysfunction in Atrial Fibrillation
Junejo, R. T., Lip, G. Y. H., & Fisher, J. P. (2020). Cerebrovascular Dysfunction in Atrial Fibrillation. FRONTIERS IN PHYSIOLOGY, 11. doi:10.3389/fphys.2020.01066
Utilizing biomarkers associated with cardiovascular events in atrial fibrillation: informing a precision medicine response
Tidbury, N., Preston, J., Ding, W. Y., Rivera-Caravaca, J. M., Marín, F., & Lip, G. Y. H. (2020). Utilizing biomarkers associated with cardiovascular events in atrial fibrillation: informing a precision medicine response. Expert Review of Precision Medicine and Drug Development, 5(5), 331-345. doi:10.1080/23808993.2020.1804864
Bleeding risk comparison between direct oral anticoagulants at doses approved for atrial fibrillation and aspirin: systematic review, meta-analysis and meta-regression
Sagris, D., Leventis, I., Georgiopoulos, G., Korompoki, E., Makaritsis, K., Vemmos, K., . . . Ntaios, G. (2020). Bleeding risk comparison between direct oral anticoagulants at doses approved for atrial fibrillation and aspirin: systematic review, meta-analysis and meta-regression. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 79, 31-36. doi:10.1016/j.ejim.2020.05.001
Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke The Global COVID-19 Stroke Registry
Ntaios, G., Michel, P., Georgiopoulos, G., Guo, Y., Li, W., Xiong, J., . . . Lip, G. Y. H. (2020). Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke The Global COVID-19 Stroke Registry. STROKE, 51(9), E254-E258. doi:10.1161/STROKEAHA.120.031208
Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis
Harrison, S. L., Fazio-Eynullayeva, E., Lane, D. A., Underhill, P., & Lip, G. Y. H. (2020). Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis. PLOS MEDICINE, 17(9). doi:10.1371/journal.pmed.1003321
Direct Oral Anticoagulants in Atrial Fibrillation Patients With Concomitant Hyperthyroidism
Chan, Y. -H., Wu, L. -S., See, L. -C., Liu, J. -R., Chang, S. -H., Chao, T. -F., . . . Lip, G. Y. H. (2020). Direct Oral Anticoagulants in Atrial Fibrillation Patients With Concomitant Hyperthyroidism. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 105(9), 2893-2904. doi:10.1210/clinem/dgaa050
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.
Nielsen, J. C., Lin, Y. -J., de Oliveira Figueiredo, M. J., Sepehri Shamloo, A., Alfie, A., Boveda, S., . . . Leclercq, C. (2020). European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.. Heart Rhythm, 17(9), e269-e316. doi:10.1016/j.hrthm.2020.05.004
Family History of Atrial Fibrillation and Risk of Cardiovascular Events A Multicenter Prospective Cohort Study
Pastori, D., Menichelli, D., Lip, G. Y. H., Sciacqua, A., Violi, F., Pignatelli, P., & Grp, A. T. H. E. R. O. A. F. S. (2020). Family History of Atrial Fibrillation and Risk of Cardiovascular Events A Multicenter Prospective Cohort Study. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 13(9). doi:10.1161/CIRCEP.120.008477
Non-vitamin K oral anticoagulants for secondary stroke prevention in patients with atrial fibrillation
Diener, H. -C., Hankey, G. J., Easton, J. D., Lip, G. Y. H., Hart, R. G., & Caso, V. (2020). Non-vitamin K oral anticoagulants for secondary stroke prevention in patients with atrial fibrillation. EUROPEAN HEART JOURNAL SUPPLEMENTS, 22(I), I13-I21. doi:10.1093/eurheartj/suaa104
Practice-derived data on non-vitamin K antagonist oral anticoagulant therapy to complement observations from randomized trials
Domek, M., Gumprecht, J., Ding, W. Y., Lip, G. Y. H., & Lane, D. A. (2020). Practice-derived data on non-vitamin K antagonist oral anticoagulant therapy to complement observations from randomized trials. EUROPEAN HEART JOURNAL SUPPLEMENTS, 22(I), I1-I12. doi:10.1093/eurheartj/suaa100
Stroke risk stratification in hypertrophic cardiomyopathy
Zhang, J., Potpara, T., & Lip, G. Y. H. (2020). Stroke risk stratification in hypertrophic cardiomyopathy. HELLENIC JOURNAL OF CARDIOLOGY, 61(5), 318-320. doi:10.1016/j.hjc.2020.11.003
The number needed to treat for net effect (NNTnet) as a metric for measuring combined benefits and harms
Li, G., Lip, G. Y. H., Marcucci, M., Thabane, L., Tian, J., & Levine, M. A. H. (2020). The number needed to treat for net effect (NNTnet) as a metric for measuring combined benefits and harms. Journal of Clinical Epidemiology, 125, 100-107. doi:10.1016/j.jclinepi.2020.05.031
Wearable cardioverter-defibrillator in patients at risk of sudden cardiac death: consensus document from Kalarus et al. contradicts current guideline recommendations-Authors' reply
Tfelt-Hansen, J., Svendsen, J. H., Kalarus, Z., Capodanno, D., Dan, G. -A., De Maria, E., . . . Lip, G. Y. H. (2020). Wearable cardioverter-defibrillator in patients at risk of sudden cardiac death: consensus document from Kalarus et al. contradicts current guideline recommendations-Authors' reply. EUROPACE, 22(9), 1442-1443. doi:10.1093/europace/euaa053
Quality indicators for the care and outcomes of adults with atrial fibrillation.
Arbelo, E., Aktaa, S., Bollmann, A., D'Avila, A., Drossart, I., Dwight, J., . . . ESC Scientific Document Group. (2020). Quality indicators for the care and outcomes of adults with atrial fibrillation.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. doi:10.1093/europace/euaa253
The 4S-AF Scheme (Stroke Risk; Symptoms; Severity of Burden; Substrate): A Novel Approach to In-Depth Characterization (Rather than Classification) of Atrial Fibrillation
Potpara, T. S., Lip, G. Y. H., Blomstrom-Lundqvist, C., Boriani, G., Van Gelder, I. C., Heidbuchel, H., . . . Camm, A. J. (2020). The 4S-AF Scheme (Stroke Risk; Symptoms; Severity of Burden; Substrate): A Novel Approach to In-Depth Characterization (Rather than Classification) of Atrial Fibrillation. Thrombosis and Haemostasis. doi:10.1055/s-0040-1716408
Low Body Weight Increases the Risk of Ischemic Stroke and Major Bleeding in Atrial Fibrillation: The COOL-AF Registry
Krittayaphong, R., Chichareon, P., Komoltri, C., Kornbongkotmas, S., Yindeengam, A., & Lip, G. Y. H. (2020). Low Body Weight Increases the Risk of Ischemic Stroke and Major Bleeding in Atrial Fibrillation: The COOL-AF Registry. JOURNAL OF CLINICAL MEDICINE, 9(9). doi:10.3390/jcm9092713
Anticoagulant Therapy in Initially Low-Risk Patients With Nonvalvular Atrial Fibrillation Who Develop Risk Factors
Choi, S. Y., Kim, M. H., Lee, K. M., Cho, Y. -R., Park, J. S., Kim, S. W., . . . Lip, G. Y. H. (2020). Anticoagulant Therapy in Initially Low-Risk Patients With Nonvalvular Atrial Fibrillation Who Develop Risk Factors. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 9(16). doi:10.1161/JAHA.120.016271
Antithrombotic treatment in atrial fibrillation patients undergoing percutaneous coronary interventions: focus on stent thrombosis.
Vitolo, M., Javed, S., Capodanno, D., Rubboli, A., Boriani, G., & Lip, G. Y. H. (2020). Antithrombotic treatment in atrial fibrillation patients undergoing percutaneous coronary interventions: focus on stent thrombosis.. Expert Review of Cardiovascular Therapy, 1-14. doi:10.1080/14779072.2020.1808463
Relationship of adverse events to quality of anticoagulation control in atrial fibrillation patients with diabetes: Real-world data from the FANTASIIA registry.
García-Fernández, A., Esteve-Pastor, M. A., Rabadán, I. R., Muñiz, J., Ruiz Ortiz, M., Cequier, Á., . . . Marín, F. (n.d.). Relationship of adverse events to quality of anticoagulation control in atrial fibrillation patients with diabetes: Real-world data from the FANTASIIA registry.. Annals of medicine. doi:10.1080/07853890.2020.1778176
Hypertension and cardiovascular risk factors when treating cancer patients: underrecognised and undertreated
Essa, H., Pettitt, A. R., & Lip, G. Y. H. (2020). Hypertension and cardiovascular risk factors when treating cancer patients: underrecognised and undertreated. JOURNAL OF HUMAN HYPERTENSION. doi:10.1038/s41371-020-00400-8
Blood pressure targets in atrial fibrillation.
Shantsila, A., Shantsila, E., & Lip, G. Y. H. (2020). Blood pressure targets in atrial fibrillation.. European heart journal, 41(30), 2860-2862. doi:10.1093/eurheartj/ehaa319
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.
Nielsen, J. C., Lin, Y. -J., de Oliveira Figueiredo, M. J., Sepehri Shamloo, A., Alfie, A., Boveda, S., . . . Leclercq, C. (2020). European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.. Journal of Arrhythmia, 36(4), 553-607. doi:10.1002/joa3.12338
Hypertension management in cardio-oncology
Essa, H., Dobson, R., Wright, D., & Lip, G. Y. H. (2020). Hypertension management in cardio-oncology. Journal of Human Hypertension. doi:10.1038/s41371-020-0391-8
Anticoagulation control in different ethnic groups receiving vitamin K antagonist therapy for stroke prevention in atrial fibrillation
Zulkifly, H., Cheli, P., Lutchman, I., Bai, Y., Lip, G. Y. H., & Lane, D. A. (2020). Anticoagulation control in different ethnic groups receiving vitamin K antagonist therapy for stroke prevention in atrial fibrillation. Thrombosis Research. doi:10.1016/j.thromres.2020.04.001
Application of the simple atrial fibrillation better care pathway for integrated care management in frail patients with atrial fibrillation: A nationwide cohort study.
Yang, P. -S., Sung, J. -H., Jang, E., Yu, H. T., Kim, T. -H., Lip, G. Y. H., & Joung, B. (2020). Application of the simple atrial fibrillation better care pathway for integrated care management in frail patients with atrial fibrillation: A nationwide cohort study.. Journal of arrhythmia, 36(4), 668-677. doi:10.1002/joa3.12364
Defibrillators for prevention from sudden cardiac death: is it that easy?-Authors' reply
Tfelt-Hansen, J., Svendsen, J. H., Kalarus, Z., Capodanno, D., Dan, G. -A., De Maria, E., . . . Lip, G. Y. H. (2020). Defibrillators for prevention from sudden cardiac death: is it that easy?-Authors' reply. EUROPACE, 22(8), 1298-1299. doi:10.1093/europace/euaa058
Determinants of low-quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. The nationwide PLECTRUM study
Pastori, D., Lip, G. Y. H., Poli, D., Antonucci, E., Rubino, L., Menichelli, D., . . . Pignatelli, P. (2020). Determinants of low-quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. The nationwide PLECTRUM study. BRITISH JOURNAL OF HAEMATOLOGY, 190(4), 588-593. doi:10.1111/bjh.16528
Edoxaban versus warfarin in vitamin K antagonist experienced and naive patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial
Koziel, M., Al-Saady, N., Hjortshoj, S. P., Goudev, A., Huber, K., Cohen, A., . . . Lip, G. Y. H. (2020). Edoxaban versus warfarin in vitamin K antagonist experienced and naive patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial. CLINICAL RESEARCH IN CARDIOLOGY, 109(8), 1018-1024. doi:10.1007/s00392-019-01594-9
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.
Nielsen, J. C., Lin, Y. -J., de Oliveira Figueiredo, M. J., Sepehri Shamloo, A., Alfie, A., Boveda, S., . . . Leclercq, C. (2020). European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 22(8), 1147-1148. doi:10.1093/europace/euaa065
Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: we could do more.
Guo, Y., Lip, G. Y. H., & Lane, D. A. (2020). Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: we could do more.. Trends in cardiovascular medicine. doi:10.1016/j.tcm.2020.03.007
Longer term stroke risk in intracerebral haemorrhage survivors
Banerjee, G., Wilson, D., Ambler, G., Hostettler, I. C., Shakeshaft, C., Cohen, H., . . . Collaborators, C. (2020). Longer term stroke risk in intracerebral haemorrhage survivors. Journal of Neurology, Neurosurgery and Psychiatry, 91(8), 840-845. doi:10.1136/jnnp-2020-323079
Neurovascular coupling and cerebral autoregulation in atrial fibrillation
Junejo, R. T., Braz, I. D., Lucas, S. J. E., van Lieshout, J. J., Phillips, A. A., Lip, G. Y. H., & Fisher, J. P. (2020). Neurovascular coupling and cerebral autoregulation in atrial fibrillation. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 40(8), 1647-1657. doi:10.1177/0271678X19870770
Predicting Adverse Events beyond Stroke and Bleeding with the ABC-Stroke and ABC-Bleeding Scores in Patients with Atrial Fibrillation: The Murcia AF Project
Camelo-Castillo, A., Miguel Rivera-Caravaca, J., Marin, F., Vicente, V., Lip, G. Y. H., & Roldan, V. (2020). Predicting Adverse Events beyond Stroke and Bleeding with the ABC-Stroke and ABC-Bleeding Scores in Patients with Atrial Fibrillation: The Murcia AF Project. THROMBOSIS AND HAEMOSTASIS, 120(08), 1200-1207. doi:10.1055/s-0040-1712914
Sample Preparation for Deprocessing of 3D Multi-Die Stacked Package
Kor, H. B., Liu, Q., & Gan, C. L. (2020). Sample Preparation for Deprocessing of 3D Multi-Die Stacked Package. In 2020 IEEE International Symposium on the Physical and Failure Analysis of Integrated Circuits (IPFA) (pp. 1-6). IEEE. doi:10.1109/ipfa49335.2020.9260707
Effects of Atrial Fibrillation and Chronic Kidney Disease on Major Adverse Cardiovascular Events.
Ding, W. Y., Lip, G. Y. H., Pastori, D., & Shantsila, A. (2020). Effects of Atrial Fibrillation and Chronic Kidney Disease on Major Adverse Cardiovascular Events.. The American journal of cardiology. doi:10.1016/j.amjcard.2020.07.004
Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation A Population-Based Cohort Study
Lau, W. C. Y., Cheung, C. -L., Man, K. K. C., Chan, E. W., Sing, C. W., Lip, G. Y. H., . . . Wong, I. C. K. (2020). Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation A Population-Based Cohort Study. ANNALS OF INTERNAL MEDICINE, 173(1), 1-+. doi:10.7326/M19-3671
Should We Reintroduce Previous Venous Thromboembolism Into Decision-Making for Anticoagulation in Atrial Fibrillation?
Overvad, T., Skjoth, F., Albertsen, I. E., Larsen, T. B., Sogaard, M., & Lip, G. (2020). Should We Reintroduce Previous Venous Thromboembolism Into Decision-Making for Anticoagulation in Atrial Fibrillation?. American Journal of Medicine. doi:10.1016/j.amjmed.2020.05.042
An interview with Professor Gregory Lip
Lip, G. Y. H., & Grech, D. (2020). An interview with Professor Gregory Lip. EXPERT OPINION ON PHARMACOTHERAPY, 21(10), 1131-1132. doi:10.1080/14656566.2020.1755192
Thoracoscopic Left Atrial Appendage Excision Plus Ablation for Atrial Fibrillation to Prevent Stroke
Ni, B., Wang, Z., Gu, W., Li, M., Chen, M., Lip, G. Y. H., & Shao, Y. (2020). Thoracoscopic Left Atrial Appendage Excision Plus Ablation for Atrial Fibrillation to Prevent Stroke. Seminars in Thoracic and Cardiovascular Surgery. doi:10.1053/j.semtcvs.2020.06.041
What is the impact of the latest ACC/AHA and ESC/ESH guidelines on the management of hypertension in the UK?
Akhmimi, A., Lip, G. Y. H., & Shantsila, A. (2020). What is the impact of the latest ACC/AHA and ESC/ESH guidelines on the management of hypertension in the UK?. EXPERT OPINION ON PHARMACOTHERAPY, 21(10), 1123-1125. doi:10.1080/14656566.2019.1707183
Acute Kidney Injury and Postoperative Atrial Fibrillation In Patients Undergoing Cardiac Surgery
Cole, O. M., Tosif, S., Shaw, M., & Lip, G. Y. H. (2020). Acute Kidney Injury and Postoperative Atrial Fibrillation In Patients Undergoing Cardiac Surgery. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 34(7), 1783-1790. doi:10.1053/j.jvca.2019.12.048
Algorithm for the management of antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention: an updated proposal based on efficacy considerations
Rubboli, A., & Lip, G. Y. H. (2020). Algorithm for the management of antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention: an updated proposal based on efficacy considerations. European Heart Journal - Cardiovascular Pharmacotherapy, 6(3), 197-198. doi:10.1093/ehjcvp/pvaa003
Baseline factors associated with early and late death in intracerebral haemorrhage survivors
Banerjee, G., Ambler, G., Wilson, D., Hostettler, I. C., Shakeshaft, C., Lunawat, S., . . . Werring, D. J. (2020). Baseline factors associated with early and late death in intracerebral haemorrhage survivors. EUROPEAN JOURNAL OF NEUROLOGY, 27(7), 1257-1263. doi:10.1111/ene.14238
Breaking the rules for studies using real-world observational data: the case of direct-acting anticoagulants and antiepileptic drugs
Brown, J., Cicali, B., Pham, P., Schmidt, S., & Lip, G. Y. H. (2020). Breaking the rules for studies using real-world observational data: the case of direct-acting anticoagulants and antiepileptic drugs. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 6(3), 155-156. doi:10.1093/ehjcvp/pvz053
Dabigatran Dual Therapy vs Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients with Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-Specified Analysis of the RE-DUAL PCI Trial
Nicolau, J. C., Bhatt, D. L., Hohnloser, S. H., Kimura, T., Lip, G. Y. H., Miede, C., . . . Cannon, C. P. (2020). Dabigatran Dual Therapy vs Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients with Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-Specified Analysis of the RE-DUAL PCI Trial. DRUGS, 80(10), 995-1005. doi:10.1007/s40265-020-01323-x
Incidence and prognostic factors for recurrence of intracerebral hemorrhage in patients with and without atrial fibrillation: A cohort study
Overvad, T. F., Andersen, S. D., Larsen, T. B., Lip, G. Y. H., Sogaard, M., Skjoth, F., & Nielsen, P. B. (2020). Incidence and prognostic factors for recurrence of intracerebral hemorrhage in patients with and without atrial fibrillation: A cohort study. THROMBOSIS RESEARCH, 191, 1-8. doi:10.1016/j.thromres.2020.03.024
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research
Bikdeli, B., Madhavan, M. V., Gupta, A., Jimenez, D., Burton, J. R., Nigoghossian, C. D., . . . Collabo, G. C. T. (2020). Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research. Thrombosis and Haemostasis, 120(07), 1004-1024. doi:10.1055/s-0040-1713152
Validation of the modified Microlife blood pressure monitor in patients with paroxysmal atrial fibrillation
Huppertz, N., Lip, G. Y. H., & Lane, D. A. (2020). Validation of the modified Microlife blood pressure monitor in patients with paroxysmal atrial fibrillation. CLINICAL RESEARCH IN CARDIOLOGY, 109(7), 802-809. doi:10.1007/s00392-019-01567-y
Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome and / or undergoing percutaneous coronary intervention
Mihajlovic, M., Marinkovic, M., Koziel, M., Mujovic, N., Lip, G. Y. H., & Potpara, T. S. (2020). Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome and / or undergoing percutaneous coronary intervention. KARDIOLOGIA POLSKA, 78(6), 512-519. doi:10.33963/KP.15428
Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up
Koziel, M., Mazurek, M., Teutsch, C., Diener, H. -C., Dubner, S. J., Halperin, J. L., . . . Lip, G. Y. H. (2020). Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up. JOURNAL OF CLINICAL MEDICINE, 9(6). doi:10.3390/jcm9061969
Role for machine learning in sex-specific prediction of successful electrical cardioversion in atrial fibrillation?
Vinter, N., Frederiksen, A. S., Albertsen, A. E., Lip, G. Y. H., Fenger-Grøn, M., Trinquart, L., . . . Møller, D. S. (2020). Role for machine learning in sex-specific prediction of successful electrical cardioversion in atrial fibrillation?. Open heart, 7(1), e001297. doi:10.1136/openhrt-2020-001297
Current and emerging drug treatment strategies for peripheral arterial disease
Essa, H., Torella, F., & Lip, G. Y. H. (2020). Current and emerging drug treatment strategies for peripheral arterial disease. Expert Opinion on Pharmacotherapy. doi:10.1080/14656566.2020.1774556
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow
Bikdeli, B., Madhavan, M. V., Jimenez, D., Chuich, T., Dreyfus, I., Driggin, E., . . . Lip, G. Y. H. (2020). COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 75(23), 2950-2973. doi:10.1016/j.jacc.2020.04.031
Label Adherence of Direct Oral Anticoagulants Dosing and Clinical Outcomes in Patients With Atrial Fibrillation
Yu, H. T., Yang, P. -S., Jang, E., Kim, T. -H., Uhm, J. -S., Kim, J. -Y., . . . Joung, B. (2020). Label Adherence of Direct Oral Anticoagulants Dosing and Clinical Outcomes in Patients With Atrial Fibrillation. Journal of the American Heart Association, 9(12). doi:10.1161/JAHA.119.014177
High variability in bodyweight is associated with an increased risk of atrial fibrillation in patients with type 2 diabetes mellitus: a nationwide cohort study
Lee, H. -J., Choi, E. -K., Han, K. -D., Kim, D. H., Lee, E., Lee, S. -R., . . . Lip, G. Y. H. (2020). High variability in bodyweight is associated with an increased risk of atrial fibrillation in patients with type 2 diabetes mellitus: a nationwide cohort study. CARDIOVASCULAR DIABETOLOGY, 19(1). doi:10.1186/s12933-020-01059-8
Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic
Combining Anticoagulant and Antiplatelet Therapies for Chronic Atherosclerotic Disease A Focus on Diabetes Mellitus as a High-Risk Patient Group
Potpara, T. S., & Lip, G. Y. H. (2020). Combining Anticoagulant and Antiplatelet Therapies for Chronic Atherosclerotic Disease A Focus on Diabetes Mellitus as a High-Risk Patient Group. Circulation, 141(23), 1855-1858. doi:10.1161/CIRCULATIONAHA.120.046905
Design and rationale of a nationwide screening analysis from the LIPIDOGRAM2015 and LIPIDOGEN2015 studies
Jozwiak, J., Kasperczyk, S., Tomasik, T., Osadnik, T., Windak, A., Studzinski, K., . . . Banach, M. (2020). Design and rationale of a nationwide screening analysis from the LIPIDOGRAM2015 and LIPIDOGEN2015 studies. ARCHIVES OF MEDICAL SCIENCE, 18(3), 604-616. doi:10.5114/aoms.2020.96052
Mobile Health for Cardiovascular Disease: The New Frontier for AF Management: Observations from the Huawei Heart Study and mAFA-II Randomised Trial.
Guo, Y., & Lip, G. Y. (2020). Mobile Health for Cardiovascular Disease: The New Frontier for AF Management: Observations from the Huawei Heart Study and mAFA-II Randomised Trial.. Arrhythmia & electrophysiology review, 9(1), 5-7. doi:10.15420/aer.2020.12
What Cannot Be Missed: Important Publications on Electrophysiology in 2019.
Grace, A., Calkins, H., Ellenbogen, K., Lambiase, P. D., Lip, G. Y., Narayan, S. M., & Katritsis, D. G. (2020). What Cannot Be Missed: Important Publications on Electrophysiology in 2019.. Arrhythmia & electrophysiology review, 9(1), 4. doi:10.15420/aer.2020.06
Poor Time in Therapeutic Range Control is Associated with Adverse Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation: A Report from the Nationwide COOL-AF Registry
Krittayaphong, R., Chantrarat, T., Rojjarekampai, R., Jittham, P., Sairat, P., & Lip, G. Y. H. (2020). Poor Time in Therapeutic Range Control is Associated with Adverse Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation: A Report from the Nationwide COOL-AF Registry. JOURNAL OF CLINICAL MEDICINE, 9(6). doi:10.3390/jcm9061698
The Effect of Integrated Care Management on Dementia in Atrial Fibrillation
Yang, P. -S., Sung, J. -H., Jang, E., Yu, H. T., Kim, T. -H., Uhm, J. -S., . . . Joung, B. (2020). The Effect of Integrated Care Management on Dementia in Atrial Fibrillation. Journal of Clinical Medicine, 9(6). doi:10.3390/jcm9061696
Adherence to Anticoagulant Guideline for Atrial Fibrillation Improves Outcomes in Asian Population The COOL-AF Registry
Krittayaphong, R., Winijkul, A., Kunjara-Na-Ayudhya, R., Apiyasawat, S., Siriwattana, K., Kanjanarutjawiwat, W., . . . Lip, G. Y. H. (2020). Adherence to Anticoagulant Guideline for Atrial Fibrillation Improves Outcomes in Asian Population The COOL-AF Registry. STROKE, 51(6), 1772-1780. doi:10.1161/STROKEAHA.120.029295
Albuminuria and Risk of Cardiovascular Events and Mortality in a General Population of Patients with Type 2 Diabetes Without Cardiovascular Disease: A Danish Cohort Study
Fangel, M. V., Nielsen, P. B., Kristensen, J. K., Larsen, T. B., Overvad, T. F., Lip, G. Y. H., & Jensen, M. B. (2020). Albuminuria and Risk of Cardiovascular Events and Mortality in a General Population of Patients with Type 2 Diabetes Without Cardiovascular Disease: A Danish Cohort Study. AMERICAN JOURNAL OF MEDICINE, 133(6), E269-E279. doi:10.1016/j.amjmed.2019.10.042
Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage
Tsai, C. -T., Liao, J. -N., Chiang, C. -E., Lin, Y. -J., Chang, S. -L., Lo, L. -W., . . . Chen, S. -A. (2020). Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage. JAMA NETWORK OPEN, 3(6). doi:10.1001/jamanetworkopen.2020.6424
Atrial fibrillation in acute heart failure: A position statement from the Acute Cardiovascular Care Association and European Heart Rhythm Association of the European Society of Cardiology
Gorenek, B., Halvorsen, S., Kudaiberdieva, G., Bueno, H., Van Gelder, I. C., Lettino, M., . . . Lip, G. Y. H. (2020). Atrial fibrillation in acute heart failure: A position statement from the Acute Cardiovascular Care Association and European Heart Rhythm Association of the European Society of Cardiology. EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 9(4), 348-357. doi:10.1177/2048872619894255
Clinical factors related to successful or unsuccessful cardioversion in the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) randomized trial.
Lip, G. Y. H., Merino, J. L., Banach, M., Al-Saady, N., Jin, J., Melino, M., . . . Goette, A. (2020). Clinical factors related to successful or unsuccessful cardioversion in the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) randomized trial.. Journal of arrhythmia, 36(3), 430-438. doi:10.1002/joa3.12341
Documenting Sex and Sex Differences in Animal Studies
Rigby, A., Lip, G. Y. H., & Weber, C. (2020). Documenting Sex and Sex Differences in Animal Studies. THROMBOSIS AND HAEMOSTASIS, 120(6), 879-882. doi:10.1055/s-0040-1710017
Ischemic Stroke in Patients With Sinus Node Disease, Atrial Fibrillation, and Other Cardiac Conditions
Bodin, A., Bisson, A., Gaborit, C., Herbert, J., Clementy, N., Babuty, D., . . . Fauchier, L. (2020). Ischemic Stroke in Patients With Sinus Node Disease, Atrial Fibrillation, and Other Cardiac Conditions. STROKE, 51(6), 1674-1681. doi:10.1161/STROKEAHA.120.029048
Stroke prevention in atrial fibrillation changes after dabigatran availability in China: The GLORIA-AF registry
Ma, C., Riou Franca, L., Lu, S., Diener, H. -C., Dubner, S. J., Halperin, J. L., . . . Rothman, K. J. (2020). Stroke prevention in atrial fibrillation changes after dabigatran availability in China: The GLORIA-AF registry. JOURNAL OF ARRHYTHMIA, 36(3), 408-416. doi:10.1002/joa3.12321
Vitamin D supplementation and incident preeclampsia: A systematic review and meta-analysis of randomized clinical trials
Fogacci, S., Fogacci, F., Banach, M., Michos, E. D., Hernandez, A. V., Lip, G. Y. H., . . . Cicero, A. F. G. (2020). Vitamin D supplementation and incident preeclampsia: A systematic review and meta-analysis of randomized clinical trials. CLINICAL NUTRITION, 39(6), 1742-1752. doi:10.1016/j.clnu.2019.08.015
Effectiveness and Safety of Oral Anticoagulants among NVAF Patients with Obesity: Insights from the ARISTOPHANES Study
Deitelzweig, S., Keshishian, A., Kang, A., Dhamane, A. D., Luo, X., Li, X., . . . Lip, G. Y. H. (n.d.). Effectiveness and Safety of Oral Anticoagulants among NVAF Patients with Obesity: Insights from the ARISTOPHANES Study. Journal of Clinical Medicine, 9(6). doi:10.3390/jcm9061633
Excessive Supraventricular Ectopic Activity and Adverse Cardiovascular Outcomes: a Systematic Review and Meta-analysis
Meng, L., Tsiaousis, G., He, J., Tse, G., Antoniadis, A. P., Korantzopoulos, P., . . . Liu, T. (2020). Excessive Supraventricular Ectopic Activity and Adverse Cardiovascular Outcomes: a Systematic Review and Meta-analysis. CURRENT ATHEROSCLEROSIS REPORTS, 22(4). doi:10.1007/s11883-020-0832-4
Comprehensive Management With the ABC (Atrial Fibrillation Better Care) Pathway in Clinically Complex Patients With Atrial Fibrillation: A Post Hoc Ancillary Analysis From the AFFIRM Trial
Proietti, M., Romiti, G. F., Olshansky, B., Lane, D. A., & Lip, G. Y. H. (2020). Comprehensive Management With the ABC (Atrial Fibrillation Better Care) Pathway in Clinically Complex Patients With Atrial Fibrillation: A Post Hoc Ancillary Analysis From the AFFIRM Trial. Journal of the American Heart Association, e014932. doi:10.1161/jaha.119.014932
Population-Based Screening or Targeted Screening Based on Initial Clinical Risk Assessment for Atrial Fibrillation: A Report from the Huawei Heart Study
Guo, Y., Wang, H., Zhang, H., Chen, Y., & Lip, G. Y. H. (2020). Population-Based Screening or Targeted Screening Based on Initial Clinical Risk Assessment for Atrial Fibrillation: A Report from the Huawei Heart Study. JOURNAL OF CLINICAL MEDICINE, 9(5). doi:10.3390/jcm9051493
Temporal Trends of Emergency Department Visits of Patients with Atrial Fibrillation: A Nationwide Population-Based Study
Lee, S. -R., Choi, E. -K., Lee, S. -Y., Lee, E., Han, K. -D., Cha, M. -J., . . . Lip, G. Y. H. (2020). Temporal Trends of Emergency Department Visits of Patients with Atrial Fibrillation: A Nationwide Population-Based Study. JOURNAL OF CLINICAL MEDICINE, 9(5). doi:10.3390/jcm9051485
Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants
Chan, Y. -H., Lee, H. -F., Li, P. -R., Liu, J. -R., Chao, T. -F., Wu, L. -S., . . . Lip, G. Y. H. (2020). Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants. CARDIOVASCULAR DIABETOLOGY, 19(1). doi:10.1186/s12933-020-01043-2
'Real-world' observational studies in arrhythmia research: data sources, methodology, and interpretation. A position document from European Heart Rhythm Association (EHRA), endorsed by Heart Rhythm Society (HRS), Asia-Pacific HRS (APHRS), and Latin America HRS (LAHRS)
Torp-Pedersen, C., Goette, A., Nielsen, P. B., Potpara, T., Fauchier, L., Camm, A. J., . . . Al-Khatib, S. M. (2020). 'Real-world' observational studies in arrhythmia research: data sources, methodology, and interpretation. A position document from European Heart Rhythm Association (EHRA), endorsed by Heart Rhythm Society (HRS), Asia-Pacific HRS (APHRS), and Latin America HRS (LAHRS). EUROPACE, 22(5), 831-+. doi:10.1093/europace/euz210
Avoiding Stroke: A Continuous Monitoring Challenge
Gumprecht, J., Domek, M., Hill, A. M., & Lip, G. Y. H. (2020). Avoiding Stroke: A Continuous Monitoring Challenge. CEREBROVASCULAR DISEASES, 49(2), 121-123. doi:10.1159/000506680
Blood Pressure Control and Dementia Risk in Midlife Patients With Atrial Fibrillation
Kim, D., Yang, P. -S., Jang, E., Yu, H., Kim, T. -H., Uhm, J. -S., . . . Joung, B. (2020). Blood Pressure Control and Dementia Risk in Midlife Patients With Atrial Fibrillation. HYPERTENSION, 75(5), 1296-1304. doi:10.1161/HYPERTENSIONAHA.119.14388
CaseReport: Aldosterone-secreting adrenal carcinoma complicating longstanding hypertension
Shantsila, A., Lip, G. Y. H., & Beevers, D. G. (2020). CaseReport: Aldosterone-secreting adrenal carcinoma complicating longstanding hypertension. JOURNAL OF HUMAN HYPERTENSION, 34(5), 411-412. doi:10.1038/s41371-019-0209-8
Comparing TEE- vs Non-TEE-guided cardioversion of atrial fibrillation: The ENSURE-AF trial
Koziel, M., Merino, J. L., De Caterina, R., Huber, K., Jin, J., Melino, M., . . . Lip, G. Y. H. (2020). Comparing TEE- vs Non-TEE-guided cardioversion of atrial fibrillation: The ENSURE-AF trial. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 50(5). doi:10.1111/eci.13221
Comparing the Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin in Elderly Asian Patients With Atrial Fibrillation A Nationwide Cohort Study
Chao, T. -F., Chiang, C. -E., Liao, J. -N., Chen, T. -J., Lip, G. Y. H., & Chen, S. -A. (2020). Comparing the Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin in Elderly Asian Patients With Atrial Fibrillation A Nationwide Cohort Study. CHEST, 157(5), 1266-1277. doi:10.1016/j.chest.2019.11.025
Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus
Lip, G. Y. H., Keshishian, A. V., Kang, A. L., Li, X., Dhamane, A. D., Luo, X., . . . Deitelzweig, S. B. (2020). Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus. MAYO CLINIC PROCEEDINGS, 95(5), 929-943. doi:10.1016/j.mayocp.2019.05.032
Generating Hypotheses Is Great, but at Some Point We Just Need to Do the Trials and Get the Answers
O'Brien, B., & Lip, G. Y. H. (2020). Generating Hypotheses Is Great, but at Some Point We Just Need to Do the Trials and Get the Answers. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 34(5), 1162-1164. doi:10.1053/j.jvca.2019.12.035
Letter by Guo et al Regarding Article, "SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation"
Guo, Y., Lane, D. A., Chen, Y., & Lip, G. Y. H. (2020). Letter by Guo et al Regarding Article, "SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation". CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 13(5), 273-274. doi:10.1161/CIRCOUTCOMES.120.006635
Mobile health technology facilitates population screening and integrated care management in patients with atrial fibrillation
Guo, Y., Lane, D. A., Chen, Y., & Lip, G. Y. H. (2020). Mobile health technology facilitates population screening and integrated care management in patients with atrial fibrillation. EUROPEAN HEART JOURNAL, 41(17), 1617-1619. doi:10.1093/eurheartj/ehaa161
Compliance of Atrial Fibrillation Treatment with the Atrial Fibrillation Better Care (ABC) Pathway Improves the Clinical Outcomes in the Middle East Population: A Report from the Gulf Survey of Atrial Fibrillation Events (SAFE) Registry
Gumprecht, J., Domek, M., Proietti, M., Li, Y. -G., Asaad, N., Rashed, W., . . . Lip, G. Y. H. (2020). Compliance of Atrial Fibrillation Treatment with the Atrial Fibrillation Better Care (ABC) Pathway Improves the Clinical Outcomes in the Middle East Population: A Report from the Gulf Survey of Atrial Fibrillation Events (SAFE) Registry. JOURNAL OF CLINICAL MEDICINE, 9(5). doi:10.3390/jcm9051286
Incident Comorbidities, Aging and the Risk of Stroke in 608,108 Patients with Atrial Fibrillation: A Nationwide Analysis
Fauchier, L., Bodin, A., Bisson, A., Herbert, J., Spiesser, P., Clementy, N., . . . Lip, G. Y. H. (2020). Incident Comorbidities, Aging and the Risk of Stroke in 608,108 Patients with Atrial Fibrillation: A Nationwide Analysis. JOURNAL OF CLINICAL MEDICINE, 9(4). doi:10.3390/jcm9041234
In patients with SBP ≥ 130 mm Hg and CV risk, intensive vs standard BP control did not increase fear of falling
Shantsila, A., & Lip, G. Y. H. (2020). In patients with SBP ≥ 130 mm Hg and CV risk, intensive vs standard BP control did not increase fear of falling. ANNALS OF INTERNAL MEDICINE, 172(8), JC42. doi:10.7326/ACPJ202004210-042
In patients with no indication for anticoagulation after TAVR, rivaroxaban increased adverse events vs antiplatelets
Ding, W. Y., Field, M., & Lip, G. Y. H. (2020). In patients with no indication for anticoagulation after TAVR, rivaroxaban increased adverse events vs antiplatelets. ANNALS OF INTERNAL MEDICINE, 172(8), JC40. doi:10.7326/ACPJ202004210-040
Usefulness of P Wave Duration in Embolic Stroke of Undetermined Source
Jung, M., Kim, J. -S., Song, J. H., Kim, J. -M., Park, K. -Y., Lee, W. -S., . . . Shin, S. Y. (2020). Usefulness of P Wave Duration in Embolic Stroke of Undetermined Source. JOURNAL OF CLINICAL MEDICINE, 9(4). doi:10.3390/jcm9041134
Etiologic Workup in Cases of Cryptogenic Stroke: A Systematic Review of International Clinical Practice Guidelines.
McMahon, N. E., Bangee, M., Benedetto, V., Bray, E. P., Georgiou, R. F., Gibson, J. M. E., . . . Watkins, C. L. (2020). Etiologic Workup in Cases of Cryptogenic Stroke: A Systematic Review of International Clinical Practice Guidelines.. Stroke, STROKEAHA119027123. doi:10.1161/strokeaha.119.027123
Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation
Guo, Y., Lane, D. A., Wang, L., Zhang, H., Wang, H., Zhang, W., . . . Fulin, G. (2020). Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation. Journal of the American College of Cardiology, 75(13), 1523-1534. doi:10.1016/j.jacc.2020.01.052
The potential for photoplethysmographic (PPG)-based smart devices in atrial fibrillation detection
Harrison, S. L., Lane, D. A., Guo, Y., & Lip, G. Y. H. (2020). The potential for photoplethysmographic (PPG)-based smart devices in atrial fibrillation detection. EXPERT REVIEW OF MEDICAL DEVICES, 17(4), 253-255. doi:10.1080/17434440.2020.1740085
Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation?
Khan, A. A., Boriani, G., & Lip, G. Y. H. (2020). Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation?. CLINICAL RESEARCH IN CARDIOLOGY, 109(4), 409-416. doi:10.1007/s00392-019-01545-4
Association between clinical risk scores and mortality in atrial fibrillation: Systematic review and network meta-regression of 669,000 patients
Proietti, M., Farcomeni, A., Romiti, G. F., Di Rocco, A., Placentino, F., Diemberger, I., . . . Boriani, G. (2020). Association between clinical risk scores and mortality in atrial fibrillation: Systematic review and network meta-regression of 669,000 patients. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 27(6), 633-644. doi:10.1177/2047487318817662
Association of Oral Anticoagulants and Verapamil or Diltiazem With Adverse Bleeding Events in Patients With Nonvalvular Atrial Fibrillation and Normal Kidney Function
Pham, P., Schmidt, S., Lesko, L., Lip, G. Y. H., & Brown, J. D. (2020). Association of Oral Anticoagulants and Verapamil or Diltiazem With Adverse Bleeding Events in Patients With Nonvalvular Atrial Fibrillation and Normal Kidney Function. JAMA NETWORK OPEN, 3(4). doi:10.1001/jamanetworkopen.2020.3593
Clinical outcomes associated with kidney function changes in anticoagulated atrial fibrillation patients: An ancillary analysis from the BOREALIS trial
Bai, Y., Shantsila, A., & Lip, G. Y. H. (2020). Clinical outcomes associated with kidney function changes in anticoagulated atrial fibrillation patients: An ancillary analysis from the BOREALIS trial. JOURNAL OF ARRHYTHMIA, 36(2), 282-288. doi:10.1002/joa3.12306
Considerations when choosing an appropriate bleeding risk assessment tool for patients with atrial fibrillation
Ding, W. Y., Harrison, S. L., Lane, D. A., & Lip, G. Y. H. (2020). Considerations when choosing an appropriate bleeding risk assessment tool for patients with atrial fibrillation. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 18(4), 788-790. doi:10.1111/jth.14738
Device-Pocket Hematoma After Cardiac Implantable Electronic Devices
Notaristefano, F., Angeli, F., Verdecchia, P., Zingarini, G., Spighi, L., Annunziata, R., . . . Cavallini, C. (2020). Device-Pocket Hematoma After Cardiac Implantable Electronic Devices. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 13(4). doi:10.1161/CIRCEP.120.008372
Effect of Lesion Complexity and Clinical Risk Factors on the Efficacy and Safety of Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention A Subgroup Analysis From the REDUAL PCI Trial
Berry, N. C., Mauri, L., Steg, P. G., Bhatt, D. L., Hohnloser, S. H., Nordaby, M., . . . Cannon, C. P. (2020). Effect of Lesion Complexity and Clinical Risk Factors on the Efficacy and Safety of Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention A Subgroup Analysis From the REDUAL PCI Trial. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 13(4). doi:10.1161/CIRCINTERVENTIONS.119.008349
Rivaroxaban Versus Apixaban for Stroke Prevention in Atrial Fibrillation An Instrumental Variable Analysis of a Nationwide Cohort
Bonde, A. N., Martinussen, T., Lee, C. J. -Y., Lip, G. Y. H., Staerk, L., Bang, C. N., . . . Hlatky, M. A. (2020). Rivaroxaban Versus Apixaban for Stroke Prevention in Atrial Fibrillation An Instrumental Variable Analysis of a Nationwide Cohort. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 13(4). doi:10.1161/CIRCOUTCOMES.119.006058
The optimal drug adherence to maximize the efficacy and safety of non-vitamin K antagonist oral anticoagulant in real-world atrial fibrillation patients.
Kim, D., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -H., Uhm, J. -S., . . . Joung, B. (2020). The optimal drug adherence to maximize the efficacy and safety of non-vitamin K antagonist oral anticoagulant in real-world atrial fibrillation patients.. EP-Europace, 22(4), 547-557. doi:10.1093/europace/euz273
Adherence to the ABC (Atrial fibrillation Better Care) pathway in the Balkan region: the BALKAN-AF survey
Koziel, M., Simovic, S., Pavlovic, N., Kocijancic, A., Paparisto, V., Music, L., . . . Potpara, T. S. (2020). Adherence to the ABC (Atrial fibrillation Better Care) pathway in the Balkan region: the BALKAN-AF survey. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 130(3), 187-195. doi:10.20452/pamw.15146
Shape-Memory Actuation in Aligned Zirconia Nanofibers for Artificial Muscle Applications at Elevated Temperatures
Du, Z., Zhou, X., Ye, P., Zeng, X., & Gan, C. L. (2020). Shape-Memory Actuation in Aligned Zirconia Nanofibers for Artificial Muscle Applications at Elevated Temperatures. ACS Applied Nano Materials, 3(3), 2156-2166. doi:10.1021/acsanm.9b02073
Trends in antithrombotic management of patients with atrial fibrillation A report from the Polish part of the EURObservational Research Programme - Atrial Fibrillation General Long-Term Registry
Lodzinski, P., Gawalko, M., Budnik, M., Tyminska, A., Ozieranski, K., Grabowski, M., . . . Balsam, P. (2020). Trends in antithrombotic management of patients with atrial fibrillation A report from the Polish part of the EURObservational Research Programme - Atrial Fibrillation General Long-Term Registry. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 130(3), 196-205. doi:10.20452/pamw.15157
Heart rate variability changes following catheter ablation for atrial fibrillation
Shantsila, A., Gupta, D., & Lip, G. Y. H. (2020). Heart rate variability changes following catheter ablation for atrial fibrillation. KARDIOLOGIA POLSKA, 78(3), 179-180. doi:10.33963/KP.15249
REPLY: Observations From the Huawei Heart Study Using Photoplethysmography-Based Smart Devices for Atrial Fibrillation Screening
Guo, Y., Liu, T., Chen, Y., & Lip, G. Y. H. (2020). REPLY: Observations From the Huawei Heart Study Using Photoplethysmography-Based Smart Devices for Atrial Fibrillation Screening. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 75(11), 1366-1367. doi:10.1016/j.jacc.2020.01.021
Bodyweight fluctuation is associated with increased risk of incident atrial fibrillation
Lee, H. -J., Choi, E. -K., Han, K. -D., Lee, E., Moon, I., Lee, S. -R., . . . Lip, G. Y. H. (2020). Bodyweight fluctuation is associated with increased risk of incident atrial fibrillation. HEART RHYTHM, 17(3), 365-371. doi:10.1016/j.hrthm.2019.09.029
Comparison of the Effect of Age (< 75 Versus ≥75) on the Efficacy and Safety of Dual Therapy (Dabigatran plus Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin plus Aspirin plus Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the RE-DUAL PCI Trial)
ten Berg, J. M., Steg, P. G., Bhatt, D. L., Hohnloser, S. H., de Veer, A., Nordaby, M., . . . Cannon, C. P. (2020). Comparison of the Effect of Age (< 75 Versus ≥75) on the Efficacy and Safety of Dual Therapy (Dabigatran plus Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin plus Aspirin plus Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the RE-DUAL PCI Trial). AMERICAN JOURNAL OF CARDIOLOGY, 125(5), 735-743. doi:10.1016/j.amjcard.2019.11.029
Effectiveness and Safety of Direct Oral Anticoagulants in Relation to Temporal Changes in Their Use
Lee, S. -R., Choi, E. -K., Kwon, S., Jung, J. -H., Han, K. -D., Cha, M. -J., . . . Lip, G. Y. H. (2020). Effectiveness and Safety of Direct Oral Anticoagulants in Relation to Temporal Changes in Their Use. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 13(3). doi:10.1161/CIRCOUTCOMES.119.005894
Galectin-3 and risk of atrial fibrillation: A systematic review and meta-analysis
Gong, M., Cheung, A., Wang, Q. -S., Li, G., Goudis, C. A., Bazoukis, G., . . . Liu, T. (2020). Galectin-3 and risk of atrial fibrillation: A systematic review and meta-analysis. JOURNAL OF CLINICAL LABORATORY ANALYSIS, 34(3). doi:10.1002/jcla.23104
Haptoglobin genotype and outcome after spontaneous intracerebral haemorrhage
Hostettler, I. C., Morton, M. J., Ambler, G., Kazmi, N., Gaunt, T., Wilson, D., . . . Werring, D. J. (2020). Haptoglobin genotype and outcome after spontaneous intracerebral haemorrhage. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 91(3), 298-304. doi:10.1136/jnnp-2019-321774
Management of atrial fibrillation in patients with chronic kidney disease in clinical practice: a joint European Heart Rhythm Association (EHRA) and European Renal Association/European Dialysis and Transplantation Association (ERA/EDTA) physician-based survey
Potpara, T. S., Ferro, C., Lip, G. Y. H., Dan, G. A., Lenarczyk, R., Mallamaci, F., . . . Dagres, N. (2020). Management of atrial fibrillation in patients with chronic kidney disease in clinical practice: a joint European Heart Rhythm Association (EHRA) and European Renal Association/European Dialysis and Transplantation Association (ERA/EDTA) physician-based survey. EUROPACE, 22(3), 496-505. doi:10.1093/europace/euz358
One-year all-cause mortality risk among atrial fibrillation patients in Middle East with and without diabetes: The Gulf SAFE registry
Domek, M., Li, Y. -G., Gumprecht, J., Asaad, N., Rashed, W., Alsheikh-Ali, A., . . . Lip, G. Y. H. (2020). One-year all-cause mortality risk among atrial fibrillation patients in Middle East with and without diabetes: The Gulf SAFE registry. INTERNATIONAL JOURNAL OF CARDIOLOGY, 302, 47-52. doi:10.1016/j.ijcard.2019.12.061
Stroke prevention in elderly patients with non-valvular atrial fibrillation in the BALKAN-AF survey
Potpara, T. S., Simovic, S., Pavlovic, N., Nedeljkovic, M., Paparisto, V., Music, L., . . . Lip, G. Y. H. (2020). Stroke prevention in elderly patients with non-valvular atrial fibrillation in the BALKAN-AF survey. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 50(3). doi:10.1111/eci.13200
Triple therapy in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention/stenting.
Kozieł, M., Potpara, T. S., & Lip, G. Y. H. (2020). Triple therapy in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention/stenting.. Research and practice in thrombosis and haemostasis, 4(3), 357-365. doi:10.1002/rth2.12319
Assessment of Arterial Stiffness in Patients With Resistant Hypertension: Additional Insights Into the Pathophysiology of This Condition?
Alsharari, R., Lip, G. Y. H., & Shantsila, A. (2020). Assessment of Arterial Stiffness in Patients With Resistant Hypertension: Additional Insights Into the Pathophysiology of This Condition?. AMERICAN JOURNAL OF HYPERTENSION, 33(2), 107-115. doi:10.1093/ajh/hpz169
Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies
Ding, W. Y., Harrison, S., Gupta, D., Lip, G. Y. H., & Lane, D. A. (2020). Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies. FRONTIERS IN MEDICINE, 7. doi:10.3389/fmed.2020.00054
Oral Anticoagulants and Antiplatelet Agents in Patients With Atrial Fibrillation and Concomitant Critical Limb Ischemia: A Nationwide Cohort Study.
Lee, H. -F., Chan, Y. -H., Li, P. -R., Liu, J. -R., Chao, T. -F., Wu, L. -S., . . . Lip, G. Y. H. (2020). Oral Anticoagulants and Antiplatelet Agents in Patients With Atrial Fibrillation and Concomitant Critical Limb Ischemia: A Nationwide Cohort Study.. The Canadian Journal of Cardiology. doi:10.1016/j.cjca.2020.02.071
Endothelial function in patients with atrial fibrillation
Khan, A. A., Thomas, G. N., Lip, G. Y. H., & Shantsila, A. (2020). Endothelial function in patients with atrial fibrillation. ANNALS OF MEDICINE, 52(1-2), 1-11. doi:10.1080/07853890.2019.1711158
Evolution of the Editorial Board Underpins a Commitment to Change and Innovation
Katritsis, D. G. (2020). Evolution of the Editorial Board Underpins a Commitment to Change and Innovation. Arrhythmia & Electrophysiology Review, 8(4), 238-239. doi:10.15420/aer.8.4.fo1
Imaging, biomarker and invasive assessment of diffuse left ventricular myocardial fibrosis in atrial fibrillation
Begg, G. A., Swoboda, P. P., Karim, R., Oesterlein, T., Rhode, K., Holden, A. V., . . . Tayebjee, M. H. (2020). Imaging, biomarker and invasive assessment of diffuse left ventricular myocardial fibrosis in atrial fibrillation. JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 22(1). doi:10.1186/s12968-020-0603-y
Blood Pressure Variability and Incidence of New-Onset Atrial Fibrillation A Nationwide Population-Based Study
Lee, S. -R., Choi, Y. -J., Choi, E. -K., Han, K. -D., Lee, E., Cha, M. -J., . . . Lip, G. Y. H. (2020). Blood Pressure Variability and Incidence of New-Onset Atrial Fibrillation A Nationwide Population-Based Study. HYPERTENSION, 75(2), 309-315. doi:10.1161/HYPERTENSIONAHA.119.13708
Challenges in stroke prevention among very elderly patients with atrial fibrillation: discerning facts from prejudices
Potpara, T. S., Mujovic, N., & Lip, G. Y. H. (2020). Challenges in stroke prevention among very elderly patients with atrial fibrillation: discerning facts from prejudices. EUROPACE, 22(2), 173-176. doi:10.1093/europace/euz344
Dabigatran Persistence and Outcomes Following Discontinuation in Atrial Fibrillation Patients from the GLORIA-AF Registry
Paquette, M., Franca, L. R., Teutsch, C., Diener, H. -C., Lu, S., Dubner, S. J., . . . Nieuwlaat, R. (2020). Dabigatran Persistence and Outcomes Following Discontinuation in Atrial Fibrillation Patients from the GLORIA-AF Registry. AMERICAN JOURNAL OF CARDIOLOGY, 125(3), 383-391. doi:10.1016/j.amjcard.2019.10.047
Diagnosis and risk stratification of chest pain patients in the emergency department: focus on acute coronary syndromes. A position paper of the Acute Cardiovascular Care Association
Stepinska, J., Lettino, M., Ahrens, I., Bueno, H., Garcia-Castrillo, L., Khoury, A., . . . Huber, K. (2020). Diagnosis and risk stratification of chest pain patients in the emergency department: focus on acute coronary syndromes. A position paper of the Acute Cardiovascular Care Association. EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 9(1), 76-89. doi:10.1177/2048872619885346
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update
Glikson, M., Wolff, R., Hindricks, G., Mandrola, J., Camm, A. J., Lip, G. Y. H., . . . Meier, B. (2020). EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update. EUROPACE, 22(2). doi:10.1093/europace/euz258
Editorial commentary: Reversal agents in the era of non-vitamin k antagonists oral anticoagulants: Necessity or psychological crutch?
Dzeshka, M. S., & Lip, G. Y. H. (2020). Editorial commentary: Reversal agents in the era of non-vitamin k antagonists oral anticoagulants: Necessity or psychological crutch?. TRENDS IN CARDIOVASCULAR MEDICINE, 30(2), 91-92. doi:10.1016/j.tcm.2019.04.007
Management of patients with newly-diagnosed atrial fibrillation: Insights from the BALKAN-AF survey.
Kozieł, M., Simovic, S., Pavlovic, N., Nedeljkovic, M., Paparisto, V., Music, L., . . . BALKAN-AF investigators. (2020). Management of patients with newly-diagnosed atrial fibrillation: Insights from the BALKAN-AF survey.. International journal of cardiology. Heart & vasculature, 26, 100461. doi:10.1016/j.ijcha.2019.100461
Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage
Lee, S. -R., Choi, E. -K., Kwon, S., Jung, J. -H., Han, K. -D., Cha, M. -J., . . . Lip, G. Y. H. (2020). Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage. STROKE, 51(2), 416-423. doi:10.1161/STROKEAHA.119.028030
Regional registries on the management of atrial fibrillation: Essential pieces in the global puzzle.
Gumprecht, J., Lip, G. Y. H., & Potpara, T. S. (2020). Regional registries on the management of atrial fibrillation: Essential pieces in the global puzzle.. International journal of cardiology. Heart & vasculature, 26, 100473. doi:10.1016/j.ijcha.2020.100473
Revisiting the dynamic risks of incident atrial fibrillation: does the use of nonsteroidal anti-inflammatory drugs contribute to risk?
Harrison, S. L., O'Flaherty, M., & Lip, G. Y. H. (2020). Revisiting the dynamic risks of incident atrial fibrillation: does the use of nonsteroidal anti-inflammatory drugs contribute to risk?. QJM : monthly journal of the Association of Physicians, 113(2), 77-78. doi:10.1093/qjmed/hcz310
The year in cardiology: arrhythmias and pacing: The year in cardiology 2019
Camm, A. J., Lip, G. Y. H., Schilling, R., Calkins, H., & Steffel, J. (2020). The year in cardiology: arrhythmias and pacing: The year in cardiology 2019. EUROPEAN HEART JOURNAL, 41(5), 619-+. doi:10.1093/eurheartj/ehz931
Which patients with atrial fibrillation undergo an ablation procedure today in Europe? A report from the ESC-EHRA-EORP Atrial Fibrillation Ablation Long-Term and Atrial Fibrillation General Pilot Registries
Tilz, R. R., Dagres, N., Arbelo, E., Blomstroem-Lundqvist, C., Crijns, H. J., Kirchhof, P., . . . Tavazzi, L. (2020). Which patients with atrial fibrillation undergo an ablation procedure today in Europe? A report from the ESC-EHRA-EORP Atrial Fibrillation Ablation Long-Term and Atrial Fibrillation General Pilot Registries. EUROPACE, 22(2), 250-258. doi:10.1093/europace/euz291
Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post PCI in Patients With Atrial Fibrillation
Steg, P. G., Ducrocq, G., Bhatt, D. L., Hohnloser, S. H., Nordaby, M., Miede, C., . . . Cannon, C. P. (2020). Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post PCI in Patients With Atrial Fibrillation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 75(2), 238-240. doi:10.1016/j.jacc.2019.09.072
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update
Glikson, M., Wolff, R., Hindricks, G., Mandrola, J., Camm, A. J., Lip, G. Y. H., . . . Meier, B. (2020). EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update. EUROINTERVENTION, 15(13), 1133-+. doi:10.4244/EIJY19M08_01
Association of Body Mass Index With Clinical Outcomes in Patients With Atrial Fibrillation: A Report From the FANTASIIA Registry
Bertomeu-Gonzalez, V., Moreno-Arribas, J., Esteve-Pastor, M. A., Roldan-Rabadan, I., Muniz, J., Rana-Miguez, P., . . . Marin, F. (2020). Association of Body Mass Index With Clinical Outcomes in Patients With Atrial Fibrillation: A Report From the FANTASIIA Registry. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 9(1). doi:10.1161/JAHA.119.013789
Cognitive Impairment Before Atrial Fibrillation-Related Ischemic Events: Neuroimaging and Prognostic Associations
Banerjee, G., Chan, E., Ambler, G., Wilson, D., Cipolotti, L., Shakeshaft, C., . . . Werring, D. J. (2020). Cognitive Impairment Before Atrial Fibrillation-Related Ischemic Events: Neuroimaging and Prognostic Associations. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 9(1). doi:10.1161/JAHA.119.014537
A Toast to the Last Decade and a Very Happy 2020 from Thrombosis and Haemostasis!
Lip, G. Y. H., Rigby, A., & Weber, C. (2020). A Toast to the Last Decade and a Very Happy 2020 from Thrombosis and Haemostasis!. THROMBOSIS AND HAEMOSTASIS, 120(1), 1-4. doi:10.1055/s-0039-3402054
Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme
Mazurek, M., Halperin, J. L., Huisman, M. V., Diener, H. -C., Dubner, S. J., Ma, C. S., . . . Lip, G. Y. H. (2020). Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme. EUROPACE, 22(1), 47-57. doi:10.1093/europace/euz278
Atrial Fibrillation in Heart Failure Focus on Antithrombotic Management
Obeidat, M., Burgess, M., & Lip, G. Y. H. (2020). Atrial Fibrillation in Heart Failure Focus on Antithrombotic Management. HEART FAILURE CLINICS, 16(1), 107-+. doi:10.1016/j.hfc.2019.08.007
Atrial high-rate episodes and risk of major adverse cardiovascular events in patients with cardiac implantable electronic devices
Pastori, D., Miyazawa, K., Li, Y., Szekely, O., Shahid, F., Farcomeni, A., & Lip, G. Y. H. (2020). Atrial high-rate episodes and risk of major adverse cardiovascular events in patients with cardiac implantable electronic devices. CLINICAL RESEARCH IN CARDIOLOGY, 109(1), 96-102. doi:10.1007/s00392-019-01493-z
Clinical performance of the atrial fibrillation in the russian population depending on the antithrombotic therapy: Findings from the gloria-af registry phase 2
Shlyakhto, E. V., Villevalde, S. V., Ezhov, A. V., Zenin, S. A., Koziolova, N. A., Korennova, O. Y., . . . Huisman, M. V. (2020). Clinical performance of the atrial fibrillation in the russian population depending on the antithrombotic therapy: Findings from the gloria-af registry phase 2. Russian Journal of Cardiology, 25(11), 73-84. doi:10.15829/1560-4071-2020-4179
Evaluation of the C<sub>2</sub>HEST Risk Score as a Possible Opportunistic Screening Tool for Incident Atrial Fibrillation in a Healthy Population (From a Nationwide Danish Cohort Study)
Lip, G. Y. H., Skjoth, F., Nielsen, P. B., & Larsen, T. B. (2020). Evaluation of the C<sub>2</sub>HEST Risk Score as a Possible Opportunistic Screening Tool for Incident Atrial Fibrillation in a Healthy Population (From a Nationwide Danish Cohort Study). AMERICAN JOURNAL OF CARDIOLOGY, 125(1), 48-54. doi:10.1016/j.amjcard.2019.09.034
Frailty and Anticoagulant Therapy in Patients Aged 65 Years or Older with Atrial Fibrillation
Liu, J., Du, X., Li, M., Jia, Z., Lu, S., Chang, S., . . . Ma, C. (2020). Frailty and Anticoagulant Therapy in Patients Aged 65 Years or Older with Atrial Fibrillation. Cardiovascular Innovations and Applications, 4(3). doi:10.15212/cvia.2019.0562
Malignant hypertension: does this still exist?
Domek, M., Gumprecht, J., Lip, G. Y. H., & Shantsila, A. (2020). Malignant hypertension: does this still exist?. JOURNAL OF HUMAN HYPERTENSION, 34(1), 1-4. doi:10.1038/s41371-019-0267-y
Reducing risk of adverse cardiovascular and renal outcomes for patients with atrial fibrillation and type 2 diabetes
Harrison, S. L., Lane, D. A., & Lip, G. Y. H. (2020). Reducing risk of adverse cardiovascular and renal outcomes for patients with atrial fibrillation and type 2 diabetes. EUROPEAN JOURNAL OF HEART FAILURE, 22(1), 136-138. doi:10.1002/ejhf.1685
Response by Lee et al to Letter Regarding Article, "Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage"
Lee, S. -R., Choi, E. -K., & Lip, G. Y. H. (2020). Response by Lee et al to Letter Regarding Article, "Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage". STROKE, 51(6), E112. doi:10.1161/STROKEAHA.120.029551
Revisiting the effects of omitting aspirin in combined antithrombotic therapies for atrial fibrillation and acute coronary syndromes or percutaneous coronary interventions: meta-analysis of pooled data from the PIONEER AF-PCI, RE-DUAL PCI, and AUGUSTUS trials
Potpara, T. S., Mujovic, N., Proietti, M., Dagres, N., Hindricks, G., Collet, J. -P., . . . Lip, G. Y. H. (2020). Revisiting the effects of omitting aspirin in combined antithrombotic therapies for atrial fibrillation and acute coronary syndromes or percutaneous coronary interventions: meta-analysis of pooled data from the PIONEER AF-PCI, RE-DUAL PCI, and AUGUSTUS trials. EUROPACE, 22(1), 33-46. doi:10.1093/europace/euz259
Risk Stratification for Ischemic Cerebrovascular Events and Mortality among Intracerebral Hemorrhage Patients with and without Atrial Fibrillation: A Nationwide Cohort Study
Nielsen, P. B., Overvad, T. F., Andersen, S. D., Larsen, T. B., Skjoth, F., Sogaard, M., & Lip, G. Y. H. (2019). Risk Stratification for Ischemic Cerebrovascular Events and Mortality among Intracerebral Hemorrhage Patients with and without Atrial Fibrillation: A Nationwide Cohort Study. CEREBROVASCULAR DISEASES, 48(3-6), 236-243. doi:10.1159/000504926
Screening for Atrial Fibrillation: Improving Efficiency of Manual Review of Handheld Electrocardiograms <sup>†</sup>.
Pandiaraja, M., Brimicombe, J., Cowie, M., Dymond, A., Lindén, H. C., Lip, G. Y. H., . . . Charlton, P. H. (2020). Screening for Atrial Fibrillation: Improving Efficiency of Manual Review of Handheld Electrocardiograms <sup>†</sup>.. Engineering proceedings, 2(1), 78. doi:10.3390/ecsa-7-08195
Social Inequalities of Oral Anticoagulation after the Introduction of Non-Vitamin K Antagonists in Patients with Atrial Fibrillation
Yu, H. T., Yang, P. -S., Hwang, J., Ryu, S., Jang, E., Kim, T. -H., . . . Joung, B. (2020). Social Inequalities of Oral Anticoagulation after the Introduction of Non-Vitamin K Antagonists in Patients with Atrial Fibrillation. KOREAN CIRCULATION JOURNAL, 50(3), 267-277. doi:10.4070/kcj.2019.0207
Spironolactone to improve exercise tolerance in people with permanent atrial fibrillation and preserved ejection fraction: the IMPRESS-AF RCT
Shantsila, E., Shahid, F., Sun, Y., Deeks, J. J., Haynes, R., Calvert, M., . . . Lip, G. Y. H. (2020). Spironolactone to improve exercise tolerance in people with permanent atrial fibrillation and preserved ejection fraction: the IMPRESS-AF RCT.
Stroke in Heart Failure
Essa, H., Sankaranarayanan, R., & Lip, G. Y. H. (2020). Stroke in Heart Failure. CLINICAL EPIDEMIOLOGY, 12, 1245-1247. doi:10.2147/CLEP.S270702
The Continuum of Stroke Prevention in Patients with Atrial Fibrillation in Clinical Practice: “Learning Curves”, New Challenges and Unmet Needs Across the Globe
Miroslav, M., & Tatjana, P. (2020). The Continuum of Stroke Prevention in Patients with Atrial Fibrillation in Clinical Practice: “Learning Curves”, New Challenges and Unmet Needs Across the Globe. Revista Argentina de Cardiologia, 88(4), 279-281. doi:10.7775/rac.v88.i4.18624
The safety of discontinuation of oral anticoagulation therapy after apparently successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry study
Yang, W. -Y., Du, X., Jiang, C., He, L., Fawzy, A. M., Wang, L., . . . Ma, C. -S. (2020). The safety of discontinuation of oral anticoagulation therapy after apparently successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry study. EUROPACE, 22(1), 90-99. doi:10.1093/europace/euz235
Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study
Lau, W. C. Y., Douglas, I. J., Wong, I. C. K., Smeeth, L., Lip, G. Y. H., Leung, W. K., . . . Chan, E. W. (2020). Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study. HEART RHYTHM, 17(1), 33-40. doi:10.1016/j.hrthm.2019.07.034
Thrombosis and Haemostasis 2019 Editor's Choice Papers
Weber, C., Rigby, A., & Lip, G. Y. H. (2020). Thrombosis and Haemostasis 2019 Editor's Choice Papers. THROMBOSIS AND HAEMOSTASIS, 120(1), 184-189. doi:10.1055/s-0039-3402055
Towards Assigning Diagnosis Codes Using Medication History
Sagi, T., Hansen, E. R., Hose, K., Lip, G. Y. H., Bjerregaard Larsen, T., & Skjøth, F. (2020). Towards Assigning Diagnosis Codes Using Medication History. In Unknown Conference (pp. 203-213). Springer International Publishing. doi:10.1007/978-3-030-59137-3_19
2019
Effectiveness and Safety of Direct Oral Anticoagulant for Secondary Prevention in Asians with Atrial Fibrillation
Park, J., Lee, S. -R., Choi, E. -K., Kwon, S., Jung, J. -H., Do-Han, K., . . . Lip, G. Y. H. (2019). Effectiveness and Safety of Direct Oral Anticoagulant for Secondary Prevention in Asians with Atrial Fibrillation. JOURNAL OF CLINICAL MEDICINE, 8(12). doi:10.3390/jcm8122228
Etiologic workup in cases of cryptogenic stroke: protocol for a systematic review and comparison of international clinical practice guidelines
Bray, E. P., McMahon, N. E., Bangee, M., Al-Khalidi, A. H., Benedetto, V., Chauhan, U., . . . Watkins, C. L. (2019). Etiologic workup in cases of cryptogenic stroke: protocol for a systematic review and comparison of international clinical practice guidelines. SYSTEMATIC REVIEWS, 8(1). doi:10.1186/s13643-019-1247-6
In older patients with AF, antiarrhythmic drugs were linked to fall-related injuries and syncope vs rate-lowering drugs
Gumprecht, J., & Lip, G. Y. H. (2019). In older patients with AF, antiarrhythmic drugs were linked to fall-related injuries and syncope vs rate-lowering drugs. ANNALS OF INTERNAL MEDICINE, 171(12), JC71. doi:10.7326/ACPJ201912170-071
Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation
Miguel Rivera-Caravaca, J., Marin, F., Asuncion Esteve-Pastor, M., Galvez, J., Lip, G. Y. H., Vicente, V., & Roldan, V. (2019). Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation. BMJ OPEN, 9(12). doi:10.1136/bmjopen-2019-033712
Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post-PCI in Patients With Atrial Fibrillation and Diabetes
Maeng, M., Steg, P. G., Bhatt, D. L., Hohnloser, S. H., Nordaby, M., Miede, C., . . . Cannon, C. P. (2019). Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post-PCI in Patients With Atrial Fibrillation and Diabetes. JACC-CARDIOVASCULAR INTERVENTIONS, 12(23), 2346-2355. doi:10.1016/j.jcin.2019.07.059
Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation The RE-DUAL PCI Trial Subanalysis
ten Berg, J. M., de Veer, A., Oldgren, J., Steg, P. G., Zateyshchikov, D. A., Jansky, P., . . . Cannon, C. P. (2019). Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation The RE-DUAL PCI Trial Subanalysis. JACC-CARDIOVASCULAR INTERVENTIONS, 12(23), 2331-2341. doi:10.1016/j.jcin.2019.08.039
Estimating individual lifetime benefit and bleeding risk of adding oral anticoagulation to aspirin for patients with stable cardiovascular disease: directions from COMPASS?
Koziel, M., & Lip, G. Y. H. (2019). Estimating individual lifetime benefit and bleeding risk of adding oral anticoagulation to aspirin for patients with stable cardiovascular disease: directions from COMPASS?. EUROPEAN HEART JOURNAL, 40(46), 3779-3781. doi:10.1093/eurheartj/ehz517
Non-vitamin K antagonist oral anticoagulants beyond atrial fibrillation: what did we learn from COMPASS and COMMANDER-HF?
Khan, A. A., & Lip, G. Y. H. (2019). Non-vitamin K antagonist oral anticoagulants beyond atrial fibrillation: what did we learn from COMPASS and COMMANDER-HF?. EUROPEAN HEART JOURNAL, 40(46), 3754-3756. doi:10.1093/eurheartj/ehz005
Oral anticoagulation among atrial fibrillation patients with anaemia: an observational cohort study
Bonde, A. N., Blanche, P., Staerk, L., Gerds, T. A., Gundlund, A., Gislason, G., . . . Olesen, J. B. (2019). Oral anticoagulation among atrial fibrillation patients with anaemia: an observational cohort study. EUROPEAN HEART JOURNAL, 40(46), 3782-3790. doi:10.1093/eurheartj/ehz155
Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group
Barkun, A. N., Almadi, M., Kuipers, E. J., Laine, L., Sung, J., Tse, F., . . . Bardou, M. (2019). Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group. ANNALS OF INTERNAL MEDICINE, 171(11), 805-+. doi:10.7326/M19-1795
Thrombotic Profile and Oral Anticoagulation in Asian and Non-Asian Patients With Nonvalvular Atrial Fibrillation
Gue, Y. X., Inoue, N., Spinthakis, N., Takei, A., Takahara, H., Otsui, K., . . . Gorog, D. A. (2019). Thrombotic Profile and Oral Anticoagulation in Asian and Non-Asian Patients With Nonvalvular Atrial Fibrillation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 74(22), 2822-2824. doi:10.1016/j.jacc.2019.01.079
Fluctuating renal function and the risk of incident atrial fibrillation: a nationwide population-based study
Kwon, S., Lee, S. -R., Choi, E. -K., Han, K. -D., Yang, S., Lee, S. -Y., . . . Lip, G. Y. H. (2019). Fluctuating renal function and the risk of incident atrial fibrillation: a nationwide population-based study. SCIENTIFIC REPORTS, 9. doi:10.1038/s41598-019-54528-w
Safety and effectiveness of dabigatran at 2 years: Final outcomes from Phase II of the GLORIA-AF registry program.
Mazurek, M., Teutsch, C., Diener, H. -C., Dubner, S. J., Halperin, J. L., Ma, C. -S., . . . GLORIA-AF Investigators. (2019). Safety and effectiveness of dabigatran at 2 years: Final outcomes from Phase II of the GLORIA-AF registry program.. American heart journal, 218, 123-127. doi:10.1016/j.ahj.2019.08.012
<i>C9orf72</i> and intracerebral hemorrhage
Hostettler, I. C., Bernal-Quiros, M., Wong, A., Sharma, N., Wilson, D., Seiffge, D. J., . . . Houlden, H. (2019). <i>C9orf72</i> and intracerebral hemorrhage. NEUROBIOLOGY OF AGING, 84. doi:10.1016/j.neurobiolaging.2019.07.007
Association Between Digoxin Use and Adverse Outcomes Among Patients in the Chinese Atrial Fibrillation Registry
Gao, Y., Chang, S., Du, X., Dong, J., Xu, X., Zhou, Y., . . . Ma, C. (2019). Association Between Digoxin Use and Adverse Outcomes Among Patients in the Chinese Atrial Fibrillation Registry. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 19(6), 579-587. doi:10.1007/s40256-019-00350-8
Behavior of Resorcinol based Phthalonitrile as High Temperature Encapsulant
Tay, Y. S., Phua, J. R. E., & Gan, C. L. (2019). Behavior of Resorcinol based Phthalonitrile as High Temperature Encapsulant. In 2019 IEEE 21st Electronics Packaging Technology Conference (EPTC) (pp. 711-715). IEEE. doi:10.1109/eptc47984.2019.9026569
Cognitive Decline Over Time in Patients With Systolic Heart Failure Insights From WARCEF
Lee, T. C., Qian, M., Liu, Y., Graham, S., Mann, D. L., Nakanishi, K., . . . Di Tullio, M. R. (2019). Cognitive Decline Over Time in Patients With Systolic Heart Failure Insights From WARCEF. JACC-HEART FAILURE, 7(12), 1042-1053. doi:10.1016/j.jchf.2019.09.003
Comparison of Risk Scores for the Prediction of the Overall Cardiovascular Risk in Patients with Ischemic Stroke: The Athens Stroke Registry
Georgiopoulos, G., Ntaios, G., Stamatelopoulos, K., Manios, E., Korompoki, E., Vemmou, E., . . . Vemmos, K. (2019). Comparison of Risk Scores for the Prediction of the Overall Cardiovascular Risk in Patients with Ischemic Stroke: The Athens Stroke Registry. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 28(12). doi:10.1016/j.jstrokecerebrovasdis.2019.104415
Differences in outcomes between oral anticoagulation “new starters” and “switchers” in patients with nonvalvular atrial fibrillation: A pooled analysis of the AMADEUS and BOREALIS trials
Bai, Y., Shantsila, A., & Lip, G. Y. H. (2019). Differences in outcomes between oral anticoagulation "new starters" and "switchers" in patients with nonvalvular atrial fibrillation: A pooled analysis of the AMADEUS and BOREALIS trials. JOURNAL OF ARRHYTHMIA, 35(6), 815-820. doi:10.1002/joa3.12255
Integrated care for the management of atrial fibrillation: what are the key components and important outcomes?
Lane, D. A., & Lip, G. Y. H. (2019). Integrated care for the management of atrial fibrillation: what are the key components and important outcomes?. EUROPACE, 21(12), 1759-1761. doi:10.1093/europace/euz211
Invited review: hypertension and atrial fibrillation: epidemiology, pathophysiology, and implications for management
Gumprecht, J., Domek, M., Lip, G. Y. H., & Shantsila, A. (2019). Invited review: hypertension and atrial fibrillation: epidemiology, pathophysiology, and implications for management. JOURNAL OF HUMAN HYPERTENSION, 33(12), 824-836. doi:10.1038/s41371-019-0279-7
Long-Term Relationship Between Atrial Fibrillation, Multimorbidity and Oral Anticoagulant Drug Use
Proietti, M., Marzona, I., Vannini, T., Tettamanti, M., Fortino, I., Merlino, L., . . . Nobili, A. (2019). Long-Term Relationship Between Atrial Fibrillation, Multimorbidity and Oral Anticoagulant Drug Use. MAYO CLINIC PROCEEDINGS, 94(12), 2427-2436. doi:10.1016/j.mayocp.2019.06.012
Mechanical response of lightweight hollow truss metal oxide lattices
Kanaujia, P. K., bin Ramezan, M. A., Yap, X. Y., Song, Y., Du, Z., Gan, C. L., . . . Lai, C. Q. (2019). Mechanical response of lightweight hollow truss metal oxide lattices. Materialia, 8, 100439. doi:10.1016/j.mtla.2019.100439
Novel Echocardiographic Biomarkers in the Management of Atrial Fibrillation
Gumprecht, J., Szulik, M., Domek, M., Mazurek, M., Shantsila, A., Oxborough, D., & Lip, G. Y. H. (2019). Novel Echocardiographic Biomarkers in the Management of Atrial Fibrillation. CURRENT CARDIOVASCULAR IMAGING REPORTS, 12(12). doi:10.1007/s12410-019-9520-6
Oral anticoagulation versus antiplatelet or placebo for stroke prevention in patients with heart failure and sinus rhythm: Systematic review and meta-analysis of randomized controlled trials
Ntaios, G., Vemmos, K., & Lip, G. Y. H. (2019). Oral anticoagulation versus antiplatelet or placebo for stroke prevention in patients with heart failure and sinus rhythm: Systematic review and meta-analysis of randomized controlled trials. INTERNATIONAL JOURNAL OF STROKE, 14(9), 856-861. doi:10.1177/1747493019877296
Prevalence of modifiable risk factors and relation to stroke and death in patients with atrial fibrillation: A report from the China atrial fibrillation registry study
Jiang, C., Lan, D. -H., Du, X., Geng, Y. -P., Chang, S. -S., Zheng, D., . . . Ma, C. -S. (2019). Prevalence of modifiable risk factors and relation to stroke and death in patients with atrial fibrillation: A report from the China atrial fibrillation registry study. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 30(12), 2759-2767. doi:10.1111/jce.14231
Real-world Comparisons of Direct Oral Anticoagulants for Stroke Prevention in Asian Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis
Chan, Y. -H., Lee, H. -F., Chao, T. -F., Wu, C. -T., Chang, S. -H., Yeh, Y. -H., . . . Lip, G. Y. H. (2019). Real-world Comparisons of Direct Oral Anticoagulants for Stroke Prevention in Asian Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis. CARDIOVASCULAR DRUGS AND THERAPY, 33(6), 701-710. doi:10.1007/s10557-019-06910-z
Thromboembolic risks associated with paroxysmal and persistent atrial fibrillation in Asian patients: a report from the Chinese atrial fibrillation registry
Wang, Y., Ma, C. -S., Du, X., He, L., Li, J., Wang, G. -H., . . . Lip, G. Y. H. (2019). Thromboembolic risks associated with paroxysmal and persistent atrial fibrillation in Asian patients: a report from the Chinese atrial fibrillation registry. BMC CARDIOVASCULAR DISORDERS, 19(1). doi:10.1186/s12872-019-1260-7
Searching for Atrial Fibrillation Poststroke A White Paper of the AF-SCREEN International Collaboration
Schnabel, R. B., Haeusler, K. G., Healey, J. S., Freedman, B., Boriani, G., Brachmann, J., . . . Yan, B. (2019). Searching for Atrial Fibrillation Poststroke A White Paper of the AF-SCREEN International Collaboration. CIRCULATION, 140(22), 1834-1850. doi:10.1161/CIRCULATIONAHA.119.040267
Prevalence and Associated Stroke Risk of Human Immunodeficiency Virus-Infected Patients With Atrial Fibrillation - A Nationwide Cohort Study.
Jung, H., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -H., Uhm, J. -S., . . . Joung, B. (2019). Prevalence and Associated Stroke Risk of Human Immunodeficiency Virus-Infected Patients With Atrial Fibrillation - A Nationwide Cohort Study.. Circulation journal : official journal of the Japanese Circulation Society, 83(12), 2547-2554. doi:10.1253/circj.cj-19-0527
Usefulness of Red Cells Distribution Width to Predict Worse Outcomes in Patients With Atrial Fibrillation
Malavasi, V. L., Proietti, M., Spagni, S., Valenti, A. C., Battista, A., Pettorelli, D., . . . Boriani, G. (2019). Usefulness of Red Cells Distribution Width to Predict Worse Outcomes in Patients With Atrial Fibrillation. AMERICAN JOURNAL OF CARDIOLOGY, 124(10), 1561-1567. doi:10.1016/j.amjcard.2019.08.008
Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation Post-PCI
Lip, G. Y. H., Bhatt, D. L., Hohnloser, S. H., Kimura, T., Miede, C., Nordaby, M., . . . Cannon, C. P. (2019). Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation Post-PCI. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 74(19), 2431-2433. doi:10.1016/j.jacc.2019.09.009
Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation
Guo, Y., Wang, H., Zhang, H., Liu, T., Liang, Z., Xia, Y., . . . Investigators, M. A. F. A. I. I. (2019). Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 74(19), 2365-2375. doi:10.1016/j.jacc.2019.08.019
Guideline-Adherent Treatment for Stroke and Death in Atrial Fibrillation Patients From UK and Japanese AF Registries.
Miyazawa, K., Ogawa, H., Mazurek, M., Shantsila, E., Lane, D. A., Wolff, A., . . . Lip, G. Y. H. (2019). Guideline-Adherent Treatment for Stroke and Death in Atrial Fibrillation Patients From UK and Japanese AF Registries.. Circulation journal : official journal of the Japanese Circulation Society, 83(12), 2434-2442. doi:10.1253/circj.cj-19-0546
A Time to Stop and Think Before the Shock
Mandrola, J., Lip, G. Y. H., & Foy, A. (2019). A Time to Stop and Think Before the Shock. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 74(18), 2275-2777. doi:10.1016/j.jacc.2019.08.1044
Identification of Markers Associated With Development of Stroke in "Clinically Low-Risk" Atrial Fibrillation Patients
Shin, S. Y., Han, S. -J., Kim, J. -S., Im, S. I., Shim, J., Ahn, J., . . . Lim, H. E. (2019). Identification of Markers Associated With Development of Stroke in "Clinically Low-Risk" Atrial Fibrillation Patients. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 8(21). doi:10.1161/JAHA.119.012697
REPLY: Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Liver Disease
Choi, E. -K., Lee, S. -R., Oh, S., & Lip, G. Y. H. (2019). REPLY: Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Liver Disease. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 74(18), 2330-2331. doi:10.1016/j.jacc.2019.09.003
Age-Dependent Prognostic Impact of Paroxysmal Versus Sustained Atrial Fibrillation on the Incidence of Cardiac Death and Heart Failure Hospitalization (the Fushimi AF Registry)
An, Y., Ogawa, H., Esato, M., Ishii, M., Iguchi, M., Masunaga, N., . . . Akao, M. (2019). Age-Dependent Prognostic Impact of Paroxysmal Versus Sustained Atrial Fibrillation on the Incidence of Cardiac Death and Heart Failure Hospitalization (the Fushimi AF Registry). AMERICAN JOURNAL OF CARDIOLOGY, 124(9), 1420-1429. doi:10.1016/j.amjcard.2019.07.048
Association between epicardial adipose tissue and embolic stroke after catheter ablation of atrial fibrillation
Ahn, J., Shin, S. Y., Shim, J., Kim, Y. -H., Han, S. -J., Choi, E. -K., . . . Lim, H. E. (2019). Association between epicardial adipose tissue and embolic stroke after catheter ablation of atrial fibrillation. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 30(11), 2209-2216. doi:10.1111/jce.14154
Determinants of left atrium thrombi in scheduled cardioversion: an ENSURE-AF study analysis
Merino, J. L., Lip, G. Y. H., Heidbuchel, H., Cohen, A. -A., De Caterina, R., de Groot, J. R., . . . Goette, A. (2019). Determinants of left atrium thrombi in scheduled cardioversion: an ENSURE-AF study analysis. EUROPACE, 21(11), 1633-1638. doi:10.1093/europace/euz213
Heart rate variability in atrial fibrillation: The balance between sympathetic and parasympathetic nervous system
Khan, A. A., Lip, G. Y. H., & Shantsila, A. (2019). Heart rate variability in atrial fibrillation: The balance between sympathetic and parasympathetic nervous system. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 49(11). doi:10.1111/eci.13174
Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation Insights From the PIONEER AF-PCI Trial
Kerneis, M., Yee, M. K., Mehran, R., Nafee, T., Bode, C., Halperin, J. L., . . . Gibson, M. (2019). Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation Insights From the PIONEER AF-PCI Trial. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 12(11). doi:10.1161/CIRCINTERVENTIONS.119.008160
Triple or dual antithrombotic therapy post-percutaneous coronary intervention: Which one is better?
Ding, W. Y., Potpara, T. S., Stables, R. H., & Lip, G. Y. H. (2019). Triple or dual antithrombotic therapy post-percutaneous coronary intervention: Which one is better?. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 30(11), 2473-2474. doi:10.1111/jce.14130
Very late arrhythmia recurrences in patients with sinus rhythm within the first year after catheter ablation: The Leipzig Heart Center AF Ablation Registry
Kornej, J., Schumacher, K., Sommer, P., Potpara, T., Arya, A., Dagres, N., . . . Hindricks, G. (2019). Very late arrhythmia recurrences in patients with sinus rhythm within the first year after catheter ablation: The Leipzig Heart Center AF Ablation Registry. EUROPACE, 21(11), 1646-1652. doi:10.1093/europace/euz233
Sex Differences in Presentation, Quality of Life, and Treatment in Chinese Atrial Fibrillation Patients: Insights from the China Atrial Fibrillation Registry Study
Li, Y. -M., Jiang, C., He, L., Li, X. -X., Hou, X. -X., Chang, S. -S., . . . Ma, C. -S. (2019). Sex Differences in Presentation, Quality of Life, and Treatment in Chinese Atrial Fibrillation Patients: Insights from the China Atrial Fibrillation Registry Study. MEDICAL SCIENCE MONITOR, 25, 8011-8018. doi:10.12659/MSM.919366
A drug safety evaluation of apixaban for the treatment of atrial fibrillation, acute coronary syndrome, and percutaneous coronary intervention
Gumprecht, J., Domek, M., & Lip, G. Y. H. (2019). A drug safety evaluation of apixaban for the treatment of atrial fibrillation, acute coronary syndrome, and percutaneous coronary intervention. EXPERT OPINION ON DRUG SAFETY. doi:10.1080/14740338.2019.1676723
Analysis of housing prices in Petaling district, Malaysia using functional relationship model
Chang, Y. F., Choong, W. C., Looi, S. Y., Pan, W. Y., & Goh, H. L. (2019). Analysis of housing prices in Petaling district, Malaysia using functional relationship model. International Journal of Housing Markets and Analysis, 12(5), 884-905. doi:10.1108/ijhma-12-2018-0099
Prevalence of Hypertension in the Middle Belt of Ghana: A Community-Based Screening Study
Dosoo, D. K., Nyame, S., Enuameh, Y., Ayetey, H., Danwonno, H., Twumasi, M., . . . Asante, K. P. (2019). Prevalence of Hypertension in the Middle Belt of Ghana: A Community-Based Screening Study. INTERNATIONAL JOURNAL OF HYPERTENSION, 2019. doi:10.1155/2019/1089578
Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease
Moon, I., Lee, S. -R., Choi, E. -K., Lee, E., Jung, J. -H., Han, K. -D., . . . Lip, G. Y. H. (2019). Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease. JOURNAL OF CLINICAL MEDICINE, 8(10). doi:10.3390/jcm8101624
Considerations when restarting anticoagulants in patients with atrial fibrillation after bleeding
Koziel, M., Ding, W. Y., Kalarus, Z., & Lip, G. Y. H. (2019). Considerations when restarting anticoagulants in patients with atrial fibrillation after bleeding. EXPERT REVIEW OF HEMATOLOGY, 12(10), 845-855. doi:10.1080/17474086.2019.1647779
Atrial high-rate episodes and thromboembolism in patients without atrial fibrillation: The West Birmingham Atrial Fibrillation Project
Li, Y. -G., Miyazawa, K., Pastori, D., Szekely, O., Shahid, F., & Lip, G. Y. H. (2019). Atrial high-rate episodes and thromboembolism in patients without atrial fibrillation: The West Birmingham Atrial Fibrillation Project. INTERNATIONAL JOURNAL OF CARDIOLOGY, 292, 126-130. doi:10.1016/j.ijcard.2019.04.055
Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Association (ACCA)
Kalarus, Z., Svendsen, J. H., Capodanno, D., Dan, G. -A., De Maria, E., Gorenek, B., . . . Berti, S. (2019). Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Association (ACCA). EUROPACE, 21(10), 1603-+. doi:10.1093/europace/euz163
Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial
Packer, M., Butler, J., Filippatos, G. S., Jamal, W., Salsali, A., Schnee, J., . . . Palmer, M. (2019). Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial. EUROPEAN JOURNAL OF HEART FAILURE, 21(10), 1270-1278. doi:10.1002/ejhf.1536
Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial.
Anker, S. D., Butler, J., Filippatos, G. S., Jamal, W., Salsali, A., Schnee, J., . . . EMPEROR-Preserved Trial Committees and Investigators. (2019). Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial.. European journal of heart failure, 21(10), 1279-1287. doi:10.1002/ejhf.1596
Recommendations on stroke prevention for patients having a CHA<sub>2</sub>DS<sub>2</sub>-VASc score of 1 (males) or 2 (females) in 2019 atrial fibrillation guidelines
Chao, T. -F., Chen, S. -A., & Lip, G. Y. H. (2019). Recommendations on stroke prevention for patients having a CHA<sub>2</sub>DS<sub>2</sub>-VASc score of 1 (males) or 2 (females) in 2019 atrial fibrillation guidelines. TRENDS IN CARDIOVASCULAR MEDICINE, 29(7), 427-428. doi:10.1016/j.tcm.2019.02.008
Venous thromboembolism prophylaxis strategies for patients undergoing elective total knee replacement
Koziel, M., & Lip, G. Y. H. (2019). Venous thromboembolism prophylaxis strategies for patients undergoing elective total knee replacement. LANCET HAEMATOLOGY, 6(10), E496-E497. doi:10.1016/S2352-3026(19)30164-4
Meeting the unmet needs to improve management and outcomes of patients with atrial fibrillation: fitting global solutions to local settings
Potpara, T. S., Mujovic, N., & Lip, G. Y. H. (2019). Meeting the unmet needs to improve management and outcomes of patients with atrial fibrillation: fitting global solutions to local settings. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 129(9), 574-576. doi:10.20452/pamw.14996
The National Institute for Health Research (NIHR) Global Health Research Group on Atrial Fibrillation management
Lip, G. Y. H., Guo, Y., Lotufo, P., Surenthirakumaran, R., Humphreys, L., Thomas, G. N., . . . Thomas, G. N. (2019). The National Institute for Health Research (NIHR) Global Health Research Group on Atrial Fibrillation management. EUROPEAN HEART JOURNAL, 40(36), 3005-3007. doi:10.1093/eurheartj/ehz648
Meta-Analysis of Oral Anticoagulant Monotherapy as an Antithrombotic Strategy in Patients With Stable Coronary Artery Disease and Nonvalvular Atrial Fibrillation
Lee, S. -R., Rhee, T. -M., Kang, D. -Y., Choi, E. -K., Oh, S., & Lip, G. Y. H. (2019). Meta-Analysis of Oral Anticoagulant Monotherapy as an Antithrombotic Strategy in Patients With Stable Coronary Artery Disease and Nonvalvular Atrial Fibrillation. AMERICAN JOURNAL OF CARDIOLOGY, 124(6), 879-885. doi:10.1016/j.amjcard.2019.05.072
Impaired Spontaneous/Endogenous Fibrinolytic Status as New Cardiovascular Risk Factor? <i>JACC</i> Review Topic of the Week
Gorog, D. A., & Lip, G. Y. H. (2019). Impaired Spontaneous/Endogenous Fibrinolytic Status as New Cardiovascular Risk Factor? <i>JACC</i> Review Topic of the Week. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 74(10), 1366-1375. doi:10.1016/j.jacc.2019.07.030
Apixaban enhances endogenous fibrinolysis in patients with atrial fibrillation
Spinthakis, N., Gue, Y., Farag, M., Srinivasan, M., Wellsted, D., Arachchillage, D. R. J., . . . Gorog, D. A. (2019). Apixaban enhances endogenous fibrinolysis in patients with atrial fibrillation. EUROPACE, 21(9), 1297-1306. doi:10.1093/europace/euz176
Atrial high rate episodes in patients with cardiac implantable electronic devices: implications for clinical outcomes
Miyazawa, K., Pastori, D., Li, Y. -G., Szekely, O., Shahid, F., Boriani, G., & Lip, G. Y. H. (2019). Atrial high rate episodes in patients with cardiac implantable electronic devices: implications for clinical outcomes. CLINICAL RESEARCH IN CARDIOLOGY, 108(9), 1034-1041. doi:10.1007/s00392-019-01432-y
Clinical factors and imaging leading to risk of incident atrial fibrillation
Shantsila, A., Oxborough, D., Fairbairn, T. A., & Lip, G. Y. H. (2019). Clinical factors and imaging leading to risk of incident atrial fibrillation. EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 20(9), 988-989. doi:10.1093/ehjci/jez199
Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation
Chan, Y. -H., Lee, H. -F., See, L. -C., Tu, H. -T., Chao, T. -F., Yeh, Y. -H., . . . Lip, G. Y. H. (2019). Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation. CHEST, 156(3), 529-543. doi:10.1016/j.chest.2019.04.108
Effects of forward gate bias stressing on the leakage current of AlGaN/GaN high electron mobility transistors
Gao, Y., Sasangka, W. A., Thompson, C. V., & Gan, C. L. (2019). Effects of forward gate bias stressing on the leakage current of AlGaN/GaN high electron mobility transistors. Microelectronics Reliability, 100-101, 113432. doi:10.1016/j.microrel.2019.113432
Iron-facilitated dynamic active-site generation on spinel CoAl2O4 with self-termination of surface reconstruction for water oxidation
Wu, T., Sun, S., Song, J., Xi, S., Du, Y., Chen, B., . . . Xu, Z. J. (n.d.). Iron-facilitated dynamic active-site generation on spinel CoAl2O4 with self-termination of surface reconstruction for water oxidation. Nature Catalysis, 2(9), 763-772. doi:10.1038/s41929-019-0325-4
Long-Term Impact of Newly Diagnosed Atrial Fibrillation During Critical Care A South Korean Nationwide Cohort Study
Kim, K., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -N., Uhm, J. -S., . . . Joung, B. (2019). Long-Term Impact of Newly Diagnosed Atrial Fibrillation During Critical Care A South Korean Nationwide Cohort Study. CHEST, 156(3), 518-528. doi:10.1016/j.chest.2019.04.011
Low-Dose Rivaroxaban and Risks of Adverse Events in Patients With Atrial Fibrillation
Cheng, W. -H., Chao, T. -F., Lin, Y. -J., Chang, S. -L., Lo, L. -W., Hu, Y. -F., . . . Chen, S. -A. (2019). Low-Dose Rivaroxaban and Risks of Adverse Events in Patients With Atrial Fibrillation. STROKE, 50(9), 2574-2577. doi:10.1161/STROKEAHA.119.025623
Renal Function and Outcomes With Dabigatran Dual Antithrombotic Therapy in Atrial Fibrillation Patients After PCI
Hohnloser, S. H., Steg, P. G., Oldgren, J., Nickenig, G., Kiss, R. G., Ongen, Z., . . . Cannon, C. P. (2019). Renal Function and Outcomes With Dabigatran Dual Antithrombotic Therapy in Atrial Fibrillation Patients After PCI. JACC-CARDIOVASCULAR INTERVENTIONS, 12(16), 1553-1561. doi:10.1016/j.jcin.2019.05.050
Atrial Fibrillation in Older People: Concepts and Controversies
Zathar, Z., Karunatilleke, A., Fawzy, A. M., & Lip, G. Y. H. (2019). Atrial Fibrillation in Older People: Concepts and Controversies. FRONTIERS IN MEDICINE, 6. doi:10.3389/fmed.2019.00175
Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation
Lee, S. -R., Choi, E. -K., Kwon, S., Han, K. -D., Jung, J. -H., Cha, M. -J., . . . Lip, G. Y. H. (2019). Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation. STROKE, 50(8), 2245-2249. doi:10.1161/STROKEAHA.119.025536
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
Ray, K. K., Colhoun, H. M., Szarek, M., Baccara-Dinet, M., Bhatt, D. L., Bittner, V. A., . . . Zobouyan, I. (2019). Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. LANCET DIABETES & ENDOCRINOLOGY, 7(8), 618-628. doi:10.1016/S2213-8587(19)30158-5
To the Editor-Patients with atrial fibrillation with hypertrophic cardiomyopathy: Do we need new stroke risk stratification?
Joung, B., & Lip, G. Y. H. (2019). To the Editor-Patients with atrial fibrillation with hypertrophic cardiomyopathy: Do we need new stroke risk stratification?. HEART RHYTHM, 16(8), E56. doi:10.1016/j.hrthm.2019.04.006
Using Blood Biomarkers to Identify Atrial Fibrillation-Related Stroke: Balancing Simplicity and Practicality
Koziel, M., Potpara, T. S., & Lip, G. Y. H. (2019). Using Blood Biomarkers to Identify Atrial Fibrillation-Related Stroke: Balancing Simplicity and Practicality. STROKE, 50(8), 1956-1957. doi:10.1161/STROKEAHA.119.026185
Kerala Atrial Fibrillation Registry: a prospective observational study on clinical characteristics, treatment pattern and outcome of atrial fibrillation in Kerala, India, cohort profile
Gopalan, B. C., Namboodiri, N., Abdullakutty, J., Lip, G. Y. H., Koshy, A. G., Nair, V. K., . . . Felix, V. (2019). Kerala Atrial Fibrillation Registry: a prospective observational study on clinical characteristics, treatment pattern and outcome of atrial fibrillation in Kerala, India, cohort profile. BMJ OPEN, 9(7). doi:10.1136/bmjopen-2018-025901
Potential missed opportunities to prevent ischaemic stroke: prospective multicentre cohort study of atrial fibrillation-associated ischaemic stroke and TIA
Wilson, D., Ambler, G., Shakeshaft, C., Banerjee, G., Charidimou, A., Seiffge, D., . . . Vahidassr, D. (2019). Potential missed opportunities to prevent ischaemic stroke: prospective multicentre cohort study of atrial fibrillation-associated ischaemic stroke and TIA. BMJ OPEN, 9(7). doi:10.1136/bmjopen-2018-028387
Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort
Kim, D., Yang, P. -S., Yu, H. T., Kim, T. -H., Jang, E., Sung, J. -H., . . . Joung, B. (2019). Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort. EUROPEAN HEART JOURNAL, 40(28), 2313-2323. doi:10.1093/eurheartj/ehz386
Stroke prevention in atrial fibrillation: State of the art
Li, Y. -G., & Lip, G. Y. H. (2019). Stroke prevention in atrial fibrillation: State of the art. INTERNATIONAL JOURNAL OF CARDIOLOGY, 287, 201-209. doi:10.1016/j.ijcard.2018.09.057
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI <i>JACC</i> State-of-the-Art Review
Capodanno, D., Huber, K., Mehran, R., Lip, G. Y. H., Faxon, D. P., Granger, C. B., . . . Angiolillo, D. J. (2019). Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI <i>JACC</i> State-of-the-Art Review. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 74(1), 83-99. doi:10.1016/j.jacc.2019.05.016
Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease
Lee, S. -R., Lee, H. -J., Choi, E. -K., Han, K. -D., Jung, J. -H., Cha, M. -J., . . . Lip, G. Y. H. (2019). Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 73(25), 3295-3308. doi:10.1016/j.jacc.2019.04.052
ABC (Atrial fibrillation Better Care) Pathway and Healthcare Costs in Atrial Fibrillation: The ATHERO-AF Study
Pastori, D., Farcomeni, A., Pignatelli, P., Violi, F., & Lip, G. Y. H. (2019). ABC (Atrial fibrillation Better Care) Pathway and Healthcare Costs in Atrial Fibrillation: The ATHERO-AF Study. AMERICAN JOURNAL OF MEDICINE, 132(7), 856-861. doi:10.1016/j.amjmed.2019.01.003
Antithrombotic treatment in patients with atrial fibrillation and acute coronary syndromes: results of the European Heart Rhythm Association survey
Lane, D. A., Dagres, N., Dan, G. -A., Garcia Seara, J., Iliodromitis, K., Lenarczyk, R., . . . Potpara, T. S. (2019). Antithrombotic treatment in patients with atrial fibrillation and acute coronary syndromes: results of the European Heart Rhythm Association survey. EUROPACE, 21(7), 1116-1125. doi:10.1093/europace/euz033
Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry
Boriani, G., Proietti, M., Laroche, C., Fauchier, L., Marin, F., Nabauer, M., . . . Lip, G. Y. H. (2019). Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry. EUROPACE, 21(7), 1013-1022. doi:10.1093/europace/euz032
Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies
Wilson, D., Ambler, G., Lee, K. -J., Lim, J. -S., Shiozawa, M., Koga, M., . . . Werring, D. J. (2019). Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies. LANCET NEUROLOGY, 18(7), 653-665. doi:10.1016/S1474-4422(19)30197-8
EHRA White Paper: knowledge gaps in arrhythmia management-status 2019
Goette, A., Auricchio, A., Boriani, G., Braunschweig, F., Brugada Terradellas, J., Burri, H., . . . Heinzel, F. R. (2019). EHRA White Paper: knowledge gaps in arrhythmia management-status 2019. EUROPACE, 21(7), 993-+. doi:10.1093/europace/euz055
Illustrated State-of-the-Art Capsules of the ISTH 2019 Congress in Melbourne, Australia
Ward, C. M., Andrews, R. K., Wolberg, A., Lip, G. Y. H., Eikelboom, J., De Meyer, S. F., . . . Magnusson, M. (2019). Illustrated State-of-the-Art Capsules of the ISTH 2019 Congress in Melbourne, Australia. RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 3(3), 431-497. doi:10.1002/rth2.12225
Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study Cohort
Pastori, D., Pignatelli, P., Menichelli, D., Violi, F., & Lip, G. Y. H. (2019). Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study Cohort. MAYO CLINIC PROCEEDINGS, 94(7), 1261-1267. doi:10.1016/j.mayocp.2018.10.022
Mobile Health (mHealth) technology for improved screening, patient involvement and optimising integrated care in atrial fibrillation: The mAFA (mAF-App) II randomised trial
Guo, Y., Lane, D. A., Wang, L., Chen, Y., Lip, G. Y. H., Wang, L., . . . Ge, F. (2019). Mobile Health (mHealth) technology for improved screening, patient involvement and optimising integrated care in atrial fibrillation: The mAFA (mAF-App) II randomised trial. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 73(7). doi:10.1111/ijcp.13352
Study of Front-Side Approach to Retrieve Stored Data in Non-Volatile Memory Devices Using Scanning Capacitance Microscopy
Tay, J. Y., Cheah, J., Liu, Q., & Gan, C. L. (2019). Study of Front-Side Approach to Retrieve Stored Data in Non-Volatile Memory Devices Using Scanning Capacitance Microscopy. In 2019 IEEE 26th International Symposium on Physical and Failure Analysis of Integrated Circuits (IPFA) (pp. 1-4). IEEE. doi:10.1109/ipfa47161.2019.8984802
Unraveling the Mechanistic Origins of Epoxy Degradation in Acids.
Lim, J. S. K., Gan, C. L., Hu, X. M., & Hu, X. M. (2019). Unraveling the Mechanistic Origins of Epoxy Degradation in Acids.. ACS omega, 4(6), 10799-10808. doi:10.1021/acsomega.9b00859
C2 HEST Score and Prediction of Incident Atrial Fibrillation in Poststroke Patients: A French Nationwide Study.
Li, Y. -G., Bisson, A., Bodin, A., Herbert, J., Grammatico-Guillon, L., Joung, B., . . . Fauchier, L. (2019). C2 HEST Score and Prediction of Incident Atrial Fibrillation in Poststroke Patients: A French Nationwide Study.. Journal of the American Heart Association, 8(13), e012546. doi:10.1161/jaha.119.012546
Control of Anticoagulation Therapy in Patients with Atrial Fibrillation Treated with Warfarin: A Study from the Chinese Atrial Fibrillation Registry
Liang, H. -F., Du, X., Zhou, Y. -C., Yang, X. -Y., Xia, S. -J., Dong, J. -Z., . . . Ma, C. -S. (2019). Control of Anticoagulation Therapy in Patients with Atrial Fibrillation Treated with Warfarin: A Study from the Chinese Atrial Fibrillation Registry. MEDICAL SCIENCE MONITOR, 25, 4691-4698. doi:10.12659/MSM.917131
β-Blocker Use in Pregnancy and the Risk for Congenital Malformations
Shantsila, A., Beevers, D. G., & Lip, G. Y. H. (2019). β-Blocker Use in Pregnancy and the Risk for Congenital Malformations. ANNALS OF INTERNAL MEDICINE, 170(12), 909. doi:10.7326/L19-0156
Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention During 2-Year Follow-Up, from a Nationwide Population Study
Park, J., Choi, E. -K., Han, K. -D., Choi, Y. -J., Lee, S. -R., Cha, M. -J., . . . Lip, G. Y. H. (2019). Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention During 2-Year Follow-Up, from a Nationwide Population Study. AMERICAN JOURNAL OF CARDIOLOGY, 123(12), 1921-1926. doi:10.1016/j.amjcard.2019.03.024
Letter by Guo et al Regarding Article, "Effectiveness of an mHealth-Based Electronic Decision Support System for Integrated Management of Chronic Conditions in Primary Care: The mWellcare Cluster-Randomized Controlled Trial"
Guo, Y., Lip, G. Y. H., & Potpara, T. (2019). Letter by Guo et al Regarding Article, "Effectiveness of an mHealth-Based Electronic Decision Support System for Integrated Management of Chronic Conditions in Primary Care: The mWellcare Cluster-Randomized Controlled Trial". CIRCULATION, 139(24), E1037-E1038. doi:10.1161/CIRCULATIONAHA.118.038961
Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity-Weighted Cohort Study
Sogaard, M., Skjoth, F., Jensen, M., Kjaeldgaard, J. N., Lip, G. Y. H., Larsen, T. B., & Nielsen, P. B. (2019). Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity-Weighted Cohort Study. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 8(11). doi:10.1161/JAHA.118.011358
Cost-effectiveness and screening performance of ECG handheld machine in a population screening programme: The Belgian Heart Rhythm Week screening programme
Proietti, M., Farcomeni, A., Goethals, P., Scavee, C., Vijgen, J., Blankoff, I., . . . Mairesse, G. H. (2019). Cost-effectiveness and screening performance of ECG handheld machine in a population screening programme: The Belgian Heart Rhythm Week screening programme. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 26(9), 964-972. doi:10.1177/2047487319839184
Etiological Research Using Observational Data, and Net Clinical Benefit. Simplicity and Practicality Matter
Nielsen, P. B., Buchan, I., & Lip, G. Y. H. (2019). Etiological Research Using Observational Data, and Net Clinical Benefit. Simplicity and Practicality Matter. AMERICAN JOURNAL OF MEDICINE, 132(6), 671-672. doi:10.1016/j.amjmed.2019.01.038
Predicting stroke in patients without atrial fibrillation
Steensig, K., Olesen, K. K. W., Thim, T., Nielsen, J. C., Madsen, M., Jensen, S. E., . . . Maeng, M. (2019). Predicting stroke in patients without atrial fibrillation. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 49(6). doi:10.1111/eci.13103
Prothrombin Complex Concentrate or Coagulation Factor Xa (Recombinant), Inactivated-zhzo Response
Lip, G. Y. H., Ruff, C. T., & Moores, L. (2019). Prothrombin Complex Concentrate or Coagulation Factor Xa (Recombinant), Inactivated-zhzo Response. CHEST, 155(6), 1309. doi:10.1016/j.chest.2019.03.001
Pulse pressure and prognosis in patients with heart failure with reduced ejection fraction
Shah, N., Qian, M., Di Tullio, M. R., Graham, S., Mann, D. L., Sacco, R. L., . . . Freudenberger, R. S. (2019). Pulse pressure and prognosis in patients with heart failure with reduced ejection fraction. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 49(6). doi:10.1111/eci.13092
Relationship of stroke and bleeding risk profiles to efficacy and safety of dabigatran dual therapy versus warfarin triple therapy in atrial fibrillation after percutaneous coronary intervention: An ancillary analysis from the RE-DUAL PCI trial
Lip, G. Y. H., Mauri, L., Montalescot, G., Ozkor, M., Vardas, P., Steg, P. G., . . . Cannon, C. P. (2019). Relationship of stroke and bleeding risk profiles to efficacy and safety of dabigatran dual therapy versus warfarin triple therapy in atrial fibrillation after percutaneous coronary intervention: An ancillary analysis from the RE-DUAL PCI trial. AMERICAN HEART JOURNAL, 212, 13-22. doi:10.1016/j.ahj.2019.02.006
Renal function and outcomes after catheter ablation of patients with atrial fibrillation: The Guangzhou atrial fibrillation ablation registry
Deng, H., Shantsila, A., Xue, Y., Bai, Y., Guo, P., Potpara, T. S., . . . Lip, G. Y. H. (2019). Renal function and outcomes after catheter ablation of patients with atrial fibrillation: The Guangzhou atrial fibrillation ablation registry. ARCHIVES OF CARDIOVASCULAR DISEASES, 112(6-7), 420-429. doi:10.1016/j.acvd.2019.02.006
The New <i>CHEST</i> Guidelines on Antithrombotic Therapy for Atrial Fibrillation Should Consider Recent Data on Rivaroxaban Response
Lip, G. Y. H., Ruff, C. T., & Moores, L. (2019). The New <i>CHEST</i> Guidelines on Antithrombotic Therapy for Atrial Fibrillation Should Consider Recent Data on Rivaroxaban Response. CHEST, 155(6), 1311-1312. doi:10.1016/j.chest.2019.03.037
The Use of Rivaroxaban in Patients With Atrial Fibrillation Receiving Hemodialysis-Antithrombotic Therapy for Atrial Fibrillation CHEST Guideline and Expert Panel Report Response
Lip, G. Y. H., Ruff, C. T., & Moores, L. (2019). The Use of Rivaroxaban in Patients With Atrial Fibrillation Receiving Hemodialysis-Antithrombotic Therapy for Atrial Fibrillation CHEST Guideline and Expert Panel Report Response. CHEST, 155(6), 1307. doi:10.1016/j.chest.2019.02.329
Revisiting the risks of incident atrial fibrillation: a narrative review. Part 2
Panchal, G., Mahmood, M., & Lip, G. Y. H. (2019). Revisiting the risks of incident atrial fibrillation: a narrative review. Part 2. KARDIOLOGIA POLSKA, 77(5), 515-524. doi:10.33963/KP.14846
Microparticles and cardiovascular diseases
Voukalis, C., Shantsila, E., & Lip, G. Y. H. (2019). Microparticles and cardiovascular diseases. ANNALS OF MEDICINE, 51(3-4), 193-223. doi:10.1080/07853890.2019.1609076
Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities
Chao, T. -F., Lip, G. Y. H., Lin, Y. -J., Chang, S. -L., Lo, L. -W., Hu, Y. -F., . . . Chen, S. -A. (2019). Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities. European heart journal, 40(19), 1504-1514. doi:10.1093/eurheartj/ehy837
Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial
Oldgren, J., Steg, P. G., Hohnloser, S. H., Lip, G. Y. H., Kimura, T., Nordaby, M., . . . Cannon, C. P. (2019). Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial. EUROPEAN HEART JOURNAL, 40(19), 1553-+. doi:10.1093/eurheartj/ehz059
Short-Term Outcomes of Apixaban Versus Warfarin in Patients With Atrial Fibrillation Is Body Weight an Important Consideration?
Lip, G. Y. H., Khan, A. A., & Olshansky, B. (2019). Short-Term Outcomes of Apixaban Versus Warfarin in Patients With Atrial Fibrillation Is Body Weight an Important Consideration?. CIRCULATION, 139(20), 2301-2303. doi:10.1161/CIRCULATIONAHA.119.040021
Time-dependent prediction of arrhythmia recurrences during long-term follow-up in patients undergoing catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry
Kornej, J., Schumacher, K., Zeynalova, S., Sommer, P., Arya, A., Weiss, M., . . . Hindricks, G. (2019). Time-dependent prediction of arrhythmia recurrences during long-term follow-up in patients undergoing catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry. SCIENTIFIC REPORTS, 9. doi:10.1038/s41598-019-43644-2
Reassessment of Risk for Stroke During Follow-up of Patients With Atrial Fibrillation
Chao, T. -F., Chiang, C. -E., Chen, T. -J., Lip, G. Y. H., & Chen, S. -A. (2019). Reassessment of Risk for Stroke During Follow-up of Patients With Atrial Fibrillation. ANNALS OF INTERNAL MEDICINE, 170(9), 663-+. doi:10.7326/M18-1177
Pharmacokinetics and pharmacodynamics of oral anticoagulants used in atrial fibrillation
Fawzy, A. M., & Lip, G. Y. H. (2019). Pharmacokinetics and pharmacodynamics of oral anticoagulants used in atrial fibrillation. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 15(5), 381-398. doi:10.1080/17425255.2019.1604686
Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with -vitamin K antagonists in patients with non-valvular atrial fibrillation: a systematic literature review
Deitelzweig, S., & Lip, G. Y. H. (2019). Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with -vitamin K antagonists in patients with non-valvular atrial fibrillation: a systematic literature review. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 19(3), 243-244. doi:10.1080/14737167.2019.1592834
Atrial Fibrillation and End-Stage COPD A Close Association Revisited
Shin, S. Y., Manuel, A. R. G., & Lip, G. Y. H. (2019). Atrial Fibrillation and End-Stage COPD A Close Association Revisited. CHEST, 155(5), 888-889. doi:10.1016/j.chest.2019.01.027
Clinical characteristics of heart failure patients undergoing atrial fibrillation ablation today in Europe. Data from the atrial fibrillation registries of the European Society of Cardiology and the European Heart Rhythm Association
Temporelli, P. L., Tilz, R. R., Arbelo, E., Dagres, N., Laroche, C., Crijns, H. J., . . . Tavazzi, L. (2019). Clinical characteristics of heart failure patients undergoing atrial fibrillation ablation today in Europe. Data from the atrial fibrillation registries of the European Society of Cardiology and the European Heart Rhythm Association. EUROPEAN JOURNAL OF HEART FAILURE, 21(5), 690-+. doi:10.1002/ejhf.1458
Effect of small-vessel disease on cognitive trajectory after atrial fibrillation-related ischaemic stroke or TIA
Banerjee, G., Chan, E., Ambler, G., Wilson, D., Cipolotti, L., Shakeshaft, C., . . . Vahidassr, D. (2019). Effect of small-vessel disease on cognitive trajectory after atrial fibrillation-related ischaemic stroke or TIA. In JOURNAL OF NEUROLOGY Vol. 266 (pp. 1250-1259). doi:10.1007/s00415-019-09256-6
Glycemic Status and Thromboembolic Risk in Patients With Atrial Fibrillation and Type 2 Diabetes Mellitus A Danish Cohort Study
Fangel, M. V., Nielsen, P. B., Kristensen, J. K., Larsen, T. B., Overvad, T. F., Lip, G. Y. H., & Jensen, M. B. (2019). Glycemic Status and Thromboembolic Risk in Patients With Atrial Fibrillation and Type 2 Diabetes Mellitus A Danish Cohort Study. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 12(5). doi:10.1161/CIRCEP.118.007030
Guideline Implications of Prothrombotic State Assessment in Low-Risk Atrial Fibrillation Patients: Consistency With CHA<sub>2</sub>DS<sub>2</sub>-VASc and Support for CHADS-65
Nattel, S., & Lip, G. Y. H. (2019). Guideline Implications of Prothrombotic State Assessment in Low-Risk Atrial Fibrillation Patients: Consistency With CHA<sub>2</sub>DS<sub>2</sub>-VASc and Support for CHADS-65. CANADIAN JOURNAL OF CARDIOLOGY, 35(5), 547-549. doi:10.1016/j.cjca.2019.03.001
Importance of Risk Reassessment in Patients With Atrial Fibrillation in Guidelines: Assessing Risk as a Dynamic Process
Chang, T. -Y., Lip, G. Y. H., Chen, S. -A., & Chao, T. -F. (2019). Importance of Risk Reassessment in Patients With Atrial Fibrillation in Guidelines: Assessing Risk as a Dynamic Process. CANADIAN JOURNAL OF CARDIOLOGY, 35(5), 611-618. doi:10.1016/j.cjca.2019.01.018
Safety of drug-eluting stents compared to bare metal stents in patients with an indication for long-term oral anticoagulation: A propensity score matched analysis
Limeres, J., Lip, G. Y. H., Garcia del Blanco, B., Ferreira-Gonzalez, I., Mutuberria, M., Alfonso, F., . . . Sambola, A. (2019). Safety of drug-eluting stents compared to bare metal stents in patients with an indication for long-term oral anticoagulation: A propensity score matched analysis. THROMBOSIS RESEARCH, 177, 180-186. doi:10.1016/j.thromres.2019.02.021
Stroke Prevention, Evaluation of Bleeding Risk, and Anticoagulant Treatment Management in Atrial Fibrillation Contemporary International Guidelines
Proietti, M., Lane, D. A., Boriani, G., & Lip, G. Y. H. (2019). Stroke Prevention, Evaluation of Bleeding Risk, and Anticoagulant Treatment Management in Atrial Fibrillation Contemporary International Guidelines. CANADIAN JOURNAL OF CARDIOLOGY, 35(5), 619-633. doi:10.1016/j.cjca.2019.02.009
Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation
Lee, S. -R., Choi, E. -K., Han, K. -D., Jung, J. -H., Oh, S., & Lip, G. Y. H. (2019). Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation. SCIENTIFIC REPORTS, 9. doi:10.1038/s41598-019-43224-4
Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function.
Lee, S. -R., Choi, E. -K., Han, K. -D., Jung, J. -H., Oh, S., & Lip, G. Y. H. (2019). Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function.. Stroke, 50(5), 1140-1148. doi:10.1161/strokeaha.118.024210
Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation
Chua, W., Purmah, Y., Cardoso, V. R., Gkoutos, G. V., Tull, S. P., Neculau, G., . . . Fabritz, L. (2019). Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation. EUROPEAN HEART JOURNAL, 40(16), 1268-+. doi:10.1093/eurheartj/ehy815
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.
Lopes, R. D., Heizer, G., Aronson, R., Vora, A. N., Massaro, T., Mehran, R., . . . AUGUSTUS Investigators. (2019). Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.. The New England journal of medicine, 380(16), 1509-1524. doi:10.1056/nejmoa1817083
Revisiting the risks of incident atrial fibrillation: a narrative review. Part 1
Panchal, G., Mahmood, M., & Lip, G. Y. H. (2019). Revisiting the risks of incident atrial fibrillation: a narrative review. Part 1. KARDIOLOGIA POLSKA, 77(4), 430-436. doi:10.33963/KP.14806
Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry disease
Hernandez-Romero, D., Sanchez-Quinones, J., Antonio Vilchez, J., Miguel Rivera-Caravaca, J., de la Morena, G., Lip, G. Y. H., . . . Marin, F. (2019). Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry disease. SCIENTIFIC REPORTS, 9. doi:10.1038/s41598-019-42727-4
Corrigendum to “Crystal orientation dependence of the stress-induced martensitic transformation in zirconia-based shape memory ceramics” [Acta Mater. 116 (2016) 124–135]
Zeng, X. M., Lai, A., Gan, C. L., & Schuh, C. A. (2019). Corrigendum to “Crystal orientation dependence of the stress-induced martensitic transformation in zirconia-based shape memory ceramics” [Acta Mater. 116 (2016) 124–135]. Acta Materialia, 168, 511-512. doi:10.1016/j.actamat.2019.02.027
Long-Term Persistence with Newly-Initiated Warfarin or Non-VKA Oral Anticoagulant (NOAC) in Patients with Non-Valvular Atrial Fibrillation: Insights from the Prospective China-AF Registry
Liu, C., Du, X., Jiang, C., He, L., Chang, S. -S., Guo, X. -Y., . . . Ma, C. -S. (2019). Long-Term Persistence with Newly-Initiated Warfarin or Non-VKA Oral Anticoagulant (NOAC) in Patients with Non-Valvular Atrial Fibrillation: Insights from the Prospective China-AF Registry. MEDICAL SCIENCE MONITOR, 25, 2649-2657. doi:10.12659/MSM.915875
Congenital absence of the deep inferior epigastric system: a case report
Harris, T. G. W., Wohlgemut, H. S., Lip, G., & Curnier, A. P. R. (2019). Congenital absence of the deep inferior epigastric system: a case report. European Journal of Plastic Surgery, 42(2), 197-200. doi:10.1007/s00238-018-1463-7
Association between mortality and implantable cardioverter-defibrillators by aetiology of heart failure: a propensity-matched analysis of the WARCEF trial
Lee, T. C., Qian, M., Mu, L., Di Tullio, M. R., Graham, S., Mann, D. L., . . . Ye, S. (2019). Association between mortality and implantable cardioverter-defibrillators by aetiology of heart failure: a propensity-matched analysis of the WARCEF trial. ESC HEART FAILURE, 6(2), 297-307. doi:10.1002/ehf2.12407
Cancer and atrial fibrillation. Author's reply
Malavasi, V. L., Marietta, M., Lip, G. Y. H., & Boriani, G. (2019). Cancer and atrial fibrillation. Author's reply. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 62, E24-E25. doi:10.1016/j.ejim.2019.01.002
Community screening for atrial fibrillation in the era of smart devices
Shin, S. Y., & Lip, G. Y. H. (2019). Community screening for atrial fibrillation in the era of smart devices. INTERNATIONAL JOURNAL OF CARDIOLOGY, 280, 95-96. doi:10.1016/j.ijcard.2019.01.001
Economic evaluation of the use of non-vitamin Koral anticoagulants in patients with atrial fibrillation on antiplatelet therapy: a modelling analysis using the healthcare system in the Netherlands
Bennaghmouch, N., de Veer, A. J. W. M., Mahmoodi, B. K., Jofre-Bonet, M., Lip, G. Y. H., Bode, K., & ten Berg, J. M. (2019). Economic evaluation of the use of non-vitamin Koral anticoagulants in patients with atrial fibrillation on antiplatelet therapy: a modelling analysis using the healthcare system in the Netherlands. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 5(2), 127-135. doi:10.1093/ehjqcco/qcy030
Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage
Nielsen, P. B., Skjoth, F., Sogaard, M., Kjaeldgaard, J. N., Lip, G. Y. H., & Larsen, T. B. (2019). Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage. STROKE, 50(4), 939-946. doi:10.1161/STROKEAHA.118.023797
Stroke risk in female patients with atrial fibrillation: Relationship to current guideline recommendations
Nielsen, P. B., Potpara, T. S., & Lip, G. Y. H. (2019). Stroke risk in female patients with atrial fibrillation: Relationship to current guideline recommendations. TRENDS IN CARDIOVASCULAR MEDICINE, 29(3), 150-152. doi:10.1016/j.tcm.2018.07.003
The Liverpool Centre for Cardiovascular Science: The Centre was established to advance cardiovascular and stroke research and innovation locally, nationally and internationally
Lip, G. Y. H., & Lane, D. A. (2019). The Liverpool Centre for Cardiovascular Science: The Centre was established to advance cardiovascular and stroke research and innovation locally, nationally and internationally. EUROPEAN HEART JOURNAL, 40(12), 957-958. doi:10.1093/eurheartj/ehz107
Impaired Cerebrovascular Reactivity in Patients With Atrial Fibrillation
Junejo, R. T., Braz, I. D., Lucas, S. J. E., van Lieshout, J. J., Lip, G. Y. H., & Fisher, J. P. (2019). Impaired Cerebrovascular Reactivity in Patients With Atrial Fibrillation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 73(10), 1230-+. doi:10.1016/j.jacc.2019.01.009
Factor XI inhibition fulfilling the optimal expectations for ideal anticoagulation
Szekely, O., Borgi, M., & Lip, G. Y. H. (2019). Factor XI inhibition fulfilling the optimal expectations for ideal anticoagulation. EXPERT OPINION ON EMERGING DRUGS, 24(1), 55-61. doi:10.1080/14728214.2019.1591368
Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Heart Rhythm Society (LAHRS).
Arnar, D. O., Mairesse, G. H., Boriani, G., Calkins, H., Chin, A., Coats, A., . . . EHRA Scientific Documents Committee. (2019). Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Heart Rhythm Society (LAHRS).. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. doi:10.1093/europace/euz046
WORLDWIDE ORAL ANTICOAGULANT PRESCRIPTION PREVALENCE AND TRENDS IN PATIENTS WITH ATRIAL FIBRILLATION FROM A MULTI-NATIONAL COHORT: INSIGHTS FROM THE INTERNATIONAL COLLABORATIVE PARTNERSHIP FOR THE STUDY OF ATRIAL FIBRILLATION (INTERAF) COLLABORATIVE
Hsu, J. C., Akao, M., Avezum Junior, A., Bloomfield, G., Kohsaka, S., Lane, D., . . . Maddox, T. (2019). WORLDWIDE ORAL ANTICOAGULANT PRESCRIPTION PREVALENCE AND TRENDS IN PATIENTS WITH ATRIAL FIBRILLATION FROM A MULTI-NATIONAL COHORT: INSIGHTS FROM THE INTERNATIONAL COLLABORATIVE PARTNERSHIP FOR THE STUDY OF ATRIAL FIBRILLATION (INTERAF) COLLABORATIVE. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 73 (pp. 376). doi:10.1016/S0735-1097(19)30984-2
Effect of hypertension duration and blood pressure level on ischaemic stroke risk in atrial fibrillation: nationwide data covering the entire Korean population
Kim, T. -H., Yang, P. -S., Yu, H. T., Jang, E., Shin, H., Kim, H. Y., . . . Lip, G. Y. H. (2019). Effect of hypertension duration and blood pressure level on ischaemic stroke risk in atrial fibrillation: nationwide data covering the entire Korean population. European Heart Journal, 40(10), 809-819. doi:10.1093/eurheartj/ehy877
Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight
Lee, S. -R., Choi, E. -K., Park, C. S., Han, K. -D., Jung, J. -H., Oh, S., & Lip, G. Y. H. (2019). Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 73(8), 919-931. doi:10.1016/j.jacc.2018.11.051
Safety of direct oral anticoagulants in real-world clinical practice: translating the trials to everyday clinical management
Fawzy, A. M., Yang, W. -Y., & Lip, G. Y. H. (2019). Safety of direct oral anticoagulants in real-world clinical practice: translating the trials to everyday clinical management. EXPERT OPINION ON DRUG SAFETY, 18(3), 187-209. doi:10.1080/14740338.2019.1578344
A Simple Clinical Risk Score (C<sub>2</sub>HEST) for Predicting Incident Atrial Fibrillation in Asian Subjects Derivation in 471,446 Chinese Subjects, With Internal Validation and External Application in 451,199 Korean Subjects
Li, Y. -G., Pastori, D., Farcomeni, A., Yang, P. -S., Jang, E., Joung, B., . . . Lip, G. Y. H. (2019). A Simple Clinical Risk Score (C<sub>2</sub>HEST) for Predicting Incident Atrial Fibrillation in Asian Subjects Derivation in 471,446 Chinese Subjects, With Internal Validation and External Application in 451,199 Korean Subjects. CHEST, 155(3), 510-518. doi:10.1016/j.chest.2018.09.011
Atrial fibrillation and human immunodeficiency virus type-1 infection: a systematic review. Implications for anticoagulant and antiarrhythmic therapy
Pastori, D., Mezzaroma, I., Pignatelli, P., Violi, F., & Lip, G. Y. H. (2019). Atrial fibrillation and human immunodeficiency virus type-1 infection: a systematic review. Implications for anticoagulant and antiarrhythmic therapy. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 85(3), 508-515. doi:10.1111/bcp.13837
COMPARATIVE EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS AMONG FRAIL NONVALVULAR ATRIAL FIBRILLATION PATIENTS
Lip, G. Y. H., Keshishian, A., Kang, A., Dhamane, A., Luo, X., Li, X., . . . Deitelzweig, S. (2019). COMPARATIVE EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS AMONG FRAIL NONVALVULAR ATRIAL FIBRILLATION PATIENTS. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 73 (pp. 320). doi:10.1016/S0735-1097(19)30928-3
EFFECTIVENESS AND SAFETY OF APIXABAN, DABIGATRAN AND RIVAROXABAN VERSUS WARFARIN IN OBESE PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION: ARISTOPHANES SUBGROUP ANALYSIS
Deitelzweig, S., Keshishian, A., Kang, A., Dhamane, A., Luo, X., Li, X., . . . Lip, G. Y. H. (2019). EFFECTIVENESS AND SAFETY OF APIXABAN, DABIGATRAN AND RIVAROXABAN VERSUS WARFARIN IN OBESE PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION: ARISTOPHANES SUBGROUP ANALYSIS. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 73 (pp. 435). doi:10.1016/S0735-1097(19)31043-5
EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS COMPARED TO WARFARIN AMONG FRAIL NONVALVULAR ATRIAL FIBRILLATION PATIENTS
Lip, G. Y. H., Keshishian, A., Kang, A., Dhamane, A., Luo, X., Li, X., . . . Deitelzweig, S. (2019). EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS COMPARED TO WARFARIN AMONG FRAIL NONVALVULAR ATRIAL FIBRILLATION PATIENTS. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 73 (pp. 432). doi:10.1016/S0735-1097(19)31040-X
EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS IN OBESE NONVALVULAR ATRIAL FIBRILLATION PATIENTS: A POOLED CLAIMS DATABASE ANALYSIS
Deitelzweig, S., Keshishian, A., Kang, A., Dhamane, A., Luo, X., Li, X., . . . Lip, G. Y. H. (2019). EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS IN OBESE NONVALVULAR ATRIAL FIBRILLATION PATIENTS: A POOLED CLAIMS DATABASE ANALYSIS. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 73 (pp. 434). doi:10.1016/S0735-1097(19)31042-3
Effectiveness of screening for atrial fibrillation and its determinants. A meta-analysis
Petryszyn, P., Niewinski, P., Staniak, A., Piotrowski, P., Well, A., Well, M., . . . Ponikowski, P. (2019). Effectiveness of screening for atrial fibrillation and its determinants. A meta-analysis. PLOS ONE, 14(3). doi:10.1371/journal.pone.0213198
Electrochemical Oxidation in AlGaN/GaN-on-Si High Electron Mobility Transistors
Gan, C. L., Sasangka, W. A., & Thompson, C. V. (2019). Electrochemical Oxidation in AlGaN/GaN-on-Si High Electron Mobility Transistors. In 2019 Electron Devices Technology and Manufacturing Conference (EDTM) (pp. 71-73). IEEE. doi:10.1109/edtm.2019.8731316
Epidemiology of out-of-hospital cardiac arrest: A French national incidence and mid-term survival rate study
Luc, G., Baert, V., Escutnaire, J., Genin, M., Vilhelm, C., Di Pompeo, C., . . . Hubert, H. (2019). Epidemiology of out-of-hospital cardiac arrest: A French national incidence and mid-term survival rate study. ANAESTHESIA CRITICAL CARE & PAIN MEDICINE, 38(2), 131-135. doi:10.1016/j.accpm.2018.04.006
Mon2 predicts poor outcome in ST-elevation myocardial infarction
Shantsila, E., Ghattas, A., Griffiths, H. R., & Lip, G. Y. H. (2019). Mon2 predicts poor outcome in ST-elevation myocardial infarction. JOURNAL OF INTERNAL MEDICINE, 285(3), 301-316. doi:10.1111/joim.12847
Sex-related risks of recurrence of atrial fibrillation after ablation: Insights from the Guangzhou Atrial Fibrillation Ablation Registry
Deng, H., Shantsila, A., Guo, P., Potpara, T. S., Zhan, X., Fang, X., . . . Lip, G. Y. H. (2019). Sex-related risks of recurrence of atrial fibrillation after ablation: Insights from the Guangzhou Atrial Fibrillation Ablation Registry. ARCHIVES OF CARDIOVASCULAR DISEASES, 112(3), 171-179. doi:10.1016/j.acvd.2018.10.006
Stroke and Thromboembolism in Patients With Atrial Fibrillation and Mitral Regurgitation
Bisson, A., Bernard, A., Bodin, A., Clementy, N., Babuty, D., Lip, G. Y. H., & Fauchier, L. (2019). Stroke and Thromboembolism in Patients With Atrial Fibrillation and Mitral Regurgitation. In CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY Vol. 12. doi:10.1161/CIRCEP.118.006990
USING THE CHA2DS2-VASC SCORE TO PREDICT ISCHEMIC STROKE IN PATIENTS WITH INTRACEREBRAL HEMORRHAGE: A NATIONWIDE COHORT STUDY
Nielsen, P. B., Overvad, T. F., Skjoth, F., Andersen, S. D., Sogaard, M., Larsen, T. B., & Lip, G. Y. H. (2019). USING THE CHA2DS2-VASC SCORE TO PREDICT ISCHEMIC STROKE IN PATIENTS WITH INTRACEREBRAL HEMORRHAGE: A NATIONWIDE COHORT STUDY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 73 (pp. 503). doi:10.1016/S0735-1097(19)31111-8
VENOUS THROMBOEMBOLISM IN PATIENTS WITH LIVER CIRRHOSIS: FINDINGS FROM THE RIETE REGISTRY
Bikdeli, B., Jimenez, D., Garcia-Tsao, G., Barba, R., Font, C., Diaz-Pedroche, M. D. C., . . . Monreal, M. (2019). VENOUS THROMBOEMBOLISM IN PATIENTS WITH LIVER CIRRHOSIS: FINDINGS FROM THE RIETE REGISTRY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 73 (pp. 2043). doi:10.1016/S0735-1097(19)32649-X
Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies
Li, G., Lip, G. Y. H., Holbrook, A., Chang, Y., Larsen, T. B., Sun, X., . . . Levine, M. A. H. (2019). Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 34(2), 173-190. doi:10.1007/s10654-018-0415-7
Impact of Body Mass Index on Outcomes in the Edoxaban Versus Warfarin Therapy Groups in Patients Underwent Cardioversion of Atrial Fibrillation (from ENSURE-AF)
Lip, G. Y. H., Merino, J. L., Banach, M., de Groot, J. R., Maier, L. S., Themistoclakis, S., . . . Goette, A. (2019). Impact of Body Mass Index on Outcomes in the Edoxaban Versus Warfarin Therapy Groups in Patients Underwent Cardioversion of Atrial Fibrillation (from ENSURE-AF). AMERICAN JOURNAL OF CARDIOLOGY, 123(4), 592-597. doi:10.1016/j.amjcard.2018.11.019
Atrial Fibrillation and Cognitive Function <i>JACC</i> Review Topic of the Week
Diener, H. -C., Hart, R. G., Koudstaal, P. J., Lane, D. A., & Lip, G. Y. H. (2019). Atrial Fibrillation and Cognitive Function <i>JACC</i> Review Topic of the Week. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 73(5), 612-619. doi:10.1016/j.jacc.2018.10.077
Efficacy and Safety of the Use of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Ischemic Heart Disease: A Meta-Analysis of Phase III Randomized Trials
Fu, L., Zhu, W., Huang, L., Hu, J., Ma, J., Lip, G. Y. H., & Hong, K. (2019). Efficacy and Safety of the Use of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Ischemic Heart Disease: A Meta-Analysis of Phase III Randomized Trials. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 19(1), 37-47. doi:10.1007/s40256-018-0299-7
Short-Term Outcomes in Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: How Important Is Ethnicity?
Ding, W. Y., Khan, A. A., Gupta, D., & Lip, G. Y. H. (2019). Short-Term Outcomes in Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: How Important Is Ethnicity?. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 8(3). doi:10.1161/JAHA.119.011953
2018 ESC/ESH Guidelines for the management of arterial hypertension (vol 39, pg 3021, 2018)
Williams, B., Mancia, G., Spiering, W., Rosei, E. A., Azizi, M., Burnier, M., . . . Desormais, I. (2019). 2018 ESC/ESH Guidelines for the management of arterial hypertension (vol 39, pg 3021, 2018). EUROPEAN HEART JOURNAL, 40(5), 475. doi:10.1093/eurheartj/ehy686
2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA)
Lip, G. Y. H., Collet, J. -P., Haude, M., Byrne, R., Chung, E. H., Fauchier, L., . . . Jardine, R. (2019). 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). EUROPACE, 21(2), 192-+. doi:10.1093/europace/euy174
Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention Insights From the PIONEER AF-PCI Trial
Kerneis, M., Yee, M. K., Mehran, R., Nafee, T., Bode, C., Halperin, J. L., . . . Gibson, C. M. (2019). Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention Insights From the PIONEER AF-PCI Trial. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 12(2). doi:10.1161/CIRCINTERVENTIONS.118.007124
Body Mass Index Variability and Long-term Risk of New-Onset Atrial Fibrillation in the General Population: A Korean Nationwide Cohort Study
Lim, Y. -M., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -H., Uhm, J. -S., . . . Lip, G. Y. H. (2019). Body Mass Index Variability and Long-term Risk of New-Onset Atrial Fibrillation in the General Population: A Korean Nationwide Cohort Study. MAYO CLINIC PROCEEDINGS, 94(2), 225-235. doi:10.1016/j.mayocp.2018.10.019
Clinical scores used for the prediction of negative events in patients undergoing catheter ablation for atrial fibrillation
Kosich, F., Schumacher, K., Potpara, T., Lip, G. Y., Hindricks, G., & Kornej, J. (2019). Clinical scores used for the prediction of negative events in patients undergoing catheter ablation for atrial fibrillation. CLINICAL CARDIOLOGY, 42(2), 320-329. doi:10.1002/clc.23139
Cost Implications of Anticoagulation Strategies After Percutaneous Coronary Intervention Among Patients With Atrial Fibrillation (A PIONEER-AF PCI Analysis)
Korjian, S., Daaboul, Y., Laliberte, F., Zhao, Q., Mehran, R., Bode, C., . . . Pinto, D. S. (2019). Cost Implications of Anticoagulation Strategies After Percutaneous Coronary Intervention Among Patients With Atrial Fibrillation (A PIONEER-AF PCI Analysis). AMERICAN JOURNAL OF CARDIOLOGY, 123(3), 355-360. doi:10.1016/j.amjcard.2018.10.033
ESC/ESH 2018 Guide on the diagnosis and treatment of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Rosei, E. A., Azizi, M., Burnier, M., . . . Desormais, I. (2019). ESC/ESH 2018 Guide on the diagnosis and treatment of arterial hypertension. REVISTA ESPANOLA DE CARDIOLOGIA, 72(2). doi:10.1016/j.recesp.2018.12.005
Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation With Hypertrophic Cardiomyopathy A Nationwide Cohort Study
Jung, H., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -H., Uhm, J. -S., . . . Lip, G. Y. H. (2019). Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation With Hypertrophic Cardiomyopathy A Nationwide Cohort Study. CHEST, 155(2), 354-363. doi:10.1016/j.chest.2018.11.009
Frailty and multi-morbidities should not govern oral anticoagulation therapy prescribing for patients with atrial fibrillation
Fawzy, A. M., Olshansky, B., & Lip, G. Y. H. (2019). Frailty and multi-morbidities should not govern oral anticoagulation therapy prescribing for patients with atrial fibrillation. AMERICAN HEART JOURNAL, 208, 120-122. doi:10.1016/j.ahj.2018.10.003
Malignant hypertension: not quite an obsolete diagnosis yet
Shantsila, A., & Lip, G. Y. H. (2019). Malignant hypertension: not quite an obsolete diagnosis yet. JOURNAL OF HYPERTENSION, 37(2), 282-283. doi:10.1097/HJH.0000000000001974
Management of atrial fibrillation: easy as ABC
Mahmood, M., & Lip, G. Y. (2019). Management of atrial fibrillation: easy as ABC. MINERVA MEDICA, 110(1), 27-34. doi:10.23736/S0026-4806.18.05824-X
Physician Estimation of Thrombotic and Bleeding Risks in Atrial Fibrillation: Let's Talk About Sex
Ding, W. Y., Gupta, D., & Lip, G. Y. H. (2019). Physician Estimation of Thrombotic and Bleeding Risks in Atrial Fibrillation: Let's Talk About Sex. CANADIAN JOURNAL OF CARDIOLOGY, 35(2), 145-146. doi:10.1016/j.cjca.2018.12.011
Relation of the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score to Risk of Thrombotic and Embolic Stroke in Community-Dwelling Individuals Without Atrial Fibrillation (From The Atherosclerosis Risk in Communities [ARIC] Study)
Koene, R. J., Alraies, M. C., Norby, F. L., Soliman, E. Z., Maheshwari, A., Lip, G. Y. H., . . . Chen, L. Y. (2019). Relation of the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score to Risk of Thrombotic and Embolic Stroke in Community-Dwelling Individuals Without Atrial Fibrillation (From The Atherosclerosis Risk in Communities [ARIC] Study). AMERICAN JOURNAL OF CARDIOLOGY, 123(3), 402-408. doi:10.1016/j.amjcard.2018.10.037
Tackling anti-coagulation under-prescription in the elderly
Fawzy, A. M., Chao, T. -F., & Lip, G. Y. H. (2019). Tackling anti-coagulation under-prescription in the elderly. AGING-US, 11(4), 1070-1072. doi:10.18632/aging.101809
The safety of NOACs in atrial fibrillation patient subgroups: A narrative review
Lip, G. Y. H. (2019). The safety of NOACs in atrial fibrillation patient subgroups: A narrative review. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 73(2). doi:10.1111/ijcp.13285
Time trends in use of the CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>VASc scores, and the geographical and specialty uptake of these scores from a popular online clinical decision tool and medical reference
Habboushe, J., Altman, C., & Lip, G. Y. H. (2019). Time trends in use of the CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>VASc scores, and the geographical and specialty uptake of these scores from a popular online clinical decision tool and medical reference. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 73(2). doi:10.1111/ijcp.13280
Validation of the MB-LATER score for prediction of late recurrence after catheter-ablation of atrial fibrillation
Potpara, T. S., Mujovic, N., Sivasambu, B., Shantsila, A., Marinkovic, M., Calkins, H., . . . Lip, G. Y. H. (2019). Validation of the MB-LATER score for prediction of late recurrence after catheter-ablation of atrial fibrillation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 276, 130-135. doi:10.1016/j.ijcard.2018.08.018
Sex differences in risk of incident venous thromboembolism in heart failure patients
Melgaard, L., Nielsen, P. B., Overvad, T. F., Skjoth, F., Lip, G. Y. H., & Larsen, T. B. (2019). Sex differences in risk of incident venous thromboembolism in heart failure patients. CLINICAL RESEARCH IN CARDIOLOGY, 108(1), 101-109. doi:10.1007/s00392-018-1329-9
2018 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) (vol 27, pg 314, 2018)
Williams, B., Mancia, G., Spiering, W., Rosei, E. A., Azizi, M., Burnier, M., . . . Desormai, I. (2019). 2018 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) (vol 27, pg 314, 2018). BLOOD PRESSURE, 28(1), 74. doi:10.1080/08037051.2018.1557365
Response by Chao et al to Letter Regarding Article, "Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study"
Chao, T. -F., Lip, G. Y. H., & Chen, S. -A. (2019). Response by Chao et al to Letter Regarding Article, "Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study". CIRCULATION, 139(1), 146-147. doi:10.1161/CIRCULATIONAHA.118.037670
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Rosei, E. A., Azizi, M., Burnier, M., . . . Lovic, D. (2019). 2018 ESC/ESH Guidelines for the management of arterial hypertension. KARDIOLOGIA POLSKA, 77(2), 71-159. doi:10.5603/KP.2019.0018
A study of clustering for the enhancement of image resolution in dynamic photon emission
Chef, S., Chua, C. T., & Gan, C. L. (2019). A study of clustering for the enhancement of image resolution in dynamic photon emission. In Conference Proceedings from the International Symposium for Testing and Failure Analysis (pp. 68-78).
Anticoagulation in elderly patients with nonvalvular atrial fibrillation: A balancing act
Fawzy, A. M., & Lip, G. Y. H. (2019). Anticoagulation in elderly patients with nonvalvular atrial fibrillation: A balancing act. HEART RHYTHM, 16(1), 38-40. doi:10.1016/j.hrthm.2018.09.011
Atrial fibrillation in patients with active malignancy and use of anticoagulants: Under-prescription but no adverse impact on all-cause mortality
Malavasi, V. L., Fantecchi, E., Gianolio, L., Pesce, F., Longo, G., Marietta, M., . . . Boriani, G. (2019). Atrial fibrillation in patients with active malignancy and use of anticoagulants: Under-prescription but no adverse impact on all-cause mortality. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 59, 27-33. doi:10.1016/j.ejim.2018.10.012
Automated Profiling Method for Laser Fault Injection in FPGAs
Breier, J., He, W., Bhasin, S., Jap, D., Chef, S., Ong, H. G., & Gan, C. L. (2019). Automated Profiling Method for Laser Fault Injection in FPGAs. In Automated Methods in Cryptographic Fault Analysis (pp. 301-325). doi:10.1007/978-3-030-11333-9-14
Causes of death in Japanese patients with atrial fibrillation: The Fushimi Atrial Fibrillation Registry
An, Y., Ogawa, H., Yamashita, Y., Ishii, M., Iguchi, M., Masunaga, N., . . . Akao, M. (2019). Causes of death in Japanese patients with atrial fibrillation: The Fushimi Atrial Fibrillation Registry. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 5(1), 35-42. doi:10.1093/ehjqcco/qcy033
Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients
Deitelzweig, S., Keshishian, A., Li, X., Kang, A., Dhamane, A. D., Luo, X., . . . Lip, G. Y. H. (2019). Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 67(8), 1662-1671. doi:10.1111/jgs.15956
ESC Council on hypertension position document on themanagement of hypertensive emergencies
van den Born, B. -J. H., Lip, G. Y. H., Brguljan-Hitij, J., Cremer, A., Segura, J., Morales, E., . . . Williams, B. (2019). ESC Council on hypertension position document on themanagement of hypertensive emergencies. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 5(1), 37-46. doi:10.1093/ehjcvp/pvy032
Early versus late anticoagulation for ischaemic stroke associated with atrial fibrillation: multicentre cohort study
Wilson, D., Ambler, G., Banerjee, G., Shakeshaft, C., Cohen, H., Yousry, T. A., . . . Werring, D. J. (2019). Early versus late anticoagulation for ischaemic stroke associated with atrial fibrillation: multicentre cohort study. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 90(3), 320-325. doi:10.1136/jnnp-2018-318890
Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism
Zeng, J., Zhang, X., Lip, G. Y. H., Shu, X., Thabane, L., Tian, J., & Li, G. (2019). Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 25. doi:10.1177/1076029619853629
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asians With Nonvalvular Atrial Fibrillation: A Network Meta-Analysis
Xiong, Q., Wang, C., Liu, H., Tan, Z., Chen, C., Li, J., . . . Hong, K. (2019). Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asians With Nonvalvular Atrial Fibrillation: A Network Meta-Analysis. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 25. doi:10.1177/1076029619885188
Elevated blood plasma levels of tissue factor-bearing extracellular vesicles in patients with atrial fibrillation
Mork, M., Andreasen, J. J., Rasmussen, L. H., Lip, G. Y. H., Pedersen, S., Baek, R., . . . Kristensen, S. R. (2019). Elevated blood plasma levels of tissue factor-bearing extracellular vesicles in patients with atrial fibrillation. THROMBOSIS RESEARCH, 173, 141-150. doi:10.1016/j.thromres.2018.11.026
Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals
Lowres, N., Olivier, J., Chao, T. -F., Chen, S. -A., Chen, Y., Diederichsen, A., . . . Freedman, B. (2019). Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals. PLOS MEDICINE, 16(9). doi:10.1371/journal.pmed.1002903
European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS)
Boriani, G., Fauchier, L., Aguinaga, L., Beattie, J. M., Lundqvist, C. B., Cohen, A., . . . Chin, A. (2019). European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS). EUROPACE, 21(1), 7-+. doi:10.1093/europace/euy110
Ghidul ESC/ESH 2018 pentru managementul hipertensiunii arteriale
Williams, B., Mancia, G., Spiering, W., Rosei, E. A., Azizi, M., Burnier, M., . . . Desormais, I. (2019). Ghidul ESC/ESH 2018 pentru managementul hipertensiunii arteriale. Revista Romana de Cardiologie, 29(1), 69-177.
Hypertrophic Cardiomyopathy in Patients with Atrial Fibrillation: Prevalence and Associated Stroke Risks in a Nationwide Cohort Study
Jung, H., Yang, P. -S., Sung, J. -H., Jang, E., Yu, H. T., Kim, T. -H., . . . Joung, B. (2019). Hypertrophic Cardiomyopathy in Patients with Atrial Fibrillation: Prevalence and Associated Stroke Risks in a Nationwide Cohort Study. THROMBOSIS AND HAEMOSTASIS, 119(2), 285-293. doi:10.1055/s-0038-1676818
Improved Population-Based Clinical Outcomes of Patients with Atrial Fibrillation by Compliance with the Simple ABC (Atrial Fibrillation Better Care) Pathway for Integrated Care Management: A Nationwide Cohort Study
Yoon, M., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -H., Uhm, J. -S., . . . Lip, G. Y. H. (2019). Improved Population-Based Clinical Outcomes of Patients with Atrial Fibrillation by Compliance with the Simple ABC (Atrial Fibrillation Better Care) Pathway for Integrated Care Management: A Nationwide Cohort Study. THROMBOSIS AND HAEMOSTASIS, 119(10), 1695-1703. doi:10.1055/s-0039-1693516
Incident Co-Morbidities in Patients with Atrial Fibrillation Initially with a CHA<sub>2</sub>DS<sub>2</sub>-VASc Score of 0 (Males) or 1 (Females): Implications for Reassessment of Stroke Risk in Initially 'Low-Risk' Patients
Chao, T. -F., Liao, J. -N., Tuan, T. -C., Lin, Y. -J., Chang, S. -L., Lo, L. -W., . . . Chen, S. -A. (2019). Incident Co-Morbidities in Patients with Atrial Fibrillation Initially with a CHA<sub>2</sub>DS<sub>2</sub>-VASc Score of 0 (Males) or 1 (Females): Implications for Reassessment of Stroke Risk in Initially 'Low-Risk' Patients. THROMBOSIS AND HAEMOSTASIS, 119(7), 1162-1170. doi:10.1055/s-0039-1683933
Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Supranormal Renal Function
Lee, S. -R., Choi, E. -K., Han, K. -D., Jung, J. -H., Cha, M. -J., Oh, S., & Lip, G. Y. H. (2019). Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Supranormal Renal Function. STROKE, 50(6), 1480-1489. doi:10.1161/STROKEAHA.118.024264
One-year risks of stroke and mortality in patients with atrial fibrillation from different clinical settings: The Gulf SAFE registry and Darlington AF registry
Li, Y. -G., Miyazawa, K., Wolff, A., Zubaid, M., Alsheikh-Ali, A. A., Sulaiman, K., & Lip, G. Y. H. (2019). One-year risks of stroke and mortality in patients with atrial fibrillation from different clinical settings: The Gulf SAFE registry and Darlington AF registry. INTERNATIONAL JOURNAL OF CARDIOLOGY, 274, 158-162. doi:10.1016/j.ijcard.2018.08.091
Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores
Miguel Rivera-Caravaca, J., Marin, F., Antonio Vilchez, J., Galvez, J., Asuncion Esteve-Pastor, M., Vicente, V., . . . Roldan, V. (2019). Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores. STROKE, 50(6), 1372-1379. doi:10.1161/STROKEAHA.118.024305
Risk assessment and management of atrial fibrillation patients with left atrial thrombus
Miyazawa, K., & Lip, G. Y. H. (2019). Risk assessment and management of atrial fibrillation patients with left atrial thrombus. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 42(1), 1-3. doi:10.1111/pace.13556
Secondary stroke prevention and guideline adherent antithrombotic treatment in patients with atrial fibrillation: Insights from the Gulf Survey of atrial fibrillation events (Gulf SAFE)
Miyazawa, K., Li, Y. -G., Rashed, W. A., Al Mahmeed, W., Shehab, A., Zubaid, M., & Lip, G. Y. H. (2019). Secondary stroke prevention and guideline adherent antithrombotic treatment in patients with atrial fibrillation: Insights from the Gulf Survey of atrial fibrillation events (Gulf SAFE). INTERNATIONAL JOURNAL OF CARDIOLOGY, 274, 126-131. doi:10.1016/j.ijcard.2018.07.120
Should We Judge Stroke Risk by Static or Dynamic Risk Scores? A Focus on the Dynamic Nature of Stroke and Bleeding Risks in Patients With Atrial Fibrillation
Domek, M., Gumprecht, J., Mazurek, M., Chao, T. -F., & Lip, G. Y. H. (2019). Should We Judge Stroke Risk by Static or Dynamic Risk Scores? A Focus on the Dynamic Nature of Stroke and Bleeding Risks in Patients With Atrial Fibrillation. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 74(6), 491-498. doi:10.1097/FJC.0000000000000750
Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study
Lip, G. Y. H., Jensen, M., Melgaard, L., Skjoth, F., Nielsen, P. B., & Larsen, T. B. (2019). Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study. EUROPACE, 21(1), 33-40. doi:10.1093/europace/euy151
Stroke: Insights into Thromboembolism Treatment and Prevention through the Decades
Ntaios, G., & Lip, G. Y. H. (2019). Stroke: Insights into Thromboembolism Treatment and Prevention through the Decades. THROMBOSIS AND HAEMOSTASIS, 119(5), 685-687. doi:10.1055/s-0039-1685454
Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study
Park, J., Choi, E. -K., Han, K. -D., Choi, Y. -J., Lee, E., Choe, W., . . . Lip, G. Y. H. (2019). Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study. PLOS ONE, 14(1). doi:10.1371/journal.pone.0209593
The CHA<sub>2</sub>DS<sub>2</sub>-VASc score for stroke risk stratification in patients with atrial fibrillation: a brief history (Retraction of Vol 36, Pg 2880, 2015)
Lip, G. Y. H. (2019). The CHA<sub>2</sub>DS<sub>2</sub>-VASc score for stroke risk stratification in patients with atrial fibrillation: a brief history (Retraction of Vol 36, Pg 2880, 2015). EUROPEAN HEART JOURNAL, 40(7). Retrieved from https://www.webofscience.com/
The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations
De Caterina, R., Ageno, W., Agnelli, G., Chan, N. C., Diener, H. -C., Hylek, E., . . . Weitz, J. I. (2019). The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations. THROMBOSIS AND HAEMOSTASIS, 119(1), 14-38. doi:10.1055/s-0038-1675816
The Use of Biomarkers in Clinical Management Guidelines: A Critical Appraisal
Asuncion Esteve-Pastor, M., Roldan, V., Miguel Rivera-Caravaca, J., Ramirez-Macias, I., Lip, G. Y. H., & Marin, F. (2019). The Use of Biomarkers in Clinical Management Guidelines: A Critical Appraisal. THROMBOSIS AND HAEMOSTASIS, 119(12), 1901-1919. doi:10.1055/s-0039-1696955
The prothrombotic state in atrial fibrillation: pathophysiological and management implications
Khan, A. A., & Lip, G. Y. H. (2019). The prothrombotic state in atrial fibrillation: pathophysiological and management implications. CARDIOVASCULAR RESEARCH, 115(1), 31-45. doi:10.1093/cvr/cvy272
Thrombosis and Haemostasis 2018 Editor's Choice Papers
Weber, C., & Lip, G. Y. H. (2019). Thrombosis and Haemostasis 2018 Editor's Choice Papers. THROMBOSIS AND HAEMOSTASIS, 119(1), 183-186. doi:10.1055/s-0038-1676653
Thrombosis and Haemostasis Wishes You a Happy New Year Ahead!
Lip, G. Y. H., & Weber, C. (2019). Thrombosis and Haemostasis Wishes You a Happy New Year Ahead!. THROMBOSIS AND HAEMOSTASIS, 119(1), 1-2. doi:10.1055/s-0038-1676651
Use of Oral Anticoagulation in Patients With Atrial Fibrillation and End-stage Renal Disease: What Is Needed Nowadays? Response
Mahmood, M., & Lip, G. Y. H. (2019). Use of Oral Anticoagulation in Patients With Atrial Fibrillation and End-stage Renal Disease: What Is Needed Nowadays? Response. REVISTA ESPANOLA DE CARDIOLOGIA, 72(1), 97-98. doi:10.1016/j.recesp.2018.07.023
Use of Oral Anticoagulation in Patients With Atrial Fibrillation and End-stage Renal Disease: What Is Needed Nowadays? Response.
Mahmood, M., & Lip, G. Y. H. (2019). Use of Oral Anticoagulation in Patients With Atrial Fibrillation and End-stage Renal Disease: What Is Needed Nowadays? Response.. Revista espanola de cardiologia (English ed.), 72(1), 97-98. doi:10.1016/j.rec.2018.08.002
Venous Thromboembolism in Patients with Liver Cirrhosis: Findings from the RIETE (Registro Informatizado de la Enfermedad TromboEmbolica) Registry
Bikdeli, B., Jimenez, D., Garcia-Tsao, G., Barba, R., Font, C., del Carmen Diaz-Pedroche, M., . . . Monreal, M. (2019). Venous Thromboembolism in Patients with Liver Cirrhosis: Findings from the RIETE (Registro Informatizado de la Enfermedad TromboEmbolica) Registry. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 45(8), 793-801. doi:10.1055/s-0039-1697682
Which patients with atrial fibrillation undergo an ablation procedure today in Europe? A report from the ESC-EHRA-EURObservational Research Programme
Tilz, R., Dagres, N., Arbelo, E., Lundqvist, C. H. B., Pokushalov, E., Crijns, H. J., . . . Tavazzi, L. (2019). Which patients with atrial fibrillation undergo an ablation procedure today in Europe? A report from the ESC-EHRA-EURObservational Research Programme. In EUROPEAN HEART JOURNAL Vol. 40 (pp. 138). Retrieved from https://www.webofscience.com/
2018
Urinary Biomarkers of Oxidative Stress in Atrial Fibrillation
Meng, L., Wong, R., Tsui, M. Y., Tse, G., Li, G., Liu, T., & Lip, G. Y. H. (2018). Urinary Biomarkers of Oxidative Stress in Atrial Fibrillation. The Open Biomarkers Journal, 8(1), 24-33. doi:10.2174/1875318301808010024
Usefulness of the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score to Predict the Risk of Sudden Cardiac Death and Ventricular Arrhythmias in Patients With Atrial Fibrillation
Kuo, L., Chao, T. -F., Liu, C. -J., Chen, S. -J., Tuan, T. -C., Lin, Y. -J., . . . Chen, S. -A. (2018). Usefulness of the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score to Predict the Risk of Sudden Cardiac Death and Ventricular Arrhythmias in Patients With Atrial Fibrillation. In AMERICAN JOURNAL OF CARDIOLOGY Vol. 122 (pp. 2049-2054). doi:10.1016/j.amjcard.2018.08.056
Single right coronary artery with congenital absence of left coronary system.
Upadhyaya, S. G. N., Mughal, L. H., Connolly, D., & Lip, G. (2018). Single right coronary artery with congenital absence of left coronary system.. BMJ case reports, 11(1), e228296. doi:10.1136/bcr-2018-228296
Current and emerging pharmacotherapy for ischemic stroke prevention in patients with atrial fibrillation
Szekely, O., Miyazawa, K., & Lip, G. Y. H. (2018). Current and emerging pharmacotherapy for ischemic stroke prevention in patients with atrial fibrillation. EXPERT OPINION ON PHARMACOTHERAPY, 19(18), 1999-2009. doi:10.1080/14656566.2018.1537368
Clinical characteristics and cardiovascular outcomes in patients with atrial fibrillation receiving rhythm-control therapy: the Fushimi AF Registry
An, Y., Esato, M., Ishii, M., Iguchi, M., Masunaga, N., Tsuji, H., . . . Akao, M. (2018). Clinical characteristics and cardiovascular outcomes in patients with atrial fibrillation receiving rhythm-control therapy: the Fushimi AF Registry. HEART AND VESSELS, 33(12), 1534-1546. doi:10.1007/s00380-018-1194-5
Clinical characteristics and cardiovascular outcomes in patients with atrial fibrillation receiving rhythm-control therapy: the Fushimi AF Registry (vol 33, pg 1534, 2018)
An, Y., Esato, M., Ishii, M., Iguchi, M., Masunaga, N., Tsuji, H., . . . Akao, M. (2018). Clinical characteristics and cardiovascular outcomes in patients with atrial fibrillation receiving rhythm-control therapy: the Fushimi AF Registry (vol 33, pg 1534, 2018). HEART AND VESSELS, 33(12), 1547-1548. doi:10.1007/s00380-018-1212-7
Does Renal Function Predict Short- and Medium-Term Mortality and Hospital Readmissions in Poststroke Patients?
Ding, W. Y., & Lip, G. Y. H. (2018). Does Renal Function Predict Short- and Medium-Term Mortality and Hospital Readmissions in Poststroke Patients?. STROKE, 49(12), 2812-2813. doi:10.1161/STROKEAHA.118.023723
Edoxaban therapy increases treatment satisfaction and reduces utilization of healthcare resources: an analysis from the EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of atrial fibrillation (ENSURE-AF) study
Goette, A., Kwong, W. J., Ezekowitz, M. D., Banach, M., Hjortshoj, S. P., Zamoryakhin, D., & Lip, G. Y. H. (2018). Edoxaban therapy increases treatment satisfaction and reduces utilization of healthcare resources: an analysis from the EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of atrial fibrillation (ENSURE-AF) study. In EUROPACE Vol. 20 (pp. 1936-1943). doi:10.1093/europace/euy141
Guest Editorial for IRSP 2018 Conference
Budiman, A. S., Gan, C. L., Pey, K. -L., Sukharev, V., & Thomas, O. (2018). Guest Editorial for IRSP 2018 Conference. IEEE Transactions on Device and Materials Reliability, 18(4), 487-489. doi:10.1109/tdmr.2018.2881614
Increasing trends in hospital care burden of atrial fibrillation in Korea, 2006 through 2015
Kim, D., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -H., Uhm, J. -S., . . . Lip, G. Y. H. (2018). Increasing trends in hospital care burden of atrial fibrillation in Korea, 2006 through 2015. HEART, 104(24), 2010-2017. doi:10.1136/heartjnl-2017-312930
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (vol 13, pg 651, 2018)
Raparelli, V., Pastori, D., Pignataro, S. F., Vestri, A. R., Pignatelli, P., Cangemi, R., . . . Basili, S. (2018). Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (vol 13, pg 651, 2018). INTERNAL AND EMERGENCY MEDICINE, 13(8), 1349. doi:10.1007/s11739-018-1922-y
Multiple biomarkers and arrhythmia outcome following catheter ablation of atrial fibrillation: The Guangzhou Atrial Fibrillation Project
Deng, H., Shantsila, E., Guo, P., Zhan, X., Fang, X., Liao, H., . . . Lip, G. Y. H. (2018). Multiple biomarkers and arrhythmia outcome following catheter ablation of atrial fibrillation: The Guangzhou Atrial Fibrillation Project. JOURNAL OF ARRHYTHMIA, 34(6), 617-625. doi:10.1002/joa3.12111
Phthalonitrile-Based Electronic Packages for High Temperature Applications
PHUA, E. J. R., LIU, M., LIM, J. S. K., CHO, B., & GAN, C. L. (2018). Phthalonitrile-Based Electronic Packages for High Temperature Applications. In 2018 IEEE 20th Electronics Packaging Technology Conference (EPTC) (pp. 537-542). IEEE. doi:10.1109/eptc.2018.8654340
The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism: comment
Brown, J. D., Goodin, A., & Lip, G. Y. H. (2018). The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism: comment. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 16(12), 2537-2539. doi:10.1111/jth.14301
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
Schwartz, G. G., Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Diaz, R., . . . Ball, E. (2018). Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome. NEW ENGLAND JOURNAL OF MEDICINE, 379(22), 2097-2107. doi:10.1056/NEJMoa1801174
Current Status, Time Trends and Outcomes of Combination Therapy With Oral Anticoagulant and Antiplatelet Drug in Patients With Atrial Fibrillation - The Fushimi AF Registry -
Masunaga, N., Abe, M., Ogawa, H., Aono, Y., Ikeda, S., Doi, K., . . . Akao, M. (2018). Current Status, Time Trends and Outcomes of Combination Therapy With Oral Anticoagulant and Antiplatelet Drug in Patients With Atrial Fibrillation - The Fushimi AF Registry -. CIRCULATION JOURNAL, 82(12), 2983-+. doi:10.1253/circj.CJ-18-0872
Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry
Boriani, G., Proietti, M., Laroche, C., Diemberger, I., Popescu, M. I., Riahi, S., . . . Lip, G. Y. H. (2018). Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry. INTERNATIONAL JOURNAL OF CARDIOLOGY, 271, 68-74. doi:10.1016/j.ijcard.2018.05.034
CAD Is an Independent Risk Factor for Stroke Among Patients With Atrial Fibrillation
Steensig, K., Olesen, K. K. W., Thim, T., Nielsen, J. C., Jensen, S. E., Jensen, L. O., . . . Maeng, M. (2018). CAD Is an Independent Risk Factor for Stroke Among Patients With Atrial Fibrillation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 72(20), 2540-2542. doi:10.1016/j.jacc.2018.08.1046
Stroke Risk Stratification for Atrial Fibrillation Patients With Hypertrophic Cardiomyopathy
Jung, H., Sung, J. -H., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -H., . . . Lip, G. Y. H. (2018). Stroke Risk Stratification for Atrial Fibrillation Patients With Hypertrophic Cardiomyopathy. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 72(19), 2409-2411. doi:10.1016/j.jacc.2018.07.098
Associations between socioeconomic status, atrial fibrillation, and outcomes: a systematic review.
Lunde, E. D., Nielsen, P. B., Riahi, S., Larsen, T. B., Lip, G. Y. H., Fonager, K., . . . Joensen, A. M. (2018). Associations between socioeconomic status, atrial fibrillation, and outcomes: a systematic review.. Expert review of cardiovascular therapy, 16(11), 857-873. doi:10.1080/14779072.2018.1533118
Antithrombotic Therapy for Atrial Fibrillation CHEST Guideline and Expert Panel Report
Lip, G. Y. H., Banerjee, A., Boriani, G., Chiang, C. E., Fargo, R., Freedman, B., . . . Moores, L. (2018). Antithrombotic Therapy for Atrial Fibrillation CHEST Guideline and Expert Panel Report. Chest, 154(5), 1121-1201. doi:10.1016/j.chest.2018.07.040
Are Alpha-Adrenergic Receptor Antagonists Beneficial to Prevent Heart Failure? Alpha-Adrenergic Receptor Antagonists Revisited
Shin, S. Y., & Lip, G. Y. H. (2018). Are Alpha-Adrenergic Receptor Antagonists Beneficial to Prevent Heart Failure? Alpha-Adrenergic Receptor Antagonists Revisited. JACC-HEART FAILURE, 6(11), 926-927. doi:10.1016/j.jchf.2018.07.013
Disease progression after ablation for atrial flutter compared with atrial fibrillation: A nationwide cohort study
Skjoth, F., Vadmann, H., Hjortshoj, S. P., Riahi, S., Lip, G. Y. H., & Larsen, T. B. (2018). Disease progression after ablation for atrial flutter compared with atrial fibrillation: A nationwide cohort study. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 72(11). doi:10.1111/ijcp.13258
Improved Outcomes by Integrated Care of Anticoagulated Patients with Atrial Fibrillation Using the Simple ABC (Atrial Fibrillation Better Care) Pathway
Proietti, M., Romiti, G. F., Olshansky, B., Lane, D. A., & Lip, G. Y. H. (2018). Improved Outcomes by Integrated Care of Anticoagulated Patients with Atrial Fibrillation Using the Simple ABC (Atrial Fibrillation Better Care) Pathway. AMERICAN JOURNAL OF MEDICINE, 131(11), 1359-+. doi:10.1016/j.amjmed.2018.06.012
Predicting recurrent atrial fibrillation after catheter ablation
Mujovic, N., Marinkovic, M., Lip, G. Y. H., & Potpara, T. S. (2018). Predicting recurrent atrial fibrillation after catheter ablation. EUROPACE, 20, F460. doi:10.1093/europace/euy022
Real world comparison of major bleeding risk among non-valvular atrial fibrillation patients newly initiated on apixaban, dabigatran, rivaroxaban or warfarin
Lip, G. Y. H., Pan, X., Kamble, S., Kawabata, H., Mardekian, J., Masseria, C., . . . Phatak, H. (2015). Real world comparison of major bleeding risk among non-valvular atrial fibrillation patients newly initiated on apixaban, dabigatran, rivaroxaban or warfarin. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 1085). Retrieved from https://www.webofscience.com/
Screening for atrial fibrillation: look harder, look longer, and improve stroke outcomes with oral anticoagulation
Miyazawa, K., Mairesse, G. H., & Lip, G. Y. H. (2018). Screening for atrial fibrillation: look harder, look longer, and improve stroke outcomes with oral anticoagulation. EUROPACE, 20, F278-F279. doi:10.1093/europace/euy088
Seasonal variation in the risk of ischemic stroke in patients with atrial fibrillation: A nationwide cohort study
Liao, J. -N., Chao, T. -F., Liu, C. -J., Chen, S. -J., Hung, C. -L., Lin, Y. -J., . . . Chen, S. -A. (2018). Seasonal variation in the risk of ischemic stroke in patients with atrial fibrillation: A nationwide cohort study. HEART RHYTHM, 15(11), 1611-1616. doi:10.1016/j.hrthm.2018.06.043
The Importance and Future of Population Screening for Atrial Fibrillation
Shin, S. Y., & Lip, G. Y. H. (2018). The Importance and Future of Population Screening for Atrial Fibrillation. CANADIAN JOURNAL OF CARDIOLOGY, 34(11), 1407-1411. doi:10.1016/j.cjca.2018.08.016
Using the MB-LATER score for predicting arrhythmia outcome after catheter ablation for atrial fibrillation: The Guangzhou atrial fibrillation project
Deng, H., Shantsila, A., Xue, Y., Potpara, T. S., Bai, Y., Zhan, X., . . . Lip, G. Y. H. (2018). Using the MB-LATER score for predicting arrhythmia outcome after catheter ablation for atrial fibrillation: The Guangzhou atrial fibrillation project. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 72(11). doi:10.1111/ijcp.13247
[2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)].
Williams, B., Mancia, G., Spiering, W., Rosei, E. A., Azizi, M., Burnier, M., . . . Desormais, I. (2018). [2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)].. Giornale italiano di cardiologia (2006), 19(11 Suppl 1), 3S-73S. doi:10.1714/3026.30245
NOninvasive Monitoring for Early Detection of Atrial Fibrillation: rationale and design of the NOMED-AF study
Kalarus, Z., Balsam, P., Bandosz, P., Grodzicki, T., Kazmierczak, J., Kiedrowicz, R., . . . Lip, G. Y. H. (2018). NOninvasive Monitoring for Early Detection of Atrial Fibrillation: rationale and design of the NOMED-AF study. KARDIOLOGIA POLSKA, 76(10), 1482-1485. doi:10.5603/KP.a2018.0193
Acute hydrocortisone administration reduces cardiovagal baroreflex sensitivity and heart rate variability in young men
Adlan, A. M., van Zanten, J. J. C. S. V., Lip, G. Y. H., Paton, J. F. R., Kitas, G. D., & Fisher, J. P. (2018). Acute hydrocortisone administration reduces cardiovagal baroreflex sensitivity and heart rate variability in young men. JOURNAL OF PHYSIOLOGY-LONDON, 596(20), 4847-4861. doi:10.1113/JP276644
Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: A systematic review and meta-analysis of 993,600 patients
Marzona, I., Proietti, M., Farcomeni, A., Romiti, G. F., Romanazzi, I., Raparelli, V., . . . Roncaglioni, M. C. (2018). Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: A systematic review and meta-analysis of 993,600 patients. INTERNATIONAL JOURNAL OF CARDIOLOGY, 269, 182-191. doi:10.1016/j.ijcard.2018.07.044
Evolving Changes of the Use of Oral Anticoagulants and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation in Taiwan
Chao, T. -F., Chiang, C. -E., Lin, Y. -J., Chang, S. -L., Lo, L. -W., Hu, Y. -F., . . . Chen, S. -A. (2018). Evolving Changes of the Use of Oral Anticoagulants and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation in Taiwan. CIRCULATION, 138(14), 1485-1487. doi:10.1161/CIRCULATIONAHA.118.036046
Female Sex as a Risk Factor for Ischemic Stroke and Systemic Embolism in Chinese Patients With Atrial Fibrillation: A Report From the China-AF Study
Lan, D. -H., Jiang, C., Du, X., He, L., Guo, X. -Y., Zuo, S., . . . Ma, C. -S. (2018). Female Sex as a Risk Factor for Ischemic Stroke and Systemic Embolism in Chinese Patients With Atrial Fibrillation: A Report From the China-AF Study. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 7(19). doi:10.1161/JAHA.118.009391
A randomized controlled crossover trial evaluating differential responses to antihypertensive drugs (used as mono- or dual therapy) on the basis of ethnicity: The comparIsoN oF Optimal Hypertension RegiMens; part of the Ancestry Informative Markers in HYpertension program-AIM-HY INFORM trial
Mukhtar, O., Cheriyan, J., Cockcroft, J. R., Collier, D., Coulson, J. M., Dasgupta, I., . . . Wilkinson, I. B. (2018). A randomized controlled crossover trial evaluating differential responses to antihypertensive drugs (used as mono- or dual therapy) on the basis of ethnicity: The comparIsoN oF Optimal Hypertension RegiMens; part of the Ancestry Informative Markers in HYpertension program-AIM-HY INFORM trial. AMERICAN HEART JOURNAL, 204, 102-108. doi:10.1016/j.ahj.2018.05.006
Anticoagulantes orales no dependientes de la vitamina K para pacientes con fibrilación auricular e insuficiencia renal grave
Mahmood, M., & Lip, G. Y. H. (2018). Anticoagulantes orales no dependientes de la vitamina K para pacientes con fibrilación auricular e insuficiencia renal grave. Revista Española de Cardiología, 71(10), 847-855. doi:10.1016/j.recesp.2018.03.023
Atrial fibrillation
Miyazawa, K., & Lip, G. Y. H. (2018). Atrial fibrillation. Medicine, 46(10), 627-631. doi:10.1016/j.mpmed.2018.07.009
Heart Failure and Stroke.
Schumacher, K., Kornej, J., Shantsila, E., & Lip, G. Y. H. (2018). Heart Failure and Stroke.. Current heart failure reports, 15(5), 287-296. doi:10.1007/s11897-018-0405-9
Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment
Di Tullio, M. R., Qian, M., Thompson, J. L. P., Labovitz, A. J., Mann, D. L., Sacco, R. L., . . . Homma, S. (2018). Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment. ESC HEART FAILURE, 5(5), 800-808. doi:10.1002/ehf2.12331
Modelling projections for the risks related with atrial fibrillation in East Asia: a focus on ischaemic stroke and death
Bai, Y., Guo, S. -D., Shantsila, A., & Lip, G. Y. H. (2018). Modelling projections for the risks related with atrial fibrillation in East Asia: a focus on ischaemic stroke and death. EUROPACE, 20(10), 1584-1590. doi:10.1093/europace/eux328
Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis
Telles-Garcia, N., Dahal, K., Kocherla, C., Lip, G. Y. H., Reddy, P., & Dominic, P. (2018). Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis. INTERNATIONAL JOURNAL OF CARDIOLOGY, 268, 143-148. doi:10.1016/j.ijcard.2018.04.034
Nonvitamin K Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Renal Dysfunction.
Mahmood, M., & Lip, G. Y. H. (2018). Nonvitamin K Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Renal Dysfunction.. Revista espanola de cardiologia (English ed.), 71(10), 847-855. doi:10.1016/j.rec.2018.05.015
Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society
Linde, C., Bongiorni, M. G., Birgersdotter-Green, T., Curtis, A. B., Deisenhofer, I., Furokawa, T., . . . Varma, N. (2018). Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society. EUROPACE, 20(10), 1565-+. doi:10.1093/europace/euy067
Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention
Chi, G., Yee, M. K., Kalayci, A., Kerneis, M., AlKhalfan, F., Mehran, R., . . . Gibson, C. M. (2018). Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 46(3), 346-350. doi:10.1007/s11239-018-1703-5
Two-year safety and effectiveness of dabigatran in Asian patients with atrial fibrillation: Phase II results from Asian countries in the GLORIA-AF Registry Program
Ma, C., Kim, Y. H., Higashino, Y., Shlyakhto, E. V., Dubner, S. J., Halperin, J. L., . . . Lip, G. Y. H. (2018). Two-year safety and effectiveness of dabigatran in Asian patients with atrial fibrillation: Phase II results from Asian countries in the GLORIA-AF Registry Program. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 72 (pp. C175-C176). doi:10.1016/j.jacc.2018.08.783
Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: A Danish nationwide cohort study
Fangel, M. V., Nielsen, P. B., Larsen, T. B., Christensen, B., Overvad, T. F., Lip, G. Y. H., . . . Jensen, M. B. (2018). Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: A Danish nationwide cohort study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 268, 137-142. doi:10.1016/j.ijcard.2018.05.037
Variations in clinical management of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation according to different equations for estimating renal function: Post hoc analysis of a prospective cohort
Malavasi, V. L., Pettorelli, D., Fantecchi, E., Zoccali, C., Laronga, G., Trenti, T., . . . Boriani, G. (2018). Variations in clinical management of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation according to different equations for estimating renal function: Post hoc analysis of a prospective cohort. INTERNAL AND EMERGENCY MEDICINE, 13(7), 1059-1067. doi:10.1007/s11739-018-1857-3
Outcomes Among Patients With Atrial Fibrillation and Appropriate Anticoagulation Control
Bonde, A. N., Staerk, L., Lee, C. J. -Y., Vinding, N. E., Bang, C. N., Torp-Pedersen, C., . . . Olesen, J. B. (2018). Outcomes Among Patients With Atrial Fibrillation and Appropriate Anticoagulation Control. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 72(12), 1357-1365. doi:10.1016/j.jacc.2018.06.065
Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS-BLED and GARFIELD-AF Bleeding Scores
Proietti, M., Miguel Rivera-Caravaca, J., Asuncion Esteve-Pastor, M., Romiti, G. F., Marin, F., & Lip, G. Y. H. (2018). Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS-BLED and GARFIELD-AF Bleeding Scores. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 7(18). doi:10.1161/JAHA.118.009766
Ideal Blood Pressure in Patients With Atrial Fibrillation
Kim, D., Yang, P. -S., Kim, T. -H., Jang, E., Shin, H., Kim, H. Y., . . . Lip, G. Y. H. (2018). Ideal Blood Pressure in Patients With Atrial Fibrillation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 72(11), 1233-1245. doi:10.1016/j.jacc.2018.05.076
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Rosei, E. A., Azizi, M., Burnier, M., . . . Desormais, I. (2018). 2018 ESC/ESH Guidelines for the management of arterial hypertension. EUROPEAN HEART JOURNAL, 39(33), 3021-+. doi:10.1093/eurheartj/ehy339
A U-shaped relationship of body mass index on atrial fibrillation recurrence post ablation: A report from the Guangzhou atrial fibrillation ablation registry
Deng, H., Shantsila, A., Guo, P., Potpara, T. S., Zhan, X., Fang, X., . . . Lip, G. Y. H. (2018). A U-shaped relationship of body mass index on atrial fibrillation recurrence post ablation: A report from the Guangzhou atrial fibrillation ablation registry. EBIOMEDICINE, 35, 40-45. doi:10.1016/j.ebiom.2018.08.034
Blood glucose reduction by diabetic drugs with minimal hypoglycaemia risk for cardiovascular outcomes: Evidence from meta-regression analysis of randomized controlled trials
Huang, C. -J., Wang, W. -T., Sung, S. -H., Chen, C. -H., Lip, G. Y. H., Cheng, H. -M., & Chiang, C. -E. (2018). Blood glucose reduction by diabetic drugs with minimal hypoglycaemia risk for cardiovascular outcomes: Evidence from meta-regression analysis of randomized controlled trials. DIABETES OBESITY & METABOLISM, 20(9), 2131-2139. doi:10.1111/dom.13342
Does ECG have additive benefit for predicting atrial fibrillation in patients with or without hypertension?
Shin, S. Y., Shantsilla, A., & Lip, G. Y. H. (2018). Does ECG have additive benefit for predicting atrial fibrillation in patients with or without hypertension?. JOURNAL OF HYPERTENSION, 36(9), 1793-1794. doi:10.1097/HJH.0000000000001788
Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated "Real-World" in Patients With Atrial Fibrillation
Asuncion Esteve-Pastor, M., Miguel Rivera-Caravaca, J., Roldan, V., Orenes-Pinero, E., Romiti, G. F., Romanazzi, I., . . . Lip, G. Y. H. (2018). Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated "Real-World" in Patients With Atrial Fibrillation. AMERICAN JOURNAL OF CARDIOLOGY, 122(5), 785-792. doi:10.1016/j.amjcard.2018.05.012
European Heart RhythmAssociation (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?
Dagres, N., Chao, T. -F., Fenelon, G., Aguinaga, L., Benhayon, D., Benjamin, E. J., . . . Shantsila, A. (2018). European Heart RhythmAssociation (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?. EUROPACE, 20(9), 1399-+. doi:10.1093/europace/euy046
Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized controlled trials
Tse, G., Gong, M., Li, G., Wong, S. H., Wu, W. K. K., Wong, W. T., . . . Liu, T. (2018). Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized controlled trials. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 84(9), 1868-1882. doi:10.1111/bcp.13621
Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial)
Lee, T. C., Qian, M., Lip, G. Y. H., Di Tullio, M. R., Graham, S., Mann, D. L., . . . Ye, S. (2018). Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial). AMERICAN JOURNAL OF CARDIOLOGY, 122(5), 821-827. doi:10.1016/j.amjcard.2018.05.024
Impact of carbon impurities on the initial leakage current of AlGaN/GaN high electron mobility transistors
Sasangka, W. A., Gao, Y., Gan, C. L., & Thompson, C. V. (2018). Impact of carbon impurities on the initial leakage current of AlGaN/GaN high electron mobility transistors. Microelectronics Reliability, 88-90, 393-396. doi:10.1016/j.microrel.2018.06.048
Increased burden of comorbidities and risk of cardiovascular death in atrial fibrillation patients in Europe over ten years: A comparison between EORP-AF pilot and EHS-AF registries
Proietti, M., Laroche, C., Nieuwlaat, R., Crijns, H. J. G. M., Maggioni, A. P., Lane, D. A., . . . Lip, G. Y. H. (2018). Increased burden of comorbidities and risk of cardiovascular death in atrial fibrillation patients in Europe over ten years: A comparison between EORP-AF pilot and EHS-AF registries. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 55, 28-34. doi:10.1016/j.ejim.2018.05.016
Inflammation and the risk of atrial high-rate episodes (AHREs) in patients with cardiac implantable electronic devices
Pastori, D., Miyazawa, K., Li, Y., Shahid, F., Hado, H., & Lip, G. Y. H. (2018). Inflammation and the risk of atrial high-rate episodes (AHREs) in patients with cardiac implantable electronic devices. CLINICAL RESEARCH IN CARDIOLOGY, 107(9), 772-777. doi:10.1007/s00392-018-1244-0
Letter by Shahid and Lip Regarding Article, "Stroke Risk Factors Unique to Women"
Shahid, F., & Lip, G. Y. H. (2018). Letter by Shahid and Lip Regarding Article, "Stroke Risk Factors Unique to Women". STROKE, 49(9), E290. doi:10.1161/STROKEAHA.118.021933
Quality of oral anticoagulation with vitamin K antagonists in 'real-world' patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry
Asuncion Esteve-Pastor, M., Miguel Rivera-Caravaca, J., Roldan-Rabadan, I., Roldan, V., Muniz, J., Rana-Miguez, P., . . . Marin, F. (2018). Quality of oral anticoagulation with vitamin K antagonists in 'real-world' patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry. EUROPACE, 20(9), 1435-1441. doi:10.1093/europace/eux314
Reply to 'Comment on 'Genotype-guided warfarin dosing <i>vs</i>. conventional dosing strategies: a systematic review and metaanalysis of randomized clinical trials' by Tse <i>et al</i>.'
Tse, G., Roever, L., Wong, M. C. S., Lip, G. Y. H., & Liu, T. (2018). Reply to 'Comment on 'Genotype-guided warfarin dosing <i>vs</i>. conventional dosing strategies: a systematic review and metaanalysis of randomized clinical trials' by Tse <i>et al</i>.'. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 84(9), 2165-2166. doi:10.1111/bcp.13658
Safety and efficacy of non-vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention: A bivariate analysis of the PIONEER AF-PCI and RE-DUAL PCI trial
Chi, G., Kerneis, M., Kalayci, A., Liu, Y., Mehran, R., Bode, C., . . . Gibson, C. M. (2018). Safety and efficacy of non-vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention: A bivariate analysis of the PIONEER AF-PCI and RE-DUAL PCI trial. AMERICAN HEART JOURNAL, 203, 17-24. doi:10.1016/j.ahj.2018.06.003
Descrambling of Embedded SRAM Using a Laser Probe
Chef, S., Chua, C. T., Tay, J. Y., Siah, Y. W., Bhasin, S., Breier, J., & Gan, C. L. (2018). Descrambling of Embedded SRAM Using a Laser Probe. In 2018 IEEE International Symposium on the Physical and Failure Analysis of Integrated Circuits (IPFA) (pp. 1-6). IEEE. doi:10.1109/ipfa.2018.8452604
Failure Analysis of Damages on Advanced Technologies Induced by Picosecond Pulsed Laser During Space Radiation SEE Testing
Chua, C. T., Liu, Q., Chef, S., Sanchez, K., Pcrdu, P., & Gan, C. L. (2018). Failure Analysis of Damages on Advanced Technologies Induced by Picosecond Pulsed Laser During Space Radiation SEE Testing. In 2018 IEEE International Symposium on the Physical and Failure Analysis of Integrated Circuits (IPFA) (pp. 1-6). IEEE. doi:10.1109/ipfa.2018.8452544
Prediction of electro-anatomical substrate and arrhythmia recurrences using APPLE, DR-FLASH and MB-LATER scores in patients with atrial fibrillation undergoing catheter ablation
Kornej, J., Schumacher, K., Dinov, B., Kosich, F., Sommer, P., Arya, A., . . . Hindricks, G. (2018). Prediction of electro-anatomical substrate and arrhythmia recurrences using APPLE, DR-FLASH and MB-LATER scores in patients with atrial fibrillation undergoing catheter ablation. SCIENTIFIC REPORTS, 8. doi:10.1038/s41598-018-31133-x
Edoxaban in Asian Patients With Atrial Fibrillation Effectiveness and Safety
Lee, S. -R., Choi, E. -K., Han, K. -D., Jung, J. -H., Oh, S., & Lip, G. Y. H. (2018). Edoxaban in Asian Patients With Atrial Fibrillation Effectiveness and Safety. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 72(8), 838-853. doi:10.1016/j.jacc.2018.05.066
Stroke prevention in atrial fibrillation: re-defining 'real-world data' within the broader data universe
Fanaroff, A. C., Steffel, J., Alexander, J. H., Lip, G. Y. H., Califf, R. M., & Lopes, R. D. (2018). Stroke prevention in atrial fibrillation: re-defining 'real-world data' within the broader data universe. EUROPEAN HEART JOURNAL, 39(32), 2932-+. doi:10.1093/eurheartj/ehy236
Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: biomarker substudy results from a prospective study with rivaroxaban (X-TRA)
Miyazawa, K., Pastori, D., Hammerstingl, C., Cappato, R., Meng, I. L., Kramer, F., . . . Marin, F. (2018). Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: biomarker substudy results from a prospective study with rivaroxaban (X-TRA). ANNALS OF MEDICINE, 50(6), 511-518. doi:10.1080/07853890.2018.1495337
Relationship of troponin to incident atrial fibrillation occurrence, recurrence after radiofrequency ablation and prognosis: a systematic review, meta-analysis and meta-regression
Bai, Y., Guo, S. -D., Liu, Y., Ma, C. -S., & Lip, G. Y. H. (2018). Relationship of troponin to incident atrial fibrillation occurrence, recurrence after radiofrequency ablation and prognosis: a systematic review, meta-analysis and meta-regression. BIOMARKERS, 23(6), 512-517. doi:10.1080/1354750X.2018.1463562
Differences in Heart Rate Response and Recovery After 6-Minute Walk Test Between Patients With Atrial Fibrillation and in Sinus Rhythm
Luo, X., Xiong, Q., Xu, J., Hong, K., Peng, Q., Li, J., . . . Hai, S. (2018). Differences in Heart Rate Response and Recovery After 6-Minute Walk Test Between Patients With Atrial Fibrillation and in Sinus Rhythm. AMERICAN JOURNAL OF CARDIOLOGY, 122(4), 592-596. doi:10.1016/j.amjcard.2018.04.048
Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey)
Erkuner, O., Dudink, E. A. M. P., Nieuwlaat, R., Rienstra, M., Van Gelder, I. C., Camm, A. J., . . . Luermans, J. G. L. M. (2018). Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey). AMERICAN JOURNAL OF CARDIOLOGY, 122(4), 578-583. doi:10.1016/j.amjcard.2018.04.053
Management of antithrombotic therapy in AF patients presenting with ACS and/or undergoing PCI
Lip, G. Y. H., Collet, J. -P., Haude, M., & Huber, K. (2018). Management of antithrombotic therapy in AF patients presenting with ACS and/or undergoing PCI. EUROPEAN HEART JOURNAL, 39(31), 2847-2850. doi:10.1093/eurheartj/ehy396
10-year nationwide trends of the incidence, prevalence, and adverse outcomes of non-valvular atrial fibrillation nationwide health insurance data covering the entire Korean population
Kim, D., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -H., Uhm, J. -S., . . . Lip, G. Y. H. (2018). 10-year nationwide trends of the incidence, prevalence, and adverse outcomes of non-valvular atrial fibrillation nationwide health insurance data covering the entire Korean population. AMERICAN HEART JOURNAL, 202, 20-26. doi:10.1016/j.ahj.2018.04.017
A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the "Real-World" vs Clinical Trials
Miguel Rivera-Caravaca, J., Asuncion Esteve-Pastor, M., Marin, F., Valdes, M., Vicente, V., Roldan, V., & Lip, G. Y. H. (2018). A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the "Real-World" vs Clinical Trials. MAYO CLINIC PROCEEDINGS, 93(8), 1065-1073. doi:10.1016/j.mayocp.2018.01.028
Ambulatory blood pressure and long-term risk for atrial fibrillation
Tihonoff, V., Kuznetsova, T., Thijs, L., Cauwenberghs, N., Stolarz-Skrzypek, K., Seidlerova, J., . . . Staessen, J. A. (2018). Ambulatory blood pressure and long-term risk for atrial fibrillation. HEART, 104(15), 1263-+. doi:10.1136/heartjnl-2017-312488
Atrial Tachyarrhythmia Prevalence in Patients with Implantable Cardiac Resynchronization Defibrillators
Gillett, S., Reyes, C., Martin, D., & Lip, G. (2018). Atrial Tachyarrhythmia Prevalence in Patients with Implantable Cardiac Resynchronization Defibrillators. In JOURNAL OF CARDIAC FAILURE Vol. 24 (pp. S57). doi:10.1016/j.cardfail.2018.07.257
Effect of Implantable Cardioverter-Defibrillators by Etiology of Heart Failure: A Propensity-Matched Mortality Analysis of the WARCEF Trial
Lee, T. C., Qian, M., Mu, L., Di Tullio, M. R., Graham, S., Mann, D. L., . . . Ye, S. (2018). Effect of Implantable Cardioverter-Defibrillators by Etiology of Heart Failure: A Propensity-Matched Mortality Analysis of the WARCEF Trial. In JOURNAL OF CARDIAC FAILURE Vol. 24 (pp. S75). doi:10.1016/j.cardfail.2018.07.311
Gender Differences in Antithrombotic Treatment for Newly Diagnosed Atrial Fibrillation: The GLORIA-AF Registry Program
Mazurek, M., Huisman, M. V., Rothman, K. J., Paquette, M., Teutsch, C., Diener, H. -C., . . . Lip, G. Y. H. (2018). Gender Differences in Antithrombotic Treatment for Newly Diagnosed Atrial Fibrillation: The GLORIA-AF Registry Program. AMERICAN JOURNAL OF MEDICINE, 131(8), 945-+. doi:10.1016/j.amjmed.2018.03.024
Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants
Pastori, D., Lip, G. Y. H., Farcomeni, A., Del Sole, F., Sciacqua, A., Perticone, F., . . . Violi, F. (2018). Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants. INTERNATIONAL JOURNAL OF CARDIOLOGY, 264, 58-63. doi:10.1016/j.ijcard.2018.01.097
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study
Raparelli, V., Pastori, D., Pignataro, S. F., Vestri, A. R., Pignatelli, P., Cangemi, R., . . . Basili, S. (2018). Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study. INTERNAL AND EMERGENCY MEDICINE, 13(5), 651-660. doi:10.1007/s11739-018-1835-9
Nitrite circumvents platelet resistance to nitric oxide in patients with heart failure preserved ejection fraction and chronic atrial fibrillation
Borgognone, A., Shantsila, E., Worrall, S. M., Prompunt, E., Loka, T., Loudon, B. L., . . . Madhani, M. (2018). Nitrite circumvents platelet resistance to nitric oxide in patients with heart failure preserved ejection fraction and chronic atrial fibrillation. CARDIOVASCULAR RESEARCH, 114(10), 1313-1323. doi:10.1093/cvr/cvy087
Rivaroxaban for stroke prevention in people with atrial fibrillation and diabetes mellitus
Li, Y. -G., Pastori, D., & Lip, G. Y. H. (2018). Rivaroxaban for stroke prevention in people with atrial fibrillation and diabetes mellitus. DIABETIC MEDICINE, 35(8), 1134-1135. doi:10.1111/dme.13685
Role of chronic kidney disease and atrial fibrillation in outcomes of patients with ischemic stroke
Khan, A. A., & Lip, G. Y. H. (2018). Role of chronic kidney disease and atrial fibrillation in outcomes of patients with ischemic stroke. EUROPEAN JOURNAL OF NEUROLOGY, 25(8), 1009-1010. doi:10.1111/ene.13664
Stroke Prevention in Atrial Fibrillation: Focus on Asian Patients
Li, Y. -G., Lee, S. -R., Choi, E. -K., & Lip, G. Y. H. (2018). Stroke Prevention in Atrial Fibrillation: Focus on Asian Patients. KOREAN CIRCULATION JOURNAL, 48(8), 665-684. doi:10.4070/kcj.2018.0190
Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation
Pastori, D., Farcomeni, A., Saliola, M., Del Sole, F., Pignatelli, P., Violi, F., & Lip, G. Y. H. (2018). Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 54, 34-39. doi:10.1016/j.ejim.2018.04.007
The prognostic accuracy of bleeding risk prediction scores in patients with atrial fibrillation: a systematic review and meta-analysis
Penson, P. E., Awad, K., Lane, D., Banach, M., & Lip, G. Y. H. (2018). The prognostic accuracy of bleeding risk prediction scores in patients with atrial fibrillation: a systematic review and meta-analysis. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 817). Retrieved from https://www.webofscience.com/
Translating guidelines into practice for the management of atrial fibrillation: results of an European Heart Rhythm Association Survey
Dan, G. -A., Iliodromitis, K., Scherr, D., Marin, F., Lenarczyk, R., Estner, H. L., . . . Lip, G. Y. H. (2018). Translating guidelines into practice for the management of atrial fibrillation: results of an European Heart Rhythm Association Survey. EUROPACE, 20(8), 1382-1387. doi:10.1093/europace/euy094
Stroke Prophylaxis After a New Emergency Department Diagnosis of Atrial Fibrillation
Kea, B., Lin, A. L., Olshansky, B., Malveau, S., Fu, R., Raitt, M., . . . Sun, B. C. (2018). Stroke Prophylaxis After a New Emergency Department Diagnosis of Atrial Fibrillation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 72(4), 471-472. doi:10.1016/j.jacc.2018.05.022
Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation
Law, S. W. Y., Lau, W. C. Y., Wong, I. C. K., Lip, G. Y. H., Mok, M. T., Siu, C. -W., & Chan, E. W. (2018). Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 72(3), 271-282. doi:10.1016/j.jacc.2018.04.066
Arrhythmias and cognitive function
Dagres, N., Chao, T. -F., Fenelon, G., Lip, G. Y. H., & Chung, M. (2018). Arrhythmias and cognitive function. EUROPEAN HEART JOURNAL, 39(26), 2446-2447. doi:10.1093/eurheartj/ehy317
Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study
Chao, T. -F., Liu, C. -J., Lin, Y. -J., Chang, S. -L., Lo, L. -W., Hu, Y. -F., . . . Chen, S. -A. (2018). Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study. CIRCULATION, 138(1), 37-47. doi:10.1161/CIRCULATIONAHA.117.031658
The relationship of systemic markers of haemostasis with retinal blood vessel responses in cardiovascular disease and/or diabetes
Heitmar, R., Nicholl, P., Lee, B., Lau, Y. C., & Lip, G. Y. H. (2018). The relationship of systemic markers of haemostasis with retinal blood vessel responses in cardiovascular disease and/or diabetes. BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 75(3), 116-121. doi:10.1080/09674845.2017.1420130
Dynamic Changes of CHA<sub>2</sub>DS<sub>2</sub>-VASc Score and the Risk of Ischaemic Stroke in Asian Patients with Atrial Fibrillation: A Nationwide Cohort Study
Yoon, M., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -H., Uhm, J. -S., . . . Joung, B. (2018). Dynamic Changes of CHA<sub>2</sub>DS<sub>2</sub>-VASc Score and the Risk of Ischaemic Stroke in Asian Patients with Atrial Fibrillation: A Nationwide Cohort Study. THROMBOSIS AND HAEMOSTASIS, 118(7), 1296-1304. doi:10.1055/s-0038-1651482
Guideline-adherent secondary prevention post-acute coronary syndromes: the importance of patient uptake and persistence
Szekely, O., Lane, D. A., & Lip, G. Y. H. (2018). Guideline-adherent secondary prevention post-acute coronary syndromes: the importance of patient uptake and persistence. EUROPEAN HEART JOURNAL, 39(25), 2365-2367. doi:10.1093/eurheartj/ehy308
Management and prognosis of atrial fibrillation in diabetic patients: an EORP-AF General Pilot Registry report
Fumagalli, S., Said, S. A., Laroche, C., Gabbai, D., Boni, S., Marchionni, N., . . . Lip, G. Y. H. (2018). Management and prognosis of atrial fibrillation in diabetic patients: an EORP-AF General Pilot Registry report. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 4(3), 172-179. doi:10.1093/ehjcvp/pvx037
Predictors of diastolic dysfunction in ethnic groups: observations from the Hypertensive Cohort of The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES)
Shantsila, A., Shantsila, E., Gill, P. S., & Lip, G. Y. H. (2018). Predictors of diastolic dysfunction in ethnic groups: observations from the Hypertensive Cohort of The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES). JOURNAL OF HUMAN HYPERTENSION, 32(7), 477-486. doi:10.1038/s41371-018-0064-z
Prognostic implication of monocytes in atrial fibrillation: The West Birmingham Atrial Fibrillation Project
Shahid, F., Rahmat, N. A., Lip, G. Y. H., & Shantsila, E. (2018). Prognostic implication of monocytes in atrial fibrillation: The West Birmingham Atrial Fibrillation Project. PLOS ONE, 13(7). doi:10.1371/journal.pone.0200373
State of play and future direction with NOACs: An expert consensus
Cohen, A. T., Lip, G. Y., De Caterina, R., Heidbuchel, H., Zamorano, J. L., Agnelli, G., . . . Camm, A. J. (2018). State of play and future direction with NOACs: An expert consensus. VASCULAR PHARMACOLOGY, 106, 9-21. doi:10.1016/j.vph.2018.04.001
The relationship of early recurrence of atrial fibrillation and the 3-month integrity of the ablation lesion set
Mujovic, N., Marinkovic, M., Markovic, N., Vucicevic, V., Lip, G. Y. H., Bunch, T. J., & Potpara, T. S. (2018). The relationship of early recurrence of atrial fibrillation and the 3-month integrity of the ablation lesion set. SCIENTIFIC REPORTS, 8. doi:10.1038/s41598-018-28072-y
Atrial fibrillation and prediction of mortality by conventional clinical score systems according to the setting of care
Diemberger, I., Fantecchi, E., Reggiani, M. L. B., Martignani, C., Angeletti, A., Massaro, G., . . . Boriani, G. (2018). Atrial fibrillation and prediction of mortality by conventional clinical score systems according to the setting of care. INTERNATIONAL JOURNAL OF CARDIOLOGY, 261, 73-77. doi:10.1016/j.ijcard.2018.03.058
Restarting oral anticoagulant therapy after major bleeding in atrial fibrillation: A systematic review and meta-analysis
Proietti, M., Romiti, G. F., Romanazzi, I., Farcomeni, A., Staerk, L., Nielsen, P. B., & Lip, G. Y. H. (2018). Restarting oral anticoagulant therapy after major bleeding in atrial fibrillation: A systematic review and meta-analysis. INTERNATIONAL JOURNAL OF CARDIOLOGY, 261, 84-91. doi:10.1016/j.ijcard.2018.03.053
Risk factors for new-onset atrial fibrillation: A focus on Asian populations
Li, Y., Pastori, D., Guo, Y., Wang, Y., & Lip, G. Y. H. (2018). Risk factors for new-onset atrial fibrillation: A focus on Asian populations. INTERNATIONAL JOURNAL OF CARDIOLOGY, 261, 92-98. doi:10.1016/j.ijcard.2018.02.051
Effect of the size of carbon nanotubes (CNTs) on the microstructure and mechanical strength of CNTs-doped composite Sn0.3Ag0.7Cu-CNTs solder
Zhu, Z., Chan, Y. -C., Chen, Z., Gan, C. -L., & Wu, F. (2018). Effect of the size of carbon nanotubes (CNTs) on the microstructure and mechanical strength of CNTs-doped composite Sn0.3Ag0.7Cu-CNTs solder. Materials Science and Engineering: A, 727, 160-169. doi:10.1016/j.msea.2018.05.002
Atrial fibrillation patient preferences for oral anticoagulation and stroke knowledge: Results of a conjoint analysis
Lane, D. A., Meyerhoff, J., Rohner, U., & Lip, G. Y. H. (2018). Atrial fibrillation patient preferences for oral anticoagulation and stroke knowledge: Results of a conjoint analysis. CLINICAL CARDIOLOGY, 41(6), 855-861. doi:10.1002/clc.22971
Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study
Wilson, D., Ambler, G., Shakeshaft, C., Brown, M. M., Charidimou, A., Salman, R. A. -S., . . . Werring, D. J. (2018). Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study. LANCET NEUROLOGY, 17(6), 539-547. doi:10.1016/S1474-4422(18)30145-5
European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS)
Gorenek, B., Boriani, G., Dan, G. -A., Fauchier, L., Fenelon, G., Huang, H., . . . Fuenmayor, A. (2018). European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS). EUROPACE, 20(6), 895-+. doi:10.1093/europace/euy051
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?
Dagres, N., Chao, T. -F., Fenelon, G., Aguinaga, L., Benhayon, D., Benjamin, E. J., . . . Chung, M. K. (2018). European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?. HEART RHYTHM, 15(6), E37-E60. doi:10.1016/j.hrthm.2018.03.005
HIGH HEART RATE PREDICTS CARDIAC FIBROSIS IN PATIENTS WITH ATRIAL FIBRILLATION AND PRESERVED LEFT VENTRICULAR FUNCTION
Shahid, F., Lip, G., & Shantsila, E. (2018). HIGH HEART RATE PREDICTS CARDIAC FIBROSIS IN PATIENTS WITH ATRIAL FIBRILLATION AND PRESERVED LEFT VENTRICULAR FUNCTION. In HEART Vol. 104 (pp. A76-A77). doi:10.1136/heartjnl-2018-BCS.91
In-hospital direct costs for thromboembolism and bleeding in Chinese patients with atrial fibrillation.
Chang, S. -S., Wu, J. -H., Liu, Y., Zhang, T., Du, X., Dong, J. -Z., . . . Ma, C. -S. (2018). In-hospital direct costs for thromboembolism and bleeding in Chinese patients with atrial fibrillation.. Chronic diseases and translational medicine, 4(2), 127-134. doi:10.1016/j.cdtm.2018.01.001
Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation
Jose Serna, M., Miguel Rivera-Caravaca, J., Gonzalez-Conejero, R., Asuncion Esteve-Pastor, M., Valdes, M., Vicente, V., . . . Marin, F. (2018). Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 48(6). doi:10.1111/eci.12929
Prognostic and therapeutic implications of vascular disease in patients with atrial fibrillation
Shahid, F., Pastori, D., Violi, F., & Lip, G. Y. H. (2018). Prognostic and therapeutic implications of vascular disease in patients with atrial fibrillation. PHARMACOLOGICAL RESEARCH, 132, 149-159. doi:10.1016/j.phrs.2018.04.019
Risk factors for the development of incident atrial fibrillation in patients with cardiac implantable electronic devices
Miyazawa, K., Kondo, Y., Nakano, M., Asuncion Esteve-Pastor, M., Miguel Rivera-Caravaca, J., Senoo, K., . . . Lip, G. Y. H. (2018). Risk factors for the development of incident atrial fibrillation in patients with cardiac implantable electronic devices. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 52, 54-59. doi:10.1016/j.ejim.2018.02.019
Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia
Dias, I. H. K., Milic, I., Lip, G. Y. H., Devitt, A., Polidori, M. C., & Griffiths, H. R. (2018). Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia. REDOX BIOLOGY, 16, 139-145. doi:10.1016/j.redox.2018.02.014
Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project
Miguel Rivera-Caravaca, J., Roldan, V., Romera, M., Asuncion Esteve-Pastor, M., Valdes, M., Lip, G. Y. H., . . . Marin, F. (2018). Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project. JOURNAL OF GENERAL INTERNAL MEDICINE, 33(6), 847-854. doi:10.1007/s11606-017-4279-4
Stroke, thromboembolism and bleeding in patients with atrial fibrillation according to the EHRA valvular heart disease classification
Bisson, A., Bodin, A., Clementy, N., Bernard, A., Babuty, D., Lip, G. Y. H., & Fauchier, L. (2018). Stroke, thromboembolism and bleeding in patients with atrial fibrillation according to the EHRA valvular heart disease classification. INTERNATIONAL JOURNAL OF CARDIOLOGY, 260, 93-98. doi:10.1016/j.ijcard.2018.03.017
Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program
McIntyre, W. F., Conen, D., Olshansky, B., Halperin, J. L., Hayek, E., Huisman, M. V., . . . Healey, J. S. (2018). Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program. CLINICAL CARDIOLOGY, 41(6), 744-751. doi:10.1002/clc.22936
TOTAL MONOCYTE COUNT AS PREDICTOR OF EXERCISE CAPACITY IN PATIENTS WITH PERMANENT ATRIAL FIBRILLATION AND PRESERVED LEFT VENTRICULAR FUNCTION - THE WEST BIRMINGHAM AF PROJECT
Khan, A., Shahid, F., Lip, G., & Shantsila, E. (2018). TOTAL MONOCYTE COUNT AS PREDICTOR OF EXERCISE CAPACITY IN PATIENTS WITH PERMANENT ATRIAL FIBRILLATION AND PRESERVED LEFT VENTRICULAR FUNCTION - THE WEST BIRMINGHAM AF PROJECT. In HEART Vol. 104 (pp. A79). doi:10.1136/heartjnl-2018-BCS.96
Time to therapeutic range (TtTR), anticoagulation control, and cardiovascular events in vitamin K antagonists-naive patients with atrial fibrillation
Pastori, D., Pignatelli, P., Cribari, F., Carnevale, R., Saliola, M., Violi, F., & Lip, G. Y. H. (2018). Time to therapeutic range (TtTR), anticoagulation control, and cardiovascular events in vitamin K antagonists-naive patients with atrial fibrillation. AMERICAN HEART JOURNAL, 200, 32-36. doi:10.1016/j.ahj.2018.03.004
Health care facility type-related challenges in the management of stroke risk in patients with atrial fibrillation: practical implications
Potpara, T. S., Andrei-Dan, G., & Lip, G. Y. H. (2018). Health care facility type-related challenges in the management of stroke risk in patients with atrial fibrillation: practical implications. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 128(5), 271-273. Retrieved from https://www.webofscience.com/
Anticoagulation Resumption After Intracerebral Hemorrhage
Li, Y. -G., & Lip, G. Y. H. (2018). Anticoagulation Resumption After Intracerebral Hemorrhage. CURRENT ATHEROSCLEROSIS REPORTS, 20(7). doi:10.1007/s11883-018-0733-y
Fitting the right non-vitamin K antagonist oral anticoagulant to the right patient with non-valvular atrial fibrillation: an evidence-based choice
Li, Y. -G., Pastori, D., & Lip, G. Y. H. (2018). Fitting the right non-vitamin K antagonist oral anticoagulant to the right patient with non-valvular atrial fibrillation: an evidence-based choice. ANNALS OF MEDICINE, 50(4), 288-302. doi:10.1080/07853890.2018.1460489
Fitting the right non-vitamin K antagonist oral anticoagulant to the right patient with non-valvular atrial fibrillation: an evidence-based choice (vol 50, pg 288, 2018)
Li, Y. -G., Pastori, D., & Lip, G. Y. H. (2018). Fitting the right non-vitamin K antagonist oral anticoagulant to the right patient with non-valvular atrial fibrillation: an evidence-based choice (vol 50, pg 288, 2018). ANNALS OF MEDICINE, 50(4), 361. doi:10.1080/07853890.2018.1468134
Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study
Staerk, L., Fosbol, E. L., Lamberts, M., Bonde, A. N., Gadsboll, K., Sindet-Pedersen, C., . . . Olesen, J. B. (2018). Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study. EUROPEAN HEART JOURNAL, 39(19), 1698-+. doi:10.1093/eurheartj/ehx598
Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review andmeta-analysis of randomized clinical trials
Golwala, H. B., Cannon, C. P., Steg, P. G., Doros, G., Qamar, A., Ellis, S. G., . . . Bhatt, D. L. (2018). Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review andmeta-analysis of randomized clinical trials. EUROPEAN HEART JOURNAL, 39(19), 1726-+. doi:10.1093/eurheartj/ehy162
Risk of incident atrial fibrillation in patients presenting with retinal artery or vein occlusion: a nationwide cohort study
Christiansen, C. B., Torp-Pedersen, C., Olesen, J. B., Gislason, G., Lamberts, M., Carlson, N., . . . Lip, G. Y. H. (2018). Risk of incident atrial fibrillation in patients presenting with retinal artery or vein occlusion: a nationwide cohort study. BMC CARDIOVASCULAR DISORDERS, 18. doi:10.1186/s12872-018-0825-1
Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry: protocol for a prospective, observational nationwide cohort study
Guo, Y., Wang, Y., Li, X., Shan, Z., Shi, X., Xi, G., & Lip, G. Y. H. (2018). Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry: protocol for a prospective, observational nationwide cohort study. BMJ OPEN, 8(5). doi:10.1136/bmjopen-2017-020191
Atrial fibrillation in the Middle East: unmapped, underdiagnosed, undertreated.
Al-Shamkhani, W., Ayetey, H., & Lip, G. Y. H. (2018). Atrial fibrillation in the Middle East: unmapped, underdiagnosed, undertreated.. Expert review of cardiovascular therapy, 16(5), 341-348. doi:10.1080/14779072.2018.1457953
Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)
Dan, G. -A., Martinez-Rubio, A., Agewall, S., Boriani, G., Borggrefe, M., Gaita, F., . . . Wolpert, C. (2018). Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP). EUROPACE, 20(5), 731-+. doi:10.1093/europace/eux373
Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP) (vol 20, pg 731, 2018)
Dan, G. -A., Martinez-Rubio, A., Agewall, S., Boriani, G., Borggrefe, M., Gaita, F., . . . Wolpert, C. (2018). Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP) (vol 20, pg 731, 2018). EUROPACE, 20(5), 738. doi:10.1093/europace/euy119
Circulating small-sized endothelial microparticles as predictors of clinical outcome after chemotherapy for breast cancer: an exploratory analysis
Garcia Garre, E., Luengo Gil, G., Montoro Garcia, S., Gonzalez Billalabeitia, E., Zafra Poves, M., Garcia Martinez, E., . . . Ayala de la Pena, F. (2018). Circulating small-sized endothelial microparticles as predictors of clinical outcome after chemotherapy for breast cancer: an exploratory analysis. BREAST CANCER RESEARCH AND TREATMENT, 169(1), 83-92. doi:10.1007/s10549-017-4656-z
Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry
Boriani, G., Proietti, M., Laroche, C., Fauchier, L., Marin, F., Nabauer, M., . . . Lip, G. Y. H. (2018). Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry. EUROPACE, 20(5), 747-757. doi:10.1093/europace/eux301
Impact of Mon2 monocyte-platelet aggregates on human coronary artery disease
Brown, R. A., Lip, G. Y. H., Varma, C., & Shantsila, E. (2018). Impact of Mon2 monocyte-platelet aggregates on human coronary artery disease. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 48(5). doi:10.1111/eci.12911
Integrating pulsed laser for a galvo mirror based SEE scanning microscope with optical failure analysis capabilities
Chua, C. T., Chef, S., Sanchez, K., Bascoul, G., Perdu, P., Tan, S. H., & Gan, C. L. (2018). Integrating pulsed laser for a galvo mirror based SEE scanning microscope with optical failure analysis capabilities. In 2018 International Conference on Radiation Effects of Electronic Devices (ICREED). IEEE. doi:10.1109/icreed.2018.8905093
REPLY: The Case of Dynamic CHA<sub>2</sub>DS<sub>2</sub>-VASc Score Beyond Risk Prediction
Chao, T. -F., Lip, G. Y. H., & Chen, S. -A. (2018). REPLY: The Case of Dynamic CHA<sub>2</sub>DS<sub>2</sub>-VASc Score Beyond Risk Prediction. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 71(17), 1942-1943. doi:10.1016/j.jacc.2018.03.012
Relation of quality of anticoagulation control with different management systems among patients with atrial fibrillation: Data from FANTASIIA Registry
Roldan Rabadan, I., Asuncion Esteve-Pastor, M., Anguita-Sanchez, M., Muniz, J., Camacho Siles, J., Angustias Quesada, M., . . . Badimon, L. (2018). Relation of quality of anticoagulation control with different management systems among patients with atrial fibrillation: Data from FANTASIIA Registry. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 48(5). doi:10.1111/eci.12910
The HAS-BLED, ATRIA, and ORBIT Bleeding Scores in Atrial Fibrillation Patients Using Non-Vitamin K Antagonist Oral Anticoagulants
Lip, G. Y. H., Skjoth, F., Nielsen, P. B., Kjaeldgaard, J. N., & Larsen, T. B. (2018). The HAS-BLED, ATRIA, and ORBIT Bleeding Scores in Atrial Fibrillation Patients Using Non-Vitamin K Antagonist Oral Anticoagulants. AMERICAN JOURNAL OF MEDICINE, 131(5). doi:10.1016/j.amjmed.2017.11.046
Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction
Potpara, T. S., Ferro, C. J., & Lip, G. Y. H. (2018). Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction. NATURE REVIEWS NEPHROLOGY, 14(5), 337-351. doi:10.1038/nrneph.2018.19
Variations of Prevalence and Incidence of Atrial Fibrillation and Oral Anticoagulation Rate According to Different Analysis Approaches
Yang, P. -S., Ryu, S., Kim, D., Jang, E., Yu, H. T., Kim, T. -H., . . . Lip, G. Y. H. (2018). Variations of Prevalence and Incidence of Atrial Fibrillation and Oral Anticoagulation Rate According to Different Analysis Approaches. SCIENTIFIC REPORTS, 8. doi:10.1038/s41598-018-25111-6
Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor
Wang, Z., Stuckey, D. J., Murdoch, C. E., Camelliti, P., Lip, G. Y. H., & Griffin, M. (2018). Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor. CELL DEATH & DISEASE, 9. doi:10.1038/s41419-018-0573-2
Comparison of the 2MACE and TIMI-AF Scores for Composite Clinical Outcomes in Anticoagulated Atrial Fibrillation Patients
Pastori, D., Miguel Rivera-Caravaca, J., Asuncion Esteve-Pastor, M., Roldan, V., Marin, F., Pignatelli, P., . . . Lip, G. Y. H. (2018). Comparison of the 2MACE and TIMI-AF Scores for Composite Clinical Outcomes in Anticoagulated Atrial Fibrillation Patients. CIRCULATION JOURNAL, 82(5), 1286-+. doi:10.1253/circj.CJ-17-1318
Incidence and Risk Factors of Stroke or Systemic Embolism in Patients With Atrial Fibrillation and Heart Failure - The Fushimi AF Registry
Iguchi, M., Tezuka, Y., Ogawa, H., Hamatani, Y., Takagi, D., An, Y., . . . Akao, M. (2018). Incidence and Risk Factors of Stroke or Systemic Embolism in Patients With Atrial Fibrillation and Heart Failure - The Fushimi AF Registry. CIRCULATION JOURNAL, 82(5), 1327-+. doi:10.1253/circj.CJ-17-1155
European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE)
Katritsis, D. G., Boriani, G., Cosio, F. G., Hindricks, G., Jais, P., Josephson, M. E., . . . Blomstrom-Lundqvist, C. (2018). European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE). EUROPEAN HEART JOURNAL, 39(16), 1442-1445. doi:10.1093/eurheartj/ehw455
Innovative strategies to improve adherence to non-vitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation
Lip, G. Y. H., Lane, D. A., & Potpara, T. S. (2018). Innovative strategies to improve adherence to non-vitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation. EUROPEAN HEART JOURNAL, 39(16), 1404-1406. doi:10.1093/eurheartj/ehx807
Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention Insights From the PIONEER AF-PCI Trial
Kerneis, M., Gibson, C. M., Chi, G., Mehran, R., AlKhalfan, F., Talib, U., . . . Cohen, M. (2018). Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention Insights From the PIONEER AF-PCI Trial. JACC-CARDIOVASCULAR INTERVENTIONS, 11(7), 626-634. doi:10.1016/j.jcin.2017.11.009
CHA<sub>2</sub>DS<sub>2</sub>-VASc score risk factors as predictors of stroke after acute coronary syndrome: Can we really be sure there is no atrial fibrillation?
Mazurek, M., & Lip, G. Y. H. (2018). CHA<sub>2</sub>DS<sub>2</sub>-VASc score risk factors as predictors of stroke after acute coronary syndrome: Can we really be sure there is no atrial fibrillation?. EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 7(3), 275-277. doi:10.1177/2048872616688455
Changes in glomerular filtration rate and outcomes in patients with atrial fibrillation
Fauchier, L., Bisson, A., Clementy, N., Vourc'h, P., Angoulvant, D., Babuty, D., . . . Lip, G. Y. H. (2018). Changes in glomerular filtration rate and outcomes in patients with atrial fibrillation. AMERICAN HEART JOURNAL, 198, 39-45. doi:10.1016/j.ahj.2017.12.017
Changes in renal function in patients with atrial fibrillation: Efficacy and safety of the non-vitamin K antagonist oral anticoagulants
Miyazawa, K., Pastori, D., & Lip, G. Y. H. (2018). Changes in renal function in patients with atrial fibrillation: Efficacy and safety of the non-vitamin K antagonist oral anticoagulants. AMERICAN HEART JOURNAL, 198, 166-168. doi:10.1016/j.ahj.2017.11.015
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study
Paciullo, F., Proietti, M., Bianconi, V., Nobili, A., Pirro, M., Mannucci, P. M., . . . Lupattelli, G. (2018). Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study. DRUGS & AGING, 35(4), 365-373. doi:10.1007/s40266-018-0532-8
Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants.
Pastori, D., Lip, G. Y. H., Farcomeni, A., Del Sole, F., Sciacqua, A., Perticone, F., . . . ATHERO-AF study group. (2018). Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants.. Data in brief, 17, 830-836. doi:10.1016/j.dib.2018.01.109
Discontinuation risk comparison among 'real-world' newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban
Lip, G. Y. H., Pan, X., Kamble, S., Kawabata, H., Mardekian, J., Masseria, C., & Phatak, H. (2018). Discontinuation risk comparison among 'real-world' newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban. PLOS ONE, 13(4). doi:10.1371/journal.pone.0195950
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: What is the best practice?
Dagres, N., Chao, T. -F., Fenelon, G., Aguinaga, L., Benhayon, D., Benjamin, E. J., . . . Chung, M. K. (2018). European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: What is the best practice?. JOURNAL OF ARRHYTHMIA, 34(2), 99-123. doi:10.1002/joa3.12050
Incident Risk Factors and Major Bleeding in Patients with Atrial Fibrillation Treated with Oral Anticoagulants: A Comparison of Baseline, Follow-up and Delta HAS-BLED Scores with an Approach Focused on Modifiable Bleeding Risk Factors
Chao, T. -F., Lip, G. Y. H., Lin, Y. -J., Chang, S. -L., Lo, L. -W., Hu, Y. -F., . . . Chen, S. -A. (2018). Incident Risk Factors and Major Bleeding in Patients with Atrial Fibrillation Treated with Oral Anticoagulants: A Comparison of Baseline, Follow-up and Delta HAS-BLED Scores with an Approach Focused on Modifiable Bleeding Risk Factors. THROMBOSIS AND HAEMOSTASIS, 118(4), 768-777. doi:10.1055/s-0038-1636534
Novel biomarker-based risk prediction for new onset atrial fibrillation in patients with ST elevation myocardial infarction: Balancing simplicity and practicality
Shin, S. Y., & Lip, G. Y. H. (2018). Novel biomarker-based risk prediction for new onset atrial fibrillation in patients with ST elevation myocardial infarction: Balancing simplicity and practicality. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 72(4). doi:10.1111/ijcp.13090
Overweight and obesity in patients with atrial fibrillation: Sex differences in 1-year outcomes in the EORP-AF General Pilot Registry
Boriani, G., Laroche, C., Diemberger, I., Fantecchi, E., Meeder, J., Kurpesa, M., . . . Lip, G. Y. H. (2018). Overweight and obesity in patients with atrial fibrillation: Sex differences in 1-year outcomes in the EORP-AF General Pilot Registry. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 29(4), 566-572. doi:10.1111/jce.13428
Risk of stroke and bleeding in patients with heart failure and chronic kidney disease: a nationwide cohort study
Melgaard, L., Overvad, T. F., Skjoth, F., Christensen, J. H., Larsen, T. B., & Lip, G. Y. H. (2018). Risk of stroke and bleeding in patients with heart failure and chronic kidney disease: a nationwide cohort study. ESC HEART FAILURE, 5(2), 319-326. doi:10.1002/ehf2.12256
Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF)
Sobue, Y., Watanabe, E., Lip, G. Y. H., Koshikawa, M., Ichikawa, T., Kawai, M., . . . Ozaki, Y. (2018). Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF). HEART AND VESSELS, 33(4), 403-412. doi:10.1007/s00380-017-1073-5
Two-year follow-up of patients treated with dabigatran for stroke prevention in atrial fibrillation: Global Registry on Long-Term Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) registry
Huisman, M. V., Rothman, K. J., Paquette, M., Teutsch, C., Diener, H. -C., Dubner, S. J., . . . Lip, G. Y. H. (2018). Two-year follow-up of patients treated with dabigatran for stroke prevention in atrial fibrillation: Global Registry on Long-Term Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) registry. AMERICAN HEART JOURNAL, 198, 55-63. doi:10.1016/j.ahj.2017.08.018
Use of the SAMe-TT<sub>2</sub>R<sub>2</sub> score to predict anticoagulation control in atrial fibrillation and venous thromboembolism patients receiving vitamin K antagonists: A review
Zulkifly, H., Lip, G. Y. H., & Lane, D. A. (2018). Use of the SAMe-TT<sub>2</sub>R<sub>2</sub> score to predict anticoagulation control in atrial fibrillation and venous thromboembolism patients receiving vitamin K antagonists: A review. HEART RHYTHM, 15(4), 615-623. doi:10.1016/j.hrthm.2017.11.026
Relationship of peripheral and coronary artery disease to cardiovascular events in patients with atrial fibrillation
Pastori, D., Pignatelli, P., Sciacqua, A., Perticone, M., Violi, F., & Lip, G. Y. H. (2018). Relationship of peripheral and coronary artery disease to cardiovascular events in patients with atrial fibrillation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 255, 69-73. doi:10.1016/j.ijcard.2017.12.076
Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy A Meta-Analysis of Randomized Trials
Bennaghmouch, N., de Veer, A. J. W. M., Bode, K., Mahmoodi, B. K., Dewilde, W. J. M., Lip, G. Y. H., . . . ten Berg, J. M. (2018). Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy A Meta-Analysis of Randomized Trials. CIRCULATION, 137(11), 1117-1129. doi:10.1161/CIRCULATIONAHA.117.028513
Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS-BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment
Brown, J. D., Goodin, A. J., Lip, G. Y. H., & Adams, V. R. (2018). Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS-BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 7(6). doi:10.1161/JAHA.117.007901
Novel high temperature polymeric encapsulation material for extreme environment electronics packaging
Phua, E. J. R., Liu, M., Cho, B., Liu, Q., Amini, S., Hu, X., & Gan, C. L. (2018). Novel high temperature polymeric encapsulation material for extreme environment electronics packaging. Materials & Design, 141, 202-209. doi:10.1016/j.matdes.2017.12.029
Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality
Miguel Rivera-Caravaca, J., Marin, F., Asuncion Esteve-Pastor, M., Valdes, M., Vicente, V., Roldan, V., & Lip, G. Y. H. (2018). Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 72(3). doi:10.1111/ijcp.13069
Arterial hypertension in patients with atrial fibrillation in Europe: A report from the EURObservational Research Programme pilot survey on atrial fibrillation
Dan, G. A., Badila, E., Weiss, E., Laroche, C., Boriani, G., Dan, A., . . . Lip, G. Y. H. (2018). Arterial hypertension in patients with atrial fibrillation in Europe: A report from the EURObservational Research Programme pilot survey on atrial fibrillation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 254, 136-141. doi:10.1016/j.ijcard.2017.10.092
BLEEDING EVENTS AND THEIR CONSEQUENCES ON CARDIOVASCULAR EVENTS, READMISSION AND NET CLINICAL BENEFIT
Steg, P., Bhatt, D., Ellis, S., Hohnloser, S., Kleine, E., Nordaby, M., . . . Cannon, C. (2018). BLEEDING EVENTS AND THEIR CONSEQUENCES ON CARDIOVASCULAR EVENTS, READMISSION AND NET CLINICAL BENEFIT. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 71 (pp. 1154). doi:10.1016/S0735-1097(18)31695-4
COMPARATIVE EFFECTIVENESS AND SAFETY OF NOACS VERSUS WARFARIN FOR SECONDARY STROKE PREVENTION IN ATRIAL FIBRILLATION: A NATIONWIDE DANISH COHORT STUDY
Nielsen, P. B., Togersen, F. A., Skjoth, F., Sogaard, M., Larsen, T. B., & Lip, G. (2018). COMPARATIVE EFFECTIVENESS AND SAFETY OF NOACS VERSUS WARFARIN FOR SECONDARY STROKE PREVENTION IN ATRIAL FIBRILLATION: A NATIONWIDE DANISH COHORT STUDY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 71 (pp. 501). doi:10.1016/S0735-1097(18)31042-8
COMPARISON OF EFFECTIVENESS, SAFETY, AND THE NET CLINICAL OUTCOME BETWEEN DIFFERENT DIRECT ORAL ANTICOAGULANTS IN 162,707 NON-VALVULAR ATRIAL FIBRILLATION PATIENTS TREATED IN US CLINICAL PRACTICE
Deitelzweig, S., Keshishian, A., Li, X., Hamilton, M., Masseria, C., Gupta, K., . . . Lip, G. Y. H. (2018). COMPARISON OF EFFECTIVENESS, SAFETY, AND THE NET CLINICAL OUTCOME BETWEEN DIFFERENT DIRECT ORAL ANTICOAGULANTS IN 162,707 NON-VALVULAR ATRIAL FIBRILLATION PATIENTS TREATED IN US CLINICAL PRACTICE. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 71 (pp. 275). doi:10.1016/S0735-1097(18)30816-7
DOES RENAL FUNCTION INFLUENCE THE BENEFIT OF DUAL ANTITHROMBOTIC THERAPY WITH DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION? RESULTS FROM RE-DUAL PCI
Hohnloser, S., Steg, P., Oldgren, J., Nickenig, G., Kiss, R. G., Ongen, Z., . . . Cannon, C. (2018). DOES RENAL FUNCTION INFLUENCE THE BENEFIT OF DUAL ANTITHROMBOTIC THERAPY WITH DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION? RESULTS FROM RE-DUAL PCI. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 71 (pp. 314). doi:10.1016/S0735-1097(18)30855-6
EFFECTIVENESS AND SAFETY OF NOAC VERSUS WARFARIN IN ATRIAL FIBRILLATION PATIENTS WITH HEMORRHAGIC STROKE
Nielsen, P. B., Skjoth, F., Sogaard, M., Larsen, T. B., & Lip, G. (2018). EFFECTIVENESS AND SAFETY OF NOAC VERSUS WARFARIN IN ATRIAL FIBRILLATION PATIENTS WITH HEMORRHAGIC STROKE. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 71 (pp. 502). doi:10.1016/S0735-1097(18)31043-X
Editor's Choice - Frailty and the management of patients with acute cardiovascular disease: A position paper from the Acute Cardiovascular Care Association.
Walker, D. M., Gale, C. P., Lip, G., Martin-Sanchez, F. J., McIntyre, H. F., Mueller, C., . . . Bueno, H. (2018). Editor's Choice - Frailty and the management of patients with acute cardiovascular disease: A position paper from the Acute Cardiovascular Care Association.. European heart journal. Acute cardiovascular care, 7(2), 176-193. doi:10.1177/2048872618758931
Epidemiology of atrial fibrillation
Zulkifly, H., Lip, G. Y. H., & Lane, D. A. (2018). Epidemiology of atrial fibrillation. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 72(3). doi:10.1111/ijcp.13070
Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in 'real-world' atrial fibrillation patients: A comparison with optimally acenocoumarol anticoagulated patients
Asuncion Esteve-Pastor, M., Miguel Rivera-Caravaca, J., Roldan, V., Vicente, V., Romiti, G. F., Romanazzi, I., . . . Lip, G. Y. H. (2018). Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in 'real-world' atrial fibrillation patients: A comparison with optimally acenocoumarol anticoagulated patients. INTERNATIONAL JOURNAL OF CARDIOLOGY, 254, 125-131. doi:10.1016/j.ijcard.2017.11.087
IMPACT OF BODY MASS INDEX AND OBESITY ON CLINICAL OUTCOMES IN THE EDOXABAN VERSUS WARFARIN IN SUBJECTS UNDERGOING CARDIOVERSION OF ATRIAL FIBRILLATION (ENSURE-AF) RANDOMIZED TRIAL
Lip, G., Merino, J. L., Banach, M., de Groot, J., Maier, L., Themistoclakis, S., . . . Goette, A. (2018). IMPACT OF BODY MASS INDEX AND OBESITY ON CLINICAL OUTCOMES IN THE EDOXABAN VERSUS WARFARIN IN SUBJECTS UNDERGOING CARDIOVERSION OF ATRIAL FIBRILLATION (ENSURE-AF) RANDOMIZED TRIAL. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 71 (pp. 518). doi:10.1016/S0735-1097(18)31059-3
IS IT SAFE TO SWITCH OAC IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION? RESULTS FROM A RE-DUAL PCI SUBANALYSIS
Ten Berg, J., de Veer, A., Oldgren, J., Steg, P., Zateyshchikov, D. A., Jansky, P., . . . Cannon, C. (2018). IS IT SAFE TO SWITCH OAC IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION? RESULTS FROM A RE-DUAL PCI SUBANALYSIS. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 71 (pp. 1206). doi:10.1016/S0735-1097(18)31747-9
Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference
Kotecha, D., Breithardt, G., Camm, A. J., Lip, G. Y. H., Schotten, U., Ahlsson, A., . . . Kirchhof, P. (2018). Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference. EUROPACE, 20(3), 395-407. doi:10.1093/europace/eux318
Major bleeding and intracranial hemorrhage risk prediction in patients with atrial fibrillation: Attention to modifiable bleeding risk factors or use of a bleeding risk stratification score? A nationwide cohort study
Chao, T. -F., Lip, G. Y. H., Lin, Y. -J., Chang, S. -L., Lo, L. -W., Hu, Y. -F., . . . Chen, S. -A. (2018). Major bleeding and intracranial hemorrhage risk prediction in patients with atrial fibrillation: Attention to modifiable bleeding risk factors or use of a bleeding risk stratification score? A nationwide cohort study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 254, 157-161. doi:10.1016/j.ijcard.2017.11.025
ORAL ANTICOAGULATION IN ATRIAL FIBRILLATION AND ANEMIA: A REPORT FROM DANISH NATIONWIDE REGISTRIES
Bonde, A. N., Lip, G., Staerk, L., Gundlund, A., Torp-Pedersen, C., Gislason, G., & Olesen, J. (2018). ORAL ANTICOAGULATION IN ATRIAL FIBRILLATION AND ANEMIA: A REPORT FROM DANISH NATIONWIDE REGISTRIES. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 71 (pp. 508). doi:10.1016/S0735-1097(18)31049-0
Prediction of long-term net clinical outcomes using the TIMI-AF score: Comparison with CHA<sub>2</sub>DS<sub>2</sub>-VASc and HAS-BLED
Miguel Rivera-Caravaca, J., Roldan, V., Asuncion Esteve-Pastor, M., Valdes, M., Vicente, V., Marin, F., & Lip, G. Y. H. (2018). Prediction of long-term net clinical outcomes using the TIMI-AF score: Comparison with CHA<sub>2</sub>DS<sub>2</sub>-VASc and HAS-BLED. AMERICAN HEART JOURNAL, 197, 27-34. doi:10.1016/j.ahj.2017.11.004
Silent Cerebral Infarction in East Asian vs. Non-Asian Atrial Fibrillation Patients - Meta - Analysis
Senoo, K., Kondo, Y., Kobayashi, Y., & Lip, G. Y. H. (2018). Silent Cerebral Infarction in East Asian vs. Non-Asian Atrial Fibrillation Patients - Meta - Analysis. CIRCULATION JOURNAL, 82(3), 672-676. doi:10.1253/circj.CJ-17-1164
Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation Should We Use a CHA(2)DS(2)-VA Score Rather Than CHA(2)DS(2)-VASc?
Nielsen, P. B., Skjoth, F., Overvad, T. F., Larsen, T. B., & Lip, G. Y. H. (2018). Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation Should We Use a CHA(2)DS(2)-VA Score Rather Than CHA(2)DS(2)-VASc?. Circulation, 137(8), 832-840. doi:10.1161/CIRCULATIONAHA.117.029081
Prediction of Incident Atrial Fibrillation According to Gender in Patients With Ischemic Stroke From a Nationwide Cohort
Bisson, A., Bodin, A., Clementy, N., Babuty, D., Lip, G. Y. H., & Fauchier, L. (2018). Prediction of Incident Atrial Fibrillation According to Gender in Patients With Ischemic Stroke From a Nationwide Cohort. AMERICAN JOURNAL OF CARDIOLOGY, 121(4), 437-444. doi:10.1016/j.amjcard.2017.11.016
Value of DAPT score to predict adverse outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: A post-hoc analysis from the AFCAS registry
Nammas, W., Kiviniemi, T., Schlitt, A., Rubboli, A., Valencia, J., Lip, G. Y. H., . . . Airaksinen, K. E. J. (2018). Value of DAPT score to predict adverse outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: A post-hoc analysis from the AFCAS registry. INTERNATIONAL JOURNAL OF CARDIOLOGY, 253, 35-39. doi:10.1016/j.ijcard.2017.07.074
Comparing Bleeding Risk Assessment Focused on Modifiable Risk Factors Only Versus Validated Bleeding Risk Scores in Atrial Fibrillation
Guo, Y., Zhu, H., Chen, Y., & Lip, G. Y. H. (2018). Comparing Bleeding Risk Assessment Focused on Modifiable Risk Factors Only Versus Validated Bleeding Risk Scores in Atrial Fibrillation. AMERICAN JOURNAL OF MEDICINE, 131(2), 185-192. doi:10.1016/j.amjmed.2017.09.009
Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation-the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study
Verdecchia, P., Reboldi, G., Angeli, F., Mazzotta, G., Lip, G. Y. H., Brueckmann, M., . . . Di Pasquale, G. (2018). Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation-the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study. EUROPACE, 20(2), 253-262. doi:10.1093/europace/eux022
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation REPLY
Cannon, C. P., Lip, G. Y. H., & Oldgren, J. (2018). Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation REPLY. NEW ENGLAND JOURNAL OF MEDICINE, 378(5), 485-486. Retrieved from https://www.webofscience.com/
Impact of quality of anticoagulation control on outcomes in patients with atrial fibrillation taking aspirin: An analysis from the SPORTIF trials
Proietti, M., & Lip, G. Y. H. (2018). Impact of quality of anticoagulation control on outcomes in patients with atrial fibrillation taking aspirin: An analysis from the SPORTIF trials. INTERNATIONAL JOURNAL OF CARDIOLOGY, 252, 96-100. doi:10.1016/j.ijcard.2017.10.091
Lifetime Risks, Projected Numbers, and Adverse Outcomes in Asian Patients With Atrial Fibrillation A Report From the Taiwan Nationwide AF Cohort Study
Chao, T. -F., Liu, C. -J., Tuan, T. -C., Chen, T. -J., Hsieh, M. -H., Lip, G. Y. H., & Chen, S. -A. (2018). Lifetime Risks, Projected Numbers, and Adverse Outcomes in Asian Patients With Atrial Fibrillation A Report From the Taiwan Nationwide AF Cohort Study. CHEST, 153(2), 453-466. doi:10.1016/j.chest.2017.10.001
Rate vs. rhythm control and adverse outcomes among European patients with atrial fibrillation
Purmah, Y., Proietti, M., Laroche, C., Mazurek, M., Tahmatzidis, D., Boriani, G., . . . Lip, G. Y. H. (2018). Rate vs. rhythm control and adverse outcomes among European patients with atrial fibrillation. EUROPACE, 20(2), 243-252. doi:10.1093/europace/euw421
Role of Monocytes in Heart Failure and Atrial Fibrillation
Shahid, F., Lip, G. Y. H., & Shantsila, E. (2018). Role of Monocytes in Heart Failure and Atrial Fibrillation. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 7(3). doi:10.1161/JAHA.117.007849
Incident Heart Failure in Patients With Rheumatoid Arthritis: A Nationwide Cohort Study
Khalid, U., Egeberg, A., Ahlehoff, O., Lane, D., Gislason, G. H., Lip, G. Y. H., & Hansen, P. R. (2018). Incident Heart Failure in Patients With Rheumatoid Arthritis: A Nationwide Cohort Study. In JOURNAL OF THE AMERICAN HEART ASSOCIATION Vol. 7. doi:10.1161/JAHA.117.007227
Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation
Chao, T. -F., Lip, G. Y. H., Liu, C. -J., Lin, Y. -J., Chang, S. -L., Lo, L. -W., . . . Chen, S. -A. (2018). Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation. Journal of the American College of Cardiology, 71(2), 122-132. doi:10.1016/j.jacc.2017.10.085
Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of <i>Edoxaban</i> for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study)
Lip, G. Y. H., Merino, J. L., Dan, G. A., Themistoclakis, S., Ellenbogen, K. A., De Caterina, R., . . . Goette, A. (2018). Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of <i>Edoxaban</i> for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study). AMERICAN JOURNAL OF CARDIOLOGY, 121(2), 193-198. doi:10.1016/j.amjcard.2017.10.008
Resumption of antiplatelet therapy in patients with primary intracranial haemorrhage: Balancing benefits and risks
Khan, A. A., & Lip, G. Y. H. (2018). Resumption of antiplatelet therapy in patients with primary intracranial haemorrhage: Balancing benefits and risks. JOURNAL OF THE NEUROLOGICAL SCIENCES, 384, 139-140. doi:10.1016/j.jns.2017.11.038
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
Valgimigli, M., Bueno, H., Byrne, R. A., Collet, J. -P., Costa, F., Jeppsson, A., . . . Aboyans, V. (2018). 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. EUROPEAN HEART JOURNAL, 39(3), 213-+. doi:10.1093/eurheartj/ehx419
Dementia and Atrial Fibrillation: A Dangerous Combination for Ischemic Stroke and Mortality
Pastori, D., Miyazawa, K., & Lip, G. Y. H. (2018). Dementia and Atrial Fibrillation: A Dangerous Combination for Ischemic Stroke and Mortality. JOURNAL OF ALZHEIMERS DISEASE, 61(3), 1129-1132. doi:10.3233/JAD-170955
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)
Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., . . . Zeymer, U. (2018). 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). EUROPEAN HEART JOURNAL, 39(2), 119-177. doi:10.1093/eurheartj/ehx393
Enhancing the 'real world' prediction of cardiovascular events and major bleeding with the CHA<sub>2</sub>DS<sub>2</sub>-VASc and HAS-BLED scores using multiple biomarkers
Roldan, V., Miguel Rivera-Caravaca, J., Shantsila, A., Garcia-Fernandez, A., Asuncion Esteve-Pastor, M., Antonio Vilchez, J., . . . Lip, G. Y. H. (2018). Enhancing the 'real world' prediction of cardiovascular events and major bleeding with the CHA<sub>2</sub>DS<sub>2</sub>-VASc and HAS-BLED scores using multiple biomarkers. ANNALS OF MEDICINE, 50(1), 26-34. doi:10.1080/07853890.2017.1378429
New anticoagulants for venous thromboembolism and atrial fibrillation: what the future holds
Dimitropoulos, G., Rahim, S. M. Z., Moss, A. S., & Lip, G. Y. H. (2018). New anticoagulants for venous thromboembolism and atrial fibrillation: what the future holds. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 27(1), 71-86. doi:10.1080/13543784.2018.1416090
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)
Valgimigli, M., Bueno, H., Byrne, R. A., Collet, J. -P., Costa, F., Jeppsson, A., . . . Aboyans, V. (2018). 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 53(1), 34-78. doi:10.1093/ejcts/ezx334
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.
Calkins, H., Hindricks, G., Cappato, R., Kim, Y. -H., Saad, E. B., Aguinaga, L., . . . Document Reviewers:. (2018). 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 20(1), e1-e160. doi:10.1093/europace/eux274
2018 ESC/ESH Guidelines for the management of arterial hypertension <i>The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension</i>
Williams, B., Mancia, G., Spiering, W., Rosei, E. A., Azizi, M., Burnier, M., . . . Desormais, I. (2018). 2018 ESC/ESH Guidelines for the management of arterial hypertension <i>The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension</i>. JOURNAL OF HYPERTENSION, 36(10), 1953-2041. doi:10.1097/HJH.0000000000001940
2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology andthe European Society of Hypertension <i>ESC</i>/<i>ESH Task Force for the Management of Arterial Hypertension</i>
Williams, B., Mancia, G., Spiering, W., Rosei, E. A., Azizi, M., Burnier, M., . . . Desormais, I. (2018). 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology andthe European Society of Hypertension <i>ESC</i>/<i>ESH Task Force for the Management of Arterial Hypertension</i>. JOURNAL OF HYPERTENSION, 36(12), 2284-2309. doi:10.1097/HJH.0000000000001961
A happy new year 2013 for Thrombosis and Haemostasis.
Weber, C., & Lip, G. Y. H. (2013). A happy new year 2013 for Thrombosis and Haemostasis.. Thrombosis and haemostasis, 109(1), 1-2. doi:10.1160/th17-11-0842
A novel model for prediction of ischemic stroke in patients without atrial fibrillation
Steensig, K., Olesen, K. K. W., Madsen, M., Thim, T., Jensen, L. O., Raungaard, B., . . . Maeng, M. (2018). A novel model for prediction of ischemic stroke in patients without atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1273). Retrieved from https://www.webofscience.com/
A prospective global registry on oral antithrombotic treatment in patients with atrial fibrillation: GLORIA-AF Phase III baseline characteristics
Huisman, M. V., Diener, H. -C., Dubner, S. J., Halperin, J. L., Rothman, K. J., Ma, C. -S., . . . Lip, G. Y. H. (2018). A prospective global registry on oral antithrombotic treatment in patients with atrial fibrillation: GLORIA-AF Phase III baseline characteristics. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 825). Retrieved from https://www.webofscience.com/
Actualización ESC 2017 sobre el tratamiento antiagregante plaquetario doble en la enfermedad coronaria, desarrollada en colaboración con la EACTS
Valgimigli, A. M. D. G. D. T. M., Bueno, H., Byrne, R. A., Collet, J. -P., Costa, F., Jeppsson, A., . . . Aboyans, V. (2018). Actualización ESC 2017 sobre el tratamiento antiagregante plaquetario doble en la enfermedad coronaria, desarrollada en colaboración con la EACTS. Revista Española de Cardiología, 71(1), 42.e1-42.e58. doi:10.1016/j.recesp.2017.11.014
Age Threshold for Ischemic Stroke Risk in Atrial Fibrillation: Cohort Data Covering the Entire Korean Population
Kim, T. -H., Yang, P. -S., Yu, H. T., Jang, E., Uhm, J. -S., Kim, J. -Y., . . . Lip, G. Y. H. (2018). Age Threshold for Ischemic Stroke Risk in Atrial Fibrillation: Cohort Data Covering the Entire Korean Population. STROKE, 49(8), 1872-1879. doi:10.1161/STROKEAHA.118.021047
Age threshold for ischemic stroke risk in atrial fibrillation: cohort data covering the entire Korean population
Kim, T. -H., Yang, P. -S., Yu, H. -T., Jang, E. S., Uhm, J. -S., Kim, J. -Y., . . . Lip, G. Y. H. (2018). Age threshold for ischemic stroke risk in atrial fibrillation: cohort data covering the entire Korean population. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 613). Retrieved from https://www.webofscience.com/
Age-dependency in the implementation of guideline-recommended therapy for stroke prevention in patients with non-valvular atrial fibrillation: insights from the BALKAN-AF Survey
Potpara, S., Dan, G. A., Kusljugic, Z., Paparisto, V., Goda, A., Trendafilova, E., . . . Lip, G. Y. H. (2018). Age-dependency in the implementation of guideline-recommended therapy for stroke prevention in patients with non-valvular atrial fibrillation: insights from the BALKAN-AF Survey. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 615-616). Retrieved from https://www.webofscience.com/
Anticoagulation control in octogenarian patients receiving vitamin K antagonists for stroke prevention in atrial fibrillation: the west birmingham AF project
Zulkifly, H., Cheli, P., Lutchman, I., Bai, Y., Lip, G. Y. H., & Lane, D. (2018). Anticoagulation control in octogenarian patients receiving vitamin K antagonists for stroke prevention in atrial fibrillation: the west birmingham AF project. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1005). Retrieved from https://www.webofscience.com/
Antiplatelet therapy use in atrial fibrillation patients taking oral anticoagulation: an analysis of adverse outcomes from the FANTASIIA registry
Esteve Pastor, M. A., Roldan-Rabadan, I., Rivera-Caravaca, J. M., Roldan, V., Muniz, J., Cequier, A., . . . Marin, F. (2018). Antiplatelet therapy use in atrial fibrillation patients taking oral anticoagulation: an analysis of adverse outcomes from the FANTASIIA registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 613). Retrieved from https://www.webofscience.com/
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of CardiologyWorking Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE) (vol 19, pg 1757, 2017)
Lip, G. Y. H. (2018). Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of CardiologyWorking Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE) (vol 19, pg 1757, 2017). EUROPACE, 20(4), 658. Retrieved from https://www.webofscience.com/
Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach
Li, X., Keshishian, A., Hamilton, M., Horblyuk, R., Gupta, K., Luo, X., . . . Deitelzweig, S. (2018). Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach. PLOS ONE, 13(1). doi:10.1371/journal.pone.0191722
Association of circulating apoptotic (annexin V plus ) microparticles with ventricular fibrosis and diastolic dysfunction in atrial fibrillation patients with heart failure with preserved ejection fraction
Dzeshka, M. S., Shantsila, E., Snezhitskiy, V. A., & Lip, G. Y. H. (2018). Association of circulating apoptotic (annexin V plus ) microparticles with ventricular fibrosis and diastolic dysfunction in atrial fibrillation patients with heart failure with preserved ejection fraction. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 612). Retrieved from https://www.webofscience.com/
Atrial Fibrillation
Kotecha, D., Senoo, K., & Lip, G. Y. H. (2018). Atrial Fibrillation. In Hematology (pp. 2152-2158). Elsevier. doi:10.1016/b978-0-323-35762-3.00147-5
Atrial high rate episodes burden improves stroke risk stratification using the CHA2DS2-VASc score: implications for anticoagulating device patients with high atrial arrhythmia burden
Miyazawa, K., Kondo, Y., Nakano, M., Senoo, K., Kobayashi, Y., & Lip, G. Y. H. (2018). Atrial high rate episodes burden improves stroke risk stratification using the CHA2DS2-VASc score: implications for anticoagulating device patients with high atrial arrhythmia burden. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 825). Retrieved from https://www.webofscience.com/
Burden of comorbidities, quality of anticoagulation control and outcomes: an analysis from the AFFIRM study
Proietti, M., Romiti, G. F., Olshansky, B., & Lip, G. Y. H. (2018). Burden of comorbidities, quality of anticoagulation control and outcomes: an analysis from the AFFIRM study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 193). Retrieved from https://www.webofscience.com/
CHA2DS2VASc score predicts exercise capacity in patients with permanent atrial fibrillation and preserved left ventricular function
Khan, A., Shahid, F., Lip, G. Y. H., & Shantsila, E. (2018). CHA2DS2VASc score predicts exercise capacity in patients with permanent atrial fibrillation and preserved left ventricular function. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 402). Retrieved from https://www.webofscience.com/
Cancer antigen-125 and risk of atrial fibrillation: a systematic review and meta-analysis.
Cheung, A., Gong, M., Bellanti, R., Ali-Hasan-Al-Saegh, S., Li, G., Roig, E., . . . Tse, G. (2018). Cancer antigen-125 and risk of atrial fibrillation: a systematic review and meta-analysis.. Heart Asia, 10(1), e010970. doi:10.1136/heartasia-2017-010970
Change in CHA2DS2-VASc score (delta CHA2DS2-VASc score) and the risk of thromboembolism over 12-years follow-up in initially low-risk patients with first-diagnosed atrial fibrillation
Potpara, T. S., Mujovic, N., Marinkovic, J., & Lip, G. Y. H. (2018). Change in CHA2DS2-VASc score (delta CHA2DS2-VASc score) and the risk of thromboembolism over 12-years follow-up in initially low-risk patients with first-diagnosed atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 616). Retrieved from https://www.webofscience.com/
Circulating monocyte-derived (CD14+) and apoptotic (annexin V-binding) microparticles correlate with recurrent atrial fibrillation
Dzeshka, M. S., Shantsila, E., Snezhitskiy, V. A., & Lip, G. Y. H. (2018). Circulating monocyte-derived (CD14+) and apoptotic (annexin V-binding) microparticles correlate with recurrent atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 412-413). Retrieved from https://www.webofscience.com/
Cognitive Impairment Before Intracerebral Hemorrhage Is Associated With Cerebral Amyloid Angiopathy
Banerjee, G., Wilson, D., Ambler, G., Appiah, K. O. -B., Shakeshaft, C., Lunawat, S., . . . Werring, D. J. (2018). Cognitive Impairment Before Intracerebral Hemorrhage Is Associated With Cerebral Amyloid Angiopathy. STROKE, 49(1), 40-+. doi:10.1161/STROKEAHA.117.019409
Comparative effectiveness and safety between non-VKA oral anticoagulants in non-valvular atrial fibrillation patients: a dose subgroup analysis of the ARISTOPHANES study
Lip, G. Y. H., Keshishian, A., Li, X., Hamilton, M., Masseria, C., Dhamane, A., . . . Deitelzweig, S. (2018). Comparative effectiveness and safety between non-VKA oral anticoagulants in non-valvular atrial fibrillation patients: a dose subgroup analysis of the ARISTOPHANES study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 612-613). Retrieved from https://www.webofscience.com/
Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients: the dose subgroup analysis of the ARISTOPHANES study
Deitelzweig, S., Keshishian, A., Li, X., Hamilton, M., Masseria, C., Dhamane, A., . . . Lip, G. Y. H. (2018). Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients: the dose subgroup analysis of the ARISTOPHANES study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 610-611). Retrieved from https://www.webofscience.com/
Comparisons of clinical and economic outcomes between non-VKA oral anticoagulants among non-valvular atrial fibrillation patients: the ARISTOPHANES study
Deitelzweig, S., Keshishian, A., Li, X., Hamilton, M., Masseria, C., Dhamane, A., . . . Lip, G. Y. H. (2018). Comparisons of clinical and economic outcomes between non-VKA oral anticoagulants among non-valvular atrial fibrillation patients: the ARISTOPHANES study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 505). Retrieved from https://www.webofscience.com/
Comparisons of clinical and economic outcomes between non-VKA oral anticoagulants and warfarin among non-valvular atrial fibrillation patients: the ARISTOPHANES study
Lip, G. Y. H., Keshishian, A., Li, X., Hamilton, M., Masseria, C., Dhamane, A., . . . Deitelzweig, S. (2018). Comparisons of clinical and economic outcomes between non-VKA oral anticoagulants and warfarin among non-valvular atrial fibrillation patients: the ARISTOPHANES study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 506). Retrieved from https://www.webofscience.com/
Coronary artery disease is an independent risk factor for ischemic stroke among patients with atrial fibrillation
Steensig, K., Olesen, K. K. W., Thim, T., Nielsen, J. C., Madsen, M., Jensen, S. E., . . . Maeng, M. (2018). Coronary artery disease is an independent risk factor for ischemic stroke among patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 432). Retrieved from https://www.webofscience.com/
Development of a risk score for incident atrial fibrillation on 471,446 chinese subjects. The C2HEST score
Li, Y. G., Pastori, D., Farcomeni, A., Wang, Y. T., Guo, Y. T., & Lip, G. Y. H. (2018). Development of a risk score for incident atrial fibrillation on 471,446 chinese subjects. The C2HEST score. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 407). Retrieved from https://www.webofscience.com/
Differences between hospitalised vs. outpatient management amongst european patients with atrial fibrillation: the EORP-AF general long-term registry
Proietti, M., Laroche, C., Fantecchi, E., Zdravkovic, M., Lenarczyk, R., Piot, O., . . . Boriani, G. (2018). Differences between hospitalised vs. outpatient management amongst european patients with atrial fibrillation: the EORP-AF general long-term registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1265). Retrieved from https://www.webofscience.com/
Dual antithrombotic therapy with dabigatran vs triple therapy with warfarin after PCI in patients with atrial fibrillation and diabetes mellitus (a RE-DUAL PCI subgroup analysis)
Maeng, M., Steg, P. G., Bhatt, D. L., Hohnloser, S. H., Nordaby, M., Miede, C., . . . Cannon, C. P. (2018). Dual antithrombotic therapy with dabigatran vs triple therapy with warfarin after PCI in patients with atrial fibrillation and diabetes mellitus (a RE-DUAL PCI subgroup analysis). In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1090-1091). Retrieved from https://www.webofscience.com/
Editors' Choice in the 60th Anniversary Year of Thrombosis and Haemostasis: Past, Present and Future
Weber, C., & Lip, G. Y. H. (2018). Editors' Choice in the 60th Anniversary Year of Thrombosis and Haemostasis: Past, Present and Future. THROMBOSIS AND HAEMOSTASIS, 118(1), 225-227. doi:10.1160/TH17-11-0844
Effect of concomitant antiplatelet agents on clinical outcomes in the Edoxaban versus Warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial
Goette, A., Merino, J., De Caterina, R., Huber, K., Heidbuchel, H., Jin, J., . . . Lip, G. Y. H. (2018). Effect of concomitant antiplatelet agents on clinical outcomes in the Edoxaban versus Warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 205-206). Retrieved from https://www.webofscience.com/
Effect of the INR stability characteristics on bleeding events among atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI trial
Yee, M. K., Kerneis, M., Nafee, T., Travis, R., Chi, G., Mehran, R., . . . Gibson, C. M. (2018). Effect of the INR stability characteristics on bleeding events among atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI trial. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 271-272). Retrieved from https://www.webofscience.com/
Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients The ARISTOPHANES Study
Lip, G. Y. H., Keshishian, A., Li, X., Hamilton, M., Masseria, C., Gupta, K., . . . Deitelzweig, S. (2018). Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients The ARISTOPHANES Study. STROKE, 49(12), 2933-2944. doi:10.1161/STROKEAHA.118.020232
Effectiveness and safety of oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-regression analysis
Bai, Y., Guo, S. -D., Deng, H., Shantsila, A., Fauchier, L., Ma, C. -S., & Lip, G. Y. H. (2018). Effectiveness and safety of oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-regression analysis. AGE AND AGEING, 47(1), 9-17. doi:10.1093/ageing/afx103
Efficacy and safety of non-vitamin K oral anticoagulants in hypertrophic cardiomyopathy with non-valvular atrial fibrillation: a nationwide cohort study
Jung, H., Yang, P. S., Jang, E., Yu, H. T., Kim, T. H., Uhm, J. S., . . . Lip, G. Y. H. (2018). Efficacy and safety of non-vitamin K oral anticoagulants in hypertrophic cardiomyopathy with non-valvular atrial fibrillation: a nationwide cohort study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 274-275). Retrieved from https://www.webofscience.com/
Estimated effectiveness and safety of non-vitamin K antagonist oral anticoagulants compared to optimally anticoagulated real-world atrial fibrillation patients taking acenocoumarol
Esteve Pastor, M. A., Rivera-Caravaca, J. M., Roldan, V., Orenes-Pinero, E., Romiti, G. F., Romanazzi, I., . . . Lip, G. Y. H. (2018). Estimated effectiveness and safety of non-vitamin K antagonist oral anticoagulants compared to optimally anticoagulated real-world atrial fibrillation patients taking acenocoumarol. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 873). Retrieved from https://www.webofscience.com/
Galectin 3 as a marker of diastolic dysfunction in patients with atrial fibrillation and heart failure with preserved ejection fraction
Dzeshka, M. S., Shantsila, E., Snezhitskiy, V. A., & Lip, G. Y. H. (2018). Galectin 3 as a marker of diastolic dysfunction in patients with atrial fibrillation and heart failure with preserved ejection fraction. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1387). Retrieved from https://www.webofscience.com/
Geographic region, stroke risk and renal function strongly affect treatment choice for stroke prevention in patients with non-valvular AF: results from the GLORIA-AF registry program
Beier, L., Franca, L. R., Lip, G. Y. H., Huisman, M. V., Zint, K., Halperin, J. L., . . . Rothman, K. J. (2018). Geographic region, stroke risk and renal function strongly affect treatment choice for stroke prevention in patients with non-valvular AF: results from the GLORIA-AF registry program. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1074). Retrieved from https://www.webofscience.com/
High body mass index and outcomes of dual antithrombotic therapy with dabigatran and a P2Y12 inhibitor in patients with atrial fibrillation undergoing PCI: Results from RE-DUAL PCI
De Caterina, R., Lopez Sendon, J. L., Mehta, S., Opolski, G., Oldgren, J., Steg, P. G., . . . Cannon, C. (2018). High body mass index and outcomes of dual antithrombotic therapy with dabigatran and a P2Y12 inhibitor in patients with atrial fibrillation undergoing PCI: Results from RE-DUAL PCI. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 458). Retrieved from https://www.webofscience.com/
How could non-vitamin K antagonist oral anticoagulants change clinical practice for stroke prevention and improve outcomes in patients with newly-diagnosed atrial fibrillation?
Chao, T. F., Lip, G. Y. H., & Chen, S. A. (2018). How could non-vitamin K antagonist oral anticoagulants change clinical practice for stroke prevention and improve outcomes in patients with newly-diagnosed atrial fibrillation?. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 457-458). Retrieved from https://www.webofscience.com/
Identification of atrial fibrillation patients who are at high bleeding risk after undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI trial
Nafee, T., Yee, M. K., Kerneis, M., Travis, R., Alkhalfan, F., Mehran, R., . . . Gibson, C. M. (2018). Identification of atrial fibrillation patients who are at high bleeding risk after undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI trial. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1073-1074). Retrieved from https://www.webofscience.com/
Impact of Renal Function on Outcomes With Edoxaban in Real-World Patients With Atrial Fibrillation A Nationwide Cohort Study
Yu, H. T., Yang, P. -S., Kim, T. -H., Jang, E., Kim, D., Uhm, J. -S., . . . Joung, B. (2018). Impact of Renal Function on Outcomes With Edoxaban in Real-World Patients With Atrial Fibrillation A Nationwide Cohort Study. STROKE, 49(10), 2421-2429. doi:10.1161/STROKEAHA.118.021387
Impact of comorbidities on major adverse events in atrial fibrillation: 3 years follow-up of the EORP-AF general pilot registry
Proietti, M., Laroche, C., Maggioni, A. P., Boriani, G., & Lip, G. Y. H. (2018). Impact of comorbidities on major adverse events in atrial fibrillation: 3 years follow-up of the EORP-AF general pilot registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1292). Retrieved from https://www.webofscience.com/
Incident comorbidities in patients with atrial fibrillation initially with a CHA2DS2-VASc score of 0 (males) or 1 (females): how frequent should we reassess stroke risk in these patients?
Chao, T. F., Lip, G. Y. H., & Chen, S. A. (2018). Incident comorbidities in patients with atrial fibrillation initially with a CHA2DS2-VASc score of 0 (males) or 1 (females): how frequent should we reassess stroke risk in these patients?. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 264-265). Retrieved from https://www.webofscience.com/
Is there an obesity paradox for adverse outcomes in patients with atrial fibrillation? insights from the FANTASIIA registry
Esteve Pastor, M. A., Rivera-Caravaca, J. M., Roldan, V., Roldan Rabadan, I., Muniz, J., Cequier, A., . . . Marin, F. (2018). Is there an obesity paradox for adverse outcomes in patients with atrial fibrillation? insights from the FANTASIIA registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 198-199). Retrieved from https://www.webofscience.com/
Left atrial voltage, circulating biomarkers of fibrosis, and atrial fibrillation ablation. A prospective cohort study
Begg, G. A., Karim, R., Oesterlein, T., Graham, L. N., Hogarth, A. J., Page, S. P., . . . Tayebjeel, M. H. (2018). Left atrial voltage, circulating biomarkers of fibrosis, and atrial fibrillation ablation. A prospective cohort study. PLOS ONE, 13(1). doi:10.1371/journal.pone.0189936
Long term cardiovascular risk prediction in Real- World atrial fibrillation patients: Validation of the 2MACE score in the FANTASIIA registry
Esteve Pastor, M. A., Rivera-Caravaca, J. M., Roldan, V., Roldan-Rabadan, I., Muniz, J., Cequier, A., . . . Marin, F. (2018). Long term cardiovascular risk prediction in Real- World atrial fibrillation patients: Validation of the 2MACE score in the FANTASIIA registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1295). Retrieved from https://www.webofscience.com/
Long-term relationship between atrial fibrillation and charlson comorbidity index in a population-based cohort study
Proietti, M., Marzona, I., Vannini, T., Basili, S., Mannucci, P. M., Boriani, G., . . . Nobili, A. (2018). Long-term relationship between atrial fibrillation and charlson comorbidity index in a population-based cohort study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1410-1411). Retrieved from https://www.webofscience.com/
MONOCYTE SUBPOPULATIONS IN PATIENTS FOLLOWING ST-ELEVATION MYOCARDIAL INFARCTION: IMPLICATIONS FOR POST-INFARCTION LEFT VENTRICULAR REMODELLING AND CLINICAL OUTCOMES
Ghattas, A., Shantsila, E., Griffiths, H., & Lip, G. (2018). MONOCYTE SUBPOPULATIONS IN PATIENTS FOLLOWING ST-ELEVATION MYOCARDIAL INFARCTION: IMPLICATIONS FOR POST-INFARCTION LEFT VENTRICULAR REMODELLING AND CLINICAL OUTCOMES. In HEART Vol. 104 (pp. A4). doi:10.1136/heartjnl-2018-BCIS.7
Mechanisms and prognostic significance of pre-existing cognitive impairment in patients with atrial fibrillation related ischaemic stroke or TIA: the CROMIS-2 study
Banerjee, G., Wilson, D., Ambler, G., Shakeshaft, C., Chan, E., Cohen, H., . . . Werring, D. J. (2018). Mechanisms and prognostic significance of pre-existing cognitive impairment in patients with atrial fibrillation related ischaemic stroke or TIA: the CROMIS-2 study. In INTERNATIONAL JOURNAL OF STROKE Vol. 13 (pp. 51). Retrieved from https://www.webofscience.com/
NOACs versus warfarin in atrial fibrillation patients and risk of dementia: a nationwide propensity-weighted cohort study
Soegaard, M., Skjoth, F., Jensen, M., Kjaeldgaard, J. N., Lip, G. Y. H., Larsen, T. B., & Nielsen, P. B. (2018). NOACs versus warfarin in atrial fibrillation patients and risk of dementia: a nationwide propensity-weighted cohort study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1073). Retrieved from https://www.webofscience.com/
Nonvitamin K Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Renal Dysfunction
Mahmood, M., & Lip, G. Y. H. (2018). Nonvitamin K Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Renal Dysfunction. REVISTA ESPANOLA DE CARDIOLOGIA, 71(10), 847-855. doi:10.1016/j.rec.2018.05.015
Performance of the Cockcroft-Gault, MDRD and CKD-EPI Formulae in Atrial Fibrillation patients. The FANTASIIA Registry
Pastor, M. A. E., Rivera-Caravaca, J. M., Roldan, V., Roldan-Rabadan, I., Muniz, J., Cequier, A., . . . Marin, F. (2018). Performance of the Cockcroft-Gault, MDRD and CKD-EPI Formulae in Atrial Fibrillation patients. The FANTASIIA Registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 714). Retrieved from https://www.webofscience.com/
Predicting bleeding events in anticoagulated patients with atrial fibrillation: a comparison between HAS-BLED and GARFIELD-AF bleeding score
Proietti, M., Rivera-Caravaca, J. M., Esteve-Pastor, M. A., Romiti, G. F., Marin, F., & Lip, G. Y. H. (2018). Predicting bleeding events in anticoagulated patients with atrial fibrillation: a comparison between HAS-BLED and GARFIELD-AF bleeding score. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 20). Retrieved from https://www.webofscience.com/
Predictors of exercise capacity in the elderly population with permanent atrial fibrillation and preserved left ventricular function
Khan, A. A., Shahid, F., Lip, G. Y. H., & Shantsila, E. (2018). Predictors of exercise capacity in the elderly population with permanent atrial fibrillation and preserved left ventricular function. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 95). Retrieved from https://www.webofscience.com/
Progression From Paroxysmal to Sustained Atrial Fibrillation Is Associated With Increased Adverse Events
Ogawa, H., An, Y., Ikeda, S., Aono, Y., Doi, K., Ishii, M., . . . Akao, M. (2018). Progression From Paroxysmal to Sustained Atrial Fibrillation Is Associated With Increased Adverse Events. STROKE, 49(10), 2301-2308. doi:10.1161/STROKEAHA.118.021396
Quantifying Time in Atrial Fibrillation and the Need for Anticoagulation
Miyazawa, K., Pastori, D., & Lip, G. Y. H. (2018). Quantifying Time in Atrial Fibrillation and the Need for Anticoagulation. PROGRESS IN CARDIOVASCULAR DISEASES, 60(4-5), 537-541. doi:10.1016/j.pcad.2017.12.002
RELATION OF STROKE AND BLEEDING RISK PROFILES TO EFFICACY AND SAFETY OF DABIGATRAN IN ATRIAL FIBRILLATION AFTER PCI: AN ANCILLARY ANALYSIS FROM THE RE-DUAL PCI TRIAL
Lip, G., Mauri, L., Montalescot, G., Ozkor, M., Vardas, P., Steg, P. G., . . . Cannon, C. (2018). RELATION OF STROKE AND BLEEDING RISK PROFILES TO EFFICACY AND SAFETY OF DABIGATRAN IN ATRIAL FIBRILLATION AFTER PCI: AN ANCILLARY ANALYSIS FROM THE RE-DUAL PCI TRIAL. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 71 (pp. 289). Retrieved from https://www.webofscience.com/
Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation A Systematic Review and Meta-Analysis
Proietti, M., Romanazzi, I., Romiti, G. F., Farcomeni, A., & Lip, G. Y. H. (2018). Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation A Systematic Review and Meta-Analysis. STROKE, 49(1), 98-+. doi:10.1161/STROKEAHA.117.018395
Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban
Tepper, P. G., Mardekian, J., Masseria, C., Phatak, H., Kamble, S., Abdulsattar, Y., . . . Lip, G. Y. H. (2018). Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban. PLOS ONE, 13(11). doi:10.1371/journal.pone.0205989
Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol
Miguel Rivera-Caravaca, J., Roldar, V., Asuncion Esteve-Pastor, M., Valdes, M., Vicente, V., Marin, F., & Lip, G. Y. H. (2018). Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol. CLINICAL THERAPEUTICS, 40(1), 114-122. doi:10.1016/j.clinthera.2017.11.014
Refining stroke and bleeding risk prediction by adding consecutive biomarkers to CHA2DS2-VASc and HAS-BLED scores
Rivera Caravaca, J. M., Esteve-Pastor, M. A., Vilchez, J. A., Galvez, J., Vicente, V., Marin, F., . . . Lip, G. Y. H. (2018). Refining stroke and bleeding risk prediction by adding consecutive biomarkers to CHA2DS2-VASc and HAS-BLED scores. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 821-822). Retrieved from https://www.webofscience.com/
Regional variation in quality of anticoagulation control among european patients with atrial fibrillation: the EORP-AF general long-term registry
Proietti, M., Laroche, C., Popescu, M. I., Tello-Montoliu, A., Garcia-Bolao, I., Lane, D. A., . . . Boriani, G. (2018). Regional variation in quality of anticoagulation control among european patients with atrial fibrillation: the EORP-AF general long-term registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 694-695). Retrieved from https://www.webofscience.com/
Relation of Renal Dysfunction to Quality of Anticoagulation Control in Patients with Atrial Fibrillation: The FANTASIIA Registry
Asuncion Esteve-Pastor, M., Miguel Rivera-Caravaca, J., Roldan-Rabadan, I., Roldan, V., Muniz, J., Rana-Miguez, P., . . . Marin, F. (2018). Relation of Renal Dysfunction to Quality of Anticoagulation Control in Patients with Atrial Fibrillation: The FANTASIIA Registry. THROMBOSIS AND HAEMOSTASIS, 118(2), 279-287. doi:10.1160/TH17-06-0416
Relationship between age and use of oral anticoagulant drugs in european atrial fibrillation patients: the EORP-AF general long-term registry
Boriani, G., Proietti, M., Laroche, C., Diemberger, I., Rheinert, C., Serdechnaya, E. V., . . . Lip, G. Y. H. (2018). Relationship between age and use of oral anticoagulant drugs in european atrial fibrillation patients: the EORP-AF general long-term registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 703-704). Retrieved from https://www.webofscience.com/
Relationship between charlson comorbidity index and risk of adverse outcomes in patients with atrial fibrillation: an analysis from the FANTASIIA registry
Proietti, M., Esteve-Pastor, M. A., Rivera-Caravaca, J. M., Roldan, V., Roldan Rabadan, I., Muniz, J., . . . Marin, P. (2018). Relationship between charlson comorbidity index and risk of adverse outcomes in patients with atrial fibrillation: an analysis from the FANTASIIA registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1420-1421). Retrieved from https://www.webofscience.com/
Relationship between inflammation and atrial high-rate episodes (AHREs) in patients with cardiac implantable electronic devices
Pastori, D., Miyazawa, K., Li, Y., Shahid, F., Hado, H., & Lip, G. Y. H. (2018). Relationship between inflammation and atrial high-rate episodes (AHREs) in patients with cardiac implantable electronic devices. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 401). Retrieved from https://www.webofscience.com/
Renal Function and Risk Stratification of Patients With Embolic Stroke of Undetermined Source
Ntaios, G., Lip, G. Y. H., Lambrou, D., Michel, P., Perlepe, K., Eskandari, A., . . . Papavasileiou, V. (2018). Renal Function and Risk Stratification of Patients With Embolic Stroke of Undetermined Source. STROKE, 49(12), 2904-2909. doi:10.1161/STROKEAHA.118.023281
Renal function stratification and outcomes following catheter ablation of patients with atrial fibrillation
Deng, H., Shantsila, A., Xue, Y. M., Potpapa, T. S., Zhan, X. Z., Liao, H. T., . . . Lip, G. Y. H. (2018). Renal function stratification and outcomes following catheter ablation of patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1221). Retrieved from https://www.webofscience.com/
Risk Stratification in Atrial Fibrillation
Shahid, F., Dzeshka, M., Shantsila, E., & Lip, G. Y. H. (2019). Risk Stratification in Atrial Fibrillation. In Stroke Prevention in Atrial Fibrillation (pp. 47-66). Elsevier. doi:10.1016/b978-0-323-55429-9.00004-2
Risk of recurrent intracerebral haemorrhage and ischaemic stroke after intracerebral haemorrhage: a multicentre prospective cohort study
Wilson, D., Ambler, G., Hostettler, I. C., Banerjee, G., Shakeshaft, C., Cohen, H., . . . Werring, D. J. (2018). Risk of recurrent intracerebral haemorrhage and ischaemic stroke after intracerebral haemorrhage: a multicentre prospective cohort study. In INTERNATIONAL JOURNAL OF STROKE Vol. 13 (pp. 11). Retrieved from https://www.webofscience.com/
SAFETY AND EFFECTIVENESS OF DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION WITH AND WITHOUT PRIOR STROKE: DATA FROM THE GLORIA-AF REGISTRY PROGRAM
Diener, H. C., Teutsch, C., Huisman, M. V., Dubner, S. J., Ma, C. S., Rothman, K. J., . . . Lip, G. Y. H. (2018). SAFETY AND EFFECTIVENESS OF DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION WITH AND WITHOUT PRIOR STROKE: DATA FROM THE GLORIA-AF REGISTRY PROGRAM. In INTERNATIONAL JOURNAL OF STROKE Vol. 13 (pp. 99). Retrieved from https://www.webofscience.com/
Self-reported physical activity is associated with biomarkers of cardiac fibrosis and cell apoptosis in patients with atrial fibrillation
Dzeshka, M. S., Shantsila, E., Snezhitskiy, V. A., & Lip, G. Y. H. (2018). Self-reported physical activity is associated with biomarkers of cardiac fibrosis and cell apoptosis in patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 611). Retrieved from https://www.webofscience.com/
Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: a systematic review and meta-analysis of 993,600 patients
Marzona, I., Proietti, M., Farcomeni, A., Romiti, G. F., Romanazzi, I., Raparelli, V., . . . Roncaglioni, M. C. (2018). Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: a systematic review and meta-analysis of 993,600 patients. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 235). Retrieved from https://www.webofscience.com/
Should the Presence or Extent of Coronary Artery Disease be Quantified in the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score in Atrial Fibrillation? A Report from the Western Denmark Heart Registry
Steensig, K., Olesen, K. K. W., Thim, T., Nielsen, J. C., Jensen, S. E., Jensen, L. O., . . . Maeng, M. (2018). Should the Presence or Extent of Coronary Artery Disease be Quantified in the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score in Atrial Fibrillation? A Report from the Western Denmark Heart Registry. THROMBOSIS AND HAEMOSTASIS, 118(12), 2162-2170. doi:10.1055/s-0038-1675401
Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study
Staerk, L., Gerds, T. A., Lip, G. Y. H., Ozenne, B., Bonde, A. N., Lamberts, M., . . . Olesen, J. B. (2018). Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study. JOURNAL OF INTERNAL MEDICINE, 283(1), 45-55. doi:10.1111/joim.12683
Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: prospective validation of the EHRA classification in a nationwide cohort study
Jensen, M., Skjoeth, F., Nielsen, P. B., Larsen, T. B., Melgaard, L., & Lip, G. Y. H. (2018). Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: prospective validation of the EHRA classification in a nationwide cohort study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 25). Retrieved from https://www.webofscience.com/
The effect of PCI complexity on the efficacy and safety of dabigatran dual therapy vs warfarin triple therapy in atrial fibrillation: a subgroup analysis from the RE-DUAL PCI trial
Mauri, L., Steg, P. S., Bhatt, D. L., Hohnloser, S. H., Nordaby, M., Miede, C., . . . Cannon, C. (2018). The effect of PCI complexity on the efficacy and safety of dabigatran dual therapy vs warfarin triple therapy in atrial fibrillation: a subgroup analysis from the RE-DUAL PCI trial. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 653). Retrieved from https://www.webofscience.com/
The effect of age on the efficacy and safety of dabigatran dual therapy in atrial fibrillation after PCI: a subgroup analysis from the RE-DUAL PCI trial
Ten Berg, J. M., Steg, P. G., Bhatt, D. L., Hohnloser, S. H., De Veer, A. N. N. E., Nordaby, M., . . . Cannon, C. P. (2018). The effect of age on the efficacy and safety of dabigatran dual therapy in atrial fibrillation after PCI: a subgroup analysis from the RE-DUAL PCI trial. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 439-440). Retrieved from https://www.webofscience.com/
The impact of hypertension on stroke and mortality in patients with atrial fibrillation: the loire valley atrial fibrillation project
Shantsila, A., Fauchier, L., Bisson, A., Bodin, A., & Lip, G. Y. H. (2018). The impact of hypertension on stroke and mortality in patients with atrial fibrillation: the loire valley atrial fibrillation project. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1411). Retrieved from https://www.webofscience.com/
The increased risk of stroke, bleeding and mortality with new-onset atrial fibrillation in critically ill patients: a nationwide cohort study
Kim, K., Yang, P., Jang, E., Yu, H. T., Kim, T., Uhm, J., . . . Lip, G. Y. H. (2018). The increased risk of stroke, bleeding and mortality with new-onset atrial fibrillation in critically ill patients: a nationwide cohort study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1075). Retrieved from https://www.webofscience.com/
Two-year outcomes of dabigatran etexilate in patients with atrial fibrillation with and without a history of coronary artery disease: data from GLORIA-AF
Halperin, J. L., Teutsch, C., Huisman, M. V., Diener, H. -C., Rothman, K. J., Ma, C. S., . . . Lip, G. Y. H. (2018). Two-year outcomes of dabigatran etexilate in patients with atrial fibrillation with and without a history of coronary artery disease: data from GLORIA-AF. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 610). Retrieved from https://www.webofscience.com/
Two-year outcomes of dabigatran etexilate treatment in patients with co-morbid heart failure and atrial fibrillation: the GLORIA-AF registry
Dubner, S. J., Huisman, M. V., Diener, H. C., Halperin, J. L., Rothman, K. J., Ma, C. S., . . . Lip, G. Y. H. (2018). Two-year outcomes of dabigatran etexilate treatment in patients with co-morbid heart failure and atrial fibrillation: the GLORIA-AF registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 606-607). Retrieved from https://www.webofscience.com/
Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: a nationwide cohort study
Fangel, M. V., Nielsen, P. B., Larsen, T. B., Christensen, B., Overvad, T. F., Lip, G. Y. H., . . . Jensen, M. B. (2018). Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: a nationwide cohort study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 404). Retrieved from https://www.webofscience.com/
Use of oral anticoagulation and association to outcomes in atrial fibrillation patients who develop chronic kidney disease: a nationwide cohort study
Bonde, A. N., Lip, G. Y. H., Kamper, A. L., Gislason, G., Torp-Pedersen, C., Hlatky, M., & Olesen, J. B. (2018). Use of oral anticoagulation and association to outcomes in atrial fibrillation patients who develop chronic kidney disease: a nationwide cohort study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 820). Retrieved from https://www.webofscience.com/
When are atrial fibrillation patients at risk to discontinue anticoagulation treatment? Results from the GLORIA-AF Registry
Paquette, M., Huisman, M. V., Lip, G. Y. H., Diener, H. -C., Dubner, S. J., Halperin, J. L., . . . Nieuwlaat, R. (2018). When are atrial fibrillation patients at risk to discontinue anticoagulation treatment? Results from the GLORIA-AF Registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1007). Retrieved from https://www.webofscience.com/
2017
Usefulness of the 2MACE Score to Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation
Miguel Rivera-Caravaca, J., Marin, F., Asuncion Esteve-Pastor, M., Rana-Miguez, P., Anguita, M., Muniz, J., . . . Roldan, V. (2017). Usefulness of the 2MACE Score to Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation. AMERICAN JOURNAL OF CARDIOLOGY, 120(12), 2176-2181. doi:10.1016/j.amjcard.2017.09.003
Comparing the ORBIT and HAS-BLED bleeding risk scores in anticoagulated atrial fibrillation patients: a systematic review and meta-analysis
Wang, C., Yu, Y., Zhu, W., Yu, J., Lip, G. Y. H., & Hong, K. (2017). Comparing the ORBIT and HAS-BLED bleeding risk scores in anticoagulated atrial fibrillation patients: a systematic review and meta-analysis. ONCOTARGET, 8(65), 109703-109711. doi:10.18632/oncotarget.19858
Cardiovascular autonomic regulation, inflammation and pain in rheumatoid arthritis
Adlan, A. M., van Zanten, J. J. C. S. V., Lip, G. Y. H., Paton, J. F. R., Kitas, G. D., & Fisher, J. P. (2017). Cardiovascular autonomic regulation, inflammation and pain in rheumatoid arthritis. AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 208, 137-145. doi:10.1016/j.autneu.2017.09.003
Clinical Impact of Asymptomatic Presentation Status in Patients With Paroxysmal and Sustained Atrial Fibrillation The Fushimi AF Registry
Esato, M., Chun, Y. -H., An, Y., Ogawa, H., Wada, H., Hasegawa, K., . . . Akao, M. (2017). Clinical Impact of Asymptomatic Presentation Status in Patients With Paroxysmal and Sustained Atrial Fibrillation The Fushimi AF Registry. CHEST, 152(6), 1266-1275. doi:10.1016/j.chest.2017.08.004
Comparison of Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation: A Multicriteria Decision Analysis
Tervonen, T., Ustyugova, A., Bhashyam, S. S., Lip, G. Y. H., Verdecchia, P., Kwan, R., . . . Marsh, K. (2017). Comparison of Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation: A Multicriteria Decision Analysis. VALUE IN HEALTH, 20(10), 1394-1402. doi:10.1016/j.jval.2017.06.006
Edoxaban for the management of elderly Japanese patients with atrial fibrillation ineligible for standard oral anticoagulant therapies: Rationale and design of the ELDERCARE-AF study
Okumura, K., Lip, G. Y. H., Akao, M., Tanizawa, K., Fukuzawae, M., Abe, K., . . . Yamashita, T. (2017). Edoxaban for the management of elderly Japanese patients with atrial fibrillation ineligible for standard oral anticoagulant therapies: Rationale and design of the ELDERCARE-AF study. AMERICAN HEART JOURNAL, 194, 99-106. doi:10.1016/j.ahj.2017.08.017
Enhanced shape memory and superelasticity in small-volume ceramics: a perspective on the controlling factors
Zeng, X., Du, Z., Schuh, C. A., & Gan, C. L. (2017). Enhanced shape memory and superelasticity in small-volume ceramics: a perspective on the controlling factors. MRS Communications, 7(4), 747-754. doi:10.1557/mrc.2017.99
External Validation of the Simple NULL-PLEASE Clinical Score in Predicting Outcome of Out-of-Hospital Cardiac Arrest
Potpara, T. S., Mihajlovic, M., Stankovic, S., Jozic, T., Jozic, I., Asanin, M. R., . . . Lip, G. Y. H. (2017). External Validation of the Simple NULL-PLEASE Clinical Score in Predicting Outcome of Out-of-Hospital Cardiac Arrest. AMERICAN JOURNAL OF MEDICINE, 130(12). doi:10.1016/j.amjmed.2017.05.035
Guía ESC 2017 sobre el tratamiento del infarto agudo de miocardio en pacientes con elevación del segmento ST
Ibáñez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., . . . Zeymer, U. (2017). Guía ESC 2017 sobre el tratamiento del infarto agudo de miocardio en pacientes con elevación del segmento ST. Revista Española de Cardiología, 70(12), 1082.e1-1082.e61. doi:10.1016/j.recesp.2017.10.048
Intra-cardiac and peripheral levels of biochemical markers of fibrosis in patients undergoing catheter ablation for atrial fibrillation
Begg, G. A., Karim, R., Oesterlein, T., Graham, L. N., Hogarth, A. J., Page, S. P., . . . Tayebjee, M. H. (2017). Intra-cardiac and peripheral levels of biochemical markers of fibrosis in patients undergoing catheter ablation for atrial fibrillation. EUROPACE, 19(12), 1944-1950. doi:10.1093/europace/euw315
Metal-sulfide-decorated ZnO/Si nano-heterostructure arrays with enhanced photoelectrochemical performance
Yadian, B., Rao, Y., Zhu, B., Liu, Z., Liu, Q., Gan, C. L., . . . Huang, Y. (2017). Metal-sulfide-decorated ZnO/Si nano-heterostructure arrays with enhanced photoelectrochemical performance. Materials Research Bulletin, 96, 503-508. doi:10.1016/j.materresbull.2017.05.017
Mobile Health Technology for Atrial Fibrillation Management Integrating Decision Support, Education, and Patient Involvement: mAF App Trial
Guo, Y., Chen, Y., Lane, D. A., Liu, L., Wang, Y., & Lip, G. Y. H. (2017). Mobile Health Technology for Atrial Fibrillation Management Integrating Decision Support, Education, and Patient Involvement: mAF App Trial. AMERICAN JOURNAL OF MEDICINE, 130(12), 1388-1396.e6. doi:10.1016/j.amjmed.2017.07.003
Non-vitamin K antagonist oral anticoagulant dosing in patients with atrial fibrillation and renal dysfunction
Khan, A. A., & Lip, G. Y. H. (2017). Non-vitamin K antagonist oral anticoagulant dosing in patients with atrial fibrillation and renal dysfunction. ANNALS OF TRANSLATIONAL MEDICINE, 5(23). doi:10.21037/atm.2017.09.19
Occupational radiation exposure in the electrophysiology laboratory with a focus on personnel with reproductive potential and during pregnancy: A European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS).
Sarkozy, A., De Potter, T., Heidbuchel, H., Ernst, S., Kosiuk, J., Vano, E., . . . ESC Scientific Document Group. (2017). Occupational radiation exposure in the electrophysiology laboratory with a focus on personnel with reproductive potential and during pregnancy: A European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS).. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 19(12), 1909-1922. doi:10.1093/europace/eux252
Outcome of octogenarians with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry
Lahtela, H. M., Bah, A., Kiviniemi, T., Nammas, W., Schlitt, A., Rubboli, A., . . . Airaksinen, K. E. J. (2017). Outcome of octogenarians with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry. CLINICAL CARDIOLOGY, 40(12), 1264-1270. doi:10.1002/clc.22821
Persistency of left atrial linear lesions after radiofrequency catheter ablation for atrial fibrillation: Data from an invasive follow-up electrophysiology study
Mujovic, N., Marinkovic, M., Markovic, N., Stankovic, G., Lip, G. Y. H., Blomstrom-Lundqvist, C., . . . Potpara, T. S. (2017). Persistency of left atrial linear lesions after radiofrequency catheter ablation for atrial fibrillation: Data from an invasive follow-up electrophysiology study. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 28(12), 1403-1414. doi:10.1111/jce.13322
Temporal trends of antithrombotic therapy for stroke prevention in Korean patients with non-valvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants: A nationwide population-based study
Lee, S. -R., Choi, E. -K., Han, K. -D., Cha, M. -J., Oh, S., & Lip, G. Y. H. (2017). Temporal trends of antithrombotic therapy for stroke prevention in Korean patients with non-valvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants: A nationwide population-based study. PLOS ONE, 12(12). doi:10.1371/journal.pone.0189495
Use of statins and adverse outcomes in patients with atrial fibrillation: An analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) general registry pilot phase
Proietti, M., Laroche, C., Nyvad, O., Haberka, M., Vassilikos, V. P., Maggioni, A. P., . . . Lip, G. Y. H. (2017). Use of statins and adverse outcomes in patients with atrial fibrillation: An analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) general registry pilot phase. INTERNATIONAL JOURNAL OF CARDIOLOGY, 248, 166-172. doi:10.1016/j.ijcard.2017.08.055
Validation of the Same-TT2R2 Score in a Multiethnic Cohort of Asian Patients with Atrial Fibrillation on Warfarin Therapy - A Multicenter Study
Khaw, C. S., Lim, M. S. H., Tiong, L. L., Tan, S. S. N., Ku, M. Y., Tan, C. S. Y., . . . Fong, A. Y. Y. (2017). Validation of the Same-TT2R2 Score in a Multiethnic Cohort of Asian Patients with Atrial Fibrillation on Warfarin Therapy - A Multicenter Study. In INTERNATIONAL JOURNAL OF CARDIOLOGY Vol. 249 (pp. S2). doi:10.1016/j.ijcard.2017.09.115
Bleeding Complications in Anticoagulated Patients With Atrial Fibrillation and Sepsis: A Propensity-Weighted Cohort Study
Sogaard, M., Skjoth, F., Kjaeldgaard, J. N., Lip, G. Y. H., & Larsen, T. B. (2017). Bleeding Complications in Anticoagulated Patients With Atrial Fibrillation and Sepsis: A Propensity-Weighted Cohort Study. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 6(11). doi:10.1161/JAHA.117.007453
Direct oral anticoagulant reversal: how, when and issues faced
Dzeshka, M. S., Pastori, D., & Lip, G. Y. H. (2017). Direct oral anticoagulant reversal: how, when and issues faced. EXPERT REVIEW OF HEMATOLOGY, 10(11), 1005-1022. doi:10.1080/17474086.2017.1379896
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE)
Lip, G. Y. H., Collet, J. P., de Caterina, R., Fauchier, L., Lane, D. A., Larsen, T. B., . . . Scott-Millar, R. (2017). Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE). EUROPACE, 19(11), 1757-+. doi:10.1093/europace/eux240
Atrial Fibrillation and Hypertension
Dzeshka, M. S., Shantsila, A., Shantsila, E., & Lip, G. Y. H. (2017). Atrial Fibrillation and Hypertension. HYPERTENSION, 70(5), 854-+. doi:10.1161/HYPERTENSIONAHA.117.08934
CHA<sub>2</sub>DS<sub>2</sub>-VASc Score for Identifying Truly Low-Risk Atrial Fibrillation for Stroke A Korean Nationwide Cohort Study
Kim, T. -H., Yang, P. -S., Kim, D., Yu, H. T., Uhm, J. -S., Kim, J. -Y., . . . Lip, G. Y. H. (2017). CHA<sub>2</sub>DS<sub>2</sub>-VASc Score for Identifying Truly Low-Risk Atrial Fibrillation for Stroke A Korean Nationwide Cohort Study. STROKE, 48(11), 2984-+. doi:10.1161/STROKEAHA.117.018551
Coronary artery disease and risk of adverse cardiac events and stroke
Olesen, K. K. W., Madsen, M., Lip, G. Y. H., Egholm, G., Thim, T., Jensen, L. O., . . . Maeng, M. (2017). Coronary artery disease and risk of adverse cardiac events and stroke. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 47(11), 819-828. doi:10.1111/eci.12804
Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation
Cha, M. -J., Choi, E. -K., Han, K. -D., Lee, S. -R., Lim, W. -H., Oh, S., & Lip, G. Y. H. (2017). Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation. STROKE, 48(11), 3040-+. doi:10.1161/STROKEAHA.117.018773
Hypertension and Atrial Fibrillation: Balancing Stroke and Bleeding Risks
Asuncion Esteve-Pastor, M., Rivera-Caravaca, J. M., & Lip, G. Y. H. (2017). Hypertension and Atrial Fibrillation: Balancing Stroke and Bleeding Risks. AMERICAN JOURNAL OF HYPERTENSION, 30(11), 1063-1065. doi:10.1093/ajh/hpx135
Meta-Analysis of Effectiveness and Safety of Oral Anticoagulants in Atrial Fibrillation With Focus on Apixaban
Bai, Y., Shi, X. -B., Ma, C. -S., & Lip, G. Y. H. (2017). Meta-Analysis of Effectiveness and Safety of Oral Anticoagulants in Atrial Fibrillation With Focus on Apixaban. AMERICAN JOURNAL OF CARDIOLOGY, 120(9), 1689-1695. doi:10.1016/j.amjcard.2017.07.072
Predictors of 5-year outcomes in malignant phase hypertension: the West Birmingham Malignant Hypertension Registry
Shantsila, A., Shantsila, E., Beevers, D. G., & Lip, G. Y. H. (2017). Predictors of 5-year outcomes in malignant phase hypertension: the West Birmingham Malignant Hypertension Registry. JOURNAL OF HYPERTENSION, 35(11), 2310-2314. doi:10.1097/HJH.0000000000001446
Pulmonary Embolism and Atrial Fibrillation: Two Sides of the Same Coin? A Systematic Review
Bikdeli, B., Abou Ziki, M. D., & Lip, G. Y. H. (2017). Pulmonary Embolism and Atrial Fibrillation: Two Sides of the Same Coin? A Systematic Review. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 43(8), 849-863. doi:10.1055/s-0036-1598005
Response to: The Cause of the Arteriolar Injury in Malignant Hypertension
Shantsila, A., & Lip, G. Y. H. (2017). Response to: The Cause of the Arteriolar Injury in Malignant Hypertension. AMERICAN JOURNAL OF HYPERTENSION, 30(11), E15. doi:10.1093/ajh/hpx149
Systolic Blood Pressure Visit-to-Visit Variability and Major Adverse Outcomes in Atrial Fibrillation The AFFIRM Study (Atrial Fibrillation Follow-Up Investigation of Rhythm Management)
Proietti, M., Romiti, G. F., Olshansky, B., & Lip, G. Y. H. (2017). Systolic Blood Pressure Visit-to-Visit Variability and Major Adverse Outcomes in Atrial Fibrillation The AFFIRM Study (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). HYPERTENSION, 70(5), 949-958. doi:10.1161/HYPERTENSIONAHA.117.10106
The ABC pathway: an integrated approach to improve AF management
Lip, G. Y. H. (2017). The ABC pathway: an integrated approach to improve AF management. NATURE REVIEWS CARDIOLOGY, 14(11), 627-+. doi:10.1038/nrcardio.2017.153
The increased risk of stroke/transient ischemic attack in women with a cardiac implantable electronic device is not associated with a higher atrial fibrillation burden
Boriani, G., Lip, G. Y. H., Ricci, R. P., Proclemer, A., Landolina, M., Lunati, M., . . . Gasparini, M. (2017). The increased risk of stroke/transient ischemic attack in women with a cardiac implantable electronic device is not associated with a higher atrial fibrillation burden. EUROPACE, 19(11), 1767-1775. doi:10.1093/europace/euw333
The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors
Butler, J., Hamo, C. E., Filippatos, G., Pocock, S. J., Bernstein, R. A., Brueckmann, M., . . . Anker, S. D. (2017). The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors. EUROPEAN JOURNAL OF HEART FAILURE, 19(11), 1390-1400. doi:10.1002/ejhf.933
The relationship of renal function to outcome: A post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study
Lip, G. Y. H., Al-Saady, N., Ezekowitz, M. D., Banach, M., & Goette, A. (2017). The relationship of renal function to outcome: A post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study. AMERICAN HEART JOURNAL, 193, 16-22. doi:10.1016/j.ahj.2017.07.010
Streamlining primary and secondary care management pathways for stroke prevention in atrial fibrillation
Lip, G. Y. H., Lane, D. A., & Sarwar, S. (2017). Streamlining primary and secondary care management pathways for stroke prevention in atrial fibrillation. EUROPEAN HEART JOURNAL, 38(40), 2980-2982. doi:10.1093/eurheartj/ehx554
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
Cannon, C. P., Bhatt, D. L., Oldgren, J., Lip, G. Y. H., Ellis, S. G., Kimura, T., . . . Hohnloser, S. H. (2017). Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation. NEW ENGLAND JOURNAL OF MEDICINE, 377(16), 1513-1524. doi:10.1056/NEJMoa1708454
The CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>-VASc scores for predicting healthcare utilization and outcomes: Observations on the Appropriate Use and Misuse of Risk scores
Tse, G., Lip, G. Y. H., & Liu, T. (2017). The CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>-VASc scores for predicting healthcare utilization and outcomes: Observations on the Appropriate Use and Misuse of Risk scores. INTERNATIONAL JOURNAL OF CARDIOLOGY, 245, 181-182. doi:10.1016/j.ijcard.2017.07.109
Efficacy and safety of triple versus dual antithrombotic therapy in atrial fibrillation and ischemic heart disease: a systematic review and meta-analysis
Zhu, W., Guo, L., Liu, F., Wan, R., Shen, Y., Lip, G. Y. H., & Hong, K. (2017). Efficacy and safety of triple versus dual antithrombotic therapy in atrial fibrillation and ischemic heart disease: a systematic review and meta-analysis. ONCOTARGET, 8(46), 81154-81166. doi:10.18632/oncotarget.20870
Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores The Murcia Atrial Fibrillation Project
Asuncion Esteve-Pastort, M., Rivera-Caravaca, J. M., Roldan, V., Vicente, V., Valdes, M., Marin, F., & Lip, G. Y. H. (2017). Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores The Murcia Atrial Fibrillation Project. THROMBOSIS AND HAEMOSTASIS, 117(10), 1848-1858. doi:10.1160/TH17-07-0478
Improvement and Aggravation of Spontaneous Unruptured Vertebral Artery Dissection.
Shibahara, T., Yasaka, M., Wakugawa, Y., Maeda, K., Uwatoko, T., Kuwashiro, T., . . . Okada, Y. (2017). Improvement and Aggravation of Spontaneous Unruptured Vertebral Artery Dissection.. Cerebrovascular diseases extra, 7(3), 153-164. doi:10.1159/000481442
Bleeding Risk Scores in Atrial Fibrillation and Venous Thromboembolism
Zulkifly, H., Lip, G. Y. H., & Lane, D. A. (2017). Bleeding Risk Scores in Atrial Fibrillation and Venous Thromboembolism. AMERICAN JOURNAL OF CARDIOLOGY, 120(7), 1139-1145. doi:10.1016/j.amjcard.2017.06.058
Bleeding-related hospital admissions and 30-day readmissions in patients with non-valvular atrial fibrillation treated with dabigatran versus warfarin
Lau, W. C. Y., Li, X., Wong, I. C. K., Man, K. K. C., Lip, G. Y. H., Leung, W. K., . . . Chan, E. W. (2017). Bleeding-related hospital admissions and 30-day readmissions in patients with non-valvular atrial fibrillation treated with dabigatran versus warfarin. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 15(10), 1923-1933. doi:10.1111/jth.13780
Brugada syndrome: A general cardiologist's perspective
Polovina, M. M., Vukicevic, M., Banko, B., Lip, G. Y. H., & Potpara, T. S. (2017). Brugada syndrome: A general cardiologist's perspective. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 44, 19-27. doi:10.1016/j.ejim.2017.06.019
Clinical scores for outcomes of rhythm control or arrhythmia progression in patients with atrial fibrillation: a systematic review
Deng, H., Bai, Y., Shantsila, A., Fauchier, L., Potpara, T. S., & Lip, G. Y. H. (2017). Clinical scores for outcomes of rhythm control or arrhythmia progression in patients with atrial fibrillation: a systematic review. CLINICAL RESEARCH IN CARDIOLOGY, 106(10), 813-823. doi:10.1007/s00392-017-1123-0
Effects of tibolone on fibrinogen and antithrombin III: A systematic review and meta-analysis of controlled trials
Bala, M., Sahebkar, A., Ursoniu, S., Serban, M. -C., Undas, A., Mikhailidis, D. P., . . . Banach, M. (2017). Effects of tibolone on fibrinogen and antithrombin III: A systematic review and meta-analysis of controlled trials. PHARMACOLOGICAL RESEARCH, 124, 64-73. doi:10.1016/j.phrs.2017.07.024
Efficacy of non-vitamin-K antagonist oral anticoagulants for intracardiac thrombi resolution in nonvalvular atrial fibrillation
Orenes-Pinero, E., Esteve-Pastor, M. A., Valdes, M., Lip, G. Y. H., & Marin, F. (2017). Efficacy of non-vitamin-K antagonist oral anticoagulants for intracardiac thrombi resolution in nonvalvular atrial fibrillation. DRUG DISCOVERY TODAY, 22(10), 1565-1571. doi:10.1016/j.drudis.2017.05.010
Hypertension and cardiac arrhythmias: executive summary of a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE)
Lip, G. Y. H., Coca, A., Kahan, T., Boriani, G., Manolis, A. S., Olsen, M. H., . . . Field, M. (2017). Hypertension and cardiac arrhythmias: executive summary of a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE). EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 3(4), 235-250. doi:10.1093/ehjcvp/pvx019
Is atrial fibrillation another manifestation of organ damage in diabetes?
Miyazawa, K., & Lip, G. Y. H. (2017). Is atrial fibrillation another manifestation of organ damage in diabetes?. LANCET DIABETES & ENDOCRINOLOGY, 5(10), 761-762. doi:10.1016/S2213-8587(17)30282-6
Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores.
Asunción Esteve-Pastor, M., Miguel Rivera-Caravaca, J., Roldán, V., Vicente, V., Valdés, M., Marín, F., & Lip, G. Y. H. (2017). Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores.. Thrombosis and haemostasis, 117(10), 1848-1858. doi:10.1160/th17-07-0478
Relationship of Preexisting Cardiovascular Comorbidities to Newly Diagnosed Atrial Fibrillation After Ischemic Stroke
Bisson, A., Clementy, N., Bodin, A., Angoulvant, D., Babuty, D., Lip, G. Y. H., & Fauchier, L. (2017). Relationship of Preexisting Cardiovascular Comorbidities to Newly Diagnosed Atrial Fibrillation After Ischemic Stroke. STROKE, 48(10), 2878-+. doi:10.1161/STROKEAHA.117.018251
Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulaci<remove>n Cardiaca y Electrofisiologia (SOLAECE)
Mairesse, G. H., Moran, P., Van Gelder, I. C., Elsner, C., Rosenqvist, M., Mant, J., . . . Sapp, J. L. (2017). Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulaci<remove>n Cardiaca y Electrofisiologia (SOLAECE). EUROPACE, 19(10), 1589-1623. doi:10.1093/europace/eux177
Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial
Essebag, V., Proietti, R., Birnie, D. H., Wang, J., Douketis, J., Coutu, B., . . . Healey, J. S. (2017). Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial. EUROPACE, 19(10), 1630-1636. doi:10.1093/europace/euw409
The Global Burden of Atrial Fibrillation and Stroke A Systematic Review of the Clinical Epidemiology of Atrial Fibrillation in Asia
Bai, Y., Wang, Y. -L., Shantsila, A., & Lip, G. Y. H. (2017). The Global Burden of Atrial Fibrillation and Stroke A Systematic Review of the Clinical Epidemiology of Atrial Fibrillation in Asia. CHEST, 152(4), 810-820. doi:10.1016/j.chest.2017.03.048
Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation
Paquette, M., Franca, L. R., Teutsch, C., Diener, H. -C., Lu, S., Dubner, S. J., . . . Nieuwlaat, R. (2017). Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation. Journal of the American College of Cardiology, 70(13), 1573-1583. doi:10.1016/j.jacc.2017.07.793
Sex-Related Differences in the Clinical Events of Patients With Atrial Fibrillation. - The Fushimi AF Registry
Ogawa, H., Hamatani, Y., Doi, K., Tezuka, Y., An, Y., Ishii, M., . . . Akao, M. (2017). Sex-Related Differences in the Clinical Events of Patients With Atrial Fibrillation. - The Fushimi AF Registry. CIRCULATION JOURNAL, 81(10), 1403-1410. doi:10.1253/circj.CJ-17-0071
Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation
Rivera-Caravaca, J. M., Roldan, V., Asuncion Esteve-Pastor, M., Valdes, M., Vicente, V., Lip, G. Y. H., & Marin, F. (2017). Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation. SCIENTIFIC REPORTS, 7. doi:10.1038/s41598-017-11683-2
Glycative and oxidative stress are associated with altered thrombus composition in diabetic patients with ST-elevation myocardial infarction
Sambola, A., Ruiz-Meana, M., Barba, I., Del Blanco, B. G., Barrabes, J. A., Lip, G. Y., . . . Garcia-Dorado, D. (2017). Glycative and oxidative stress are associated with altered thrombus composition in diabetic patients with ST-elevation myocardial infarction. INTERNATIONAL JOURNAL OF CARDIOLOGY, 243, 9-14. doi:10.1016/j.ijcard.2017.04.089
Clinical implications, benefits and pitfalls of using and reversing non-vitamin K antagonist oral anticoagulants
Moss, A. S., Dimitropoulous, G., & Lip, G. Y. H. (2017). Clinical implications, benefits and pitfalls of using and reversing non-vitamin K antagonist oral anticoagulants. EXPERT REVIEW OF HEMATOLOGY, 10(9), 833-845. doi:10.1080/17474086.2017.1358085
Non-vitamin K antagonist oral anticoagulants: impact of non-adherence and discontinuation
Rivera-Caravaca, J. M., Asuncion Esteve-Pastora, M., Roldan, V., Marin, F., & Lip, G. Y. H. (2017). Non-vitamin K antagonist oral anticoagulants: impact of non-adherence and discontinuation. EXPERT OPINION ON DRUG SAFETY, 16(9), 1051-1062. doi:10.1080/14740338.2017.1351542
Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report fromthe EURObservational research programme pilot survey on atrial fibrillation
Proietti, M., Raparelli, V., Laroche, C., Dan, G. -A., Janion, M., Popescu, R., . . . Lip, G. Y. H. (2017). Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report fromthe EURObservational research programme pilot survey on atrial fibrillation. EUROPACE, 19(9), 1439-1448. doi:10.1093/europace/euw169
All Types of Hemorrhagic Stroke Are Not Created Equally Reply
Nielsen, P. B., Larsen, T. B., & Lip, G. Y. H. (2017). All Types of Hemorrhagic Stroke Are Not Created Equally Reply. JAMA INTERNAL MEDICINE, 177(9), 1399. doi:10.1001/jamainternmed.2017.3240
Anticoagulation Control in <i>Warfarin</i>-Treated Patients Undergoing Cardioversion of Atrial Fibrillation (from the <i>Edoxaban</i> Versus <i>Enoxaparin</i>-<i>Warfarin</i> in Patients Undergoing Cardioversion of Atrial Fibrillation Trial)
Lip, G. Y. H., Al-Saady, N., Jin, J., Sun, M., Melino, M., Winters, S. M., . . . Goette, A. (2017). Anticoagulation Control in <i>Warfarin</i>-Treated Patients Undergoing Cardioversion of Atrial Fibrillation (from the <i>Edoxaban</i> Versus <i>Enoxaparin</i>-<i>Warfarin</i> in Patients Undergoing Cardioversion of Atrial Fibrillation Trial). AMERICAN JOURNAL OF CARDIOLOGY, 120(5), 792-796. doi:10.1016/j.amjcard.2017.06.005
Atrial fibrillation and hypertrophic cardiomyopathy: co-existing conditions with additive risks
Miyazawa, K., & Lip, G. Y. H. (2017). Atrial fibrillation and hypertrophic cardiomyopathy: co-existing conditions with additive risks. HELLENIC JOURNAL OF CARDIOLOGY, 58(5), 340-341. doi:10.1016/j.hjc.2017.11.012
Characterisation of defects generated during constant current InGaN-on-silicon LED operation
Made, R. I., Gao, Y., Syaranamual, G. J., Sasangka, W. A., Zhang, L., Nguyen, X. S., . . . Gan, C. L. (2017). Characterisation of defects generated during constant current InGaN-on-silicon LED operation. Microelectronics Reliability, 76-77, 561-565. doi:10.1016/j.microrel.2017.07.072
Device-detected subclinical atrial tachyarrhythmias: definition, implications and management-an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart RhythmSociety (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE)
Gorenek, B., Bax, J., Boriani, G., Chen, S. -A., Dagres, N., Glotzer, T. V., . . . Savelieva, I. (2017). Device-detected subclinical atrial tachyarrhythmias: definition, implications and management-an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart RhythmSociety (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE). EUROPACE, 19(9), 1556-1578. doi:10.1093/europace/eux163
Improved reliability of AlGaN/GaN-on-Si high electron mobility transistors (HEMTs) with high density silicon nitride passivation
Sasangka, W. A., Syaranamual, G. J., Gao, Y., I Made, R., Gan, C. L., & Thompson, C. V. (2017). Improved reliability of AlGaN/GaN-on-Si high electron mobility transistors (HEMTs) with high density silicon nitride passivation. Microelectronics Reliability, 76-77, 287-291. doi:10.1016/j.microrel.2017.06.057
Influence of renal function on anticoagulation control in patients with non-valvular atrial fibrillation taking vitamin K antagonists
Lobos-Bejarano, J. M., Castellanos Rodriguez, A., Barrios, V., Escobar, C., Polo-Garcia, J., Carlos del Castillo-Rodriguez, J., . . . Lip, G. Y. H. (2017). Influence of renal function on anticoagulation control in patients with non-valvular atrial fibrillation taking vitamin K antagonists. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 71(9). doi:10.1111/ijcp.12974
Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Ntaios, G., Papavasileiou, V., Makaritsis, K., Vemmos, K., Michel, P., & Lip, G. Y. H. (2017). Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.. Stroke, 48(9), 2494-2503. doi:10.1161/strokeaha.117.017549
Synthesis of monodisperse CeO<sub>2</sub>–ZrO<sub>2</sub> particles exhibiting cyclic superelasticity over hundreds of cycles
Du, Z., Ye, P., Zeng, X. M., Schuh, C. A., Tamura, N., Zhou, X., & Gan, C. L. (2017). Synthesis of monodisperse CeO<sub>2</sub>–ZrO<sub>2</sub> particles exhibiting cyclic superelasticity over hundreds of cycles. Journal of the American Ceramic Society, 100(9), 4199-4208. doi:10.1111/jace.14972
Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation
Korompoki, E., Filippidis, F. T., Nielsen, P. B., Del Giudice, A., Lip, G. Y. H., Kuramatsu, J. B., . . . Veltkamp, R. (2017). Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation. NEUROLOGY, 89(7), 687-696. doi:10.1212/WNL.0000000000004235
Age- and sex-specific analysis of patients with embolic stroke of undetermined source
Ntaios, G., Lip, G. Y. H., Vemmos, K., Koroboki, E., Manios, E., Vemmou, A., . . . Papavasileiou, V. (2017). Age- and sex-specific analysis of patients with embolic stroke of undetermined source. NEUROLOGY, 89(6), 532-539. doi:10.1212/WNL.0000000000004199
Apixaban may have lower risk of GI bleeding compared with dabigatran and rivaroxaban in patients with atrial fibrillation.
Rivera-Caravaca, J. M., & Lip, G. Y. H. (2017). Apixaban may have lower risk of GI bleeding compared with dabigatran and rivaroxaban in patients with atrial fibrillation.. Evidence-based medicine, 22(4), 154-155. doi:10.1136/ebmed-2017-110764
Aspirin Does Not Increase Heart Failure Events in Heart Failure Patients From the WARCEF Trial
Teerlink, J. R., Qian, M., Bello, N. A., Freudenberger, R. S., Levin, B., Di Tullio, M. R., . . . Homma, S. (2017). Aspirin Does Not Increase Heart Failure Events in Heart Failure Patients From the WARCEF Trial. JACC-HEART FAILURE, 5(8), 603-610. doi:10.1016/j.jchf.2017.04.011
Effectiveness and Safety of Standard-Dose Nonvitamin K Antagonist Oral Anticoagulants and Warfarin Among Patients With Atrial Fibrillation With a Single Stroke Risk Factor A Nationwide Cohort Study
Lip, G. Y. H., Skjoth, F., Nielsen, P. B., Kjaeldgaard, J. N., & Larsen, T. B. (2017). Effectiveness and Safety of Standard-Dose Nonvitamin K Antagonist Oral Anticoagulants and Warfarin Among Patients With Atrial Fibrillation With a Single Stroke Risk Factor A Nationwide Cohort Study. JAMA CARDIOLOGY, 2(8), 872-881. doi:10.1001/jamacardio.2017.1883
Efficacy and Safety of Alternate-Day Versus Daily Dosing of Statins: a Systematic Review and Meta-Analysis
Awad, K., Mikhailidis, D. P., Toth, P. P., Jones, S. R., Moriarty, P., Lip, G. Y. H., . . . Banach, M. (2017). Efficacy and Safety of Alternate-Day Versus Daily Dosing of Statins: a Systematic Review and Meta-Analysis. CARDIOVASCULAR DRUGS AND THERAPY, 31(4), 419-431. doi:10.1007/s10557-017-6743-0
Guideline-Adherent Antithrombotic Treatment Improves Outcomes in Patients With Atrial Fibrillation: Insights From the Community-Based Darlington Atrial Fibrillation Registry
Mazurek, M., Shantsila, E., Lane, D. A., Wolff, A., Proietti, M., & Lip, G. Y. H. (2017). Guideline-Adherent Antithrombotic Treatment Improves Outcomes in Patients With Atrial Fibrillation: Insights From the Community-Based Darlington Atrial Fibrillation Registry. MAYO CLINIC PROCEEDINGS, 92(8), 1203-1213. doi:10.1016/j.mayocp.2017.05.023
Hypertension and Atrial Fibrillation: An Intimate Association of Epidemiology, Pathophysiology, and Outcomes
Dzeshka, M. S., Shahid, F., Shantsila, A., & Lip, G. Y. H. (2017). Hypertension and Atrial Fibrillation: An Intimate Association of Epidemiology, Pathophysiology, and Outcomes. AMERICAN JOURNAL OF HYPERTENSION, 30(8), 733-755. doi:10.1093/ajh/hpx013
In-situ studies on martensitic transformation and high-temperature shape memory in small volume zirconia
Zeng, X. M., Du, Z., Tamura, N., Liu, Q., Schuh, C. A., & Gan, C. L. (2017). In-situ studies on martensitic transformation and high-temperature shape memory in small volume zirconia. Acta Materialia, 134, 257-266. doi:10.1016/j.actamat.2017.06.006
Intensity of anticoagulation and risk of thromboembolism after elective cardioversion of atrial fibrillation
Hellman, T., Kiviniemi, T., Nuotio, I., Vasankari, T., Hartikainen, J., Lip, G. Y. H., & Airaksinen, K. E. J. (2017). Intensity of anticoagulation and risk of thromboembolism after elective cardioversion of atrial fibrillation. THROMBOSIS RESEARCH, 156, 163-167. doi:10.1016/j.thromres.2017.06.026
P-Wave Indices and Risk of Ischemic Stroke A Systematic Review and Meta-Analysis
He, J., Tse, G., Korantzopoulos, P., Letsas, K. P., Ali-Hasan-Al-Saegh, S., Kamel, H., . . . Liu, T. (2017). P-Wave Indices and Risk of Ischemic Stroke A Systematic Review and Meta-Analysis. STROKE, 48(8), 2066-+. doi:10.1161/STROKEAHA.117.017293
Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial
Kirchhoff, P., Blank, B. F., Calvert, M., Camm, A. J., Chlouverakis, G., Diener, H. -C., . . . Vardas, P. (2017). Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial. AMERICAN HEART JOURNAL, 190, 12-18. doi:10.1016/j.ahj.2017.04.015
Secondary Versus Primary Stroke Prevention in Atrial Fibrillation: Insights From the Darlington Atrial Fibrillation Registry
Mazurek, M., Shantsila, E., Lane, D. A., Wolff, A., Proietti, M., & Lip, G. Y. H. (2017). Secondary Versus Primary Stroke Prevention in Atrial Fibrillation: Insights From the Darlington Atrial Fibrillation Registry. STROKE, 48(8), 2198-2205. doi:10.1161/STROKEAHA.116.016146
The Patterns of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Use in Patients with Atrial Fibrillation in Seven Balkan Countries: a Report from the BALKAN-AF Survey
Potpara, T. S., Trendafilova, E., Dan, G. -A., Goda, A., Kusljugic, Z., Manola, S., . . . Lip, G. Y. H. (2017). The Patterns of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Use in Patients with Atrial Fibrillation in Seven Balkan Countries: a Report from the BALKAN-AF Survey. ADVANCES IN THERAPY, 34(8), 2043-2057. doi:10.1007/s12325-017-0589-5
The non-vitamin K antagonist oral anticoagulants (NOACs) and extremes of body weight-a systematic literature review
De Caterina, R., & Lip, G. Y. H. (2017). The non-vitamin K antagonist oral anticoagulants (NOACs) and extremes of body weight-a systematic literature review. CLINICAL RESEARCH IN CARDIOLOGY, 106(8), 565-572. doi:10.1007/s00392-017-1102-5
Time in therapeutic range and major adverse outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry
Proietti, M., Airaksinen, K. E. J., Rubboli, A., Schlitt, A., Kiviniemi, T., Karjalainen, P. P., & Lip, G. Y. H. (2017). Time in therapeutic range and major adverse outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry. AMERICAN HEART JOURNAL, 190, 86-93. doi:10.1016/j.ahj.2017.05.016
Considerations and treatment options for patients with comorbid atrial fibrillation and diabetes mellitus
Moss, A. S., Dimitropoulos, G., Connolly, D. L., & Lip, G. Y. H. (2017). Considerations and treatment options for patients with comorbid atrial fibrillation and diabetes mellitus. EXPERT OPINION ON PHARMACOTHERAPY, 18(11), 1101-1114. doi:10.1080/14656566.2017.1350647
A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial
Kotecha, D., Calvert, M., Deeks, J. J., Griffith, M., Kirchhof, P., Lip, G. Y. H., . . . Townend, J. N. (2017). A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial. BMJ OPEN, 7(7). doi:10.1136/bmjopen-2016-015099
Long-Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC-Stroke and CHA<sub>2</sub>DS<sub>2</sub>-VASc Scores
Rivera-Caravaca, J. M., Roldan, V., Esteve-Pastor, M. A., Valdes, M., Vicente, V., Lip, G. Y. H., & Marin, F. (2017). Long-Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC-Stroke and CHA<sub>2</sub>DS<sub>2</sub>-VASc Scores. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 6(7). doi:10.1161/JAHA.117.006490
Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary.
Heidbuchel, H., Verhamme, P., Alings, M., Antz, M., Diener, H. -C., Hacke, W., . . . ESC Scientific Document Group. (2017). Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary.. European heart journal, 38(27), 2137-2149. doi:10.1093/eurheartj/ehw058
Copper nanoparticle paste on different metallic substrates for low temperature bonded interconnection
Kim, J., Lee, B., Koo, J. -M., & Gan, C. L. (2017). Copper nanoparticle paste on different metallic substrates for low temperature bonded interconnection. In 2017 IEEE 19th Electronics Packaging Technology Conference (EPTC) (pp. 1-4). IEEE. doi:10.1109/eptc.2017.8277556
Review on test vehicles for electromigration (EM) study in solder interconnects
Zhu, Z., Chan, Y. -C., Wu, F., Gan, C. L., & Chen, Z. (2017). Review on test vehicles for electromigration (EM) study in solder interconnects. In 2017 IEEE 19th Electronics Packaging Technology Conference (EPTC) (pp. 1-5). IEEE. doi:10.1109/eptc.2017.8277478
Effects of morning vs evening statin administration on lipid profile: A systematic review and meta-analysis
Awad, K., Serban, M. -C., Penson, P., Mikhailidis, D. P., Toth, P. P., Jones, S. R., . . . Banach, M. (2017). Effects of morning vs evening statin administration on lipid profile: A systematic review and meta-analysis. JOURNAL OF CLINICAL LIPIDOLOGY, 11(4), 972-985. doi:10.1016/j.jacl.2017.06.001
Microvesicles in vascular homeostasis and diseases.
Ridger, V. C., Boulanger, C. M., Angelillo-Scherrer, A., Badimon, L., Blanc-Brude, O., Bochaton-Piallat, M. -L., . . . Harrison, P. (2017). Microvesicles in vascular homeostasis and diseases.. Thrombosis and haemostasis, 117(7), 1296-1316. doi:10.1160/th16-12-0943
Oral anticoagulation for elderly patients with non-valvular atrial fibrillation: recent insights from randomised trials and the 'real world'
Voukalis, C., & Lip, G. Y. H. (2017). Oral anticoagulation for elderly patients with non-valvular atrial fibrillation: recent insights from randomised trials and the 'real world'. HEART, 103(13), 977-978. doi:10.1136/heartjnl-2017-311162
Peripheral arterial disease amongst British ethnic minorities in a community based population: The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES)
Vitalis, A., Shantsila, A., Vohra, R. K., Kay, M., Bennett, P. C., Lip, G. Y. H., & Gill, P. S. (2017). Peripheral arterial disease amongst British ethnic minorities in a community based population: The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES). INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 71(7). doi:10.1111/ijcp.12977
Renin-angiotensin blockade in atrial fibrillation: where are we now?
Shahid, F., Lip, G. Y. H., & Shantsila, E. (2017). Renin-angiotensin blockade in atrial fibrillation: where are we now?. JOURNAL OF HUMAN HYPERTENSION, 31(7), 425-426. doi:10.1038/jhh.2017.6
Resting Heart Rate and Ischemic Stroke in Patients with Heart Failure
Nakanishi, K., Di Tullio, M. R., Qian, M., Thompson, J. L. P., Labovitz, A. J., Mann, D. L., . . . Homma, S. (2017). Resting Heart Rate and Ischemic Stroke in Patients with Heart Failure. CEREBROVASCULAR DISEASES, 44(1-2), 43-50. doi:10.1159/000474958
Risk Stratification Models in Atrial Fibrillation
Shahid, F., & Lip, G. Y. H. (2017). Risk Stratification Models in Atrial Fibrillation. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 43(5), 505-513. doi:10.1055/s-0036-1597285
Stroke prevention in atrial fibrillation: Past, present and future.
Lip, G. Y. H., Freedman, B., De Caterina, R., & Potpara, T. S. (2017). Stroke prevention in atrial fibrillation: Past, present and future.. Thrombosis and haemostasis, 117(7), 1230-1239. doi:10.1160/th16-11-0876
Viewpoint: Stroke Prevention in Recent Guidelines for the Management of Patients with Atrial Fibrillation: An Appraisal
Potpara, T. S., Lip, G. Y. H., Blomstrom-Lundqvist, C., Chiang, C. -E., & Camm, A. J. (2017). Viewpoint: Stroke Prevention in Recent Guidelines for the Management of Patients with Atrial Fibrillation: An Appraisal. AMERICAN JOURNAL OF MEDICINE, 130(7), 773-779. doi:10.1016/j.amjmed.2017.02.026
Microvesicles in vascular homeostasis and diseases Position Paper of the European Society of Cardiology (ESC) Working Group on Atherosclerosis and Vascular Biology
Ridger, V. C., Boulanger, C. M., Angelillo-Scherrer, A., Badimon, L., Blanc-Brude, O., Bochaton-Piallat, M. -L., . . . Harrison, P. (2017). Microvesicles in vascular homeostasis and diseases Position Paper of the European Society of Cardiology (ESC) Working Group on Atherosclerosis and Vascular Biology. THROMBOSIS AND HAEMOSTASIS, 117(7), 1296-1316. doi:10.1160/TH16-12-0943
Stroke prevention in atrial fibrillation: Past, present and future Comparing the guidelines and practical decision-making
Lip, G. Y. H., Freedman, B., De Caterina, R., & Potpara, T. S. (2017). Stroke prevention in atrial fibrillation: Past, present and future Comparing the guidelines and practical decision-making. THROMBOSIS AND HAEMOSTASIS, 117(7), 1230-1239. doi:10.1160/TH16-11-0876
Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients
Rivera-Caravaca, J. M., Roldan, V., Asuncion Esteve-Pastor, M., Valdes, M., Vicente, V., Lip, G. Y. H., & Marin, F. (2017). Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients. THROMBOSIS AND HAEMOSTASIS, 117(7), 1448-1454. doi:10.1160/TH16-12-0961
Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention?
Kuo, L., Chao, T. -F., Liu, C. -J., Lin, Y. -J., Chang, S. -L., Lo, L. -W., . . . Chen, S. -A. (2017). Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention?. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 6(6). doi:10.1161/JAHA.116.005307
Granular shape memory ceramic packings
Yu, H. Z., Hassani-Gangaraj, M., Du, Z., Gan, C. L., & Schuh, C. A. (2017). Granular shape memory ceramic packings. Acta Materialia, 132, 455-466. doi:10.1016/j.actamat.2017.04.057
Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis
Niessner, A., Tamargo, J., Morais, J., Koller, L., Wassmann, S., Husted, S. E., . . . Agewall, S. (2017). Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis. EUROPEAN HEART JOURNAL, 38(22), 1710-1U99. doi:10.1093/eurheartj/ehv676
Update in General Internal Medicine (vol 131, pg 199, 1999)
Lip, G. Y., Keshishian, A., Kamble, S., Pan, X., Mardekian, J., & Horblyuk, R. (2017). Update in General Internal Medicine (vol 131, pg 199, 1999). ANNALS OF INTERNAL MEDICINE, 166(11), 856. doi:10.7326/M17-0898
Evaluating adherence to non-vitamin-K antagonist oral anticoagulants in post-approval observational studies of patients with atrial fibrillation
Potpara, T. S., Boriani, G., & Lip, G. Y. H. (2017). Evaluating adherence to non-vitamin-K antagonist oral anticoagulants in post-approval observational studies of patients with atrial fibrillation. CURRENT MEDICAL RESEARCH AND OPINION, 33(6), 1175-1177. doi:10.1080/03007995.2017.1313210
Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in "real-world" clinical practice
Li, X., Deitelzweig, S., Keshishian, A., Hamilton, M., Horblyuk, R., Gupta, K., . . . Lip, G. Y. H. (2017). Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in "real-world" clinical practice. THROMBOSIS AND HAEMOSTASIS, 117(6), 1072-1082. doi:10.1160/TH17-01-0068
Atrial Fibrillation and End Stage Renal Failure in Patients Receiving Dialysis: Balancing the Risks and Benefits of Stroke Prevention
Voukalis, C., & Lip, G. Y. H. (2017). Atrial Fibrillation and End Stage Renal Failure in Patients Receiving Dialysis: Balancing the Risks and Benefits of Stroke Prevention. CANADIAN JOURNAL OF CARDIOLOGY, 33(6), 705-707. doi:10.1016/j.cjca.2017.02.010
CHA<sub>2</sub>DS<sub>2</sub> - VASc Score (Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65-74, Female) for Stroke in Asian Patients With Atrial Fibrillation A Korean Nationwide Sample Cohort Study
Kim, T. -H., Yang, P. -S., Uhm, J. -S., Kim, J. -Y., Pak, H. -N., Lee, M. -H., . . . Lip, G. Y. H. (2017). CHA<sub>2</sub>DS<sub>2</sub> - VASc Score (Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65-74, Female) for Stroke in Asian Patients With Atrial Fibrillation A Korean Nationwide Sample Cohort Study. STROKE, 48(6), 1524-+. doi:10.1161/STROKEAHA.117.016926
Drug-induced liver injury with oral anticoagulants: a threat or not?
Potpara, T. S., & Lip, G. Y. H. (2017). Drug-induced liver injury with oral anticoagulants: a threat or not?. HEART, 103(11), 809-811. doi:10.1136/heartjnl-2016-310983
Geographical differences in thromboembolic and bleeding risks in patients with non-valvular atrial fibrillation: An ancillary analysis from the SPORTIF trials
Proietti, M., & Lip, G. Y. H. (2017). Geographical differences in thromboembolic and bleeding risks in patients with non-valvular atrial fibrillation: An ancillary analysis from the SPORTIF trials. INTERNATIONAL JOURNAL OF CARDIOLOGY, 236, 244-248. doi:10.1016/j.ijcard.2017.02.127
Hypertension and cardiac arrhythmias: a consensus document fromthe European Heart RhythmAssociation (EHRA) and ESC Council on Hypertension, endorsed by the Heart RhythmSociety (HRS), Asia-Pacific Heart RhythmSociety (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE)
Lip, G. Y. H., Coca, A., Kahan, T., Boriani, G., Manolis, A. S., Olsen, M. H., . . . Field, M. (2017). Hypertension and cardiac arrhythmias: a consensus document fromthe European Heart RhythmAssociation (EHRA) and ESC Council on Hypertension, endorsed by the Heart RhythmSociety (HRS), Asia-Pacific Heart RhythmSociety (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE). EUROPACE, 19(6), 891-911. doi:10.1093/europace/eux091
Impact of aerobic fitness on cerebral blood flow and cerebral vascular responsiveness to CO<sub>2</sub> in young and older men
Braz, I. D., Fluck, D., Lip, G. Y. H., Lundby, C., & Fisher, J. P. (2017). Impact of aerobic fitness on cerebral blood flow and cerebral vascular responsiveness to CO<sub>2</sub> in young and older men. SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS, 27(6), 634-642. doi:10.1111/sms.12674
Malignant Hypertension Revisited-Does This Still Exist?
Shantsila, A., & Lip, G. Y. H. (2017). Malignant Hypertension Revisited-Does This Still Exist?. AMERICAN JOURNAL OF HYPERTENSION, 30(6), 543-549. doi:10.1093/ajh/hpx008
RIVAROXABAN VS. DABIGATRAN OR WARFARIN IN REAL-WORLD OBSERVATIONAL STUDIES OF STROKE PREVENTION IN ATRIAL FIBRILLATION: SYSTEMATIC REVIEW AND META-ANALYSIS
Bai, Y., Deng, H., Shantsila, A., & Lip, G. Y. H. (2017). RIVAROXABAN VS. DABIGATRAN OR WARFARIN IN REAL-WORLD OBSERVATIONAL STUDIES OF STROKE PREVENTION IN ATRIAL FIBRILLATION: SYSTEMATIC REVIEW AND META-ANALYSIS. In HEART Vol. 103 (pp. A36-A37). doi:10.1136/heartjnl-2017-311726.44
Response by Bai et al to Letter Regarding Article, "Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis"
Bai, Y., Shantsila, A., & Lip, G. Y. H. (2017). Response by Bai et al to Letter Regarding Article, "Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis". STROKE, 48(6), E149. doi:10.1161/STROKEAHA.117.017460
Synergic impact of oral anticoagulation control and renal function in determining major adverse events in atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the AFCAS registry
Proietti, M., Airaksinen, K. E. J., Rubboli, A., Schlitt, A., Kiviniemi, T., Karjalainen, P. P., & Lip, G. Y. H. (2017). Synergic impact of oral anticoagulation control and renal function in determining major adverse events in atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the AFCAS registry. CLINICAL RESEARCH IN CARDIOLOGY, 106(6), 420-427. doi:10.1007/s00392-016-1071-0
Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis
Halvorsen, S., Storey, R. F., Rocca, B., Sibbing, D., ten Berg, J., Grove, E. L., . . . Huber, K. (2017). Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis. EUROPEAN HEART JOURNAL, 38(19), 1455-1462C. doi:10.1093/eurheartj/ehw454
Screening for Atrial Fibrillation A Report of the AF-SCREEN International Collaboration
Freedman, B., Camm, J., Calkins, H., Healey, J. S., Rosenqvist, M., Wang, J., . . . Yan, B. P. (2017). Screening for Atrial Fibrillation A Report of the AF-SCREEN International Collaboration. CIRCULATION, 135(19), 1851-+. doi:10.1161/CIRCULATIONAHA.116.026693
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
Sabatine, M. S., Giugliano, R. P., Keech, A. C., Honarpour, N., Wiviott, S. D., Murphy, S. A., . . . FOURIER Steering Committee and Investigators. (2017). Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.. The New England journal of medicine, 376(18), 1713-1722. doi:10.1056/nejmoa1615664
'Real-world' atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase
Proietti, M., Laroche, C., Opolski, G., Maggioni, A. P., Boriani, G., & Lip, G. Y. H. (2017). 'Real-world' atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase. EUROPACE, 19(5), 722-733. doi:10.1093/europace/euw112
Death and thrombo-embolic risk after ablation of atrial flutter compared with atrial fibrillation: a nationwide cohort study
Vadmann, H., Gorst-Rasmussen, A., Hjortshoj, S. P., Riahi, S., Lip, G. Y. H., & Larsen, T. B. (2017). Death and thrombo-embolic risk after ablation of atrial flutter compared with atrial fibrillation: a nationwide cohort study. EUROPACE, 19(5), 838-842. doi:10.1093/europace/euw107
Does Reader Performance with Digital Breast Tomosynthesis Vary according to Experience with Two-dimensional Mammography?
Tucker, L., Gilbert, F. J., Astley, S. M., Dibden, A., Seth, A., Morel, J., . . . Stoner, K. (2017). Does Reader Performance with Digital Breast Tomosynthesis Vary according to Experience with Two-dimensional Mammography?. RADIOLOGY, 283(2), 371-380. doi:10.1148/radiol.2017151936
Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study
Larsen, T. B., Skjoth, F., Kjaeldgaard, J. N., Lip, G. Y. H., Nielsen, P. B., & Sogaard, M. (2017). Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study. LANCET HAEMATOLOGY, 4(5), E237-E244. doi:10.1016/S2352-3026(17)30054-6
New-onset atrial fibrillation after percutaneous coronary intervention with stent: Updated proposal of an algorithm for the choice of oral anticoagulant and its dose
Rubboli, A., Agewall, S., Huber, K., & Lip, G. Y. H. (2017). New-onset atrial fibrillation after percutaneous coronary intervention with stent: Updated proposal of an algorithm for the choice of oral anticoagulant and its dose. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 40, E11-E12. doi:10.1016/j.ejim.2017.01.003
Patients' experiences of atrial fibrillation and non-vitamin K antagonist oral anticoagulants (NOACs), and their educational needs: A qualitative study
Clarkesmith, D. E., Lip, G. Y. H., & Lane, D. A. (2017). Patients' experiences of atrial fibrillation and non-vitamin K antagonist oral anticoagulants (NOACs), and their educational needs: A qualitative study. THROMBOSIS RESEARCH, 153, 19-27. doi:10.1016/j.thromres.2017.03.002
Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care
Lane, D. A., Skjoth, F., Lip, G. Y. H., Larsen, T. B., & Kotecha, D. (2017). Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care. Journal of the American Heart Association, 6(5). doi:10.1161/JAHA.116.005155
Retinal vessel diameters and reactivity in diabetes mellitus and/or cardiovascular disease
Heitmar, R., Lip, G. Y. H., Ryder, R. E., & Blann, A. D. (2017). Retinal vessel diameters and reactivity in diabetes mellitus and/or cardiovascular disease. CARDIOVASCULAR DIABETOLOGY, 16. doi:10.1186/s12933-017-0534-6
Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.
Ridker, P. M., Revkin, J., Amarenco, P., Brunell, R., Curto, M., Civeira, F., . . . SPIRE Cardiovascular Outcome Investigators. (2017). Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.. The New England journal of medicine, 376(16), 1527-1539. doi:10.1056/nejmoa1701488
Pulmonary Embolism and Atrial Fibrillation: Two Sides of the Same Coin? A Systematic Review (vol 43, pg 849, 2017)
Bikdeli, B., Abou Ziki, M. D., & Lip, G. Y. H. (2017). Pulmonary Embolism and Atrial Fibrillation: Two Sides of the Same Coin? A Systematic Review (vol 43, pg 849, 2017). SEMINARS IN THROMBOSIS AND HEMOSTASIS, 43(8), E1. doi:10.1055/s-0037-1602761
Risk and Prediction of Sudden Cardiac Death and Ventricular Arrhythmias for Patients with Atrial Fibrillation - A Nationwide Cohort Study
Chao, T. -F., Liu, C. -J., Tuan, T. -C., Chen, S. -J., Chen, T. -J., Lip, G. Y. H., & Chen, S. -A. (2017). Risk and Prediction of Sudden Cardiac Death and Ventricular Arrhythmias for Patients with Atrial Fibrillation - A Nationwide Cohort Study. SCIENTIFIC REPORTS, 7. doi:10.1038/srep46445
Guideline: ACP and AAFP recommend systolic BP targets based on history and risk level in adults ≥ 60 years of age
Shantsila, A., & Lip, G. Y. H. (2017). Guideline: ACP and AAFP recommend systolic BP targets based on history and risk level in adults ≥ 60 years of age. ANNALS OF INTERNAL MEDICINE, 166(8), JC38. doi:10.7326/ACPJC-2017-166-8-038
Relation of Stroke and Major Bleeding to Creatinine Clearance in Patients With Atrial Fibrillation (from the Fushimi AF Registry)
Abe, M., Ogawa, H., Ishii, M., Masunaga, N., Esato, M., Chun, Y. -H., . . . Akao, M. (2017). Relation of Stroke and Major Bleeding to Creatinine Clearance in Patients With Atrial Fibrillation (from the Fushimi AF Registry). AMERICAN JOURNAL OF CARDIOLOGY, 119(8), 1229-1237. doi:10.1016/j.amjcard.2017.01.005
Ethnic differences in the prevalence of peripheral arterial disease: a systematic review and meta-analysis
Vitalis, A., Lip, G. Y. H., Kay, M., Vohra, R. K., & Shantsil, A. (2017). Ethnic differences in the prevalence of peripheral arterial disease: a systematic review and meta-analysis. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 15(4), 327-338. doi:10.1080/14779072.2017.1305890
'Real-world' atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (vol 19, pg 722, 2017)
Proietti, M., Laroche, C., Opolski, G., Maggioni, A. P., Boriani, G., & Lip, G. Y. H. (2017). 'Real-world' atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (vol 19, pg 722, 2017). EUROPACE, 19(4), 543. doi:10.1093/europace/euw443
Clinical Features and Prognosis in Patients with Atrial Fibrillation and Prior Stroke: Comparing the Fushimi and Darlington AF Registries
Ogawa, H., Senoo, K., An, Y., Shantsila, A., Shantsila, E., Lane, D. A., . . . Lip, G. Y. H. (2017). Clinical Features and Prognosis in Patients with Atrial Fibrillation and Prior Stroke: Comparing the Fushimi and Darlington AF Registries. EBIOMEDICINE, 18, 199-203. doi:10.1016/j.ebiom.2017.03.022
Decision-making interventions to stop the global atrial fibrillation-related stroke tsunami
Cerasuolo, J. O., Montero-Odasso, M., Ibanez, A., Doocy, S., Lip, G. Y. H., & Sposato, L. A. (2017). Decision-making interventions to stop the global atrial fibrillation-related stroke tsunami. INTERNATIONAL JOURNAL OF STROKE, 12(3), 222-228. doi:10.1177/1747493016687579
Efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in Chinese patients with atrial fibrillation: the Hong Kong Atrial Fibrillation Project
Li, W. -H., Huang, D., Chiang, C. -E., Lau, C. -P., Tse, H. -F., Chan, E. W., . . . Siu, C. -W. (2017). Efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in Chinese patients with atrial fibrillation: the Hong Kong Atrial Fibrillation Project. CLINICAL CARDIOLOGY, 40(4), 222-229. doi:10.1002/clc.22649
Gastrointestinal Bleeding and Direct Oral Anticoagulants Amongst Patients With Atrial Fibrillation in the "Real World"
Mazurek, M., & Lip, G. Y. H. (2017). Gastrointestinal Bleeding and Direct Oral Anticoagulants Amongst Patients With Atrial Fibrillation in the "Real World". GASTROENTEROLOGY, 152(5), 932-934. doi:10.1053/j.gastro.2017.02.027
Is There an Obesity Paradox for Outcomes in Atrial Fibrillation? A Systematic Review and Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulant Trials
Proietti, M., Guiducci, E., Cheli, P., & Lip, G. Y. H. (2017). Is There an Obesity Paradox for Outcomes in Atrial Fibrillation? A Systematic Review and Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulant Trials. STROKE, 48(4), 857-866. doi:10.1161/STROKEAHA.116.015984
Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation
Nielsen, P. B., Larsen, T. B., Skjoth, F., & Lip, G. Y. H. (2017). Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation. JAMA INTERNAL MEDICINE, 177(4), 563-570. doi:10.1001/jamainternmed.2016.9369
Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation
Bai, Y., Deng, H., Shantsila, A., & Lip, G. Y. H. (2017). Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation. Stroke, 48(4), 970-976. doi:10.1161/STROKEAHA.116.016275
Self-reported physical activity and major adverse events in patients with atrial fibrillation: a report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry
Proietti, M., Boriani, G., Laroche, C., Diemberger, I., Popescu, M. I., Rasmussen, L. H., . . . Lip, G. Y. H. (2017). Self-reported physical activity and major adverse events in patients with atrial fibrillation: a report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry. EUROPACE, 19(4), 535-543. doi:10.1093/europace/euw150
Association Between Dabigatran vs Warfarin and Risk of Osteoporotic Fractures Among Patients With Nonvalvular Atrial Fibrillation
Lau, W. C. Y., Chan, E. W., Cheung, C. -L., Sing, C. W., Man, K. K. C., Lip, G. Y. H., . . . Wong, I. C. K. (2017). Association Between Dabigatran vs Warfarin and Risk of Osteoporotic Fractures Among Patients With Nonvalvular Atrial Fibrillation. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 317(11), 1151-1158. doi:10.1001/jama.2017.1363
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1
Diener, H. -C., Aisenberg, J., Ansell, J., Atar, D., Breithardt, G., Eikelboom, J., . . . Lip, G. Y. H. (2017). Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1. EUROPEAN HEART JOURNAL, 38(12), 852-859B. doi:10.1093/eurheartj/ehv643
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2
Diener, H. -C., Aisenberg, J., Ansell, J., Atar, D., Breithardt, G., Eikelboom, J., . . . Lip, G. Y. H. (2017). Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. EUROPEAN HEART JOURNAL, 38(12), 860-868. doi:10.1093/eurheartj/ehw069
Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark
Gadsboll, K., Staerk, L., Fosbol, E. L., Sindet-Pedersen, C., Gundlund, A., Lip, G. Y. H., . . . Olesen, J. B. (2017). Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark. EUROPEAN HEART JOURNAL, 38(12), 899-906. doi:10.1093/eurheartj/ehw658
Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study
Staerk, L., Fosbol, E. L., Lip, G. Y. H., Lamberts, M., Bonde, A. N., Torp-Pedersen, C., . . . Olesen, J. B. (2017). Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study. EUROPEAN HEART JOURNAL, 38(12), 907-915. doi:10.1093/eurheartj/ehw496
Postapproval Observational Studies of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation
Potpara, T. S., & Lip, G. Y. H. (2017). Postapproval Observational Studies of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 317(11), 1115-1116. doi:10.1001/jama.2017.1152
Carotid plaque detection improves the predictive value of CHA<sub>2</sub>DS<sub>2</sub>-VASc score in patients with non-valvular atrial fibrillation: The ARAPACIS Study
Basili, S., Loffredo, L., Pastori, D., Proietti, M., Farcomeni, A., Vestri, A. R., . . . Violi, F. (2017). Carotid plaque detection improves the predictive value of CHA<sub>2</sub>DS<sub>2</sub>-VASc score in patients with non-valvular atrial fibrillation: The ARAPACIS Study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 231, 143-149. doi:10.1016/j.ijcard.2017.01.001
Atrial Fibrillation in the Elderly
Fumagalli, S., Gabbai, D., Padeletti, L., Crijns, H. J., & Lip, G. Y. H. (2017). Atrial Fibrillation in the Elderly. In Cardiac Management in the Frail Elderly Patient and the Oldest Old (pp. 149-163). Springer International Publishing. doi:10.1007/978-3-319-43468-1_12
REPLY: Apixaban Dosing in Chronic Kidney Disease Differences Between US and EU Labeling
Proietti, M., & Lip, G. Y. H. (2017). REPLY: Apixaban Dosing in Chronic Kidney Disease Differences Between US and EU Labeling. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 69(9), 1212. doi:10.1016/j.jacc.2016.11.075
Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials
Abdul-Rahim, A. H., Perez, A. -C., MacIsaac, R. L., Jhund, P. S., Claggett, B. L., Carson, P. E., . . . McMurray, J. J. V. (2017). Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials. EUROPEAN HEART JOURNAL, 38(10), 742-750. doi:10.1093/eurheartj/ehw509
Applicability of the modified CHA<sub>2</sub>DS<sub>2</sub>-VASc score for stroke risk stratification in Caucasian atrial fibrillation patients
Garcia-Fernandez, A., Roldan, V., Rivera-Caravaca, J. M., Lip, G. Y. H., & Marin, F. (2017). Applicability of the modified CHA<sub>2</sub>DS<sub>2</sub>-VASc score for stroke risk stratification in Caucasian atrial fibrillation patients. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 38, E21-E22. doi:10.1016/j.ejim.2016.11.006
Balancing thromboembolic and bleeding risk with non-vitamin K antagonist oral anticoagulants (NOACs): A systematic review and meta-analysis on gender differences
Proietti, M., Cheli, P., Basili, S., Mazureka, M., & Lip, G. Y. H. (2017). Balancing thromboembolic and bleeding risk with non-vitamin K antagonist oral anticoagulants (NOACs): A systematic review and meta-analysis on gender differences. PHARMACOLOGICAL RESEARCH, 117, 274-282. doi:10.1016/j.phrs.2017.01.004
Current Understanding of Atherogenesis
Brown, R. A., Shantsila, E., Varma, C., & Lip, G. Y. H. (2017). Current Understanding of Atherogenesis. AMERICAN JOURNAL OF MEDICINE, 130(3), 268-282. doi:10.1016/j.amjmed.2016.10.022
European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE)
Katritsis, D. G., Boriani, G., Cosio, F. G., Hindricks, G., Jais, P., Josephson, M. E., . . . Rickard, J. (2017). European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE). EUROPACE, 19(3), 465-511. doi:10.1093/europace/euw301
INCIDENT ATRIAL FIBRILLATION ACCORDING TO GENDER IN PATIENTS WITH ISCHEMIC STROKE: A NATIONWIDE COHORT STUDY
Fauchier, L., Bisson, A., Angoulvant, D., Clementy, N., Babuty, D., & Lip, G. (2017). INCIDENT ATRIAL FIBRILLATION ACCORDING TO GENDER IN PATIENTS WITH ISCHEMIC STROKE: A NATIONWIDE COHORT STUDY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 69 (pp. 367). doi:10.1016/S0735-1097(17)33756-7
INCREASED RATE OF PREVIOUS STROKE IN ASYMPTOMATIC/MINIMALLY SYMPTOMATIC VERSUS SYMPTOMATIC PATIENTS WITH NEWLY DETECTED ATRIAL FIBRILLATION WORLDWIDE: RESULTS FROM THE GLORIA-AF REGISTRY
Christow, S., Seidl, K., Diener, H. -C., Huisman, M., Lip, G., Rauch-Kroenert, U., . . . Senges, J. (2017). INCREASED RATE OF PREVIOUS STROKE IN ASYMPTOMATIC/MINIMALLY SYMPTOMATIC VERSUS SYMPTOMATIC PATIENTS WITH NEWLY DETECTED ATRIAL FIBRILLATION WORLDWIDE: RESULTS FROM THE GLORIA-AF REGISTRY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 69 (pp. 450). doi:10.1016/S0735-1097(17)33839-1
PERSISTENCE WITH THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION: THE GLORIA-AF REGISTRY
Paquette, M., Huisman, M., Lip, G., Diener, H. -C., Dubner, S., Halperin, J., . . . Nieuwlaat, R. (2017). PERSISTENCE WITH THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION: THE GLORIA-AF REGISTRY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 69 (pp. 374). doi:10.1016/S0735-1097(17)33763-4
PREDICTORS OF ANTICOAGULANT PRESCRIPTION IN PATIENTS WITH ATRIAL FIBRILLATION IN NORTH AMERICA: THE GLORIA-AF REGISTRY
McIntyre, W. F., Conen, D., Olshansky, B., Halperin, J., Hayek, E., Huisman, M., . . . Healey, J. (2017). PREDICTORS OF ANTICOAGULANT PRESCRIPTION IN PATIENTS WITH ATRIAL FIBRILLATION IN NORTH AMERICA: THE GLORIA-AF REGISTRY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 69 (pp. 413). doi:10.1016/S0735-1097(17)33802-0
PREDICTORS OF INCIDENT ATRIAL FIBRILLATION IN PATIENTS WITH ISCHEMIC STROKE: A NATIONWIDE COHORT STUDY
Fauchier, L., Bisson, A., Angoulvant, D., Clementy, N., Babuty, D., & Lip, G. (2017). PREDICTORS OF INCIDENT ATRIAL FIBRILLATION IN PATIENTS WITH ISCHEMIC STROKE: A NATIONWIDE COHORT STUDY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 69 (pp. 328). doi:10.1016/S0735-1097(17)33717-8
Predicting Unsuccessful Electrical Cardioversion for Acute Atrial Fibrillation (from the AF-CVS Score)
Jaakkola, S., Lip, G. Y. H., Biancari, F., Nuotio, I., Hartikainen, J. E. K., Ylitalo, A., & Airaksinen, K. E. J. (2017). Predicting Unsuccessful Electrical Cardioversion for Acute Atrial Fibrillation (from the AF-CVS Score). AMERICAN JOURNAL OF CARDIOLOGY, 119(5), 749-752. doi:10.1016/j.amjcard.2016.11.026
Prognosis in patients with atrial fibrillation and a presumed "temporary cause" in a community-based cohort study
Fauchier, L., Clementy, N., Bisson, A., Stamboul, K., Ivanes, F., Angoulvant, D., . . . Lip, G. Y. H. (2017). Prognosis in patients with atrial fibrillation and a presumed "temporary cause" in a community-based cohort study. CLINICAL RESEARCH IN CARDIOLOGY, 106(3), 202-210. doi:10.1007/s00392-016-1040-7
RATES OF STROKE AND BLEEDING WITH DABIGATRAN 150 AND 110 MG BID IN CLINICAL PRACTICE: THE GLORIA-AF REGISTRY
Lip, G., Huisman, M., Diener, H. -C., Dubner, S., Ma, C., Rothman, K., . . . Halperin, J. (2017). RATES OF STROKE AND BLEEDING WITH DABIGATRAN 150 AND 110 MG BID IN CLINICAL PRACTICE: THE GLORIA-AF REGISTRY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 69 (pp. 541). doi:10.1016/S0735-1097(17)33930-X
Renal dysfunction and diastolic impairment among British ethnic minorities with hypertension: the Ethnic-Echocardiographic Heart of England Screening Study
Shantsila, A., Shantsila, E., Gill, P. S., & Lip, G. Y. H. (2017). Renal dysfunction and diastolic impairment among British ethnic minorities with hypertension: the Ethnic-Echocardiographic Heart of England Screening Study. JOURNAL OF HUMAN HYPERTENSION, 31(3), 206-211. doi:10.1038/jhh.2016.68
Reply
Voukalis, C., Shantsila, E., & Lip, G. Y. H. (2017). Reply. Journal of the Royal College of Physicians of Edinburgh, 47(2), 205-206. doi:10.1177/1478271520174702003
The wearable cardioverter-defibrillator: current technology and evolving indications.
Reek, S., Burri, H., Roberts, P. R., Perings, C., Epstein, A. E., Klein, H. U., . . . Savelieva, I. (2017). The wearable cardioverter-defibrillator: current technology and evolving indications.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 19(3), 335-345. doi:10.1093/europace/euw180
High-Density 3D-Boron Nitride and 3D-Graphene for High-Performance Nano-Thermal Interface Material.
Loeblein, M., Tsang, S. H., Pawlik, M., Phua, E. J. R., Yong, H., Zhang, X. W., . . . Teo, E. H. T. (2017). High-Density 3D-Boron Nitride and 3D-Graphene for High-Performance Nano-Thermal Interface Material.. ACS nano, 11(2), 2033-2044. doi:10.1021/acsnano.6b08218
Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes (vol 6, 30271, 2016)
Boriani, G., Laroche, C., Diemberger, I., Popescu, M. I., Rasmussen, L. H., Petrescu, L., . . . Lip, G. Y. H. (2017). Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes (vol 6, 30271, 2016). SCIENTIFIC REPORTS, 7. doi:10.1038/srep42379
A halogen-free epoxy with intrinsic flame retardance for use in electronic packaging
Lim, S. K. J., Phua, J. R. E., Bai, Y., Hu, X., & Gan, C. L. (2016). A halogen-free epoxy with intrinsic flame retardance for use in electronic packaging. In 2016 IEEE 18th Electronics Packaging Technology Conference (EPTC) (pp. 337-341). IEEE. doi:10.1109/eptc.2016.7861500
The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2
Huisman, M. V., Rothman, K. J., Paquette, M., Teutsch, C., Diener, H. -C., Dubner, S. J., . . . Investigators, G. L. O. R. I. A. -A. F. (2017). The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 69(7), 777-785. doi:10.1016/j.jacc.2016.11.061
Effect of Reduced Renal Function on Time in Therapeutic Range Among Anticoagulated Atrial Fibrillation Patients
Bonde, A. N., Lip, G. Y. H., Kamper, A. -L., Staerk, L., Torp-Pedersen, C., Gislason, G. H., & Olesen, J. B. (2017). Effect of Reduced Renal Function on Time in Therapeutic Range Among Anticoagulated Atrial Fibrillation Patients. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 69(6), 752-753. doi:10.1016/j.jacc.2016.11.031
Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
Nielsen, P. B., Skjoth, F., Sogaard, M., Kjaeldgaard, J. N., Lip, G. Y. H., & Larsen, T. B. (2017). Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study. BMJ-BRITISH MEDICAL JOURNAL, 356. doi:10.1136/bmj.j510
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., . . . Cooney, M. -T. (2017). 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.. Revista espanola de cardiologia (English ed.), 70(2), 115. doi:10.1016/j.rec.2017.01.002
Atrial high-rate episodes and stroke prevention
Camm, A. J., Simantirakis, E., Goette, A., Lip, G. Y. H., Vardas, P., Calvert, M., . . . Kirchhof, P. (2017). Atrial high-rate episodes and stroke prevention. EUROPACE, 19(2), 169-179. doi:10.1093/europace/euw279
Cerebrovascular disease, associated risk factors and antithrombotic therapy in a population screening cohort: Insights from the Belgian Heart Rhythm Week programme
Proietti, M., Mairesse, G. H., Goethals, P., Scavee, C., Vijgen, J., Blankoff, I., . . . Lip, G. Y. H. (2017). Cerebrovascular disease, associated risk factors and antithrombotic therapy in a population screening cohort: Insights from the Belgian Heart Rhythm Week programme. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 24(3), 328-334. doi:10.1177/2047487316682349
Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor
Potpara, T. S., Dagres, N., Mujovic, N., Vasic, D., Asanin, M., Nedeljkovic, M., . . . Lip, G. Y. H. (2017). Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor. ADVANCES IN THERAPY, 34(2), 357-377. doi:10.1007/s12325-016-0458-7
European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS)
Gorenek, B., Pelliccia, A., Benjamin, E. J., Boriani, G., Crijns, H. J., Fogel, R. I., . . . Abreu, A. (2017). European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). EUROPACE, 19(2), 190-225. doi:10.1093/europace/euw242
Increased sympathetic nerve activity and reduced cardiac baroreflex sensitivity in rheumatoid arthritis
Adlan, A. M., Paton, J. F. R., Lip, G. Y. H., Kitas, G. D., & Fisher, J. P. (2017). Increased sympathetic nerve activity and reduced cardiac baroreflex sensitivity in rheumatoid arthritis. JOURNAL OF PHYSIOLOGY-LONDON, 595(3), 967-981. doi:10.1113/JP272944
Ischemic stroke risk in East Asian patients with CHA<sub>2</sub>DS<sub>2</sub>-VASc score of 1: systematic review and meta-analysis
Bai, Y., Shantsila, A., & Lip, G. Y. H. (2017). Ischemic stroke risk in East Asian patients with CHA<sub>2</sub>DS<sub>2</sub>-VASc score of 1: systematic review and meta-analysis. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 15(2), 145-150. doi:10.1080/14779072.2017.1281742
Registries in Atrial Fibrillation: From Trials to Real-Life Clinical Practice
Mazurek, M., Huisman, M. V., & Lip, G. Y. H. (2017). Registries in Atrial Fibrillation: From Trials to Real-Life Clinical Practice. AMERICAN JOURNAL OF MEDICINE, 130(2), 135-145. doi:10.1016/j.amjmed.2016.09.012
White Matter Hyperintensities Improve Ischemic Stroke Recurrence Prediction
Andersen, S. D., Larsen, T. B., Gorst-Rasmussen, A., Yavarian, Y., Lip, G. Y. H., & Bach, F. W. (2017). White Matter Hyperintensities Improve Ischemic Stroke Recurrence Prediction. CEREBROVASCULAR DISEASES, 43(1-2), 17-24. doi:10.1159/000450962
Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?
Garcia-Fernandez, A., Roldan, V., Rivera-Caravaca, J. M., Hernandez-Romero, D., Valdes, M., Vicente, V., . . . Marin, F. (2017). Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?. SCIENTIFIC REPORTS, 7. doi:10.1038/srep41565
Adherence to oral anticoagulant therapy in patients with atrial fibrillation Focus on non-vitamin K antagonist oral anticoagulants
Raparelli, V., Proietti, M., Cangemi, R., Lip, G. Y. H., Lane, D. A., & Basili, S. (2017). Adherence to oral anticoagulant therapy in patients with atrial fibrillation Focus on non-vitamin K antagonist oral anticoagulants. THROMBOSIS AND HAEMOSTASIS, 117(2), 209-218. doi:10.1160/TH16-10-0757
Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy
Gibson, C. M., Pinto, D. S., Chi, G., Arbetter, D., Yee, M., Mehran, R., . . . Fox, K. A. A. (2017). Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy. CIRCULATION, 135(4), 323-+. doi:10.1161/CIRCULATIONAHA.116.025783
Hypertension and cardiac arrhythmias
Lip, G. Y. H., & Coca, A. (2017). Hypertension and cardiac arrhythmias. EUROPEAN HEART JOURNAL, 38(4), 223-225. doi:10.1093/eurheartj/ehw664
Prediction of very late arrhythmia recurrence after radiofrequency catheter ablation of atrial fibrillation: The MB-LATER clinical score
Mujovic, N., Marinkovic, M., Markovic, N., Shantsila, A., Lip, G. Y. H., & Potpara, T. S. (2017). Prediction of very late arrhythmia recurrence after radiofrequency catheter ablation of atrial fibrillation: The MB-LATER clinical score. SCIENTIFIC REPORTS, 7. doi:10.1038/srep40828
Adding Rigor to Stroke Rate Investigations in Patients With Atrial Fibrillation
Nielsen, P. B., & Lip, G. Y. H. (2017). Adding Rigor to Stroke Rate Investigations in Patients With Atrial Fibrillation. CIRCULATION, 135(3), 220-223. doi:10.1161/CIRCULATIONAHA.116.025944
Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study
Nayarese, E. P., Kolodziejczak, M., Winter, M. -P., Alimohammadi, A., Lang, I. M., Buffon, A., . . . Siller-Matula, J. M. (2017). Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 227, 644-649. doi:10.1016/j.ijcard.2016.10.084
Superelasticity in micro-scale shape memory ceramic particles
Du, Z., Zeng, X. M., Liu, Q., Schuh, C. A., & Gan, C. L. (2017). Superelasticity in micro-scale shape memory ceramic particles. Acta Materialia, 123, 255-263. doi:10.1016/j.actamat.2016.10.047
To occlude or not? Left atrial appendage occlusion for stroke prevention in atrial fibrillation
Mazurek, M., & Lip, G. Y. H. (2017). To occlude or not? Left atrial appendage occlusion for stroke prevention in atrial fibrillation. HEART, 103(2), 93-95. doi:10.1136/heartjnl-2016-310255
Novel Risk Markers and Risk Assessments for Cardiovascular Disease
Thomas, M. R., & Lip, G. Y. H. (2017). Novel Risk Markers and Risk Assessments for Cardiovascular Disease. CIRCULATION RESEARCH, 120(1), 133-149. doi:10.1161/CIRCRESAHA.116.309955
A happy and prosperous New Year 2017 with "Thrombosis and Haemostasis".... and our 60th Anniversary!
Lip, G. Y. H., & Weber, C. (2017). A happy and prosperous New Year 2017 with "Thrombosis and Haemostasis".... and our 60th Anniversary!. THROMBOSIS AND HAEMOSTASIS, 117(1), 1-2. doi:10.1160/TH16-12-0903
Editors' Choice 2016 papers in Thrombosis and Haemostasis
Weber, C., & Lip, G. Y. H. (2017). Editors' Choice 2016 papers in Thrombosis and Haemostasis. THROMBOSIS AND HAEMOSTASIS, 117(1), 204-206. doi:10.1160/TH16-11-0899
2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS.
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., . . . Vardas, P. (2017). 2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS.. Revista espanola de cardiologia (English ed.), 70(1), 50. doi:10.1016/j.rec.2016.11.033
2016 ESC POSITION PAPER ON CANCER TREATMENTS AND CARDIOVASCULAR TOXICITY DEVELOPED UNDER THE AUSPICES OF THE ESC COMMITTEE FOR PRACTICE GUIDELINES
Article, E. (n.d.). 2016 ESC POSITION PAPER ON CANCER TREATMENTS AND CARDIOVASCULAR TOXICITY DEVELOPED UNDER THE AUSPICES OF THE ESC COMMITTEE FOR PRACTICE GUIDELINES. Russian Journal of Cardiology, (3), 105-139. doi:10.15829/1560-4071-2017-3-105-139
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)
Luis Zamorano, J., Lancellotti, P., Rodriguez Munoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., . . . Ringwald, J. (2017). 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). EUROPEAN JOURNAL OF HEART FAILURE, 19(1), 9-42. doi:10.1002/ejhf.654
Anticoagulation control in different ethnic-minority patients receiving vitamin K antagonists for stroke prevention in atrial fibrillation: the west Birmingham AF Project
Zulkifly, H., Cheli, P., Lutchman, I., Bai, Y., Lip, G. Y. H., & Lane, D. A. (2017). Anticoagulation control in different ethnic-minority patients receiving vitamin K antagonists for stroke prevention in atrial fibrillation: the west Birmingham AF Project. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 770-771). Retrieved from https://www.webofscience.com/
Antiplatelet and Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Coronary Stenting.
Dzeshka, M. S., Brown, R. A., Capodanno, D., & Lip, G. Y. H. (2017). Antiplatelet and Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Coronary Stenting.. Interventional cardiology clinics, 6(1), 91-117. doi:10.1016/j.iccl.2016.08.007
Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE)
Lip, G. Y. H., Collet, J. P., de Caterina, R., Fauchier, L., Lane, D. A., Larsen, T. B., . . . Rocca, B. (2017). Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE). THROMBOSIS AND HAEMOSTASIS, 117(12), 2215-2236. doi:10.1160/TH-17-10-0709
Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial
Asuncion Esteve-Pastor, M., Miguel Rivera-Caravaca, J., Shantsila, A., Roldan, V., Lip, G. Y. H., & Marin, F. (2017). Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial. THROMBOSIS AND HAEMOSTASIS, 117(12), 2261-2266. doi:10.1160/TH17-10-0710
Atherothrombotic strokes in NVAF Reply
Voukalis, C., Shantsila, E., & Lip, G. Y. H. (2017). Atherothrombotic strokes in NVAF Reply. JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 47(2), 205-206. Retrieved from https://www.webofscience.com/
Atrial Fibrillation
Kotecha, D., Senoo, K., & Lip, G. Y. H. (2017). Atrial Fibrillation. In Hematology: Basic Principles and Practice (pp. 2152-2158). doi:10.1016/B978-0-323-35762-3.00147-5
Atrial Fibrillation Diagnosis Timing, Ambulatory ECG Monitoring Utilization, and Risk of Recurrent Stroke
Lip, G. Y. H., Hunter, T. D., Quiroz, M. E., Ziegler, P. D., & Turakhia, M. P. (2017). Atrial Fibrillation Diagnosis Timing, Ambulatory ECG Monitoring Utilization, and Risk of Recurrent Stroke. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 10(1). doi:10.1161/CIRCOUTCOMES.116.002864
CLINICAL PORTRAIT OF THE ATRIAL FIBRILLATION PATIENT IN Russian FEDERATION. DATA FROM THE GLOBAL REGISTRY Gloria AF
Shlyakhto, E. V., Ezhov, А. V., Zenin, S. А., Koziolova, N. А., Korennova, О. Y., Novikova, Т. N., . . . Rothman, K. J. (n.d.). CLINICAL PORTRAIT OF THE ATRIAL FIBRILLATION PATIENT IN Russian FEDERATION. DATA FROM THE GLOBAL REGISTRY Gloria AF. Russian Journal of Cardiology, (9), 21-27. doi:10.15829/1560-4071-2017-9-21-27
Cerebrovascular Reactivity in Atrial Fibrillation
Fisher, J. P., Braz, I. D., Lucas, S. J. E., Edwards, L., Van Lieshout, J. J., & Lip, G. Y. H. (2017). Cerebrovascular Reactivity in Atrial Fibrillation. In FASEB JOURNAL Vol. 31. Retrieved from https://www.webofscience.com/
Changes in thromboembolic risk profile and antithrombotic therapy use over a decade: a comparison of Euro Heart Survey on AF and EURObservational research programme AF pilot registry
Proietti, M., Bouvet, P. E., Laroche, C., Nieuwlaat, R., Crijns, H. J. G. M., Maggioni, A. P., . . . Lip, G. Y. H. (2017). Changes in thromboembolic risk profile and antithrombotic therapy use over a decade: a comparison of Euro Heart Survey on AF and EURObservational research programme AF pilot registry. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1220-1221). Retrieved from https://www.webofscience.com/
Characterization of Access vs. Non-Access Site Bleeding Following PCI in Patients With Atrial Fibrillation
Nafee, T., Chi, G., Yee, M. K., Arbetter, D., Pinto, D. S., Mehran, R., . . . Gibson, C. M. (2017). Characterization of Access vs. Non-Access Site Bleeding Following PCI in Patients With Atrial Fibrillation. In CIRCULATION Vol. 136. Retrieved from https://www.webofscience.com/
Circulating biomarkers of fibrosis and cardioversion of atrial fibrillation: A prospective, controlled cohort study
Begg, G. A., Lip, G. Y. H., Plein, S., & Tayebjee, M. H. (2017). Circulating biomarkers of fibrosis and cardioversion of atrial fibrillation: A prospective, controlled cohort study. CLINICAL BIOCHEMISTRY, 50(1-2), 11-15. doi:10.1016/j.clinbiochem.2016.09.008
Clinical predictors of left atrium thrombi in patients scheduled for cardioversion of atrial fibrillation: a subanalysis from the ENSURE-AF study
Merino, J. L., Lip, G. Y. H., Heidbuchel, H., Cohen, A. -A., De Caterina, R., De Groot, J. R., . . . Goette, A. (2017). Clinical predictors of left atrium thrombi in patients scheduled for cardioversion of atrial fibrillation: a subanalysis from the ENSURE-AF study. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1367-1368). Retrieved from https://www.webofscience.com/
Cost-effectiveness analysis of a handheld ECG machine used for a population-wide screening programme: the Belgian Heart Rhythm Week Screening programme
Proietti, M., Farcomeni, A., Goethals, P., Scavee, C., Vijgen, J., Blankoff, I., . . . Lip, G. Y. H. (2017). Cost-effectiveness analysis of a handheld ECG machine used for a population-wide screening programme: the Belgian Heart Rhythm Week Screening programme. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 973-974). Retrieved from https://www.webofscience.com/
Dynamic CHA2DS2-VASc score and risk of ischemic stroke in patients with atrial fibrillation
Chao, T. F., Lip, G. Y. H., & Chen, S. A. (2017). Dynamic CHA2DS2-VASc score and risk of ischemic stroke in patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 774). Retrieved from https://www.webofscience.com/
EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication
Goette, A., Kalman, J. M., Aguinaga, L., Akar, J., Angel Cabrera, J., Chen, S. A., . . . Nattel, S. (2017). EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication. HEART RHYTHM, 14(1), E3-E40. doi:10.1016/j.hrthm.2016.05.028
Effect of procedure and lesion characteristics on bleeding and ischemic outcomes among atrial fibrillation patients undergoing percutaneous coronary intervention: results from the PIONEER AF-PCI trial
Chi, G., Korjian, S., Daaboul, Y., Nafee, T., Mehran, R., Bode, C., . . . Gibson, C. M. (2017). Effect of procedure and lesion characteristics on bleeding and ischemic outcomes among atrial fibrillation patients undergoing percutaneous coronary intervention: results from the PIONEER AF-PCI trial. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1290). Retrieved from https://www.webofscience.com/
Effectiveness and Safety of Apixaban Compared to Other Oral Anticoagulants Among Non-Valvular Atrial Fibrillation Patients With Coronary Artery Disease or Peripheral Arterial Disease: A Propensity Score Matched Analysis of Four Large Databases
Lip, G. Y., Keshishian, A., Li, X., Hamilton, M., Masseria, C., Gupta, K., . . . Deitelzweig, S. (2017). Effectiveness and Safety of Apixaban Compared to Other Oral Anticoagulants Among Non-Valvular Atrial Fibrillation Patients With Coronary Artery Disease or Peripheral Arterial Disease: A Propensity Score Matched Analysis of Four Large Databases. In CIRCULATION Vol. 136. Retrieved from https://www.webofscience.com/
Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Among Non-Valvular Atrial Fibrillation Patients: A Propensity Score Matched Analysis of Four Large Databases
Deitelzweig, S., Keshishian, A., Li, X., Hamilton, M., Masseria, C., Gupta, K., . . . Lip, G. Y. (2017). Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Among Non-Valvular Atrial Fibrillation Patients: A Propensity Score Matched Analysis of Four Large Databases. In CIRCULATION Vol. 136. Retrieved from https://www.webofscience.com/
Effectiveness and safety of apixaban versus warfarin among high-risk subgroups of non-valvular atrial fibrillation patients: a propensity score matched analysis
Li, X., Deitelzweig, S., Keshishian, A., Hamilton, M., Horblyuk, R., Gupta, K., . . . Lip, G. Y. H. (2017). Effectiveness and safety of apixaban versus warfarin among high-risk subgroups of non-valvular atrial fibrillation patients: a propensity score matched analysis. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 767). Retrieved from https://www.webofscience.com/
Effectiveness and safety of standard and lower dose apixaban compared to warfarin in non-valvular atrial fibrillation patients: a propensity score matched analysis
Li, X., Lip, G. Y. H., Keshishian, A., Hamilton, M., Horblyuk, R., Gupta, K., . . . Deitelzweig, S. (2017). Effectiveness and safety of standard and lower dose apixaban compared to warfarin in non-valvular atrial fibrillation patients: a propensity score matched analysis. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 772). Retrieved from https://www.webofscience.com/
Effects of morning versus evening statin therapy on lipid profile: a systematic review and meta-analysis
Awad, K., Serban, M. G., Penson, P., Mikhailidis, D. P., Toth, P. P., Jones, S. R., . . . Banach, M. (2017). Effects of morning versus evening statin therapy on lipid profile: a systematic review and meta-analysis. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 642-643). Retrieved from https://www.webofscience.com/
Efficacy and safety of alternate-day versus daily dosing of statins: a systematic review and meta-analysis
Awad, K., Mikhailidis, D. P., Toth, P. P., Jones, S. R., Moriarty, P., Lip, G. Y. H., . . . Banach, M. (2017). Efficacy and safety of alternate-day versus daily dosing of statins: a systematic review and meta-analysis. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 12). Retrieved from https://www.webofscience.com/
Epidemiological Trends in Atrial Fibrillation in Europe: The EURObservational Research Programme in Atrial Fibrillation Pilot and Long-Term Registries and Euro Heart Survey on Atrial Fibrillation
Proietti, M., Laroche, C., Nieuwlaat, R., Crijns, H. J., Maggioni, A., Lane, D. A., . . . Lip, G. Y. (2017). Epidemiological Trends in Atrial Fibrillation in Europe: The EURObservational Research Programme in Atrial Fibrillation Pilot and Long-Term Registries and Euro Heart Survey on Atrial Fibrillation. In CIRCULATION Vol. 136. Retrieved from https://www.webofscience.com/
European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS)
Gorenek, B., Pelliccia, A., Benjamin, E. J., Boriani, G., Crijns, H. J., Fogel, R. I., . . . Abreu, A. (2017). European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 24(1), 4-40. doi:10.1177/2047487316676037
Evaluation of ABC-stroke and CHA2DS2-VASc ischemic scores in real-world atrial fibrillation patients receiving oral anticoagulation treatment
Rivera-Caravaca, J. M., Roldan, V., Esteve Pastor, M. A., Valdes, M., Vicente, V., Lip, G. Y. H., & Marin, F. (2017). Evaluation of ABC-stroke and CHA2DS2-VASc ischemic scores in real-world atrial fibrillation patients receiving oral anticoagulation treatment. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1233). Retrieved from https://www.webofscience.com/
Female sex is a risk modifier - not a risk factor - for stroke risk assessment in atrial fibrillation: Using a CHA2DS2-VA score rather than CHA2DS2-VASc
Nielsen, P. B., Skjoeth, F., Overvad, T. F., Larsen, T. B., & Lip, G. Y. H. (2017). Female sex is a risk modifier - not a risk factor - for stroke risk assessment in atrial fibrillation: Using a CHA2DS2-VA score rather than CHA2DS2-VASc. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1220). Retrieved from https://www.webofscience.com/
Guía ESC 2016 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración con la EACTS
Agewall, S., Camm, J., Barón Esquivias, G., Budts, W., Carerj, S., Casselman, F., . . . Vardas, P. (2017). Guía ESC 2016 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración con la EACTS. Revista Española de Cardiología, 70(1), 50.e1-50.e84. doi:10.1016/j.recesp.2016.11.014
HEALTH CARE COST IN PATIENTS UNDERGOING ELECTRICAL CARDIOVERSION: AN ANALYSIS FROM THE EDOXABAN VERSUS WARFARIN IN SUBJECTS UNDERGOING CARDIOVERSION OF ATRIAL FIBRILLATION (ENSURE-AF) STUDY
Barrrios, R. J., Goette, A., Kwong, J., Ezekowitz, M. D., Banach, M. S., Hjortshen, S. P., . . . Lip, G. (2017). HEALTH CARE COST IN PATIENTS UNDERGOING ELECTRICAL CARDIOVERSION: AN ANALYSIS FROM THE EDOXABAN VERSUS WARFARIN IN SUBJECTS UNDERGOING CARDIOVERSION OF ATRIAL FIBRILLATION (ENSURE-AF) STUDY. In VALUE IN HEALTH Vol. 20 (pp. A608). Retrieved from https://www.webofscience.com/
Impact of Age and Gender on Clinical Outcomes in the Edoxaban versus Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation (ENSURE-AF) Randomized Trial
Goette, A., de Groot, J. R., Le Heuzey, J. -Y., Banach, M., Huber, K., Jin, J., . . . Lip, G. (2017). Impact of Age and Gender on Clinical Outcomes in the Edoxaban versus Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation (ENSURE-AF) Randomized Trial. In CIRCULATION Vol. 136. Retrieved from https://www.webofscience.com/
Impact of atrial fibrillation on quality of life and clinical outcomes: the EURObservational research programme in atrial fibrillation (EORP-AF) general pilot registry
Proietti, M., Lane, D. A., Laroche, C., Maggioni, A. P., Boriani, G., & Lip, G. Y. H. (2017). Impact of atrial fibrillation on quality of life and clinical outcomes: the EURObservational research programme in atrial fibrillation (EORP-AF) general pilot registry. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1233). Retrieved from https://www.webofscience.com/
Increased evidence of left ventricular myocardial fibrosis in patients with paroxysmal atrial fibrillation and sinus node dysfunction
Dzeshka, M. S., Appadoo, K., Shantsila, E., Snezhitskiy, V. A., & Lip, G. Y. H. (2017). Increased evidence of left ventricular myocardial fibrosis in patients with paroxysmal atrial fibrillation and sinus node dysfunction. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 379). Retrieved from https://www.webofscience.com/
LONG-TERM PREDICTION OF THE RISK OF ICTUS IN PATIENTS WITH ATRIAL FIBRILLATION: COMPARISON OF THE ABC-STROKE AND CHA2DS2-VASC SCALES
Rivera Caravaca, J. M., Esteve Pastor, M. A., Valdes, M., Vicente, V., Lip, G. Y. H., Marin, F., & Roldan, V. (2017). LONG-TERM PREDICTION OF THE RISK OF ICTUS IN PATIENTS WITH ATRIAL FIBRILLATION: COMPARISON OF THE ABC-STROKE AND CHA2DS2-VASC SCALES. In HAEMATOLOGICA Vol. 102 (pp. 2-3). Retrieved from https://www.webofscience.com/
Lifetime risks, projected numbers and adverse outcomes in asian patients with atrial fibrillation
Chao, T. F., Lip, G. Y. H., & Chen, S. A. (2017). Lifetime risks, projected numbers and adverse outcomes in asian patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 980). Retrieved from https://www.webofscience.com/
Lower Risk in Young Patients Aged <50 With Atrial Fibrillation and Low CHA<sub>2</sub>DS<sub>2</sub>-VASc Risk Score
Fauchier, L., Bisson, A., Clementy, N., Angoulvant, D., Babuty, D., Lip, G. Y., & Freedman, B. (2017). Lower Risk in Young Patients Aged <50 With Atrial Fibrillation and Low CHA<sub>2</sub>DS<sub>2</sub>-VASc Risk Score. In CIRCULATION Vol. 136. Retrieved from https://www.webofscience.com/
Medication burden and perception of anticoagulation treatments in atrial fibrillation patients: results from an international survey
Lane, D. A., Meyerhoff, J., Rohner, U., & Lip, G. Y. H. (2017). Medication burden and perception of anticoagulation treatments in atrial fibrillation patients: results from an international survey. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 777). Retrieved from https://www.webofscience.com/
Monocyte counts predict major bleeding events in patients with atrial fibrillation
Shahid, F., Lip, G. Y. H., Montoro-Garcia, S., Rahmat, A., & Shantsila, E. (2017). Monocyte counts predict major bleeding events in patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 779-780). Retrieved from https://www.webofscience.com/
Outcomes in vitamin K antagonist treated atrial fibrillation patients with stable international normalized ratios
Bonde, A. N., Staerk, L., Gislason, G., Torp-Pedersen, C., Lip, G. Y. H., & Olesen, J. B. (2017). Outcomes in vitamin K antagonist treated atrial fibrillation patients with stable international normalized ratios. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 838-839). Retrieved from https://www.webofscience.com/
Periprocedural anticoagulation is associated with the risk of thromboembolism after elective cardioversion of atrial fibrillation
Hellman, T. A., Kiviniemi, T., Nuotio, I., Vasankari, T., Hartikainen, J., Lip, G. Y. H., & Airaksinen, K. E. (2017). Periprocedural anticoagulation is associated with the risk of thromboembolism after elective cardioversion of atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 839). Retrieved from https://www.webofscience.com/
Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE
Mont, L., Pelliccia, A., Sharma, S., Biffi, A., Borjesson, M., Brugada Terradellas, J., . . . Piepoli, M. (2017). Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 24(1), 41-69. doi:10.1177/2047487316676042
Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE
Mont, L., Pelliccia, A., Sharma, S., Biffi, A., Borjesson, M., Brugada Terradellas, J., . . . Piepoli, M. (2017). Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE. EUROPACE, 19(1), 139-163. doi:10.1093/europace/euw243
Predictive value of the HAS-BLED, ATRIA, and ORBIT bleeding risk classification in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants (NOACs)
Nielsen, P. B., Skjoeth, F., Larsen, T. B., Kjaeldgaard, J. N., & Lip, G. Y. H. (2017). Predictive value of the HAS-BLED, ATRIA, and ORBIT bleeding risk classification in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants (NOACs). In EUROPEAN HEART JOURNAL Vol. 38 (pp. 964). Retrieved from https://www.webofscience.com/
Predictors of warfarin discontinuation or switching among non-valvular atrial fibrillation patients
Lip, G. Y. H., Keshishian, A., Li, X., Lee, T. C., Mardekian, J., Posner, N., & Luo, X. (2017). Predictors of warfarin discontinuation or switching among non-valvular atrial fibrillation patients. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 774-775). Retrieved from https://www.webofscience.com/
Prescribing of dabigatran etexilate in accordance with the European label for stroke prevention in atrial fibrillation: Findings from the GLORIA-AF Registry
Lip, G. Y. H., Teusch, C., Huisman, M. V., Diener, H. C., Dubner, S. J., Ma, C. S., . . . Halperin, J. L. (2017). Prescribing of dabigatran etexilate in accordance with the European label for stroke prevention in atrial fibrillation: Findings from the GLORIA-AF Registry. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 975). Retrieved from https://www.webofscience.com/
Previous thromboembolic disease and risk of death in atrial fibrillation: the EURObservational research programme in atrial fibrillation (EORP-AF) general pilot registry
Proietti, M., Laroche, C., Maggioni, A. P., Boriani, G., & Lip, G. Y. H. (2017). Previous thromboembolic disease and risk of death in atrial fibrillation: the EURObservational research programme in atrial fibrillation (EORP-AF) general pilot registry. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 83). Retrieved from https://www.webofscience.com/
Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry
Mazurek, M., Huisman, M. V., Rothman, K. J., Paquette, M., Teutsch, C., Diener, H. -C., . . . Lip, G. Y. H. (2017). Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry. THROMBOSIS AND HAEMOSTASIS, 117(12), 2376-2388. doi:10.1160/TH17-08-0555
Relation of congestive heart failure history to efficacy and safety of edoxaban for cardioversion of atrial fibrillation: subanalysis from the ENSURE-AF study
Dan, A., Dan, G. A., Merino, J. L., Merkely, B., Jin, J., Melino, M., . . . Goette, A. (2017). Relation of congestive heart failure history to efficacy and safety of edoxaban for cardioversion of atrial fibrillation: subanalysis from the ENSURE-AF study. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1368-1369). Retrieved from https://www.webofscience.com/
Relation of renal dysfunction to quality of anticoagulation control in patients with atrial fibrillation: The FANTASIIA registry
Esteve Pastor, M. A., Rivera-Caravaca, J. M., Roldan, V., Roldan Rabadan, I., Muniz, J., Cequier, A., . . . Marin, F. (2017). Relation of renal dysfunction to quality of anticoagulation control in patients with atrial fibrillation: The FANTASIIA registry. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1321). Retrieved from https://www.webofscience.com/
Relationship between renal function and circulating microparticles, soluble P-selectin and E- selectin levels in atrial fibrillation
Lau, Y. C., Xiong, Q., Blann, A. D., & Lip, G. Y. H. (2017). Relationship between renal function and circulating microparticles, soluble P-selectin and E- selectin levels in atrial fibrillation. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 43(1), 18-23. doi:10.1007/s11239-016-1427-3
Renal Function, Time in Therapeutic Range and Outcomes in Warfarin-Treated Atrial Fibrillation Patients: A Retrospective Analysis of Nationwide Registries
Bonde, A. N., Lip, G. Y. H., Kamper, A. -L., Staerk, L., Torp-Pedersen, C., Gislason, G., & Olesen, J. B. (2017). Renal Function, Time in Therapeutic Range and Outcomes in Warfarin-Treated Atrial Fibrillation Patients: A Retrospective Analysis of Nationwide Registries. THROMBOSIS AND HAEMOSTASIS, 117(12), 2291-2299. doi:10.1160/TH17-03-0198
Restarting Oral Anticoagulant Therapy After Major Bleeding Events in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Real-World Studies
Proietti, M., Romiti, G. F., Romanazzi, I., Farcomeni, A., Staerk, L., Nielsen, P. B., & Lip, G. Y. (2017). Restarting Oral Anticoagulant Therapy After Major Bleeding Events in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Real-World Studies. In CIRCULATION Vol. 136. Retrieved from https://www.webofscience.com/
Rivaroxaban strategies improve the number of days patients remain out of the hospital and event free: A PIONEER substudy
Gibson, C. M., Arbetter, D. F., Jain, P., Mehran, R., Bode, C., Halperin, J., . . . Fox, K. A. A. (2017). Rivaroxaban strategies improve the number of days patients remain out of the hospital and event free: A PIONEER substudy. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 768). Retrieved from https://www.webofscience.com/
Rivaroxaban treatment strategies reduce costs associated with rehospitalizations due to bleeding and cardiovascular events: results from the PIONEER AF-PCI trial
Pinto, D. S., Tamez, H., Korjian, S., Daaboul, Y., Mehran, R., Bode, C., . . . Gibson, C. M. (2017). Rivaroxaban treatment strategies reduce costs associated with rehospitalizations due to bleeding and cardiovascular events: results from the PIONEER AF-PCI trial. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 965). Retrieved from https://www.webofscience.com/
Rivaroxaban treatment strategies reduce not only the first bleeding event, but all (including multiple) bleeding events: A PIONEER Substudy
Yee, M. K., Chi, G., Jain, P., Mehran, R., Bode, C., Halperin, J., . . . Gibson, C. M. (2017). Rivaroxaban treatment strategies reduce not only the first bleeding event, but all (including multiple) bleeding events: A PIONEER Substudy. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 963-964). Retrieved from https://www.webofscience.com/
Spontaneous Cardioversion in Nonvalvular Atrial Fibrillation in Patients Planned for Electrical Cardioversion: A Subanalysis of the ENSURE-AF Trial
Cohen, A. A., Heidbuchel, H., Le Heuzey, J. -Y., De Caterina, R., Merino, J. L., Jin, J., . . . Lip, G. Y. (2017). Spontaneous Cardioversion in Nonvalvular Atrial Fibrillation in Patients Planned for Electrical Cardioversion: A Subanalysis of the ENSURE-AF Trial. In CIRCULATION Vol. 136. Retrieved from https://www.webofscience.com/
Stroke prevention in Atrial Fibrillation
Lip, G. Y. H. (2017). Stroke prevention in Atrial Fibrillation. EUROPEAN HEART JOURNAL, 38(1), 4-5. doi:10.1093/eurheartj/ehw584
Stroke prevention in atrial fibrillation
Voukalis, C., Shantsila, E., & Lip, G. Y. H. (2017). Stroke prevention in atrial fibrillation. JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 47(1), 13-23. doi:10.4997/JRCPE.2017.105
Stroke-Prophylaxis and 30-Day Clinical Outcomes After United States Emergency Department Diagnosis and Discharge for Atrial Fibrillation
Kea, B., Lin, A., Olshansky, B., Raitt, M., Lip, G. Y., Fu, R., & Sun, B. (2017). Stroke-Prophylaxis and 30-Day Clinical Outcomes After United States Emergency Department Diagnosis and Discharge for Atrial Fibrillation. In CIRCULATION Vol. 136. Retrieved from https://www.webofscience.com/
Subgroup Analysis From the RE-DUAL PCI Trial: Dual Antithrombotic Therapy With Dabigatran in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
Oldgren, J., Steg, P. -G., Hohnloser, S. H., Lip, G. Y., Ellis, S. G., Kimura, T., . . . Kleine, E. (2017). Subgroup Analysis From the RE-DUAL PCI Trial: Dual Antithrombotic Therapy With Dabigatran in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. In CIRCULATION Vol. 136 (pp. E457). Retrieved from https://www.webofscience.com/
Synergic effects of blood pressure control and quality of anticoagulation control on outcomes in patients with atrial fibrillation: the SPORTIF III and V trials
Proietti, M., & Lip, G. Y. H. (2017). Synergic effects of blood pressure control and quality of anticoagulation control on outcomes in patients with atrial fibrillation: the SPORTIF III and V trials. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 770). Retrieved from https://www.webofscience.com/
The 2MACE score predicts cardiovascular events in real-world patients with atrial fibrillation: The FANTASIIA registry
Esteve Pastor, M. A., Perez-Copete, J., Rivera-Caravaca, J. M., Roldan, V., Roldan Rabadan, I., Muniz, J., . . . Marin, F. (2017). The 2MACE score predicts cardiovascular events in real-world patients with atrial fibrillation: The FANTASIIA registry. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1126-1127). Retrieved from https://www.webofscience.com/
The Effect of Anticoagulation Rates on Time-Trends in Stroke Rates for Atrial Fibrillation: A Nationwide Study Using the Korean National Health Insurance Data
Kim, T. -H., Yang, P. -S., Yu, H. T., Uhm, J. -S., Kim, J. -Y., Pak, H. -N., . . . Lip, G. Y. (2017). The Effect of Anticoagulation Rates on Time-Trends in Stroke Rates for Atrial Fibrillation: A Nationwide Study Using the Korean National Health Insurance Data. In CIRCULATION Vol. 136. Retrieved from https://www.webofscience.com/
The Effect of Utilization of Non-vitamin K Antagonist Oral Anticoagulants on Time-Trends In Mortality and Hospitalization Rates for Atrial Fibrillation: A Nationwide Study Using the Korean National Health Insurance Data
Yu, H. T., Yang, P. -S., Hwang, J., Ryu, S., Kim, T. -H., Uhm, J. -S., . . . Lip, G. Y. (2017). The Effect of Utilization of Non-vitamin K Antagonist Oral Anticoagulants on Time-Trends In Mortality and Hospitalization Rates for Atrial Fibrillation: A Nationwide Study Using the Korean National Health Insurance Data. In CIRCULATION Vol. 136. Retrieved from https://www.webofscience.com/
The comparison of the lipid profile in the population of Poland between 2004, 2006 and 2015 based on the results of the LIPIDOGRAM cohort studies
Banach, M., Wojtowicz, E., Tomaszewski, M., Catapano, A. L., Toth, P. P., Sattar, N., . . . Jozwiak, J. (2017). The comparison of the lipid profile in the population of Poland between 2004, 2006 and 2015 based on the results of the LIPIDOGRAM cohort studies. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1116). Retrieved from https://www.webofscience.com/
The relationship of renal function to outcome: a post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE-AF) study
Lip, G. Y. H., Al-Saady, N., Ezekowitz, M. D., Banach, M., & Goette, A. (2017). The relationship of renal function to outcome: a post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE-AF) study. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1369). Retrieved from https://www.webofscience.com/
Thrombosis and Haemostasis: Past, present and future
Lip, G. Y. H., & Weber, C. (2017). Thrombosis and Haemostasis: Past, present and future. THROMBOSIS AND HAEMOSTASIS, 117(7), 1217-1218. doi:10.1160/TH17-05-0350
Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA<sub>2</sub>DS<sub>2</sub>-VASc score
Overvad, T. F., Nielsen, P. B., & Lip, G. Y. H. (2017). Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA<sub>2</sub>DS<sub>2</sub>-VASc score. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 3(1), 37-41. doi:10.1093/ehjcvp/pvw022
Use of multiple biomarkers to improve CHA2DS2-VASc and HAS-BLED scores in the prediction of thromboembolic and bleeding events
Roldan, V., Esteve Pastor, M. A., Rivera-Caravaca, J. M., Shantsila, A., Garcia Fernandez, A., Valdes, M., . . . Lip, G. Y. H. (2017). Use of multiple biomarkers to improve CHA2DS2-VASc and HAS-BLED scores in the prediction of thromboembolic and bleeding events. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1232). Retrieved from https://www.webofscience.com/
Use of statins and adverse outcomes in patients with atrial fibrillation: the EURObservational research programme atrial fibrillation (EORP-AF) general pilot registry
Proietti, M., Laroche, C., Nyvad, O., Haberka, M., Vassilikos, V. P., Maggioni, A. P., . . . Lip, G. Y. H. (2017). Use of statins and adverse outcomes in patients with atrial fibrillation: the EURObservational research programme atrial fibrillation (EORP-AF) general pilot registry. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 12). Retrieved from https://www.webofscience.com/
VLSI for space applications: Single event effect investigation and optical analysis on an integrated laser platform
Chef, S., Chua, C. T., Siah, Y. W., Perdu, P., Gan, C. L., Tan, S. H., & Koh, L. S. (2017). VLSI for space applications: Single event effect investigation and optical analysis on an integrated laser platform. In Conference Proceedings from the International Symposium for Testing and Failure Analysis Vol. 2017-November (pp. 621-630).
2016
Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease (vol 68, pg 1452, 2016)
Lau, Y. C., Proietti, M., Guiducci, E., Blann, A. D., & Lip, G. Y. H. (2016). Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease (vol 68, pg 1452, 2016). JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 68(25), 2921. doi:10.1016/j.jacc.2016.09.923
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
Gibson, C. M., Mehran, R., Bode, C., Halperin, J., Verheugt, F. W., Wildgoose, P., . . . Fox, K. A. (2016). Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI. NEW ENGLAND JOURNAL OF MEDICINE, 375(25), 2423-2434. doi:10.1056/NEJMoa1611594
What do the guidelines suggest for non-vitamin K antagonist oral anticoagulant use for stroke prevention in atrial fibrillation?
Shahid, F., Shantsila, E., & Lip, G. Y. H. (2016). What do the guidelines suggest for non-vitamin K antagonist oral anticoagulant use for stroke prevention in atrial fibrillation?. EUROPEAN HEART JOURNAL SUPPLEMENTS, 18(I), 18-24. doi:10.1093/eurheartj/suw049
Persistence with Dabigatran Therapy for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation: The Gloria-AF Registry
Teutsch, C., Huisman, M. V., Lip, G. Y. H., Diener, H. -C., Dubner, S. J., Changsheng, M., . . . Halperin, J. (2016). Persistence with Dabigatran Therapy for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation: The Gloria-AF Registry. In BLOOD Vol. 128. doi:10.1182/blood.V128.22.2616.2616
A population screening programme for atrial fibrillation: a report from the Belgian Heart Rhythm Week screening programme
Proietti, M., Mairesse, G. H., Goethals, P., Scavee, C., Vijgen, J., Blankoff, I., . . . Lip, G. Y. H. (2016). A population screening programme for atrial fibrillation: a report from the Belgian Heart Rhythm Week screening programme. EUROPACE, 18(12), 1779-1786. doi:10.1093/europace/euw069
Atrial Fibrillation and Heart Failure: How Should We Manage Our Patients?
Shahid, F., & Lip, G. Y. H. (2016). Atrial Fibrillation and Heart Failure: How Should We Manage Our Patients?. Arrhythmia & electrophysiology review, 5(3), 162-163. doi:10.15420/aer.2016.5.3.ed3
Causes of Death and Influencing Factors in Patients with Atrial Fibrillation
Fauchier, L., Villejoubert, O., Clementy, N., Bernard, A., Pierre, B., Angoulvant, D., . . . Lip, G. Y. H. (2016). Causes of Death and Influencing Factors in Patients with Atrial Fibrillation. AMERICAN JOURNAL OF MEDICINE, 129(12). doi:10.1016/j.amjmed.2016.06.045
Chronic Osteomyelitis and Atrial Fibrillation: Revisiting the Link Between Inflammation Burden and Arrhythmia
Shahid, F., Lip, G. Y. H., & Shantsila, E. (2016). Chronic Osteomyelitis and Atrial Fibrillation: Revisiting the Link Between Inflammation Burden and Arrhythmia. CANADIAN JOURNAL OF CARDIOLOGY, 32(12), 1366-1368. doi:10.1016/j.cjca.2016.05.002
Determinants of Time in Therapeutic Range in Patients Receiving Oral Anticoagulants (A Substudy of IMPACT)
Lip, G. Y. H., Waldo, A. L., Ip, J., Martin, D. T., Bersohn, M. M., Choucair, W. K., . . . Halperin, J. L. (2016). Determinants of Time in Therapeutic Range in Patients Receiving Oral Anticoagulants (A Substudy of IMPACT). AMERICAN JOURNAL OF CARDIOLOGY, 118(11), 1680-1684. doi:10.1016/j.amjcard.2016.08.047
Drug-drug interactions of non-vitamin K oral anticoagulants
Voukalis, C., Lip, G. Y. H., & Shantsila, E. (2016). Drug-drug interactions of non-vitamin K oral anticoagulants. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 12(12), 1445-1461. doi:10.1080/17425255.2016.1225037
Embolic Stroke of Undetermined Source and Detection of Atrial Fibrillation on Follow-Up: How Much Causality Is There?
Ntaios, G., Papavasileiou, V., Lip, G. Y. H., Milionis, H., Makaritsis, K., Vemmou, A., . . . Vemmos, K. (2016). Embolic Stroke of Undetermined Source and Detection of Atrial Fibrillation on Follow-Up: How Much Causality Is There?. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 25(12), 2975-2980. doi:10.1016/j.jstrokecerebrovasdis.2016.08.015
Executive Summary: European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias
Katritsis, D. G., Boriani, G., Cosio, F. G., Jais, P., Hindricks, G., Josephson, M. E., . . . Lundqvist, C. B. (2016). Executive Summary: European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias. ARRHYTHMIA & ELECTROPHYSIOLOGY REVIEW, 5(3), 210-224. doi:10.15420/aer.2016.5.3.GL1
Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica
Ponikowski, A. M. D. G. D. T. P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., . . . Zamorano, J. L. (2016). Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica. Revista Española de Cardiología, 69(12), 1167.e1-1167.e85. doi:10.1016/j.recesp.2016.10.014
How to REVISIT the increasing "real world" evidence for stroke prevention in non-valvular atrial fibrillation?
Lip, G. Y. H. (2016). How to REVISIT the increasing "real world" evidence for stroke prevention in non-valvular atrial fibrillation?. CURRENT MEDICAL RESEARCH AND OPINION, 32(12), 2055-2057. doi:10.1080/03007995.2016.1254604
Stroke Prevention in Atrial Fibrillation: Focus on Latin America
Massaro, A. R., & Lip, G. Y. H. (2016). Stroke Prevention in Atrial Fibrillation: Focus on Latin America. ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 107(6), 576-588. doi:10.5935/abc.20160116
Stroke and death in elderly patients with atrial fibrillation in Japan compared with the United Kingdom
Senoo, K., An, Y., Ogawa, H., Lane, D. A., Wolff, A., Shantsila, E., . . . Lip, G. Y. H. (2016). Stroke and death in elderly patients with atrial fibrillation in Japan compared with the United Kingdom. HEART, 102(23), 1878-1882. doi:10.1136/heartjnl-2016-309741
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
Luis Zamorano, J., Lancellotti, P., Rodriguez Munoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., . . . Suter, T. M. (2016). 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. KARDIOLOGIA POLSKA, 74(11), 1193-1233. doi:10.5603/KP.2016.0156
Aspirin and renal insufficiency progression in patients with atrial fibrillation and chronic kidney disease
Pastori, D., Pignatelli, P., Perticone, F., Sciacqua, A., Carnevale, R., Farcomeni, A., . . . Violi, F. (2016). Aspirin and renal insufficiency progression in patients with atrial fibrillation and chronic kidney disease. In INTERNATIONAL JOURNAL OF CARDIOLOGY Vol. 223 (pp. 619-624). doi:10.1016/j.ijcard.2016.08.224
Dabigatran in clinical practice: Contemporary overview of the evidence (vol 220, pg 417, 2016)
Ageno, W., Eikelboom, J., & Lip, G. Y. H. (2016). Dabigatran in clinical practice: Contemporary overview of the evidence (vol 220, pg 417, 2016). INTERNATIONAL JOURNAL OF CARDIOLOGY, 223, 1074-1076. doi:10.1016/j.ijcard.2016.08.332
Meta-analysis of uninterrupted as compared to interrupted oral anticoagulation with or without bridging in patients undergoing coronary angiography with or without percutaneous coronary intervention
Kowalewski, M., Suwalski, P., Raffa, G. M., Slomka, A., Kowalkowska, M. E., Szwed, K. A., . . . Lip, G. Y. H. (2016). Meta-analysis of uninterrupted as compared to interrupted oral anticoagulation with or without bridging in patients undergoing coronary angiography with or without percutaneous coronary intervention. INTERNATIONAL JOURNAL OF CARDIOLOGY, 223, 186-194. doi:10.1016/j.ijcard.2016.08.089
Anticoagulation Control in Warfarin Treated Patients Undergoing Cardioversion for Atrial Fibrillation: A Pre-specified Ancillary Analysis From the ENSURE-AF Trial
Lip, G. Y., Al-Saady, N., Jin, J., Sun, M., Melino, M., Winters, S. M., . . . Zamoryakhin, D. (2016). Anticoagulation Control in Warfarin Treated Patients Undergoing Cardioversion for Atrial Fibrillation: A Pre-specified Ancillary Analysis From the ENSURE-AF Trial. In CIRCULATION Vol. 134. Retrieved from http://gateway.webofknowledge.com/
High brightness formamidinium lead bromide perovskite nanocrystal light emitting devices.
Perumal, A., Shendre, S., Li, M., Tay, Y. K. E., Sharma, V. K., Chen, S., . . . Demir, H. V. (2016). High brightness formamidinium lead bromide perovskite nanocrystal light emitting devices.. Scientific reports, 6, 36733. doi:10.1038/srep36733
International Collaborative Partnership for the Study of Atrial Fibrillation (INTERAF): Rationale, Design, and Initial Descriptives
Hsu, J. C., Akao, M., Abe, M., Anderson, K. L., Avezum, A., Glusenkamp, N., . . . Maddox, T. M. (2016). International Collaborative Partnership for the Study of Atrial Fibrillation (INTERAF): Rationale, Design, and Initial Descriptives. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 5(11). doi:10.1161/JAHA.116.004037
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., . . . Zeppenfeld, K. (2016). 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. EUROPACE, 18(11). doi:10.1093/europace/euw295
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., . . . Zeppenfeld, K. (2016). 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 50(5), e1-e88. doi:10.1093/ejcts/ezw313
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study
Proietti, M., Nobili, A., Raparelli, V., Napoleone, L., Mannucci, P. M., & Lip, G. Y. H. (2016). Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study. CLINICAL RESEARCH IN CARDIOLOGY, 105(11), 912-920. doi:10.1007/s00392-016-0999-4
Atrial fibrillation and risk of stroke: a nationwide cohort study
Christiansen, C. B., Gerds, T. A., Olesen, J. B., Kristensen, S. L., Lamberts, M., Lip, G. Y. H., . . . Torp-Pedersen, C. (2016). Atrial fibrillation and risk of stroke: a nationwide cohort study. EUROPACE, 18(11), 1689-1697. doi:10.1093/europace/euv401
COMPARISON OF ORAL ANTI-COAGULANTS FOR STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION: TWO MULTI-CRITERIA DECISION ANALYSES
Tervonen, T., Ustyugova, A. V., Lip, G., Verdecchia, P., Bhashyam, S. S., Heinrich-Nols, J., . . . Marsh, K. (2016). COMPARISON OF ORAL ANTI-COAGULANTS FOR STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION: TWO MULTI-CRITERIA DECISION ANALYSES. In VALUE IN HEALTH Vol. 19 (pp. A349). doi:10.1016/j.jval.2016.09.014
Effects of Aspirin on Endothelial Function and Hypertension
Dzeshka, M. S., Shantsila, A., & Lip, G. Y. H. (2016). Effects of Aspirin on Endothelial Function and Hypertension. CURRENT HYPERTENSION REPORTS, 18(11). doi:10.1007/s11906-016-0688-8
Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillation
Lau, Y. C., Xiong, Q., Shantsila, E., Lip, G. Y. H., & Blann, A. D. (2016). Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillation. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 42(4), 535-544. doi:10.1007/s11239-016-1399-3
Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry
Proietti, M., Laroche, C., Drozd, M., Vijgen, J., Cozma, D. C., Drozdz, J., . . . Lip, G. Y. H. (2016). Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry. AMERICAN HEART JOURNAL, 181, 83-91. doi:10.1016/j.ahj.2016.08.011
Is oral anticoagulation needed in patients with atrial fibrillation and stent implantation at low-moderate risk of stroke?
Fauchier, L., Ruiz-Nodar, J. M., Valdes, M., Angoulvant, D., Lip, G. Y. H., & Marin, F. (2016). Is oral anticoagulation needed in patients with atrial fibrillation and stent implantation at low-moderate risk of stroke?. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 35, E9-E10. doi:10.1016/j.ejim.2016.08.022
Optimizing stroke prevention in elderly patients with atrial fibrillation
Lip, G. Y. H. (2016). Optimizing stroke prevention in elderly patients with atrial fibrillation. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 14(11), 2121-2123. doi:10.1111/jth.13480
Renal Function and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation An Observational Cohort Study
Bonde, A. N., Lip, G. Y. H., Kamper, A. -L., Fosbol, E. L., Staerk, L., Carlson, N., . . . Olesen, J. B. (2016). Renal Function and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation An Observational Cohort Study. STROKE, 47(11), 2707-2713. doi:10.1161/STROKEAHA.116.014422
Response by Nielsen and Lip to Letter Regarding Article, "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA<sub>2</sub>DS<sub>2</sub>-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke"
Nielsen, P. B., & Lip, G. Y. H. (2016). Response by Nielsen and Lip to Letter Regarding Article, "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA<sub>2</sub>DS<sub>2</sub>-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke". CIRCULATION, 134(18), E389-E390. doi:10.1161/CIRCULATIONAHA.116.024013
Rivaroxaban versus warfarin and dabigatran in atrial fibrillation: comparative effectiveness and safety in Danish routine care
Gorst-Rasmussen, A., Lip, G. Y. H., & Larsen, T. B. (2016). Rivaroxaban versus warfarin and dabigatran in atrial fibrillation: comparative effectiveness and safety in Danish routine care. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 25(11), 1236-1244. doi:10.1002/pds.4034
Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin A propensity score matched analysis
Lip, G. Y. H., Keshishian, A., Kamble, S., Pan, X., Mardekian, J., Horblyuk, R., & Hamilton, M. (2016). Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin A propensity score matched analysis. THROMBOSIS AND HAEMOSTASIS, 116(5), 975-986. doi:10.1160/TH16-05-0403
Premature Cardiac Aging in South Asian Compared to Afro-Caribbean Subjects in a Community-Based Screening Study
Shantsila, E., Shantsila, A., Gill, P. S., & Lip, G. Y. H. (2016). Premature Cardiac Aging in South Asian Compared to Afro-Caribbean Subjects in a Community-Based Screening Study. Journal of the American Heart Association, 5(11). doi:10.1161/JAHA.116.004110
Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial
Goette, A., Merino, J. L., Ezekowitz, M. D., Zamoryakhin, D., Melino, M., Jin, J., . . . Investigators, E. N. S. U. R. E. -A. F. (2016). Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial. The Lancet, 388(10055), 1995-2003. doi:10.1016/S0140-6736(16)31474-X
In patients with type 2 diabetes and high CV risk, liraglutide reduced a composite CV outcome at a median 3.8 years
Mazurek, M., & Lip, G. Y. H. (2016). In patients with type 2 diabetes and high CV risk, liraglutide reduced a composite CV outcome at a median 3.8 years. ANNALS OF INTERNAL MEDICINE, 165(8), JC38. doi:10.7326/ACPJC-2016-165-8-038
Predictive abilities of the HAS-BLED and ORBIT bleeding risk scores in non-warfarin anticoagulated atrial fibrillation patients: An ancillary analysis from the AMADEUS trial
Senoo, K., & Lip, G. Y. H. (2016). Predictive abilities of the HAS-BLED and ORBIT bleeding risk scores in non-warfarin anticoagulated atrial fibrillation patients: An ancillary analysis from the AMADEUS trial. INTERNATIONAL JOURNAL OF CARDIOLOGY, 221, 379-382. doi:10.1016/j.ijcard.2016.07.100
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., . . . ESC Scientific Document Group. (2016). 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.. European heart journal, 37(39), 2999-3058. doi:10.1093/eurheartj/ehw272
Non-vitamin K oral anticoagulants versus vitamin K antagonists in the treatment of venous thromboembolic disease
Voukalis, C., Lip, G. Y. H., & Shantsila, E. (2016). Non-vitamin K oral anticoagulants versus vitamin K antagonists in the treatment of venous thromboembolic disease. EXPERT OPINION ON PHARMACOTHERAPY, 17(15), 2033-2047. doi:10.1080/14656566.2016.1232393
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., . . . ESC Scientific Document Group. (2016). 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.. European heart journal, 37(38), 2893-2962. doi:10.1093/eurheartj/ehw210
IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation rationale and design of the IMPRESS-AF randomised controlled trial
Shantsila, E., Haynes, R., Calvert, M., Fisher, J., Kirchhof, P., Gill, P. S., & Lip, G. Y. H. (2016). IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation rationale and design of the IMPRESS-AF randomised controlled trial. BMJ OPEN, 6(10). doi:10.1136/bmjopen-2016-012241
Is an Oral Anticoagulant Necessary for Young Atrial Fibrillation Patients With a CHA<sub>2</sub>DS<sub>2</sub>-VASc Score of 1 (Men) or 2 (Women)?
Hung, Y., Chao, T. -F., Liu, C. -J., Tuan, T. -C., Lin, Y. -J., Chang, S. -L., . . . Chen, S. -A. (2016). Is an Oral Anticoagulant Necessary for Young Atrial Fibrillation Patients With a CHA<sub>2</sub>DS<sub>2</sub>-VASc Score of 1 (Men) or 2 (Women)?. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 5(10). doi:10.1161/JAHA.116.003839
2016 European Guidelines on cardiovascular disease prevention in clinical practice.
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., . . . Monique Verschuren, W. M. (2016). 2016 European Guidelines on cardiovascular disease prevention in clinical practice.. Revista espanola de cardiologia (English ed.), 69(10), 939. doi:10.1016/j.rec.2016.09.009
Assessment of atrial fibrosis for the rhythm control of atrial fibrillation
Begg, G. A., Holden, A. V., Lip, G. Y. H., Plein, S., & Tayebjee, M. H. (2016). Assessment of atrial fibrosis for the rhythm control of atrial fibrillation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 220, 155-161. doi:10.1016/j.ijcard.2016.06.144
CHA<sub>2</sub>DS<sub>2</sub>-VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythm
Ye, S., Qian, M., Zhao, B., Buchsbaum, R., Sacco, R. L., Levin, B., . . . Homma, S. (2016). CHA<sub>2</sub>DS<sub>2</sub>-VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythm. EUROPEAN JOURNAL OF HEART FAILURE, 18(10), 1261-1266. doi:10.1002/ejhf.613
Dabigatran in clinical practice: Contemporary overview of the evidence
Ageno, W., Eikelboom, J., & Lip, G. Y. H. (2016). Dabigatran in clinical practice: Contemporary overview of the evidence. INTERNATIONAL JOURNAL OF CARDIOLOGY, 220, 417-428. doi:10.1016/j.ijcard.2016.06.078
Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With Stenting
Cannon, C. P., Gropper, S., Bhatt, D. L., Ellis, S. G., Kimura, T., Lip, G. Y. H., . . . Hohnloser, S. H. (2016). Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With Stenting. CLINICAL CARDIOLOGY, 39(10), 555-564. doi:10.1002/clc.22572
EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication
Goette, A., Kalman, J. M., Aguinaga, L., Akar, J., Angel Cabrera, J., Chen, S. A., . . . Nattel, S. (2016). EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. EUROPACE, 18(10), 1455-1490. doi:10.1093/europace/euw161
Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms
Chrusciel, P., Sahebkar, A., Rembek-Wieliczko, M., Serban, M. -C., Ursoniu, S., Mikhailidis, D. P., . . . Banach, M. (2016). Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms. ATHEROSCLEROSIS, 253, 194-208. doi:10.1016/j.atherosclerosis.2016.07.897
Major Outcomes in Atrial Fibrillation Patients with One Risk Factor: Impact of Time in Therapeutic Range Observations from the SPORTIF Trials
Proietti, M., & Lip, G. Y. H. (2016). Major Outcomes in Atrial Fibrillation Patients with One Risk Factor: Impact of Time in Therapeutic Range Observations from the SPORTIF Trials. AMERICAN JOURNAL OF MEDICINE, 129(10), 1110-1116. doi:10.1016/j.amjmed.2016.03.024
Modelling projections for the uptake of edoxaban in an European population to 2050: effects on stroke, thromboembolism, and health economics perspectives
Blann, A. D., Boriani, G., & Lip, G. Y. H. (2016). Modelling projections for the uptake of edoxaban in an European population to 2050: effects on stroke, thromboembolism, and health economics perspectives. EUROPACE, 18(10), 1507-1513. doi:10.1093/europace/euw211
Net Clinical Benefit of Dabigatran Over Warfarin in Patients With Atrial Fibrillation Stratified by CHA<sub>2</sub>DS<sub>2</sub>-VASc and Time in Therapeutic Range
Chan, P. -H., Huang, D., Lau, C. -P., Chan, E. W., Wong, I. C. K., Lip, G. Y. H., . . . Siu, C. -W. (2016). Net Clinical Benefit of Dabigatran Over Warfarin in Patients With Atrial Fibrillation Stratified by CHA<sub>2</sub>DS<sub>2</sub>-VASc and Time in Therapeutic Range. CANADIAN JOURNAL OF CARDIOLOGY, 32(10). doi:10.1016/j.cjca.2016.01.016
Response by Fauchier et al to Letter Regarding Article, "Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA<sub>2</sub>DS<sub>2</sub>-VASc Risk Factor Be Anticoagulated?"
Fauchier, L., Bisson, A., & Lip, G. Y. H. (2016). Response by Fauchier et al to Letter Regarding Article, "Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA<sub>2</sub>DS<sub>2</sub>-VASc Risk Factor Be Anticoagulated?". STROKE, 47(10), E239. doi:10.1161/STROKEAHA.116.014619
Stroke prevention strategies in patients with atrial fibrillation and heart valve abnormalities: perceptions of 'valvular' atrial fibrillation: results of the European Heart Rhythm Association Survey
Potpara, T. S., Lip, G. Y. H., Larsen, T. B., Madrid, A., Dobreanu, D., Jedrzejczyk-Patej, E., & Dagres, N. (2016). Stroke prevention strategies in patients with atrial fibrillation and heart valve abnormalities: perceptions of 'valvular' atrial fibrillation: results of the European Heart Rhythm Association Survey. EUROPACE, 18(10), 1593-1598. doi:10.1093/europace/euw302
The Yin-Yang of Atrial Fibrillation and Pulmonary Embolism
Abou Ziki, M., Bikdeli, B., & Lip, G. (2016). The Yin-Yang of Atrial Fibrillation and Pulmonary Embolism. In CHEST Vol. 150 (pp. 1189A). doi:10.1016/j.chest.2016.08.1298
Time in Therapeutic Range and Percentage of International Normalized Ratio in the Therapeutic Range as a Measure of Quality of Anticoagulation Control in Patients With Atrial Fibrillation
Chan, P. -H., Li, W. -H., Hai, J. -J., Chan, E. W., Wong, I. C. K., Tse, H. -F., . . . Siu, C. -W. (2016). Time in Therapeutic Range and Percentage of International Normalized Ratio in the Therapeutic Range as a Measure of Quality of Anticoagulation Control in Patients With Atrial Fibrillation. CANADIAN JOURNAL OF CARDIOLOGY, 32(10). doi:10.1016/j.cjca.2015.10.029
Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study
Xia, S. -J., Du, X., Li, C., Wu, J. -H., Tang, R. -B., Chang, S. -S., . . . Ma, C. -S. (2016). Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 220, 284-289. doi:10.1016/j.ijcard.2016.06.113
Validation of a Modified CHA<sub>2</sub>DS<sub>2</sub>-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study
Chao, T. -F., Lip, G. Y. H., Liu, C. -J., Tuan, T. -C., Chen, S. -J., Wang, K. -L., . . . Chen, S. -A. (2016). Validation of a Modified CHA<sub>2</sub>DS<sub>2</sub>-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study. STROKE, 47(10), 2462-2469. doi:10.1161/STROKEAHA.116.013880
"Unreal world" or "real world" data in oral anticoagulant treatment of atrial fibrillation
Freedman, B., & Lip, G. Y. H. (2016). "Unreal world" or "real world" data in oral anticoagulant treatment of atrial fibrillation. THROMBOSIS AND HAEMOSTASIS, 116(4), 587-589. doi:10.1160/TH16-08-0658
Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease
Lau, Y. C., Proietti, M., Guiducci, E., Blann, A. D., & Lip, G. Y. H. (2016). Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 68(13), 1452-1464. doi:10.1016/j.jacc.2016.06.057
Role and analysis of monocyte subsets in cardiovascular disease Joint consensus document of the European Society of Cardiology (ESC) Working Groups "Atherosclerosis & Vascular Biology" and "Thrombosis"
Weber, C., Shantsila, E., Hristov, M., Caligiuri, G., Guzik, T., Heine, G. H., . . . Lip, G. Y. H. (2016). Role and analysis of monocyte subsets in cardiovascular disease Joint consensus document of the European Society of Cardiology (ESC) Working Groups "Atherosclerosis & Vascular Biology" and "Thrombosis". THROMBOSIS AND HAEMOSTASIS, 116(4), 626-637. doi:10.1160/TH16-02-0091
Is the ORBIT Bleeding Risk Score Superior to the HAS-BLED Score in Anticoagulated Atrial Fibrillation Patients?
Asuncion Esteve-Pastor, M., Garcia-Fernandez, A., Macias, M., Sogorb, F., Valdes, M., Roldan, V., . . . Marin, F. (2016). Is the ORBIT Bleeding Risk Score Superior to the HAS-BLED Score in Anticoagulated Atrial Fibrillation Patients?. CIRCULATION JOURNAL, 80(10), 2102-2108. doi:10.1253/circj.CJ-16-0471
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
Zamorano, J. L., Lancellotti, P., Munoz, D. R., Aboyans, V., Asteggiano, R., Galderisi, M., . . . Windecker, S. (2016). 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. EUROPEAN HEART JOURNAL, 37(36), 2768-2801. doi:10.1093/eurheartj/ehw211
Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm
Shantsila, E., & Lip, G. Y. H. (2016). Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (9). doi:10.1002/14651858.CD003333.pub3
Response by Chao et al to Letters Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage"
Chao, T. -F., Liu, C. -J., Liao, J. -N., Wang, K. -L., Lin, Y. -J., Chang, S. -L., . . . Chen, S. -A. (2016). Response by Chao et al to Letters Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage". CIRCULATION, 134(11), E230-E231. doi:10.1161/CIRCULATIONAHA.116.024174
A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials investigating the effects of statin therapy on plasma lipid concentrations in HIV-infected patients
Banach, M., Dinca, M., Ursoniu, S., Serban, M. -C., Howard, G., Mikhailidis, D. P., . . . Sahebkar, A. (2016). A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials investigating the effects of statin therapy on plasma lipid concentrations in HIV-infected patients. PHARMACOLOGICAL RESEARCH, 111, 343-356. doi:10.1016/j.phrs.2016.06.005
Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort
Huisman, M. V., Ma, C. S., Diener, H. -C., Dubner, S. J., Halperin, J. L., Rothman, K. J., . . . Lip, G. Y. H. (2016). Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort. EUROPACE, 18(9), 1308-1318. doi:10.1093/europace/euw073
Atrial Fibrillation in Patients With Hypertension Trajectories of Risk Factors in Yet Another Manifestation of Hypertensive Target Organ Damage
Lip, G. Y. H. (2016). Atrial Fibrillation in Patients With Hypertension Trajectories of Risk Factors in Yet Another Manifestation of Hypertensive Target Organ Damage. HYPERTENSION, 68(3), 544-545. doi:10.1161/HYPERTENSIONAHA.116.07901
Bleeding risk assessment in atrial fibrillation: observations on the use and misuse of bleeding risk scores
Lip, G. Y. H., & Lane, D. A. (2016). Bleeding risk assessment in atrial fibrillation: observations on the use and misuse of bleeding risk scores. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 14(9), 1711-1714. doi:10.1111/jth.13386
Crystal orientation dependence of the stress-induced martensitic transformation in zirconia-based shape memory ceramics
Zeng, X. M., Lai, A., Gan, C. L., & Schuh, C. A. (2016). Crystal orientation dependence of the stress-induced martensitic transformation in zirconia-based shape memory ceramics. Acta Materialia, 116, 124-135. doi:10.1016/j.actamat.2016.06.030
Determinants and Time Trends for Ischaemic and Haemorrhagic Stroke in a Large Chinese Population
Guo, Y., Wang, H., Tao, T., Tian, Y., Wang, Y., Chen, Y., & Lip, G. Y. H. (2016). Determinants and Time Trends for Ischaemic and Haemorrhagic Stroke in a Large Chinese Population. PLOS ONE, 11(9). doi:10.1371/journal.pone.0163171
Echocardiographic Structure and Function in Hypertensive Disorders of Pregnancy: A Systematic Review
Castleman, J. S., Ganapathy, R., Taki, F., Lip, G. Y. H., Steeds, R. P., & Kotecha, D. (2016). Echocardiographic Structure and Function in Hypertensive Disorders of Pregnancy: A Systematic Review. CIRCULATION-CARDIOVASCULAR IMAGING, 9(9). doi:10.1161/CIRCIMAGING.116.004888
Effects of voltage stress on the single event upset (SEU) response of 65 nm flip flop
Chua, C. T., Ong, H. G., Sanchez, K., Perdu, P., & Gan, C. L. (2016). Effects of voltage stress on the single event upset (SEU) response of 65 nm flip flop. Microelectronics Reliability, 64, 199-203. doi:10.1016/j.microrel.2016.07.107
Evaluation of 5 Prognostic Scores for Prediction of Stroke, Thromboembolic and Coronary Events, All-Cause Mortality, and Major Adverse Cardiac Events in Patients With Atrial Fibrillation and Coronary Stenting
Fauchier, L., Lecoq, C., Ancedy, Y., Stamboul, K., Saint Etienne, C., Ivanes, F., . . . Lip, G. Y. H. (2016). Evaluation of 5 Prognostic Scores for Prediction of Stroke, Thromboembolic and Coronary Events, All-Cause Mortality, and Major Adverse Cardiac Events in Patients With Atrial Fibrillation and Coronary Stenting. AMERICAN JOURNAL OF CARDIOLOGY, 118(5), 700-707. doi:10.1016/j.amjcard.2016.06.018
Major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a "real-world" observational study in the United States
Lip, G. Y. H., Pan, X., Kamble, S., Kawabata, H., Mardekian, J., Masseria, C., . . . Phatak, H. (2016). Major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a "real-world" observational study in the United States. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 70(9), 752-763. doi:10.1111/ijcp.12863
Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation <i>A Meta</i>-<i>Analysis of Randomized Controlled Trials</i>
Kumar, S., Danik, S. B., Altman, R. K., Barrett, C. D., Lip, G. Y. H., Chatterjee, S., . . . Danik, J. S. (2016). Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation <i>A Meta</i>-<i>Analysis of Randomized Controlled Trials</i>. CARDIOLOGY IN REVIEW, 24(5), 218-223. doi:10.1097/CRD.0000000000000088
Pulmonary Embolism As a Consequence of Ultrasonographic Examination of Extremities for Suspected Venous Thrombosis: A Systematic Review
Mehdipoor, G., Shabestari, A. A., Lip, G. Y. H., & Bikdeli, B. (2016). Pulmonary Embolism As a Consequence of Ultrasonographic Examination of Extremities for Suspected Venous Thrombosis: A Systematic Review. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 42(6), 636-641. doi:10.1055/s-0036-1571336
Risk Stratification for Recurrence and Mortality in Embolic Stroke of Undetermined Source
Ntaios, G., Vemmos, K., Lip, G. Y. H., Koroboki, E., Manios, E., Vemmou, A., . . . Papavasileiou, V. (2016). Risk Stratification for Recurrence and Mortality in Embolic Stroke of Undetermined Source. STROKE, 47(9), 2278-2285. doi:10.1161/STROKEAHA.116.013713
Role of two-dimensional electron gas (2DEG) in AlGaN/GaN high electron mobility transistor (HEMT) ON-state degradation
Syaranamual, G. J., Sasangka, W. A., Made, R. I., Arulkumaran, S., Ng, G. I., Foo, S. C., . . . Thompson, C. V. (2016). Role of two-dimensional electron gas (2DEG) in AlGaN/GaN high electron mobility transistor (HEMT) ON-state degradation. Microelectronics Reliability, 64, 589-593. doi:10.1016/j.microrel.2016.07.012
Stroke prevention in atrial fibrillation: can we do better?
Lane, D. A., & Lip, G. Y. H. (2016). Stroke prevention in atrial fibrillation: can we do better?. NATURE REVIEWS CARDIOLOGY, 13(9), 511-512. doi:10.1038/nrcardio.2016.117
Threading dislocation movement in AlGaN/GaN-on-Si high electron mobility transistors under high temperature reverse bias stressing
Sasangka, W. A., Syaranamual, G. J., Made, R. I., Thompson, C. V., & Gan, C. L. (2016). Threading dislocation movement in AlGaN/GaN-on-Si high electron mobility transistors under high temperature reverse bias stressing. AIP Advances, 6(9). doi:10.1063/1.4962544
Use of non-vitamin K antagonist oral anticoagulants in patients with heart failure and atrial fibrillation: does concomitant kidney disease change our practice?
Shahid, F., Shantsila, E., & Lip, G. Y. H. (2016). Use of non-vitamin K antagonist oral anticoagulants in patients with heart failure and atrial fibrillation: does concomitant kidney disease change our practice?. EUROPEAN JOURNAL OF HEART FAILURE, 18(9), 1172-1174. doi:10.1002/ejhf.552
Altered fibrin clot structure in patients with atrial fibrillation and worsening renal function
Lau, Y. C., Hardy, L. J., Philippou, H., Blann, A. D., & Lip, G. Y. H. (2016). Altered fibrin clot structure in patients with atrial fibrillation and worsening renal function. THROMBOSIS AND HAEMOSTASIS, 116(3), 408-409. doi:10.1160/TH16-05-0361
An investigation into different nickel and nickel–phosphorus stacked thin coatings for the corrosion protection of electrical contacts
Murugan, V. K., Jia, Z., Syaranamual, G. J., Gan, C. L., Huang, Y., & Chen, Z. (2016). An investigation into different nickel and nickel–phosphorus stacked thin coatings for the corrosion protection of electrical contacts. Surface and Coatings Technology, 300, 95-103. doi:10.1016/j.surfcoat.2016.05.013
Assessing bleeding risk in 4824 Asian patients with atrial fibrillation: The Beijing PLA Hospital Atrial Fibrillation Project
Guo, Y. -T., Zhang, Y., Shi, X. -M., Shan, Z. -L., Wang, C. -J., Wang, Y. -T., . . . Lip, G. Y. H. (2016). Assessing bleeding risk in 4824 Asian patients with atrial fibrillation: The Beijing PLA Hospital Atrial Fibrillation Project. SCIENTIFIC REPORTS, 6. doi:10.1038/srep31755
Temporal Trends in Stroke Severity and Prior Antithrombotic Use Among Acute Ischemic Stroke Patients in Japan
Nezu, T., Hosomi, N., Lip, G. Y. H., Aoki, S., Shimomura, R., Maruyama, H., . . . Kobayashi, S. (2016). Temporal Trends in Stroke Severity and Prior Antithrombotic Use Among Acute Ischemic Stroke Patients in Japan. CIRCULATION JOURNAL, 80(9), 2033-2036. doi:10.1253/circj.CJ-16-0374
Stroke prevention in atrial fibrillation
Freedman, B., Potpara, T. S., & Lip, G. Y. H. (2016). Stroke prevention in atrial fibrillation. LANCET, 388(10046), 806-817. doi:10.1016/S0140-6736(16)31257-0
Epidemiology and pathogenesis of diffuse obstructive coronary artery disease: the role of arterial stiffness, shear stress, monocyte subsets and circulating microparticles
Brown, R. A., Shantsila, E., Varma, C., & Lip, G. Y. H. (2016). Epidemiology and pathogenesis of diffuse obstructive coronary artery disease: the role of arterial stiffness, shear stress, monocyte subsets and circulating microparticles. ANNALS OF MEDICINE, 48(6), 444-455. doi:10.1080/07853890.2016.1190861
The HAS-BLED score predicts long-term major bleeding and death in anticoagulated non-valvular atrial fibrillation patients undergoing electrical cardioversion
Garcia-Fernandez, A., Marin, F., Roldan, V., Galcera-Jornet, E., Gabriel Martinez-Martinez, J., Valdes, M., . . . Lip, G. Y. H. (2016). The HAS-BLED score predicts long-term major bleeding and death in anticoagulated non-valvular atrial fibrillation patients undergoing electrical cardioversion. INTERNATIONAL JOURNAL OF CARDIOLOGY, 217, 42-48. doi:10.1016/j.ijcard.2016.04.167
Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: Temporal trends 2011-2015 in Denmark
Staerk, L., Fosbol, E. L., Gadsboll, K., Sindet-Pedersen, C., Pallisgaard, J. L., Lamberts, M., . . . Olesen, J. B. (2016). Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: Temporal trends 2011-2015 in Denmark. SCIENTIFIC REPORTS, 6. doi:10.1038/srep31477
Left atrial enlargement is an independent predictor of stroke and systemic embolism in patients with non-valvular atrial fibrillation
Hamatani, Y., Ogawa, H., Takabayashi, K., Yamashita, Y., Takagi, D., Esato, M., . . . Akao, M. (2016). Left atrial enlargement is an independent predictor of stroke and systemic embolism in patients with non-valvular atrial fibrillation. SCIENTIFIC REPORTS, 6. doi:10.1038/srep31042
Response by Lip to Letter Regarding Article, "How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring"
Lip, G. Y. H. (2016). Response by Lip to Letter Regarding Article, "How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring". CIRCULATION, 134(5), E33-E34. doi:10.1161/CIRCULATIONAHA.116.023663
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., . . . Document Reviewers. (2016). 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.. European journal of heart failure, 18(8), 891-975. doi:10.1002/ejhf.592
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., . . . ESC Scientific Document Group. (2016). 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).. European heart journal, 37(29), 2315-2381. doi:10.1093/eurheartj/ehw106
Associations of retinal artery occlusion and retinal vein occlusion to mortality, stroke, and myocardial infarction: a systematic review
Woo, S. C. Y., Lip, G. Y. H., & Lip, P. L. (2016). Associations of retinal artery occlusion and retinal vein occlusion to mortality, stroke, and myocardial infarction: a systematic review. EYE, 30(8), 1031-1038. doi:10.1038/eye.2016.111
EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.
Goette, A., Kalman, J. M., Aguinaga, L., Akar, J., Cabrera, J. A., Chen, S. A., . . . Review coordinator: Alena Shantsila (UK). (2016). EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.. Journal of arrhythmia, 32(4), 247-278. doi:10.1016/j.joa.2016.05.002
Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study
Chan, E. W., Lau, W. C. Y., Siu, C. W., Lip, G. Y. H., Leung, W. K., Anand, S., . . . Wong, I. C. K. (2016). Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study. HEART RHYTHM, 13(8), 1581-1588. doi:10.1016/j.hrthm.2016.03.049
From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency
Cremer, A., Amraoui, F., Lip, G. Y. H., Morales, E., Rubin, S., Segura, J., . . . Gosse, P. (2016). From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency. JOURNAL OF HUMAN HYPERTENSION, 30(8), 463-466. doi:10.1038/jhh.2015.112
Interfacial evolution and bond reliability in thermosonic Pd coated Cu wire bonding on aluminum metallization: Effect of palladium distribution
Lim, A. B. Y., Boothroyd, C. B., Yauw, O., Chylak, B., Gan, C. L., & Chen, Z. (2016). Interfacial evolution and bond reliability in thermosonic Pd coated Cu wire bonding on aluminum metallization: Effect of palladium distribution. Microelectronics Reliability, 63, 214-223. doi:10.1016/j.microrel.2016.04.003
Laboratory assessment of anti-thrombotic therapy in heart failure, atrial fibrillation and coronary artery disease: insights using thrombelastography and a micro-titre plate assay of thrombogenesis and fibrinolysis
Lau, Y. C., Xiong, Q., Ranjit, P., Lip, G. Y. H., & Blann, A. D. (2016). Laboratory assessment of anti-thrombotic therapy in heart failure, atrial fibrillation and coronary artery disease: insights using thrombelastography and a micro-titre plate assay of thrombogenesis and fibrinolysis. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 42(2), 233-244. doi:10.1007/s11239-016-1344-5
Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial
Di Tullio, M. R., Qian, M., Thompson, J. L. P., Labovitz, A. J., Mann, D. L., Sacco, R. L., . . . Homma, S. (2016). Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial. STROKE, 47(8), 2031-2037. doi:10.1161/STROKEAHA.116.013679
Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF)
Lip, G. Y. H., Hammerstingl, C., Marin, F., Cappato, R., Meng, I. L., Kirsch, B., . . . Cohen, A. (2016). Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF). AMERICAN HEART JOURNAL, 178, 126-134. doi:10.1016/j.ahj.2016.05.007
Relation of the SAMe-TT<sub>2</sub>R<sub>2</sub> score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: Observations from the SPORTIF trials
Proietti, M., Lane, D. A., & Lip, G. Y. H. (2016). Relation of the SAMe-TT<sub>2</sub>R<sub>2</sub> score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: Observations from the SPORTIF trials. INTERNATIONAL JOURNAL OF CARDIOLOGY, 216, 168-172. doi:10.1016/j.ijcard.2016.04.131
The first prognostic model for stroke and death in patients with systolic heart failure
Freudenberger, R. S., Cheng, B., Mann, D. L., Thompson, J. L. P., Sacco, R. L., Buchsbaum, R., . . . Homma, S. (2016). The first prognostic model for stroke and death in patients with systolic heart failure. JOURNAL OF CARDIOLOGY, 68(1-2), 100-103. doi:10.1016/j.jjcc.2015.09.014
Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes
Boriani, G., Laroche, C., Diemberger, I., Popescu, M. I., Rasmussen, L. H., Petrescu, L., . . . Lip, G. Y. H. (2016). Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes. SCIENTIFIC REPORTS, 6. doi:10.1038/srep30271
Efficacy of Statin Therapy in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis
Rysz-Gorzynska, M., Gluba-Brzozka, A., Sahebkar, A., Serban, M. -C., Mikhailidis, D. P., Ursoniu, S., . . . Banach, M. (2016). Efficacy of Statin Therapy in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis. SCIENTIFIC REPORTS, 6. doi:10.1038/srep30060
Cardiac Arrhythmias in Patients with Chronic Kidney Disease: Implications of Renal Failure for Antiarrhythmic Drug Therapy
Potpara, T. S., Jokic, V., Dagres, N., Marin, F., Prostran, M. S., Blomstrom-Lundqvist, C., & Lip, G. Y. H. (2016). Cardiac Arrhythmias in Patients with Chronic Kidney Disease: Implications of Renal Failure for Antiarrhythmic Drug Therapy. CURRENT MEDICINAL CHEMISTRY, 23(19), 2070-2083. doi:10.2174/0929867323666160309114246
Non-Vitamin K Oral Anticoagulant Drugs for Stroke Prevention in Patients with Atrial Fibrillation and Chronic Kidney Disease
Potpara, T. S., Jokic, V., Dagres, N., Larsen, T. B., Lane, D. A., Hindricks, G., & Lip, G. Y. H. (2016). Non-Vitamin K Oral Anticoagulant Drugs for Stroke Prevention in Patients with Atrial Fibrillation and Chronic Kidney Disease. CURRENT MEDICINAL CHEMISTRY, 23(19), 2055-2069. doi:10.2174/0929867323666160210130109
Effects of Quercetin on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Serban, M. -C., Sahebkar, A., Zanchetti, A., Mikhailidis, D. P., Howard, G., Antal, D., . . . Banach, M. (2016). Effects of Quercetin on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 5(7). doi:10.1161/JAHA.115.002713
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., . . . Zamorano, J. L. (2016). 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 23(11), NP1-NP96. doi:10.1177/2047487316653709
Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants
Enriquez, A., Lip, G. Y. H., & Baranchuk, A. (2016). Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants. EUROPACE, 18(7), 955-964. doi:10.1093/europace/euv030
Current Status and Time Trends of Oral Anticoagulation Use Among Chinese Patients With Nonvalvular Atrial Fibrillation The Chinese Atrial Fibrillation Registry Study
Chang, S. -S., Dong, J. -Z., Ma, C. -S., Du, X., Wu, J. -H., Tang, R. -B., . . . Lip, G. Y. H. (2016). Current Status and Time Trends of Oral Anticoagulation Use Among Chinese Patients With Nonvalvular Atrial Fibrillation The Chinese Atrial Fibrillation Registry Study. STROKE, 47(7), 1803-1810. doi:10.1161/STROKEAHA.116.012988
Evaluation of the Efficacy and Safety of Dual Antiplatelet Therapy with or Without Warfarin in Patients with a Clinical Indication for DAPT and Chronic Anticoagulation: A Meta-Analysis of Observational Studies
Bavishi, C., Koulova, A., Bangalore, S., Sawant, A., Chatterjee, S., Ather, S., . . . Tamis-Holland, J. E. (2016). Evaluation of the Efficacy and Safety of Dual Antiplatelet Therapy with or Without Warfarin in Patients with a Clinical Indication for DAPT and Chronic Anticoagulation: A Meta-Analysis of Observational Studies. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 88(1), E12-E22. doi:10.1002/ccd.26234
Letter by Nielsen et al Regarding Article, "Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA<sub>2</sub>DS<sub>2</sub>-VASc Score of 1: Systematic Review and Meta-Analysis"
Nielsen, P. B., Larsen, T. B., & Lip, G. Y. H. (2016). Letter by Nielsen et al Regarding Article, "Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA<sub>2</sub>DS<sub>2</sub>-VASc Score of 1: Systematic Review and Meta-Analysis". STROKE, 47(7), e193. doi:10.1161/STROKEAHA.116.013672
Relation of Nonvalvular Atrial Fibrillati to Body Mass Index (from the SPORTIF Trials)
Proietti, M., Lane, D. A., & Lip, G. Y. H. (2016). Relation of Nonvalvular Atrial Fibrillati to Body Mass Index (from the SPORTIF Trials). In AMERICAN JOURNAL OF CARDIOLOGY Vol. 118 (pp. 72-78). doi:10.1016/j.amjcard.2016.04.013
Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA<sub>2</sub>DS<sub>2</sub>-VASc Risk Factor Be Anticoagulated?
Fauchier, L., Clementy, N., Bisson, A., Ivanes, F., Angoulvant, D., Babuty, D., & Lip, G. Y. H. (2016). Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA<sub>2</sub>DS<sub>2</sub>-VASc Risk Factor Be Anticoagulated?. STROKE, 47(7), 1831-1836. doi:10.1161/STROKEAHA.116.013253
Enhanced copper micro/nano-particle mixed paste sintered at low temperature for 3D interconnects
Dai, Y. Y., Ng, M. Z., Anantha, P., Lin, Y. D., Li, Z. G., Gan, C. L., & Tan, C. S. (2016). Enhanced copper micro/nano-particle mixed paste sintered at low temperature for 3D interconnects. Applied Physics Letters, 108(26). doi:10.1063/1.4954966
HAS-BLED Versus ATRIA Risk Scores for Intracranial Hemorrhage in Patients Receiving Thrombolytics for Pulmonary Embolism
Chatterjee, S., Lip, G. Y. H., & Giri, J. (2016). HAS-BLED Versus ATRIA Risk Scores for Intracranial Hemorrhage in Patients Receiving Thrombolytics for Pulmonary Embolism. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 67(24), 2904-2905. doi:10.1016/j.jacc.2016.03.577
Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
Larsen, T. B., Skjoth, F., Nielsen, P. B., Kjaeldgaard, J. N., & Lip, G. Y. H. (2016). Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study. BMJ: British Medical Journal, 353. doi:10.1136/bmj.i3189
Non-vitamin K antagonist oral anticoagulants (NOACs) for the management of venous thromboembolism
Blann, A. D., & Lip, G. Y. H. (2016). Non-vitamin K antagonist oral anticoagulants (NOACs) for the management of venous thromboembolism. HEART, 102(12), 975-983. doi:10.1136/heartjnl-2014-307019
Rationale and design of the Chinese Atrial Fibrillation Registry Study
Du, X., Ma, C., Wu, J., Li, S., Ning, M., Tang, R., . . . Lip, G. Y. H. (2016). Rationale and design of the Chinese Atrial Fibrillation Registry Study. BMC CARDIOVASCULAR DISORDERS, 16. doi:10.1186/s12872-016-0308-1
Stroke and thromboembolic event rates in atrial fibrillation according to different guideline treatment thresholds: A nationwide cohort study
Nielsen, P. B., Larsen, T. B., Skjoth, F., Overvad, T. F., & Lip, G. Y. H. (2016). Stroke and thromboembolic event rates in atrial fibrillation according to different guideline treatment thresholds: A nationwide cohort study. SCIENTIFIC REPORTS, 6. doi:10.1038/srep27410
The SAME-TT<sub>2</sub>R<sub>2</sub> score predicts the quality of anticoagulation control in patients with acute VIE A real-life inception cohort study
Palareti, G., Antonucci, E., Lip, G. Y. H., Testa, S., Guazzaloca, G., Falanga, A., . . . Poli, D. (2016). The SAME-TT<sub>2</sub>R<sub>2</sub> score predicts the quality of anticoagulation control in patients with acute VIE A real-life inception cohort study. THROMBOSIS AND HAEMOSTASIS, 115(6), 1101-1108. doi:10.1160/TH15-10-0830
Carotid Atherosclerosis and Stroke in Atrial Fibrillation The Atherosclerosis Risk in Communities Study
Bekwelem, W., Jensen, P. N., Norby, F. L., Soliman, E. Z., Agarwal, S. K., Lip, G. Y. H., . . . Chen, L. Y. (2016). Carotid Atherosclerosis and Stroke in Atrial Fibrillation The Atherosclerosis Risk in Communities Study. STROKE, 47(6), 1643-U565. doi:10.1161/STROKEAHA.116.013133
Chronic Kidney Disease, Time in Therapeutic Range and Adverse Clinical Outcomes in Anticoagulated Patients with Non-valvular Atrial Fibrillation: Observations from the SPORTIF Trials
Proietti, M., Lane, D. A., & Lip, G. Y. H. (2016). Chronic Kidney Disease, Time in Therapeutic Range and Adverse Clinical Outcomes in Anticoagulated Patients with Non-valvular Atrial Fibrillation: Observations from the SPORTIF Trials. EBIOMEDICINE, 8, 309-316. doi:10.1016/j.ebiom.2016.04.013
Cost-Effectiveness of Apixaban versus Warfarin in Chinese Patients with Non-Valvular Atrial Fibrillation: A Real-Life and Modelling Analyses
Li, X., Tse, V. C., Lau, W. C. Y., Cheung, B. M. Y., Lip, G. Y. H., Wong, I. C. K., & Chan, E. W. (2016). Cost-Effectiveness of Apixaban versus Warfarin in Chinese Patients with Non-Valvular Atrial Fibrillation: A Real-Life and Modelling Analyses. PLOS ONE, 11(6). doi:10.1371/journal.pone.0157129
Deep vs Lobar Intracerebral Hemorrhage on HAS-BLED Scoring System Response
Nielsen, P. B., Larsen, T. B., & Lip, G. Y. H. (2016). Deep vs Lobar Intracerebral Hemorrhage on HAS-BLED Scoring System Response. CHEST, 149(6), 1590-1591. doi:10.1016/j.chest.2016.03.057
Evaluation of a 'color coding' system for the assessment of patients undergoing primary percutaneous coronary intervention
Ruiz-Nodar, J. M., Gomez-Sansano, J. M., Galcera, E., Mainar, V., Valencia, J., Pineda, J., . . . Lip, G. Y. H. (2016). Evaluation of a 'color coding' system for the assessment of patients undergoing primary percutaneous coronary intervention. INTERNATIONAL JOURNAL OF CARDIOLOGY, 212, 371-376. doi:10.1016/j.ijcard.2016.03.077
Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin
Senoo, K., Proietti, M., Lane, D. A., & Lip, G. Y. H. (2016). Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin. AMERICAN JOURNAL OF MEDICINE, 129(6), 600-607. doi:10.1016/j.amjmed.2015.10.001
Female Sex, Time in Therapeutic Range, and Clinical Outcomes in Atrial Fibrillation Patients Taking Warfarin
Senoo, K., & Lip, G. Y. H. (2016). Female Sex, Time in Therapeutic Range, and Clinical Outcomes in Atrial Fibrillation Patients Taking Warfarin. STROKE, 47(6), 1665-U623. doi:10.1161/STROKEAHA.116.013173
Impact of an Atrial Fibrillation Decision Support Tool on thromboprophylaxis for atrial fibrillation
Eckman, M. H., Lip, G. Y. H., Wise, R. E., Speer, B., Sullivan, M., Walker, N., . . . Kues, J. (2016). Impact of an Atrial Fibrillation Decision Support Tool on thromboprophylaxis for atrial fibrillation. AMERICAN HEART JOURNAL, 176, 17-27. doi:10.1016/j.ahj.2016.02.009
Multiple Silent Lacunes Are Associated with Recurrent Ischemic Stroke
Andersen, S. D., Skjoth, F., Yavarian, Y., Bach, F. W., Lip, G. Y. H., & Larsen, T. B. (2016). Multiple Silent Lacunes Are Associated with Recurrent Ischemic Stroke. CEREBROVASCULAR DISEASES, 42(1-2), 73-80. doi:10.1159/000445196
Net clinical benefit of adding aspirin to warfarin in patients with atrial fibrillation: Insights from the J-RHYTHM Registry
Watanabe, E., Yamamoto, M., Kodama, I., Inoue, H., Atarashi, H., Okumura, K., . . . Origasa, H. (2016). Net clinical benefit of adding aspirin to warfarin in patients with atrial fibrillation: Insights from the J-RHYTHM Registry. INTERNATIONAL JOURNAL OF CARDIOLOGY, 212, 311-317. doi:10.1016/j.ijcard.2016.03.008
Thermal reliability of a bilayer of Ni(P)/Cu as a diffusion barrier for Cu/Sn/Cu bonding
Lee, B., Jeon, H., Gan, C. L., & Lee, H. -J. (2016). Thermal reliability of a bilayer of Ni(P)/Cu as a diffusion barrier for Cu/Sn/Cu bonding. Japanese Journal of Applied Physics, 55(6S3), 06JF03. doi:10.7567/jjap.55.06jf03
'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry
Boriani, G., Laroche, C., Diemberger, I., Fantecchi, E., Popescu, M. I., Rasmussen, L. H., . . . Lip, G. Y. H. (2016). 'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry. EUROPACE, 18(5), 648-657. doi:10.1093/europace/euv390
Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis
Chan, P. -H., Huang, D., Yip, P. -S., Hai, J., Tse, H. -F., Chan, T. -M., . . . Siu, C. -W. (2016). Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis. EUROPACE, 18(5), 665-671. doi:10.1093/europace/euv289
Effect of renal function on whole blood and fibrin clot formation in atrial fibrillation patients on warfarin
Lau, Y. C., Xiong, Q., Lip, G. Y. H., & Blann, A. D. (2016). Effect of renal function on whole blood and fibrin clot formation in atrial fibrillation patients on warfarin. ANNALS OF MEDICINE, 48(4), 275-281. doi:10.3109/07853890.2016.1166516
Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm (Withdrawn Paper. 2016, art. no. CD003333)
Lip, G. Y. H., Wrigley, B. J., & Pisters, R. (2016). Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm (Withdrawn Paper. 2016, art. no. CD003333). COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (5). doi:10.1002/14651858.CD003333.pub2
Oral anticoagulation, stroke and thromboembolism in patients with atrial fibrillation and valve bioprosthesis The Loire Valley Atrial Fibrillation Project
Philippart, R., Brunet-Bernard, A., Clementy, N., Bourguignon, T., Mirza, A., Angoulvant, D., . . . Fauchier, L. (2016). Oral anticoagulation, stroke and thromboembolism in patients with atrial fibrillation and valve bioprosthesis The Loire Valley Atrial Fibrillation Project. THROMBOSIS AND HAEMOSTASIS, 115(5), 1056-1063. doi:10.1160/TH16-01-0007
A tailored treatment strategy: a modern approach for stroke prevention in patients with atrial fibrillation
Lip, G. Y. H., Potpara, T., Boriani, G., & Blomstrom-Lundqvist, C. (2016). A tailored treatment strategy: a modern approach for stroke prevention in patients with atrial fibrillation. JOURNAL OF INTERNAL MEDICINE, 279(5), 467-476. doi:10.1111/joim.12468
Atmospheric corrosion resistance of electroplated Ni/Ni–P/Au electronic contacts
Murugan, V. K., Jia, Z., Syaranamual, G. J., Gan, C. L., Huang, Y., & Chen, Z. (2016). Atmospheric corrosion resistance of electroplated Ni/Ni–P/Au electronic contacts. Microelectronics Reliability, 60, 84-92. doi:10.1016/j.microrel.2016.02.014
Atrial Fibrillation and Stroke Making Sense of Recent Observations on Anticoagulation
Proietti, M., & Lip, G. Y. H. (2016). Atrial Fibrillation and Stroke Making Sense of Recent Observations on Anticoagulation. CARDIOLOGY CLINICS, 34(2), 317-+. doi:10.1016/j.ccl.2015.12.006
Impact on Outcomes of Changing Treatment Guideline Recommendations for Stroke Prevention in Atrial Fibrillation: A Nationwide Cohort Study
Chao, T. -F., Liu, C. -J., Tuan, T. -C., Wang, K. -L., Lin, Y. -J., Chang, S. -L., . . . Chen, S. -A. (2016). Impact on Outcomes of Changing Treatment Guideline Recommendations for Stroke Prevention in Atrial Fibrillation: A Nationwide Cohort Study. MAYO CLINIC PROCEEDINGS, 91(5), 567-574. doi:10.1016/j.mayocp.2016.03.007
Misconceptions on Interpretation of Risk Prediction Tools in Atrial Fibrillation
Nielsen, P. B., Larsen, T. B., & Lip, G. Y. H. (2016). Misconceptions on Interpretation of Risk Prediction Tools in Atrial Fibrillation. AMERICAN JOURNAL OF MEDICINE, 129(5), E31. doi:10.1016/j.amjmed.2015.11.038
Outcomes in a Warfarin-Treated Population With Atrial Fibrillation
Bjorck, F., Renlund, H., Lip, G. Y. H., Wester, P., Svensson, P. J., & Sjalander, A. (2016). Outcomes in a Warfarin-Treated Population With Atrial Fibrillation. JAMA CARDIOLOGY, 1(2), 172-180. doi:10.1001/jamacardio.2016.0199
Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial
Proietti, M., Raparelli, V., Olshansky, B., & Lip, G. Y. H. (2016). Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial. CLINICAL RESEARCH IN CARDIOLOGY, 105(5), 412-420. doi:10.1007/s00392-015-0936-y
Using an Atrial Fibrillation Decision Support Tool for Thromboprophylaxis in Atrial Fibrillation: Effect of Sex and Age
Eckman, M. H., Lip, G. Y. H., Wise, R. E., Speer, B., Sullivan, M., Walker, N., . . . Kues, J. (2016). Using an Atrial Fibrillation Decision Support Tool for Thromboprophylaxis in Atrial Fibrillation: Effect of Sex and Age. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 64(5), 1054-1060. doi:10.1111/jgs.14099
miRNA-197 and miRNA-223 and cardiovascular death in coronary artery disease patients
Orenes-Pinero, E., Marin, F., & Lip, G. Y. H. (2016). miRNA-197 and miRNA-223 and cardiovascular death in coronary artery disease patients. ANNALS OF TRANSLATIONAL MEDICINE, 4(10). doi:10.21037/atm.2016.05.27
Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis
Kotecha, D., Manzano, L., Krum, H., Rosano, G., Holmes, J., Altman, D. G., . . . Flather, M. D. (2016). Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis. BMJ-BRITISH MEDICAL JOURNAL, 353. doi:10.1136/bmj.i1855
Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage
Chao, T. -F., Liu, C. -J., Liao, J. -N., Wang, K. -L., Lin, Y. -J., Chang, S. -L., . . . Chen, S. -A. (2016). Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage. CIRCULATION, 133(16), 1540-1547. doi:10.1161/CIRCULATIONAHA.115.019794
Diabetes mellitus and risk of ischemic stroke in patients with heart failure and no atrial fibrillation
Melgaard, L., Gorst-Rasmussen, A., Sogaard, P., Rasmussen, L. H., Lip, G. Y. H., & Larsen, T. B. (2016). Diabetes mellitus and risk of ischemic stroke in patients with heart failure and no atrial fibrillation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 209, 1-6. doi:10.1016/j.ijcard.2016.02.004
Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores
Proietti, M., Senoo, K., Lane, D. A., & Lip, G. Y. H. (2016). Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores. SCIENTIFIC REPORTS, 6. doi:10.1038/srep24376
Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA<sub>2</sub>DS<sub>2</sub>-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? <i>Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke</i>
Lip, G. Y. H., & Nielsen, P. B. (2016). Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA<sub>2</sub>DS<sub>2</sub>-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? <i>Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke</i>. CIRCULATION, 133(15), 1498-1503. doi:10.1161/CIRCULATIONAHA.115.016713
PHYSICAL ACTIVITY AND MAJOR ADVERSE EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION: A REPORT FROM THE EUROBSERVATIONAL RESEARCH PROGRAMME PILOT SURVEY ON ATRIAL FIBRILLATION (EORP-AF) GENERAL REGISTRY
Proietti, M., Boriani, G., Laroche, C., Diemberger, I., Popescu, M. I., Rasmussen, L. H., . . . Lip, G. (2016). PHYSICAL ACTIVITY AND MAJOR ADVERSE EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION: A REPORT FROM THE EUROBSERVATIONAL RESEARCH PROGRAMME PILOT SURVEY ON ATRIAL FIBRILLATION (EORP-AF) GENERAL REGISTRY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 67 (pp. 688). doi:10.1016/S0735-1097(16)30689-1
Ankle-Brachial Index and cardiovascular events in atrial fibrillation The ARAPACIS Study
Violi, F., Davi, G., Proietti, M., Pastori, D., Hiatt, W. R., Corazza, G. R., . . . Basili, S. (2016). Ankle-Brachial Index and cardiovascular events in atrial fibrillation The ARAPACIS Study. THROMBOSIS AND HAEMOSTASIS, 115(4), 856-863. doi:10.1160/TH15-07-0612
Anticoagulant therapy after venous thromboembolism and 10-year mortality
Larsen, T. B., Lip, G. Y. H., & Gorst-Rasmussen, A. (2016). Anticoagulant therapy after venous thromboembolism and 10-year mortality. INTERNATIONAL JOURNAL OF CARDIOLOGY, 208, 72-78. doi:10.1016/j.ijcard.2016.01.190
Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation
Dzeshka, M. S., & Lip, G. Y. H. (2016). Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation. HEART FAILURE CLINICS, 12(2), 257-+. doi:10.1016/j.hfc.2015.08.021
Atrial fibrillation and its complications: a focus on identifying risk factors and risk stratification
Shahid, F., Shantsila, E., & Lip, G. Y. H. (2016). Atrial fibrillation and its complications: a focus on identifying risk factors and risk stratification. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2(2), 88-+. doi:10.1093/ehjcvp/pvv057
CHA2DS2-VASC SCORE AND ADVERSE EVENTS IN PATIENTS WITH HEART FAILURE AND SINUS RHYTHM
Ye, S., Qian, M., Zhao, B., Lip, G., Buchsbaum, R., Sacco, R., . . . Homma, S. (2016). CHA2DS2-VASC SCORE AND ADVERSE EVENTS IN PATIENTS WITH HEART FAILURE AND SINUS RHYTHM. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 67 (pp. 1335). doi:10.1016/S0735-1097(16)31336-5
Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke
Diamantopoulos, A., Sawyer, L. M., Lip, G. Y. H., Witte, K. K., Reynolds, M. R., Fauchier, L., . . . Diener, H. -C. (2016). Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke. INTERNATIONAL JOURNAL OF STROKE, 11(3), 302-312. doi:10.1177/1747493015620803
EACVI/EHRA Expert Consensus Document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation
Donal, E., Lip, G. Y. H., Galderisi, M., Goette, A., Shah, D., Marwan, M., . . . Habib, G. (2016). EACVI/EHRA Expert Consensus Document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation. EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 17(4), 355-383. doi:10.1093/ehjci/jev354
IMPACT OF L-CARNITINE ON PLASMA LIPOPROTEIN(A) CONCENTRATIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Serban, M. C., Mikhailidis, D. P., Toth, P., Jones, S., Muntner, P., Blaha, M., . . . Banach, M. (2016). IMPACT OF L-CARNITINE ON PLASMA LIPOPROTEIN(A) CONCENTRATIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 67 (pp. 2032). doi:10.1016/S0735-1097(16)32033-2
Microstructure, crystallization and shape memory behavior of titania and yttria co-doped zirconia
Zeng, X. M., Du, Z., Schuh, C. A., Tamura, N., & Gan, C. L. (2016). Microstructure, crystallization and shape memory behavior of titania and yttria co-doped zirconia. Journal of the European Ceramic Society, 36(5), 1277-1283. doi:10.1016/j.jeurceramsoc.2015.11.042
Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor The Loire Valley Atrial Fibrillation Project
Fauchier, L., Lecoq, C., Clementy, N., Bernard, A., Angoulvant, D., Ivanes, F., . . . Lip, G. Y. H. (2016). Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor The Loire Valley Atrial Fibrillation Project. CHEST, 149(4), 960-968. doi:10.1378/chest.15-1622
Oral anticoagulants in coronary heart disease (Section IV) Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease
De Caterina, R., Husted, S., Wallentin, L., Andreotti, F., Arnesen, H., Bachmann, F., . . . Weitz, J. I. (2016). Oral anticoagulants in coronary heart disease (Section IV) Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease. THROMBOSIS AND HAEMOSTASIS, 115(4), 685-711. doi:10.1160/TH15-09-0703
REAL WORLD COMPARISON OF MAJOR BLEEDING RISK AMONG NON-VALVULAR ATRIAL FIBRILLATION PATIENTS NEWLY INITIATED ON APIXABAN, WARFARIN, DABIGATRAN OR RIVAROXABAN: A 1:1 PROPENSITY-SCORE MATCHED ANALYSIS
Lip, G., Keshishian, A., Kamble, S., Pan, X., Burns, L., Mardekian, J., . . . Phatak, H. (2016). REAL WORLD COMPARISON OF MAJOR BLEEDING RISK AMONG NON-VALVULAR ATRIAL FIBRILLATION PATIENTS NEWLY INITIATED ON APIXABAN, WARFARIN, DABIGATRAN OR RIVAROXABAN: A 1:1 PROPENSITY-SCORE MATCHED ANALYSIS. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 67 (pp. 882). doi:10.1016/S0735-1097(16)30883-X
REAL-WORLD COMPARISON OF INPATIENT BLEEDING RISK, BLEEDING-RELATED HOSPITALIZATION RATES AND COSTS AMONG NON-VALVULAR ATRIAL FIBRILLATION PATIENTS ON APIXABAN, DABIGATRAN, RIVAROXABAN: COHORTS COMPRISING NEW INITIATORS AND/OR SWITCHERS FROM WARFARIN
Tepper, P., Mardekian, J., Masseria, C., Horblyuk, R., Kamble, S., Hamilton, M., . . . Lip, G. Y. H. (2016). REAL-WORLD COMPARISON OF INPATIENT BLEEDING RISK, BLEEDING-RELATED HOSPITALIZATION RATES AND COSTS AMONG NON-VALVULAR ATRIAL FIBRILLATION PATIENTS ON APIXABAN, DABIGATRAN, RIVAROXABAN: COHORTS COMPRISING NEW INITIATORS AND/OR SWITCHERS FROM WARFARIN. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 67 (pp. 662). doi:10.1016/S0735-1097(16)30663-5
SEX DIFFERENCES IN ANTITHROMBOTIC THERAPY: OBSERVATIONS FROM THE GLORIA-AF REGISTRY PROGRAM
Teutsch, C., Lip, G. Y. H., Diener, H. -C., Dubner, S., Halperin, J., Ma, C., . . . Huisman, M. (2016). SEX DIFFERENCES IN ANTITHROMBOTIC THERAPY: OBSERVATIONS FROM THE GLORIA-AF REGISTRY PROGRAM. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 67 (pp. 794). doi:10.1016/S0735-1097(16)30795-1
STROKE AND BLEEDING RISK IN PATIENTS WITH ATRIAL FIBRILLATION WITH RESUMPTION OF ORAL ANTICOAGULATION FOLLOWING TRAUMATIC INJURY: A DANISH NATIONWIDE COHORT STUDY
Staerk, L., Gislason, G., Lip, G., Fosbol, E., Sindet-Pedersen, C., Gadsboll, K., . . . Olesen, J. (2016). STROKE AND BLEEDING RISK IN PATIENTS WITH ATRIAL FIBRILLATION WITH RESUMPTION OF ORAL ANTICOAGULATION FOLLOWING TRAUMATIC INJURY: A DANISH NATIONWIDE COHORT STUDY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 67 (pp. 892). doi:10.1016/S0735-1097(16)30893-2
Treatment of Atrial Fibrillation in Patients With Chronic Kidney Disease Is Stroke Prevention Worth the Risk?
Shahid, F., Shantsila, E., & Lip, G. Y. H. (2016). Treatment of Atrial Fibrillation in Patients With Chronic Kidney Disease Is Stroke Prevention Worth the Risk?. CHEST, 149(4), 891-892. doi:10.1016/j.chest.2015.09.026
WHAT DO REAL WORLD DATA SAY ABOUT SAFETY AND RESOURCE USE OF ORAL ANTAGONISTS? EARLY ANALYSIS OF NEWLY ANTICOAGULATED NON-VALVULAR ATRIAL FIBRILLATION PATIENTS USING EITHER APIXABAN, DABIGATRAN, RIVAROXABAN OR WARFARIN
Pan, X., Kamble, S., Burns, L., Kawabata, H., Mardekian, J., Masseria, C., . . . Lip, G. Y. H. (2016). WHAT DO REAL WORLD DATA SAY ABOUT SAFETY AND RESOURCE USE OF ORAL ANTAGONISTS? EARLY ANALYSIS OF NEWLY ANTICOAGULATED NON-VALVULAR ATRIAL FIBRILLATION PATIENTS USING EITHER APIXABAN, DABIGATRAN, RIVAROXABAN OR WARFARIN. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 67 (pp. 894). doi:10.1016/S0735-1097(16)30895-6
[2015 ESC Guidelines for the management of infective endocarditis. The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)].
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J. -P., Del Zotti, F., . . . Task Force per il Trattamento dell'Endocardite Infettiva della Società Europea di Cardiologia (ESC). (2016). [2015 ESC Guidelines for the management of infective endocarditis. The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)].. Giornale italiano di cardiologia (2006), 17(4), 277-319. doi:10.1714/2214.23904
Atrial fibrillation
Lip, G. Y. H., Fauchier, L., Freedman, S. B., Van Gelder, I., Natale, A., Gianni, C., . . . Lane, D. A. (2016). Atrial fibrillation. NATURE REVIEWS DISEASE PRIMERS, 2. doi:10.1038/nrdp.2016.16
Atrial fibrillation.
Atrial fibrillation. (2016). Nature reviews. Disease primers, 2, 16017. doi:10.1038/nrdp.2016.17
Endotoxemia as a trigger of thrombosis in cirrhosis
Violi, F., Lip, G. Y. H., & Cangemi, R. (2016). Endotoxemia as a trigger of thrombosis in cirrhosis. HAEMATOLOGICA, 101(4). doi:10.3324/haematol.2015.139972
How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring
Lip, G. Y. H. (2016). How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring. CIRCULATION, 133(13), 1290-1295. doi:10.1161/CIRCULATIONAHA.115.016797
Polish and European management strategies in patients with atrial fibrillation Data from the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot)
Lenarczyk, R., Mitrega, K., Mazurek, M., Janion, M., Opolski, G., Drozdz, J., . . . Kalarus, Z. (2016). Polish and European management strategies in patients with atrial fibrillation Data from the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot). POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 126(3), 138-148. doi:10.20452/pamw.3322
Interfacial strength and deformation mechanism of SiC–Al composite micro-pillars
Guo, X., Guo, Q., Li, Z., Fan, G., Xiong, D. -B., Su, Y., . . . Zhang, D. (2016). Interfacial strength and deformation mechanism of SiC–Al composite micro-pillars. Scripta Materialia, 114, 56-59. doi:10.1016/j.scriptamat.2015.11.018
Relation of female sex to left atrial diameter and cardiovascular death in atrial fibrillation: The AFFIRM Trial
Proietti, M., Raparelli, V., Basili, S., Olshansky, B., & Lip, G. Y. H. (2016). Relation of female sex to left atrial diameter and cardiovascular death in atrial fibrillation: The AFFIRM Trial. INTERNATIONAL JOURNAL OF CARDIOLOGY, 207, 258-263. doi:10.1016/j.ijcard.2016.01.169
Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF.
Pokorney, S. D., Piccini, J. P., Stevens, S. R., Patel, M. R., Pieper, K. S., Halperin, J. L., . . . ROCKET AF Steering Committee Investigators. (2016). Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF.. Journal of the American Heart Association, 5(3), e002197. doi:10.1161/jaha.115.002197
Interaction Between Dietary Vitamin K Intake and Anticoagulation by Vitamin K Antagonists: Is It Really True? <i>A Systematic Review</i>
Violi, F., Lip, G. Y. H., Pignatelli, P., & Pastori, D. (2016). Interaction Between Dietary Vitamin K Intake and Anticoagulation by Vitamin K Antagonists: Is It Really True? <i>A Systematic Review</i>. MEDICINE, 95(10). doi:10.1097/MD.0000000000002895
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Roffi, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., . . . Patrono, C. (2016). 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Russian Journal of Cardiology, 131(3), 9-63. doi:10.15829/1560-4071-2016-3-9-63
Cardiovascular risk stratification in patients with non-valvular atrial fibrillation: the 2MACE score
Pastori, D., Farcomeni, A., Poli, D., Antonucci, E., Angelico, F., Del Ben, M., . . . Violi, F. (2016). Cardiovascular risk stratification in patients with non-valvular atrial fibrillation: the 2MACE score. INTERNAL AND EMERGENCY MEDICINE, 11(2), 199-204. doi:10.1007/s11739-015-1326-1
Symptom-to-door times in patients presenting with ST elevation myocardial infarction-do ethnic or gender differences exist?
Brown, R. A., Shantsila, E., Varma, C., & Lip, G. Y. H. (2016). Symptom-to-door times in patients presenting with ST elevation myocardial infarction-do ethnic or gender differences exist?. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 109(3), 175-180. doi:10.1093/qjmed/hcv112
Use of the SAMe-TT<sub>2</sub>R<sub>2</sub> Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke Incidence
Chan, P. H., Hai, J. J., Chan, E. W., Li, W. H., Tse, H. F., Wong, I. C. K., . . . Siu, C. W. (2016). Use of the SAMe-TT<sub>2</sub>R<sub>2</sub> Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke Incidence. PLOS ONE, 11(3). doi:10.1371/journal.pone.0150674
Vascular Disease and Risk Stratification for Ischemic Stroke and All-Cause Death in Heart Failure Patients without Diagnosed Atrial Fibrillation: A Nationwide Cohort Study
Melgaard, L., Gorst-Rasmussen, A., Rasmussen, L. H., Lip, G. Y. H., & Larsen, T. B. (2016). Vascular Disease and Risk Stratification for Ischemic Stroke and All-Cause Death in Heart Failure Patients without Diagnosed Atrial Fibrillation: A Nationwide Cohort Study. PLOS ONE, 11(3). doi:10.1371/journal.pone.0152269
Edoxaban in venous thromboembolism and stroke prevention: an appraisal
Proietti, M., & Lip, G. Y. H. (2016). Edoxaban in venous thromboembolism and stroke prevention: an appraisal. VASCULAR HEALTH AND RISK MANAGEMENT, 12, 45-51. doi:10.2147/VHRM.S81569
Clinical and Echocardiographic Factors Associated With New-Onset Atrial Fibrillation in Heart Failure - Subanalysis of the WARCEF Trial -
Kato, T. S., Di Tullio, M. R., Qian, M., Wu, M., Thompson, J. L. P., Mann, D. L., . . . Homma, S. (2016). Clinical and Echocardiographic Factors Associated With New-Onset Atrial Fibrillation in Heart Failure - Subanalysis of the WARCEF Trial -. CIRCULATION JOURNAL, 80(3), 619-+. doi:10.1253/circj.CJ-15-1054
Long-Term Predictors of Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion
Garcia-Fernandez, A., Marin, F., Roldan, V., Gomez-Sansano, J. M., Hernandez-Romero, D., Valdes, M., . . . Lip, G. Y. H. (2016). Long-Term Predictors of Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion. CIRCULATION JOURNAL, 80(3), 605-612. doi:10.1253/circj.CJ-15-0992
Application of copper nanoparticles as die attachment for high power LED
Lee, B. H., Ng, M. Z., Zinn, A. A., & Gan, C. L. (2015). Application of copper nanoparticles as die attachment for high power LED. In 2015 IEEE 17th Electronics Packaging and Technology Conference (EPTC) (pp. 1-5). IEEE. doi:10.1109/eptc.2015.7412383
Evaluation of the corrosion performance of Cu-Al intermetallic compounds and the effect of Pd addition
Lim, A. B. Y., Neo, W. J., Yauw, O., Chylak, B., Gan, C. L., & Chen, Z. (2015). Evaluation of the corrosion performance of Cu-Al intermetallic compounds and the effect of Pd addition. In 2015 IEEE 17th Electronics Packaging and Technology Conference (EPTC) (pp. 1-5). IEEE. doi:10.1109/eptc.2015.7412261
Stroke prevention in atrial fibrillation and 'real world' adherence to guidelines in the Balkan Region: The BALKAN-AF Survey
Potpara, T. S., Dan, G. -A., Trendafilova, E., Goda, A., Kusljugic, Z., Manola, S., . . . Lip, G. Y. H. (2016). Stroke prevention in atrial fibrillation and 'real world' adherence to guidelines in the Balkan Region: The BALKAN-AF Survey. SCIENTIFIC REPORTS, 6. doi:10.1038/srep20432
Body Mass Index and Adverse Outcomes in Elderly Patients With Atrial Fibrillation The AMADEUS Trial
Senoo, K., & Lip, G. Y. H. (2016). Body Mass Index and Adverse Outcomes in Elderly Patients With Atrial Fibrillation The AMADEUS Trial. STROKE, 47(2), 523-526. doi:10.1161/STROKEAHA.115.011876
Clinical Characteristics and Outcomes in Extreme Elderly (Age ≥ 85 Years) Japanese Patients With Atrial Fibrillation The Fushimi AF Registry
Yamashita, Y., Hamatani, Y., Esato, M., Chun, Y. -H., Tsuji, H., Wada, H., . . . Akao, M. (2016). Clinical Characteristics and Outcomes in Extreme Elderly (Age ≥ 85 Years) Japanese Patients With Atrial Fibrillation The Fushimi AF Registry. CHEST, 149(2), 401-412. doi:10.1378/chest.15-1095
Emerging Tools for Stroke Prevention in Atrial Fibrillation
Voukalis, C., Lip, G. Y. H., & Shantsila, E. (2016). Emerging Tools for Stroke Prevention in Atrial Fibrillation. EBIOMEDICINE, 4, 26-39. doi:10.1016/j.ebiom.2016.01.017
Endothelial Progenitors and Blood Microparticles: Are They Relevant to Heart Failure With Preserved Ejection Fraction?
Shantsila, E., & Lip, G. Y. H. (2016). Endothelial Progenitors and Blood Microparticles: Are They Relevant to Heart Failure With Preserved Ejection Fraction?. EBIOMEDICINE, 4, 5-6. doi:10.1016/j.ebiom.2016.01.025
Guía ESC 2015 sobre el tratamiento de pacientes con arritmiasventriculares y prevención de la muerte súbita cardiaca
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., . . . Zannad, F. (2016). Guía ESC 2015 sobre el tratamiento de pacientes con arritmiasventriculares y prevención de la muerte súbita cardiaca. Revista Española de Cardiología, 69(2), 176.e1-176.e77. doi:10.1016/j.recesp.2016.01.001
Guía ESC/ERS 2015 sobre diagnóstico y tratamiento de la hipertensión pulmonar
Galiè, N., Humbert, M., Vachiery, J. -L., Gibbs, S., Lang, I., Torbicki, A., . . . Zamorano, J. L. (2016). Guía ESC/ERS 2015 sobre diagnóstico y tratamiento de la hipertensión pulmonar. Revista Española de Cardiología, 69(2), 177.e1-177.e62. doi:10.1016/j.recesp.2016.01.002
Impact of Variations in Kidney Function on Nonvitamin K Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Recent Acute Heart Failure
Andreu-Cayuelas, J. M., Pastor-Perez, F. J., Puche, C. M., Mateo-Martinez, A., Garcia-Alberola, A., Flores-Blanco, P. J., . . . Manzano-Fernandez, S. (2016). Impact of Variations in Kidney Function on Nonvitamin K Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Recent Acute Heart Failure. REVISTA ESPANOLA DE CARDIOLOGIA, 69(2), 134-140. doi:10.1016/j.rec.2015.06.021
Impact of deposition conditions on the crystallization kinetics of amorphous GeTe films
Khoo, C. Y., Liu, H., Sasangka, W. A., Made, R. I., Tamura, N., Kunz, M., . . . Thompson, C. V. (2016). Impact of deposition conditions on the crystallization kinetics of amorphous GeTe films. Journal of Materials Science, 51(4), 1864-1872. doi:10.1007/s10853-015-9493-z
Net Clinical Benefit of Edoxaban for Stroke, Mortality, and Bleeding Risk: Modeling Projections for a European Population.
Blann, A. D., Pisters, R., & Lip, G. Y. H. (2016). Net Clinical Benefit of Edoxaban for Stroke, Mortality, and Bleeding Risk: Modeling Projections for a European Population.. JACC. Clinical electrophysiology, 2(1), 47-54. doi:10.1016/j.jacep.2015.09.015
Recalibration of the HAS- BLED Score Should Hemorrhagic Stroke Account for One or Two Points?
Nielsen, P. B., Larsen, T. B., & Lip, G. Y. H. (2016). Recalibration of the HAS- BLED Score Should Hemorrhagic Stroke Account for One or Two Points?. CHEST, 149(2), 311-314. doi:10.1378/chest.15-1509
Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups
Lip, G. Y. H., Mitchell, S. A., Liu, X., Liu, L. Z., Phatak, H., Kachroo, S., & Batson, S. (2016). Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups. INTERNATIONAL JOURNAL OF CARDIOLOGY, 204, 88-94. doi:10.1016/j.ijcard.2015.11.084
Suboptimal oral anticoagulant treatment among Chinese non-valvular atrial fibrillation patients: the Nanchang Atrial Fibrillation Project
Xiong, Q., Shantsila, A., Li, J., Hong, K., & Lip, G. Y. H. (2016). Suboptimal oral anticoagulant treatment among Chinese non-valvular atrial fibrillation patients: the Nanchang Atrial Fibrillation Project. ARCHIVES OF MEDICAL SCIENCE, 12(1), 216-218. doi:10.5114/aoms.2016.57598
The SAMe-TT2R2 score and decision-making between a vitamin K antagonist or a non-vitamin K antagonist oral anticoagulant in patients with atrial fibrillation.
Esteve-Pastor, M. A., Roldán, V., Valdés, M., Lip, G. Y. H., & Marín, F. (2016). The SAMe-TT2R2 score and decision-making between a vitamin K antagonist or a non-vitamin K antagonist oral anticoagulant in patients with atrial fibrillation.. Expert review of cardiovascular therapy, 14(2), 177-187. doi:10.1586/14779072.2016.1116941
Usefulness of the SAME-TT<sub>2</sub>R<sub>2</sub> score to predict anticoagulation control on VKA in patients with atrial fibrillation and obstructive sleep apnea
Szymanski, F. M., Lip, G. Y. H., Filipiak, K. J., Platek, A. E., & Karpinski, G. (2016). Usefulness of the SAME-TT<sub>2</sub>R<sub>2</sub> score to predict anticoagulation control on VKA in patients with atrial fibrillation and obstructive sleep apnea. INTERNATIONAL JOURNAL OF CARDIOLOGY, 204, 200-205. doi:10.1016/j.ijcard.2015.11.158
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac Death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology].
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., . . . Task Force per il Trattamento dei Pazienti con Aritmie Ventricolari e la Prevenzione della Morte Cardiaca Improvvisa della Società Europea di Cardiologia. (2016). [2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac Death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology].. Giornale italiano di cardiologia (2006), 17(2), 108-170. doi:10.1714/2174.23496
β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure Association With Mortality in a Nationwide Cohort Study
Nielsen, P. B., Larsen, T. B., Gorst-Rasmussen, A., Skjoth, F., & Lip, G. Y. H. (2016). β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure Association With Mortality in a Nationwide Cohort Study. CIRCULATION-HEART FAILURE, 9(2), 1-9. doi:10.1161/CIRCHEARTFAILURE.115.002597
CHA<sub>2</sub>DS<sub>2</sub>-VASc Score for Predicting Stroke and Thromboembolism in Patients With AF and Biological Valve Prosthesis
Philippart, R., Brunet-Bernard, A., Clementy, N., Bourguignon, T., Mirza, A., Angoulvant, D., . . . Fauchier, L. (2016). CHA<sub>2</sub>DS<sub>2</sub>-VASc Score for Predicting Stroke and Thromboembolism in Patients With AF and Biological Valve Prosthesis. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 67(3), 343-344. doi:10.1016/j.jacc.2015.10.061
Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type
Wilson, D., Charidimou, A., Shakeshaft, C., Ambler, G., White, M., Cohen, H., . . . Werring, D. J. (2016). Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type. NEUROLOGY, 86(4), 360-366. doi:10.1212/WNL.0000000000002310
RISKS OF ANTITHROMBOTIC TREATMENT AFTER GASTROINTESTINAL BLEEDING IN ATRIAL FIBRILLATION Reply
Staerk, L., & Lip, G. Y. H. (2016). RISKS OF ANTITHROMBOTIC TREATMENT AFTER GASTROINTESTINAL BLEEDING IN ATRIAL FIBRILLATION Reply. BMJ-BRITISH MEDICAL JOURNAL, 352. doi:10.1136/bmj.i266
The 5-factor ORBIT bleeding score predicted major bleeding at 2 years in patients with atrial fibrillation
Lip, G. Y. H., & Lane, D. A. (2016). The 5-factor ORBIT bleeding score predicted major bleeding at 2 years in patients with atrial fibrillation. ANNALS OF INTERNAL MEDICINE, 164(2), JC11. doi:10.7326/ACPJC-2016-164-2-011
A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation
Marcucci, M., Skjoth, F., Lip, G. Y. H., Iorio, A., & Larsen, T. B. (2016). A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 203, 785-790. doi:10.1016/j.ijcard.2015.11.035
Antithrombotic management in patients with atrial fibrillation undergoing coronary stent implantation: What is the impact of guideline adherence?
Ancedy, Y., Lecoq, C., Saint Etienne, C., Ivanes, F., Angoulvant, D., Babuty, D., . . . Fauchier, L. (2016). Antithrombotic management in patients with atrial fibrillation undergoing coronary stent implantation: What is the impact of guideline adherence?. INTERNATIONAL JOURNAL OF CARDIOLOGY, 203, 987-994. doi:10.1016/j.ijcard.2015.11.090
Association between peripheral plasma markers and left atrial anatomy in patients with atrial fibrillation
Nedios, S., Seewoester, T., Lip, G. H. Y., Husser, D., Hindricks, G., Bollmann, A., & Kornej, J. (2016). Association between peripheral plasma markers and left atrial anatomy in patients with atrial fibrillation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 203, 621-623. doi:10.1016/j.ijcard.2015.11.022
Atrial fibrillation and heart failure due to reduced <i>versus</i> preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes
Kotecha, D., Chudasama, R., Lane, D. A., Kirchhof, P., & Lip, G. Y. H. (2016). Atrial fibrillation and heart failure due to reduced <i>versus</i> preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes. INTERNATIONAL JOURNAL OF CARDIOLOGY, 203, 660-666. doi:10.1016/j.ijcard.2015.10.220
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)
Roffi, M., Patrono, C., Collet, J. -P., Mueller, C., Valgimigli, M., Andreotti, F., . . . Zamorano, J. L. (2016). 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). EUROPEAN HEART JOURNAL, 37(3), 267-+. doi:10.1093/eurheartj/ehv320
Association of Smoking, Alcohol, and Obesity with Cardiovascular Death and Ischemic Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study and Cardiovascular Health Study (CHS)
Kwon, Y., Norby, F. L., Jensen, P. N., Agarwal, S. K., Soliman, E. Z., Lip, G. Y. H., . . . Chen, L. Y. (2016). Association of Smoking, Alcohol, and Obesity with Cardiovascular Death and Ischemic Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study and Cardiovascular Health Study (CHS). PLOS ONE, 11(1). doi:10.1371/journal.pone.0147065
Impact of L-carnitine on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of randomized controlled trials
Serban, M. -C., Sahebkar, A., Mikhailidis, D. P., Toth, P. P., Jones, S. R., Muntner, P., . . . Banach, M. (2016). Impact of L-carnitine on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of randomized controlled trials. SCIENTIFIC REPORTS, 6. doi:10.1038/srep19188
Low volume-high intensity interval exercise elicits antioxidant and anti-inflammatory effects in humans
Wadley, A. J., Chen, Y. -W., Lip, G. Y. H., Fisher, J. P., & Aldred, S. (2016). Low volume-high intensity interval exercise elicits antioxidant and anti-inflammatory effects in humans. JOURNAL OF SPORTS SCIENCES, 34(1), 1-9. doi:10.1080/02640414.2015.1035666
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).
Galiè, N., Humbert, M., Humbert, M., Vachiery, J. -L., Gibbs, S., Lang, I., . . . ESC Scientific Document Group . (2016). 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).. European heart journal, 37(1), 67-119. doi:10.1093/eurheartj/ehv317
Adherence to ESC antithrombotic guidelines improves mortality among Italian elderly AF patients: insights from the REPOSI study
Proietti, M., Nobili, A., Raparelli, V., Cangemi, R., Napoleone, L., Basili, S., . . . Lip, G. Y. H. (2016). Adherence to ESC antithrombotic guidelines improves mortality among Italian elderly AF patients: insights from the REPOSI study. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 845). Retrieved from https://www.webofscience.com/
Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report from the eurobservational research programme pilot survey on atrial fibrillation
Proietti, M., Raparelli, V., Laroche, C., Dan, G. A., Janion, M., Popescu, R., . . . Lip, G. Y. H. (2016). Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report from the eurobservational research programme pilot survey on atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 289). Retrieved from https://www.webofscience.com/
An Open-label, Randomized, Controlled, Multicenter Study Exploring Two Treatment Strategies of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention PIONEER AF-PCI
Gibson, C. M., Mehran, R., Bode, C., Halperin, J., Verheugt, F. W., Wildgoose, P., . . . Fox, K. (2016). An Open-label, Randomized, Controlled, Multicenter Study Exploring Two Treatment Strategies of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention PIONEER AF-PCI. In CIRCULATION Vol. 134 (pp. E705). Retrieved from https://www.webofscience.com/
Anticoagulation Control in Warfarin Treated Patients Undergoing Cardioversion for Atrial Fibrillation: A Pre-specified Ancillary Analysis From the ENSURE-AF Trial
Lip, G. Y., Al-Saady, N., Jin, J., Sun, M., Melino, M., Winters, S. M., . . . Zamoryakhin, D. (2016). Anticoagulation Control in Warfarin Treated Patients Undergoing Cardioversion for Atrial Fibrillation: A Pre-specified Ancillary Analysis From the ENSURE-AF Trial. In CIRCULATION Vol. 134. Retrieved from https://www.webofscience.com/
Antihypertensive and anti-inflammatory effects of pentoxifylline? A Systematic review and meta-analysis of randomized controlled trials
Brie, D., Sahebkar, A., Dinca, M., Ursoniu, S., Penson, P., Serban, M. C., . . . Banach, M. (2016). Antihypertensive and anti-inflammatory effects of pentoxifylline? A Systematic review and meta-analysis of randomized controlled trials. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 339). Retrieved from https://www.webofscience.com/
Atrial fibrillation and diabetes mellitus: evidence of a risky, synergistic, interaction. The results of the EURObservational Research Programme - Atrial Fibrillation (EORP-AF) General Pilot Registry
Fumagalli, S., Said, S., Laroche, C., Gabbai, D., Boni, S., Marchionni, N., . . . Lip, G. (2016). Atrial fibrillation and diabetes mellitus: evidence of a risky, synergistic, interaction. The results of the EURObservational Research Programme - Atrial Fibrillation (EORP-AF) General Pilot Registry. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 285-286). Retrieved from https://www.webofscience.com/
Beta-blockers in heart failure patients with atrial fibrillation: insights from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry
Boriani, G., Laroche, C., Diemberger, I., Popescu, M. I., Rasmussen, L. H., Sinagra, G., . . . Lip, G. Y. H. (2016). Beta-blockers in heart failure patients with atrial fibrillation: insights from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 205). Retrieved from https://www.webofscience.com/
Bleeding risk for non-valvular AF patients prescribed warfarin, or standard doses of apixaban 5mg BID, dabigatran 150mg BID or rivaroxaban 20mg QD in real-world practice: Findings from EHR
Lin, I., Masseria, C., Mardekian, J., Park, S., Horblyuk, R., Kamble, S., . . . Lip, G. Y. H. (2016). Bleeding risk for non-valvular AF patients prescribed warfarin, or standard doses of apixaban 5mg BID, dabigatran 150mg BID or rivaroxaban 20mg QD in real-world practice: Findings from EHR. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 402). Retrieved from https://www.webofscience.com/
Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients
Rivera-Caravaca, J. M., Esteve-Pastor, M. A., Vicente, V., Valdes, M., Lip, G. Y., Marin, F., & Roldan-Schilling, V. (2016). Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1347-1348). Retrieved from https://www.webofscience.com/
Characteristics and outcomes in elderly Japanese and British patients with atrial fibrillation: Comparative analysis from the Fushimi and Darlington Atrial Fibrillation Registries
Ogawa, H., Senoo, K., An, Y., Shantsila, A., Shantsila, E., Lane, D. A., . . . Lip, G. Y. H. (2016). Characteristics and outcomes in elderly Japanese and British patients with atrial fibrillation: Comparative analysis from the Fushimi and Darlington Atrial Fibrillation Registries. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1345). Retrieved from https://www.webofscience.com/
Combining oral anticoagulants with antiplatelet therapy in patients with non-valvular atrial fibrillation: findings from the GLORIA-AF registry program
Teutsch, C., Halperin, J., Diener, H. -C., Dubner, S., Ma, C., Rothman, K., . . . Lip, G. Y. H. (2016). Combining oral anticoagulants with antiplatelet therapy in patients with non-valvular atrial fibrillation: findings from the GLORIA-AF registry program. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1192-1193). Retrieved from https://www.webofscience.com/
Comparison of oral anti-coagulants for stroke prevention in non-valvular atrial fibrillation: a multi-criteria decision analysis
Lip, G. Y. H., Verdecchia, P., Tervonen, T., Ustyugova, A., Heinrich-Nols, J., Gropper, S., . . . Marsh, K. (2016). Comparison of oral anti-coagulants for stroke prevention in non-valvular atrial fibrillation: a multi-criteria decision analysis. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 41). Retrieved from https://www.webofscience.com/
Comprehensive Laser Sensitivity Profiling and Data Register Bit-Flips for Cryptographic Fault Attacks in 65 Nm FPGA
He, W., Breier, J., Bhasin, S., Jap, D., Ong, H. G., & Gan, C. L. (2016). Comprehensive Laser Sensitivity Profiling and Data Register Bit-Flips for Cryptographic Fault Attacks in 65 Nm FPGA. In Unknown Conference (pp. 47-65). Springer International Publishing. doi:10.1007/978-3-319-49445-6_3
Contemporary results from EHR study of real-world bleeding risk among elderly and overall non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, rivaroxaban and warfarin
Lin, I., Masseria, C., Mardekian, J., Park, S., Horblyuk, R., Kamble, S., . . . Lip, G. Y. H. (2016). Contemporary results from EHR study of real-world bleeding risk among elderly and overall non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, rivaroxaban and warfarin. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 235-236). Retrieved from https://www.webofscience.com/
Coronary artery disease and use of dual or triple antithrombotic therapy in patients with atrial fibrillation: the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry
Proietti, M., Raparelli, V., Tavazzi, L., Maggioni, A. P., Laroche, C., Boriani, G., & Lip, G. Y. H. (2016). Coronary artery disease and use of dual or triple antithrombotic therapy in patients with atrial fibrillation: the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1397). Retrieved from https://www.webofscience.com/
Country differences in patient perceptions of atrial fibrillation, stroke risk, and oral anticoagulation treatment
Lane, D. A., Meyerhoff, J., Rohner, U., & Lip, G. Y. H. (2016). Country differences in patient perceptions of atrial fibrillation, stroke risk, and oral anticoagulation treatment. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 506). Retrieved from https://www.webofscience.com/
Deprivation and prediction of heart failure in minority ethnic patients: the Ethnic - Echocardiographic Heart of England Screening Study (E-ECHOES)
Shantsila, A., Shantsila, E., Gill, P. S., & Lip, G. Y. H. (2016). Deprivation and prediction of heart failure in minority ethnic patients: the Ethnic - Echocardiographic Heart of England Screening Study (E-ECHOES). In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1108). Retrieved from https://www.webofscience.com/
Difficult situations in anticoagulation after stroke: between Scylla and Charybdis
Ntaios, G., & Lip, G. Y. H. (2016). Difficult situations in anticoagulation after stroke: between Scylla and Charybdis. CURRENT OPINION IN NEUROLOGY, 29(1), 42-48. doi:10.1097/WCO.0000000000000283
Does renal impairment affect the predictive value of the CHA2DS2VASc score for stroke risk assessment in patients with atrial fibrillation?
Fauchier, L., Halimi, J. M., Angoulvant, D., Vourc'h, P., Andres, C., Bisson, A., . . . Lip, G. Y. H. (2016). Does renal impairment affect the predictive value of the CHA2DS2VASc score for stroke risk assessment in patients with atrial fibrillation?. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 245). Retrieved from https://www.webofscience.com/
Editors' Choice 2015 papers in Thrombosis and Haemostasis
Weber, C., & Lip, G. Y. H. (2016). Editors' Choice 2015 papers in Thrombosis and Haemostasis. THROMBOSIS AND HAEMOSTASIS, 115(1), 230-232. doi:10.1160/TH15-11-0911
Effect of Anticoagulation on Hospitalization Costs After Intracranial Hemorrhage in Atrial Fibrillation A Registry Study
Vestergaard, A. S., Skjoth, F., Lip, G. Y. H., & Larsen, T. B. (2016). Effect of Anticoagulation on Hospitalization Costs After Intracranial Hemorrhage in Atrial Fibrillation A Registry Study. STROKE, 47(4), 979-985. doi:10.1161/STROKEAHA.115.012338
Effect of beta-blocker use on mortality in patients with atrial fibrillation. A cohort study
Fauchier, L., Clementy, N., Bisson, A., Angoulvant, D., Angoulvant, T. B., Bernard, A., . . . Lip, G. Y. H. (2016). Effect of beta-blocker use on mortality in patients with atrial fibrillation. A cohort study. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 290). Retrieved from https://www.webofscience.com/
Effects of pentoxifylline on inflammatory markers and blood pressure: a systematic review and meta-analysis of randomized controlled trials
Brie, D., Sahebkar, A., Penson, P. E., Dinca, M., Ursoniu, S., Serban, M. -C., . . . Banach, M. (2016). Effects of pentoxifylline on inflammatory markers and blood pressure: a systematic review and meta-analysis of randomized controlled trials. JOURNAL OF HYPERTENSION, 34(12), 2318-2329. doi:10.1097/HJH.0000000000001086
Ethnic disparities between Japanese and British atrial fibrillation patients with previous stroke: Comparative analysis from the Fushimi and Darlington Atrial Fibrillation Registries
Ogawa, H., Senoo, K., An, Y., Shantsila, A., Shantsila, E., Lane, D. A., . . . Lip, G. Y. H. (2016). Ethnic disparities between Japanese and British atrial fibrillation patients with previous stroke: Comparative analysis from the Fushimi and Darlington Atrial Fibrillation Registries. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1137-1138). Retrieved from https://www.webofscience.com/
Evaluation of the corrosion performance of Cu–Al intermetallic compounds and the effect of Pd addition
Lim, A. B. Y., Neo, W. J., Yauw, O., Chylak, B., Gan, C. L., & Chen, Z. (2016). Evaluation of the corrosion performance of Cu–Al intermetallic compounds and the effect of Pd addition. Microelectronics Reliability, 56, 155-161. doi:10.1016/j.microrel.2015.10.012
Factors associated with quality of anticoagulation control in patients with atrial fibrillation and risk of stroke and bleeding
Bonde, A. N., Lip, G. Y. H., Kamper, A. L., Staerk, L., Gislason, G., Torp-Pedersen, C., & Olesen, J. B. (2016). Factors associated with quality of anticoagulation control in patients with atrial fibrillation and risk of stroke and bleeding. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 402). Retrieved from https://www.webofscience.com/
From clinical trials to real-world clinical practice: observations on the direct oral anticoagulants
Lip, G. Y. H. (2016). From clinical trials to real-world clinical practice: observations on the direct oral anticoagulants. LANCET HAEMATOLOGY, 3(1), E2-E3. doi:10.1016/S2352-3026(15)00282-3
Guideline-adherent antithrombotic treatment improves outcomes in patients with atrial fibrillation - Insights from the community-based darlington atrial fibrillation registry
Mazurek, M., Shantsila, E., Lane, D., Wolff, A., Proietti, M., & Lip, G. Y. (2016). Guideline-adherent antithrombotic treatment improves outcomes in patients with atrial fibrillation - Insights from the community-based darlington atrial fibrillation registry. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1348). Retrieved from https://www.webofscience.com/
Guía ESC 2015 sobre el tratamiento de la endocarditis infecciosa
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J. -P., Zotti, F. D., . . . Walker, D. M. (2016). Guía ESC 2015 sobre el tratamiento de la endocarditis infecciosa. Revista Española de Cardiología, 69(1), 69.e1-69.e49. doi:10.1016/j.recesp.2015.11.015
Heart failure and risk of venous thromboembolism: a systematic review and meta-analysis
Tang, L., Wu, Y. -Y., Lip, G. Y. H., Yin, P., & Hu, Y. (2016). Heart failure and risk of venous thromboembolism: a systematic review and meta-analysis. LANCET HAEMATOLOGY, 3(1), E30-E44. doi:10.1016/S2352-3026(15)00228-8
Hypertension in patients with Atrial Fibrillation: the EURObservational research programme on atrial fibrillation (EORP-AF) pilot registry
Dan, G. A., Badila, E., Weiss, E., Laroche, C., Boriani, G., Dan, A., . . . Lip, G. Y. H. (2016). Hypertension in patients with Atrial Fibrillation: the EURObservational research programme on atrial fibrillation (EORP-AF) pilot registry. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 617). Retrieved from https://www.webofscience.com/
IMPACT OF AN ATRIAL FIBRILLATION DECISION SUPPORT TOOL (AFDST) ON THROMBOPROPHYLAXIS FOR ATRIAL FIBRILLATION
Eckman, M. H., Lip, G. Y., Wise, R. E., Speer, B., Sullivan, M. D., Walker, N., . . . Kues, J. (2016). IMPACT OF AN ATRIAL FIBRILLATION DECISION SUPPORT TOOL (AFDST) ON THROMBOPROPHYLAXIS FOR ATRIAL FIBRILLATION. In JOURNAL OF GENERAL INTERNAL MEDICINE Vol. 31 (pp. S258-S259). Retrieved from https://www.webofscience.com/
Impact of statin therapy on plasma adiponectin concentrations: a systematic review and meta-analysis of 43 randomized controlled trial arms
Chrusciel, P., Sahebkar, A., Rembek, M., Serban, M. C., Ursoniu, S., Mikhailidis, D. P., . . . Banach, M. (2016). Impact of statin therapy on plasma adiponectin concentrations: a systematic review and meta-analysis of 43 randomized controlled trial arms. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 736). Retrieved from https://www.webofscience.com/
Inflammation and myocardial stiffness in hypertension: observations from the Hypertensive Cohort of The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES)
Shantsila, A., Shantsila, E., Gill, P. S., & Lip, G. Y. H. (2016). Inflammation and myocardial stiffness in hypertension: observations from the Hypertensive Cohort of The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES). In JOURNAL OF HUMAN HYPERTENSION Vol. 30 (pp. 648). Retrieved from https://www.webofscience.com/
Is major bleeding risk for oral anticoagulants similar between non-valvular atrial fibrillation patients newly initiated on warfarin and propensity-score matched NOAC initiators? A real world study
Lip, G. Y. H., Keshishian, A., Kamble, S., Pan, X., Burns, L., Mardekian, J., . . . Hamilton, M. (2016). Is major bleeding risk for oral anticoagulants similar between non-valvular atrial fibrillation patients newly initiated on warfarin and propensity-score matched NOAC initiators? A real world study. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 493). Retrieved from https://www.webofscience.com/
Left atrial thrombus resolution in atrial fibrillation or flutter: results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF)
Lip, G. Y. H., Hammerstingl, C., Marin, F., Cappato, R., Meng, I. L., Kirsch, B., . . . Cohen, A. (2016). Left atrial thrombus resolution in atrial fibrillation or flutter: results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF). In EUROPEAN HEART JOURNAL Vol. 37 (pp. 501). Retrieved from https://www.webofscience.com/
Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: results of a prospective study with rivaroxaban (X-TRA) biomarker substudy
Marin, F., Hammerstingl, C., Cappato, R., Kramer, F., Meng, I. L., Cohen, A., . . . Lip, G. Y. H. (2016). Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: results of a prospective study with rivaroxaban (X-TRA) biomarker substudy. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 503). Retrieved from https://www.webofscience.com/
Major bleeding risk in patients 75 years of age or older with non-valvular atrial fibrillation initiating oral anticoagulants: a real-world comparison of warfarin, apixaban, dabigatran, or rivaroxaban
Lip, G. Y. H., Keshishian, A., Kamble, S., Pan, X., Burns, L., Mardekian, J., . . . Hamilton, M. (2016). Major bleeding risk in patients 75 years of age or older with non-valvular atrial fibrillation initiating oral anticoagulants: a real-world comparison of warfarin, apixaban, dabigatran, or rivaroxaban. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 500-501). Retrieved from https://www.webofscience.com/
Major cardiovascular outcomes in anticoagulated atrial fibrillation patients with one stroke risk factor (CHA2DS2-VASc 1 in males, 2 in females): impact of time in therapeutic range
Proietti, M., Lane, D. A., & Lip, G. Y. H. (2016). Major cardiovascular outcomes in anticoagulated atrial fibrillation patients with one stroke risk factor (CHA2DS2-VASc 1 in males, 2 in females): impact of time in therapeutic range. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1348). Retrieved from https://www.webofscience.com/
Major cardiovascular risk factors in an unselected "real world" screening cohort: insights from the Belgian heart rhythm week programme
Proietti, M., Mairesse, G. H., Goethals, P., Scavee, C., Vijgen, J., Blankoff, I., . . . Lip, G. Y. H. (2016). Major cardiovascular risk factors in an unselected "real world" screening cohort: insights from the Belgian heart rhythm week programme. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 347-348). Retrieved from https://www.webofscience.com/
Management of atrial fibrillation in specific patient populations
Szymanski, F. M., Lip, G. Y. H., & Filipiak, K. J. (2016). Management of atrial fibrillation in specific patient populations. KARDIOLOGIA POLSKA, 74(1), 1-8. doi:10.5603/KP.a2015.0223
May your New Year be happy and prosperous with "Thrombosis and Haemostasis"
Lip, G. Y. H., & Weber, C. (2016). May your New Year be happy and prosperous with "Thrombosis and Haemostasis". THROMBOSIS AND HAEMOSTASIS, 115(1), 1-2. doi:10.1160/TH15-11-0912
Monocyte-platelet aggregates associated with CD14++CD16+monocytes predict diffuse coronary artery disease: relationship to microvascular function
Brown, R. A., Lip, G. Y. H., Varma, C., & Shantsila, E. (2016). Monocyte-platelet aggregates associated with CD14++CD16+monocytes predict diffuse coronary artery disease: relationship to microvascular function. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 812). Retrieved from https://www.webofscience.com/
Multiple risk factors and ischaemic stroke in the elderly Asian population with and without atrial fibrillation An analysis of 425,600 Chinese individuals without prior stroke
Guo, Y., Wang, H., Tian, Y., Wang, Y., & Lip, G. Y. H. (2016). Multiple risk factors and ischaemic stroke in the elderly Asian population with and without atrial fibrillation An analysis of 425,600 Chinese individuals without prior stroke. THROMBOSIS AND HAEMOSTASIS, 115(1), 184-192. doi:10.1160/TH15-07-0577
Non-vitamin K antagonist oral anticoagulation usage in elderly patients with atrial fibrillation: Danish nationwide data with temporal trends from 2011 to 2015
Staerk, L., Fosbol, E. L. F., Gadsboll, K. G., Sindet-Pedersen, C. S. P., Pallisgaard, J. L. P., Lamberts, M. L., . . . Olesen, J. B. O. (2016). Non-vitamin K antagonist oral anticoagulation usage in elderly patients with atrial fibrillation: Danish nationwide data with temporal trends from 2011 to 2015. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 501). Retrieved from https://www.webofscience.com/
Overweight and obesity in female and male patients with atrial fibrillation: insights from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry
Boriani, G., Laroche, C., Diemberger, I., Popescu, M. I., Rasmussen, L. H., Sinagra, G., . . . Lip, G. Y. H. (2016). Overweight and obesity in female and male patients with atrial fibrillation: insights from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 929). Retrieved from https://www.webofscience.com/
Poor anticoagulation control in warfarin treated atrial fibrillation patients with reduced renal function
Bonde, A. N., Lip, G. Y. H., Kamper, A. L., Staerk, L., Torp-Pedersen, C., Gislason, G., & Olesen, J. B. (2016). Poor anticoagulation control in warfarin treated atrial fibrillation patients with reduced renal function. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 499-500). Retrieved from https://www.webofscience.com/
Predicting the Risk of Failure and Recurrence After Electrical Cardioversion for Acute Atrial Fibrillation: Derivation and Validation of the AF-CVS Score
Jaakkola, S., Lip, G. Y., Nuotio, I., Biancari, F., Hartikainen, J. E., & Airaksinen, J. K. (2016). Predicting the Risk of Failure and Recurrence After Electrical Cardioversion for Acute Atrial Fibrillation: Derivation and Validation of the AF-CVS Score. In CIRCULATION Vol. 134. Retrieved from https://www.webofscience.com/
Predicting the Risk of Failure and Recurrence After Electrical Cardioversion for Acute Atrial Fibrillation: Derivation and Validation of the AF-CVS Score
Jaakkola, S., Lip, G. Y., Nuotio, I., Biancari, F., Hartikainen, J. E., & Airaksinen, J. K. (2016). Predicting the Risk of Failure and Recurrence After Electrical Cardioversion for Acute Atrial Fibrillation: Derivation and Validation of the AF-CVS Score. In CIRCULATION Vol. 134. Retrieved from https://www.webofscience.com/
Preexisting cardiovascular comorbidities underlie newly diagnosed atrial fibrillation after acute ischemic stroke
Fauchier, L., Bisson, A., Clementy, N., Angoulvant, D., Babuty, D., & Lip, G. Y. H. (2016). Preexisting cardiovascular comorbidities underlie newly diagnosed atrial fibrillation after acute ischemic stroke. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 615). Retrieved from https://www.webofscience.com/
Premature cardiac ageing in South Asians: the ethnic-echocardiographic heart of England screening study (E-ECHOES)
Shantsila, E., Shantsila, A., Gill, P. S., & Lip, G. Y. H. (2016). Premature cardiac ageing in South Asians: the ethnic-echocardiographic heart of England screening study (E-ECHOES). In EUROPEAN HEART JOURNAL Vol. 37 (pp. 931). Retrieved from https://www.webofscience.com/
Preventing Thrombosis to Improve Outcomes in Heart Failure Patients
Shantsila, E., & Lip, G. Y. H. (2016). Preventing Thrombosis to Improve Outcomes in Heart Failure Patients. PROGRESS IN CARDIOVASCULAR DISEASES, 58(4), 386-392. doi:10.1016/j.pcad.2015.09.005
Real World Bleeding Risks in Non-valvular Atrial Fibrillation Patients With Heart Failure: Contemporary EHR Results Among Prescribed Apixaban, Dabigatran, Rivaroxaban and Warfarin
Lin, I., Horblyuk, R., Mardekian, J., Park, S. H., Kamble, S., Hamilton, M., . . . Lip, G. Y. (2016). Real World Bleeding Risks in Non-valvular Atrial Fibrillation Patients With Heart Failure: Contemporary EHR Results Among Prescribed Apixaban, Dabigatran, Rivaroxaban and Warfarin. In CIRCULATION Vol. 134. Retrieved from https://www.webofscience.com/
Real world comparison of major bleeding risk among nonvalvular atrial fibrillation patients newly initiated on apixaban, warfarin, dabigatran or rivaroxaban: a 1:1 propensity-score matched analysis
Lip, G., Keshishian, A., Kamble, S., Pan, X., Burns, L., Mardekian, J., . . . Phatak, H. (2016). Real world comparison of major bleeding risk among nonvalvular atrial fibrillation patients newly initiated on apixaban, warfarin, dabigatran or rivaroxaban: a 1:1 propensity-score matched analysis. In PHARMACOTHERAPY Vol. 36 (pp. E213). Retrieved from https://www.webofscience.com/
Real-world comparisons of major bleeding risk and major bleeding-related hospitalization costs among elderly non-valvular atrial fibrillation patients newly initiated on apixaban or warfarin
Kamble, S., Keshishian, A., Pan, X., Mardekian, J., Horbkyuk, R., Hamilton, M., & Lip, G. Y. H. (2016). Real-world comparisons of major bleeding risk and major bleeding-related hospitalization costs among elderly non-valvular atrial fibrillation patients newly initiated on apixaban or warfarin. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 496). Retrieved from https://www.webofscience.com/
Recent advances in the understanding and management of atrial fibrillation: a focus on stroke prevention.
Shahid, F., Shantsila, E., & Lip, G. Y. H. (2016). Recent advances in the understanding and management of atrial fibrillation: a focus on stroke prevention.. F1000Research, 5, 2887. doi:10.12688/f1000research.10176.1
Relation of the SAMe-TT2R2 score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: the SPORTIF trials
Proietti, M., Lane, D. A., & Lip, G. Y. H. (2016). Relation of the SAMe-TT2R2 score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: the SPORTIF trials. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1348). Retrieved from https://www.webofscience.com/
Relationship between COPD and all-cause death in patients with atrial fibrillation: insights from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry
Proietti, M., Laroche, C., Tavazzi, L., Maggioni, A. P., Boriani, G., & Lip, G. Y. H. (2016). Relationship between COPD and all-cause death in patients with atrial fibrillation: insights from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 292). Retrieved from https://www.webofscience.com/
Relationship of left ventricular hypertrophy to vascular events in patients with non-valvular atrial fibrillation: the ARAPACIS study
Proietti, M., Marra, A. M., Tassone, E. J., Corrao, S., Vestri, A. R., Perticone, F., . . . Raparelli, V. (2016). Relationship of left ventricular hypertrophy to vascular events in patients with non-valvular atrial fibrillation: the ARAPACIS study. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 848-849). Retrieved from https://www.webofscience.com/
Relationship of rate and rhythm control strategies to adverse outcomes in patients with atrial fibrillation: the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot Registry
Purmah, Y., Proietti, M., Laroche, C., Tavazzi, L., Maggioni, A. P., Boriani, G., . . . Lip, G. Y. H. (2016). Relationship of rate and rhythm control strategies to adverse outcomes in patients with atrial fibrillation: the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot Registry. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 601-602). Retrieved from https://www.webofscience.com/
Reply to: "Inadequate anticoagulation by vitamin K antagonists and major adverse cardiovascular events other than stroke"
Pastori, D., Pignatelli, P., Saliola, M., Carnevale, R., Vicario, T., Cangemi, R., . . . Violi, F. (2016). Reply to: "Inadequate anticoagulation by vitamin K antagonists and major adverse cardiovascular events other than stroke". INTERNATIONAL JOURNAL OF CARDIOLOGY, 202, 934-935. doi:10.1016/j.ijcard.2015.10.122
Secondary versus primary stroke prevention in atrial fibrillation - Insights from the community-based darlington atrial fibrillation registry
Mazurek, M., Shantsila, E., Lane, D., Wolff, A., Proietti, M., & Lip, G. Y. (2016). Secondary versus primary stroke prevention in atrial fibrillation - Insights from the community-based darlington atrial fibrillation registry. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 845). Retrieved from https://www.webofscience.com/
Short runs of atrial arrhythmia and stroke risk: a European-wide online survey among stroke physicians and cardiologists
Tran, R. T., Rankin, A. J., Abdul-Rahim, A. H., Lip, G. Y. H., Rankin, A. C., & Lees, K. R. (2016). Short runs of atrial arrhythmia and stroke risk: a European-wide online survey among stroke physicians and cardiologists. JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 46(2), 87-92. doi:10.4997/JRCPE.2016.204
Stroke and Thromboembolism in Patients With Atrial Fibrillation and Mitral Regurgitation
Fauchier, L., Philippart, R., Bernard, A., Clementy, N., Bourguignon, T., Angoulvant, D., . . . Lip, G. (2016). Stroke and Thromboembolism in Patients With Atrial Fibrillation and Mitral Regurgitation. In CIRCULATION Vol. 134. Retrieved from https://www.webofscience.com/
Stroke and all cause mortality with non-vitamin K antagonist oral anticoagulation versus warfarin in atrial fibrillation: a nationwide study
Staerk, L., Fosbol, E. L. F., Bonde, A. N. B., Lip, G. Y. H. L., Torp-Pedersen, C. T. P., & Gislason, G. H. G. (2016). Stroke and all cause mortality with non-vitamin K antagonist oral anticoagulation versus warfarin in atrial fibrillation: a nationwide study. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 393). Retrieved from https://www.webofscience.com/
Stroke prevention in atrial fibrillation: changing concepts (vol 1, pg 76, 2015)
Lip, G. Y. H. (2016). Stroke prevention in atrial fibrillation: changing concepts (vol 1, pg 76, 2015). EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2(4), 217. Retrieved from https://www.webofscience.com/
The Obesity Paradox in patients with non-valvular atrial fibrillation: observations from the SPORTIF trials
Proietti, M., Lane, D. A., & Lip, G. Y. H. (2016). The Obesity Paradox in patients with non-valvular atrial fibrillation: observations from the SPORTIF trials. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 828). Retrieved from https://www.webofscience.com/
The impact of atrial fibrillation on risk of recurrence and mortality among patients with venous thromboembolism
Chao, T. F., Lip, G. Y. H., & Chen, S. A. (2016). The impact of atrial fibrillation on risk of recurrence and mortality among patients with venous thromboembolism. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 615). Retrieved from https://www.webofscience.com/
The impact of statin therapy on plasma levels of von Willebrand factor antigen Systematic review and meta-analysis of randomised placebo-controlled trials
Sahebkar, A., Serban, C., Ursoniu, S., Mikhailidis, D. P., Undas, A., Lip, G. Y. H., . . . Banach, M. (2016). The impact of statin therapy on plasma levels of von Willebrand factor antigen Systematic review and meta-analysis of randomised placebo-controlled trials. THROMBOSIS AND HAEMOSTASIS, 115(3), 520-532. doi:10.1160/TH15-08-0620
Time in Therapeutic Range and Major Adverse Outcomes in Anticoagulated Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention on Triple Antithrombotic Therapy: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) Registry
Proietti, M., Airaksinen, K. E. J., Rubboli, A., Schlitt, A., Kiviniemi, T., Karjalainen, P. P., & Lip, G. Y. (2016). Time in Therapeutic Range and Major Adverse Outcomes in Anticoagulated Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention on Triple Antithrombotic Therapy: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) Registry. In CIRCULATION Vol. 134. Retrieved from https://www.webofscience.com/
Time in Therapeutic Range and Major Adverse Outcomes in Anticoagulated Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention on Triple Antithrombotic Therapy: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) Registry
Proietti, M., Airaksinen, K. E. J., Rubboli, A., Schlitt, A., Kiviniemi, T., Karjalainen, P. P., & Lip, G. Y. (2016). Time in Therapeutic Range and Major Adverse Outcomes in Anticoagulated Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention on Triple Antithrombotic Therapy: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) Registry. In CIRCULATION Vol. 134. Retrieved from https://www.webofscience.com/
Validation of a modified CHA2DS2-VASc score for stroke risk stratification in Asian patients with atrial fibrillation
Chao, T. F., Lip, G. Y. H., & Chen, S. A. (2016). Validation of a modified CHA2DS2-VASc score for stroke risk stratification in Asian patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1006). Retrieved from https://www.webofscience.com/
Von Willebrand factor predicts adverse events in real world anticoagulated atrial fibrillation patients
Roldan-Schilling, V., Rivera-Caravaca, J. M., Hernandez-Romero, D., Esteve-Pastor, M. A., Vicente, V., Valdes, M., . . . Marin, F. (2016). Von Willebrand factor predicts adverse events in real world anticoagulated atrial fibrillation patients. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1200). Retrieved from https://www.webofscience.com/
When should we start thromboprophylaxis? The stroke risk threshold discrepancy between European and US guidelines for atrial fibrillation
Nielsen, P. B., Larsen, T. B., Skjoeth, F., Overvad, T. F., & Lip, G. Y. H. (2016). When should we start thromboprophylaxis? The stroke risk threshold discrepancy between European and US guidelines for atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 235). Retrieved from https://www.webofscience.com/
Which Oral Anti-Coagulant Do Patients Prefer for Stroke Prevention in Non-Valvular Atrial Fibrillation?
Lip, G. Y., Verdecchia, P., Tervonen, T., Ustyugova, A., Heinrich-Nols, J., Gropper, S., . . . Marsh, K. (2016). Which Oral Anti-Coagulant Do Patients Prefer for Stroke Prevention in Non-Valvular Atrial Fibrillation?. In CIRCULATION Vol. 134. Retrieved from https://www.webofscience.com/
2015
A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference
Kirchhof, P., Breithardt, G., Bax, J., Benninger, G., Blomstrom-Lundqvist, C., Boriani, G., . . . Camm, A. J. (2016). A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference. EUROPACE, 18(1), 37-50. doi:10.1093/europace/euv304
European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society
Lip, G. Y. H., Heinzel, F. R., Gaita, F., Gonzalez Juanatey, J. R., Le Heuzey, J. Y., Potpara, T., . . . Pieske, B. (2016). European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. EUROPACE, 18(1), 12-36. doi:10.1093/europace/euv191
Patients with atrial fibrillation undergoing percutaneous coronary intervention
Dzeshka, M. S., Brown, R. A., & Lip, G. Y. H. (2015). Patients with atrial fibrillation undergoing percutaneous coronary intervention. POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 125(1-2), 73-+. doi:10.20452/pamw.2650
Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation
Pastori, D., Pignatelli, P., Saliola, M., Carnevale, R., Vicario, T., Del Ben, M., . . . Violi, F. (2015). Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 201, 513-516. doi:10.1016/j.ijcard.2015.08.054
Net clinical benefit of edoxaban versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study
Blann, A. D., Banerjee, A., Lane, D. A., Torp-Pedersen, C., & Lip, G. Y. H. (2015). Net clinical benefit of edoxaban versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 201, 693-698. doi:10.1016/j.ijcard.2015.08.074
Sex differences in clinical characteristics and inpatient outcomes among 2442 hospitalized Chinese patients with nonvalvular atrial fibrillation: The Nanchang Atrial Fibrillation Project
Xiong, Q., Shantsila, A., Lane, D. A., Zhou, Q., Liu, Y., Shen, Y., . . . Lip, G. Y. H. (2015). Sex differences in clinical characteristics and inpatient outcomes among 2442 hospitalized Chinese patients with nonvalvular atrial fibrillation: The Nanchang Atrial Fibrillation Project. INTERNATIONAL JOURNAL OF CARDIOLOGY, 201, 195-199. doi:10.1016/j.ijcard.2015.08.076
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis
Andreotti, F., Rocca, B., Husted, S., Ajjan, R. A., ten Berg, J., Cattaneo, M., . . . Storey, R. F. (2015). Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis. EUROPEAN HEART JOURNAL, 36(46), 3238-+. doi:10.1093/eurheartj/ehv304
Assessing bleeding risk in atrial fibrillation with the HAS-BLED and ORBIT scores: clinical application requires focus on the reversible bleeding risk factors
Lip, G. Y. H., & Lane, D. A. (2015). Assessing bleeding risk in atrial fibrillation with the HAS-BLED and ORBIT scores: clinical application requires focus on the reversible bleeding risk factors. EUROPEAN HEART JOURNAL, 36(46), 3265-3267. doi:10.1093/eurheartj/ehv415
Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II
Huisman, M. V., Rothman, K. J., Paquette, M., Teutsch, C., Diener, H. C., Dubner, S. J., . . . Lip, G. Y. H. (2015). Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II. In AMERICAN JOURNAL OF MEDICINE Vol. 128 (pp. 1306-+). doi:10.1016/j.amjmed.2015.07.013
Blood pressure and prognosis in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study
Lip, G. Y. H., Skjoth, F., Overvad, K., Rasmussen, L. H., & Larsen, T. B. (2015). Blood pressure and prognosis in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study. CLINICAL RESEARCH IN CARDIOLOGY, 104(12), 1088-1096. doi:10.1007/s00392-015-0878-4
CD4<SUP>+</SUP> T cell surface alpha enolase is lower in older adults
Bennett, S. J., Augustyniak, E. M., Dunston, C. R., Brown, R. A., Shantsila, E., Lip, G. Y. H., . . . Griffiths, H. R. (2015). CD4<SUP>+</SUP> T cell surface alpha enolase is lower in older adults. MECHANISMS OF AGEING AND DEVELOPMENT, 152, 56-62. doi:10.1016/j.mad.2015.09.005
Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)
Lane, D. A., Aguinaga, L., Blomstrom-Lundqvist, C., Boriani, G., Dan, G. -A., Hills, M. T., . . . Potpara, T. S. (2015). Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). EUROPACE, 17(12), 1747-1769. doi:10.1093/europace/euv233
Exposure-response for biomarkers of anticoagulant effects by the oral direct thrombin inhibitor AZD0837 in patients with atrial fibrillation
Lip, G. Y. H., Rasmussen, L. H., Olsson, S. B., Jensen, E., Hamren, B., Eriksson, U. G., & Wahlander, K. (2015). Exposure-response for biomarkers of anticoagulant effects by the oral direct thrombin inhibitor AZD0837 in patients with atrial fibrillation. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 80(6), 1362-1373. doi:10.1111/bcp.12719
Guía ESC 2015 sobre el tratamiento de los síndromes coronarios agudos en pacientes sin elevación persistente del segmento ST
Roffi, M., Patrono, C., Collet, J. -P., Mueller, C., Valgimigli, M., Andreotti, F., . . . Zamorano, J. L. (2015). Guía ESC 2015 sobre el tratamiento de los síndromes coronarios agudos en pacientes sin elevación persistente del segmento ST. Revista Española de Cardiología, 68(12), 1125.e1-1125.e64. doi:10.1016/j.recesp.2015.10.012
Incidence of Stroke or Systemic Embolism in Paroxysmal Versus Sustained Atrial Fibrillation The Fushimi Atrial Fibrillation Registry
Takabayashi, K., Hamatani, Y., Yamashita, Y., Takagi, D., Unoki, T., Ishii, M., . . . Akao, M. (2015). Incidence of Stroke or Systemic Embolism in Paroxysmal Versus Sustained Atrial Fibrillation The Fushimi Atrial Fibrillation Registry. STROKE, 46(12), 3354-3361. doi:10.1161/STROKEAHA.115.010947
LDL-lipids from patients with hypercholesterolaemia and Alzheimer's disease are inflammatory to microvascular endothelial cells: mitigation by statin intervention
Dias, H. K. I., Brown, C. L. R., Polidori, M. C., Lip, G. Y. H., & Griffiths, H. R. (2015). LDL-lipids from patients with hypercholesterolaemia and Alzheimer's disease are inflammatory to microvascular endothelial cells: mitigation by statin intervention. CLINICAL SCIENCE, 129(12), 1195-1206. doi:10.1042/CS20150351
Matching the NOAC to the Patient Remember the Modifiable Bleeding Risk Factors
Lip, G. Y. H., & Lane, D. A. (2015). Matching the NOAC to the Patient Remember the Modifiable Bleeding Risk Factors. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 66(21), 2282-2284. doi:10.1016/j.jacc.2015.07.086
Response to Letter Regarding Article, " Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation : Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure ( CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca- Heart Failure ( GISSI- HF) Trials."
Abdul-Rahim, A. H., Perez, A. -C., Fulton, R. L., Jhund, P. S., Latini, R., Tognoni, G., . . . McMurray, J. J. V. (2015). Response to Letter Regarding Article, " Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation : Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure ( CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca- Heart Failure ( GISSI- HF) Trials.". CIRCULATION, 132(22), E358. doi:10.1161/CIRCULATIONAHA.115.018395
Risk of Ischemic Stroke after Intracranial Hemorrhage in Patients with Atrial Fibrillation
Lerario, M. P., Gialdini, G., Lapidus, D. M., Shaw, M. M., Navi, B. B., Merkler, A. E., . . . Kamel, H. (2015). Risk of Ischemic Stroke after Intracranial Hemorrhage in Patients with Atrial Fibrillation. PLOS ONE, 10(12). doi:10.1371/journal.pone.0145579
Stroke Risk,Factors Beyond the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score: Can We Improve Our Identification of "High. Stroke Risk" Patients With Atrial Fibrillation?
Szymanski, F. M., Lip, G. Y. H., Filipiak, K. J., Platek, A. E., Hrynkiewicz-Szymanska, A., & Opolski, G. (2015). Stroke Risk,Factors Beyond the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score: Can We Improve Our Identification of "High. Stroke Risk" Patients With Atrial Fibrillation?. AMERICAN JOURNAL OF CARDIOLOGY, 116(11), 1781-1788. doi:10.1016/j.amjcard.2015.08.049
Stroke prevention in atrial fibrillation: Where are we now?
Lip, G. Y. H. (2015). Stroke prevention in atrial fibrillation: Where are we now?. Indian heart journal, 67 Suppl 2, S1-S3. doi:10.1016/j.ihj.2015.11.002
Edoxaban for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation
Dzeshka, M. S., & Lip, G. Y. H. (2015). Edoxaban for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. EXPERT OPINION ON PHARMACOTHERAPY, 16(17), 2661-2678. doi:10.1517/14656566.2015.1104301
2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J. -P., Del Zotti, F., . . . ESC Scientific Document Group . (2015). 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).. European heart journal, 36(44), 3075-3128. doi:10.1093/eurheartj/ehv319
Copper micro and nano particles mixture for 3D interconnections application
Yuan Yuan Dai., Mei Zhen Ng., Anantha, P., Chee Lip Gan., & Chuan Seng Tan. (2015). Copper micro and nano particles mixture for 3D interconnections application. In 2015 International 3D Systems Integration Conference (3DIC) (pp. TS8.9.1-TS8.9.5). IEEE. doi:10.1109/3dic.2015.7334614
Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study
Staerk, L., Lip, G. Y. H., Olesen, J. B., Fosbol, E. L., Pallisgaard, J. L., Bonde, A. N., . . . Gislason, G. H. (2015). Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study. In BMJ-BRITISH MEDICAL JOURNAL Vol. 351. doi:10.1136/bmj.h5876
Predictive accuracy of CHA<sub>2</sub>DS<sub>2</sub>-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy
Capodanno, D., Rossini, R., Musumeci, G., Lettieri, C., Senni, M., Valsecchi, O., . . . Lip, G. Y. H. (2015). Predictive accuracy of CHA<sub>2</sub>DS<sub>2</sub>-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy. INTERNATIONAL JOURNAL OF CARDIOLOGY, 199, 319-325. doi:10.1016/j.ijcard.2015.07.064
Risk and prediction of dementia in patients with atrial fibrillation - A nationwide population-based cohort study
Liao, J. -N., Chao, T. -F., Liu, C. -J., Wang, K. -L., Chen, S. -J., Tuan, T. -C., . . . Chen, S. -A. (2015). Risk and prediction of dementia in patients with atrial fibrillation - A nationwide population-based cohort study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 199, 25-30. doi:10.1016/j.ijcard.2015.06.170
Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry
Lip, G. Y. H., Laroche, C., Popescu, M. I., Rasmussen, L. H., Vitali-Serdoz, L., Dan, G. -A., . . . Boriani, G. (2015). Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry. EUROPACE, 17(12), 1777-1786. doi:10.1093/europace/euv269
2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS).
Adler, Y., Charron, P., Imazio, M., Badano, L., Barón-Esquivias, G., Bogaert, J., . . . ESC Scientific Document Group . (2015). 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS).. European heart journal, 36(42), 2921-2964. doi:10.1093/eurheartj/ehv318
Withdrawn as Duplicate: The CHA₂DS₂-VASc score for stroke risk stratification in patients with atrial fibrillation: a brief history.
Lip, G. Y. H. (2015). Withdrawn as Duplicate: The CHA₂DS₂-VASc score for stroke risk stratification in patients with atrial fibrillation: a brief history.. European heart journal, 36(42), 2880-2885. doi:10.1093/eurheartj/ehv431
Predictors for Stroke and Death in Non-Anticoagulated Asian Patients with Atrial Fibrillation: The Fushimi AF Registry
Hamatani, Y., Yamashita, Y., Esato, M., Chun, Y. -H., Tsuji, H., Wada, H., . . . Akao, M. (2015). Predictors for Stroke and Death in Non-Anticoagulated Asian Patients with Atrial Fibrillation: The Fushimi AF Registry. In PLOS ONE Vol. 10. doi:10.1371/journal.pone.0142394
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., . . . ESC Scientific Document Group . (2015). 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).. European heart journal, 36(41), 2793-2867. doi:10.1093/eurheartj/ehv316
Cost-effectiveness of Apixaban Compared With Edoxaban for Stroke Prevention in Nonvalvular Atrial Fibrillation
Lip, G. Y. H., Lanitis, T., Kongnakorn, T., Phatak, H., Chalkiadaki, C., Liu, X., . . . Dorian, P. (2015). Cost-effectiveness of Apixaban Compared With Edoxaban for Stroke Prevention in Nonvalvular Atrial Fibrillation. CLINICAL THERAPEUTICS, 37(11), 2476-2488. doi:10.1016/j.clinthera.2015.09.005
Metabolic syndrome, atrial fibrillation, and stroke: Tackling an emerging epidemic
Hajhosseiny, R., Matthews, G. K., & Lip, G. Y. H. (2015). Metabolic syndrome, atrial fibrillation, and stroke: Tackling an emerging epidemic. HEART RHYTHM, 12(11), 2332-2343. doi:10.1016/j.hrthm.2015.06.038
Non-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta-analysis of randomized trials
Xiong, Q., Lau, Y. C., Senoo, K., Lane, D. A., Hong, K., & Lip, G. Y. H. (2015). Non-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta-analysis of randomized trials. EUROPEAN JOURNAL OF HEART FAILURE, 17(11), 1192-1200. doi:10.1002/ejhf.343
Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH: comment
Husted, S., Lip, G. Y. H., & De Caterina, R. (2015). Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH: comment. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 13(11), 2130-2132. doi:10.1111/jth.13124
Relationship of Age With Stroke and Death in Anticoagulated Patients With Nonvalvular Atrial Fibrillation AMADEUS Trial
Senoo, K., & Lip, G. Y. H. (2015). Relationship of Age With Stroke and Death in Anticoagulated Patients With Nonvalvular Atrial Fibrillation AMADEUS Trial. STROKE, 46(11), 3202-3207. doi:10.1161/STROKEAHA.115.010614
Safety and efficacy of abciximab in older adults undergoing percutaneous coronary intervention
Brown, R. A., Shantsila, E., Varma, C., & Lip, G. Y. H. (2015). Safety and efficacy of abciximab in older adults undergoing percutaneous coronary intervention. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 69(11), 1334-1340. doi:10.1111/ijcp.12702
Small-size Microparticles as Indicators of Acute Decompensated State in Ischemic Heart Failure
Montoro-Garcia, S., Shantsila, E., Wrigley, B. J., Tapp, L. D., Abellan Aleman, J., & Lip, G. Y. H. (2015). Small-size Microparticles as Indicators of Acute Decompensated State in Ischemic Heart Failure. REVISTA ESPANOLA DE CARDIOLOGIA, 68(11), 951-958. doi:10.1016/j.rec.2014.11.016
Stroke in atrial fibrillation and improving the identification of 'high-risk' patients: the crossroads of immunity and thrombosis
Shantsila, E., & Lip, G. Y. H. (2015). Stroke in atrial fibrillation and improving the identification of 'high-risk' patients: the crossroads of immunity and thrombosis. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 13(11), 1968-1970. doi:10.1111/jth.13121
The SAMe-TT<sub>2</sub>R<sub>2</sub> Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study
Roldan, V., Cancio, S., Galvez, J., Valdes, M., Vicente, V., Marin, F., & Lip, G. Y. H. (2015). The SAMe-TT<sub>2</sub>R<sub>2</sub> Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study. AMERICAN JOURNAL OF MEDICINE, 128(11), 1237-1243. doi:10.1016/j.amjmed.2015.05.036
Use of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic
Lee, S. I., Sayers, M., Lip, G. Y. H., & Lane, D. A. (2015). Use of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 69(11), 1341-1348. doi:10.1111/ijcp.12712
Intracerebral haemorrhage, atrial fibrillation, and anticoagulation
Wilson, D., Salman, R. A. -S., Klijn, C. J. M., Lip, G. Y. H., & Werring, D. J. (2015). Intracerebral haemorrhage, atrial fibrillation, and anticoagulation. LANCET, 386(10005), 1736-1737. doi:10.1016/S0140-6736(15)00695-9
Composite end point analyses of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation
Madzak, A., Larsen, T. B., Lane, D. A., Lip, G. Y. H., & Nielsen, P. B. (2015). Composite end point analyses of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 13(10), 1155-1163. doi:10.1586/14779072.2015.1086643
An update on atrial fibrillation: focus on stroke risk reduction strategies
Potpara, T. S., Jokic, V., Medic, B., Prostran, M., & Lip, G. Y. H. (2015). An update on atrial fibrillation: focus on stroke risk reduction strategies. MINERVA MEDICA, 106(5), 259-273. Retrieved from https://www.webofscience.com/
Gastrointestinal haemorrhage in atrial fibrillation patients: impact of quality of anticoagulation control.
Chan, P. -H., Li, W. -H., Hai, J. -J., Chan, K. -H., Tse, H. -F., Cheung, B. M. -Y., . . . Siu, C. -W. (2015). Gastrointestinal haemorrhage in atrial fibrillation patients: impact of quality of anticoagulation control.. European heart journal. Cardiovascular pharmacotherapy, 1(4), 265-272. doi:10.1093/ehjcvp/pvv032
Gender differences in clinical characteristics and inpatient outcomes amongst 2442 hospitalized Chinese patients with nonvalvular atrial fibrillation: The Nanchang Atrial Fibrillation Registry
Xiong, Q., Shantsila, A., Zhou, Q., Liu, Y., Shen, Y., Lane, D., . . . Lip, G. Y. H. (2015). Gender differences in clinical characteristics and inpatient outcomes amongst 2442 hospitalized Chinese patients with nonvalvular atrial fibrillation: The Nanchang Atrial Fibrillation Registry. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 66 (pp. C184). doi:10.1016/j.jacc.2015.06.703
Lights and shadows in the management of old and new oral anticoagulants in the real world of atrial fibrillation by Italian internists. A survey from the Atrial Fibrillation Registry for Ankle-Brachial Index Prevalence Assessment-Collaborative Italian Study
Pignatelli, P., Pastori, D., Perticone, F., Corazza, G. R., & Violi, F. (2015). Lights and shadows in the management of old and new oral anticoagulants in the real world of atrial fibrillation by Italian internists. A survey from the Atrial Fibrillation Registry for Ankle-Brachial Index Prevalence Assessment-Collaborative Italian Study. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 26(8), E31-E33. doi:10.1016/j.ejim.2015.06.007
New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint
Rubboli, A., Agewall, S., Huber, K., & Lip, G. Y. H. (2015). New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint. INTERNATIONAL JOURNAL OF CARDIOLOGY, 196, 133-138. doi:10.1016/j.ijcard.2015.06.006
Non-vitamin K Antagonist Oral Anticoagulants (NOACs) in Patients with Atrial Fibrillation and Heart Failure: A Systemic Review and Meta-analysis of randomized trials
Xiong, Q., Lau, Y., Senoo, K., Hong, K., & Lip, G. Y. H. (2015). Non-vitamin K Antagonist Oral Anticoagulants (NOACs) in Patients with Atrial Fibrillation and Heart Failure: A Systemic Review and Meta-analysis of randomized trials. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 66 (pp. C269-C270). doi:10.1016/j.jacc.2015.06.1049
Optimizing Atrial Fibrillation Management From ICU and Beyond
Walkey, A. J., Hogarth, K., & Lip, G. Y. H. (2015). Optimizing Atrial Fibrillation Management From ICU and Beyond. CHEST, 148(4), 859-864. doi:10.1378/chest.15-0358
Statins and the risk of dementia in patients with atrial fibrillation: A nationwide population-based cohort study
Chao, T. -F., Liu, C. -J., Chen, S. -J., Wang, K. -L., Lin, Y. -J., Chang, S. -L., . . . Chen, S. -A. (2015). Statins and the risk of dementia in patients with atrial fibrillation: A nationwide population-based cohort study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 196, 91-97. doi:10.1016/j.ijcard.2015.05.159
The Clinical Relevance of Microbleeds in Stroke study (CROMIS-2): rationale, design, and methods
Charidimou, A., Wilson, D., Shakeshaft, C., Ambler, G., White, M., Cohen, H., . . . Werring, D. J. (2015). The Clinical Relevance of Microbleeds in Stroke study (CROMIS-2): rationale, design, and methods. INTERNATIONAL JOURNAL OF STROKE, 10, 155-161. doi:10.1111/ijs.12569
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)
Priori, S. G., Blomstrom-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., . . . Zannad, F. (2015). 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). EUROPEAN HEART JOURNAL, 36(41), 2793-+. doi:10.1093/eurheartj/ehv316
Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation Meta-Analysis
Wang, K. -L., Lip, G. Y. H., Lin, S. -J., & Chiang, C. -E. (2015). Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation Meta-Analysis. STROKE, 46(9), 2555-2561. doi:10.1161/STROKEAHA.115.009947
Patients With Ischemic Stroke and Incident Atrial Fibrillation A Nationwide Cohort Study
Fauchier, L., Clementy, N., Pelade, C., Collignon, C., Nicolle, E., & Lip, G. Y. H. (2015). Patients With Ischemic Stroke and Incident Atrial Fibrillation A Nationwide Cohort Study. STROKE, 46(9), 2432-2437. doi:10.1161/STROKEAHA.115.010270
Recurrent Stroke The Value of the CHA<sub>2</sub>DS<sub>2</sub> VASc Score and the Essen Stroke Risk Score in a Nationwide Stroke Cohort
Andersen, S. D., Gorst-Rasmussen, A., Lip, G. Y. H., Bach, F. W., & Larsen, T. B. (2015). Recurrent Stroke The Value of the CHA<sub>2</sub>DS<sub>2</sub> VASc Score and the Essen Stroke Risk Score in a Nationwide Stroke Cohort. STROKE, 46(9), 2491-2497. doi:10.1161/STROKEAHA.115.009912
Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation AMADEUS Trial
Senoo, K., Lip, G. Y. H., Lane, D. A., Bueller, H. R., & Kotecha, D. (2015). Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation AMADEUS Trial. STROKE, 46(9), 2523-2528. doi:10.1161/STROKEAHA.115.009487
Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation A Nationwide Cohort Study From Taiwan
Chao, T. -F., Wang, K. -L., Liu, C. -J., Lin, Y. -J., Chang, S. -L., Lo, L. -W., . . . Chen, S. -A. (2015). Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation A Nationwide Cohort Study From Taiwan. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 66(12), 1339-1347. doi:10.1016/j.jacc.2015.07.026
Atrial flutter and thromboembolic risk: a systematic review
Vadmann, H., Nielsen, P. B., Hjortshoj, S. P., Riahi, S., Rasmussen, L. H., Lip, G. Y. H., & Larsen, T. B. (2015). Atrial flutter and thromboembolic risk: a systematic review. HEART, 101(18), 1446-1455. doi:10.1136/heartjnl-2015-307550
Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin
Ye, S., Cheng, B., Lip, G. Y. H., Buchsbaum, R., Sacco, R. L., Levin, B., . . . Homma, S. (2015). Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin. AMERICAN JOURNAL OF CARDIOLOGY, 116(6), 904-912. doi:10.1016/j.amjcard.2015.06.016
Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation
Proietti, M., Marra, A. M., Tassone, E. J., De Vuono, S., Corrao, S., Gobbi, P., . . . Raparelli, V. (2015). Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation. AMERICAN JOURNAL OF CARDIOLOGY, 116(6), 877-882. doi:10.1016/j.amjcard.2015.05.060
The CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>-VASc scores for predicting ischemic stroke among East Asian patients with atrial fibrillation: A systemic review and meta-analysis
Xiong, Q., Chen, S., Senoo, K., Proietti, M., Hong, K., & Lip, G. Y. H. (2015). The CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>-VASc scores for predicting ischemic stroke among East Asian patients with atrial fibrillation: A systemic review and meta-analysis. INTERNATIONAL JOURNAL OF CARDIOLOGY, 195, 237-242. doi:10.1016/j.ijcard.2015.05.115
Assessment of the CHA(2)DS(2)-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation
Melgaard, L., Gorst-Rasmussen, A., Lane, D. A., Rasmussen, L. H., Larsen, T. B., & Lip, G. Y. H. (2015). Assessment of the CHA(2)DS(2)-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 314(10), 1030-1038. doi:10.1001/jama.2015.10725
Nonsteroidal anti-inflammatory drugs and bleeding risk in anticoagulated patients with atrial fibrillation.
Lip, G. Y. (2015). Nonsteroidal anti-inflammatory drugs and bleeding risk in anticoagulated patients with atrial fibrillation.. Expert review of cardiovascular therapy, 13(9), 963-965. doi:10.1586/14779072.2015.1071665
Assessing Bleeding Risk With the HAS-BLED Score: Balancing Simplicity, Practicality, and Predictive Value in Bleeding-Risk Assessment
Lip, G. Y. H. (2015). Assessing Bleeding Risk With the HAS-BLED Score: Balancing Simplicity, Practicality, and Predictive Value in Bleeding-Risk Assessment. CLINICAL CARDIOLOGY, 38(9), 562-564. doi:10.1002/clc.22436
Assessing Eligibility for Anticoagulation After Diagnosis of Atrial Fibrillation Reply
Lip, G. Y. H., & Lane, D. A. (2015). Assessing Eligibility for Anticoagulation After Diagnosis of Atrial Fibrillation Reply. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 314(9), 949-950. doi:10.1001/jama.2015.8995
European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society
Lip, G. Y. H., Heinzel, F. R., Gaita, F., Gonzalez Juanatey, J. R., Le Heuzey, J. Y., Potpara, T., . . . Pieske, B. (2015). European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. EUROPEAN JOURNAL OF HEART FAILURE, 17(9), 848-874. doi:10.1002/ejhf.338
Impact of advanced age on management and prognosis in atrial fibrillation: insights from a population-based study in general practice
Wolff, A., Shantsila, E., Lip, G. Y. H., & Lane, D. A. (2015). Impact of advanced age on management and prognosis in atrial fibrillation: insights from a population-based study in general practice. AGE AND AGEING, 44(5), 874-878. doi:10.1093/ageing/afv071
Influence of age on respiratory modulation of muscle sympathetic nerve activity, blood pressure and baroreflex function in humans
Shantsila, A., McIntyre, D. B., Lip, G. Y. H., Fadel, P. J., Paton, J. F. R., Pickering, A. E., & Fisher, J. P. (2015). Influence of age on respiratory modulation of muscle sympathetic nerve activity, blood pressure and baroreflex function in humans. EXPERIMENTAL PHYSIOLOGY, 100(9), 1039-1051. doi:10.1113/EP085071
Monitoring the Effects and Antidotes of the Non-vitamin K Oral Anticoagulants.
Rahmat, N. A., & Lip, G. Y. H. (2015). Monitoring the Effects and Antidotes of the Non-vitamin K Oral Anticoagulants.. Arrhythmia & electrophysiology review, 4(2), 90-95. doi:10.15420/aer.2015.04.02.90
Oral Anticoagulant Therapy in Atrial Fibrillation Patients at High Stroke and Bleeding Risk
Potpara, T. S., & Lip, G. Y. H. (2015). Oral Anticoagulant Therapy in Atrial Fibrillation Patients at High Stroke and Bleeding Risk. PROGRESS IN CARDIOVASCULAR DISEASES, 58(2), 177-194. doi:10.1016/j.pcad.2015.07.003
Urinary 11-dehydro-thromboxane B<sub>2</sub> is associated with cardiovascular events and mortality in patients with atrial fibrillation
Pastori, D., Pignatelli, P., Farcomeni, A., Cangemi, R., Hiatt, W. R., Bartimoccia, S., . . . Violi, F. (2015). Urinary 11-dehydro-thromboxane B<sub>2</sub> is associated with cardiovascular events and mortality in patients with atrial fibrillation. AMERICAN HEART JOURNAL, 170(3), 490-+. doi:10.1016/j.ahj.2015.05.011
sST2 levels are associated with all-cause mortality in anticoagulated patients with atrial fibrillation
Vilchez, J. A., Perez-Cuellar, M., Marin, F., Gallego, P., Manzano-Fernandez, S., Valdes, M., . . . Roldan, V. (2015). sST2 levels are associated with all-cause mortality in anticoagulated patients with atrial fibrillation. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 45(9), 899-905. doi:10.1111/eci.12482
Association between statin use and plasma D-dimer levels
Sahebkar, A., Serban, C., Mikhailidis, D. P., Undas, A., Lip, G. Y. H., Muntner, P., . . . Banach, M. (2015). Association between statin use and plasma D-dimer levels. THROMBOSIS AND HAEMOSTASIS, 114(3), 546-557. doi:10.1160/TH14-11-0937
Erectile dysfunction in atrial fibrillation: A risk factor for stroke or a reflection of stroke risk factors?
Brown, R. A., & Lip, G. Y. H. (2015). Erectile dysfunction in atrial fibrillation: A risk factor for stroke or a reflection of stroke risk factors?. CARDIOLOGY JOURNAL, 22(4), 359-361. doi:10.5603/CJ.2015.0049
Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data
Ziff, O. J., Lane, D. A., Samra, M., Griffith, M., Kirchhof, P., Lip, G. Y. H., . . . Kotecha, D. (2015). Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data. BMJ: British Medical Journal, 351. doi:10.1136/bmj.h4451
Cardiac Fibrosis in Patients With Atrial Fibrillation Mechanisms and Clinical Implications
Dzeshka, M. S., Lip, G. Y. H., Snezhitskiy, V., & Shantsila, E. (2015). Cardiac Fibrosis in Patients With Atrial Fibrillation Mechanisms and Clinical Implications. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 66(8), 943-959. doi:10.1016/j.jacc.2015.06.1313
Decapsulation of 3D multi-die stacked package
Kor, H. B., Liu, Q., Siah, Y. W., & Gan, C. L. (2015). Decapsulation of 3D multi-die stacked package. In 2015 IEEE 22nd International Symposium on the Physical and Failure Analysis of Integrated Circuits (pp. 465-468). IEEE. doi:10.1109/ipfa.2015.7224433
Erratum: Stroke prevention in atrial fibrillation: A systematic review (JAMA - Journal of the American Medical Association (2015) 313:19 (1950-1962))
Lip, G. Y. H., & Lane, D. A. (2015). Erratum: Stroke prevention in atrial fibrillation: A systematic review (JAMA - Journal of the American Medical Association (2015) 313:19 (1950-1962)). JAMA - Journal of the American Medical Association, 314(8), 837.
Evaluation of copper nanoparticles for low temperature bonded interconnections
Byung Hoon Lee., Mei Zhen Ng., Zinn, A. A., & Chee Lip Gan. (2015). Evaluation of copper nanoparticles for low temperature bonded interconnections. In 2015 IEEE 22nd International Symposium on the Physical and Failure Analysis of Integrated Circuits (pp. 102-106). IEEE. doi:10.1109/ipfa.2015.7224343
Stroke Prevention in Atrial Fibrillation: A Systematic Review (vol 313, pg 1950, 2015)
Lip, G. Y. H., & Lane, D. A. (2015). Stroke Prevention in Atrial Fibrillation: A Systematic Review (vol 313, pg 1950, 2015). JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 314(8), 837. doi:10.1001/jama.2015.9181
Smoking, atrial fibrillation, and ischemic stroke: a confluence of epidemics
Albertsen, I. E., Overvad, T. F., Lip, G. Y. H., & Larsen, T. B. (2015). Smoking, atrial fibrillation, and ischemic stroke: a confluence of epidemics. CURRENT OPINION IN CARDIOLOGY, 30(5), 512-517. doi:10.1097/HCO.0000000000000205
Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding A Nationwide Cohort Study
Nielsen, P. B., Larsen, T. B., Skjoth, F., Gorst-Rasmussen, A., Rasmussen, L. H., & Lip, G. Y. H. (2015). Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding A Nationwide Cohort Study. CIRCULATION, 132(6), 517-525. doi:10.1161/CIRCULATIONAHA.115.015735
Patterns in atrial fibrillation management and 'real-world' adherence to guidelines in the Balkan Region: an overview of the Balkan-atrial fibrillation survey
Potpara, T. S., & Lip, G. Y. H. (2015). Patterns in atrial fibrillation management and 'real-world' adherence to guidelines in the Balkan Region: an overview of the Balkan-atrial fibrillation survey. EUROPEAN HEART JOURNAL, 36(30), 1943-1944. Retrieved from https://www.webofscience.com/
A Phase II, double-blind, randomized, parallel group, dose-finding study of the safety and tolerability of darexaban compared with warfarin in patients with non-valvular atrial fibrillation: the oral factor Xa inhibitor for prophylaxis of stroke in atrial fibrillation study 2 (OPAL-2)
Lip, G. Y. H., Halperin, J. L., Petersen, P., Rodgers, G. M., Pall, D., & Renfurm, R. W. (2015). A Phase II, double-blind, randomized, parallel group, dose-finding study of the safety and tolerability of darexaban compared with warfarin in patients with non-valvular atrial fibrillation: the oral factor Xa inhibitor for prophylaxis of stroke in atrial fibrillation study 2 (OPAL-2). JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 13(8), 1405-1413. doi:10.1111/jth.13025
Age-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe: The EORP-AF General Pilot Registry (EURObservational Research Programme-Atrial Fibrillation).
Fumagalli, S., Said, S. A. M., Laroche, C., Gabbai, D., Marchionni, N., Boriani, G., . . . EORP-AF Investigators. (2015). Age-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe: The EORP-AF General Pilot Registry (EURObservational Research Programme-Atrial Fibrillation).. JACC. Clinical electrophysiology, 1(4), 326-334. doi:10.1016/j.jacep.2015.02.019
Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESCWorking Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS)
Sticherling, C., Marin, F., Birnie, D., Boriani, G., Calkins, H., Dan, G. -A., . . . Lip, G. Y. H. (2015). Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESCWorking Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS). EUROPACE, 17(8), 1197-1214. doi:10.1093/europace/euv190
Apixaban versus edoxaban for stroke prevention in nonvalvular atrial fibrillation
Xiong, Q., Lau, Y. C., & Lip, G. Y. H. (2015). Apixaban versus edoxaban for stroke prevention in nonvalvular atrial fibrillation. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 4(4), 367-376. doi:10.2217/CER.15.15
Benefit of Anticoagulation Therapy in Hyperthyroidism-Related Atrial Fibrillation
Chan, P. -H., Hai, J., Yeung, C. -Y., Lip, G. Y. H., Lam, K. S. -L., Tse, H. -F., & Siu, C. -W. (2015). Benefit of Anticoagulation Therapy in Hyperthyroidism-Related Atrial Fibrillation. CLINICAL CARDIOLOGY, 38(8), 476-482. doi:10.1002/clc.22427
Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making - a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society
Boriani, G., Savelieva, I., Dan, G. -A., Deharo, J. C., Ferro, C., Israel, C. W., . . . Lip, G. Y. H. (2015). Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making - a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. Europace, 17(8), 1169-1196. doi:10.1093/europace/euv202
Development and validation of a new assay for assessing clot integrity
Ranjit, P., Lau, Y., Lip, G. Y. H., & Blann, A. D. (2015). Development and validation of a new assay for assessing clot integrity. VASCULAR PHARMACOLOGY, 71, 102-107. doi:10.1016/j.vph.2015.02.013
Duration of Diabetes Mellitus and Risk of Thromboembolism and Bleeding in Atrial Fibrillation Nationwide Cohort Study
Overvad, T. F., Skjoth, F., Lip, G. Y. H., Lane, D. A., Albertsen, I. E., Rasmussen, L. H., & Larsen, T. B. (2015). Duration of Diabetes Mellitus and Risk of Thromboembolism and Bleeding in Atrial Fibrillation Nationwide Cohort Study. STROKE, 46(8), 2168-2174. doi:10.1161/STROKEAHA.115.009371
Effect of Active Smoking on Comparative Efficacy of Antithrombotic Therapy in Patients With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project
Angoulvant, D., Villejoubert, O., Bejan-Angoulvant, T., Ivanes, F., Saint Etienne, C., Lip, G. Y. H., & Fauchier, L. (2015). Effect of Active Smoking on Comparative Efficacy of Antithrombotic Therapy in Patients With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project. CHEST, 148(2), 491-498. doi:10.1378/chest.14-3006
Ethnic differences in the diurnal variation of symptom onset time for acute ST elevation myocardial infarction - An observational cohort study
Brown, R. A., Lip, G. Y. H., Varma, C., & Shantsila, E. (2015). Ethnic differences in the diurnal variation of symptom onset time for acute ST elevation myocardial infarction - An observational cohort study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 187, 414-416. doi:10.1016/j.ijcard.2015.03.371
Gender differences in stroke prevention in atrial fibrillation in general practice: using the GRASP-AF audit tool
Shantsila, E., Wolff, A., Lip, G. Y. H., & Lane, D. A. (2015). Gender differences in stroke prevention in atrial fibrillation in general practice: using the GRASP-AF audit tool. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 69(8), 840-845. doi:10.1111/ijcp.12625
Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials
Sahebkar, A., Kotani, K., Serban, C., Ursoniu, S., Mikhailidis, D. P., Jones, S. R., . . . Banach, M. (2015). Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials. ATHEROSCLEROSIS, 241(2), 433-442. doi:10.1016/j.atherosclerosis.2015.05.022
Thromboembolic risk stratification of patients hospitalized with heart failure in sinus rhythm: a nationwide cohort study
Wolsk, E., Lamberts, M., Hansen, M. L., Blanche, P., Kober, L., Torp-Pedersen, C., . . . Gislason, G. (2015). Thromboembolic risk stratification of patients hospitalized with heart failure in sinus rhythm: a nationwide cohort study. EUROPEAN JOURNAL OF HEART FAILURE, 17(8), 828-836. doi:10.1002/ejhf.309
Unsupervised learning for signal mapping in dynamic photon emission
Chef, S., Jacquir, S., Sanchez, K., Perdu, P., Binczak, S., & Gan, C. L. (2015). Unsupervised learning for signal mapping in dynamic photon emission. Microelectronics Reliability, 55(9-10), 1564-1568. doi:10.1016/j.microrel.2015.06.043
Difficult decision making in the management of patients with atrial fibrillation and acute coronary syndrome or invasive cardiovascular interventions: new recommendations for daily practice
Boriani, G., Lane, D. A., Windecker, S., Huber, K., Kirchhof, P., & Lip, G. Y. H. (2015). Difficult decision making in the management of patients with atrial fibrillation and acute coronary syndrome or invasive cardiovascular interventions: new recommendations for daily practice. EUROPACE, 17(9), 1319-1322. doi:10.1093/europace/euu303
Non-vitamin K antagonist oral anticoagulants in the cardioversion of patients with atrial fibrillation: systematic review and meta-analysis
Caldeira, D., Costa, J., Ferreira, J. J., Lip, G. Y. H., & Pinto, F. J. (2015). Non-vitamin K antagonist oral anticoagulants in the cardioversion of patients with atrial fibrillation: systematic review and meta-analysis. CLINICAL RESEARCH IN CARDIOLOGY, 104(7), 582-590. doi:10.1007/s00392-015-0821-8
Sex-related predictors for thromboembolic events after catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry
Kornej, J., Kosiuk, J., Hindricks, G., Arya, A., Sommer, P., Rolf, S., . . . Bollmann, A. (2015). Sex-related predictors for thromboembolic events after catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry. CLINICAL RESEARCH IN CARDIOLOGY, 104(7), 603-610. doi:10.1007/s00392-015-0823-6
Net Clinical Benefit for Oral Anticoagulation, Aspirin, or No Therapy in Nonvalvular Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score (Beyond Sex)
Lip, G. Y. H., Skjoth, F., Rasmussen, L. H., Nielsen, P. B., & Larsen, T. B. (2015). Net Clinical Benefit for Oral Anticoagulation, Aspirin, or No Therapy in Nonvalvular Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score (Beyond Sex). JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 66(4), 488-490. doi:10.1016/j.jacc.2015.05.044
Statin therapy and plasma coenzyme Q10 concentrations-A systematic review and meta-analysis of placebo-controlled trials
Banach, M., Serban, C., Ursoniu, S., Rysz, J., Muntner, P., Toth, P. P., . . . Sahebkar, A. (2015). Statin therapy and plasma coenzyme Q10 concentrations-A systematic review and meta-analysis of placebo-controlled trials. PHARMACOLOGICAL RESEARCH, 99, 329-336. doi:10.1016/j.phrs.2015.07.008
Antidotes to non-vitamin K oral anticoagulants: necessary or not?
Proietti, M., & Lip, G. Y. H. (2015). Antidotes to non-vitamin K oral anticoagulants: necessary or not?. EXPERT OPINION ON PHARMACOTHERAPY, 16(11), 1573-1576. doi:10.1517/14656566.2015.1057119
Prognostic value of CHA<sub>2</sub>DS<sub>2</sub>-VASc score in patients with 'non-valvular atrial fibrillation' and valvular heart disease: the Loire Valley Atrial Fibrillation Project
Philippart, R., Brunet-Bernard, A., Clementy, N., Bourguignon, T., Mirza, A., Babuty, D., . . . Fauchier, L. (2015). Prognostic value of CHA<sub>2</sub>DS<sub>2</sub>-VASc score in patients with 'non-valvular atrial fibrillation' and valvular heart disease: the Loire Valley Atrial Fibrillation Project. EUROPEAN HEART JOURNAL, 36(28), 1822-1830. doi:10.1093/eurheartj/ehv163
Asymptomatic versus symptomatic atrial fibrillation: A systematic review of age/gender differences and cardiovascular outcomes
Xiong, Q., Proietti, M., Senoo, K., & Lip, G. Y. H. (2015). Asymptomatic versus symptomatic atrial fibrillation: A systematic review of age/gender differences and cardiovascular outcomes. INTERNATIONAL JOURNAL OF CARDIOLOGY, 191, 172-177. doi:10.1016/j.ijcard.2015.05.011
CD36 expression and lipid metabolism following an oral glucose challenge in South Asians
Patel, J. V., Banerjee, A., Montoro-Garcia, S., Shantsila, E., Alam, M., Flinders, P., . . . Gill, P. S. (2015). CD36 expression and lipid metabolism following an oral glucose challenge in South Asians. WORLD JOURNAL OF DIABETES, 6(7), 983-989. doi:10.4239/wjd.v6.i7.983
Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices
Martin, D. T., Bersohn, M. M., Waldo, A. L., Wathen, M. S., Choucair, W. K., Lip, G. Y. H., . . . Halperin, J. L. (2015). Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices. EUROPEAN HEART JOURNAL, 36(26), 1660-1668. doi:10.1093/eurheartj/ehv115
A comprehensive insight of novel antioxidant therapies for atrial fibrillation management
Orenes-Pinero, E., Valdes, M., Lip, G. Y. H., & Marin, F. (2015). A comprehensive insight of novel antioxidant therapies for atrial fibrillation management. DRUG METABOLISM REVIEWS, 47(3), 388-400. doi:10.3109/03602532.2015.1077858
Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation
Shields, A. M., & Lip, G. Y. H. (2015). Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation. JOURNAL OF INTERNAL MEDICINE, 278(1), 1-18. doi:10.1111/joim.12360
Simple decision-making between a vitamin K antagonist and a non-vitamin K antagonist oral anticoagulant: using the SAMe-TT<sub>2</sub>R<sub>2</sub> score
Proietti, M., & Lip, G. Y. H. (2015). Simple decision-making between a vitamin K antagonist and a non-vitamin K antagonist oral anticoagulant: using the SAMe-TT<sub>2</sub>R<sub>2</sub> score. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 1(3), 150-152. doi:10.1093/ehjcvp/pvv012
THE IMPACT OF DIFFERENT GLYCAEMIC INDEX CARBOHYDRATE STAPLE FOODS ON SOUTH ASIAN DIABETIC AND CARDIOVASCULAR INDICES OF HEALTH: A RCT
Patel, J., Flinders, P., Gill, P., Lip, G., & Hughes, E. (2015). THE IMPACT OF DIFFERENT GLYCAEMIC INDEX CARBOHYDRATE STAPLE FOODS ON SOUTH ASIAN DIABETIC AND CARDIOVASCULAR INDICES OF HEALTH: A RCT. In ATHEROSCLEROSIS Vol. 241 (pp. E191-E192). doi:10.1016/j.atherosclerosis.2015.04.936
Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation
Guo, Y., Wang, H., Tian, Y., Wang, Y., & Lip, G. Y. H. (2015). Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation. CHEST, 148(1), 62-72. doi:10.1378/chest.14-2018
Recent scientific documents from the European Heart Rhythm Association (EHRA)
Gorenek, B., & Lip, G. Y. H. (2015). Recent scientific documents from the European Heart Rhythm Association (EHRA). EUROPACE, 17(8), 1161-1163. doi:10.1093/europace/euv193
Relationship between Mediterranean diet and time in therapeutic range in atrial fibrillation patients taking vitamin K antagonists
Pignatelli, P., Pastori, D., Vicario, T., Bucci, T., Del Ben, M., Russo, R., . . . Violi, F. (2015). Relationship between Mediterranean diet and time in therapeutic range in atrial fibrillation patients taking vitamin K antagonists. EUROPACE, 17(8), 1223-1228. doi:10.1093/europace/euv127
Risk of gastrointestinal adverse effects of dabigatran compared with warfarin among patients with atrial fibrillation: a nationwide cohort study
Staerk, L., Gislason, G. H., Lip, G. Y. H., Fosbol, E. L., Hansen, M. L., Lamberts, M., . . . Olesen, J. B. (2015). Risk of gastrointestinal adverse effects of dabigatran compared with warfarin among patients with atrial fibrillation: a nationwide cohort study. EUROPACE, 17(8), 1215-1222. doi:10.1093/europace/euv119
Significant enhancement of UV emission in ZnO nanorods subject to Ga+ ion beam irradiation
Yadian, B., Chen, R., Liu, H., Sun, H., Liu, Q., Gan, C. L., . . . Huang, Y. (2015). Significant enhancement of UV emission in ZnO nanorods subject to Ga+ ion beam irradiation. Nano Research, 8(6), 1857-1864. doi:10.1007/s12274-014-0693-7
Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors - Results from a systematic review and meta-analysis of randomized controlled trials
Sahebkar, A., Serban, C., Ursoniu, S., Wong, N. D., Muntner, P., Graham, I. M., . . . Banach, M. (2015). Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors - Results from a systematic review and meta-analysis of randomized controlled trials. INTERNATIONAL JOURNAL OF CARDIOLOGY, 189, 47-55. doi:10.1016/j.ijcard.2015.04.008
Pharmacodynamic profile and drug interactions with non-vitamin K antagonist oral anticoagulants: implications for patients with atrial fibrillation
Xiong, Q., Lau, Y. C., & Lip, G. Y. H. (2015). Pharmacodynamic profile and drug interactions with non-vitamin K antagonist oral anticoagulants: implications for patients with atrial fibrillation. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 11(6), 937-948. doi:10.1517/17425255.2015.1027683
Can venous thromboembolism navigate the prevention of cardiovascular complications?
Shantsila, A., & Lip, G. Y. H. (2015). Can venous thromboembolism navigate the prevention of cardiovascular complications?. ANNALS OF TRANSLATIONAL MEDICINE, 3(9). doi:10.3978/j.issn.2305-5839.2015.04.10
Comparison of Estimated Glomerular Filtration Rate Equations for Dosing New Oral Anticoagulants in Patients With Atrial Fibrillation
Manzano-Fernandez, S., Andreu-Cayuelas, J. M., Marin, F., Orenes-Pinero, E., Gallego, P., Valdes, M., . . . Roldan, V. (2015). Comparison of Estimated Glomerular Filtration Rate Equations for Dosing New Oral Anticoagulants in Patients With Atrial Fibrillation. REVISTA ESPANOLA DE CARDIOLOGIA, 68(6), 497-504. doi:10.1016/j.rec.2014.06.026
DIGOXIN - FRIEND OR FOE? A COMPREHENSIVE REVIEW OF DIGOXIN USE AND MORTALITY
Ziff, O., Kotecha, D., Samra, M., Kirchhof, P., Steeds, R., Griffith, M., . . . Lip, G. Y. H. (2015). DIGOXIN - FRIEND OR FOE? A COMPREHENSIVE REVIEW OF DIGOXIN USE AND MORTALITY. In HEART Vol. 101 (pp. A14-A15). doi:10.1136/heartjnl-2015-308066.26
Ethnic-Specific Normative Reference Values for Echocardiographic LA and LV Size, LV Mass, and Systolic Function: The EchoNoRMAL Study.
Echocardiographic Normal Ranges Meta-Analysis of the Left Heart Collaboration. (2015). Ethnic-Specific Normative Reference Values for Echocardiographic LA and LV Size, LV Mass, and Systolic Function: The EchoNoRMAL Study.. JACC. Cardiovascular imaging, 8(6), 656-665. doi:10.1016/j.jcmg.2015.02.014
FROM MALIGNANT HYPERTENSION TO HYPERTENSION-MOD: MA MODERN DEFINITION FOR AN OLD BUT STILL DANGEROUS EMERGENCY
Gosse, P., Cremer, A., Amraoui, F., Lip, G., Morales, E., Rubin, S., . . . Van den Born, B. (2015). FROM MALIGNANT HYPERTENSION TO HYPERTENSION-MOD: MA MODERN DEFINITION FOR AN OLD BUT STILL DANGEROUS EMERGENCY. In JOURNAL OF HYPERTENSION Vol. 33 (pp. E397). doi:10.1097/01.hjh.0000468619.68444.40
Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation
Lip, G. Y. H., Laroche, C., Popescu, M. I., Rasmussen, L. H., Vitali-Serdoz, L., Dan, G. -A., . . . Boriani, G. (2015). Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation. EUROPEAN JOURNAL OF HEART FAILURE, 17(6), 570-582. doi:10.1002/ejhf.254
Incidence of Myocardial Infarction and Vascular Death in Elderly Patients With Atrial Fibrillation Taking Anticoagulants Relation to Atherosclerotic Risk Factors
Pastori, D., Pignatelli, P., Angelico, F., Farcomeni, A., Del Ben, M., Vicario, T., . . . Violi, F. (2015). Incidence of Myocardial Infarction and Vascular Death in Elderly Patients With Atrial Fibrillation Taking Anticoagulants Relation to Atherosclerotic Risk Factors. CHEST, 147(6), 1644-1650. doi:10.1378/chest.14-2414
Intracranial Hemorrhage and Subsequent Ischemic Stroke in Patients With Atrial Fibrillation A Nationwide Cohort Study
Nielsen, P. B., Larsen, T. B., Gorst-Rasmussen, A., Skjoth, F., Rasmussen, L. H., & Lip, G. Y. H. (2015). Intracranial Hemorrhage and Subsequent Ischemic Stroke in Patients With Atrial Fibrillation A Nationwide Cohort Study. CHEST, 147(6), 1651-1658. doi:10.1378/chest.14-2099
Not all thromboembolism comes from the left atrial appendage in atrial fibrillation
Senoo, K., & Lip, G. Y. H. (2015). Not all thromboembolism comes from the left atrial appendage in atrial fibrillation. HEART, 101(11), 830-831. doi:10.1136/heartjnl-2015-307451
Renal Impairment and Prognosis of Patients with Atrial Fibrillation Undergoing Coronary Intervention - The AFCAS Trial
Lahtela, H. M., Kiviniemi, T. O., Puurunen, M. K., Schlitt, A., Rubboli, A., Ylitalo, A., . . . Airaksinen, K. E. J. (2015). Renal Impairment and Prognosis of Patients with Atrial Fibrillation Undergoing Coronary Intervention - The AFCAS Trial. PLOS ONE, 10(6). doi:10.1371/journal.pone.0128492
SOUTH ASIAN ETHNICITY IS INDEPENDENTLY RELATED TO DIASTOLIC FUNCTION IN HYPERTENSION
Shantsila, A., Gill, P. S., Shantsila, E., & Lip, G. Y. H. (2015). SOUTH ASIAN ETHNICITY IS INDEPENDENTLY RELATED TO DIASTOLIC FUNCTION IN HYPERTENSION. In HEART Vol. 101 (pp. A71). doi:10.1136/heartjnl-2015-308066.124
Using the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score for Stroke Prevention in Atrial Fibrillation: A Focus on Vascular Disease, Women, and Simple Practical Application
Nielsen, P. B., Skjoth, F., Rasmussen, L. H., Larsen, T. B., & Lip, G. Y. H. (2015). Using the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score for Stroke Prevention in Atrial Fibrillation: A Focus on Vascular Disease, Women, and Simple Practical Application. CANADIAN JOURNAL OF CARDIOLOGY, 31(6). doi:10.1016/j.cjca.2015.01.034
Effects of Body Mass Index on the Lipid Profile and Biomarkers of Inflammation and a Fibrinolytic and Prothrombotic State
Orenes-Pinero, E., Pineda, J., Roldan, V., Hernandez-Romero, D., Marco, P., Tello-Montoliu, A., . . . Marin, F. (2015). Effects of Body Mass Index on the Lipid Profile and Biomarkers of Inflammation and a Fibrinolytic and Prothrombotic State. JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 22(6), 610-617. doi:10.5551/jat.26161
Origin of physical degradation in AlGaN/GaN on Si high electron mobility transistors under reverse bias stressing
Sasangka, W. A., Syaranamual, G. J., Gan, C. L., & Thompson, C. V. (2015). Origin of physical degradation in AlGaN/GaN on Si high electron mobility transistors under reverse bias stressing. In 2015 IEEE International Reliability Physics Symposium (pp. 6C.3.1-6C.3.4). IEEE. doi:10.1109/irps.2015.7112768
Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentr cohort study
Violi, F., Pastori, D., Perticone, F., Hiatt, W. R., Sciacqua, A., Basili, S., . . . Pignatelli, P. (2015). Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentr cohort study. BMJ OPEN, 5(5). doi:10.1136/bmjopen-2015-008026
Atrial fibrillation (chronic).
Lane, D. A., Boos, C. J., & Lip, G. Y. H. (2015). Atrial fibrillation (chronic).. BMJ clinical evidence, 2015, 0217.
Stroke Prevention in Atrial Fibrillation: A Systematic Review
Lip, G. Y. H., & Lane, D. A. (2015). Stroke Prevention in Atrial Fibrillation: A Systematic Review. JAMA: Journal of the American Medical Association, 313(19), 1950-1962. doi:10.1001/jama.2015.4369
A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations
Serban, C., Sahebkar, A., Ursoniu, S., Mikhailidis, D. P., Rizzo, M., Lip, G. Y. H., . . . Banach, M. (2015). A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations. In SCIENTIFIC REPORTS Vol. 5. doi:10.1038/srep09902
Inflammatory Biomarkers and Atrial Fibrillation: Potential Role of Inflammatory Pathways in the Pathogenesis of Atrial Fibrillation-induced Thromboembolism
Guo, Y., Lip, G. Y. H., & Apostolakis, S. (2015). Inflammatory Biomarkers and Atrial Fibrillation: Potential Role of Inflammatory Pathways in the Pathogenesis of Atrial Fibrillation-induced Thromboembolism. CURRENT VASCULAR PHARMACOLOGY, 13(2), 192-201. doi:10.2174/15701611113116660165
Quality of Anticoagulation Control in Preventing Adverse Events in Patients With Heart Failure in Sinus Rhythm Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction Trial Substudy
Homma, S., Thompson, J. L. P., Qian, M., Ye, S., Di Tullio, M. R., Lip, G. Y. H., . . . Anker, S. D. (2015). Quality of Anticoagulation Control in Preventing Adverse Events in Patients With Heart Failure in Sinus Rhythm Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction Trial Substudy. CIRCULATION-HEART FAILURE, 8(3), 504-509. doi:10.1161/CIRCHEARTFAILURE.114.001725
Synthesis of ultrathin face-centered-cubic au@pt and au@pd core-shell nanoplates from hexagonal-close-packed au square sheets.
Fan, Z., Zhu, Y., Huang, X., Han, Y., Wang, Q., Liu, Q., . . . Zhang, H. (2015). Synthesis of ultrathin face-centered-cubic au@pt and au@pd core-shell nanoplates from hexagonal-close-packed au square sheets.. Angewandte Chemie (International ed. in English), 54(19), 5672-5676. doi:10.1002/anie.201500993
A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study
Lip, G. Y. H., Merino, J., Ezekowitz, M., Ellenbogen, K., Zamoryakhin, D., Lanz, H., . . . Goette, A. (2015). A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study. AMERICAN HEART JOURNAL, 169(5), 597-U28. doi:10.1016/j.ahj.2015.02.009
Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry
Boriani, G., Laroche, C., Diemberger, I., Fantecchi, E., Popescu, M. I., Rasmussen, L. H., . . . Lip, G. Y. H. (2015). Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry. AMERICAN JOURNAL OF MEDICINE, 128(5), 509-U212. doi:10.1016/j.amjmed.2014.11.026
ESTIMATING THE LIFETIME CLINICAL RISK/BENEFITS OF APIXABAN VERSUS EDOXABAN IN NON-VALVULAR ATRIAL FIBRILLATION
Phatak, H., Dorian, P., Kongnakorn, T., Lanitis, T., Liu, X., Mardekian, J., . . . Lip, G. (2015). ESTIMATING THE LIFETIME CLINICAL RISK/BENEFITS OF APIXABAN VERSUS EDOXABAN IN NON-VALVULAR ATRIAL FIBRILLATION. In VALUE IN HEALTH Vol. 18 (pp. A131). doi:10.1016/j.jval.2015.03.762
Non-vitamin K oral anticoagulants in atrial fibrillation: Where are we now?
Dzeshka, M. S., & Lip, G. Y. H. (2015). Non-vitamin K oral anticoagulants in atrial fibrillation: Where are we now?. TRENDS IN CARDIOVASCULAR MEDICINE, 25(4), 315-336. doi:10.1016/j.tcm.2014.10.017
Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis
Nielsen, P. B., Lane, D. A., Rasmussen, L. H., Lip, G. Y. H., & Larsen, T. B. (2015). Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis. CLINICAL RESEARCH IN CARDIOLOGY, 104(5), 418-429. doi:10.1007/s00392-014-0797-9
Simultaneous computerised activation of the primary percutaneous coronary intervention pathway reduces out-of-hours door-to-balloon time but not mortality
Brown, R. A., Varma, C., Connolly, D. L., Ahmad, R., Shantsila, E., & Lip, G. Y. H. (2015). Simultaneous computerised activation of the primary percutaneous coronary intervention pathway reduces out-of-hours door-to-balloon time but not mortality. INTERNATIONAL JOURNAL OF CARDIOLOGY, 186, 226-230. doi:10.1016/j.ijcard.2015.03.172
Size effects and shape memory properties in ZrO2 ceramic micro- and nano-pillars
Du, Z., Zeng, X. M., Liu, Q., Lai, A., Amini, S., Miserez, A., . . . Gan, C. L. (2015). Size effects and shape memory properties in ZrO2 ceramic micro- and nano-pillars. Scripta Materialia, 101, 40-43. doi:10.1016/j.scriptamat.2015.01.013
The SAMe-TT<sub>2</sub>R<sub>2</sub> score and quality of anticoagulation in atrial fibrillation: a simple aid to decision-making on who is suitable (or not) for vitamin K antagonists
Fauchier, L., Angoulvant, D., & Lip, G. Y. H. (2015). The SAMe-TT<sub>2</sub>R<sub>2</sub> score and quality of anticoagulation in atrial fibrillation: a simple aid to decision-making on who is suitable (or not) for vitamin K antagonists. EUROPACE, 17(5), 671-673. doi:10.1093/europace/euv088
Meet the Editorial Board
Lip, G. (2015). Meet the Editorial Board. Current Pharmaceutical Design, 21(17), 2167. doi:10.2174/138161282117150430124606
Risk of Bleeding and Stroke with Oral Anticoagulation and Antiplatelet Therapy in Patients with Atrial Fibrillation in Taiwan: A Nationwide Cohort Study
Chen, P. -C., Lip, G. Y. H., Yeh, G., Lin, H. -J., & Chien, K. -L. (2015). Risk of Bleeding and Stroke with Oral Anticoagulation and Antiplatelet Therapy in Patients with Atrial Fibrillation in Taiwan: A Nationwide Cohort Study. PLOS ONE, 10(4). doi:10.1371/journal.pone.0125257
Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials
Abdul-Rahim, A. H., Perez, A. -C., Fulton, R. L., Jhund, P. S., Latini, R., Tognoni, G., . . . McMurray, J. J. V. (2015). Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials. CIRCULATION, 131(17), 1486-1494. doi:10.1161/CIRCULATIONAHA.114.013760
The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment
Kooiman, J., van Hagen, N., del Sol, A. I., Planken, E. V., Lip, G. Y. H., van der Meer, F. J. M., . . . Huisman, M. V. (2015). The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment. PLOS ONE, 10(4). doi:10.1371/journal.pone.0122520
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials
Navarese, E. P., Andreotti, F., Schulze, V., Kolodziejczak, M., Buffon, A., Brouwer, M., . . . Valgimigli, M. (2015). Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials. BMJ-BRITISH MEDICAL JOURNAL, 350. doi:10.1136/bmj.h1618
Effect of palladium on the mechanical properties of Cu–Al intermetallic compounds
Lim, A. B. Y., Long, X., Shen, L., Chen, X., Ramanujan, R. V., Gan, C. L., & Chen, Z. (2015). Effect of palladium on the mechanical properties of Cu–Al intermetallic compounds. Journal of Alloys and Compounds, 628, 107-112. doi:10.1016/j.jallcom.2014.12.119
Free Light Chains in patients with acute coronary syndromes: Relationships to inflammation and renal function
Shantsila, E., Tapp, L. D., & Lip, G. Y. H. (2015). Free Light Chains in patients with acute coronary syndromes: Relationships to inflammation and renal function. INTERNATIONAL JOURNAL OF CARDIOLOGY, 185, 322-327. doi:10.1016/j.ijcard.2015.03.105
Oral Anticoagulation, Aspirin, or No Therapy in Patients With Nonvalvular AF With 0 or 1 Stroke Risk Factor Based on the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score
Lip, G. Y. H., Skjoth, F., Rasmussen, L. H., & Larsen, T. B. (2015). Oral Anticoagulation, Aspirin, or No Therapy in Patients With Nonvalvular AF With 0 or 1 Stroke Risk Factor Based on the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 65(14), 1385-1394. doi:10.1016/j.jacc.2015.01.044
Developing an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making
Eckman, M. H., Wise, R. E., Naylor, K., Arduser, L., Lip, G. Y. H., Kissela, B., . . . Costea, A. (2015). Developing an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making. CURRENT MEDICAL RESEARCH AND OPINION, 31(4), 603-614. doi:10.1185/03007995.2015.1019608
Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study
Gorst-Rasmussen, A., Skjoth, F., Larsen, T. B., Rasmussen, L. H., Lip, G. Y. H., & Lane, D. A. (2015). Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 13(4), 495-504. doi:10.1111/jth.12845
Female gender and atrial fibrillation: An association with worse prognosis and outcomes
Kornej, J., Bollmann, A., Hindricks, G., & Lip, G. Y. H. (2015). Female gender and atrial fibrillation: An association with worse prognosis and outcomes. INTERNATIONAL JOURNAL OF CARDIOLOGY, 184, 321-322. doi:10.1016/j.ijcard.2015.02.062
Non-steroidal anti-inflammatory drugs and incident atrial fibrillation
Proietti, M., & Lip, G. Y. H. (2015). Non-steroidal anti-inflammatory drugs and incident atrial fibrillation. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 1(2), 115-116. doi:10.1093/ehjcvp/pvv007
Optimizing stroke prevention in atrial fibrillation: better adherence and compliance from patients and physicians leads to better outcomes
Potpara, T. S., Lane, D. A., & Lip, G. Y. H. (2015). Optimizing stroke prevention in atrial fibrillation: better adherence and compliance from patients and physicians leads to better outcomes. EUROPACE, 17(4), 507-508. doi:10.1093/europace/euv041
Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF)
Lip, G. Y. H., Hammerstingl, C., Marin, F., Cappato, R., Meng, I. L., Kirsch, B., . . . Cohen, A. (2015). Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF). AMERICAN HEART JOURNAL, 169(4), 464-+. doi:10.1016/j.ahj.2014.12.020
Stroke prevention in atrial fibrillation: changing concepts.
Lip, G. Y. H. (2015). Stroke prevention in atrial fibrillation: changing concepts.. European heart journal. Cardiovascular pharmacotherapy, 1(2), 76-79. doi:10.1093/ehjcvp/pvu003
The Impact of Associated Diabetic Retinopathy on Stroke and Severe Bleeding Risk in Diabetic Patients With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project
Lip, G. Y. H., Clementy, N., Pierre, B., Boyer, M., & Fauchier, L. (2015). The Impact of Associated Diabetic Retinopathy on Stroke and Severe Bleeding Risk in Diabetic Patients With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project. CHEST, 147(4), 1103-1110. doi:10.1378/chest.14-2096
Use of psychotropic drugs following venous thromboembolism in youth. A nationwide cohort study
Hojen, A. A., Gorst-Rasmussen, A., Lip, G. Y. H., Lane, D. A., Rasmussen, L. H., Sorensen, E. E., & Larsen, T. B. (2015). Use of psychotropic drugs following venous thromboembolism in youth. A nationwide cohort study. THROMBOSIS RESEARCH, 135(4), 643-647. doi:10.1016/j.thromres.2015.01.024
open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI)
Gibson, C. M., Mehran, R., Bode, C., Halperin, J., Verheugt, F., Wildgoose, P., . . . Fox, K. (2015). open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI). AMERICAN HEART JOURNAL, 169(4), 472-+. doi:10.1016/j.ahj.2014.12.006
Leukoaraiosis and stroke recurrence risk in patients with and without atrial fibrillation
Ntaios, G., Lip, G. Y. H., Lambrou, D., Papavasileiou, V., Manios, E., Milionis, H., . . . Vemmos, K. (2015). Leukoaraiosis and stroke recurrence risk in patients with and without atrial fibrillation. NEUROLOGY, 84(12), 1213-1219. doi:10.1212/WNL.0000000000001402
Bridging therapy with low molecular weight heparin in patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: The AFCAS study
Kiviniemi, T., Airaksinen, K. E. J., Rubboli, A., Biancari, F., Valencia, J., Lip, G. Y. H., . . . Schlitt, A. (2015). Bridging therapy with low molecular weight heparin in patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: The AFCAS study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 183, 105-110. doi:10.1016/j.ijcard.2015.01.056
Misperceptions of aspirin efficacy and safety may perpetuate anticoagulant underutilization in atrial fibrillation
Ben Freedman, S., Gersh, B. J., & Lip, G. Y. H. (2015). Misperceptions of aspirin efficacy and safety may perpetuate anticoagulant underutilization in atrial fibrillation. EUROPEAN HEART JOURNAL, 36(11), 653-656. doi:10.1093/eurheartj/ehu494
Monitoring changes in thioredoxin and over-oxidised peroxiredoxin in response to exercise in humans
Wadley, A. J., Chen, Y. W., Bennett, S. J., Lip, G. Y. H., Turner, J. E., Fisher, J. P., & Aldred, S. (2015). Monitoring changes in thioredoxin and over-oxidised peroxiredoxin in response to exercise in humans. FREE RADICAL RESEARCH, 49(3), 290-298. doi:10.3109/10715762.2014.1000890
ANTITHROMBOTIC TREATMENT IN RELATION TO AGE IN PATIENTS WITH NEWLY DIAGNOSED ATRIAL FIBRILLATION IN NORTH AMERICA (GLORIA-AF PHASE II)
Halperin, J. L., Huisman, M., Diener, H. -C., Dubner, S., Ma, C., Rothman, K., . . . Lip, G. (2015). ANTITHROMBOTIC TREATMENT IN RELATION TO AGE IN PATIENTS WITH NEWLY DIAGNOSED ATRIAL FIBRILLATION IN NORTH AMERICA (GLORIA-AF PHASE II). In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 65 (pp. A1518). doi:10.1016/S0735-1097(15)61518-2
Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation? The Prospective Global Anticoagulant Registry in the FIELD-Atrial Fibrillation
Lip, G. Y. H., Rushton-Smith, S. K., Goldhaber, S. Z., Fitzmaurice, D. A., Mantovani, L. G., Goto, S., . . . Worthy, V. (2015). Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation? The Prospective Global Anticoagulant Registry in the FIELD-Atrial Fibrillation. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 8(2), S12-S20. doi:10.1161/CIRCOUTCOMES.114.001556
ESTIMATING THE LIFETIME CLINICAL BENEFITS OF APIXABAN VERSUS ASPIRIN IN THE LOW RISK NON-VALVULAR ATRIAL FIBRILLATION PATIENTS IN THE US: HOW MAY RESULTS FROM AVERROES HELP IMPROVE PATIENT CARE?
Lip, G. Y. H., Lanitis, T., Mardekian, J., Kongnakorn, T., Phatak, H., & Dorian, P. (2015). ESTIMATING THE LIFETIME CLINICAL BENEFITS OF APIXABAN VERSUS ASPIRIN IN THE LOW RISK NON-VALVULAR ATRIAL FIBRILLATION PATIENTS IN THE US: HOW MAY RESULTS FROM AVERROES HELP IMPROVE PATIENT CARE?. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 65 (pp. A347). doi:10.1016/S0735-1097(15)60347-3
Female sex is associated with a lower risk of stroke in patients with heart failure
Melgaard, L., Gorst-Rasmussen, A., Lip, G. Y. H., Rasmussen, L. H., & Larsen, T. B. (2015). Female sex is associated with a lower risk of stroke in patients with heart failure. AMERICAN HEART JOURNAL, 169(3), 396-403. doi:10.1016/j.ahj.2014.12.004
Increased Stroke Risk in Atrial Fibrillation Patients With Heart Failure Does Ejection Fraction Matter?
Kotecha, D., Banerjee, A., & Lip, G. Y. H. (2015). Increased Stroke Risk in Atrial Fibrillation Patients With Heart Failure Does Ejection Fraction Matter?. STROKE, 46(3), 608-609. doi:10.1161/STROKEAHA.114.008421
Optimising stroke prevention in patients with atrial fibrillation
Lane, D. A., Wolff, A., Shantsila, E., & Lip, G. Y. H. (2015). Optimising stroke prevention in patients with atrial fibrillation. BRITISH JOURNAL OF GENERAL PRACTICE, 65(632), 117. doi:10.3399/bjgp15X683905
PATTERNS OF NEWLY DETECTED ATRIAL FIBRILLATION AND ANTITHROMBOTIC TREATMENT IN NORTH AMERICA (GLORIA-AF PHASE II)
Halperin, J. L., Huisman, M., Diener, H. -C., Dubner, S. J., Ma, C., Rothman, K., . . . Lip, G. (2015). PATTERNS OF NEWLY DETECTED ATRIAL FIBRILLATION AND ANTITHROMBOTIC TREATMENT IN NORTH AMERICA (GLORIA-AF PHASE II). In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 65 (pp. A1520). doi:10.1016/S0735-1097(15)61520-0
Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score (Beyond Sex) Receive Oral Anticoagulation?
Chao, T. -F., Liu, C. -J., Wang, K. -L., Lin, Y. -J., Chang, S. -L., Lo, L. -W., . . . Chen, S. -A. (2015). Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score (Beyond Sex) Receive Oral Anticoagulation?. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 65(7), 635-642. doi:10.1016/j.jacc.2014.11.046
Increased pre-surgical numbers of endothelial progenitor cells and circulating endothelial cells in colorectal cancer fail to predict outcome
Ramcharan, K. S., Lip, G. Y. H., Stonelake, P. S., & Blann, A. D. (2015). Increased pre-surgical numbers of endothelial progenitor cells and circulating endothelial cells in colorectal cancer fail to predict outcome. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 30(3), 315-321. doi:10.1007/s00384-014-2116-3
Stroke risk reduction with oral anticoagulation using CHA<sub>2</sub>DS<sub>2</sub>-VASc in a Japanese AF population: A modeling analysis
Senoo, K., Lane, D. A., & Lip, G. Y. H. (2015). Stroke risk reduction with oral anticoagulation using CHA<sub>2</sub>DS<sub>2</sub>-VASc in a Japanese AF population: A modeling analysis. INTERNATIONAL JOURNAL OF CARDIOLOGY, 181, 247-254. doi:10.1016/j.ijcard.2014.11.196
What we have learned from the ESC position paper on arrhythmias in acute coronary syndromes
Gorenek, B., Kudaiberdieva, G., & Lip, G. (2015). What we have learned from the ESC position paper on arrhythmias in acute coronary syndromes. ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY, 15(2), 94-96. doi:10.5152/akd.2015.6206
Triple Therapy for Atrial Fibrillation and ACS With or Without PCI
Capodanno, D., & Lip, G. Y. H. (2015). Triple Therapy for Atrial Fibrillation and ACS With or Without PCI. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 65(5), 515-516. doi:10.1016/j.jacc.2014.10.063
Adverse cardiovascular outcomes in relation to suboptimal antithrombotic therapy use in patients undergoing peripheral artery disease angioplasty: lost opportunities?
Bodansky, D. M. S., Allon, I. R., Apostolakis, S., & Lip, G. Y. H. (2015). Adverse cardiovascular outcomes in relation to suboptimal antithrombotic therapy use in patients undergoing peripheral artery disease angioplasty: lost opportunities?. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 69(2), 162-168. doi:10.1111/ijcp.12470
Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study
Friberg, L., Benson, L., & Lip, G. Y. H. (2015). Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study. EUROPEAN HEART JOURNAL, 36(5), 297-306. doi:10.1093/eurheartj/ehu139
Dabigatran and Myocardial Infarction
Hohnloser, S. H., & Lip, G. Y. H. (2015). Dabigatran and Myocardial Infarction. CHEST, 147(2), E70-E71. doi:10.1378/chest.14-2534
Fondaparinux in atrial fibrillation - old dog, new tricks?
Lau, Y. C., Brown, R. A., & Lip, G. Y. H. (2015). Fondaparinux in atrial fibrillation - old dog, new tricks?. ARCHIVES OF CARDIOVASCULAR DISEASES, 108(2), 85-87. doi:10.1016/j.acvd.2014.12.001
Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal
Lip, G. Y. H., Wang, K. -L., & Chiang, C. -E. (2015). Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal. INTERNATIONAL JOURNAL OF CARDIOLOGY, 180, 246-254. doi:10.1016/j.ijcard.2014.11.182
Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry
Lip, G. Y. H., Laroche, C., Boriani, G., Dan, G. -A., Santini, M., Kalarus, Z., . . . Tavazzi, L. (2015). Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry. EUROPACE, 17(2), 194-206. doi:10.1093/europace/euu201
Selection of Warfarin or One of the New Oral Antithrombotic Agents for Long-Term Prevention of Stroke among Persons with Atrial Fibrillation
Xiong, Q., & Lip, G. Y. H. (2015). Selection of Warfarin or One of the New Oral Antithrombotic Agents for Long-Term Prevention of Stroke among Persons with Atrial Fibrillation. CURRENT TREATMENT OPTIONS IN NEUROLOGY, 17(2). doi:10.1007/s11940-014-0331-4
Risk of major bleeding in different indications for new oral anticoagulants: Insights from a meta-analysis of approved dosages from 50 randomized trials
Sardar, P., Chatterjee, S., Lavie, C. J., Giri, J. S., Ghosh, J., Mukherjee, D., & Lip, G. Y. H. (2015). Risk of major bleeding in different indications for new oral anticoagulants: Insights from a meta-analysis of approved dosages from 50 randomized trials. INTERNATIONAL JOURNAL OF CARDIOLOGY, 179, 279-287. doi:10.1016/j.ijcard.2014.11.101
Catheter Ablation of Atrial Fibrillation and Thromboembolic Risk
Kornej, J., Hindricks, G., Lip, G. Y. H., & Bollmann, A. (2015). Catheter Ablation of Atrial Fibrillation and Thromboembolic Risk. CIRCULATION JOURNAL, 79(2), 444. doi:10.1253/circj.CJ-14-1006
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in Japanese Patients With Atrial Fibrillation - Meta-Analysis -
Senoo, K., Lau, Y. C., Dzeshka, M., Lane, D., Okumura, K., & Lip, G. Y. H. (2015). Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in Japanese Patients With Atrial Fibrillation - Meta-Analysis -. CIRCULATION JOURNAL, 79(2), 339-345. doi:10.1253/circj.CJ-14-1042
Analysis of vitamin D levels in patients with and without statin-associated myalgia - A systematic review and meta-analysis of 7 studies with 2420 patients
Michalska-Kasiczak, M., Sahebkar, A., Mikhailidis, D. P., Rysz, J., Muntner, P., Toth, P. P., . . . Banach, M. (2015). Analysis of vitamin D levels in patients with and without statin-associated myalgia - A systematic review and meta-analysis of 7 studies with 2420 patients. INTERNATIONAL JOURNAL OF CARDIOLOGY, 178, 111-116. doi:10.1016/j.ijcard.2014.10.118
Changes in renal function after catheter ablation of atrial fibrillation are associated with CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>-VASc scores and arrhythmia recurrences
Kornej, J., Hindricks, G., Banerjee, A., Arya, A., Sommer, P., Rolf, S., . . . Bollmann, A. (2015). Changes in renal function after catheter ablation of atrial fibrillation are associated with CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>-VASc scores and arrhythmia recurrences. HEART, 101(2), 126-131. doi:10.1136/heartjnl-2014-306013
Safety and efficacy of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation: a Bayesian meta-analysis approach
Verdecchia, P., Angeli, F., Bartolini, C., De Filippo, V., Aita, A., Di Giacomo, L., . . . Reboldi, G. (2015). Safety and efficacy of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation: a Bayesian meta-analysis approach. EXPERT OPINION ON DRUG SAFETY, 14(1), 7-20. doi:10.1517/14740338.2014.971009
Warfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation
Dzeshka, M. S., & Lip, G. Y. H. (2015). Warfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation. EXPERT OPINION ON DRUG SAFETY, 14(1), 45-62. doi:10.1517/14740338.2015.973847
A Happy New Year from Thrombosis and Haemostasis. A 5 year reflection from the Editorial team
Lip, G. Y. H., & Weber, C. (2015). A Happy New Year from Thrombosis and Haemostasis. A 5 year reflection from the Editorial team. THROMBOSIS AND HAEMOSTASIS, 113(1), 1-2. Retrieved from https://www.webofscience.com/
Ability of bleeding risk scores for stratification of bleeding events in elderly patients with atrial fibrillation
Fauchier, L., Banerjee, A., Lagrenade, I., Clementy, N., Bernard, A., Angoulvant, D., . . . Lip, G. Y. H. (2015). Ability of bleeding risk scores for stratification of bleeding events in elderly patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 1081-1082). Retrieved from https://www.webofscience.com/
Antithrombotic management in patients with atrial fibrillation undergoing stent implantation: what is the impact of the ESC guidelines adherence?
Fauchier, L., Ancedy, Y., Lecoq, C., Saint Etienne, C., Ivanes, F., Babuty, D., . . . Lip, G. Y. H. (2015). Antithrombotic management in patients with atrial fibrillation undergoing stent implantation: what is the impact of the ESC guidelines adherence?. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 1084). Retrieved from https://www.webofscience.com/
Assessment of a stroke risk stratification scheme in a heart failure population in sinus rhythm
Melgaard, L., Gorst-Rasmussen, A., Rasmussen, L. H., Lip, G. Y., & Larsen, T. B. (2015). Assessment of a stroke risk stratification scheme in a heart failure population in sinus rhythm. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 327). Retrieved from https://www.webofscience.com/
Atrial Fibrillation Patients Categorized as "Not for Anticoagulation" According to the 2014 Canadian Cardiovascular Society Algorithm Are Not "Low Risk"
Lip, G. Y. H., Nielsen, P. B., Skjoth, F., Rasmussen, L. H., & Larsen, T. B. (2015). Atrial Fibrillation Patients Categorized as "Not for Anticoagulation" According to the 2014 Canadian Cardiovascular Society Algorithm Are Not "Low Risk". CANADIAN JOURNAL OF CARDIOLOGY, 31(1), 24-28. doi:10.1016/j.cjca.2014.10.018
CD14<SUP>+</SUP>+CD16<SUP>+</SUP>CCR2+MONOCYTES ARE INCREASED IN DIFFUSE CORONARY ARTERY DISEASE
Brown, R., Lip, G., Varma, C., & Shantsila, E. (2015). CD14<SUP>+</SUP>+CD16<SUP>+</SUP>CCR2+MONOCYTES ARE INCREASED IN DIFFUSE CORONARY ARTERY DISEASE. In HEART Vol. 101 (pp. A90). Retrieved from https://www.webofscience.com/
Cardiovascular risk prediction: balancing complexity against simple practicality
Dzeshka, M. S., Gill, P. S., & Lip, G. Y. H. (2015). Cardiovascular risk prediction: balancing complexity against simple practicality. BRITISH JOURNAL OF GENERAL PRACTICE, 65(630), 4-5. doi:10.3399/bjgp15X683005
Cerebral Microcirculation: An Introduction
Dalkara, T. (2015). Cerebral Microcirculation: An Introduction. In PanVascular Medicine (pp. 655-680). Springer Berlin Heidelberg. doi:10.1007/978-3-642-37078-6_29
Characteristics of patients initiating oral anticoagulant therapy for management of non-valvular atrial fibrillation (NVAF)
Masseria, C., Lin, I., Mardekian, J., Frean, M., Phatak, H., Kamble, S., . . . Lip, G. Y. H. (2015). Characteristics of patients initiating oral anticoagulant therapy for management of non-valvular atrial fibrillation (NVAF). In EUROPEAN HEART JOURNAL Vol. 36 (pp. 1084). Retrieved from https://www.webofscience.com/
Clinical and Economic Implications of Apixaban Versus Aspirin in the Low-Risk Nonvalvular Atrial Fibrillation Patients
Lip, G. Y. H., Lanitis, T., Mardekian, J., Kongnakorn, T., Phatak, H., & Dorian, P. (2015). Clinical and Economic Implications of Apixaban Versus Aspirin in the Low-Risk Nonvalvular Atrial Fibrillation Patients. STROKE, 46(10), 2830-2837. doi:10.1161/STROKEAHA.115.009995
Clinical and demographic characteristics according to dosage among non-valvular atrial fibrillation patients newly initiated on novel oral anticoagulants
Masseria, C., Lin, I., Mardekian, J., Frean, M., Phatak, H., Kamble, S., . . . Lip, G. Y. H. (2015). Clinical and demographic characteristics according to dosage among non-valvular atrial fibrillation patients newly initiated on novel oral anticoagulants. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 1079). Retrieved from https://www.webofscience.com/
Comparative Efficacy and Safety of the Non-Vitamin K Antagonist Oral Anticoagulants for Patients with Nonvalvular Atrial Fibrillation
Senoo, K., & Lip, G. Y. H. (2015). Comparative Efficacy and Safety of the Non-Vitamin K Antagonist Oral Anticoagulants for Patients with Nonvalvular Atrial Fibrillation. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 41(2), 146-153. doi:10.1055/s-0035-1544156
Comparative cost-effectiveness of oral anticoagulants for stroke prevention in non-valvular atrial fibrillation patients in the UK
Lip, G. Y. H., Lanitis, T., Kongnakorn, T., Phatak, H., Liu, L., Lawrence, J., & Dorian, P. (2015). Comparative cost-effectiveness of oral anticoagulants for stroke prevention in non-valvular atrial fibrillation patients in the UK. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 864). Retrieved from https://www.webofscience.com/
Comparative efficacy and safety of anticoagulant strategies for acute coronary syndromes Comprehensive network meta-analysis of 42 randomised trials involving 117,353 patients
Navarese, E. P., Andreotti, F., Kolodziejczak, M., Schulze, V., Wolff, G., Dias, S., . . . Kelm, M. (2015). Comparative efficacy and safety of anticoagulant strategies for acute coronary syndromes Comprehensive network meta-analysis of 42 randomised trials involving 117,353 patients. THROMBOSIS AND HAEMOSTASIS, 114(5), 933-944. doi:10.1160/TH14-12-1066
Cost-Effectiveness of Anticoagulation in Patients with Nonvalvular Atrial Fibrillation with Edoxaban Compared to Warfarin in Germany
Krejczy, M., Harenberg, J., Wehling, M., Obermann, K., & Lip, G. Y. H. (2015). Cost-Effectiveness of Anticoagulation in Patients with Nonvalvular Atrial Fibrillation with Edoxaban Compared to Warfarin in Germany. BIOMED RESEARCH INTERNATIONAL, 2015. doi:10.1155/2015/876923
Cryptogenic Strokes and Second Ischemic Stroke Rates in Relation to the CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>-VASc Risk Scores
Hunter, T. D., Lip, G. Y., Quiroz, M. E., MolIenkopf, S. A., & Turakhia, M. P. (2015). Cryptogenic Strokes and Second Ischemic Stroke Rates in Relation to the CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>-VASc Risk Scores. In STROKE Vol. 46. Retrieved from https://www.webofscience.com/
D-Dimer elevation and adverse outcomes
Halaby, R., Popma, C. J., Cohen, A., Chi, G., Zacarkim, M. R., Romero, G., . . . Gibson, C. M. (2015). D-Dimer elevation and adverse outcomes. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 39(1), 55-59. doi:10.1007/s11239-014-1101-6
DOES HOME-BASED, SLOW DEEP BREATHING TRAINING REDUCE CENTRAL SYMPATHETIC OUTFLOW AND ENHANCE BAROREFLEX SENSIVITIY IN PRIMARY HYPERTENSION?
Shantsila, A., Adlan, A. M., Lip, G. Y. H., Pickering, A. E., Paton, J. F. R., & Fisher, J. P. (2015). DOES HOME-BASED, SLOW DEEP BREATHING TRAINING REDUCE CENTRAL SYMPATHETIC OUTFLOW AND ENHANCE BAROREFLEX SENSIVITIY IN PRIMARY HYPERTENSION?. In HEART Vol. 101 (pp. A83). Retrieved from https://www.webofscience.com/
Development of Recommendations to Continue Anticoagulation with One of the Two Types of Oral Anticoagulants Based on the Identification of Patients' Preference
Zolfaghari, S., Harenberg, J., Froelich, L., Weiss, C., Wehling, M., Wild, P., . . . Lip, G. Y. H. (2015). Development of Recommendations to Continue Anticoagulation with One of the Two Types of Oral Anticoagulants Based on the Identification of Patients' Preference. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 41(2), 166-177. doi:10.1055/s-0035-1546467
Diabetes as a risk factor of stroke and death in heart failure patients in sinus rhythm - a nationwide cohort study
Melgaard, L. L., Gorst-Rasmussen, A., Lip, G., & Larsen, T. B. (2015). Diabetes as a risk factor of stroke and death in heart failure patients in sinus rhythm - a nationwide cohort study. In EUROPEAN JOURNAL OF HEART FAILURE Vol. 17 (pp. 70). Retrieved from https://www.webofscience.com/
Do all AF patients with a CHA2DS2-VASc score of 2 (males) or 3 (females) have the same risk of ischemic stroke? A nationwide population-based cohort study
Liao, J. -N., Chao, T. F., Lip, G. Y., & Chen, S. A. (2015). Do all AF patients with a CHA2DS2-VASc score of 2 (males) or 3 (females) have the same risk of ischemic stroke? A nationwide population-based cohort study. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 901). Retrieved from https://www.webofscience.com/
Duration of diabetes mellitus and thromboembolic events in atrial fibrillation: a nationwide cohort study
Overvad, T. F., Skjoeth, F., Lip, G. Y. H., Lane, D. A., Albertsen, I. E., Rasmussen, L. H., & Larsen, T. B. (2015). Duration of diabetes mellitus and thromboembolic events in atrial fibrillation: a nationwide cohort study. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 910). Retrieved from https://www.webofscience.com/
Editors' Choice papers in Thrombosis and Haemostasis
Weber, C., & Lip, G. Y. H. (2015). Editors' Choice papers in Thrombosis and Haemostasis. THROMBOSIS AND HAEMOSTASIS, 113(1), 217-220. Retrieved from https://www.webofscience.com/
Edoxaban versus placebo, aspirin, or aspirin plus clopidogrel for stroke prevention in atrial fibrillation An indirect comparison analysis
Blann, A. D., Skjoth, F., Rasmussen, L. H., Larsen, T. B., & Lip, G. Y. H. (2015). Edoxaban versus placebo, aspirin, or aspirin plus clopidogrel for stroke prevention in atrial fibrillation An indirect comparison analysis. THROMBOSIS AND HAEMOSTASIS, 114(2), 403-409. doi:10.1160/TH15-05-0383
Effect of alcohol intake on diastolic function: the Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES)
Shantsila, E., Shantsila, A., Gill, P. S., & Lip, G. Y. H. (2015). Effect of alcohol intake on diastolic function: the Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES). In EUROPEAN HEART JOURNAL Vol. 36 (pp. 314-315). Retrieved from https://www.webofscience.com/
Effect of digoxin on all-cause mortality in patients with atrial fibrillation: a population-based cohort study
Fauchier, L., Laborie, G., Clementy, N., Bernard, A., Angoulvant, D., Lip, G. Y. H., & Babuty, D. (2015). Effect of digoxin on all-cause mortality in patients with atrial fibrillation: a population-based cohort study. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 899). Retrieved from https://www.webofscience.com/
Effect of rivaroxaban and warfarin on fibrin clot structure
Lau, Y. C., Xiong, Q., Blann, A., & Lip, G. Y. H. (2015). Effect of rivaroxaban and warfarin on fibrin clot structure. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 744). Retrieved from https://www.webofscience.com/
Effects of Coenzyme Q10 on Statin-Induced Myopathy: A Meta-analysis of Randomized Controlled Trials
Banach, M., Serban, C., Sahebkar, A., Ursoniu, S., Rysz, J., Muntner, P., . . . Mikhailidis, D. P. (2015). Effects of Coenzyme Q10 on Statin-Induced Myopathy: A Meta-analysis of Randomized Controlled Trials. MAYO CLINIC PROCEEDINGS, 90(1), 24-34. doi:10.1016/j.mayocp.2014.08.021
Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials.
Banach, M., Serban, C., Sahebkar, A., Ursoniu, S., Rysz, J., Muntner, P., . . . Lipid and Blood Pressure Meta-analysis Collaboration Group. (2015). Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials.. Mayo Clinic proceedings, 90(1), 24-34. doi:10.1016/j.mayocp.2014.08.021
Futility of supplementation with Coenzyme Q10 for statin-induced myopathy: an updated (2015) meta-analysis of randomized controlled trials
Banach, M., Serban, C., Sahebkar, A., Rysz, J., Muntner, P., Toth, P. P., . . . Mikhailidis, D. P. (2015). Futility of supplementation with Coenzyme Q10 for statin-induced myopathy: an updated (2015) meta-analysis of randomized controlled trials. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 1047). Retrieved from https://www.webofscience.com/
Guideline adherence for stroke prevention and risk of mortality in patients with atrial fibrillation
Chao, T. F., Lip, G. Y. H., & Chen, S. A. (2015). Guideline adherence for stroke prevention and risk of mortality in patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 907-908). Retrieved from https://www.webofscience.com/
Is Major Bleeding Risk for Oral Anticoagulants Similar Among Newly Initiated Non Valvular Atrial Fibrillation Patients?
Lip, G. Y., Pan, X., Kamble, S., Kawabata, H., Mardekian, J., Masseria, C., . . . Hemant, P. (2015). Is Major Bleeding Risk for Oral Anticoagulants Similar Among Newly Initiated Non Valvular Atrial Fibrillation Patients?. In CIRCULATION Vol. 132. Retrieved from https://www.webofscience.com/
Ischemic Stroke and Intracranial Hemorrhage With Aspirin, Dabigatran, and Warfarin Impact of Quality of Anticoagulation Control
Ho, C. -W., Ho, M. -H., Chan, P. -H., Hai, J. -J., Cheung, E., Yeung, C. -Y., . . . Siu, C. -W. (2015). Ischemic Stroke and Intracranial Hemorrhage With Aspirin, Dabigatran, and Warfarin Impact of Quality of Anticoagulation Control. STROKE, 46(1), 23-30. doi:10.1161/STROKEAHA.114.006476
Leukoaraiosis and stroke recurrence risk in patients with and without atrial fibrillation
Ntaios, G., Lip, G. Y. H., Lambrou, D., Papavasileiou, V., Manios, E., Milionis, H., . . . Vemmos, K. (2015). Leukoaraiosis and stroke recurrence risk in patients with and without atrial fibrillation. In INTERNATIONAL JOURNAL OF STROKE Vol. 10 (pp. 49-50). Retrieved from https://www.webofscience.com/
Mental health prognosis of young venous thromboembolism patients. A nationwide cohort study on psychotropic drug purchases
Hojen, A., Gorst-Rasmussen, A., Lip, G. Y. H., Lane, D. A., Rasmussen, L. H., Sorensen, E. E., & Larsen, T. B. (2015). Mental health prognosis of young venous thromboembolism patients. A nationwide cohort study on psychotropic drug purchases. In EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING Vol. 14 (pp. S7). Retrieved from https://www.webofscience.com/
Missed opportunities to prevent ischaemic stroke? Frequency of non-anticoagulation in a prospective multicentre cohort study of AF-associated ischaemic stroke and TIA
Wilson, D., Shakeshaft, C., Charidimou, A., Ambler, G., White, M., Cohen, H., . . . Werring, D. (2015). Missed opportunities to prevent ischaemic stroke? Frequency of non-anticoagulation in a prospective multicentre cohort study of AF-associated ischaemic stroke and TIA. In INTERNATIONAL JOURNAL OF STROKE Vol. 10 (pp. 6). Retrieved from https://www.webofscience.com/
Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA<sub>2</sub>DS<sub>2</sub>-VASc score
Lip, G. Y. H., Skjoth, F., Nielsen, P. B., & Larsen, T. B. (2015). Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA<sub>2</sub>DS<sub>2</sub>-VASc score. THROMBOSIS AND HAEMOSTASIS, 114(4), 826-834. doi:10.1160/TH15-07-0565
Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort
Shantsila, E., Wolff, A., Lip, G. Y. H., & Lane, D. A. (2015). Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort. BRITISH JOURNAL OF GENERAL PRACTICE, 65(630), E16-E23. doi:10.3399/bjgp15X683113
Paroxysmal versus non-paroxysmal atrial fibrillation in Europe: the EORP-AF General Pilot Registry
Boriani, G., Laroche, C., Diemberger, I., Popescu, M. I., Rasmussen, L. H., Dan, G. A., . . . Lip, G. Y. H. (2015). Paroxysmal versus non-paroxysmal atrial fibrillation in Europe: the EORP-AF General Pilot Registry. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 803). Retrieved from https://www.webofscience.com/
Patterns of Newly Detected Atrial Fibrillation and Antithrombotic Treatment in GLORIA-AF Phase II
Halperin, J. L., Huisman, M. V., Diener, H. -C., Dubner, S. J., Ma, C., Rothman, K. J., . . . Lip, G. H. (2015). Patterns of Newly Detected Atrial Fibrillation and Antithrombotic Treatment in GLORIA-AF Phase II. In CIRCULATION Vol. 132. Retrieved from https://www.webofscience.com/
Plasma cell-free DNA levels are elevated in patients with acute ischemic heart failure partially due to neutrophil extracellular trap formation
Brill, A., Shantsila, E., Ponomaryov, T., Dinsdale, R., Harrison, P., & Lip, G. (2015). Plasma cell-free DNA levels are elevated in patients with acute ischemic heart failure partially due to neutrophil extracellular trap formation. In JOURNAL OF THROMBOSIS AND HAEMOSTASIS Vol. 13 (pp. 379-380). Retrieved from https://www.webofscience.com/
Predicting intracranial bleeding risk in patients with atrial fibrillation using several bleeding risk scores
Fauchier, L., Banerjee, A., Lagrenade, I., Clementy, N., Angoulvant, D., Bernard, A., . . . Lip, G. Y. H. (2015). Predicting intracranial bleeding risk in patients with atrial fibrillation using several bleeding risk scores. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 338). Retrieved from https://www.webofscience.com/
Predictive Value of the SAMe-TTR2R2 to predict quality of oral anticoagulation in atrial fibrillation: a prospective validation in the multicentre Spanish observational registry fantasiia
Marin, F., Roldan-Schilling, V., Bertomeu-Gonzalez, V., Cequier, A., Muniz, J., Roldan, I., . . . Anguita, M. (2015). Predictive Value of the SAMe-TTR2R2 to predict quality of oral anticoagulation in atrial fibrillation: a prospective validation in the multicentre Spanish observational registry fantasiia. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 1064-1065). Retrieved from https://www.webofscience.com/
Prevalence and associations of small vessel disease markers in an ischaemic stroke and TIA cohort with atrial fibrillation: Baseline characteristics of patients in the CROMIS-2 study
Wilson, D., Shakeshaft, C., Charidimou, A., Ambler, G., White, M., Cohen, H., . . . Werring, D. (2015). Prevalence and associations of small vessel disease markers in an ischaemic stroke and TIA cohort with atrial fibrillation: Baseline characteristics of patients in the CROMIS-2 study. In INTERNATIONAL JOURNAL OF STROKE Vol. 10 (pp. 11-12). Retrieved from https://www.webofscience.com/
Prevalence, Incidence, and Lifetime Risk of Atrial Fibrillation in China New Insights Into the Global Burden of Atrial Fibrillation
Guo, Y., Tian, Y., Wang, H., Si, Q., Wang, Y., & Lip, G. Y. H. (2015). Prevalence, Incidence, and Lifetime Risk of Atrial Fibrillation in China New Insights Into the Global Burden of Atrial Fibrillation. CHEST, 147(1), 109-119. doi:10.1378/chest.14-0321
Prognosis in patients with atrial fibrillation and CHA2DS2-VASc score=1 in a community based cohort study
Fauchier, L., Lecoq, C., Clementy, N., Angoulvant, D., Babuty, D., & Lip, G. Y. H. (2015). Prognosis in patients with atrial fibrillation and CHA2DS2-VASc score=1 in a community based cohort study. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 863). Retrieved from https://www.webofscience.com/
Prognosis in patients with atrial fibrillation with a presumed temporary cause in a community based cohort study
Fauchier, L., Clementy, N., Angoulvant, D., Babuty, D., Bernard, A., & Lip, G. Y. H. (2015). Prognosis in patients with atrial fibrillation with a presumed temporary cause in a community based cohort study. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 164). Retrieved from https://www.webofscience.com/
Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on theTreatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013
Van Wagoner, D. R., Piccini, J. P., Albert, C. M., Anderson, M. E., Benjamin, E. J., Brundel, B., . . . Wehrens, X. H. T. (2015). Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on theTreatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013. In HEART RHYTHM Vol. 12 (pp. E5-U37). doi:10.1016/j.hrthm.2014.11.011
Psychosocial consequences of venous thromboembolism in youth. Results from a mixed methods study
Hojen, A. A., Gorst-Rasmussen, A., Lip, G. Y. H., Lane, D. A., Rasmussen, L. H., Sorensen, E. E., . . . Larsen, T. B. (2015). Psychosocial consequences of venous thromboembolism in youth. Results from a mixed methods study. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 283). Retrieved from https://www.webofscience.com/
Real-world bleeding risk among non-valvular atrial fibrillation (NVAF) patients prescribed apixaban, dabigatran, rivaroxaban and warfarin: analysis of electronic health records
Lin, I., Masseria, C., Mardekian, J., Frean, M., Phatak, H., Kamble, S., . . . Lip, G. Y. H. (2015). Real-world bleeding risk among non-valvular atrial fibrillation (NVAF) patients prescribed apixaban, dabigatran, rivaroxaban and warfarin: analysis of electronic health records. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 1084). Retrieved from https://www.webofscience.com/
Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients on apixaban, dabigatran, rivaroxaban: cohorts comprising new initiators and/or switchers from warfarin
Tepper, P., Mardekian, J., Masseria, C., Phatak, H., Kamble, S., Abdulsattar, Y., . . . Lip, G. Y. H. (2015). Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients on apixaban, dabigatran, rivaroxaban: cohorts comprising new initiators and/or switchers from warfarin. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 339). Retrieved from https://www.webofscience.com/
Relation of prior cerebral microbleeds to clinical characteristics of patients presenting with acute intracerebral hemorrhage
Nakamura, A., Yasaka, M., Lip, G. Y., Wakugawa, Y., Kuwashiro, T., Tsurusaki, Y., . . . Okada, Y. (2015). Relation of prior cerebral microbleeds to clinical characteristics of patients presenting with acute intracerebral hemorrhage. In INTERNATIONAL JOURNAL OF STROKE Vol. 10 (pp. 293). Retrieved from https://www.webofscience.com/
Relationship of renal impairment and diastolic dysfunction to hypertension in minority ethnic groups: ethnic-echocardiographic heart of England screening study (E-ECHOES)
Shantsila, A., Gill, P. S., Shantsila, E., & Lip, G. Y. H. (2015). Relationship of renal impairment and diastolic dysfunction to hypertension in minority ethnic groups: ethnic-echocardiographic heart of England screening study (E-ECHOES). In EUROPEAN HEART JOURNAL Vol. 36 (pp. 25). Retrieved from https://www.webofscience.com/
Renal, endothelial function, warfarin management, and the CHADS<sub>2</sub>, CHA<sub>2</sub>DS<sub>2</sub>VASc and HAS-BLED scores in predicting MACE in AF
Blann, A. D., & Lip, G. Y. H. (2015). Renal, endothelial function, warfarin management, and the CHADS<sub>2</sub>, CHA<sub>2</sub>DS<sub>2</sub>VASc and HAS-BLED scores in predicting MACE in AF. THROMBOSIS AND HAEMOSTASIS, 113(5), 1155-1157. doi:10.1160/TH14-11-0932
Safety and efficacy of well managed warfarin A report from the Swedish quality register Auricula
Sjogren, V., Grzymala-Lubanski, B., Renlund, H., Friberg, L., Lip, G. Y. H., Svensson, P. J., & Sjalander, A. (2015). Safety and efficacy of well managed warfarin A report from the Swedish quality register Auricula. THROMBOSIS AND HAEMOSTASIS, 113(6), 1370-1377. doi:10.1160/TH14-10-0859
Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation
Pignatelli, P., Pastori, D., Carnevale, R., Farcomeni, A., Cangemi, R., Nocella, C., . . . Violi, F. (2015). Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation. THROMBOSIS AND HAEMOSTASIS, 113(3), 617-624. doi:10.1160/TH14-07-0571
Sex-related differences in epidemiologic and clinical presentation of atrial fibrillation in the Balkan countries - insights from the BALKAN AF Snap Shot Survey
Polovina, M., Goshev, E., Kusljugic, Z., Music, L. J., Gjergo, H., Dan, G. A., . . . Lip, G. Y. H. (2015). Sex-related differences in epidemiologic and clinical presentation of atrial fibrillation in the Balkan countries - insights from the BALKAN AF Snap Shot Survey. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 900-901). Retrieved from https://www.webofscience.com/
Statin therapy reduces von Willebrand factor antigen levels: A systematic review and meta-analysis of randomized placebo-controlled trials
Sahebkar, A., Serban, C., Ursoniu, S., Mihaescu, R., Mikhailidis, D. P., Muntner, P., . . . Banach, M. (2015). Statin therapy reduces von Willebrand factor antigen levels: A systematic review and meta-analysis of randomized placebo-controlled trials. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 224). Retrieved from https://www.webofscience.com/
Statin treatment is associated with improved prognosis in patients with af-related stroke
Ntaios, G., Papavasileiou, V., Makaritsis, K., Milionis, H., Manios, E., Michel, P., . . . Vemmos, K. (2015). Statin treatment is associated with improved prognosis in patients with af-related stroke. In INTERNATIONAL JOURNAL OF STROKE Vol. 10 (pp. 275-276). Retrieved from https://www.webofscience.com/
Stroke and Major Bleeding Risk in Elderly Patients Aged ≥75 Years With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project
Lip, G. Y. H., Clementy, N., Pericart, L., Banerjee, A., & Fauchier, L. (2015). Stroke and Major Bleeding Risk in Elderly Patients Aged ≥75 Years With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project. STROKE, 46(1), 143-150. doi:10.1161/STROKEAHA.114.007199
Stroke and bleeding risk-associated use of antithrombotic therapies for stroke prevention in atrial fibrillation in routine clinical practice: the BALKAN-AF Survey
Potpara, T. S., Dan, G. A., Trendafilova, E., Paparisto, V., Kusljugic, Z., Polovina, M. M., . . . Lip, G. Y. H. (2015). Stroke and bleeding risk-associated use of antithrombotic therapies for stroke prevention in atrial fibrillation in routine clinical practice: the BALKAN-AF Survey. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 1082-1083). Retrieved from https://www.webofscience.com/
Suboptimal oral anticoagulation use among Chinese nonvalvular Atrial Fibrillation Patients: the Nanchang Atrial Fibrillation project
Xiong, Q., Shantsila, A., Cheng, X., Hong, K., & Lip, G. Y. H. (2015). Suboptimal oral anticoagulation use among Chinese nonvalvular Atrial Fibrillation Patients: the Nanchang Atrial Fibrillation project. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 66 (pp. C271-C272). Retrieved from https://www.webofscience.com/
Switching from a vitamin K antagonist to a NOAC
Senoo, K., & Lip, G. Y. H. (2015). Switching from a vitamin K antagonist to a NOAC. LANCET HAEMATOLOGY, 2(4), E132-E133. doi:10.1016/S2352-3026(15)00041-1
Sympathetic nerve activity and arterial baroreflex function in rheumatoid arthritis
Adlan, A. M., Paton, J. F. R., Lip, G. Y. H., Kitas, G. D., & Fisher, J. P. (2015). Sympathetic nerve activity and arterial baroreflex function in rheumatoid arthritis. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 728). Retrieved from https://www.webofscience.com/
The CHA<sub>2</sub>DS<sub>2</sub>-VASc score for stroke risk stratification in patients with atrial fibrillation: a brief history
Lip, G. Y. H. (2015). The CHA<sub>2</sub>DS<sub>2</sub>-VASc score for stroke risk stratification in patients with atrial fibrillation: a brief history. EUROPEAN HEART JOURNAL, 36(42), 2880-2885. Retrieved from https://www.webofscience.com/
The CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>-VASc scores for predicting ischemic stroke amongst Asian patients with atrial fibrillation: A systemic review and meta-analysis
Xiong, Q., Chen, S., Senoo, K., Proietti, M., Hong, K., & Lip, G. Y. H. (2015). The CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>-VASc scores for predicting ischemic stroke amongst Asian patients with atrial fibrillation: A systemic review and meta-analysis. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 66 (pp. C271). Retrieved from https://www.webofscience.com/
Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement
Capodanno, D., Lip, G. Y. H., Windecker, S., Huber, K., Kirchhof, P., Boriani, G., . . . Byrne, R. A. (2015). Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement. EUROINTERVENTION, 10(9), 1015-1021. doi:10.4244/EIJV10I9A174
Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in atrial fibrillation patients
Pastori, D., Pignatelli, P. P., Cangemi, R. C., Hiatt, W. R. H., Farcomeni, A. F., Vicario, T. V., . . . Violi, F. V. (2015). Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in atrial fibrillation patients. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 903). Retrieved from https://www.webofscience.com/
Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in atrial fibrillation patients
Pignatelli, P., Pastori, D., Hiatt, W. R., Lip, G., & Violi, F. (2015). Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in atrial fibrillation patients. In JOURNAL OF THROMBOSIS AND HAEMOSTASIS Vol. 13 (pp. 519). Retrieved from https://www.webofscience.com/
Use of an Insertable Cardiac Monitor to Detect Atrial Fibrillation is Cost Effective in Patients with Cryptogenic Stroke
Diamantopoulos, A., Sawyer, L., Sungher, D., Lip, G., Witte, K., Reynolds, M. R., . . . Diener, H. -C. (2015). Use of an Insertable Cardiac Monitor to Detect Atrial Fibrillation is Cost Effective in Patients with Cryptogenic Stroke. In STROKE Vol. 46. Retrieved from https://www.webofscience.com/
Use of antithrombotic therapy in patients with atrial fibrillation and prior stroke: insights from the global GLORIA-AF registry
Lip, G. Y. H., Halperin, J. L., Diener, H. C., Dubner, S. J., Ma, C. S., Rothman, K. J., . . . Huisman, M. V. (2015). Use of antithrombotic therapy in patients with atrial fibrillation and prior stroke: insights from the global GLORIA-AF registry. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 243). Retrieved from https://www.webofscience.com/
Use of oral anticoagulants in combination with antiplatelet therapy: insights from the GLORIA-AF registry
Lip, G. Y. H., Halperin, J., Diener, H. C., Dubner, S. J., Ma, C. S., Rothman, K. J., . . . Huisman, M. V. (2015). Use of oral anticoagulants in combination with antiplatelet therapy: insights from the GLORIA-AF registry. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 235). Retrieved from https://www.webofscience.com/
Validation of SAME-TT2R2 score for predicting poor anticoagulation in a prospective real world cohort of atrial fibrillation patients initiating Vitamin K antagonists
Roldan-Schilling, V., Marin, F., Cancio, S., Galvez, J., Valdes, M., Vicente, V., & Lip, G. Y. H. (2015). Validation of SAME-TT2R2 score for predicting poor anticoagulation in a prospective real world cohort of atrial fibrillation patients initiating Vitamin K antagonists. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 803-804). Retrieved from https://www.webofscience.com/
Vascular disease as a risk factor of stroke or death in heart failure patients in sinus rhythm: a nationwide cohort study
Melgaard, L., Gorst-Rasmussen, A., Larsen, T. B., & Lip, G. (2015). Vascular disease as a risk factor of stroke or death in heart failure patients in sinus rhythm: a nationwide cohort study. In EUROPEAN JOURNAL OF HEART FAILURE Vol. 17 (pp. 249). Retrieved from https://www.webofscience.com/
Vascular disease as a risk factor of stroke or death in heart failure patients in sinus rhythm: a nationwide cohort study
Melgaard, L., Gorst-Rasmussen, A., Lip, G., & Larsen, T. B. (2015). Vascular disease as a risk factor of stroke or death in heart failure patients in sinus rhythm: a nationwide cohort study. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 28-29). Retrieved from https://www.webofscience.com/
Volume and functional outcome of intracerebral haemorrhage associated with non-vitamin K oral anticoagulants compared to warfarin: Prospective, multicentre cross sectional study
Wilson, D., Charidimou, A., Shakeshaft, C., Ambler, G., White, M., Cohen, H., . . . Werring, D. (2015). Volume and functional outcome of intracerebral haemorrhage associated with non-vitamin K oral anticoagulants compared to warfarin: Prospective, multicentre cross sectional study. In INTERNATIONAL JOURNAL OF STROKE Vol. 10 (pp. 62). Retrieved from https://www.webofscience.com/
Volume and functional outcome of intracerebral hemorrhage associated with non-vitamin K oral anticoagulants compared to warfarin: Multicenter cross sectional observational study
Wilson, D., Charidimou, A., Shakeshaft, C., Ambler, G., White, M. J., Cohen, H., . . . Werring, D. J. (2015). Volume and functional outcome of intracerebral hemorrhage associated with non-vitamin K oral anticoagulants compared to warfarin: Multicenter cross sectional observational study. In INTERNATIONAL JOURNAL OF STROKE Vol. 10 (pp. 59-60). Retrieved from https://www.webofscience.com/
Warfarin and major adverse cardiovascular events in the "Real World" of patients with atrial fibrillation
Pignatelli, P., Pastori, D., Lip, G., & Violi, F. (2015). Warfarin and major adverse cardiovascular events in the "Real World" of patients with atrial fibrillation. In JOURNAL OF THROMBOSIS AND HAEMOSTASIS Vol. 13 (pp. 392). Retrieved from https://www.webofscience.com/
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death].
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., . . . Van Veldhuisen, D. J. (2015). [2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death].. Kardiologia polska, 73(10), 795-900. doi:10.5603/kp.2015.0190
2014
Patients with atrial fibrillation undergoing percutaneous coronary intervention Current concepts and concerns: part II
Dzeshka, M. S., Brown, R. A., & Lip, G. Y. H. (2015). Patients with atrial fibrillation undergoing percutaneous coronary intervention Current concepts and concerns: part II. POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 125(3), 172-180. Retrieved from https://www.webofscience.com/
Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis
Kotecha, D., Holmes, J., Krum, H., Altman, D. G., Manzano, L., Cleland, J. G. F., . . . Flather, M. D. (2014). Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. LANCET, 384(9961), 2235-2243. doi:10.1016/S0140-6736(14)61373-8
Net Clinical Benefit of Antithrombotic Therapy in Patients With Atrial Fibrillation and Chronic Kidney Disease A Nationwide Observational Cohort Study
Bonde, A. N., Lip, G. Y. H., Kamper, A. -L., Hansen, P. R., Lamberts, M., Hommel, K., . . . Olesen, J. B. (2014). Net Clinical Benefit of Antithrombotic Therapy in Patients With Atrial Fibrillation and Chronic Kidney Disease A Nationwide Observational Cohort Study. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 64(23), 2471-2482. doi:10.1016/j.jacc.2014.09.051
'Lone' atrial fibrillation: no longer lone or even alone.
Potpara, T. S., & Lip, G. Y. H. (2015). 'Lone' atrial fibrillation: no longer lone or even alone.. Current pharmaceutical design, 21(5), 531-532. doi:10.2174/1381612820666140826124522
A Brief History of 'Lone' Atrial Fibrillation: From 'A Peculiar Pulse Irregularity' to a Modern Public Health Concern
Potpara, T. S., & Lip, G. Y. H. (2015). A Brief History of 'Lone' Atrial Fibrillation: From 'A Peculiar Pulse Irregularity' to a Modern Public Health Concern. CURRENT PHARMACEUTICAL DESIGN, 21(5), 679-696. doi:10.2174/1381612820666140929100209
Association of quality of life with anticoagulant control in patients with heart failure: The Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trial
Shaffer, J. A., Thompson, J. L. P., Cheng, B., Ye, S., Lip, G. Y. H., Mann, D. L., . . . Homma, S. (2014). Association of quality of life with anticoagulant control in patients with heart failure: The Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trial. INTERNATIONAL JOURNAL OF CARDIOLOGY, 177(2), 715-717. doi:10.1016/j.ijcard.2014.10.012
Best Practice for Atrial Fibrillation Patient Education
Lane, D. A., Barker, R. V., & Lip, G. Y. H. (2015). Best Practice for Atrial Fibrillation Patient Education. CURRENT PHARMACEUTICAL DESIGN, 21(5), 533-543. Retrieved from https://www.webofscience.com/
Clinical risk factors and subclinical target organ damage as predictors of new-onset of atrial fibrillation: The Catanzaro atrial fibrillation project
Perticone, F., Sciacqua, A., Perticone, M., Tassone, E. J., Sesti, G., Violi, F., & Lip, G. Y. H. (2014). Clinical risk factors and subclinical target organ damage as predictors of new-onset of atrial fibrillation: The Catanzaro atrial fibrillation project. INTERNATIONAL JOURNAL OF CARDIOLOGY, 177(2), 666-668. doi:10.1016/j.ijcard.2014.09.169
Endothelial (Dys) Function in Lone Atrial Fibrillation
Polovina, M. M., Lip, G. Y. H., & Potpara, T. S. (2015). Endothelial (Dys) Function in Lone Atrial Fibrillation. CURRENT PHARMACEUTICAL DESIGN, 21(5), 622-645. Retrieved from https://www.webofscience.com/
Prognosis and treatment of atrial fibrillation patients by European cardiologists: One Year Follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry)
Lip, G. Y. H., Laroche, C., Ioachim, P. M., Rasmussen, L. H., Vitali-Serdoz, L., Petrescu, L., . . . Boriani, G. (2014). Prognosis and treatment of atrial fibrillation patients by European cardiologists: One Year Follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry). EUROPEAN HEART JOURNAL, 35(47), 3365-3376. doi:10.1093/eurheartj/ehu374
Non-Vitamin K Antagonist Oral Anticoagulants and the Treatment of Venous Thromboembolism in Cancer Patients: A Semi Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes
Larsen, T. B., Nielsen, P. B., Skjoth, F., Rasmussen, L. H., & Lip, G. Y. H. (2014). Non-Vitamin K Antagonist Oral Anticoagulants and the Treatment of Venous Thromboembolism in Cancer Patients: A Semi Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes. PLOS ONE, 9(12). doi:10.1371/journal.pone.0114445
Anticoagulant-related gastrointestinal bleeding-could this facilitate early detection of benign or malignant gastrointestinal lesions?
Clemens, A., Strack, A., Noack, H., Konstantinides, S., Brueckmann, M., & Lip, G. Y. H. (2014). Anticoagulant-related gastrointestinal bleeding-could this facilitate early detection of benign or malignant gastrointestinal lesions?. ANNALS OF MEDICINE, 46(8), 672-678. doi:10.3109/07853890.2014.952327
Autonomic function and rheumatoid arthritis-A systematic review
Adlan, A. M., Lip, G. Y. H., Paton, J. F. R., Kitas, G. D., & Fisher, J. P. (2014). Autonomic function and rheumatoid arthritis-A systematic review. SEMINARS IN ARTHRITIS AND RHEUMATISM, 44(3), 283-304. doi:10.1016/j.semarthrit.2014.06.003
Cardiovascular risk in patients with sleep apnoea with or without continuous positive airway pressure therapy: follow-up of 4.5 million Danish adults
Lamberts, M., Nielsen, O. W., Lip, G. Y. H., Ruwald, M. H., Christiansen, C. B., Kristensen, S. L., . . . Gislason, G. H. (2014). Cardiovascular risk in patients with sleep apnoea with or without continuous positive airway pressure therapy: follow-up of 4.5 million Danish adults. JOURNAL OF INTERNAL MEDICINE, 276(6), 659-666. doi:10.1111/joim.12302
Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study
Larsen, T. B., Rasmussen, L. H., Gorst-Rasmussen, A., Skjoth, F., Lane, D. A., & Lip, G. Y. H. (2014). Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study. AMERICAN JOURNAL OF MEDICINE, 127(12), 1172-1178. doi:10.1016/j.amjmed.2014.07.023
Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis
Wagstaff, A. J., Overvad, T. F., Lip, G. Y. H., & Lane, D. A. (2014). Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 107(12), 955-967. doi:10.1093/qjmed/hcu054
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)
Lip, G. Y. H., Windecker, S., Huber, K., Kirchhof, P., Marin, F., Ten Berg, J. M., . . . Lane, D. (2014). Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS). EUROPEAN HEART JOURNAL, 35(45), 3155-3179. doi:10.1093/eurheartj/ehu298
The atrial fibrillation epidemic: a validated diagnosis, or not?
Olesen, J. B., Lip, G. Y. H., & Fauchier, L. (2014). The atrial fibrillation epidemic: a validated diagnosis, or not?. EUROPACE, 16(12), 1701-+. doi:10.1093/europace/euu173
Atrial fibrillation (acute onset).
Lip, G. Y. H., & Apostolakis, S. (2014). Atrial fibrillation (acute onset).. BMJ clinical evidence, 2014, 0210.
Plasma CX<sub>3</sub>CL1 Levels and Long Term Outcomes of Patients with Atrial Fibrillation: The West Birmingham Atrial Fibrillation Project
Guo, Y., Apostalakis, S., Blann, A. D., & Lip, G. Y. H. (2014). Plasma CX<sub>3</sub>CL1 Levels and Long Term Outcomes of Patients with Atrial Fibrillation: The West Birmingham Atrial Fibrillation Project. CEREBROVASCULAR DISEASES, 38(3), 204-211. doi:10.1159/000365841
Recurrent Stroke in the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial
Pullicino, P. M., Qian, M., Sacco, R. L., Freudenberger, R., Graham, S., Teerlink, J. R., . . . Homma, S. (2014). Recurrent Stroke in the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial. CEREBROVASCULAR DISEASES, 38(3), 176-181. doi:10.1159/000365502
Cognitive Function in Ambulatory Patients with Systolic Heart Failure: Insights from the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial
Graham, S., Ye, S., Qian, M., Sanford, A. R., Di Tullio, M. R., Sacco, R. L., . . . Homma, S. (2014). Cognitive Function in Ambulatory Patients with Systolic Heart Failure: Insights from the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial. PLOS ONE, 9(11). doi:10.1371/journal.pone.0113447
Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation
Lip, G. Y. H., Laroche, C., Boriani, G., Cimaglia, P., Dan, G. -A., Santinis, M., . . . Maggioni, A. P. (2015). Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation. EUROPACE, 17(1), 24-31. doi:10.1093/europace/euu155
New Biomarkers and Risk Stratification in Atrial Fibrillation Simplicity and Practicality Matter
Griffiths, H. R., & Lip, G. Y. H. (2014). New Biomarkers and Risk Stratification in Atrial Fibrillation Simplicity and Practicality Matter. CIRCULATION, 130(21), 1837-1839. doi:10.1161/CIRCULATIONAHA.114.012870
Nonsteroidal Anti-inflammatory Drugs and Serious Bleeding and Thromboembolism in Patients With Atrial Fibrillation
Lamberts, M., Lip, G. Y. H., Hansen, M. L., Lindhardsen, J., Olesen, J. B., Raunso, J., . . . Gislason, G. H. (2014). Nonsteroidal Anti-inflammatory Drugs and Serious Bleeding and Thromboembolism in Patients With Atrial Fibrillation. ANNALS OF INTERNAL MEDICINE, 161(10). doi:10.7326/P14-9039
Relation of Nonsteroidal Anti-inflammatory Drugs to Serious Bleeding and Thromboembolism Risk in Patients With Atrial Fibrillation Receiving Antithrombotic Therapy A Nationwide Cohort Study
Lamberts, M., Lip, G. Y. H., Hansen, M. L., Lindhardsen, J., Olesen, J. B., Raunso, J., . . . Gislason, G. H. (2014). Relation of Nonsteroidal Anti-inflammatory Drugs to Serious Bleeding and Thromboembolism Risk in Patients With Atrial Fibrillation Receiving Antithrombotic Therapy A Nationwide Cohort Study. ANNALS OF INTERNAL MEDICINE, 161(10), 690-U136. doi:10.7326/M13-1581
Statin treatment is associated with improved prognosis in patients with AF-related stroke
Ntaios, G., Papavasileiou, V., Makaritsis, K., Milionis, H., Manios, E., Michel, P., . . . Vemmos, K. (2014). Statin treatment is associated with improved prognosis in patients with AF-related stroke. INTERNATIONAL JOURNAL OF CARDIOLOGY, 177(1), 129-133. doi:10.1016/j.ijcard.2014.09.031
Effects of Radiofrequency Catheter Ablation of Atrial Fibrillation on Soluble P-Selectin, Von Willebrand Factor and IL-6 in the Peripheral and Cardiac Circulation
Kornej, J., Dinov, B., Blann, A. D., Rolf, S., Arya, A., Schmidl, J., . . . Lip, G. Y. H. (2014). Effects of Radiofrequency Catheter Ablation of Atrial Fibrillation on Soluble P-Selectin, Von Willebrand Factor and IL-6 in the Peripheral and Cardiac Circulation. PLOS ONE, 9(11). doi:10.1371/journal.pone.0111760
Acute myocardial infarction in patients with atrial fibrillation with a CHA<sub>2</sub>DS<sub>2</sub>-VASc score of 0 or 1: A nationwide cohort study
Chao, T. -F., Huang, Y. -C., Liu, C. -J., Chen, S. -J., Wang, K. -L., Lin, Y. -J., . . . Chen, S. -A. (2014). Acute myocardial infarction in patients with atrial fibrillation with a CHA<sub>2</sub>DS<sub>2</sub>-VASc score of 0 or 1: A nationwide cohort study. HEART RHYTHM, 11(11), 1941-1947. doi:10.1016/j.hrthm.2014.08.003
Atrial Fibrillation During Sepsis A Determinant of Long-term Outcomes?
Lau, Y. C., & Lip, G. Y. H. (2014). Atrial Fibrillation During Sepsis A Determinant of Long-term Outcomes?. CHEST, 146(5), 1138-1140. doi:10.1378/chest.14-0986
Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force.
Gorenek, B., Blomström Lundqvist, C., Brugada Terradellas, J., Camm, A. J., Hindricks, G., Huber, K., . . . Savelieva, I. (2014). Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 16(11), 1655-1673. doi:10.1093/europace/euu208
Early cerebral thromboembolic complications after radiofrequency catheter ablation of atrial fibrillation: Incidence, characteristics, and risk factors
Kosiuk, J., Kornej, J., Bollmann, A., Piorkowski, C., Myrda, K., Arya, A., . . . Hindricks, G. (2014). Early cerebral thromboembolic complications after radiofrequency catheter ablation of atrial fibrillation: Incidence, characteristics, and risk factors. HEART RHYTHM, 11(11), 1934-1940. doi:10.1016/j.hrthm.2014.07.039
Exercise-induced changes in inflammatory processes: Implications for thrombogenesis in cardiovascular disease
Chen, Y. -W., Apostolakis, S., & Lip, G. Y. H. (2014). Exercise-induced changes in inflammatory processes: Implications for thrombogenesis in cardiovascular disease. ANNALS OF MEDICINE, 46(7), 439-455. doi:10.3109/07853890.2014.927713
Expression of monocyte subsets and angiogenic markers in relation to carotid plaque neovascularization in patients with pre-existing coronary artery disease and carotid stenosis
Jaipersad, A. S., Shantsila, A., Lip, G. Y. H., & Shantsila, E. (2014). Expression of monocyte subsets and angiogenic markers in relation to carotid plaque neovascularization in patients with pre-existing coronary artery disease and carotid stenosis. ANNALS OF MEDICINE, 46(7), 530-538. doi:10.3109/07853890.2014.931101
SAMe-TT<sub>2</sub>R<sub>2</sub> Score, Time in Therapeutic Range, and Outcomes in Anticoagulated Patients with Atrial Fibrillation
Gallego, P., Roldan, V., Marin, F., Galvez, J., Valdes, M., Vicente, V., & Lip, G. Y. H. (2014). SAMe-TT<sub>2</sub>R<sub>2</sub> Score, Time in Therapeutic Range, and Outcomes in Anticoagulated Patients with Atrial Fibrillation. AMERICAN JOURNAL OF MEDICINE, 127(11), 1083-1088. doi:10.1016/j.amjmed.2014.05.023
Stroke Prevention in Atrial Fibrillation - Outcomes and Future Directions.
Mountfort, K., Reviewed for accuracy by:., Camm, J., Lip, G., Goette, A., & Le Heuzey, J. -Y. (2014). Stroke Prevention in Atrial Fibrillation - Outcomes and Future Directions.. Arrhythmia & electrophysiology review, 3(3), 194-200. doi:10.15420/aer.2014.3.3.194
The Value of the European Society of Cardiology Guidelines for Refining Stroke Risk Stratification in Patients With Atrial Fibrillation Categorized as Low Risk Using the Anticoagulation and Risk Factors in Atrial Fibrillation Stroke Score A Nationwide Cohort Study
Lip, G. Y. H., Nielsen, P. B., Skjoth, F., Lane, D. A., Rasmussen, L. H., & Larsen, T. B. (2014). The Value of the European Society of Cardiology Guidelines for Refining Stroke Risk Stratification in Patients With Atrial Fibrillation Categorized as Low Risk Using the Anticoagulation and Risk Factors in Atrial Fibrillation Stroke Score A Nationwide Cohort Study. CHEST, 146(5), 1337-1346. doi:10.1378/chest.14-0533
Effect of standard chemotherapy and antiangiogenic therapy on plasma markers and endothelial cells in colorectal cancer
Ramcharan, K. S., Lip, G. Y. H., Stonelake, P. S., & Blann, A. D. (2014). Effect of standard chemotherapy and antiangiogenic therapy on plasma markers and endothelial cells in colorectal cancer. BRITISH JOURNAL OF CANCER, 111(9), 1742-1749. doi:10.1038/bjc.2014.491
Using the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score for Refining Stroke Risk Stratification in 'Low-Risk' Asian Patients With Atrial Fibrillation
Chao, T. -F., Liu, C. -J., Wang, K. -L., Lin, Y. -J., Chang, S. -L., Lo, L. -W., . . . Chen, S. -A. (2014). Using the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score for Refining Stroke Risk Stratification in 'Low-Risk' Asian Patients With Atrial Fibrillation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 64(16), 1658-1665. doi:10.1016/j.jacc.2014.06.1203
Free Light Chains in Patients With Acute Heart Failure Secondary to Atherosclerotic Coronary Artery Disease
Shantsila, E., Wrigley, B., & Lip, G. Y. H. (2014). Free Light Chains in Patients With Acute Heart Failure Secondary to Atherosclerotic Coronary Artery Disease. AMERICAN JOURNAL OF CARDIOLOGY, 114(8), 1243-1248. doi:10.1016/j.amjcard.2014.07.049
Hormone Replacement Therapy and Adverse Outcomes in Women With Atrial Fibrillation An Analysis From the Atrial Fibrillation Follow-Up Investigation of Rhythm Management Trial
Apostolakis, S., Sullivan, R. M., Olshansky, B., & Lip, G. Y. H. (2014). Hormone Replacement Therapy and Adverse Outcomes in Women With Atrial Fibrillation An Analysis From the Atrial Fibrillation Follow-Up Investigation of Rhythm Management Trial. STROKE, 45(10), 3076-+. doi:10.1161/STROKEAHA.114.006668
Benefits valuation of potable water quality improvement in Malaysia: the case of Kajang Municipality
Othman, J., Lip, G. H., & Jafari, Y. (2014). Benefits valuation of potable water quality improvement in Malaysia: the case of Kajang Municipality. International Journal of Water Resources Development, 30(4), 621-634. doi:10.1080/07900627.2013.876851
Atrial fibrillation
Lau, Y. C., & Lip, G. Y. H. (2014). Atrial fibrillation. Medicine, 42(10), 598-603. doi:10.1016/j.mpmed.2014.07.013
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias
Pedersen, C. T., Kay, G. N., Kalman, J., Borggrefe, M., Della‐Bella, P., Dickfeld, T., . . . Savelieva, I. (2014). EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Journal of Arrhythmia, 30(5), 327-349. doi:10.1016/j.joa.2014.08.001
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias.
Pedersen, C. T., Kay, G. N., Kalman, J., Borggrefe, M., Della-Bella, P., Dickfeld, T., . . . EP-Europace,UK. (2014). EHRA/HRS/APHRS expert consensus on ventricular arrhythmias.. Heart rhythm, 11(10), e166-e196. doi:10.1016/j.hrthm.2014.07.024
Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis.
Chao, T. -F., Liu, C. -J., Wang, K. -L., Lin, Y. -J., Chang, S. -L., Lo, L. -W., . . . Chen, S. -A. (2014). Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis.. Heart rhythm, 11(10), 1752-1759. doi:10.1016/j.hrthm.2014.06.021
New advances in the treatment of atrial fibrillation: focus on stroke prevention
Lau, Y. C., & Lip, G. Y. H. (2014). New advances in the treatment of atrial fibrillation: focus on stroke prevention. EXPERT OPINION ON PHARMACOTHERAPY, 15(15), 2193-2204. doi:10.1517/14656566.2014.948418
Non-vitamin K antagonist oral anticoagulants in atrial fibrillation and venous thromboembolism: where are we now?
Hajhosseiny, R., Sabir, I., & Lip, G. Y. H. (2014). Non-vitamin K antagonist oral anticoagulants in atrial fibrillation and venous thromboembolism: where are we now?. Hospital practice (1995), 42(4), 153-162. doi:10.3810/hp.2014.10.1152
Oxidised LDL lipids, statins and a blood-brain barrier
Helen, G., Dias, I., Lip, G. Y. H., Corinne, S., & Cristina, P. (2014). Oxidised LDL lipids, statins and a blood-brain barrier. In FREE RADICAL BIOLOGY AND MEDICINE Vol. 75 (pp. S15-S16). doi:10.1016/j.freeradbiomed.2014.10.591
Pocket Ready to Eat at Home in Primary Care Reply
Prasad, V., Kim, J., & Rho, J. (2014). Pocket Ready to Eat at Home in Primary Care Reply. AMERICAN JOURNAL OF MEDICINE, 127(3), E21. doi:10.1016/j.amjmed.2013.11.005
Prediction of stroke in patients without atrial fibrillation using the CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>-VASc scores: a justification for more widespread thromboprophylaxis?
Senoo, K., & Lip, G. Y. H. (2014). Prediction of stroke in patients without atrial fibrillation using the CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>-VASc scores: a justification for more widespread thromboprophylaxis?. HEART, 100(19), 1485-1486. doi:10.1136/heartjnl-2014-306161
Prior History of Falls and Risk of Outcomes in Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project
Banerjee, A., Clementy, N., Haguenoer, K., Fauchier, L., & Lip, G. Y. H. (2014). Prior History of Falls and Risk of Outcomes in Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project. AMERICAN JOURNAL OF MEDICINE, 127(10), 972-978. doi:10.1016/j.amjmed.2014.05.035
Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey
Marcucci, M., Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Crijns, H. J. G. M., & Iorio, A. (2014). Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey. AMERICAN JOURNAL OF MEDICINE, 127(10), 979-U199. doi:10.1016/j.amjmed.2014.05.003
Stroke and Bleeding Risk in Atrial Fibrillation: Navigating the Alphabet Soup of Risk-Score Acronyms (CHADS<sub>2</sub>, CHA<sub>2</sub>DS<sub>2</sub>-VASc, R<sub>2</sub>CHADS<sub>2</sub>, HAS-BLED, ATRIA, and More)
Dzeshka, M. S., Lane, D. A., & Lip, G. Y. H. (2014). Stroke and Bleeding Risk in Atrial Fibrillation: Navigating the Alphabet Soup of Risk-Score Acronyms (CHADS<sub>2</sub>, CHA<sub>2</sub>DS<sub>2</sub>-VASc, R<sub>2</sub>CHADS<sub>2</sub>, HAS-BLED, ATRIA, and More). CLINICAL CARDIOLOGY, 37(10), 634-644. doi:10.1002/clc.22294
Stroke/Thromboembolism and Intracranial Hemorrhage in a Real-world Atrial Fibrillation Population The Complications of Atrial Fibrillation in the Bologna Area (CAFBO) Study
Palareti, G., Salomone, L., Cavazza, M., Guidi, M., Muscari, A., Boriani, G., . . . Lip, G. Y. H. (2014). Stroke/Thromboembolism and Intracranial Hemorrhage in a Real-world Atrial Fibrillation Population The Complications of Atrial Fibrillation in the Bologna Area (CAFBO) Study. CHEST, 146(4), 1073-1080. doi:10.1378/chest.13-2443
Correction: Twice- or Once-Daily Dosing of Novel Oral Anticoagulants for Stroke Prevention: A Fixed-Effects Meta-Analysis with Predefined Heterogeneity Quality Criteria
Correction: Twice- or Once-Daily Dosing of Novel Oral Anticoagulants for Stroke Prevention: A Fixed-Effects Meta-Analysis with Predefined Heterogeneity Quality Criteria (n.d.). PLoS ONE, 9(9), e109437. doi:10.1371/journal.pone.0109437
Laboratory Monitoring of the Non-Vitamin K Oral Anticoagulants
Blann, A. D., & Lip, G. Y. H. (2014). Laboratory Monitoring of the Non-Vitamin K Oral Anticoagulants. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 64(11), 1140-1142. doi:10.1016/j.jacc.2014.07.010
Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study.
Montalescot, G., Pitt, B., Lopez de Sa, E., Hamm, C. W., Flather, M., Verheugt, F., . . . REMINDER Investigators. (2014). Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study.. European heart journal, 35(34), 2295-2302. doi:10.1093/eurheartj/ehu164
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias
Pedersen, C. T., Kay, G. N., Kalman, J., Borggrefe, M., Della-Bella, P., Dickfeld, T., . . . Savelieva, I. (2014). EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. EUROPACE, 16(9), 1257-1283. doi:10.1093/europace/euu194
Integrating Real-Time Clinical Information to Provide Estimates of Net Clinical Benefit of Antithrombotic Therapy for Patients With Atrial Fibrillation
Eckman, M. H., Wise, R. E., Speer, B., Sullivan, M., Walker, N., Lip, G. Y. H., . . . Costea, A. (2014). Integrating Real-Time Clinical Information to Provide Estimates of Net Clinical Benefit of Antithrombotic Therapy for Patients With Atrial Fibrillation. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 7(5), 680-686. doi:10.1161/CIRCOUTCOMES.114.001163
Relationship of the SAMe-TT<sub>2</sub>R<sub>2</sub> Score to Poor-Quality Anticoagulation, Stroke, Clinically Relevant Bleeding, and Mortality in Patients With Atrial Fibrillation
Lip, G. Y. H., Haguenoer, K., Saint-Etienne, C., & Fauchier, L. (2014). Relationship of the SAMe-TT<sub>2</sub>R<sub>2</sub> Score to Poor-Quality Anticoagulation, Stroke, Clinically Relevant Bleeding, and Mortality in Patients With Atrial Fibrillation. CHEST, 146(3), 719-726. doi:10.1378/chest.13-2976
Response to Letter Regarding Article, "Warfarin Versus Aspirin for Prevention of Cognitive Decline in Atrial Fibrillation: Randomized Controlled Trial (Birmingham Atrial Fibrillation Treatment of the Aged Study)"
Mavaddat, N., Roalfe, A., Fletcher, K., Lip, G. Y. H., Hobbs, F. D. R., Fitzmaurice, D., & Mant, J. (2014). Response to Letter Regarding Article, "Warfarin Versus Aspirin for Prevention of Cognitive Decline in Atrial Fibrillation: Randomized Controlled Trial (Birmingham Atrial Fibrillation Treatment of the Aged Study)". STROKE, 45(9), E192. doi:10.1161/STROKEAHA.114.006301
Stroke and Bleeding Risk in Atrial Fibrillation
Senoo, K., Lane, D., & Lip, G. Y. H. (2014). Stroke and Bleeding Risk in Atrial Fibrillation. KOREAN CIRCULATION JOURNAL, 44(5), 281-290. doi:10.4070/kcj.2014.44.5.281
The Impact of Heart Failure and Left Ventricular Dysfunction in Predicting Stroke, Thromboembolism, and Mortality in Atrial Fibrillation Patients: A Systematic Review
Agarwal, M., Apostolakis, S., Lane, D. A., & Lip, G. Y. H. (2014). The Impact of Heart Failure and Left Ventricular Dysfunction in Predicting Stroke, Thromboembolism, and Mortality in Atrial Fibrillation Patients: A Systematic Review. CLINICAL THERAPEUTICS, 36(9), 1135-1144. doi:10.1016/j.clinthera.2014.07.015
Contemporary Management of Atrial Fibrillation: What Can Clinical Registries Tell Us About Stroke Prevention and Current Therapeutic Approaches?
Lip, G. Y. H., Al-Khatib, S. M., Cosio, F. G., Banerjee, A., Savelieva, I., Ruskin, J., . . . Camm, A. J. (2014). Contemporary Management of Atrial Fibrillation: What Can Clinical Registries Tell Us About Stroke Prevention and Current Therapeutic Approaches?. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 3(4). doi:10.1161/JAHA.114.001179
MY APPROACH to the use of NOACs for stroke prevention in patients with atrial fibrillation
Lip, G. Y. H. (2014). MY APPROACH to the use of NOACs for stroke prevention in patients with atrial fibrillation. TRENDS IN CARDIOVASCULAR MEDICINE, 24(6), 265-266. doi:10.1016/j.tcm.2014.05.012
Prognostic value of two polymorphisms in non-sarcomeric genes for the development of atrial fibrillation in patients with hypertrophic cardiomyopathy
Orenes-Pinero, E., Hernandez-Romero, D., Romero-Aniorte, A. I., Martinez, M., Garcia-Honrubia, A., Caballero, L., . . . Marin, F. (2014). Prognostic value of two polymorphisms in non-sarcomeric genes for the development of atrial fibrillation in patients with hypertrophic cardiomyopathy. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 107(8), 613-621. doi:10.1093/qjmed/hcu046
Thrombotic Complications in Heart Failure An Underappreciated Challenge
Shantsila, E., & Lip, G. Y. H. (2014). Thrombotic Complications in Heart Failure An Underappreciated Challenge. CIRCULATION, 130(5), 387-389. doi:10.1161/CIRCULATIONAHA.114.011353
Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation
Dorian, P., Kongnakorn, T., Phatak, H., Rublee, D. A., Kuznik, A., Lanitis, T., . . . Lip, G. Y. H. (2014). Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation. EUROPEAN HEART JOURNAL, 35(28), 1897-1906. doi:10.1093/eurheartj/ehu006
Edoxaban: a focused review of its clinical pharmacology
Lip, G. Y. H., & Agnelli, G. (2014). Edoxaban: a focused review of its clinical pharmacology. EUROPEAN HEART JOURNAL, 35(28), 1844-1855. doi:10.1093/eurheartj/ehu181
A Persisting Dilemma for Triple Antithrombotic Therapy Are We Close to Finding the Correct Answer? Reply
Lamberts, M., Gislason, G. H., Olesen, J. B., Kristensen, S. L., Olsen, A. -M. S., Mikkelsen, A., . . . Hansen, M. L. (2014). A Persisting Dilemma for Triple Antithrombotic Therapy Are We Close to Finding the Correct Answer? Reply. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 64(2), 231-232. doi:10.1016/j.jacc.2013.11.049
An "unlikely" Wells rule score (≤ 1) plus a negative D-dimer result excluded DVT in noncancer patients
Brown, R. A., & Lip, G. Y. H. (2014). An "unlikely" Wells rule score (≤ 1) plus a negative D-dimer result excluded DVT in noncancer patients. ANNALS OF INTERNAL MEDICINE, 161(2). doi:10.7326/0003-4819-161-2-201407150-02009
Small-size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P-selectin
Montoro-Garcia, S., Shantsila, E., Hernandez-Romero, D., Jover, E., Valdes, M., Marin, F., & Lip, G. Y. H. (2014). Small-size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P-selectin. In CARDIOVASCULAR RESEARCH Vol. 103. doi:10.1093/cvr/cvu094.1
Antithrombotic Treatment in Patients With Heart Failure and Associated Atrial Fibrillation and Vascular Disease A Nationwide Cohort Study
Lamberts, M., Lip, G. Y. H., Ruwald, M. H., Hansen, M. L., Ozcan, C., Kristensen, S. L., . . . Gislason, G. H. (2014). Antithrombotic Treatment in Patients With Heart Failure and Associated Atrial Fibrillation and Vascular Disease A Nationwide Cohort Study. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 63(24), 2689-2698. doi:10.1016/j.jacc.2014.03.039
Edoxaban in the Evolving Scenario of Non Vitamin K Antagonist Oral Anticoagulants Imputed Placebo Analysis and Multiple Treatment Comparisons
Verdecchia, P., Angeli, F., Lip, G. Y. H., & Reboldi, G. (2014). Edoxaban in the Evolving Scenario of Non Vitamin K Antagonist Oral Anticoagulants Imputed Placebo Analysis and Multiple Treatment Comparisons. PLOS ONE, 9(6). doi:10.1371/journal.pone.0100478
Performance of Bleeding Risk-Prediction Scores in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
Kiviniemi, T., Puurunen, M., Schlitt, A., Rubboli, A., Karjalainen, P., Vikman, S., . . . Airaksinen, K. E. J. (2014). Performance of Bleeding Risk-Prediction Scores in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. AMERICAN JOURNAL OF CARDIOLOGY, 113(12), 1995-2001. doi:10.1016/j.amjcard.2014.03.038
Twice- or Once-Daily Dosing of Novel Oral Anticoagulants for Stroke Prevention: A Fixed-Effects Meta-Analysis with Predefined Heterogeneity Quality Criteria
Clemens, A., Noack, H., Brueckmann, M., & Lip, G. Y. H. (2014). Twice- or Once-Daily Dosing of Novel Oral Anticoagulants for Stroke Prevention: A Fixed-Effects Meta-Analysis with Predefined Heterogeneity Quality Criteria. PLOS ONE, 9(6). doi:10.1371/journal.pone.0099276
Aspirin still overprescribed for stroke prevention in atrial fibrillation.
Taylor, J. (2014). Aspirin still overprescribed for stroke prevention in atrial fibrillation.. European heart journal, 35(22), 1422.
Early management of atrial fibrillation to prevent cardiovascular complications
Nattel, S., Guasch, E., Savelieva, I., Cosio, F. G., Valverde, I., Halperin, J. L., . . . Camm, A. J. (2014). Early management of atrial fibrillation to prevent cardiovascular complications. EUROPEAN HEART JOURNAL, 35(22), 1448-1U32. doi:10.1093/eurheartj/ehu028
ETHNIC AND GENDER DIFFERENCES IN SYMPTOM-TO-DOOR TIMES IN PATIENTS PRESENTING WITH ST ELEVATION MYOCARDIAL INFARCTION
Brown, R., Shantsila, E., Varma, C., & Lip, G. (2014). ETHNIC AND GENDER DIFFERENCES IN SYMPTOM-TO-DOOR TIMES IN PATIENTS PRESENTING WITH ST ELEVATION MYOCARDIAL INFARCTION. In HEART Vol. 100 (pp. A18-A19). doi:10.1136/heartjnl-2014-306118.34
MONOCYTE SUBPOPULATIONS COUNTS AND ASSOCIATIONS WITH GLOBAL LONGITUDINAL STRAIN IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS WITH NORMAL EJECTION FRACTION
Ghattas, A., Shantsila, E., Griffiths, H., & Lip, G. (2014). MONOCYTE SUBPOPULATIONS COUNTS AND ASSOCIATIONS WITH GLOBAL LONGITUDINAL STRAIN IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS WITH NORMAL EJECTION FRACTION. In HEART Vol. 100 (pp. A19-A20). doi:10.1136/heartjnl-2014-306118.36
Primary Prevention of Ischaemic Stroke in Atrial Fibrillation: New Oral Anticoagulant Drugs for all?
Foley, J., Kirchhof, P., & Lip, G. Y. H. (2014). Primary Prevention of Ischaemic Stroke in Atrial Fibrillation: New Oral Anticoagulant Drugs for all?. CURRENT VASCULAR PHARMACOLOGY, 12(3), 373-383. doi:10.2174/157016111203140518153503
ACP Journal Club. In anticoagulated patients with AF, HAS-BLED predicted major bleeding better than CHADS2 and CHA2DS2-VASc.
Marcucci, M. (2014). ACP Journal Club. In anticoagulated patients with AF, HAS-BLED predicted major bleeding better than CHADS2 and CHA2DS2-VASc.. Annals of internal medicine, 160(10), JC13. doi:10.7326/0003-4819-160-10-201405200-02013
Ablation reduced recurrent atrial tachyarrhythmia more than antiarrhythmic drugs in paroxysmal AF
Lau, Y. C., & Lip, G. Y. H. (2014). Ablation reduced recurrent atrial tachyarrhythmia more than antiarrhythmic drugs in paroxysmal AF. ANNALS OF INTERNAL MEDICINE, 160(10). doi:10.7326/0003-4819-160-10-201405200-02005
Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry
Puurunen, M., Kiviniemi, T., Nammas, W., Schlitt, A., Rubboli, A., Nyman, K., . . . Airaksinen, J. K. E. (2014). Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry. BMJ OPEN, 4(5). doi:10.1136/bmjopen-2013-004700
Efficacy and Safety of Vitamin K-Antagonists (VKA) for Atrial Fibrillation in Non-Dialysis Dependent Chronic Kidney Disease
Kooiman, J., van Rein, N., Spaans, B., van Beers, K. A. J., Bank, J. R., de Peppel, W. R. V., . . . Huisman, M. V. (2014). Efficacy and Safety of Vitamin K-Antagonists (VKA) for Atrial Fibrillation in Non-Dialysis Dependent Chronic Kidney Disease. PLOS ONE, 9(5). doi:10.1371/journal.pone.0094420
Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation
Skjoth, F., Larsen, T. B., Rasmussen, L. H., & Lip, G. Y. H. (2014). Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation. THROMBOSIS AND HAEMOSTASIS, 111(5), 981-988. doi:10.1160/TH14-02-0118
Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel
Husted, S., de Caterina, R., Andreotti, F., Arnesen, H., Bachmann, F., Huber, K., . . . Weitz, J. I. (2014). Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel. THROMBOSIS AND HAEMOSTASIS, 111(5), 781-782. doi:10.1160/TH14-03-0228
Patient outcomes using the European label for dabigatran A post-hoc analysis from the RE-LY database
Lip, G. Y. H., Clemens, A., Noack, H., Ferreira, J., Connolly, S. J., & Yusuf, S. (2014). Patient outcomes using the European label for dabigatran A post-hoc analysis from the RE-LY database. THROMBOSIS AND HAEMOSTASIS, 111(5), 933-942. doi:10.1160/TH13-09-0734
Stroke prevention in atrial fibrillation: An Asian perspective
Chiang, C. -E., Wang, K. -L., & Lip, G. Y. H. (2014). Stroke prevention in atrial fibrillation: An Asian perspective. THROMBOSIS AND HAEMOSTASIS, 111(5), 789-797. doi:10.1160/TH13-11-0948
Acetylsalicylic acid for stroke prevention in atrial fibrillation: a conspiracy that needs to end?
Lau, Y. C., & Lip, G. Y. H. (2014). Acetylsalicylic acid for stroke prevention in atrial fibrillation: a conspiracy that needs to end?. EUROPACE, 16(5), 619-620. doi:10.1093/europace/eut356
NT-PROBNP PROVIDED COMPLEMENTARY PROGNOSTIC INFORMATION TO AN ESTABLISHED CLINICAL RISK SCORE (CHA2DS2-VASC) FOR THE PREDICTION OF STROKE/SYSTEMIC EMBOLISM
Roldan, V., Antonio Vilchez, J., Manzano-Fernandez, S., Jover, E., Gallego, P., Puche, C. M., . . . Marin, F. (2014). NT-PROBNP PROVIDED COMPLEMENTARY PROGNOSTIC INFORMATION TO AN ESTABLISHED CLINICAL RISK SCORE (CHA2DS2-VASC) FOR THE PREDICTION OF STROKE/SYSTEMIC EMBOLISM. In THROMBOSIS RESEARCH Vol. 133 (pp. S18). doi:10.1016/S0049-3848(14)50079-5
RELATIONSHIP OF THE SAME-TT2R2 SCORE TO POOR QUALITY ANTICOAGULATION, STROKE, CLINICALLY RELEVANT BLEEDING AND MORTALITY IN PATIENTS WITH ATRIAL FIBRILLATION
Lip, G. Y. H., Haguenoer, K., Saint-Etienne, C., & Fauchier, L. (2014). RELATIONSHIP OF THE SAME-TT2R2 SCORE TO POOR QUALITY ANTICOAGULATION, STROKE, CLINICALLY RELEVANT BLEEDING AND MORTALITY IN PATIENTS WITH ATRIAL FIBRILLATION. In THROMBOSIS RESEARCH Vol. 133 (pp. S19). doi:10.1016/S0049-3848(14)50081-3
THE PREDICTIVE VALUE OF THE SAME-TT2R2 SCORE FOR ANTICOAGULATION CONTROL AND ADVERSE OUTCOMES IN ANTICOAGULATED PATIENTS WITH ATRIAL FIBRILLATION
Gallego, P., Roldan, V., Marin, F., Galvez, J., Valdes, M., Vicente, V., & Lip, G. H. Y. (2014). THE PREDICTIVE VALUE OF THE SAME-TT2R2 SCORE FOR ANTICOAGULATION CONTROL AND ADVERSE OUTCOMES IN ANTICOAGULATED PATIENTS WITH ATRIAL FIBRILLATION. In THROMBOSIS RESEARCH Vol. 133 (pp. S89). doi:10.1016/S0049-3848(14)50288-5
VALIDATION OF THE APIXABAN COST-EFFECTIVENESS MODEL IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
Kachroo, S., Phatak, H., Dorian, P., Kongnakorn, T., Lanitis, T., Kuznik, A., . . . Lip, G. Y. (2014). VALIDATION OF THE APIXABAN COST-EFFECTIVENESS MODEL IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION. In VALUE IN HEALTH Vol. 17 (pp. A113). doi:10.1016/j.jval.2014.03.661
The Potential Role of Edoxaban in Stroke Prevention Guidelines.
Plunkett, O., & Lip, G. Y. H. (2014). The Potential Role of Edoxaban in Stroke Prevention Guidelines.. Arrhythmia & electrophysiology review, 3(1), 40-43. doi:10.15420/aer.2011.3.1.40
Ankle-Brachial Index in Patients With Nonvalvular Atrial Fibrillation Reply
Violi, F., Davi, G., Hiatt, W., Lip, G. Y. H., Corazza, G. R., Perticone, F., . . . Basili, S. (2014). Ankle-Brachial Index in Patients With Nonvalvular Atrial Fibrillation Reply. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 63(14), 1457-1458. doi:10.1016/j.jacc.2013.11.011
Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant A Nationwide Cohort Study
Lamberts, M., Gislason, G. H., Lip, G. Y. H., Lassen, J. F., Olesen, J. B., Mikkelsen, A. P., . . . Hansen, M. L. (2014). Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant A Nationwide Cohort Study. CIRCULATION, 129(15), 1577-1585. doi:10.1161/CIRCULATIONAHA.113.004834
Atrial Fibrillation and Heart Failure: A Bad Combination
Lau, Y. C., Lane, D. A., & Lip, G. Y. H. (2014). Atrial Fibrillation and Heart Failure: A Bad Combination. AMERICAN JOURNAL OF CARDIOLOGY, 113(7), 1196-1197. doi:10.1016/j.amjcard.2014.01.002
CLINICAL OUTCOME OF PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION WITH BARE-METAL VERSUS DRUG-ELUTING STENTS: INSIGHTS FROM THE AFCAS REGISTRY
Puurunen, M. K., Kiviniemi, T., Schlitt, A., Rubboli, A., Karjalainen, P., Biancari, F., . . . Airaksinen, J. (2014). CLINICAL OUTCOME OF PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION WITH BARE-METAL VERSUS DRUG-ELUTING STENTS: INSIGHTS FROM THE AFCAS REGISTRY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 63 (pp. A1681). doi:10.1016/S0735-1097(14)61684-3
COGNITIVE FUNCTION IN AMBULATORY PATIENTS WITH SYSTOLIC HEART FAILURE: INSIGHTS FROM THE WARFARIN VERSUS ASPIRIN IN REDUCED CARDIAC EJECTION FRACTION (WARCEF) TRIAL
Ye, S., Graham, S., Qian, M., Sanford, L. R., Di Tullio, M., Sacco, R., . . . Homma, S. (2014). COGNITIVE FUNCTION IN AMBULATORY PATIENTS WITH SYSTOLIC HEART FAILURE: INSIGHTS FROM THE WARFARIN VERSUS ASPIRIN IN REDUCED CARDIAC EJECTION FRACTION (WARCEF) TRIAL. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 63 (pp. A946). doi:10.1016/S0735-1097(14)60946-3
Contemporary real life cardioversion of atrial fibrillation: Results from the multinational RHYTHM-AF study
Crijns, H. J. G. M., Weijs, B., Fairley, A. -M., Lewalter, T., Maggioni, A. P., Martin, A., . . . Le Heuzey, J. -Y. (2014). Contemporary real life cardioversion of atrial fibrillation: Results from the multinational RHYTHM-AF study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 172(3), 588-594. doi:10.1016/j.ijcard.2014.01.099
ESTIMATING THE LIFETIME CLINICAL BENEFITS OF APIXABAN VERSUS CURRENT STANDARD OF CARE REGIMEN IN A UNITED STATES NON-VALVULAR ATRIAL FIBRILLATION POPULATION SIMILAR TO THAT ENROLLED IN ARISTOTLE AND AVERROES
Phatak, H., Dorian, P., Kongnakorn, T., Lanitis, T., Kuznik, A., Mardekian, J., . . . Lip, G. (2014). ESTIMATING THE LIFETIME CLINICAL BENEFITS OF APIXABAN VERSUS CURRENT STANDARD OF CARE REGIMEN IN A UNITED STATES NON-VALVULAR ATRIAL FIBRILLATION POPULATION SIMILAR TO THAT ENROLLED IN ARISTOTLE AND AVERROES. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 63 (pp. A422). doi:10.1016/S0735-1097(14)60422-8
High-sensitivity troponin T as a biomarker for the development of atrial fibrillation after cardiac surgery
Hernandez-Romero, D., Antonio Vilchez, J., Lahoz, A., Romero-Aniorte, A. I., Orenes-Pinero, E., Caballero, L., . . . Marin, F. (2014). High-sensitivity troponin T as a biomarker for the development of atrial fibrillation after cardiac surgery. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 45(4), 733-738. doi:10.1093/ejcts/ezt488
IMPACT OF ANEMIA ON CLINICAL OUTCOME IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE AFCAS REGISTRY
Puurunen, M. K., Kiviniemi, T., Nammas, W., Schlitt, A., Rubboli, A., Nyman, K., . . . Airaksinen, J. (2014). IMPACT OF ANEMIA ON CLINICAL OUTCOME IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE AFCAS REGISTRY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 63 (pp. A1857). doi:10.1016/S0735-1097(14)61860-X
Management of Atrial Fibrillation in Patients With Kidney Disease.
Lau, Y. C., & Lip, G. Y. H. (2014). Management of Atrial Fibrillation in Patients With Kidney Disease.. Journal of atrial fibrillation, 6(6), 989. doi:10.4022/jafib.989
PREDICTING MAJOR BLEEDING IN PATIENTS WITH SYSTOLIC HEART FAILURE TREATED WITH WARFARIN OR ASPIRIN
Ye, S., Cheng, B., Buchsbaum, R., Lip, G., Sacco, R., Di Tullio, M., . . . Homma, S. (2014). PREDICTING MAJOR BLEEDING IN PATIENTS WITH SYSTOLIC HEART FAILURE TREATED WITH WARFARIN OR ASPIRIN. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 63 (pp. A749). doi:10.1016/S0735-1097(14)60749-X
Stroke And Bleeding Risk Assessment: Where Are We Now?
Dzeshka, M. S., & Lip, G. Y. H. (2014). Stroke And Bleeding Risk Assessment: Where Are We Now?. Journal of atrial fibrillation, 6(6), 1042. doi:10.4022/jafib.1042
THE GLOBAL REGISTRY PROGRAM ON LONG-TERM ORAL ANTI-THROMBOTIC TREATMENT IN PATIENTS WITH ATRIAL FIBRILLATION (GLORIA-AF): FIRST ASSESSMENT OF BASELINE CHARACTERISTICS OF DABIGATRAN AND VKA COHORTS IN NORTH AMERICA
Rothman, K., Huisman, M. V., Lip, G., Diener, H. -C., Dubner, S. J., Ma, C. -S., . . . Halperin, J. (2014). THE GLOBAL REGISTRY PROGRAM ON LONG-TERM ORAL ANTI-THROMBOTIC TREATMENT IN PATIENTS WITH ATRIAL FIBRILLATION (GLORIA-AF): FIRST ASSESSMENT OF BASELINE CHARACTERISTICS OF DABIGATRAN AND VKA COHORTS IN NORTH AMERICA. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 63 (pp. A417). doi:10.1016/S0735-1097(14)60417-4
URINARY ISOPROSTANES PREDICT VASCULAR EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION: A PROSPECTIVE STUDY
Pignatelli, P., Pastori, D., Falcomeri, A., Cangemi, R., Lip, G., & Violi, F. (2014). URINARY ISOPROSTANES PREDICT VASCULAR EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION: A PROSPECTIVE STUDY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 63 (pp. A468). doi:10.1016/S0735-1097(14)60468-X
Anticoagulation versus placebo for heart failure in sinus rhythm
Lip, G. Y. H., & Shantsila, E. (2014). Anticoagulation versus placebo for heart failure in sinus rhythm. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (3). doi:10.1002/14651858.CD003336.pub3
Warfarin or novel oral anticoagulants for atrial fibrillation?
Larsen, T. B., & Lip, G. Y. H. (2014). Warfarin or novel oral anticoagulants for atrial fibrillation?. LANCET, 383(9921), 931-933. doi:10.1016/S0140-6736(13)62376-4
Composite risk scores and composite endpoints in the risk prediction of outcomes in anticoagulated patients with atrial fibrillation The Loire Valley Atrial Fibrillation Project
Banerjee, A., Fauchier, L., Bernard-Brunet, A., Clementy, N., & Lip, G. Y. H. (2014). Composite risk scores and composite endpoints in the risk prediction of outcomes in anticoagulated patients with atrial fibrillation The Loire Valley Atrial Fibrillation Project. THROMBOSIS AND HAEMOSTASIS, 111(3), 549-556. doi:10.1160/TH13-12-1033
Patient's values and preferences for stroke prevention in atrial fibrillation: balancing stroke and bleeding risk with oral anticoagulation
Lane, D. A., & Lip, G. Y. H. (2014). Patient's values and preferences for stroke prevention in atrial fibrillation: balancing stroke and bleeding risk with oral anticoagulation. THROMBOSIS AND HAEMOSTASIS, 111(3), 381-383. doi:10.1160/TH14-01-0063
A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry
Lip, G. Y. H., Laroche, C., Dan, G. -A., Santini, M., Kalarus, Z., Rasmussen, L. H., . . . Maggioni, A. P. (2014). A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry. EUROPACE, 16(3), 308-319. doi:10.1093/europace/eut373
Common Questions in Anticoagulation Management in Atrial Fibrillation.
Gallego, P., Roldán, V., & Lip, G. Y. H. (2014). Common Questions in Anticoagulation Management in Atrial Fibrillation.. Cardiac electrophysiology clinics, 6(1), 79-86. doi:10.1016/j.ccep.2013.10.005
Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: A global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation
Huisman, M. V., Lip, G. Y. H., Diener, H. C., Dubner, S. J., Halperin, J. L., Ma, C. S., . . . Bartels, D. B. (2014). Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: A global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation. AMERICAN HEART JOURNAL, 167(3), 329-334. doi:10.1016/j.ahj.2013.12.006
The Impact of Smoking on Thromboembolism and Mortality in Patients With Incident Atrial Fibrillation
Albertsen, I. E., Rasmussen, L. H., Lane, D. A., Overvad, T. F., Skjoth, F., Overvad, K., . . . Larsen, T. B. (2014). The Impact of Smoking on Thromboembolism and Mortality in Patients With Incident Atrial Fibrillation. CHEST, 145(3), 559-566. doi:10.1378/chest.13-1740
The membrane expression of P-selectin, but not monocyte-platelet aggregates, is influenced by variability in response to aspirin in patients with coronary artery disease
Kuzniatsova, N., Shantsila, E., Lip, G. Y. H., & Blann, A. D. (2014). The membrane expression of P-selectin, but not monocyte-platelet aggregates, is influenced by variability in response to aspirin in patients with coronary artery disease. PLATELETS, 25(2), 142-143. doi:10.3109/09537104.2012.739720
Circulating microparticles: challenges and perspectives of flow cytometric assessment
Shantsila, E., Montoro-Garcia, S., Gallego, P., & Lip, G. Y. H. (2014). Circulating microparticles: challenges and perspectives of flow cytometric assessment. THROMBOSIS AND HAEMOSTASIS, 111(6), 1009-1014. doi:10.1160/TH13-11-0937
Comparison of Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation
Aakre, C. A., McLeod, C. J., Cha, S. S., Tsang, T. S. M., Lip, G. Y. H., & Gersh, B. J. (2014). Comparison of Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation. STROKE, 45(2), 426-431. doi:10.1161/STROKEAHA.113.002585
Coronary artery diseases in Japanese patients with nonvalvular atrial fibrillation
Senoo, K., Suzuki, S., Sagara, K., Otsuka, T., Matsuno, S., Uejima, T., . . . Yamashita, T. (2014). Coronary artery diseases in Japanese patients with nonvalvular atrial fibrillation. JOURNAL OF CARDIOLOGY, 63(1-2), 123-127. doi:10.1016/j.jjcc.2013.08.007
Cost-Effectiveness of Apixaban Versus Other New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation
Lip, G. Y. H., Kongnakorn, T., Phatak, H., Kuznik, A., Lanitiss, T., Liu, L. Z., . . . Dorian, P. (2014). Cost-Effectiveness of Apixaban Versus Other New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation. CLINICAL THERAPEUTICS, 36(2), 192-210. doi:10.1016/j.clinthera.2013.12.011
Management of acute coronary syndrome in patients with non-valvular atrial fibrillation: results of the European Heart Rhythm Association Survey
Potpara, T. S., Lip, G. Y. H., Dagres, N., Estner, H. L., Larsen, T. B., & Blomstrom-Lundqvist, C. (2014). Management of acute coronary syndrome in patients with non-valvular atrial fibrillation: results of the European Heart Rhythm Association Survey. EUROPACE, 16(2), 293-298. doi:10.1093/europace/euu008
Overtreatment and Undertreatment With Anticoagulation in Relation to Cardioversion of Atrial Fibrillation (the RHYTHM-AF Study)
Lip, G. Y. H., Gitt, A. K., Le Heuzey, J. -Y., Bash, L. D., Morabito, C. J., Bernhardt, A. A., . . . Crijns, H. J. (2014). Overtreatment and Undertreatment With Anticoagulation in Relation to Cardioversion of Atrial Fibrillation (the RHYTHM-AF Study). AMERICAN JOURNAL OF CARDIOLOGY, 113(3), 480-484. doi:10.1016/j.amjcard.2013.10.036
Use of novel oral anticoagulants in patients with heart failure.
Shantsila, E., & Lip, G. Y. H. (2014). Use of novel oral anticoagulants in patients with heart failure.. Current treatment options in cardiovascular medicine, 16(2), 285. doi:10.1007/s11936-013-0285-y
Development of ruggedized timer and temperature sensor packaging for 300&#x00B0;C/30kpsi downhole environment
Yuan, H. H., Kuruveettil, H., Ching, E. W. L., Rong, E. P. J., Lip, G. C., & Woo, D. R. M. (2014). Development of ruggedized timer and temperature sensor packaging for 300&#x00B0;C/30kpsi downhole environment. In 2014 IEEE 16th Electronics Packaging Technology Conference (EPTC) (pp. 606-610). IEEE. doi:10.1109/eptc.2014.7028366
The Role of Monocytes in Angiogenesis and Atherosclerosis
Jaipersad, A. S., Lip, G. Y. H., Silverman, S., & Shantsila, E. (2014). The Role of Monocytes in Angiogenesis and Atherosclerosis. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 63(1), 1-11. doi:10.1016/j.jacc.2013.09.019
"Finding atrial fibrillation in acute stroke patients: just keep looking, just keep looking (with prolonged ECG monitoring)"
Weerathunga, J., Kausar, S., Blann, A., & Lip, G. (2014). "Finding atrial fibrillation in acute stroke patients: just keep looking, just keep looking (with prolonged ECG monitoring)". In CEREBROVASCULAR DISEASES Vol. 37 (pp. 224). Retrieved from https://www.webofscience.com/
'Real-World' Antithrombotic Treatment in Atrial Fibrillation: The EORP-AF Pilot Survey
Lip, G. Y. H., Laroche, C., Dan, G. -A., Santini, M., Kalarus, Z., Rasmussen, L. H., . . . Maggioni, A. P. (2014). 'Real-World' Antithrombotic Treatment in Atrial Fibrillation: The EORP-AF Pilot Survey. AMERICAN JOURNAL OF MEDICINE, 127(6), 519-+. doi:10.1016/j.amjmed.2013.12.022
A Prospective Study of Estimated Glomerular Filtration Rate and Outcomes in Patients With Atrial Fibrillation
Banerjee, A., Fauchier, L., Vourc'h, P., Andres, C. R., Taillandier, S., Halimi, J. M., & Lip, G. Y. H. (2014). A Prospective Study of Estimated Glomerular Filtration Rate and Outcomes in Patients With Atrial Fibrillation. CHEST, 145(6), 1370-1382. doi:10.1378/chest.13-2103
A multi-biomarker strategy for predicting stroke in stable anticoagulated patients with atrial fibrillation
Roldan-Schilling, V., Gallego, P., Vilchez, J. A., Jover, E., Puche, C., Manzano-Fernandez, S., . . . Marin, F. (2014). A multi-biomarker strategy for predicting stroke in stable anticoagulated patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 179). Retrieved from https://www.webofscience.com/
A prospective validation of the SAME-TT<sub>2</sub>R<sub>2</sub> score: how to identify atrial fibrillation patients who will have good anticoagulation control on warfarin
Poli, D., Antonucci, E., Testa, S., & Lip, G. Y. H. (2014). A prospective validation of the SAME-TT<sub>2</sub>R<sub>2</sub> score: how to identify atrial fibrillation patients who will have good anticoagulation control on warfarin. INTERNAL AND EMERGENCY MEDICINE, 9(4), 443-447. doi:10.1007/s11739-014-1065-8
A very happy new year 2014 from <i>Thrombosis and Haemostasis</i>!
Lip, G. Y. H., & Weber, C. (2014). A very happy new year 2014 from <i>Thrombosis and Haemostasis</i>!. THROMBOSIS AND HAEMOSTASIS, 111(1), 1-2. Retrieved from https://www.webofscience.com/
Abnormal fibrin clot structure in chronic heart failure
Ranjit, P., Lau, Y. C., Blann, A., & Lip, G. Y. H. (2014). Abnormal fibrin clot structure in chronic heart failure. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 507). Retrieved from https://www.webofscience.com/
Addition of Smoking Status Improves Risk Prediction of Ischemic Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study
Kwon, Y., Lopez, F. L., Agarwal, S. K., Soliman, E. Z., Lip, G. Y., Alonso, A., & Chen, L. Y. (2014). Addition of Smoking Status Improves Risk Prediction of Ischemic Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study. In CIRCULATION Vol. 130. Retrieved from https://www.webofscience.com/
Age Dependence of Risk Factors for Stroke and Death in Young Patients With Atrial Fibrillation A Nationwide Study
Melgaard, L., Rasmussen, L. H., Skjoth, F., Lip, G. Y. H., & Larsen, T. B. (2014). Age Dependence of Risk Factors for Stroke and Death in Young Patients With Atrial Fibrillation A Nationwide Study. STROKE, 45(5), 1331-1337. doi:10.1161/STROKEAHA.114.004903
Analysis of Vitamin D Levels in Patients With and Without Statin-induced Myalgia - A Systematic Review and Meta-analysis of 7 Studies with 2416 Patients
Michalska-Kasiczak, M., Sahebkar, A., Mikhailidis, D. P., Rysz, J., Muntner, P., Toth, P. P., . . . Banach, M. (2014). Analysis of Vitamin D Levels in Patients With and Without Statin-induced Myalgia - A Systematic Review and Meta-analysis of 7 Studies with 2416 Patients. In CIRCULATION Vol. 130. Retrieved from https://www.webofscience.com/
Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation
Dzeshka, M. S., & Lip, G. Y. H. (2014). Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation. CARDIOLOGY CLINICS, 32(4), 585-+. doi:10.1016/j.ccl.2014.07.009
Antithrombotic treatment of atrial fibrillation in general practice: application of the GRASP-AF audit tool
Shantsila, E., Wolff, A., Lip, G. Y. H., & Lane, D. A. (2014). Antithrombotic treatment of atrial fibrillation in general practice: application of the GRASP-AF audit tool. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 1104). Retrieved from https://www.webofscience.com/
Antithrombotic treatment pattern and baseline characteristics of dabigatran and vitamin K antagonist cohorts in North America - The GLORIA-AF registry program
Huisman, M. V., Lip, G. Y. H., Diener, H. C., Dubner, S. J., Ma, C. S., Rothman, K. J., . . . Halperin, J. L. (2014). Antithrombotic treatment pattern and baseline characteristics of dabigatran and vitamin K antagonist cohorts in North America - The GLORIA-AF registry program. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 777). Retrieved from https://www.webofscience.com/
Assess bleeding risk with HAS-BLED and assess stroke risk with CHA<sub>2</sub>DS<sub>2</sub>-VASc in patients with atrial fibrillation
Lau, Y. C., Lip, G. Y. H., & Gallego, P. (2014). Assess bleeding risk with HAS-BLED and assess stroke risk with CHA<sub>2</sub>DS<sub>2</sub>-VASc in patients with atrial fibrillation. HYPERTENSION RESEARCH, 37(7), 699-700. doi:10.1038/hr.2014.63
Atrial Fibrillation in Cryptogenic Stroke Look Harder, Look Longer, But Just Keep Looking
Lau, Y. C., Lane, D. A., & Lip, G. Y. H. (2014). Atrial Fibrillation in Cryptogenic Stroke Look Harder, Look Longer, But Just Keep Looking. STROKE, 45(11), 3184-3185. doi:10.1161/STROKEAHA.114.006862
Atrial fibrillation ... more than simply being irregularly irregular
Lip, G. Y. H. (2014). Atrial fibrillation ... more than simply being irregularly irregular. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 68(4), 408-409. doi:10.1111/ijcp.12416
Atrial fibrillation and heart failure: meta-analysis of clinical outcomes in reduced versus preserved ejection fraction
Kotecha, D., Chudasama, R., Lane, D. A., Kirchhof, P., & Lip, G. Y. H. (2014). Atrial fibrillation and heart failure: meta-analysis of clinical outcomes in reduced versus preserved ejection fraction. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 1029). Retrieved from https://www.webofscience.com/
Atrial fibrillation and retinal vein or artery occlusion: looking beyond the eye
Plunkett, O., Lip, P. L., & Lip, G. Y. H. (2014). Atrial fibrillation and retinal vein or artery occlusion: looking beyond the eye. BRITISH JOURNAL OF OPHTHALMOLOGY, 98(9), 1141-1143. doi:10.1136/bjophthalmol-2013-304646
Atrial fibrillation and stroke prevention: brief observations on the last decade.
Lip, G. Y. (2014). Atrial fibrillation and stroke prevention: brief observations on the last decade.. Expert review of cardiovascular therapy, 12(4), 403-406. doi:10.1586/14779072.2014.896196
Au-In-based Hermetic Sealing for MEMS Packaging for Down-Hole Application
Chidambaram, V., Chen, B., Lip, G. C., & Woo, D. R. M. (2014). Au-In-based Hermetic Sealing for MEMS Packaging for Down-Hole Application. JOURNAL OF ELECTRONIC MATERIALS, 43(7), 2498-2509. doi:10.1007/s11664-014-3131-4
Bare-Metal vs. Drug-Eluting Stents in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention - Insights From the AFCAS Registry
Kiviniemi, T., Puurunen, M., Schlitt, A., Rubboli, A., Karjalainen, P., Nammas, W., . . . Airaksinen, K. E. J. (2014). Bare-Metal vs. Drug-Eluting Stents in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention - Insights From the AFCAS Registry. CIRCULATION JOURNAL, 78(11), 2674-2681. doi:10.1253/circj.CJ-14-0792
Biomarkers in atrial fibrillation: an overview
Vilchez, J. A., Roldan, V., Hernandez-Romero, D., Valdes, M., Lip, G. Y. H., & Marin, F. (2014). Biomarkers in atrial fibrillation: an overview. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 68(4), 434-443. doi:10.1111/ijcp.12304
Bivalirudin use during percutaneous coronary intervention in patients on chronic warfarin therapy
Kiviniemi, T., Karjalainen, P., Niemela, M., Rubboli, A., Lip, G. Y. H., Schlitt, A., . . . Airaksinen, K. E. J. (2014). Bivalirudin use during percutaneous coronary intervention in patients on chronic warfarin therapy. THROMBOSIS RESEARCH, 133(4), 695-696. doi:10.1016/j.thromres.2014.01.038
Bleeding Events Among New Starters and Switchers to Dabigatran Compared with Warfarin in Atrial Fibrillation
Larsen, T. B., Gorst-Rasmussen, A., Rasmussen, L. H., Skjoth, F., Rosenzweig, M., & Lip, G. Y. H. (2014). Bleeding Events Among New Starters and Switchers to Dabigatran Compared with Warfarin in Atrial Fibrillation. AMERICAN JOURNAL OF MEDICINE, 127(7), 650-+. doi:10.1016/j.amjmed.2014.01.031
CHADS<sub>2</sub>, CHA<sub>2</sub>DS<sub>2</sub>-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention
Puurunen, M. K., Kiviniemi, T., Schlitt, A., Rubboli, A., Dietrich, B., Karjalainen, P., . . . Airaksinen, K. E. J. (2014). CHADS<sub>2</sub>, CHA<sub>2</sub>DS<sub>2</sub>-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention. THROMBOSIS RESEARCH, 133(4), 560-566. doi:10.1016/j.thromres.2014.01.007
Cardiopulmonary resuscitation with a different slant: the importance of perimortem caesarean delivery
Castleman, J. S., Miti, C., Ajibona, O. O., Lip, G. Y. H., & Ganapathy, R. (2014). Cardiopulmonary resuscitation with a different slant: the importance of perimortem caesarean delivery. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 1208-1209). Retrieved from https://www.webofscience.com/
Cardiovascular risk in patients with sleep apnea with or without continuous positive airway pressure therapy among 4.5 million Danes
Lamberts, M., Nielsen, O. W., Lip, G. Y. H., Ruwald, M. H., Christiansen, C. B., Kristensen, S. L., . . . Gislason, G. H. (2014). Cardiovascular risk in patients with sleep apnea with or without continuous positive airway pressure therapy among 4.5 million Danes. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 345-346). Retrieved from https://www.webofscience.com/
Comparing the 'New' R<sub>2</sub>CHADS<sub>2</sub> With the 'Old' CHA<sub>2</sub>DS<sub>2</sub>-VASc Scores for Predicting Thromboembolism in Patients Undergoing Atrial Fibrillation Ablation: New Does Not Mean Better
Kornej, J., & Lip, G. Y. H. (2014). Comparing the 'New' R<sub>2</sub>CHADS<sub>2</sub> With the 'Old' CHA<sub>2</sub>DS<sub>2</sub>-VASc Scores for Predicting Thromboembolism in Patients Undergoing Atrial Fibrillation Ablation: New Does Not Mean Better. CANADIAN JOURNAL OF CARDIOLOGY, 30(4), 385-387. doi:10.1016/j.cjca.2013.12.015
Comparison of estimated glomerular filtration rate equations for dosing new oral anticoagulants in patients with atrial fibrillation
Andreu Cayuelas, J. M., Manzano-Fernandez, S., Sanchez-Martinez, M., Marin, F., Orenes-Pinero, E., Gallego, P., . . . Roldan, V. (2014). Comparison of estimated glomerular filtration rate equations for dosing new oral anticoagulants in patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 383). Retrieved from https://www.webofscience.com/
Cost-effectiveness of Apixaban Against Dabigatran and Rivaroxaban for Stroke Prevention in Non-valvular Atrial Fibrillation Patients
Lip, G. Y., Lanitis, T., Kongnakorn, T., Phatak, H., Liu, L. Z., Lawrence, J., & Dorian, P. (2014). Cost-effectiveness of Apixaban Against Dabigatran and Rivaroxaban for Stroke Prevention in Non-valvular Atrial Fibrillation Patients. In CIRCULATION Vol. 130. Retrieved from https://www.webofscience.com/
Cost-effectiveness of apixaban compared to edoxaban for stroke prevention in non-valvular atrial fibrillation
Lip, G. Y. H., Kongnakorn, T., Lanitis, T., Phatak, H., Liu, J. X. C., Kuznik, A., . . . Dorian, P. (2014). Cost-effectiveness of apixaban compared to edoxaban for stroke prevention in non-valvular atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 1108-1109). Retrieved from https://www.webofscience.com/
Cost-effectiveness of non-Vitamin-K oral anticoagulants compared to warfarin in patients with non-valvular atrial fibrillation
Harenberg, J., Krejczy, M., Wehling, M., Obermann, K., & Lip, G. Y. H. (2014). Cost-effectiveness of non-Vitamin-K oral anticoagulants compared to warfarin in patients with non-valvular atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 1107). Retrieved from https://www.webofscience.com/
Dabigatran etexilate for venous thromboembolism: a safety evaluation
Brown, R., Lip, G. Y. H., & Gallego, P. (2014). Dabigatran etexilate for venous thromboembolism: a safety evaluation. EXPERT OPINION ON DRUG SAFETY, 13(5), 639-647. doi:10.1517/14740338.2014.895321
Device-guided slow deep breathing in essential hypertension: is cardiac or sympathetic baroreflex sensitivity altered?
Shantsila, A., Adlan, A., Lip, G., Pickering, A., Paton, J., & Fisher, J. (2014). Device-guided slow deep breathing in essential hypertension: is cardiac or sympathetic baroreflex sensitivity altered?. In FASEB JOURNAL Vol. 28. Retrieved from https://www.webofscience.com/
Effect of device guided slow deep breathing on central sympathetic outflow and arterial baroreflex sensitivity in young healthy individuals
Shantsila, A., Adlan, A. M., Lip, G., Pickering, A., Paton, J., & Fisher, J. (2014). Effect of device guided slow deep breathing on central sympathetic outflow and arterial baroreflex sensitivity in young healthy individuals. In FASEB JOURNAL Vol. 28. Retrieved from https://www.webofscience.com/
Efficacy and safety of apixaban vs edoxaban for stroke prevention in non-valvular atrial fibrillation: an indirect treatment analysis
Lip, G. Y. H., Mitchell, S. A., Liu, X. C., Phatak, H., & Batson, S. (2014). Efficacy and safety of apixaban vs edoxaban for stroke prevention in non-valvular atrial fibrillation: an indirect treatment analysis. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 895-896). Retrieved from https://www.webofscience.com/
Female sex as a risk factor for thromboembolism and death in patients with incident atrial fibrillation
Overvad, T. F., Rasmussen, L. H., Skjoth, F., Overvad, K., Albertsen, I. E., Lane, D. A., . . . Larsen, T. B. (2014). Female sex as a risk factor for thromboembolism and death in patients with incident atrial fibrillation. THROMBOSIS AND HAEMOSTASIS, 112(4), 789-795. doi:10.1160/TH14-06-0545
Impact of Non-Vitamin K Antagonist Oral Anticoagulants on Intracranial Bleeding in Asian Patients With Non-Valvular Atrial Fibrillation
Yasaka, M., & Lip, G. Y. H. (2014). Impact of Non-Vitamin K Antagonist Oral Anticoagulants on Intracranial Bleeding in Asian Patients With Non-Valvular Atrial Fibrillation. CIRCULATION JOURNAL, 78(10), 2367-2372. doi:10.1253/circj.CJ-14-0720
Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis
Chao, T. -F., Liu, C. -J., Wang, K. -L., Lin, Y. -J., Chang, S. -L., Lo, L. -W., . . . Chen, S. -A. (2014). Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis. HEART RHYTHM, 11(10), 1752-1759. doi:10.1016/j.hrthm.20l4.06.021
Increased Carotid Intima-Media Thickness and Presence of Carotid Plaque are Associated With Increased Stroke Incidence in Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study
Bekwelem, W., Lopez, F. L., Soliman, E. Z., Agarwal, S., Lip, G. Y., Pan, W., . . . Chen, L. Y. (2014). Increased Carotid Intima-Media Thickness and Presence of Carotid Plaque are Associated With Increased Stroke Incidence in Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study. In CIRCULATION Vol. 130. Retrieved from https://www.webofscience.com/
Is oral anticoagulation needed in patients with atrial fibrillation, stent implantation and low-moderate risk of stroke?
Marin, F., Fauchier, L., Ruiz-Nodar, J. M., Saint Etienne, C., Manzano-Fernandez, S., Ivanes, F., . . . Lip, G. (2014). Is oral anticoagulation needed in patients with atrial fibrillation, stent implantation and low-moderate risk of stroke?. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 1112). Retrieved from https://www.webofscience.com/
Left ventricular geometry and outcomes in patients with atrial fibrillation: The AFFIRM Trial
Apostolakis, S., Sullivan, R. M., Olshansky, B., & Lip, G. Y. H. (2014). Left ventricular geometry and outcomes in patients with atrial fibrillation: The AFFIRM Trial. INTERNATIONAL JOURNAL OF CARDIOLOGY, 170(3), 303-308. doi:10.1016/j.ijcard.2013.11.002
Lone atrial fibrillation - an overview
Potpara, T. S., & Lip, G. Y. H. (2014). Lone atrial fibrillation - an overview. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 68(4), 418-433. doi:10.1111/ijcp.12281
Long-term cardiovascular outcomes in patients with atrial fibrillation and atherothrombosis in the REACH Registry
Ruff, C. T., Bhatt, D. L., Steg, P. G., Gersh, B. J., Alberts, M. J., Hoffman, E. B., . . . Goto, S. (2014). Long-term cardiovascular outcomes in patients with atrial fibrillation and atherothrombosis in the REACH Registry. INTERNATIONAL JOURNAL OF CARDIOLOGY, 170(3), 413-418. doi:10.1016/j.ijcard.2013.11.030
Long-term predictors of death and incident myocardial infarction in cardiology patients assessed for coronary artery disease
Kotecha, D., Jenkins, E., Flather, M. D., Krum, H., Eccleston, D., Collins, P., . . . New, G. (2014). Long-term predictors of death and incident myocardial infarction in cardiology patients assessed for coronary artery disease. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 819). Retrieved from https://www.webofscience.com/
Management of atrial fibrillation in patients with kidney disease
Lau, Y. C., & Lip, G. Y. H. (2014). Management of atrial fibrillation in patients with kidney disease. Journal of Atrial Fibrillation, 6(6), 83-90.
Measurement of rivaroxaban and apixaban in serum samples of patients
Harenberg, J., Kraemer, S., Du, S., Zolfaghari, S., Schulze, A., Kraemer, R., . . . Lip, G. Y. H. (2014). Measurement of rivaroxaban and apixaban in serum samples of patients. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 44(8), 743-752. doi:10.1111/eci.12291
Modern Management of Atrial Fibrillation Requires Initial Identification of "Low-Risk" Patients Using the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score, and Not Focusing on "High-Risk" Prediction
Lip, G. Y. H., & Lane, D. A. (2014). Modern Management of Atrial Fibrillation Requires Initial Identification of "Low-Risk" Patients Using the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score, and Not Focusing on "High-Risk" Prediction. CIRCULATION JOURNAL, 78(8), 1843-1845. doi:10.1253/circj.CJ-14-0584
Modification of Outcomes With Aspirin or Apixaban in Relation to Female and Male Sex in Patients With Atrial Fibrillation A Secondary Analysis of the AVERROES Study
Lip, G. Y. H., Eikelboom, J., Yusuf, S., Shestakovska, O., Hart, R. G., & Connolly, S. (2014). Modification of Outcomes With Aspirin or Apixaban in Relation to Female and Male Sex in Patients With Atrial Fibrillation A Secondary Analysis of the AVERROES Study. STROKE, 45(7), 2127-2130. doi:10.1161/STROKEAHA.114.005746
Monocyte subpopulation counts and function are associated with global longitudinal strain in patients with normal ejection fraction after ST elevation mycardial infarction
Ghattas, A., Shantsila, E., Griffiths, H., & Lip, G. (2014). Monocyte subpopulation counts and function are associated with global longitudinal strain in patients with normal ejection fraction after ST elevation mycardial infarction. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 488). Retrieved from https://www.webofscience.com/
Monocyte subsets in coronary artery disease and their associations with markers of inflammation and fibrinolysis
Shantsila, E., Tapp, L. D., Wrigley, B. J., Pamukcu, B., Apostolakis, S., Montoro-Garcia, S., & Lip, G. Y. H. (2014). Monocyte subsets in coronary artery disease and their associations with markers of inflammation and fibrinolysis. ATHEROSCLEROSIS, 234(1), 4-10. doi:10.1016/j.atherosclerosis.2014.02.009
Monocytes circulate in constant reversible interaction with platelets in a [Ca2+]-dependent manner
Shantsila, E., Montoro-Garcia, S., & Lip, G. Y. H. (2014). Monocytes circulate in constant reversible interaction with platelets in a [Ca2+]-dependent manner. PLATELETS, 25(3), 197-201. doi:10.3109/09537104.2013.784248
Myocardial Ischemic Events in 'Real World' Patients with Atrial Fibrillation Treated with Dabigatran or Warfarin
Larsen, T. B., Rasmussen, L. H., Gorst-Rasmussen, A., Skjoth, F., Rosenzweig, M., Lane, D. A., & Lip, G. Y. H. (2014). Myocardial Ischemic Events in 'Real World' Patients with Atrial Fibrillation Treated with Dabigatran or Warfarin. AMERICAN JOURNAL OF MEDICINE, 127(4), 329-+. doi:10.1016/j.amjmed.2013.12.005
New Oral Anticoagulants in Elderly Adults: Evidence from a Meta-Analysis of Randomized Trials
Sardar, P., Chatterjee, S., Chaudhari, S., & Lip, G. Y. H. (2014). New Oral Anticoagulants in Elderly Adults: Evidence from a Meta-Analysis of Randomized Trials. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 62(5), 857-864. doi:10.1111/jgs.12799
Non-Vitamin K Antagonist Oral Anticoagulants An Appeal for Consensus on Terminology
Lip, G. Y. H., Camm, A. J., Hylek, E. M., Halperin, J. L., & Weitz, J. I. (2014). Non-Vitamin K Antagonist Oral Anticoagulants An Appeal for Consensus on Terminology. CHEST, 145(5), 1177-1178. doi:10.1378/chest.13-2951
Novel Oral Anticoagulants in Cardiovascular Disease
Gallego, P., Roldan, V., & Lip, G. Y. H. (2014). Novel Oral Anticoagulants in Cardiovascular Disease. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 19(1), 34-44. doi:10.1177/1074248413501392
One year re-infarction rates in non-culprit vessels following index ST elevation myocardial infarction in patients with multivessel coronary artery disease
Brown, R. A., Shantsila, E., Khan, J., Lee, H. L., Connolly, D. L., Ahmad, R., . . . Varma, C. (2014). One year re-infarction rates in non-culprit vessels following index ST elevation myocardial infarction in patients with multivessel coronary artery disease. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 479-480). Retrieved from https://www.webofscience.com/
One-Year Outcome of Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting: An Analysis of the AFCAS Registry
Rubboli, A., Schlitt, A., Kiviniemi, T., Biancari, F., Karjalainen, P. P., Valencia, J., . . . Airaksinen, K. E. J. (2014). One-Year Outcome of Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting: An Analysis of the AFCAS Registry. CLINICAL CARDIOLOGY, 37(6), 357-364. doi:10.1002/clc.22254
Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation
Senoo, K., Lane, D. A., & Lip, G. Y. H. (2014). Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation. CURRENT PROBLEMS IN CARDIOLOGY, 39(9), 319-344. doi:10.1016/j.cpcardiol.2014.07.001
Oxidized LDL lipids increase β-amyloid production by SH-SY5Y cells through glutathione depletion and lipid raft formation
Dias, I. H. K., Mistry, J., Fell, S., Reis, A., Spickett, C. M., Polidori, M. C., . . . Griffiths, H. R. (2014). Oxidized LDL lipids increase β-amyloid production by SH-SY5Y cells through glutathione depletion and lipid raft formation. FREE RADICAL BIOLOGY AND MEDICINE, 75, 48-59. doi:10.1016/j.freeradbiomed.2014.07.012
Patent Foramen Ovale and Migraine Attacks: A Systematic Review
Lip, P. Z. Y., & Lip, G. Y. H. (2014). Patent Foramen Ovale and Migraine Attacks: A Systematic Review. AMERICAN JOURNAL OF MEDICINE, 127(5), 411-420. doi:10.1016/j.amjmed.2013.12.006
Post myocardial infarction and atrial fibrillation: Thromboprophylaxis and risk stratification using the CHA<sub>2</sub>DS<sub>2</sub>-VASc score
Lau, Y. C., & Lip, G. Y. H. (2014). Post myocardial infarction and atrial fibrillation: Thromboprophylaxis and risk stratification using the CHA<sub>2</sub>DS<sub>2</sub>-VASc score. CARDIOLOGY JOURNAL, 21(5), 451-453. doi:10.5603/CJ.2014.0075
Potential value of targeting von Willebrand factor in atherosclerotic cardiovascular disease
Montoro-Garcia, S., Shantsila, E., & Lip, G. Y. H. (2014). Potential value of targeting von Willebrand factor in atherosclerotic cardiovascular disease. EXPERT OPINION ON THERAPEUTIC TARGETS, 18(1), 43-53. doi:10.1517/14728222.2013.840585
Predictive role of ST2 for mortality in anticoagulated patients with atrial fibrillation
Marin, F., Vilchez, J. A., Perez, M., Gallego, P., Manzano-Fernandez, S., Valdes, M., . . . Roldan-Schilling, V. (2014). Predictive role of ST2 for mortality in anticoagulated patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 221). Retrieved from https://www.webofscience.com/
Predictive value of atrial high-rate episodes for arterial stiffness and endothelial dysfunction in dual-chamber pacemaker patients
Krishnamoorthy, S., Khoo, C. W., Lim, H. S., & Lip, G. Y. H. (2014). Predictive value of atrial high-rate episodes for arterial stiffness and endothelial dysfunction in dual-chamber pacemaker patients. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 44(1), 13-21. doi:10.1111/eci.12182
Remote monitoring of cardiac implantable electronic devices in Europe: results of the European Heart Rhythm Association survey
Hernandez-Madrid, A., Lewalter, T., Proclemer, A., Pison, L., Lip, G. Y. H., & Blomstrom-Lundqvist, C. (2014). Remote monitoring of cardiac implantable electronic devices in Europe: results of the European Heart Rhythm Association survey. EUROPACE, 16(1), 129-132. doi:10.1093/europace/eut414
Response to Ansell et al "Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel"
Husted, S., & Lip, G. Y. H. (2014). Response to Ansell et al "Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel". THROMBOSIS AND HAEMOSTASIS, 112(4), 842. doi:10.1160/TH14-06-0564
Rheumatoid arthritis and autonomic function
Adlan, A., Shantsila, A., Kitas, G., Paton, J., Lip, G., & Fisher, J. (2014). Rheumatoid arthritis and autonomic function. In FASEB JOURNAL Vol. 28. Retrieved from https://www.webofscience.com/
Rhythm outcomes after catheter ablation of atrial fibrillation Clinical implication of biomarkers
Kornej, J., Husser, D., Bollmann, A., & Lip, G. Y. H. (2014). Rhythm outcomes after catheter ablation of atrial fibrillation Clinical implication of biomarkers. HAMOSTASEOLOGIE, 34(1), 9-+. doi:10.5482/HAMO-13-09-0051
Risk of acute myocardial infarction in patients with atrial fibrillation having a CHA2DS2-VASc score of 0 or 1
Chao, T. F., Huang, Y. C., Liu, C. J., Chen, T. J., Lip, G. Y. H., & Chen, S. A. (2014). Risk of acute myocardial infarction in patients with atrial fibrillation having a CHA2DS2-VASc score of 0 or 1. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 441). Retrieved from https://www.webofscience.com/
Risk of stroke and intracranial hemorrhage in 9727 Chinese with atrial fibrillation in Hong Kong
Siu, C. -W., Lip, G. Y. H., Lam, K. -F., & Tse, H. -F. (2014). Risk of stroke and intracranial hemorrhage in 9727 Chinese with atrial fibrillation in Hong Kong. HEART RHYTHM, 11(8), 1401-1408. doi:10.1016/j.hrthm.2014.04.021
SAMeTT<sub>2</sub>R<sub>2</sub> Does Not Predict Time in Therapeutic Range of the International Normalized Ratio in Patients Attending a High-Quality Anticoagulation Clinic <i>Response</i>
Apostolakis, S., Sullivan, R. M., Olshansky, B., & Lip, G. Y. H. (2014). SAMeTT<sub>2</sub>R<sub>2</sub> Does Not Predict Time in Therapeutic Range of the International Normalized Ratio in Patients Attending a High-Quality Anticoagulation Clinic <i>Response</i>. CHEST, 145(1), 188-189. doi:10.1378/chest.13-2641
SAMeTT2R2 Scores Predict Stroke Risk After Initiation of Vitamin K Antagonist Therapy for Atrial Fibrillation: a Real-world Practice Study
Martinez, C., Katholing, A., Reitbrock, S., Lip, G. Y., & Freedman, B. (2014). SAMeTT2R2 Scores Predict Stroke Risk After Initiation of Vitamin K Antagonist Therapy for Atrial Fibrillation: a Real-world Practice Study. In CIRCULATION Vol. 130. Retrieved from https://www.webofscience.com/
Safety of new oral anticoagulant drugs: a perspective.
Vílchez, J. A., Gallego, P., & Lip, G. Y. H. (2014). Safety of new oral anticoagulant drugs: a perspective.. Therapeutic advances in drug safety, 5(1), 8-20. doi:10.1177/2042098613507945
Simultaneous computerised activation of the primary percutaneous coronary intervention pathway reduced out-of-hours door-to-balloon time but did not improve mortality
Brown, R. A., Lip, G. Y. H., Shantsila, E., Connolly, D. L., Davis, R., Badri, M., . . . Varma, C. (2014). Simultaneous computerised activation of the primary percutaneous coronary intervention pathway reduced out-of-hours door-to-balloon time but did not improve mortality. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 1173). Retrieved from https://www.webofscience.com/
Small-size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P-selectin
Montoro-Garcia, S., Shantsila, E., Hernandez-Romero, D., Jover, E., Valdes, M., Marin, F., & Lip, G. Y. H. (2014). Small-size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P-selectin. BRITISH JOURNAL OF HAEMATOLOGY, 166(4), 571-580. doi:10.1111/bjh.12913
Specific risk scores for specific purposes: Use CHA<sub>2</sub>DS<sub>2</sub>-VASc for assessing stroke risk, and use HAS-BLED for assessing bleeding risk in atrial fibrillation
Dzeshka, M. S., & Lip, G. Y. H. (2014). Specific risk scores for specific purposes: Use CHA<sub>2</sub>DS<sub>2</sub>-VASc for assessing stroke risk, and use HAS-BLED for assessing bleeding risk in atrial fibrillation. THROMBOSIS RESEARCH, 134(2), 217-218. doi:10.1016/j.thromres.2014.06.003
Stroke Prevention in Asian Patients With Atrial Fibrillation
Yasaka, M., & Lip, G. Y. H. (2014). Stroke Prevention in Asian Patients With Atrial Fibrillation. STROKE, 45(6), 1608-1609. doi:10.1161/STROKEAHA.114.005339
Stroke and bleeding risk assessment: Where are we now?
Dzeshka, M. S., & Lip, G. Y. H. (2014). Stroke and bleeding risk assessment: Where are we now?. Journal of Atrial Fibrillation, 6(6), 49-57.
The Association of CHA<sub>2</sub>DS<sub>2</sub>-VASc Score and Blood Biomarkers with Ischemic Stroke Outcomes: The Belgrade Stroke Study
Potpara, T. S., Polovina, M. M., Djikic, D., Marinkovic, J. M., Kocev, N., & Lip, G. Y. H. (2014). The Association of CHA<sub>2</sub>DS<sub>2</sub>-VASc Score and Blood Biomarkers with Ischemic Stroke Outcomes: The Belgrade Stroke Study. PLOS ONE, 9(9). doi:10.1371/journal.pone.0106439
The CHADS2 and CHA2DS2-VASC scores as predictors of thromboembolism in patients with non-valvular atrial fibrillation undergoing direct-current cardioversion
Garcia Fernandez, A., Marin Ortuno, F., Roldan Schilling, V., Ibanez Criado, A., Ibanez Criado, J. L., Valdes Chavarri, M., . . . Lip, G. Y. H. (2014). The CHADS2 and CHA2DS2-VASC scores as predictors of thromboembolism in patients with non-valvular atrial fibrillation undergoing direct-current cardioversion. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 291-292). Retrieved from https://www.webofscience.com/
The SAMe-TT<sub>2</sub>R<sub>2</sub> Score Far From Clinical Application <i>Response</i>
Apostolakis, S., Sullivan, R. M., Olshansky, B., & Lip, G. Y. H. (2014). The SAMe-TT<sub>2</sub>R<sub>2</sub> Score Far From Clinical Application <i>Response</i>. CHEST, 145(2), 419-420. doi:10.1378/chest.13-2775
The experiences of consultations on oral anticoagulation for AF: the importance of qualitative research in cardiovascular sciences
Xuereb, C. B., Shaw, R. L., Lip, G. Y. H., & Lane, D. A. (2014). The experiences of consultations on oral anticoagulation for AF: the importance of qualitative research in cardiovascular sciences. In JOURNAL OF THROMBOSIS AND HAEMOSTASIS Vol. 12 (pp. 11). Retrieved from https://www.webofscience.com/
The management of patients with atrial fibrillation undergoing percutaneous intervention with stent implantation (AFCAS): triple therapy with lmwh bridging is associated with higher risk
Kiviniemi, T. K., Airaksinen, K. E. J., Rubboli, A., Valencia, J., Lip, G. Y. H., Karjalainen, P. P., . . . Schlitt, A. (2014). The management of patients with atrial fibrillation undergoing percutaneous intervention with stent implantation (AFCAS): triple therapy with lmwh bridging is associated with higher risk. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 990-991). Retrieved from https://www.webofscience.com/
The optimal management of patients on oral anticoagulation undergoing coronary artery stenting The 10th Anniversary Overview
Rubboli, A., Faxon, D. P., Airaksinen, K. E. J., Schlitt, A., Marin, F., Bhatt, D. L., & Lip, G. Y. H. (2014). The optimal management of patients on oral anticoagulation undergoing coronary artery stenting The 10th Anniversary Overview. THROMBOSIS AND HAEMOSTASIS, 112(6), 1080-1087. doi:10.1160/TH14-08-0681
The predictive value of the SAME-TT2R2 score for anticoagulation control and adverse outcomes in anticoagulated patients with atrial fibrillation
Roldan-Schilling, V., Gallego, P., Marin, F., Galvez, J., Valdes, M., Vicente, V., & Lip, G. Y. (2014). The predictive value of the SAME-TT2R2 score for anticoagulation control and adverse outcomes in anticoagulated patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 382). Retrieved from https://www.webofscience.com/
Time-dependent rate of events after coronary stent implantation in patients with atrial fibrillation
Fauchier, L., Ruiz-Nodar, J. M., Saint Etienne, C., Manzano-Fernandez, S., Ivanes, F., Valdes, M., . . . Marin, F. (2014). Time-dependent rate of events after coronary stent implantation in patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 867-868). Retrieved from https://www.webofscience.com/
Updated NICE guideline: management of atrial fibrillation (2014).
Senoo, K., Lau, Y. C., & Lip, G. Y. (2014). Updated NICE guideline: management of atrial fibrillation (2014).. Expert review of cardiovascular therapy, 12(9), 1037-1040. doi:10.1586/14779072.2014.943189
Urinary 11-Dehydro-Thromboxane B2 is Associated With Vascular and Non-Vascular Events in Atrial Fibrillation Patients
Pastori, D., Pignatelli, P., Cangemi, R., Hiatt, W., Farcomeni, A., Bartimoccia, S., . . . Violi, F. (2014). Urinary 11-Dehydro-Thromboxane B2 is Associated With Vascular and Non-Vascular Events in Atrial Fibrillation Patients. In CIRCULATION Vol. 130. Retrieved from https://www.webofscience.com/
Use of Propensity Score Methodology to Assess Comparability of Treatment Groups in a Registry Program
Rothman, K. J., Huisman, M. V., Lip, G. Y. H., Diener, H. -C., Dubner, S. J., Ma, C. -S., . . . Halperin, J. (2014). Use of Propensity Score Methodology to Assess Comparability of Treatment Groups in a Registry Program. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 23 (pp. 13). Retrieved from https://www.webofscience.com/
Use of the HAS-BLED bleeding score in real-life settings
Lane, D. A., & Lip, G. Y. H. (2014). Use of the HAS-BLED bleeding score in real-life settings. THROMBOSIS RESEARCH, 134(1), 202. doi:10.1016/j.thromres.2014.03.027
Usefulness of N-Terminal Pro-B-Type Natriuretic Peptide Levels for Stroke Risk Prediction in Anticoagulated Patients With Atrial Fibrillation
Roldan, V., Antonio Vilchez, J., Manzano-Fernandez, S., Jover, E., Galvez, J., Puche, C. M., . . . Marin, F. (2014). Usefulness of N-Terminal Pro-B-Type Natriuretic Peptide Levels for Stroke Risk Prediction in Anticoagulated Patients With Atrial Fibrillation. STROKE, 45(3), 696-701. doi:10.1161/STROKEAHA.113.003338
Using the CHA2DS2-VASc score for refining stroke risk stratification in low-risk Asian patients (ATRIA score 0-5) with atrial fibrillation
Chao, T. F., Liu, C. J., Chen, T. J., Lip, G. Y. H., & Chen, S. A. (2014). Using the CHA2DS2-VASc score for refining stroke risk stratification in low-risk Asian patients (ATRIA score 0-5) with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 1033). Retrieved from https://www.webofscience.com/
Utility of HAS-BLED score in evaluating the risk of major bleeding and death in patients with non-valvular atrial fibrillation undergoing direct-current cardioversion
Garcia Fernandez, A., Marin Ortuno, F., Roldan Schilling, V., Ibanez Criado, A., Ibanez Criado, J. L., Valdes Chavarri, M., . . . Lip, G. Y. H. (2014). Utility of HAS-BLED score in evaluating the risk of major bleeding and death in patients with non-valvular atrial fibrillation undergoing direct-current cardioversion. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 1101). Retrieved from https://www.webofscience.com/
Ventricular-arterial coupling in obstructive sleep apnea
Shantsila, A., Shantsila, E., Butt, M., Khair, O. A., Dwivedi, G., & Lip, G. Y. H. (2014). Ventricular-arterial coupling in obstructive sleep apnea. JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 8(9), 624-629. doi:10.1016/j.jash.2014.05.013
Vernakalant hydrochloride to treat atrial fibrillation
Brown, R. A., Lau, Y. C., & Lip, G. Y. H. (2014). Vernakalant hydrochloride to treat atrial fibrillation. EXPERT OPINION ON PHARMACOTHERAPY, 15(6), 865-872. doi:10.1517/14656566.2014.898751
Warfarin Versus Aspirin for Prevention of Cognitive Decline in Atrial Fibrillation
Mavaddat, N., Roalfe, A., Fletcher, K., Lip, G. Y. H., Hobbs, F. D. R., Fitzmaurice, D., & Mant, J. (2014). Warfarin Versus Aspirin for Prevention of Cognitive Decline in Atrial Fibrillation. STROKE, 45(5), 1381-1386. doi:10.1161/STROKEAHA.113.004009
Warfarin is associated with a net clinical benefit in patients with atrial fibrillation and chronic kidney disease
Bonde, A. N., Lip, G. Y. H., Hansen, P. R., Lamberts, M., Hommel, K., Kamper, A. L., . . . Olesen, J. B. (2014). Warfarin is associated with a net clinical benefit in patients with atrial fibrillation and chronic kidney disease. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 344). Retrieved from https://www.webofscience.com/
Which drug should we use for stroke prevention in atrial fibrillation?
Lau, Y. C., & Lip, G. Y. H. (2014). Which drug should we use for stroke prevention in atrial fibrillation?. CURRENT OPINION IN CARDIOLOGY, 29(4), 293-300. doi:10.1097/HCO.0000000000000065
2013
ACP Journal Club. PCI in noninfarction arteries reduced cardiac events in acute STEMI with multivessel coronary disease.
Brown, R., & Lip, G. Y. H. (2013). ACP Journal Club. PCI in noninfarction arteries reduced cardiac events in acute STEMI with multivessel coronary disease.. Annals of internal medicine, 159(12), JC3. doi:10.7326/0003-4819-159-12-201312170-02003
Prevalence of Peripheral Artery Disease by Abnormal Ankle-Brachial Index in Atrial Fibrillation Implications for Risk and Therapy
Violi, F., Davi, G., Hiatt, W., Lip, G. Y. H., Corazza, G. R., Perticone, F., . . . Basili, S. (2013). Prevalence of Peripheral Artery Disease by Abnormal Ankle-Brachial Index in Atrial Fibrillation Implications for Risk and Therapy. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 62(23), 2255-2256. doi:10.1016/j.jacc.2013.07.035
Treatment of hypertension in peripheral arterial disease
Lane, D. A., & Lip, G. Y. H. (2013). Treatment of hypertension in peripheral arterial disease. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (12). doi:10.1002/14651858.CD003075.pub3
Renal function and outcomes in anticoagulated patients with non-valvular atrial fibrillation: the AMADEUS trial
Apostolakis, S., Guo, Y., Lane, D. A., Buller, H., & Lip, G. Y. H. (2013). Renal function and outcomes in anticoagulated patients with non-valvular atrial fibrillation: the AMADEUS trial. EUROPEAN HEART JOURNAL, 34(46), 3572-3579. doi:10.1093/eurheartj/eht328
Combination of a new oral anticoagulant, aspirin and clopidogrel after acute coronary syndrome: new therapeutic standard?
Rubboli, A., Oldgren, J., Marìn, F., & Lip, G. (2013). Combination of a new oral anticoagulant, aspirin and clopidogrel after acute coronary syndrome: new therapeutic standard?. Internal and emergency medicine, 8(8), 673-680. doi:10.1007/s11739-013-1008-9
The effect of statin therapy withdrawal on monocyte subsets
Jaipersad, A. S., Shantsila, E., Blann, A., & Lip, G. Y. H. (2013). The effect of statin therapy withdrawal on monocyte subsets. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 43(12), 1307-1313. doi:10.1111/eci.12183
The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the Atrial Fibrillation undergoing Coronary Artery Stenting study.
Schlitt, A., Rubboli, A., Lip, G. Y. H., Lahtela, H., Valencia, J., Karjalainen, P. P., . . . AFCAS (Management of patients with Atrial Fibrillation undergoing Coronary Artery Stenting Study Group). (2013). The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the Atrial Fibrillation undergoing Coronary Artery Stenting study.. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 82(7), E864-E870. doi:10.1002/ccd.25064
Balancing bleeding and thrombotic risk with new oral anticoagulants in patients with atrial fibrillation.
Overvad, T. F., Larsen, T. B., Albertsen, I. E., Rasmussen, L. H., & Lip, G. Y. H. (2013). Balancing bleeding and thrombotic risk with new oral anticoagulants in patients with atrial fibrillation.. Expert review of cardiovascular therapy, 11(12), 1619-1629. doi:10.1586/14779072.2013.839214
Comparison of the CHADS<sub>2</sub>, CHA<sub>2</sub>DS<sub>2</sub> -VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: The AMADEUS trial
Apostolakis, S., Lane, D. A., Buller, H., & Lip, G. Y. H. (2013). Comparison of the CHADS<sub>2</sub>, CHA<sub>2</sub>DS<sub>2</sub> -VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: The AMADEUS trial. THROMBOSIS AND HAEMOSTASIS, 110(5), 1074-1079. doi:10.1160/TH13-07-0552
Cost effectiveness of treatments for stroke prevention in atrial fibrillation: focus on the novel oral anticoagulants.
Kasmeridis, C., Apostolakis, S., Ehlers, L., Rasmussen, L. H., Boriani, G., & Lip, G. Y. H. (2013). Cost effectiveness of treatments for stroke prevention in atrial fibrillation: focus on the novel oral anticoagulants.. PharmacoEconomics, 31(11), 971-980. doi:10.1007/s40273-013-0090-1
Finding atrial fibrillation: just keep looking, just keep looking … (but remember stroke prevention).
Lip, G. Y. H. (2013). Finding atrial fibrillation: just keep looking, just keep looking … (but remember stroke prevention).. Journal of internal medicine, 274(5), 457-460. doi:10.1111/joim.12118
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference
Kirchhof, P., Breithardt, G., Aliot, E., Al Khatib, S., Apostolakis, S., Auricchio, A., . . . Camm, A. J. (2013). Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. In EUROPACE Vol. 15 (pp. 1540-1556). doi:10.1093/europace/eut232
The immunological axis in heart failure: importance of the leukocyte differential
Vaduganathan, M., Greene, S. J., Butler, J., Sabbah, H. N., Shantsila, E., Lip, G. Y. H., & Gheorghiade, M. (2013). The immunological axis in heart failure: importance of the leukocyte differential. HEART FAILURE REVIEWS, 18(6), 835-845. doi:10.1007/s10741-012-9352-9
Using the CHADS2 and CHA2DS2-VASc scores for stroke risk prediction as well as the identification of stroke outcomes and cardiac complications in patients with and without atrial fibrillation.
Lip, G. Y. H. (2013). Using the CHADS2 and CHA2DS2-VASc scores for stroke risk prediction as well as the identification of stroke outcomes and cardiac complications in patients with and without atrial fibrillation.. Cerebrovascular diseases (Basel, Switzerland), 36(4), 281-282. doi:10.1159/000355981
Psychological interventions for depression in adolescent and adult congenital heart disease
Lane, D. A., Millane, T. A., & Lip, G. Y. H. (2013). Psychological interventions for depression in adolescent and adult congenital heart disease. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (10). doi:10.1002/14651858.CD004372.pub2
Monocytes in Coronary Artery Disease and Atherosclerosis Where Are We Now?
Ghattas, A., Griffiths, H. R., Devitt, A., Lip, G. Y. H., & Shantsila, E. (2013). Monocytes in Coronary Artery Disease and Atherosclerosis Where Are We Now?. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 62(17), 1541-1551. doi:10.1016/j.jacc.2013.07.043
Subclinical thyroid dysfunction and cardiac function amongst minority ethnic groups in the UK: a cross sectional study.
Gill, P. S., Patel, J. V., Chackathayil, J., Webster, C., Davis, R. C., Hughes, E., & Lip, G. Y. H. (2013). Subclinical thyroid dysfunction and cardiac function amongst minority ethnic groups in the UK: a cross sectional study.. International journal of cardiology, 168(6), 5218-5220. doi:10.1016/j.ijcard.2013.08.030
A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study.
Potpara, T. S., Polovina, M. M., Marinkovic, J. M., & Lip, G. Y. H. (2013). A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study.. International journal of cardiology, 168(5), 4744-4749. doi:10.1016/j.ijcard.2013.07.234
Sequential changes in renal function and the risk of stroke and death in patients with atrial fibrillation.
Guo, Y., Wang, H., Zhao, X., Zhang, Y., Zhang, D., Ma, J., . . . Lip, G. Y. H. (2013). Sequential changes in renal function and the risk of stroke and death in patients with atrial fibrillation.. International journal of cardiology, 168(5), 4678-4684. doi:10.1016/j.ijcard.2013.07.179
Anticoagulation management in nonvalvular atrial fibrillation: current and future directions.
Kornej, J., Potpara, T., & Lip, G. Y. H. (2013). Anticoagulation management in nonvalvular atrial fibrillation: current and future directions.. Polskie Archiwum Medycyny Wewnetrznej, 123(11), 623-634. doi:10.20452/pamw.1978
Cholesterol-adjusted vitamin E serum levels are associated with cardiovascular events in patients with non-valvular atrial fibrillation
Cangemi, R., Pignatelli, P., Carnevale, R., Corazza, G. R., Pastori, D., Farcomeni, A., . . . Violi, F. (2013). Cholesterol-adjusted vitamin E serum levels are associated with cardiovascular events in patients with non-valvular atrial fibrillation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 168(4), 3241-3247. doi:10.1016/j.ijcard.2013.04.142
Low stroke risk after elective cardioversion of atrial fibrillation: an analysis of the Flec-SL trial.
Apostolakis, S., Haeusler, K. G., Oeff, M., Treszl, A., Andresen, D., Borggrefe, M., . . . Kirchhof, P. (2013). Low stroke risk after elective cardioversion of atrial fibrillation: an analysis of the Flec-SL trial.. International journal of cardiology, 168(4), 3977-3981. doi:10.1016/j.ijcard.2013.06.090
Antithrombotic therapy in atrial fibrillation and stent implantation: treatment or threats by the use of triple or dual antithrombotic therapy.
Marín, F., Huber, K., & Lip, G. Y. H. (2013). Antithrombotic therapy in atrial fibrillation and stent implantation: treatment or threats by the use of triple or dual antithrombotic therapy.. Thrombosis and haemostasis, 110(4), 623-625. doi:10.1160/th13-08-0677
Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation.
Gallego, P., Roldan, V., Marín, F., Romera, M., Valdés, M., Vicente, V., & Lip, G. Y. H. (2013). Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation.. Thrombosis and haemostasis, 110(6), 1189-1198. doi:10.1160/th13-07-0556
Comparative assessment of the HAS-BLED score with other published bleeding risk scoring schemes, for intracranial haemorrhage risk in a non-atrial fibrillation population: the Chin-Shan Community Cohort Study.
Lip, G. Y. H., Lin, H. -J., Hsu, H. -C., Su, T. -C., Chen, M. -F., Lee, Y. -T., & Chien, K. -L. (2013). Comparative assessment of the HAS-BLED score with other published bleeding risk scoring schemes, for intracranial haemorrhage risk in a non-atrial fibrillation population: the Chin-Shan Community Cohort Study.. International journal of cardiology, 168(3), 1832-1836. doi:10.1016/j.ijcard.2012.12.076
Ambulatory blood pressure in atrial fibrillation: an irregular conundrum of rate and rhythm.
Kotecha, D., & Lip, G. Y. H. (2013). Ambulatory blood pressure in atrial fibrillation: an irregular conundrum of rate and rhythm.. Hypertension research : official journal of the Japanese Society of Hypertension, 36(10), 854-855. doi:10.1038/hr.2013.59
Hospital delay in South Asian patients with acute ST-elevation myocardial infarction in the UK.
Kendall, H., Marley, A., Patel, J. V., Khan, J. M., Blann, A. D., Lip, G. Y. H., & Dwivedi, G. (2013). Hospital delay in South Asian patients with acute ST-elevation myocardial infarction in the UK.. European journal of preventive cardiology, 20(5), 737-742. doi:10.1177/2047487312447844
Inflammation does not influence arterial stiffness and pulse-wave velocity in patients with coronary artery disease.
Blann, A. D., Kuzniatsova, N., & Lip, G. Y. H. (2013). Inflammation does not influence arterial stiffness and pulse-wave velocity in patients with coronary artery disease.. Journal of human hypertension, 27(10), 629-634. doi:10.1038/jhh.2013.17
Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey.
Lip, G. Y. H., Bongiorni, M. G., Dobreanu, D., Lewalter, T., Hastrup Svendsen, J., Blomström-Lundqvist, C., & Scientific Initiative Committee, European Heart Rhythm Association. (2013). Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 15(10), 1526-1532. doi:10.1093/europace/eut292
Pharmacokinetic considerations for antithrombotic therapies in stroke
Apostolakis, S., Lip, G. Y. H., & Shantsila, E. (2013). Pharmacokinetic considerations for antithrombotic therapies in stroke. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 9(10), 1335-1347. doi:10.1517/17425255.2013.808331
Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
Kornej, J., Hindricks, G., Kosiuk, J., Arya, A., Sommer, P., Husser, D., . . . Bollmann, A. (2013). Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.. Circulation. Arrhythmia and electrophysiology, 6(5), 868-874. doi:10.1161/circep.113.000869
Stroke Prevention in Atrial Fibrillation in Heart Failure
Shantsila, E., & Lip, G. Y. H. (2013). Stroke Prevention in Atrial Fibrillation in Heart Failure. HEART FAILURE CLINICS, 9(4), 427-+. doi:10.1016/j.hfc.2013.07.008
The emerging role of biomarkers in atrial fibrillation.
Kornej, J., Apostolakis, S., Bollmann, A., & Lip, G. Y. H. (2013). The emerging role of biomarkers in atrial fibrillation.. The Canadian journal of cardiology, 29(10), 1181-1193. doi:10.1016/j.cjca.2013.04.016
Assessment of stroke risk in Middle Eastern patients with atrial fibrillation: The Gulf SAFE registry
Apostolakis, S., Zubaid, M., Rashed, W. A., Alsheikh-Ali, A. A., Almahmeed, W., Shehab, A., . . . Lip, G. Y. H. (2013). Assessment of stroke risk in Middle Eastern patients with atrial fibrillation: The Gulf SAFE registry. INTERNATIONAL JOURNAL OF CARDIOLOGY, 168(2), 1644-1646. doi:10.1016/j.ijcard.2013.02.003
Relation of renal dysfunction to the increased risk of stroke and death in female patients with atrial fibrillation.
Guo, Y., Wang, H., Zhao, X., Zhang, Y., Zhang, D., Ma, J., . . . Lip, G. Y. H. (2013). Relation of renal dysfunction to the increased risk of stroke and death in female patients with atrial fibrillation.. International journal of cardiology, 168(2), 1502-1508. doi:10.1016/j.ijcard.2012.12.099
Validation of contemporary stroke and bleeding risk stratification scores in non-anticoagulated Chinese patients with atrial fibrillation.
Guo, Y., Apostolakis, S., Blann, A. D., Wang, H., Zhao, X., Zhang, Y., . . . Lip, G. Y. H. (2013). Validation of contemporary stroke and bleeding risk stratification scores in non-anticoagulated Chinese patients with atrial fibrillation.. International journal of cardiology, 168(2), 904-909. doi:10.1016/j.ijcard.2012.10.052
Comparative assessment of published atrial fibrillation stroke risk stratification schemes for predicting stroke, in a non-atrial fibrillation population: the Chin-Shan Community Cohort Study.
Lip, G. Y. H., Lin, H. -J., Chien, K. -L., Hsu, H. -C., Su, T. -C., Chen, M. -F., & Lee, Y. -T. (2013). Comparative assessment of published atrial fibrillation stroke risk stratification schemes for predicting stroke, in a non-atrial fibrillation population: the Chin-Shan Community Cohort Study.. International journal of cardiology, 168(1), 414-419. doi:10.1016/j.ijcard.2012.09.148
Stroke risk and suboptimal thromboprophylaxis in Chinese patients with atrial fibrillation: would the novel oral anticoagulants have an impact?
Guo, Y., Pisters, R., Apostolakis, S., Blann, A. D., Wang, H., Zhao, X., . . . Lip, G. Y. H. (2013). Stroke risk and suboptimal thromboprophylaxis in Chinese patients with atrial fibrillation: would the novel oral anticoagulants have an impact?. International journal of cardiology, 168(1), 515-522. doi:10.1016/j.ijcard.2012.09.187
Anticoagulant treatment is effective in atrial fibrillation.
Robson, J. P., & Lip, G. Y. H. (2013). Anticoagulant treatment is effective in atrial fibrillation.. BMJ (Clinical research ed.), 347, f5429. doi:10.1136/bmj.f5429
Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
Lamberts, M., Gislason, G. H., Olesen, J. B., Kristensen, S. L., Schjerning Olsen, A. -M., Mikkelsen, A., . . . Hansen, M. L. (2013). Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.. Journal of the American College of Cardiology, 62(11), 981-989. doi:10.1016/j.jacc.2013.05.029
Pattern of atrial fibrillation and risk of outcomes: The Loire Valley Atrial Fibrillation Project
Banerjee, A., Taillandier, S., Olesen, J. B., Lane, D. A., Lallemand, B., Lip, G. Y. H., & Fauchier, L. (2013). Pattern of atrial fibrillation and risk of outcomes: The Loire Valley Atrial Fibrillation Project. INTERNATIONAL JOURNAL OF CARDIOLOGY, 167(6), 2682-2687. doi:10.1016/j.ijcard.2012.06.118
Educational Intervention Improves Anticoagulation Control in Atrial Fibrillation Patients: The TREAT Randomised Trial
Clarkesmith, D. E., Pattison, H. M., Lip, G. Y. H., & Lane, D. A. (2013). Educational Intervention Improves Anticoagulation Control in Atrial Fibrillation Patients: The TREAT Randomised Trial. PLOS ONE, 8(9). doi:10.1371/journal.pone.0074037
Reply: Dabigatran's 'real-world' data about risk of myocardial infarction and gastrointestinal bleeding contradicts with randomized trials.
Larsen, T. B., Rasmussen, L. H., Skjøth, F., Due, K. M., Callréus, T., Rosenzweig, M., & Lip, G. Y. H. (2013). Reply: Dabigatran's 'real-world' data about risk of myocardial infarction and gastrointestinal bleeding contradicts with randomized trials.. Journal of the American College of Cardiology, 62(10), 946-947. doi:10.1016/j.jacc.2013.05.067
Atrial fibrillation as a risk factor for cognitive impairment: a semi-systematic review
Udompanich, S., Lip, G. Y. H., Apostolakis, S., & Lane, D. A. (2013). Atrial fibrillation as a risk factor for cognitive impairment: a semi-systematic review. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 106(9), 795-802. doi:10.1093/qjmed/hct129
Atrial fibrillation in CKD: balancing the risks and benefits of anticoagulation.
Ng, K. P., Edwards, N. C., Lip, G. Y. H., Townend, J. N., & Ferro, C. J. (2013). Atrial fibrillation in CKD: balancing the risks and benefits of anticoagulation.. American journal of kidney diseases : the official journal of the National Kidney Foundation, 62(3), 615-632. doi:10.1053/j.ajkd.2013.02.381
New oral anticoagulants in heart failure.
Van Gelder, I. C., Van Veldhuisen, D. J., & Lip, G. Y. H. (2013). New oral anticoagulants in heart failure.. European journal of heart failure, 15(9), 966-973. doi:10.1093/eurjhf/hft135
Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060.
Krijthe, B. P., Kunst, A., Benjamin, E. J., Lip, G. Y. H., Franco, O. H., Hofman, A., . . . Heeringa, J. (2013). Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060.. European heart journal, 34(35), 2746-2751. doi:10.1093/eurheartj/eht280
Role of microRNAs in cardiac remodelling: new insights and future perspectives.
Orenes-Piñero, E., Montoro-García, S., Patel, J. V., Valdés, M., Marín, F., & Lip, G. Y. H. (2013). Role of microRNAs in cardiac remodelling: new insights and future perspectives.. International journal of cardiology, 167(5), 1651-1659. doi:10.1016/j.ijcard.2012.09.120
Vitamin D deficiency amongst minority ethnic groups in the UK: a cross sectional study.
Patel, J. V., Chackathayil, J., Hughes, E. A., Webster, C., Lip, G. Y. H., & Gill, P. S. (2013). Vitamin D deficiency amongst minority ethnic groups in the UK: a cross sectional study.. International journal of cardiology, 167(5), 2172-2176. doi:10.1016/j.ijcard.2012.05.081
Patient preferences at ten years following initial diagnosis of atrial fibrillation: the Belgrade Atrial Fibrillation Study.
Potpara, T. S., Polovina, M. M., Mujovic, N. M., Kocijancic, A. M., & Lip, G. Y. (2013). Patient preferences at ten years following initial diagnosis of atrial fibrillation: the Belgrade Atrial Fibrillation Study.. Patient preference and adherence, 7, 835-842. doi:10.2147/ppa.s50990
Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a 'real-world' community cohort of patients with atrial fibrillation
Krishnamoorthy, S., Khoo, C. W., Lim, H. S., Lane, D. A., Pignatelli, P., Basili, S., . . . Lip, G. Y. H. (2013). Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a 'real-world' community cohort of patients with atrial fibrillation. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 43(10), 1032-1038. doi:10.1111/eci.12140
Ethnic/racial differences in circulating markers of angiogenesis and their association with cardiovascular risk factors and cardiovascular disease.
Bennett, P. C., Gill, P. S., Silverman, S., Blann, A. D., Balakrishnan, B., & Lip, G. Y. H. (2013). Ethnic/racial differences in circulating markers of angiogenesis and their association with cardiovascular risk factors and cardiovascular disease.. International journal of cardiology, 167(4), 1247-1250. doi:10.1016/j.ijcard.2012.03.158
Conventional and new oral anticoagulants in the treatment of chest disease and its complications.
Gallego, P., Roldan, V., & Lip, G. Y. H. (2013). Conventional and new oral anticoagulants in the treatment of chest disease and its complications.. American journal of respiratory and critical care medicine, 188(4), 413-421. doi:10.1164/rccm.201301-0141pp
Thrombocytopenia in patients with atrial fibrillation on oral anticoagulation undergoing percutaneous coronary intervention.
Kiviniemi, T., Karjalainen, P., Rubboli, A., Schlitt, A., Tuomainen, P., Niemelä, M., . . . Airaksinen, K. E. J. (2013). Thrombocytopenia in patients with atrial fibrillation on oral anticoagulation undergoing percutaneous coronary intervention.. The American journal of cardiology, 112(4), 493-498. doi:10.1016/j.amjcard.2013.04.007
Receptors to interleukin-6 and adhesion molecules on circulating monocyte subsets in acute myocardial infarction
Shantsila, E., Tapp, L. D., Wrigley, B. J., Montoro-Garcia, S., & Lip, G. Y. H. (2013). Receptors to interleukin-6 and adhesion molecules on circulating monocyte subsets in acute myocardial infarction. THROMBOSIS AND HAEMOSTASIS, 110(2), 340-348. doi:10.1160/TH13-02-0085
Alcohol intake and prognosis of atrial fibrillation
Overvad, T. F., Rasmussen, L. H., Skjoth, F., Overvad, K., Albertsen, I. E., Lane, D. A., . . . Larsen, T. B. (2013). Alcohol intake and prognosis of atrial fibrillation. HEART, 99(15), 1093-1099. doi:10.1136/heartjnl-2013-304036
Angiogenin outperforms VEGF, EPCs and CECs in predicting Dukes' and AJCC stage in colorectal cancer.
Ramcharan, S. K., Lip, G. Y. H., Stonelake, P. S., & Blann, A. D. (2013). Angiogenin outperforms VEGF, EPCs and CECs in predicting Dukes' and AJCC stage in colorectal cancer.. European journal of clinical investigation, 43(8), 801-808. doi:10.1111/eci.12108
Bridging therapy: a challenging area in the management of patients with atrial fibrillation.
Guo, Y., Lip, G. Y. H., & Apostolakis, S. (2013). Bridging therapy: a challenging area in the management of patients with atrial fibrillation.. American journal of cardiovascular drugs : drugs, devices, and other interventions, 13(4), 259-261. doi:10.1007/s40256-013-0032-5
Current practice for diagnosis and management of silent atrial fibrillation: results of the European Heart Rhythm Association survey.
Dobreanu, D., Svendsen, J. H., Lewalter, T., Hernández-Madrid, A., Lip, G. Y. H., Blomström-Lundqvist, C., & Scientific Initiatives Committee, European Heart Rhythm Association. (2013). Current practice for diagnosis and management of silent atrial fibrillation: results of the European Heart Rhythm Association survey.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 15(8), 1223-1225. doi:10.1093/europace/eut227
Evaluation of Carotid Plaque Neovascularization Using Contrast Ultrasound
Jaipersad, A. S., Shantsila, A., Silverman, S., Lip, G. Y. H., & Shantsila, E. (2013). Evaluation of Carotid Plaque Neovascularization Using Contrast Ultrasound. ANGIOLOGY, 64(6), 447-450. doi:10.1177/0003319712457013
Is bleeding a necessary evil? The inherent risk of antithrombotic pharmacotherapy used for stroke prevention in atrial fibrillation.
Myat, A., Ahmad, Y., Haldar, S., Tantry, U. S., Redwood, S. R., Gurbel, P. A., & Lip, G. Y. (2013). Is bleeding a necessary evil? The inherent risk of antithrombotic pharmacotherapy used for stroke prevention in atrial fibrillation.. Expert review of cardiovascular therapy, 11(8), 1029-1049. doi:10.1586/14779072.2013.815423
Retinal vein and artery occlusions: a risk factor for stroke in atrial fibrillation.
Christiansen, C. B., Lip, G. Y. H., Lamberts, M., Gislason, G., Torp-Pedersen, C., & Olesen, J. B. (2013). Retinal vein and artery occlusions: a risk factor for stroke in atrial fibrillation.. Journal of thrombosis and haemostasis : JTH, 11(8), 1485-1492. doi:10.1111/jth.12297
A comprehensive assessment of cardiac structure and function in patients with treated malignant phase hypertension: The West Birmingham Malignant Hypertension project
Shantsila, A., Dwivedi, G., Shantsila, E., Butt, M., Beevers, D. G., & Lip, G. Y. H. (2013). A comprehensive assessment of cardiac structure and function in patients with treated malignant phase hypertension: The West Birmingham Malignant Hypertension project. INTERNATIONAL JOURNAL OF CARDIOLOGY, 167(1), 67-72. doi:10.1016/j.ijcard.2011.11.077
Differences between ACC/AHA and ESC Guidelines on antiplatelet therapy in patients with acute coronary syndromes.
Huber, K., & Lip, G. Y. H. (2013). Differences between ACC/AHA and ESC Guidelines on antiplatelet therapy in patients with acute coronary syndromes.. Thrombosis and haemostasis, 110(1), 11-13. doi:10.1160/th13-06-0453
Increased expression of cell adhesion molecule receptors on monocyte subsets in ischaemic heart failure
Wrigley, B. J., Shantsila, E., Tapp, L. D., & Lip, G. Y. H. (2013). Increased expression of cell adhesion molecule receptors on monocyte subsets in ischaemic heart failure. THROMBOSIS AND HAEMOSTASIS, 110(1), 92-100. doi:10.1160/TH13-02-0088
Antiplatelet therapy and anticoagulants.
Schlitt, A., Rubboli, A., Airaksinen, K. E. J., & Lip, G. Y. H. (2013). Antiplatelet therapy and anticoagulants.. Lancet (London, England), 382(9886), 24-25. doi:10.1016/s0140-6736(13)61521-4
Body mass index and adverse events in patients with incident atrial fibrillation.
Overvad, T. F., Rasmussen, L. H., Skjøth, F., Overvad, K., Lip, G. Y. H., & Larsen, T. B. (2013). Body mass index and adverse events in patients with incident atrial fibrillation.. The American journal of medicine, 126(7), 640.e9-640.17. doi:10.1016/j.amjmed.2012.11.024
Warfarin for stroke prevention in atrial fibrillation: time to switch?
Ahmad, Y., & Lip, G. Y. H. (2013). Warfarin for stroke prevention in atrial fibrillation: time to switch?. International journal of clinical practice, 67(7), 603-605. doi:10.1111/ijcp.12157
Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study.
Larsen, T. B., Rasmussen, L. H., Skjøth, F., Due, K. M., Callréus, T., Rosenzweig, M., & Lip, G. Y. H. (2013). Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study.. Journal of the American College of Cardiology, 61(22), 2264-2273. doi:10.1016/j.jacc.2013.03.020
Age as a risk factor for stroke in atrial fibrillation patients: Implications in thromboprophylaxis in the era of novel oral anticoagulants
Mitrousi, K., Lip, G. Y. H., & Apostolakis, S. (2013). Age as a risk factor for stroke in atrial fibrillation patients: Implications in thromboprophylaxis in the era of novel oral anticoagulants. Journal of Atrial Fibrillation, 6(1), 104-109.
Bleeding risk during oral anticoagulation therapy for atrial fibrillation
Gallego, P., Lip, G. Y. H., & Lane, D. A. (2013). Bleeding risk during oral anticoagulation therapy for atrial fibrillation. EUROPACE, 15(6), 773-774. doi:10.1093/europace/eut061
Cardioversion for atrial fibrillation in current European practice: results of the European Heart Rhythm Association survey.
Hernández-Madrid, A., Svendsen, J. H., Lip, G. Y. H., Van Gelder, I. C., Dobreanu, D., Blomstrom-Lundqvist, C., & Scientific Initiatives Committee, European Heart Rhythm Association (EHRA). (2013). Cardioversion for atrial fibrillation in current European practice: results of the European Heart Rhythm Association survey.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 15(6), 915-918. doi:10.1093/europace/eut143
Does obesity influence target organ damage and outcomes in patients with malignant phase hypertension? The West Birmingham Malignant Hypertension Project
Shantsila, A., Lane, D. A., Beevers, D. G., & Lip, G. Y. H. (2013). Does obesity influence target organ damage and outcomes in patients with malignant phase hypertension? The West Birmingham Malignant Hypertension Project. HYPERTENSION RESEARCH, 36(6), 546-549. doi:10.1038/hr.2012.222
Estimated glomerular filtration rate is associated with major bleeding complications but not thromboembolic events, in anticoagulated patients taking warfarin.
Wieloch, M., Jönsson, K. M., Själander, A., Lip, G. Y. H., Eriksson, N., & Svensson, P. J. (2013). Estimated glomerular filtration rate is associated with major bleeding complications but not thromboembolic events, in anticoagulated patients taking warfarin.. Thrombosis research, 131(6), 481-486. doi:10.1016/j.thromres.2013.01.006
Novel oral anticoagulants in non-valvular atrial fibrillation.
Potpara, T. S., & Lip, G. Y. H. (2013). Novel oral anticoagulants in non-valvular atrial fibrillation.. Best practice & research. Clinical haematology, 26(2), 115-129. doi:10.1016/j.beha.2013.07.008
The CHADS2 and CHA 2DS 2-VASc scores predict new occurrence of atrial fibrillation and ischemic stroke.
Zuo, M. -L., Liu, S., Chan, K. -H., Lau, K. -K., Chong, B. -H., Lam, K. -F., . . . Siu, C. -W. (2013). The CHADS2 and CHA 2DS 2-VASc scores predict new occurrence of atrial fibrillation and ischemic stroke.. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 37(1), 47-54. doi:10.1007/s10840-012-9776-0
The challenge of antiplatelet therapy in patients with atrial fibrillation and heart failure.
Guo, Y., Lip, G. Y. H., & Apostolakis, S. (2013). The challenge of antiplatelet therapy in patients with atrial fibrillation and heart failure.. Journal of cardiovascular translational research, 6(3), 388-397. doi:10.1007/s12265-012-9427-y
Stroke Prevention With Oral Anticoagulation Therapy in Patients With Atrial Fibrillation -Focus on the Elderly-
Lip, G. Y. H., & Lane, D. A. (2013). Stroke Prevention With Oral Anticoagulation Therapy in Patients With Atrial Fibrillation -Focus on the Elderly-. CIRCULATION JOURNAL, 77(6), 1380-1388. doi:10.1253/circj.CJ-13-0465
Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.
Ahmad, Y., & Lip, G. Y. H. (2013). Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.. In Unknown Book (Vol. 179, pp. 81-91). doi:10.1159/000346726
Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
Banerjee, A., Fauchier, L., Vourc'h, P., Andres, C. R., Taillandier, S., Halimi, J. M., & Lip, G. Y. H. (2013). Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.. Journal of the American College of Cardiology, 61(20), 2079-2087. doi:10.1016/j.jacc.2013.02.035
Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry.
Kakkar, A. K., Mueller, I., Bassand, J. -P., Fitzmaurice, D. A., Goldhaber, S. Z., Goto, S., . . . GARFIELD Registry Investigators. (2013). Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry.. PloS one, 8(5), e63479. doi:10.1371/journal.pone.0063479
Response to letter regarding article, "Bridging evidence-based practice and practice-based evidence in periprocedural anticoagulation".
Gallego, P., Apostolakis, S., & Lip, G. Y. H. (2013). Response to letter regarding article, "Bridging evidence-based practice and practice-based evidence in periprocedural anticoagulation".. Circulation, 127(19), e617. doi:10.1161/circulationaha.113.001659
Sympathetic nerve activity during non-sustained ventricular tachycardia in chronic heart failure.
Adlan, A. M., Lip, G. Y. H., Fadel, P. J., & Fisher, J. P. (2013). Sympathetic nerve activity during non-sustained ventricular tachycardia in chronic heart failure.. International journal of cardiology, 165(2), e15-e17. doi:10.1016/j.ijcard.2012.10.088
Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
Roldán, V., Marín, F., Manzano-Fernandez, S., Fernández, H., Gallego, P., Valdés, M., . . . Lip, G. Y. H. (2013). Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?. Thrombosis and haemostasis, 109(5), 956-960. doi:10.1160/th13-01-0054
Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study.
Sørensen, R., Gislason, G., Torp-Pedersen, C., Olesen, J. B., Fosbøl, E. L., Hvidtfeldt, M. W., . . . Hansen, M. L. (2013). Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study.. BMJ open, 3(5), e002758. doi:10.1136/bmjopen-2013-002758
ATRIAL FIBRILLATION Anticoagulation for AF: can we GRASP-AF patients?
Lane, D. A., & Lip, G. Y. H. (2013). ATRIAL FIBRILLATION Anticoagulation for AF: can we GRASP-AF patients?. NATURE REVIEWS CARDIOLOGY, 10(5), 241-242. doi:10.1038/nrcardio.2013.47
Atherosclerosis and thromboembolic risk in atrial fibrillation: focus on peripheral vascular disease.
Jover, E., Marín, F., Roldán, V., Montoro-García, S., Valdés, M., & Lip, G. Y. H. (2013). Atherosclerosis and thromboembolic risk in atrial fibrillation: focus on peripheral vascular disease.. Annals of medicine, 45(3), 274-290. doi:10.3109/07853890.2012.732702
Awareness and treatment of atrial fibrillation in older adults: the present and the future.
Lip, G. Y. H. (2013). Awareness and treatment of atrial fibrillation in older adults: the present and the future.. QJM : monthly journal of the Association of Physicians, 106(5), 393-394. doi:10.1093/qjmed/hct074
Heart failure in East Asia.
Guo, Y., Lip, G. Y. H., & Banerjee, A. (2013). Heart failure in East Asia.. Current cardiology reviews, 9(2), 112-122. doi:10.2174/1573403x11309020004
Reduction of stroke and mortality in patients with atrial fibrillation by catheter ablation? Finally, tackling the hard endpoints.
Kornej, J., Lip, G. Y. H., & Bollmann, A. (2013). Reduction of stroke and mortality in patients with atrial fibrillation by catheter ablation? Finally, tackling the hard endpoints.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 15(5), 620-622. doi:10.1093/europace/eus389
Risk of stroke or systemic embolism in atrial fibrillation patients treated with warfarin: a systematic review and meta-analysis.
Albertsen, I. E., Rasmussen, L. H., Overvad, T. F., Graungaard, T., Larsen, T. B., & Lip, G. Y. H. (2013). Risk of stroke or systemic embolism in atrial fibrillation patients treated with warfarin: a systematic review and meta-analysis.. Stroke, 44(5), 1329-1336. doi:10.1161/strokeaha.113.000883
The impact of atherosclerotic vascular disease in predicting a stroke, thromboembolism and mortality in atrial fibrillation patients: a systematic review
Anandasundaram, B., Lane, D. A., Apostolakis, S., & Lip, G. Y. H. (2013). The impact of atherosclerotic vascular disease in predicting a stroke, thromboembolism and mortality in atrial fibrillation patients: a systematic review. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 11(5), 975-987. doi:10.1111/jth.12177
Upper limb arterial thromboembolism: a systematic review on incidence, risk factors, and prognosis, including a meta-analysis of risk-modifying drugs.
Andersen, L. V., Lip, G. Y. H., Lindholt, J. S., & Frost, L. (2013). Upper limb arterial thromboembolism: a systematic review on incidence, risk factors, and prognosis, including a meta-analysis of risk-modifying drugs.. Journal of thrombosis and haemostasis : JTH, 11(5), 836-844. doi:10.1111/jth.12181
Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding).
Roldán, V., Marín, F., Fernández, H., Manzano-Fernández, S., Gallego, P., Valdés, M., . . . Lip, G. Y. H. (2013). Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding).. The American journal of cardiology, 111(8), 1159-1164. doi:10.1016/j.amjcard.2012.12.045
Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why?
Lip, G. Y. H. (2013). Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why?. European heart journal, 34(14), 1041-1049. doi:10.1093/eurheartj/ehs435
Metabolic syndrome and renal disease.
Gluba, A., Mikhailidis, D. P., Lip, G. Y. H., Hannam, S., Rysz, J., & Banach, M. (2013). Metabolic syndrome and renal disease.. International journal of cardiology, 164(2), 141-150. doi:10.1016/j.ijcard.2012.01.013
Aspirin and aspirin resistance in coronary artery disease.
Kasmeridis, C., Apostolakis, S., & Lip, G. Y. H. (2013). Aspirin and aspirin resistance in coronary artery disease.. Current opinion in pharmacology, 13(2), 242-250. doi:10.1016/j.coph.2012.12.004
Current practice of antiarrhythmic drug therapy for prevention of atrial fibrillation in Europe: The European Heart Rhythm Association survey.
Dagres, N., Lewalter, T., Lip, G. Y. H., Pison, L., Proclemer, A., Blomström-Lundqvist, C., & Scientific Initiatives Committee, European Heart Rhythm Association. (2013). Current practice of antiarrhythmic drug therapy for prevention of atrial fibrillation in Europe: The European Heart Rhythm Association survey.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 15(4), 478-481. doi:10.1093/europace/eut063
Left Ventricular Fibrosis in Atrial Fibrillation
Shantsila, E., Shantsila, A., Blann, A. D., & Lip, G. Y. H. (2013). Left Ventricular Fibrosis in Atrial Fibrillation. AMERICAN JOURNAL OF CARDIOLOGY, 111(7), 996-1001. doi:10.1016/j.amjcard.2012.12.005
Localized retinal nerve fiber layer defects and arterial hypertension: insights into pathophysiology and perhaps an eye for detail?
Kalitzeos, A. A., Heitmar, R., & Lip, G. Y. H. (2013). Localized retinal nerve fiber layer defects and arterial hypertension: insights into pathophysiology and perhaps an eye for detail?. American journal of hypertension, 26(4), 454-455. doi:10.1093/ajh/hpt013
Recommendations for thromboprophylaxis in the 2012 focused update of the ESC guidelines on atrial fibrillation: a commentary.
Lip, G. Y. H. (2013). Recommendations for thromboprophylaxis in the 2012 focused update of the ESC guidelines on atrial fibrillation: a commentary.. Journal of thrombosis and haemostasis : JTH, 11(4), 615-626. doi:10.1111/jth.12140
Small-size circulating microparticles in acute coronary syndromes: Relevance to fibrinolytic status, reparative markers and outcomes
Montoro-Garcia, S., Shantsila, E., Tapp, L. D., Lopez-Cuenca, A., Isabel Romero, A., Hernandez-Romero, D., . . . Lip, G. Y. H. (2013). Small-size circulating microparticles in acute coronary syndromes: Relevance to fibrinolytic status, reparative markers and outcomes. ATHEROSCLEROSIS, 227(2), 313-322. doi:10.1016/j.atherosclerosis.2013.01.028
Which is the optimal antihypertensive combination in different diseases, a renin- angiotensin-aldosterone system inhibitor with a diuretic or with a calcium channel blocker?
Riva, N., & Lip, G. Y. H. (2013). Which is the optimal antihypertensive combination in different diseases, a renin- angiotensin-aldosterone system inhibitor with a diuretic or with a calcium channel blocker?. Current pharmaceutical design, 19(21), 3753-3765. doi:10.2174/13816128113199990299
Cardiovascular Risk Profiles amongst Women in a Multiethnic Population in Inner City Britain: A Potential Impact of Anaemia.
Chackathayil, J., Patel, J. V., Gill, P. S., Potluri, R., Natalwala, A., Uppal, H., . . . Lip, G. Y. H. (2013). Cardiovascular Risk Profiles amongst Women in a Multiethnic Population in Inner City Britain: A Potential Impact of Anaemia.. International journal of endocrinology, 2013, 303859. doi:10.1155/2013/303859
CHADS₂, CHA₂S₂DS₂-VASc, and long-term stroke outcome in patients without atrial fibrillation.
Ntaios, G., Lip, G. Y. H., Makaritsis, K., Papavasileiou, V., Vemmou, A., Koroboki, E., . . . Vemmos, K. (2013). CHADS₂, CHA₂S₂DS₂-VASc, and long-term stroke outcome in patients without atrial fibrillation.. Neurology, 80(11), 1009-1017. doi:10.1212/wnl.0b013e318287281b
CXCR4 positive and angiogenic monocytes in myocardial infarction
Shantsila, E., Tapp, L. D., Wrigley, B. J., Montoro-Garcia, S., & Lip, G. Y. H. (2013). CXCR4 positive and angiogenic monocytes in myocardial infarction. THROMBOSIS AND HAEMOSTASIS, 109(2), 255-262. doi:10.1160/TH12-06-0395
Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation A modelling analysis from the Euro Heart Survey
Pisters, R., Nieuwlaat, R., Lane, D. A., Crijns, H. J. G. M., & Lip, G. Y. H. (2013). Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation A modelling analysis from the Euro Heart Survey. THROMBOSIS AND HAEMOSTASIS, 109(2), 328-336. doi:10.1160/TH12-08-0539
EUR Observational research programme: atrial fibrillation general registry pilot phase.
Lip, G. Y. H. (2013). EUR Observational research programme: atrial fibrillation general registry pilot phase.. European heart journal, 34(11), 794.
Interleukin-6 and high-sensitivity C-reactive protein for the prediction of outcomes in non-ST-segment elevation acute coronary syndromes.
López-Cuenca, Á., Manzano-Fernández, S., Lip, G. Y. H., Casas, T., Sánchez-Martínez, M., Mateo-Martínez, A., . . . Marín, F. (2013). Interleukin-6 and high-sensitivity C-reactive protein for the prediction of outcomes in non-ST-segment elevation acute coronary syndromes.. Revista espanola de cardiologia (English ed.), 66(3), 185-192. doi:10.1016/j.rec.2012.07.019
Safety and efficacy of new anticoagulants in patients with heart failure.
Pisters, R., & Lip, G. Y. H. (2013). Safety and efficacy of new anticoagulants in patients with heart failure.. Current heart failure reports, 10(1), 18-25. doi:10.1007/s11897-012-0125-5
TLR4 expression on monocyte subsets in myocardial infarction
Tapp, L. D., Shantsila, E., Wrigley, B. J., Montoro-Garcia, S., & Lip, G. Y. H. (2013). TLR4 expression on monocyte subsets in myocardial infarction. JOURNAL OF INTERNAL MEDICINE, 273(3), 294-305. doi:10.1111/joim.12011
Using the CHA(2)DS(2)-VASc score for stroke risk stratification in atrial fibrillation: a clinical perspective.
Lip, G. Y. H. (2013). Using the CHA(2)DS(2)-VASc score for stroke risk stratification in atrial fibrillation: a clinical perspective.. Expert review of cardiovascular therapy, 11(3), 259-262. doi:10.1586/erc.13.13
General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease.
De Caterina, R., Husted, S., Wallentin, L., Andreotti, F., Arnesen, H., Bachmann, F., . . . European Society of Cardiology Working Group on Thrombosis Task Force on Anticoagulants in Heart Disease. (2013). General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease.. Thrombosis and haemostasis, 109(4), 569-579. doi:10.1160/th12-10-0772
Atrial fibrillation and thrombosis: the missing molecular links.
Blann, A. D., & Lip, G. Y. H. (2013). Atrial fibrillation and thrombosis: the missing molecular links.. Journal of the American College of Cardiology, 61(8), 861-862. doi:10.1016/j.jacc.2012.11.047
Reply: To PMID 22575324.
Lip, G. Y. H., Larsen, T. B., Skjøth, F., & Rasmussen, L. H. (2013). Reply: To PMID 22575324.. Journal of the American College of Cardiology, 61(5), 596. doi:10.1016/j.jacc.2012.10.034
Benefit-risk assessment of dronedarone in the treatment of atrial fibrillation.
Adlan, A. M. A., & Lip, G. Y. H. (2013). Benefit-risk assessment of dronedarone in the treatment of atrial fibrillation.. Drug safety, 36(2), 93-110. doi:10.1007/s40264-012-0012-8
CD14++CD16+ monocytes in patients with acute ischaemic heart failure
Wrigley, B. J., Shantsila, E., Tapp, L. D., & Lip, G. Y. H. (2013). CD14++CD16+ monocytes in patients with acute ischaemic heart failure. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 43(2), 121-130. doi:10.1111/eci.12023
Current practice in Europe: how do we manage patients with ventricular tachycardia? European Heart Rhythm Association survey.
Proclemer, A., Dagres, N., Marinskis, G., Pison, L., Lip, G. Y. H., Blomstrom-Lundqvist, C., & Scientific Initiative Committee, European Heart Rhythm Association. (2013). Current practice in Europe: how do we manage patients with ventricular tachycardia? European Heart Rhythm Association survey.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 15(2), 167-169. doi:10.1093/europace/eus436
Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complications
Karthikeyan, V. J., Lane, D. A., Beevers, D. G., Lip, G. Y. H., & Blann, A. D. (2013). Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complications. JOURNAL OF HUMAN HYPERTENSION, 27(2), 72-78. doi:10.1038/jhh.2012.8
Modification of outcomes with aspirin or apixaban in relation to CHADS(2) and CHA(2)DS(2)-VASc scores in patients with atrial fibrillation: a secondary analysis of the AVERROES study.
Lip, G. Y. H., Connolly, S., Yusuf, S., Shestakovska, O., Flaker, G., Hart, R., . . . ERROES Investigators. (2013). Modification of outcomes with aspirin or apixaban in relation to CHADS(2) and CHA(2)DS(2)-VASc scores in patients with atrial fibrillation: a secondary analysis of the AVERROES study.. Circulation. Arrhythmia and electrophysiology, 6(1), 31-38. doi:10.1161/circep.112.975847
Periprocedural antithrombotic management of patients undergoing ablation for atrial fibrillation: what we currently do...and what should we do?
Pisters, R., & Lip, G. Y. H. (2013). Periprocedural antithrombotic management of patients undergoing ablation for atrial fibrillation: what we currently do...and what should we do?. The Canadian journal of cardiology, 29(2), 139-141. doi:10.1016/j.cjca.2012.05.016
Prior aspirin therapy and cardiovascular implantable electronic device infections.
Gallego, P., Marin, F., & Lip, G. Y. H. (2013). Prior aspirin therapy and cardiovascular implantable electronic device infections.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 15(2), 163-164. doi:10.1093/europace/eus346
The prognostic role of the adiponectin levels in atrial fibrillation.
Hernández-Romero, D., Jover, E., Marín, F., Vilchez, J. A., Manzano-Fernandez, S., Romera, M., . . . Roldán, V. (2013). The prognostic role of the adiponectin levels in atrial fibrillation.. European journal of clinical investigation, 43(2), 168-173. doi:10.1111/eci.12028
The Analysis of Bleeding Risk-Prediction Scores Should Include All Major Bleeds Reply
Apostolakis, S., Lane, D. A., Guo, Y., Buller, H., & Lip, G. Y. H. (2013). The Analysis of Bleeding Risk-Prediction Scores Should Include All Major Bleeds Reply. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 61(4), 482-483. doi:10.1016/j.jacc.2012.10.033
Do open label blinded outcome studies of novel anticoagulants versus warfarin have equivalent validity to those carried out under double-blind conditions?
O'Neil, W. M., Welner, S. A., & Lip, G. Y. H. (2013). Do open label blinded outcome studies of novel anticoagulants versus warfarin have equivalent validity to those carried out under double-blind conditions?. Thrombosis and haemostasis, 109(3), 497-503. doi:10.1160/th12-10-0715
Performance of the HEMORR<sub>2</sub>HAGES, ATRIA, and HAS-BLED Bleeding Risk-Prediction Scores in Nonwarfarin Anticoagulated Atrial Fibrillation Patients
Apostolakis, S., Lane, D. A., Guo, Y., Buller, H., & Lip, G. Y. H. (2013). Performance of the HEMORR<sub>2</sub>HAGES, ATRIA, and HAS-BLED Bleeding Risk-Prediction Scores in Nonwarfarin Anticoagulated Atrial Fibrillation Patients. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 61(3), 386-387. doi:10.1016/j.jacc.2012.10.010
The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy.
Coppens, M., Eikelboom, J. W., Hart, R. G., Yusuf, S., Lip, G. Y. H., Dorian, P., . . . Connolly, S. J. (2013). The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy.. European heart journal, 34(3), 170-176. doi:10.1093/eurheartj/ehs314
A new era of oral anticoagulation in atrial fibrillation: implications in clinical practice.
Kasmeridis, C., Lip, G. Y., & Apostolakis, S. (2013). A new era of oral anticoagulation in atrial fibrillation: implications in clinical practice.. In Hospital practice (1995) (Vol. 41, Iss. 1, pp. 61-70). [Print]. doi:10.3810/hp.2013.02.1011
A very happy new year 2014 from Thrombosis and Haemostasis! Reflections on the past, the present and the future.
Lip, G. Y. H., & Weber, C. (2014). A very happy new year 2014 from Thrombosis and Haemostasis! Reflections on the past, the present and the future.. Thrombosis and haemostasis, 111(1), 1-2. doi:10.1055/s-0037-1608911
Antithrombotic management and type of stent in atrial fibrillation patients undergoing percutaneous coronary intervention.
Ruiz-Nodar, J. M., Marín, F., & Lip, G. Y. H. (2013). Antithrombotic management and type of stent in atrial fibrillation patients undergoing percutaneous coronary intervention.. Revista espanola de cardiologia (English ed.), 66(1), 12-16. doi:10.1016/j.recesp.2012.07.018
Bleeding risk assessment in patients with atrial fibrillation who are taking oral anticoagulants.
Guo, Y., Lip, G. Y., & Apostolakis, S. (2013). Bleeding risk assessment in patients with atrial fibrillation who are taking oral anticoagulants.. In Hospital practice (1995) (Vol. 41, Iss. 1, pp. 71-78). [Print]. doi:10.3810/hp.2013.02.1012
Common Clinical Indications for Anticoagulation
Krishnamoorthy, S., Khoo, C. W., Shantsila, E., & Lip, G. Y. H. (2013). Common Clinical Indications for Anticoagulation. In Handbook of Oral Anticoagulation (pp. 7-31). Springer Healthcare Ltd.. doi:10.1007/978-1-908517-96-8_2
Development of a Novel Composite Stroke and Bleeding Risk Score in Patients With Atrial Fibrillation The AMADEUS Study
Lip, G. Y. H., Lane, D. A., Buller, H., & Apostolakis, S. (2013). Development of a Novel Composite Stroke and Bleeding Risk Score in Patients With Atrial Fibrillation The AMADEUS Study. CHEST, 144(6), 1839-1847. doi:10.1378/chest.13-1635
Differences between indirect comparison studies of the oral anticoagulants for stroke prevention in atrial fibrillation: where do we go next?
Harenberg, J., & Lip, G. Y. H. (2013). Differences between indirect comparison studies of the oral anticoagulants for stroke prevention in atrial fibrillation: where do we go next?. QJM : monthly journal of the Association of Physicians, 106(1), 95-96. doi:10.1093/qjmed/hcs224
Editors' Choice papers in <i>Thrombosis and Haemostasis</i>
Weber, C., & Lip, G. Y. H. (2014). Editors' Choice papers in <i>Thrombosis and Haemostasis</i>. THROMBOSIS AND HAEMOSTASIS, 111(1), 183-188. Retrieved from https://www.webofscience.com/
Editors’ Choice papers in Thrombosis and Haemostasis
Weber, C., & Lip, G. Y. H. (2013). Editors’ Choice papers in Thrombosis and Haemostasis. Thrombosis and Haemostasis, 109(01), 170-173. doi:10.1055/s-0037-1609008
Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score.
Apostolakis, S., Sullivan, R. M., Olshansky, B., & Lip, G. Y. H. (2013). Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score.. Chest, 144(5), 1555-1563. doi:10.1378/chest.13-0054
Future Directions
Shantsila, E., & Lip, G. Y. H. (2013). Future Directions. In Handbook of Oral Anticoagulation (pp. 87-88). Springer Healthcare Ltd.. doi:10.1007/978-1-908517-96-8_6
Handbook of Oral Anticoagulation
Lip, G. Y. H., & Shantsila, E. (Eds.) (2013). Handbook of Oral Anticoagulation. Springer Healthcare Ltd.. doi:10.1007/978-1-908517-96-8
Hemorrhage Risks, Patient Perspectives, and Quality-of-Life Issues
Tay, K. -H., Apostolakis, S., Lane, D. A., & Lip, G. Y. H. (2013). Hemorrhage Risks, Patient Perspectives, and Quality-of-Life Issues. In Handbook of Oral Anticoagulation (pp. 41-51). Springer Healthcare Ltd.. doi:10.1007/978-1-908517-96-8_4
Increased Formation of Monocyte-Platelet Aggregates in Ischemic Heart Failure
Wrigley, B. J., Shantsila, E., Tapp, L. D., & Lip, G. Y. H. (2013). Increased Formation of Monocyte-Platelet Aggregates in Ischemic Heart Failure. CIRCULATION-HEART FAILURE, 6(1), 127-+. doi:10.1161/CIRCHEARTFAILURE.112.968073
Is the higher risk of cardiovascular disease amongst South Asian populations linked to abnormalities of haemoglobin? A preliminary case control study.
Patel, J. V., Chackathayil, J., Gammon, B., Tracey, I., Lovick, A., Gill, P. S., . . . Hughes, E. A. (2013). Is the higher risk of cardiovascular disease amongst South Asian populations linked to abnormalities of haemoglobin? A preliminary case control study.. Atherosclerosis, 226(1), 198-200. doi:10.1016/j.atherosclerosis.2012.09.017
Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: results of the European Heart Rhythm Association survey.
Lip, G. Y. H., Dagres, N., Proclemer, A., Svendsen, J. H., Pison, L., Blomstrom-Lundqvist, C., & Scientific Initiative Committee, European Heart Rhythm Association. (2013). Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: results of the European Heart Rhythm Association survey.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 15(1), 141-143. doi:10.1093/europace/eus413
New Oral Anticoagulants
Shantsila, E., Apostolakis, S., & Lip, G. Y. H. (2013). New Oral Anticoagulants. In Handbook of Oral Anticoagulation (pp. 53-86). Springer Healthcare Ltd.. doi:10.1007/978-1-908517-96-8_5
Oral anticoagulation for heart failure in sinus rhythm: from evidence to clinical recommendations, or not?
Marín, F., & Lip, G. Y. H. (2013). Oral anticoagulation for heart failure in sinus rhythm: from evidence to clinical recommendations, or not?. European journal of heart failure, 15(1), 3-4. doi:10.1093/eurjhf/hfs198
Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting.
Caballero, L., Ruiz-Nodar, J. M., Marín, F., Roldán, V., Hurtado, J. A., Valencia, J., . . . Lip, G. Y. H. (2013). Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting.. Age and ageing, 42(1), 70-75. doi:10.1093/ageing/afs121
Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a "real-world" population with atrial fibrillation receiving anticoagulant therapy.
Roldán, V., Marín, F., Fernández, H., Manzano-Fernandez, S., Gallego, P., Valdés, M., . . . Lip, G. Y. H. (2013). Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a "real-world" population with atrial fibrillation receiving anticoagulant therapy.. Chest, 143(1), 179-184. doi:10.1378/chest.12-0608
Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study.
Potpara, T. S., Polovina, M. M., Licina, M. M., Marinkovic, J. M., & Lip, G. Y. H. (2013). Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study.. European journal of heart failure, 15(4), 415-424. doi:10.1093/eurjhf/hft004
Recent Developments in Understanding Epidemiology and Risk Determinants of Atrial Fibrillation as a Cause of Stroke
Ahmad, Y., Lip, G. Y. H., & Lane, D. A. (2013). Recent Developments in Understanding Epidemiology and Risk Determinants of Atrial Fibrillation as a Cause of Stroke. CANADIAN JOURNAL OF CARDIOLOGY, 29(7), S4-S13. doi:10.1016/j.cjca.2013.03.009
Recent advances in management of atrial fibrillation in patients with heart failure
Shantsila, E., & Lip, G. Y. H. (2013). Recent advances in management of atrial fibrillation in patients with heart failure. CURRENT OPINION IN CARDIOLOGY, 28(2), 197-208. doi:10.1097/HCO.0b013e32835bd465
Retinal vessel tortuosity measures and their applications.
Kalitzeos, A. A., Lip, G. Y. H., & Heitmar, R. (2013). Retinal vessel tortuosity measures and their applications.. Experimental eye research, 106, 40-46. doi:10.1016/j.exer.2012.10.015
Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure: background, aims and design of the RACE 3 study
Alings, M., Smit, M. D., Moes, M. L., Crijns, H. J. G. M., Tijssen, J. G. P., Brugemann, J., . . . Van Gelder, I. C. (2013). Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure: background, aims and design of the RACE 3 study. NETHERLANDS HEART JOURNAL, 21(7-8), 354-363. doi:10.1007/s12471-013-0428-5
Stroke risk stratification scores in atrial fibrillation: current recommendations for clinical practice and future perspectives.
Durrant, J., Lip, G. Y. H., & Lane, D. A. (2013). Stroke risk stratification scores in atrial fibrillation: current recommendations for clinical practice and future perspectives.. Expert review of cardiovascular therapy, 11(1), 77-90. doi:10.1586/erc.12.161
The Coagulation Pathway and Approaches to Anticoagulation
Tay, K. H., Shantsila, E., & Lip, G. Y. H. (2013). The Coagulation Pathway and Approaches to Anticoagulation. In Handbook of Oral Anticoagulation (pp. 1-5). Springer Healthcare Ltd.. doi:10.1007/978-1-908517-96-8_1
Vascular and platelet responses to aspirin in patients with coronary artery disease.
Blann, A. D., Kuzniatsova, N., & Lip, G. Y. H. (2013). Vascular and platelet responses to aspirin in patients with coronary artery disease.. European journal of clinical investigation, 43(1), 91-99. doi:10.1111/eci.12021
Vitamin K Antagonists and Their Limitations
Khoo, C. W., Shantsila, E., & Lip, G. Y. H. (2013). Vitamin K Antagonists and Their Limitations. In Handbook of Oral Anticoagulation (pp. 33-40). Springer Healthcare Ltd.. doi:10.1007/978-1-908517-96-8_3
β-Trace protein and prognosis in patients with atrial fibrillation receiving anticoagulation treatment.
Vílchez, J. A., Roldán, V., Manzano-Fernández, S., Fernández, H., Avilés-Plaza, F., Martínez-Hernández, P., . . . Lip, G. Y. H. (2013). β-Trace protein and prognosis in patients with atrial fibrillation receiving anticoagulation treatment.. Chest, 144(5), 1564-1570. doi:10.1378/chest.13-0922
2012
Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm An Executive Summary<SUP>#</SUP> of a joint Consensus Document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis
Lip, G. Y. H., Ponikowski, P., Andreotti, F., Anker, S. D., Filippatos, G., Homma, S., . . . Lane, D. A. (2012). Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm An Executive Summary<SUP>#</SUP> of a joint Consensus Document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis. THROMBOSIS AND HAEMOSTASIS, 108(6), 1009-1022. doi:10.1160/TH12-08-0578
Relation of gender-specific risk of ischemic stroke in patients with atrial fibrillation to differences in warfarin anticoagulation control (from AFFIRM).
Sullivan, R. M., Zhang, J., Zamba, G., Lip, G. Y. H., & Olshansky, B. (2012). Relation of gender-specific risk of ischemic stroke in patients with atrial fibrillation to differences in warfarin anticoagulation control (from AFFIRM).. The American journal of cardiology, 110(12), 1799-1802. doi:10.1016/j.amjcard.2012.08.014
Inflammation in atrial fibrillation.
Guo, Y., Lip, G. Y. H., & Apostolakis, S. (2012). Inflammation in atrial fibrillation.. Journal of the American College of Cardiology, 60(22), 2263-2270. doi:10.1016/j.jacc.2012.04.063
A contemporary viewpoint on 'aspirin resistance'
Kuzniatsova, N., Shantsila, E., Blann, A., & Lip, G. Y. H. (2012). A contemporary viewpoint on 'aspirin resistance'. ANNALS OF MEDICINE, 44(8), 773-783. doi:10.3109/07853890.2011.605388
Ankle brachial index as an independent predictor of mortality in anticoagulated atrial fibrillation.
Gallego, P., Roldán, V., Marín, F., Jover, E., Manzano-Fernández, S., Valdés, M., . . . Lip, G. Y. H. (2012). Ankle brachial index as an independent predictor of mortality in anticoagulated atrial fibrillation.. European journal of clinical investigation, 42(12), 1302-1308. doi:10.1111/eci.12004
Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial.
Flaker, G. C., Eikelboom, J. W., Shestakovska, O., Connolly, S. J., Kaatz, S., Budaj, A., . . . Hart, R. G. (2012). Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial.. Stroke, 43(12), 3291-3297. doi:10.1161/strokeaha.112.664144
New oral anticoagulants for stroke prevention in atrial fibrillation: impact of gender, heart failure, diabetes mellitus and paroxysmal atrial fibrillation.
Ahmad, Y., Lip, G. Y. H., & Apostolakis, S. (2012). New oral anticoagulants for stroke prevention in atrial fibrillation: impact of gender, heart failure, diabetes mellitus and paroxysmal atrial fibrillation.. Expert review of cardiovascular therapy, 10(12), 1471-1480. doi:10.1586/erc.12.148
Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research Database.
Lee, S., Monz, B. U., Clemens, A., Brueckmann, M., & Lip, G. Y. H. (2012). Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research Database.. BMJ open, 2(6), e001768. doi:10.1136/bmjopen-2012-001768
Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.
Dentali, F., Riva, N., Crowther, M., Turpie, A. G. G., Lip, G. Y. H., & Ageno, W. (2012). Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.. Circulation, 126(20), 2381-2391. doi:10.1161/circulationaha.112.115410
Response to Letter Regarding Article, “Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation: A Report From the Swedish Atrial Fibrillation Cohort Study”
Friberg, L., Rosenqvist, M., & Lip, G. Y. H. (2012). Response to Letter Regarding Article, “Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation: A Report From the Swedish Atrial Fibrillation Cohort Study”. Circulation, 126(20). doi:10.1161/circulationaha.112.134841
Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis.
Rasmussen, L. H., Larsen, T. B., Graungaard, T., Skjøth, F., & Lip, G. Y. H. (2012). Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis.. BMJ (Clinical research ed.), 345, e7097. doi:10.1136/bmj.e7097
Atrial Fibrillation
Khoo, C. W., & Lip, G. Y. H. (2012). Atrial Fibrillation. In Unknown Book (pp. 143-173). Wiley. doi:10.1002/9781118399378.ch6
Gender-related differences in presentation, treatment and long-term outcome in patients with first-diagnosed atrial fibrillation and structurally normal heart: the Belgrade atrial fibrillation study.
Potpara, T. S., Marinkovic, J. M., Polovina, M. M., Stankovic, G. R., Seferovic, P. M., Ostojic, M. C., & Lip, G. Y. H. (2012). Gender-related differences in presentation, treatment and long-term outcome in patients with first-diagnosed atrial fibrillation and structurally normal heart: the Belgrade atrial fibrillation study.. International journal of cardiology, 161(1), 39-44. doi:10.1016/j.ijcard.2011.04.022
High sensitivity cardiac troponin T and interleukin‐6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation: a reply to a rebuttal
ROLDÁN, V., MARÍN, F., GALLEGO, P., VICENTE, V., & LIP, G. Y. H. (2012). High sensitivity cardiac troponin T and interleukin‐6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation: a reply to a rebuttal. Journal of Thrombosis and Haemostasis, 10(11), 2414-2415. doi:10.1111/j.1538-7836.2012.04918.x
How European centres diagnose, treat, and prevent CIED infections: results of an European Heart Rhythm Association survey.
Bongiorni, M. G., Marinskis, G., Lip, G. Y. H., Svendsen, J. H., Dobreanu, D., Blomström-Lundqvist, C., & Scientific Initiative Committee, European Heart Rhythm Association. (2012). How European centres diagnose, treat, and prevent CIED infections: results of an European Heart Rhythm Association survey.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 14(11), 1666-1669. doi:10.1093/europace/eus350
No effect of clopidogrel activity or cessation on vascular function or markers of inflammation.
Kuzniatsova, N., Balakrishnan, B., Lip, G. Y. H., & Blann, A. D. (2012). No effect of clopidogrel activity or cessation on vascular function or markers of inflammation.. The International journal of angiology : official publication of the International College of Angiology, Inc, 21(4), 195-200. doi:10.1055/s-0032-1328777
Prevalence of atrial fibrillation in the general population and in high-risk groups: the ECHOES study.
Davis, R. C., Hobbs, F. D. R., Kenkre, J. E., Roalfe, A. K., Iles, R., Lip, G. Y. H., & Davies, M. K. (2012). Prevalence of atrial fibrillation in the general population and in high-risk groups: the ECHOES study.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 14(11), 1553-1559. doi:10.1093/europace/eus087
Stroke prevention in atrial fibrillation: concepts and controversies.
Ahmad, Y., & Lip, G. Y. H. (2012). Stroke prevention in atrial fibrillation: concepts and controversies.. Current cardiology reviews, 8(4), 290-301. doi:10.2174/157340312803760820
ACP Journal Club. Various risk stratification schemes predict ischemic stroke and bleeding in atrial fibrillation.
Gage, B. F., & Andrade, A. (2012). ACP Journal Club. Various risk stratification schemes predict ischemic stroke and bleeding in atrial fibrillation.. Annals of internal medicine, 157(8), JC4-J13. doi:10.7326/0003-4819-157-8-201210160-02013
Chronic Atrial Fibrillation
Lane, D. A., Apostolakis, S., Boos, C. J., & Lip, G. Y. H. (2012). Chronic Atrial Fibrillation. AMERICAN FAMILY PHYSICIAN, 86(8), 757-758. Retrieved from https://www.webofscience.com/
RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers.
Crijns, H. J. G. M., Bash, L. D., Chazelle, F., Le Heuzey, J. -Y., Lewalter, T., Lip, G. Y. H., . . . Gitt, A. K. (2012). RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers.. BMC cardiovascular disorders, 12, 85. doi:10.1186/1471-2261-12-85
A cross-sectional study of quality of life in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation Treatment of the Aged study.
Roalfe, A. K., Bryant, T. L., Davies, M. H., Hackett, T. G., Saba, S., Fletcher, K., . . . BAFTA investigators. (2012). A cross-sectional study of quality of life in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation Treatment of the Aged study.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 14(10), 1420-1427. doi:10.1093/europace/eus102
Assessing the Risk of Bleeding in Patients With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project
Lip, G. Y. H., Banerjee, A., Lagrenade, I., Lane, D. A., Taillandier, S., & Fauchier, L. (2012). Assessing the Risk of Bleeding in Patients With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 5(5), 941-948. doi:10.1161/CIRCEP.112.972869
Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: NICE guidance.
Ahmad, Y., & Lip, G. Y. H. (2012). Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: NICE guidance.. Heart (British Cardiac Society), 98(19), 1404-1406. doi:10.1136/heartjnl-2012-302101
Eosinophil count predicts mortality following percutaneous coronary intervention.
Toor, I. S., Jaumdally, R., Lip, G. Y. H., Millane, T., & Varma, C. (2012). Eosinophil count predicts mortality following percutaneous coronary intervention.. Thrombosis research, 130(4), 607-611. doi:10.1016/j.thromres.2012.05.033
Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).
Vahanian, A., Alfieri, O., Andreotti, F., Antunes, M. J., Barón-Esquivias, G., Baumgartner, H., . . . European Association for Cardio-Thoracic Surgery (EACTS). (2012). Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 42(4), S1-44. doi:10.1093/ejcts/ezs455
Pre and post-operative treatments for prevention of atrial fibrillation after cardiac surgery.
Orenes-Piñero, E., Montoro-García, S., Banerjee, A., Valdés, M., Lip, G. Y. H., & Marín, F. (2012). Pre and post-operative treatments for prevention of atrial fibrillation after cardiac surgery.. Mini reviews in medicinal chemistry, 12(13), 1419-1431. doi:10.2174/13895575112091419
Risk of stroke and oral anticoagulant use in atrial fibrillation: a cross-sectional survey.
Holt, T. A., Hunter, T. D., Gunnarsson, C., Khan, N., Cload, P., & Lip, G. Y. H. (2012). Risk of stroke and oral anticoagulant use in atrial fibrillation: a cross-sectional survey.. The British journal of general practice : the journal of the Royal College of General Practitioners, 62(603), e710-e717. doi:10.3399/bjgp12x656856
Stroke risk assessment in atrial fibrillation
Apostolakis, S., & Lip, G. Y. H. (2012). Stroke risk assessment in atrial fibrillation. In Unknown Book (pp. 10-29). Future Medicine Ltd. doi:10.2217/ebo.12.47
Subclinical atherosclerotic endothelial damage as predictor for bleeding in anticoagulated atrial fibrillation patients.
Hernández-Romero, D., Marín, F., Roldán, V., & Lip, G. Y. H. (2012). Subclinical atherosclerotic endothelial damage as predictor for bleeding in anticoagulated atrial fibrillation patients.. Journal of internal medicine, 272(4), 409. doi:10.1111/j.1365-2796.2012.02565.x
[ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012].
McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., . . . Heart Failure Association. (2012). [ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012].. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 40 Suppl 3, 77-137.
Bridging evidence-based practice and practice-based evidence in periprocedural anticoagulation.
Gallego, P., Apostolakis, S., & Lip, G. Y. H. (2012). Bridging evidence-based practice and practice-based evidence in periprocedural anticoagulation.. Circulation, 126(13), 1573-1576. doi:10.1161/circulationaha.112.135681
New anticoagulant treatments to protect against stroke in atrial fibrillation.
Potpara, T. S., Lip, G. Y. H., & Apostolakis, S. (2012). New anticoagulant treatments to protect against stroke in atrial fibrillation.. Heart (British Cardiac Society), 98(18), 1341-1347. doi:10.1136/heartjnl-2012-301841
Seasonality, incidence and prognosis in atrial fibrillation and stroke in Denmark and New Zealand.
Christensen, A. L., Rasmussen, L. H., Baker, M. G., Lip, G. Y. H., Dethlefsen, C., & Larsen, T. B. (2012). Seasonality, incidence and prognosis in atrial fibrillation and stroke in Denmark and New Zealand.. BMJ open, 2(4), e001210. doi:10.1136/bmjopen-2012-001210
Prevention of venous thromboembolism with new oral anticoagulants versus standard pharmacological treatment in acute medically ill patients: a systematic review and meta-analysis.
Albertsen, I. E., Larsen, T. B., Rasmussen, L. H., Overvad, T. F., & Lip, G. Y. H. (2012). Prevention of venous thromboembolism with new oral anticoagulants versus standard pharmacological treatment in acute medically ill patients: a systematic review and meta-analysis.. Drugs, 72(13), 1755-1764. doi:10.2165/11635630-000000000-00000
Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study.
Mikkelsen, A. P., Lindhardsen, J., Lip, G. Y. H., Gislason, G. H., Torp-Pedersen, C., & Olesen, J. B. (2012). Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study.. Journal of thrombosis and haemostasis : JTH, 10(9), 1745-1751. doi:10.1111/j.1538-7836.2012.04853.x
Renal function and aspirin resistance in patients with coronary artery disease.
Blann, A. D., Kuzniatsova, N., Velu, S., & Lip, G. Y. H. (2012). Renal function and aspirin resistance in patients with coronary artery disease.. Thrombosis research, 130(3), e103-e106. doi:10.1016/j.thromres.2012.06.026
Performance of the HEMORR<sub>2</sub>HAGES, ATRIA, and HAS-BLED Bleeding Risk-Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation
Apostolakis, S., Lane, D. A., Guo, Y., Buller, H., & Lip, G. Y. H. (2012). Performance of the HEMORR<sub>2</sub>HAGES, ATRIA, and HAS-BLED Bleeding Risk-Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 60(9), 861-867. doi:10.1016/j.jacc.2012.06.019
Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
Lip, G. Y. H., Larsen, T. B., Skjøth, F., & Rasmussen, L. H. (2012). Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.. Journal of the American College of Cardiology, 60(8), 738-746. doi:10.1016/j.jacc.2012.03.019
Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease
Olesen, J. B., Lip, G. Y. H., Kamper, A. -L., Hommel, K., Kober, L., Lane, D. A., . . . Torp-Pedersen, C. (2012). Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease. NEW ENGLAND JOURNAL OF MEDICINE, 367(7), 625-635. doi:10.1056/NEJMoa1105594
Use of the CHA<sub>2</sub>DS<sub>2</sub>-VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation
Lane, D. A., & Lip, G. Y. H. (2012). Use of the CHA<sub>2</sub>DS<sub>2</sub>-VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation. CIRCULATION, 126(7), 860-865. doi:10.1161/CIRCULATIONAHA.111.060061
Edoxaban in Japanese patients with nonvalvular atrial fibrillation: not the same dose for everybody.
Roldán, V., Marín, F., & Lip, G. Y. H. (2012). Edoxaban in Japanese patients with nonvalvular atrial fibrillation: not the same dose for everybody.. Circulation journal : official journal of the Japanese Circulation Society, 76(8), 1826-1827. doi:10.1253/circj.cj-12-0765
A contemporary view on endothelial function in heart failure
Shantsila, E., Wrigley, B. J., Blann, A. D., Gill, P. S., & Lip, G. Y. H. (2012). A contemporary view on endothelial function in heart failure. EUROPEAN JOURNAL OF HEART FAILURE, 14(8), 873-881. doi:10.1093/eurjhf/hfs066
An innovative flow cytometric approach for small-size platelet microparticles: Influence of calcium
Montoro-Garcia, S., Shantsila, E., Orenes-Pinero, E., Luisa Lozano, M., & Lip, G. Y. H. (2012). An innovative flow cytometric approach for small-size platelet microparticles: Influence of calcium. THROMBOSIS AND HAEMOSTASIS, 108(2), 373-383. doi:10.1160/TH12-02-0120
Antiplatelet therapy in stroke prevention.
Apostolakis, S., Marín, F., & Lip, G. Y. H. (2012). Antiplatelet therapy in stroke prevention.. Advances in cardiology, 47, 141-154. doi:10.1159/000338050
Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
Harenberg, J., Marx, S., Diener, H. -C., Lip, G. Y. H., Marder, V. J., Wehling, M., & Weiss, C. (2012). Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.. International angiology : a journal of the International Union of Angiology, 31(4), 330-339.
Current practice in out-of-hospital cardiac arrest management: a European heart rhythm association EP network survey.
Proclemer, A., Dobreanu, D., Pison, L., Lip, G. Y. H., Svendsen, J. H., Lundqvist, C. B., & Scientific Initiative Committee-European Heart Rhythm Association. (2012). Current practice in out-of-hospital cardiac arrest management: a European heart rhythm association EP network survey.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 14(8), 1195-1198. doi:10.1093/europace/eus232
High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation.
Roldán, V., Marín, F., Díaz, J., Gallego, P., Jover, E., Romera, M., . . . Lip, G. Y. H. (2012). High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation.. Journal of thrombosis and haemostasis : JTH, 10(8), 1500-1507. doi:10.1111/j.1538-7836.2012.04812.x
Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
Ruiz-Nodar, J. M., Marín, F., Roldán, V., Valencia, J., Manzano-Fernández, S., Caballero, L., . . . Lip, G. Y. H. (2012). Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?. Circulation. Cardiovascular interventions, 5(4), 459-466. doi:10.1161/circinterventions.112.968792
The effects of exercise and diurnal variation on monocyte subsets and monocyte-platelet aggregates
Shantsila, E., Tapp, L. D., Wrigley, B. J., Montoro-Garcia, S., Ghattas, A., Jaipersad, A., & Lip, G. Y. H. (2012). The effects of exercise and diurnal variation on monocyte subsets and monocyte-platelet aggregates. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 42(8), 832-839. doi:10.1111/j.1365-2362.2012.02656.x
Vascular Disease and Stroke Risk in Atrial Fibrillation: A Nationwide Cohort Study
Olesen, J. B., Lip, G. Y. H., Lane, D. A., Kober, L., Hansen, M. L., Karasoy, D., . . . Torp-Pedersen, C. (2012). Vascular Disease and Stroke Risk in Atrial Fibrillation: A Nationwide Cohort Study. AMERICAN JOURNAL OF MEDICINE, 125(8). doi:10.1016/j.amjmed.2011.11.024
Stroke and mortality in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study.
Lip, G. Y. H., Rasmussen, L. H., Skjøth, F., Overvad, K., & Larsen, T. B. (2012). Stroke and mortality in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study.. BMJ open, 2(4), e000975. doi:10.1136/bmjopen-2012-000975
Comparison of frequency of major adverse events in patients with atrial fibrillation receiving bare-metal versus drug-eluting stents in their coronary arteries.
Fauchier, L., Pellegrin, C., Bernard, A., Clementy, N., Angoulvant, D., Lip, G. Y. H., & Babuty, D. (2012). Comparison of frequency of major adverse events in patients with atrial fibrillation receiving bare-metal versus drug-eluting stents in their coronary arteries.. The American journal of cardiology, 110(1), 7-12. doi:10.1016/j.amjcard.2012.02.042
Fibrinolytic status hi acute coronary syndromes: Evidence of differences in relation to clinical features and pathophysiological pathways
Shantsila, E., Montoro-Garcia, S., Tapp, L. D., Apostolakis, S., Wrigley, B. J., & Lip, G. Y. H. (2012). Fibrinolytic status hi acute coronary syndromes: Evidence of differences in relation to clinical features and pathophysiological pathways. THROMBOSIS AND HAEMOSTASIS, 108(1), 32-40. doi:10.1160/TH12-01-0011
Monocyte-derived and CD34+/KDR+ endothelial progenitor cells in heart failure
Shantsila, E., Wrigley, B. J., Shantsila, A., Tapp, L. D., Gill, P. S., & Lip, G. Y. H. (2012). Monocyte-derived and CD34+/KDR+ endothelial progenitor cells in heart failure. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 10(7), 1252-1261. doi:10.1111/j.1538-7836.2012.04753.x
Novel oral anticoagulants: focus on the direct factor Xa inhibitor darexaban.
Apostolakis, S., & Lip, G. Y. H. (2012). Novel oral anticoagulants: focus on the direct factor Xa inhibitor darexaban.. Expert opinion on investigational drugs, 21(7), 1057-1064. doi:10.1517/13543784.2012.689286
Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation.
Jover, E., Roldán, V., Gallego, P., Hernández-Romero, D., Valdés, M., Vicente, V., . . . Marín, F. (2012). Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation.. Revista espanola de cardiologia (English ed.), 65(7), 627-633. doi:10.1016/j.recesp.2012.02.017
Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
Taillandier, S., Olesen, J. B., Clémenty, N., Lagrenade, I., Babuty, D., Lip, G. Y. H., & Fauchier, L. (2012). Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.. Journal of cardiovascular electrophysiology, 23(7), 708-713. doi:10.1111/j.1540-8167.2011.02257.x
Resource utilization and outcomes in patients with atrial fibrillation: a case control study.
Boggon, R., Lip, G. Y. H., Gallagher, A. M., & van Staa, T. P. (2012). Resource utilization and outcomes in patients with atrial fibrillation: a case control study.. Applied health economics and health policy, 10(4), 249-259. doi:10.2165/11599940-000000000-00000
The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction
Tapp, L. D., Shantsila, E., Wrigley, B. J., Pamukcu, B., & Lip, G. Y. H. (2012). The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 10(7), 1231-1241. doi:10.1111/j.1538-7836.2011.04603.x
The unmet need of stroke prevention in atrial fibrillation in the Far East and South East Asia
Guo, Y., Lip, G. Y. H., & ApostolaLAkis, S. (2012). The unmet need of stroke prevention in atrial fibrillation in the Far East and South East Asia. Malaysian Journal of Medical Sciences, 19(3), 1-7.
Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A Joint Consensus Document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis
Lip, G. Y. H., Ponikowski, P., Andreotti, F., Anker, S. D., Filippatos, G., Homma, S., . . . Lane, D. A. (2012). Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A Joint Consensus Document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis. EUROPEAN JOURNAL OF HEART FAILURE, 14(7), 681-695. doi:10.1093/eurjhf/hfs073
Vascular ventricular coupling in patients with malignant phase hypertension: the West Birmingham malignant hypertension project
Shantsila, A., Dwivedi, G., Shantsila, E., Steeds, R. P., Beevers, G., & Lip, G. Y. H. (2012). Vascular ventricular coupling in patients with malignant phase hypertension: the West Birmingham malignant hypertension project. HYPERTENSION RESEARCH, 35(7), 725-728. doi:10.1038/hr.2012.18
Atrial fibrillation, arrhythmia burden and thrombogenesis.
Khoo, C. W., Krishnamoorthy, S., Lim, H. S., & Lip, G. Y. H. (2012). Atrial fibrillation, arrhythmia burden and thrombogenesis.. International journal of cardiology, 157(3), 318-323. doi:10.1016/j.ijcard.2011.06.088
Anticoagulation versus placebo for heart failure in sinus rhythm.
Lip, G. Y., Wrigley, B. J., & Pisters, R. (2012). Anticoagulation versus placebo for heart failure in sinus rhythm.. The Cochrane database of systematic reviews, (6), CD003336. doi:10.1002/14651858.cd003336.pub2
An audience with... Gregory Lip. Interview by Asher Mullard.
Lip, G. (2012). An audience with... Gregory Lip. Interview by Asher Mullard.. Nature reviews. Drug discovery, 11(6), 434. doi:10.1038/nrd3752
Angiotensin receptor blockers and tumorigenesis: something to be (or not to be) concerned about?
Tchaikovski, V., & Lip, G. Y. H. (2012). Angiotensin receptor blockers and tumorigenesis: something to be (or not to be) concerned about?. Current hypertension reports, 14(3), 183-192. doi:10.1007/s11906-012-0263-x
Dabigatran for the prevention of stroke in atrial fibrillation: is RE-LY reliable?
Marín, F., Roldán, V., & Lip, G. Y. H. (2012). Dabigatran for the prevention of stroke in atrial fibrillation: is RE-LY reliable?. Expert opinion on pharmacotherapy, 13(8), 1087-1090. doi:10.1517/14656566.2012.688954
Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
Friberg, L., Rosenqvist, M., & Lip, G. Y. H. (2012). Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.. European heart journal, 33(12), 1500-1510. doi:10.1093/eurheartj/ehr488
Heparin bridging vs. uninterrupted oral anticoagulation in patients with Atrial Fibrillation undergoing Coronary Artery Stenting. Results from the AFCAS registry.
Lahtela, H., Rubboli, A., Schlitt, A., Karjalainen, P. P., Niemelä, M., Vikman, S., . . . AFCAS (Management of patients with Atrial Fibrillation undergoing Coronary Artery Stenting) study group. (2012). Heparin bridging vs. uninterrupted oral anticoagulation in patients with Atrial Fibrillation undergoing Coronary Artery Stenting. Results from the AFCAS registry.. Circulation journal : official journal of the Japanese Circulation Society, 76(6), 1363-1368. doi:10.1253/circj.cj-11-1206
Insights from the RCPE UK Consensus Conference on approaching the comprehensive management of atrial fibrillation.
Lip, G. Y. H., & Ramsay, S. G. (2012). Insights from the RCPE UK Consensus Conference on approaching the comprehensive management of atrial fibrillation.. In Expert review of cardiovascular therapy Vol. 10 (pp. 697-700). doi:10.1586/erc.12.48
Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Potpara, T. S., Polovina, M. M., Licina, M. M., Stojanovic, R. M., Prostran, M. S., & Lip, G. Y. H. (2012). Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.. Advances in therapy, 29(6), 491-507. doi:10.1007/s12325-012-0026-8
Peripheral artery disease and atrial fibrillation: a potentially dangerous combination.
Violi, F., Lip, G. Y. H., & Basili, S. (2012). Peripheral artery disease and atrial fibrillation: a potentially dangerous combination.. Internal and emergency medicine, 7(3), 213-218. doi:10.1007/s11739-011-0637-0
The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
Olesen, J. B., Torp-Pedersen, C., Hansen, M. L., & Lip, G. Y. H. (2012). The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.. Thrombosis and haemostasis, 107(6), 1172-1179. doi:10.1160/th12-03-0175
Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study.
Friberg, L., Benson, L., Rosenqvist, M., & Lip, G. Y. H. (2012). Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study.. BMJ (Clinical research ed.), 344, e3522. doi:10.1136/bmj.e3522
Bleeding risk assessment and management in atrial fibrillation patients. Key messages for clinical practice from the European Heart Rhythm Association position statement.
Guo, Y., Lip, G. Y. H., & Apostolakis, S. (2012). Bleeding risk assessment and management in atrial fibrillation patients. Key messages for clinical practice from the European Heart Rhythm Association position statement.. Polskie Archiwum Medycyny Wewnetrznej, 122(5), 235-242.
Warfarin and aspirin in patients with heart failure and sinus rhythm.
Homma, S., Thompson, J. L. P., Pullicino, P. M., Levin, B., Freudenberger, R. S., Teerlink, J. R., . . . WARCEF Investigators. (2012). Warfarin and aspirin in patients with heart failure and sinus rhythm.. The New England journal of medicine, 366(20), 1859-1869. doi:10.1056/nejmoa1202299
Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study.
Friberg, L., Rosenqvist, M., & Lip, G. Y. H. (2012). Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study.. Circulation, 125(19), 2298-2307. doi:10.1161/circulationaha.111.055079
Added predictive ability of the CHA2DS2VASc risk score for stroke and death in patients with atrial fibrillation: the prospective Danish Diet, Cancer, and Health cohort study.
Larsen, T. B., Lip, G. Y. H., Skjøth, F., Due, K. M., Overvad, K., & Hvilsted Rasmussen, L. (2012). Added predictive ability of the CHA2DS2VASc risk score for stroke and death in patients with atrial fibrillation: the prospective Danish Diet, Cancer, and Health cohort study.. Circulation. Cardiovascular quality and outcomes, 5(3), 335-342. doi:10.1161/circoutcomes.111.964023
An observational study of endothelial function in early arthritis.
Foster, W., Lip, G. Y. H., Raza, K., Carruthers, D., & Blann, A. D. (2012). An observational study of endothelial function in early arthritis.. European journal of clinical investigation, 42(5), 510-516. doi:10.1111/j.1365-2362.2011.02607.x
Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: resolving uncertainties in routine practice.
Huisman, M. V., Lip, G. Y. H., Diener, H. -C., Brueckmann, M., van Ryn, J., & Clemens, A. (2012). Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: resolving uncertainties in routine practice.. Thrombosis and haemostasis, 107(5), 838-847. doi:10.1160/th11-10-0718
Do the current atrial fibrillation guidelines for stroke prevention need to be changed with the availability of new data on the new oral anticoagulants?
Foley, J., & Lip, G. Y. H. (2012). Do the current atrial fibrillation guidelines for stroke prevention need to be changed with the availability of new data on the new oral anticoagulants?. International journal of clinical practice, 66(5), 422-424. doi:10.1111/j.1742-1241.2011.02815.x
How early is early enough to prevent stroke in atrial fibrillation?
Guo, Y., Lip, G. Y., & Apostolakis, S. (2012). How early is early enough to prevent stroke in atrial fibrillation?. Expert review of cardiovascular therapy, 10(5), 585-588. doi:10.1586/erc.12.36
Periprocedural anticoagulation therapy for devices and atrial fibrillation ablation.
Lip, G. Y. H., Proclemer, A., Dagres, N., Bongiorni, M. G., Lewalter, T., Blomström-Lundqvist, C., & Scientific Initiative Committee, European Heart Rhythm Association. (2012). Periprocedural anticoagulation therapy for devices and atrial fibrillation ablation.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 14(5), 741-744. doi:10.1093/europace/eus105
Population health status of South Asian and African-Caribbean communities in the United Kingdom.
Calvert, M., Duffy, H., Freemantle, N., Davis, R., Lip, G. Y. H., & Gill, P. (2012). Population health status of South Asian and African-Caribbean communities in the United Kingdom.. BMC health services research, 12, 101. doi:10.1186/1472-6963-12-101
2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.
Calkins, H., Kuck, K. H., Cappato, R., Brugada, J., Camm, A. J., Chen, S. -A., . . . Wilber, D. (2012). 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.. In Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology Vol. 14 (pp. 528-606). doi:10.1093/europace/eus027
Angiogenin and Hemoxygenase in Pregnancy: Influence of Hypertension
Karthikeyan, V. J., Lip, G. Y. H., Baghdadi, S., Lane, D. A., Beevers, D. G., & Blann, A. D. (2012). Angiogenin and Hemoxygenase in Pregnancy: Influence of Hypertension. ANGIOLOGY, 63(3), 194-198. doi:10.1177/0003319711410308
Anthropometric discriminators of the risk of high blood pressure amongst public schoolchildren in Gujarat, India.
Patel, J. V., Lip, G. Y., Prabharkaran, D., Reddy, K. S., Gill, P. S., & Hughes, E. A. (2012). Anthropometric discriminators of the risk of high blood pressure amongst public schoolchildren in Gujarat, India.. International journal of clinical practice, 66(4), 418-420. doi:10.1111/j.1742-1241.2011.02875.x
Comments on the Spanish Society of Cardiology critical review of the ESC 2010 clinical practice guidelines on atrial fibrillation.
Lip, G. Y. H., & Camm, A. J. (2012). Comments on the Spanish Society of Cardiology critical review of the ESC 2010 clinical practice guidelines on atrial fibrillation.. Revista espanola de cardiologia (English ed.), 65(4), 390-391. doi:10.1016/j.recesp.2011.12.007
Monitoring in the management of atrial fibrillation.
Lewalter, T., Morgan, J., Halimi, F., Lip, G., Dagres, N., Blomström-Lundqvist, C., & Scientific Initiative Committee, European Heart Rhythm Association. (2012). Monitoring in the management of atrial fibrillation.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 14(4), 591-592. doi:10.1093/europace/eus073
Preventative measures of stroke in patients with atrial fibrillation
Adlan, A., & Lip, G. Y. H. (2012). Preventative measures of stroke in patients with atrial fibrillation. Journal of Atrial Fibrillation, 2(10).
Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
Gallego, P., Roldán, V., Torregrosa, J. M., Gálvez, J., Valdés, M., Vicente, V., . . . Lip, G. Y. H. (2012). Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.. Circulation. Arrhythmia and electrophysiology, 5(2), 312-318. doi:10.1161/circep.111.967000
Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study.
Potpara, T. S., Polovina, M. M., Licina, M. M., Marinkovic, J. M., Prostran, M. S., & Lip, G. Y. H. (2012). Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study.. Circulation. Arrhythmia and electrophysiology, 5(2), 319-326. doi:10.1161/circep.111.966713
The management of patients on oral anticoagulation undergoing coronary stent implantation: a survey among interventional cardiologists from eight European countries.
Rubboli, A., Dewilde, W., Huber, K., Eeckhout, E., Herzfeld, I., Valencia, J., . . . Lip, G. Y. H. (2012). The management of patients on oral anticoagulation undergoing coronary stent implantation: a survey among interventional cardiologists from eight European countries.. Journal of interventional cardiology, 25(2), 163-169. doi:10.1111/j.1540-8183.2011.00683.x
Blood leukocytes in heart failure with preserved ejection fraction: Impact on prognosis
Shantsila, E., Bialiuk, N., Navitski, D., Pyrochkin, A., Gill, P. S., Pyrochkin, V., . . . Lip, G. Y. H. (2012). Blood leukocytes in heart failure with preserved ejection fraction: Impact on prognosis. INTERNATIONAL JOURNAL OF CARDIOLOGY, 155(2), 337-338. doi:10.1016/j.ijcard.2011.12.048
Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation Project
Banerjee, A., Taillandier, S., Olesen, J. B., Lane, D. A., Lallemand, B., Lip, G. Y. H., & Fauchier, L. (2012). Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation Project. EUROPEAN JOURNAL OF HEART FAILURE, 14(3), 295-301. doi:10.1093/eurjhf/hfs005
Highlights of the American Heart Association Scientific Sessions 2011: a focus on ATLAS-TIMI 51, TRACER and PALLAS.
Shantsila, A., & Lip, G. Y. H. (2012). Highlights of the American Heart Association Scientific Sessions 2011: a focus on ATLAS-TIMI 51, TRACER and PALLAS.. In Expert review of cardiovascular therapy Vol. 10 (pp. 305-307). doi:10.1586/erc.11.192
Left Ventricular Systolic and Diastolic Function in Obstructive Sleep Apnea Impact of Continuous Positive Airway Pressure Therapy
Butt, M., Dwivedi, G., Shantsila, A., Khair, O. A., & Lip, G. Y. H. (2012). Left Ventricular Systolic and Diastolic Function in Obstructive Sleep Apnea Impact of Continuous Positive Airway Pressure Therapy. CIRCULATION-HEART FAILURE, 5(2), 226-233. doi:10.1161/CIRCHEARTFAILURE.111.964106
Practices of cardiac implantable electronic device follow-up: results of the European Heart Rhythm Association survey.
Marinskis, G., van Erven, L., Bongiorni, M. G., Lip, G. Y. H., Pison, L., Blomström-Lundqvist, C., & Scientific Initiative Committee, European Heart Rhythm Association. (2012). Practices of cardiac implantable electronic device follow-up: results of the European Heart Rhythm Association survey.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 14(3), 423-425. doi:10.1093/europace/eus020
Atrial fibrillation
Lip, G. Y. H., Tse, H. F., & Lane, D. A. (2012). Atrial fibrillation. In LANCET Vol. 379 (pp. 648-661). doi:10.1016/S0140-6736(11)61514-6
A new era for anticoagulation in atrial fibrillation. Which anticoagulant should we choose for long‑term prevention of thromboembolic complications in patients with atrial fibrillation?
Riva, N., & Lip, G. Y. H. (2012). A new era for anticoagulation in atrial fibrillation. Which anticoagulant should we choose for long‑term prevention of thromboembolic complications in patients with atrial fibrillation?. Polskie Archiwum Medycyny Wewnetrznej, 122(1-2), 45-53.
Antiplatelet therapy in atherothrombotic cardiovascular diseases for primary and secondary prevention: a focus on old and new antiplatelet agents.
Pamukcu, B., Huber, K., & Lip, G. Y. H. (2012). Antiplatelet therapy in atherothrombotic cardiovascular diseases for primary and secondary prevention: a focus on old and new antiplatelet agents.. Current pharmaceutical design, 18(6), 850-860. doi:10.2174/138161212799277716
Dronedarone: an overview.
Kozlowski, D., Budrejko, S., Lip, G. Y. H., Mikhailidis, D. P., Rysz, J., Raczak, G., & Banach, M. (2012). Dronedarone: an overview.. Annals of medicine, 44(1), 60-72. doi:10.3109/07853890.2011.594808
Idiopathic atrial fibrillation revisited in a large longitudinal clinical cohort.
Weijs, B., Pisters, R., Nieuwlaat, R., Breithardt, G., Le Heuzey, J. -Y., Vardas, P. E., . . . Crijns, H. J. G. M. (2012). Idiopathic atrial fibrillation revisited in a large longitudinal clinical cohort.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 14(2), 184-190. doi:10.1093/europace/eur379
Improving the diagnosis and prognosis of atrial fibrillation in stroke: quo vadis?
Banerjee, A., & Lip, G. Y. H. (2012). Improving the diagnosis and prognosis of atrial fibrillation in stroke: quo vadis?. European journal of neurology, 19(2), 187-188. doi:10.1111/j.1468-1331.2011.03516.x
Pharmacological Modulation of Microparticle Release: New Strategies for the Management of Atherothrombotic Vascular Disorders
Montoro-Garcia, S., Orenes-Pinero, E., Marin, F., Mariano, V., Lip, G. Y. H., & Shantsila, E. (2012). Pharmacological Modulation of Microparticle Release: New Strategies for the Management of Atherothrombotic Vascular Disorders. CURRENT PHARMACEUTICAL DESIGN, 18(6), 840-849. doi:10.2174/138161212799277789
Silent cerebral embolism after catheter ablation of atrial fibrillation
Shantsila, A., & Lip, G. Y. H. (2012). Silent cerebral embolism after catheter ablation of atrial fibrillation. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 66(2), 118-120. doi:10.1111/j.1742-1241.2011.02820.x
Stroke aetiology and predictors of outcome in patients with heart failure and acute stroke: a 10-year follow-up study.
Vemmos, K., Ntaios, G., Savvari, P., Vemmou, A. M., Koroboki, E., Manios, E., . . . Lip, G. Y. H. (2012). Stroke aetiology and predictors of outcome in patients with heart failure and acute stroke: a 10-year follow-up study.. European journal of heart failure, 14(2), 211-218. doi:10.1093/eurjhf/hfr172
Stroke prevention in atrial fibrillation: do we still need warfarin?
Diener, H. -C., Weber, R., Lip, G. Y. H., & Hohnloser, S. H. (2012). Stroke prevention in atrial fibrillation: do we still need warfarin?. Current opinion in neurology, 25(1), 27-35. doi:10.1097/wco.0b013e32834e604a
<i>Clinical Practice</i>: a new direction
<i>Clinical Practice</i>: a new direction (2012). Clinical Practice, 9(1), 1-3. doi:10.2217/cpr.11.130
A 12-year follow-up study of patients with newly diagnosed lone atrial fibrillation: implications of arrhythmia progression on prognosis: the Belgrade Atrial Fibrillation study.
Potpara, T. S., Stankovic, G. R., Beleslin, B. D., Polovina, M. M., Marinkovic, J. M., Ostojic, M. C., & Lip, G. Y. H. (2012). A 12-year follow-up study of patients with newly diagnosed lone atrial fibrillation: implications of arrhythmia progression on prognosis: the Belgrade Atrial Fibrillation study.. Chest, 141(2), 339-347. doi:10.1378/chest.11-0340
A proposal for new clinical concepts in the management of atrial fibrillation.
Camm, A. J., Al-Khatib, S. M., Calkins, H., Halperin, J. L., Kirchhof, P., Lip, G. Y. H., . . . Williams, E. S. (2012). A proposal for new clinical concepts in the management of atrial fibrillation.. American heart journal, 164(3), 292-302.e1. doi:10.1016/j.ahj.2012.05.017
Antithrombotic Therapy for Atrial Fibrillation Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
You, J. J., Singer, D. E., Howard, P. A., Lane, D. A., Eckman, M. H., Fang, M. C., . . . Lip, G. Y. H. (2012). Antithrombotic Therapy for Atrial Fibrillation Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. CHEST, 141(2), E531S-E575S. doi:10.1378/chest.11-2304
Atrial fibrillation and vascular disease--a bad combination.
Olesen, J. B., Gislason, G. H., Torp-Pedersen, C., & Lip, G. Y. H. (2012). Atrial fibrillation and vascular disease--a bad combination.. Clinical cardiology, 35 Suppl 1, 15-20. doi:10.1002/clc.20955
Benefits and risks of using clopidogrel before coronary artery bypass surgery: systematic review and meta-analysis of randomized trials and observational studies.
Biancari, F., Airaksinen, K. E. J., & Lip, G. Y. H. (2012). Benefits and risks of using clopidogrel before coronary artery bypass surgery: systematic review and meta-analysis of randomized trials and observational studies.. The Journal of thoracic and cardiovascular surgery, 143(3), 665-675.e4. doi:10.1016/j.jtcvs.2011.01.069
Can we predict stroke in atrial fibrillation?
Lip, G. Y. H. (2012). Can we predict stroke in atrial fibrillation?. Clinical cardiology, 35 Suppl 1, 21-27. doi:10.1002/clc.20969
Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options-a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference
Kirchhof, P., Lip, G. Y. H., Van Gelder, I. C., Bax, J., Hylek, E., Kaab, S., . . . Camm, A. J. (2012). Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options-a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. In EUROPACE Vol. 14 (pp. 8-27). doi:10.1093/europace/eur241
Development and clinical applications of novel oral anticoagulants. Part I. Clinically approved drugs.
Ahrens, I., Peter, K., Lip, G. Y. H., & Bode, C. (2012). Development and clinical applications of novel oral anticoagulants. Part I. Clinically approved drugs.. Discovery medicine, 13(73), 433-443.
Development and clinical applications of novel oral anticoagulants. Part II. Drugs under clinical investigation.
Ahrens, I., Peter, K., Lip, G. Y. H., & Bode, C. (2012). Development and clinical applications of novel oral anticoagulants. Part II. Drugs under clinical investigation.. Discovery medicine, 13(73), 445-450.
Highlights and hot topics from 2011 in Thrombosis and Haemostasis
Weber, C., & Lip, G. Y. H. (2012). Highlights and hot topics from 2011 in Thrombosis and Haemostasis. Thrombosis and Haemostasis, 107(01), 196-199. doi:10.1055/s-0037-1608981
Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group 'Hypertension Arrhythmias and Thrombosis' of the European Society of Hypertension.
Manolis, A. J., Rosei, E. A., Coca, A., Cifkova, R., Erdine, S. E., Kjeldsen, S., . . . Mancia, G. (2012). Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group 'Hypertension Arrhythmias and Thrombosis' of the European Society of Hypertension.. Journal of hypertension, 30(2), 239-252. doi:10.1097/hjh.0b013e32834f03bf
International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD).
Kakkar, A. K., Mueller, I., Bassand, J. -P., Fitzmaurice, D. A., Goldhaber, S. Z., Goto, S., . . . Turpie, A. G. G. (2012). International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD).. American heart journal, 163(1), 13-19.e1. doi:10.1016/j.ahj.2011.09.011
Lack of impact of pulse pressure on outcomes in patients with malignant phase hypertension: the West Birmingham Malignant Hypertension study
Shantsila, A., Lane, D. A., Beevers, D. G., & Lip, G. Y. H. (2012). Lack of impact of pulse pressure on outcomes in patients with malignant phase hypertension: the West Birmingham Malignant Hypertension study. JOURNAL OF HYPERTENSION, 30(5), 974-979. doi:10.1097/HJH.0b013e3283526e47
Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study
Banerjee, A., Lane, D. A., Torp-Pedersen, C., & Lip, G. Y. H. (2012). Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study. THROMBOSIS AND HAEMOSTASIS, 107(3), 584-589. doi:10.1160/TH11-11-0784
Oral antithrombotic therapy and gastrointestinal bleeding: the good, the bad and the ugly.
Riva, N., Apostolakis, S., & Lip, G. Y. H. (2012). Oral antithrombotic therapy and gastrointestinal bleeding: the good, the bad and the ugly.. International journal of clinical practice, 66(1), 2-4. doi:10.1111/j.1742-1241.2011.02828.x
Plasma levels of matrix metalloproteinases and their inhibitors in hypertension: a systematic review and meta-analysis.
Marchesi, C., Dentali, F., Nicolini, E., Maresca, A. M., Tayebjee, M. H., Franz, M., . . . Grandi, A. M. (2012). Plasma levels of matrix metalloproteinases and their inhibitors in hypertension: a systematic review and meta-analysis.. Journal of hypertension, 30(1), 3-16. doi:10.1097/hjh.0b013e32834d249a
Risk Factors for Stroke and Thromboembolism in Relation to Age Among Patients With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project
Olesen, J. B., Fauchier, L., Lane, D. A., Taillandier, S., & Lip, G. Y. H. (2012). Risk Factors for Stroke and Thromboembolism in Relation to Age Among Patients With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project. CHEST, 141(1), 147-153. doi:10.1378/chest.11-0862
Role of the CHADS2 score in acute coronary syndromes: with or without atrial fibrillation.
Adlan, A. M. A., & Lip, G. Y. H. (2012). Role of the CHADS2 score in acute coronary syndromes: with or without atrial fibrillation.. Chest, 141(6), 1375-1376. doi:10.1378/chest.11-2780
Soluble Fas and Fas Ligand in Pregnancy: Influence of Hypertension
Karthikeyan, V. J., Lip, G. Y. H., Baghdadi, S., Lane, D. A., Beevers, D. G., & Blann, A. D. (2012). Soluble Fas and Fas Ligand in Pregnancy: Influence of Hypertension. ANGIOLOGY, 63(1), 35-38. doi:10.1177/0003319711406901
Stroke Prevention in Atrial Fibrillation: Where are We Now?
Ahmad, Y., & Lip, G. Y. H. (2012). Stroke Prevention in Atrial Fibrillation: Where are We Now?. Clinical Medicine Insights. Cardiology, 6, 65-78. doi:10.4137/cmc.s8976
Stroke and Thromboembolism in Atrial Fibrillation - Systematic Review of Stroke Risk Factors and Risk Stratification Schema -
Pisters, R., Lane, D. A., Marin, F., Camm, A. J., & Lip, G. Y. H. (2012). Stroke and Thromboembolism in Atrial Fibrillation - Systematic Review of Stroke Risk Factors and Risk Stratification Schema -. CIRCULATION JOURNAL, 76(10), 2289-2304. doi:10.1253/circj.CJ-12-1036
The Global Burden of Atrial Fibrillation and Stroke A Systematic Review of the Epidemiology of Atrial Fibrillation in Regions Outside North America and Europe
Lip, G. Y. H., Brechin, C. M., & Lane, D. A. (2012). The Global Burden of Atrial Fibrillation and Stroke A Systematic Review of the Epidemiology of Atrial Fibrillation in Regions Outside North America and Europe. CHEST, 142(6), 1489-1498. doi:10.1378/chest.11-2888
The role of echocardiography in stroke risk assessment in patients with atrial fibrillation: is it additive or does it simply echo clinical risk factors?
Pisters, R., Olesen, J. B., & Lip, G. Y. H. (2012). The role of echocardiography in stroke risk assessment in patients with atrial fibrillation: is it additive or does it simply echo clinical risk factors?. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 14(1), 1-2. doi:10.1093/europace/eur310
Translating regulatory advice into practice: use of dronedarone and older anti-arrhythmics in AF management
Camm. (2012). Translating regulatory advice into practice: use of dronedarone and older anti-arrhythmics in AF management. British Journal of Cardiology. doi:10.5837/bjc.2012.020
Treatment pathways for atrial fibrillation: simplifying the approach to thromboprophylaxis.
Potpara, T. S., & Lip, G. Y. H. (2012). Treatment pathways for atrial fibrillation: simplifying the approach to thromboprophylaxis.. International journal of clinical practice, 66(1), 4-6. doi:10.1111/j.1742-1241.2011.02816.x
Welcome to a new year in Thrombosis and Haemostasis…..
Lip, G. Y. H., & Weber, C. (2012). Welcome to a new year in Thrombosis and Haemostasis…... Thrombosis and Haemostasis, 107(01), 1-2. doi:10.1055/s-0037-1608982
What is the most effective and safest delivery of thromboprophylaxis in atrial fibrillation?
Lip, G. Y. H. (2012). What is the most effective and safest delivery of thromboprophylaxis in atrial fibrillation?. The journal of the Royal College of Physicians of Edinburgh, 42 Suppl 18, 35-44. doi:10.4997/jrcpe.2012.s04
Wytyczne ESC dotycza̧ce rozpoznania oraz leczenia ostrej i przewlekłej niewydolności serca na 2012 rok
McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Boḧm, M., Dickstein, K., . . . Bax, J. J. (2012). Wytyczne ESC dotycza̧ce rozpoznania oraz leczenia ostrej i przewlekłej niewydolności serca na 2012 rok. Kardiologia Polska, 70(SUPPL. 2), 101-175.
2011
Atrial fibrillation in 2011: Stroke prevention in AF.
Lip, G. Y. H. (2011). Atrial fibrillation in 2011: Stroke prevention in AF.. Nature reviews. Cardiology, 9(2), 71-73. doi:10.1038/nrcardio.2011.203
Antiplatelet agents and anticoagulants for hypertension.
Lip, G. Y., Felmeden, D. C., & Dwivedi, G. (2011). Antiplatelet agents and anticoagulants for hypertension.. The Cochrane database of systematic reviews, (12), CD003186. doi:10.1002/14651858.cd003186.pub3
Bleeding risk assessment and management in atrial fibrillation patients Executive Summary* of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis
Lip, G. Y. H., Andreotti, F., Fauchier, L., Huber, K., Hylek, E., Knight, E., . . . Kirchhof, P. (2011). Bleeding risk assessment and management in atrial fibrillation patients Executive Summary* of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis. THROMBOSIS AND HAEMOSTASIS, 106(6), 997-1011. doi:10.1160/TH11-10-0690
Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options Executive summary* of the report from the 3rd AFNET/EHRA consensus conference
Kirchhof, P., Lip, G. Y. H., Van Gelder, I. C., Bax, J., Hylek, E., Kaeaeb, S., . . . Camm, A. J. (2011). Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options Executive summary* of the report from the 3rd AFNET/EHRA consensus conference. THROMBOSIS AND HAEMOSTASIS, 106(6), 1012-1019. doi:10.1160/TH11-07-0517
Diabetes Health, Residence & Metabolism in Asians: the DHRMA study, research into foods from the Indian subcontinent - a blinded, randomised, placebo controlled trial.
Patel, J. V., Hughes, E. A., Lip, G. Y. H., & Gill, P. S. (2011). Diabetes Health, Residence & Metabolism in Asians: the DHRMA study, research into foods from the Indian subcontinent - a blinded, randomised, placebo controlled trial.. BMC cardiovascular disorders, 11, 70. doi:10.1186/1471-2261-11-70
Atrial Fibrillation: Non Surgical Management
Khoo, C. W., & Lip, G. Y. H. (2010). Atrial Fibrillation: Non Surgical Management. In Mitral Valve Surgery (pp. 133-143). Springer London. doi:10.1007/978-1-84996-426-5_13
Differences between South Asians and White Europeans in five year outcome following percutaneous coronary intervention.
Toor, I. S., Jaumdally, R., Lip, G. Y. H., Pagano, D., Dimitri, W., Millane, T., & Varma, C. (2011). Differences between South Asians and White Europeans in five year outcome following percutaneous coronary intervention.. International journal of clinical practice, 65(12), 1259-1266. doi:10.1111/j.1742-1241.2011.02776.x
Dronedarone A New Hope for Stroke Prevention in Atrial Fibrillation?
Shantsila, A., & Lip, G. Y. H. (2011). Dronedarone A New Hope for Stroke Prevention in Atrial Fibrillation?. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 11(6), 355-356. doi:10.2165/11595330-000000000-00000
Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy.
Orenes-Piñero, E., Hernández-Romero, D., Jover, E., Valdés, M., Lip, G. Y. H., & Marín, F. (2011). Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy.. Journal of the renin-angiotensin-aldosterone system : JRAAS, 12(4), 521-530. doi:10.1177/1470320311405247
Intracardiac expression of markers of endothelial damage/dysfunction, inflammation, thrombosis, and tissue remodeling, and the development of postoperative atrial fibrillation.
Kaireviciute, D., Lip, G. Y. H., Balakrishnan, B., Uzdavinys, G., Norkunas, G., Kalinauskas, G., . . . Blann, A. D. (2011). Intracardiac expression of markers of endothelial damage/dysfunction, inflammation, thrombosis, and tissue remodeling, and the development of postoperative atrial fibrillation.. Journal of thrombosis and haemostasis : JTH, 9(12), 2345-2352. doi:10.1111/j.1538-7836.2011.04523.x
Is plasminogen activator inhibitor-1 (PAI-1) a surrogate marker of vascular damage?
Montoro-García, S., Marín, F., Roldán, V., & Lip, G. Y. H. (2011). Is plasminogen activator inhibitor-1 (PAI-1) a surrogate marker of vascular damage?. Thrombosis research, 128(6), 601-602. doi:10.1016/j.thromres.2011.07.005
Nebivolol for the treatment of heart failure.
Riva, N., & Lip, G. Y. H. (2011). Nebivolol for the treatment of heart failure.. Expert opinion on investigational drugs, 20(12), 1733-1746. doi:10.1517/13543784.2011.625011
Peripheral Artery Disease and Angiogenesis: A Link Between Angiogenesis and Atherothrombosis
Bennett, P. C., Silverman, S., Gill, P., & Lip, G. Y. H. (2010). Peripheral Artery Disease and Angiogenesis: A Link Between Angiogenesis and Atherothrombosis. In Therapeutic Angiogenesis for Vascular Diseases (pp. 339-359). Springer Netherlands. doi:10.1007/978-90-481-9495-7_15
Systolic heart failure in South Asians
Shantsila, E., Lip, G. Y. H., & Gill, P. S. (2011). Systolic heart failure in South Asians. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 65(12), 1274-1282. doi:10.1111/j.1742-1241.2011.02796.x
The Quest for New Anticoagulants: From Clinical Development to Clinical Practice
Apostolakis, S., Lip, G. Y. H., Lane, D. A., & Shantsila, E. (2011). The Quest for New Anticoagulants: From Clinical Development to Clinical Practice. CARDIOVASCULAR THERAPEUTICS, 29(6), E12-E22. doi:10.1111/j.1755-5922.2010.00160.x
Prevalence of heart failure and atrial fibrillation in minority ethnic subjects: the Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES).
Gill, P. S., Calvert, M., Davis, R., Davies, M. K., Freemantle, N., & Lip, G. Y. H. (2011). Prevalence of heart failure and atrial fibrillation in minority ethnic subjects: the Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES).. PloS one, 6(11), e26710. doi:10.1371/journal.pone.0026710
Atrial fibrillation (chronic).
Lane, D. A., Apostolakis, S., Boos, C. J., & Lip, G. Y. H. (2011). Atrial fibrillation (chronic).. BMJ clinical evidence, 2011, 0217.
A new landscape for stroke prevention in atrial fibrillation: focus on new anticoagulants, antiarrhythmic drugs, and devices.
Banerjee, A., Marín, F., & Lip, G. Y. H. (2011). A new landscape for stroke prevention in atrial fibrillation: focus on new anticoagulants, antiarrhythmic drugs, and devices.. Stroke, 42(11), 3316-3322. doi:10.1161/strokeaha.111.617886
Advancing age and bleeding risk are the strongest barriers to anticoagulant prescription in atrial fibrillation
Riva, N., Smith, D. E., Lip, G. Y. H., & Lane, D. A. (2011). Advancing age and bleeding risk are the strongest barriers to anticoagulant prescription in atrial fibrillation. AGE AND AGEING, 40(6), 653-655. doi:10.1093/ageing/afr128
Circulating microparticles: new insights into the biochemical basis of microparticle release and activity
Montoro-Garcia, S., Shantsila, E., Marin, F., Blann, A., & Lip, G. Y. H. (2011). Circulating microparticles: new insights into the biochemical basis of microparticle release and activity. BASIC RESEARCH IN CARDIOLOGY, 106(6), 911-923. doi:10.1007/s00395-011-0198-4
Dronedarone (Multaq<sup>®</sup>) for the treatment of atrial fibrillation
Kuzniatsova, N., Pamukcu, B., & Lip, G. Y. H. (2011). Dronedarone (Multaq<sup>®</sup>) for the treatment of atrial fibrillation. Therapy, 8(6), 681-689. doi:10.2217/thy.11.67
Ethnic Differences in Macrovascular and Microvascular Function in Systolic Heart Failure
Shantsila, E., Wrigley, B., Shantsila, A., Tapp, L. D., Blann, A. D., Gill, P. S., & Lip, G. Y. H. (2011). Ethnic Differences in Macrovascular and Microvascular Function in Systolic Heart Failure. CIRCULATION-HEART FAILURE, 4(6), 754-762. doi:10.1161/CIRCHEARTFAILURE.111.962365
Ischemic stroke and atrial fibrillation--a deadly serious combination.
Potpara, T. S., & Lip, G. Y. H. (2011). Ischemic stroke and atrial fibrillation--a deadly serious combination.. Cerebrovascular diseases (Basel, Switzerland), 32(5), 461-462. doi:10.1159/000332030
Safety of coronary artery bypass surgery during therapeutic oral anticoagulation.
Airaksinen, K. E. J., Biancari, F., Karjalainen, P., Mikkola, R., Kuttila, K., Porela, P., . . . Lip, G. Y. H. (2011). Safety of coronary artery bypass surgery during therapeutic oral anticoagulation.. Thrombosis research, 128(5), 435-439. doi:10.1016/j.thromres.2011.05.021
Stroke prevention in non-valvular atrial fibrillation: can warfarin do better?
Apostolakis, S., & Lip, G. Y. H. (2011). Stroke prevention in non-valvular atrial fibrillation: can warfarin do better?. Thrombosis and haemostasis, 106(5), 753-754. doi:10.1160/th11-08-0580
The impact of dilated left atrium on rhythm control in patients with newly diagnosed persistent atrial fibrillation: the Belgrade atrial fibrillation project.
Potpara, T. S., Polovina, M. M., Licina, M. M., Mujovic, N. M., Marinkovic, J. M., Petrovic, M., . . . Lip, G. Y. H. (2011). The impact of dilated left atrium on rhythm control in patients with newly diagnosed persistent atrial fibrillation: the Belgrade atrial fibrillation project.. International journal of clinical practice, 65(11), 1202-1203. doi:10.1111/j.1742-1241.2011.02772.x
The role of monocytes and inflammation in the pathophysiology of heart failure
Wrigley, B. J., Lip, G. Y. H., & Shantsila, E. (2011). The role of monocytes and inflammation in the pathophysiology of heart failure. EUROPEAN JOURNAL OF HEART FAILURE, 13(11), 1161-1171. doi:10.1093/eurjhf/hfr122
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: similarities and dissimilarities between North America and Europe.
Huber, K., Airaksinen, K. J., Cuisset, T., Marín, F., Rubboli, A., & Lip, G. Y. H. (2011). Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: similarities and dissimilarities between North America and Europe.. Thrombosis and haemostasis, 106(4), 569-571. doi:10.1160/th11-08-0602
Erratum to “Angiogenin, a marker of Angiogenesis increases with coronary heart disease severity” [Antheroscler. Suppl. 9 (May (1)) (2008) 247–248]
Chackathayil, J., Abraheem, A., Panja, N., Patel, J., Gunarathne, A., Dotsenko, O., . . . Lip, G. (2011). Erratum to “Angiogenin, a marker of Angiogenesis increases with coronary heart disease severity” [Antheroscler. Suppl. 9 (May (1)) (2008) 247–248]. Atherosclerosis, 218(2), 552. doi:10.1016/j.atherosclerosis.2011.07.018
Erratum to “Circulating adiponectin reflects severity of coronary atherosclerosis but not cardiac function abnormalities” [Atheroscler. Suppl. 9 (May (1)) (2008) 78]
Dotsenko, O., Abraheem, O., Chackathayil, J., Patel, J. V., Gunarathne, A., Panjal, N., . . . Lip, G. Y. (2011). Erratum to “Circulating adiponectin reflects severity of coronary atherosclerosis but not cardiac function abnormalities” [Atheroscler. Suppl. 9 (May (1)) (2008) 78]. Atherosclerosis, 218(2), 553. doi:10.1016/j.atherosclerosis.2011.07.017
Impact of high-dose atorvastatin on endothelial, platelet, and angiogenic indices: effect of ethnicity, cardiovascular disease, and diabetes.
Jaumdally, R. J., Lip, G. Y. H., Varma, C., & Blann, A. D. (2011). Impact of high-dose atorvastatin on endothelial, platelet, and angiogenic indices: effect of ethnicity, cardiovascular disease, and diabetes.. Angiology, 62(7), 571-578. doi:10.1177/0003319711401904
Influence of cardiac resynchronization therapy on indices of inflammation, the prothrombotic state and tissue remodeling in systolic heart failure: a pilot study.
Marín, F., Roldán, V., Martínez, J. G., Hernández-Madrid, A., Hernández-Romero, D., Ortego, M., . . . Moro, C. (2011). Influence of cardiac resynchronization therapy on indices of inflammation, the prothrombotic state and tissue remodeling in systolic heart failure: a pilot study.. Thrombosis research, 128(4), 391-394. doi:10.1016/j.thromres.2011.05.022
Looking through the PRISM: new insights for young patients with atrial fibrillation and stroke.
Banerjee, A., & Lip, G. Y. H. (2011). Looking through the PRISM: new insights for young patients with atrial fibrillation and stroke.. Cerebrovascular diseases (Basel, Switzerland), 32(4), 383-384. doi:10.1159/000331464
New anticoagulation drugs for atrial fibrillation.
Potpara, T. S., & Lip, G. Y. H. (2011). New anticoagulation drugs for atrial fibrillation.. Clinical pharmacology and therapeutics, 90(4), 502-506. doi:10.1038/clpt.2011.180
RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome.
Steg, P. G., Mehta, S. R., Jukema, J. W., Lip, G. Y. H., Gibson, C. M., Kovar, F., . . . RUBY-1 Investigators. (2011). RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome.. European heart journal, 32(20), 2541-2554. doi:10.1093/eurheartj/ehr334
Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a 'real world' nationwide cohort study
Olesen, J. B., Lip, G. Y. H., Lindhardsen, J., Lane, D. A., Ahlehoff, O., Hansen, M. L., . . . Torp-Pedersen, C. (2011). Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a 'real world' nationwide cohort study. THROMBOSIS AND HAEMOSTASIS, 106(4), 739-749. doi:10.1160/TH11-05-0364
Comparative Analysis of the HAS-BLED Score With Other Bleeding Risk Scores, Using Estimates of Net Reclassification Improvement and Integrated Discrimination Improvement
Lip, G. Y. H., Frison, L., Halperin, J. L., & Lane, D. (2011). Comparative Analysis of the HAS-BLED Score With Other Bleeding Risk Scores, Using Estimates of Net Reclassification Improvement and Integrated Discrimination Improvement. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 58(13), 1398-1399. doi:10.1016/j.jacc.2011.03.065
Periprocedural and Long‐Term Anticoagulation
Connolly, S. J., Callans, D., Hocini, M., Lip, G. Y. H., Michaud, G. F., Waldo, A. L., & Themistoclakis, S. (2011). Periprocedural and Long‐Term Anticoagulation. In Unknown Book (pp. 77-84). Wiley. doi:10.1002/9781119963868.ch6
Atrial fibrillation and upper limb thromboembolectomy: a national cohort study.
Andersen, L. V., Mortensen, L. S., Lip, G. Y. H., Lindholt, J. S., Faergeman, O., Henneberg, E. W., & Frost, L. (2011). Atrial fibrillation and upper limb thromboembolectomy: a national cohort study.. Journal of thrombosis and haemostasis : JTH, 9(9), 1738-1743. doi:10.1111/j.1538-7836.2011.04435.x
Intracerebral hemorrhage and warfarin: perceived versus actual risk.
Banerjee, A., & Lip, G. Y. H. (2011). Intracerebral hemorrhage and warfarin: perceived versus actual risk.. Stroke, 42(9), 2383-2384. doi:10.1161/strokeaha.111.626739
Myocardial Perfusion by Myocardial Contrast Echocardiography and Endothelial Dysfunction in Obstructive Sleep Apnea
Butt, M., Khair, O. A., Dwivedi, G., Shantsila, A., Shantsila, E., & Lip, G. Y. H. (2011). Myocardial Perfusion by Myocardial Contrast Echocardiography and Endothelial Dysfunction in Obstructive Sleep Apnea. HYPERTENSION, 58(3), 417-U177. doi:10.1161/HYPERTENSIONAHA.111.170910
Atorvastatin and its collateral effects on microparticles
Montoro-Garcia, S., Lip, G. Y. H., & Shantsila, E. (2011). Atorvastatin and its collateral effects on microparticles. THROMBOSIS AND HAEMOSTASIS, 106(2), 185-186. doi:10.1160/TH11-05-0335
Altered blood vessel responses in the eye and finger in coronary artery disease.
Heitmar, R., Cubbidge, R. P., Lip, G. Y. H., Gherghel, D., & Blann, A. D. (2011). Altered blood vessel responses in the eye and finger in coronary artery disease.. Investigative ophthalmology & visual science, 52(9), 6199-6205. doi:10.1167/iovs.10-6628
An epidemic of atrial fibrillation?
Olesen, J. B., Lip, G. Y. H., & Lane, D. A. (2011). An epidemic of atrial fibrillation?. EUROPACE, 13(8), 1059-1060. doi:10.1093/europace/eur141
Bleeding risk in 'real world' patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort.
Olesen, J. B., Lip, G. Y. H., Hansen, P. R., Lindhardsen, J., Ahlehoff, O., Andersson, C., . . . Torp-Pedersen, C. (2011). Bleeding risk in 'real world' patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort.. Journal of thrombosis and haemostasis : JTH, 9(8), 1460-1467. doi:10.1111/j.1538-7836.2011.04378.x
Response to Magnesium and Vascular Dysfunction in Malignant Hypertension
Shantsila, A., Dwivedi, G., & Lip, G. Y. H. (2011). Response to Magnesium and Vascular Dysfunction in Malignant Hypertension. HYPERTENSION, 58(2), E8. doi:10.1161/HYPERTENSIONAHA.111.176107
Strategies to Improve Oral Anticoagulation Management
Smith, D. E., Lip, G. Y. H., & Lane, D. A. (2011). Strategies to Improve Oral Anticoagulation Management. CHEST, 140(2), 281-282. doi:10.1378/chest.11-0418
The CD40-CD40L system in cardiovascular disease
Pamukcu, B., Lip, G. Y. H., Snezhitskiy, V., & Shantsila, E. (2011). The CD40-CD40L system in cardiovascular disease. ANNALS OF MEDICINE, 43(5), 331-340. doi:10.3109/07853890.2010.546362
The nuclear factor - kappa B pathway in atherosclerosis: A potential therapeutic target for atherothrombotic vascular disease
Pamukcu, B., Lip, G. Y. H., & Shantsila, E. (2011). The nuclear factor - kappa B pathway in atherosclerosis: A potential therapeutic target for atherothrombotic vascular disease. THROMBOSIS RESEARCH, 128(2), 117-123. doi:10.1016/j.thromres.2011.03.025
The role of aspirin for stroke prevention in atrial fibrillation.
Lip, G. Y. H. (2011). The role of aspirin for stroke prevention in atrial fibrillation.. Nature reviews. Cardiology, 8(10), 602-606. doi:10.1038/nrcardio.2011.112
Angiogenin and apoptosis in hypertension in pregnancy
Karthikeyan, V. J., Lip, G. Y. H., Lane, D. A., & Blann, A. D. (2011). Angiogenin and apoptosis in hypertension in pregnancy. PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 1(3-4), 191-196. doi:10.1016/j.preghy.2011.07.002
Bleeding Risk in Patients With Atrial Fibrillation The AMADEUS Study
Lane, D. A., Kamphuisen, P. W., Minini, P., Buller, H. R., & Lip, G. Y. H. (2011). Bleeding Risk in Patients With Atrial Fibrillation The AMADEUS Study. CHEST, 140(1), 146-155. doi:10.1378/chest.10-3270
Bleeding risk with oral anticoagulation - new frontiers and new questions
Banerjee, A., Lane, D. A., & Lip, G. Y. H. (2011). Bleeding risk with oral anticoagulation - new frontiers and new questions. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 65(7), 719-721. doi:10.1111/j.1742-1241.2011.02716.x
Characterization of the proportion of untreated and antiplatelet therapy treated patients with atrial fibrillation.
Ogilvie, I. M., Welner, S. A., Cowell, W., & Lip, G. Y. H. (2011). Characterization of the proportion of untreated and antiplatelet therapy treated patients with atrial fibrillation.. The American journal of cardiology, 108(1), 151-161. doi:10.1016/j.amjcard.2011.02.353
Endothelial Progenitor Cells and Circulating Endothelial Cells in Early Prostate Cancer: A Comparison With Plasma Vascular Markers
Blann, A. D., Balakrishnan, B., Shantsila, E., Ryan, P., & Lip, G. Y. H. (2011). Endothelial Progenitor Cells and Circulating Endothelial Cells in Early Prostate Cancer: A Comparison With Plasma Vascular Markers. PROSTATE, 71(10), 1047-1053. doi:10.1002/pros.21319
Guidelines for the management of atrial fibrillation
Guidelines for the management of atrial fibrillation (2011). EP Europace, 13(7), 1058. doi:10.1093/europace/eur134
Impact of vascular disease in predicting stroke and death in patients with atrial fibrillation: the Danish Diet, Cancer and Health cohort study.
Rasmussen, L. H., Larsen, T. B., Due, K. M., Tjønneland, A., Overvad, K., & Lip, G. Y. H. (2011). Impact of vascular disease in predicting stroke and death in patients with atrial fibrillation: the Danish Diet, Cancer and Health cohort study.. Journal of thrombosis and haemostasis : JTH, 9(7), 1301-1307. doi:10.1111/j.1538-7836.2011.04308.x
Ischaemic stroke and bleeding rates in 'real-world' atrial fibrillation patients.
Ogilvie, I. M., Welner, S. A., Cowell, W., & Lip, G. Y. H. (2011). Ischaemic stroke and bleeding rates in 'real-world' atrial fibrillation patients.. Thrombosis and haemostasis, 106(1), 34-44. doi:10.1160/th10-10-0674
Stroke in atrial fibrillation: epidemiology and thromboprophylaxis.
Lip, G. Y. H. (2011). Stroke in atrial fibrillation: epidemiology and thromboprophylaxis.. Journal of thrombosis and haemostasis : JTH, 9 Suppl 1, 344-351. doi:10.1111/j.1538-7836.2011.04302.x
The Reply
Ogilvie, I. M., Newton, N., Welner, S. A., Cowell, W., & Lip, G. Y. H. (2011). The Reply. The American Journal of Medicine, 124(7), e13. doi:10.1016/j.amjmed.2011.03.004
The angiome: a new concept in cancer biology.
Blann, A. D., Ramcharan, K. S., Stonelake, P. S., Luesley, D., & Lip, G. Y. H. (2011). The angiome: a new concept in cancer biology.. Journal of clinical pathology, 64(7), 637-643. doi:10.1136/jcp.2011.088948
The endotheliome: a new concept in vascular biology.
Ramcharan, K. S., Lip, G. Y. H., Stonelake, P. S., & Blann, A. D. (2011). The endotheliome: a new concept in vascular biology.. Thrombosis research, 128(1), 1-7. doi:10.1016/j.thromres.2010.11.019
Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial.
Hobbs, F. D. R., Roalfe, A. K., Lip, G. Y. H., Fletcher, K., Fitzmaurice, D. A., Mant, J., & Birmingham Atrial Fibrillation in the Aged Investigators and Midland Research Practices Consortium Network. (2011). Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial.. BMJ (Clinical research ed.), 342, d3653. doi:10.1136/bmj.d3653
Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients.
Roldán, V., Marín, F., Muiña, B., Torregrosa, J. M., Hernández-Romero, D., Valdés, M., . . . Lip, G. Y. H. (2011). Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients.. Journal of the American College of Cardiology, 57(25), 2496-2504. doi:10.1016/j.jacc.2010.12.033
Validation of the Edinburgh Claudication Questionnaire in 1st generation Black African-Caribbean and South Asian UK migrants: a sub-study to the Ethnic-Echocardiographic Heart of England Screening (E-ECHOES) study.
Bennett, P. C., Lip, G. Y. H., Silverman, S., Blann, A. D., & Gill, P. S. (2011). Validation of the Edinburgh Claudication Questionnaire in 1st generation Black African-Caribbean and South Asian UK migrants: a sub-study to the Ethnic-Echocardiographic Heart of England Screening (E-ECHOES) study.. BMC medical research methodology, 11, 85. doi:10.1186/1471-2288-11-85
An evaluation of the CHADS₂ stroke risk score in patients with atrial fibrillation who undergo percutaneous coronary revascularization.
Ruiz-Nodar, J. M., Marín, F., Manzano-Fernández, S., Valencia-Martín, J., Hurtado, J. A., Roldán, V., . . . Lip, G. Y. H. (2011). An evaluation of the CHADS₂ stroke risk score in patients with atrial fibrillation who undergo percutaneous coronary revascularization.. Chest, 139(6), 1402-1409. doi:10.1378/chest.10-1408
Endothelial damage/dysfunction and hypertension in pregnancy.
Karthikeyan, V. J., & Lip, G. Y. H. (2011). Endothelial damage/dysfunction and hypertension in pregnancy.. Frontiers in bioscience (Elite edition), 3(3), 1100-1108. doi:10.2741/314
Endothelial dysfunction in hypertension in pregnancy: associations between circulating endothelial cells, circulating progenitor cells and plasma von Willebrand factor
Karthikeyan, V. J., Blann, A. D., Baghdadi, S., Lane, D. A., Beevers, D. G., & Lip, G. Y. H. (2011). Endothelial dysfunction in hypertension in pregnancy: associations between circulating endothelial cells, circulating progenitor cells and plasma von Willebrand factor. CLINICAL RESEARCH IN CARDIOLOGY, 100(6), 531-537. doi:10.1007/s00392-010-0277-9
Improving stroke risk stratification using the CHADS2 and CHA2DS2-VASc risk scores in patients with paroxysmal atrial fibrillation by continuous arrhythmia burden monitoring.
Boriani, G., Botto, G. L., Padeletti, L., Santini, M., Capucci, A., Gulizia, M., . . . Italian AT-500 Registry Investigators. (2011). Improving stroke risk stratification using the CHADS2 and CHA2DS2-VASc risk scores in patients with paroxysmal atrial fibrillation by continuous arrhythmia burden monitoring.. Stroke, 42(6), 1768-1770. doi:10.1161/strokeaha.110.609297
Increased levels of plasma haemoxygenase-1 in prostate cancer.
Blann, A. D., Balakrishnan, B., Ryan, P., & Lip, G. Y. H. (2011). Increased levels of plasma haemoxygenase-1 in prostate cancer.. Prostate cancer and prostatic diseases, 14(2), 114-117. doi:10.1038/pcan.2010.56
Interactions between clopidogrel and proton pump inhibitors: a review of evidence.
Muñoz-Esparza, C., Jover, E., Hernández-Romero, D., Saura, D., Valdés, M., Lip, G. Y. H., & Marín, F. (2011). Interactions between clopidogrel and proton pump inhibitors: a review of evidence.. Current medicinal chemistry, 18(16), 2386-2400. doi:10.2174/092986711795843245
Soluble vascular endothelial growth factor receptor (VEGFR)-2 in macular oedema--a mechanism for regulating angiogenesis?
Montoro-García, S., Lip, P. -L., Chan, C. -C., & Lip, G. Y. H. (2011). Soluble vascular endothelial growth factor receptor (VEGFR)-2 in macular oedema--a mechanism for regulating angiogenesis?. The British journal of ophthalmology, 95(6), 757-758. doi:10.1136/bjo.2010.198002
Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function.
Damman, K., Ng Kam Chuen, M. J., MacFadyen, R. J., Lip, G. Y. H., Gaze, D., Collinson, P. O., . . . van Veldhuisen, D. J. (2011). Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function.. Journal of the American College of Cardiology, 57(22), 2233-2241. doi:10.1016/j.jacc.2010.10.065
Aortic coarctation and twin pregnancy.
Beevers, D. G., & Lip, G. Y. (2011). Aortic coarctation and twin pregnancy.. Journal of paediatrics and child health, 47(5), 316. doi:10.1111/j.1440-1754.2011.02092.x
Assessing the Performance of the HAS-BLED Score Is the C Statistic Sufficient? <i>Response</i>
Pisters, R., Lane, D. A., Nieuwlaat, R., Crijns, H. J. G. M., & Lip, G. Y. H. (2011). Assessing the Performance of the HAS-BLED Score Is the C Statistic Sufficient? <i>Response</i>. CHEST, 139(5), 1248. doi:10.1378/chest.11-0184
Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis
Lip, G. Y. H., Andreotti, F., Fauchier, L., Huber, K., Hylek, E., Knight, E., . . . Camm, J. (2011). Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis. EUROPACE, 13(5), 723-746. doi:10.1093/europace/eur126
Coronary stent implantation in patients committed to long-term oral anticoagulation therapy: successfully navigating the treatment options.
Rubboli, A., Kovacic, J. C., Mehran, R., & Lip, G. Y. H. (2011). Coronary stent implantation in patients committed to long-term oral anticoagulation therapy: successfully navigating the treatment options.. Chest, 139(5), 981-987. doi:10.1378/chest.10-2719
Endothelium-dependent and endothelium-independent vasodilatation of the cutaneous circulation in sickle cell disease.
Mohan, J. S., Lip, G. Y. H., Blann, A. D., Bareford, D., & Marshall, J. M. (2011). Endothelium-dependent and endothelium-independent vasodilatation of the cutaneous circulation in sickle cell disease.. European journal of clinical investigation, 41(5), 546-551. doi:10.1111/j.1365-2362.2010.02444.x
Immunophenotypic characterization of human monocyte subsets: possible implications for cardiovascular disease pathophysiology
Shantsila, E., Wrigley, B., Tapp, L., Apostolakis, S., Montoro-Garcia, S., Drayson, M. T., & Lip, G. Y. H. (2011). Immunophenotypic characterization of human monocyte subsets: possible implications for cardiovascular disease pathophysiology. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 9(5), 1056-1066. doi:10.1111/j.1538-7836.2011.04244.x
Safety and efficacy of oral anticoagulation therapy in Chinese patients with concomitant atrial fibrillation and hypertension.
Ho, L. Y., Siu, C. W., Yue, W. S., Lau, C. P., Lip, G. Y., & Tse, H. F. (2011). Safety and efficacy of oral anticoagulation therapy in Chinese patients with concomitant atrial fibrillation and hypertension.. Journal of human hypertension, 25(5), 304-310. doi:10.1038/jhh.2010.57
The HAS-BLED Score and Renal Failure <i>Response</i>
Pisters, R., Nieuwlaat, R., Lane, D. A., Crijns, H. J. G. M., & Lip, G. Y. H. (2011). The HAS-BLED Score and Renal Failure <i>Response</i>. CHEST, 139(5), 1249-1250. doi:10.1378/chest.10-3237
Time-trends in treatment and cardiovascular events in patients with heart failure: a pharmacosurveillance study.
de Peuter, O. R., Lip, G. Y. H., Souverein, P. C., Klungel, O. H., de Boer, A., Büller, H. R., & Kamphuisen, P. W. (2011). Time-trends in treatment and cardiovascular events in patients with heart failure: a pharmacosurveillance study.. European journal of heart failure, 13(5), 489-495. doi:10.1093/eurjhf/hfq228
What are the costs of atrial fibrillation?
Blomstrom Lundqvist, C., Lip, G. Y. H., & Kirchhof, P. (2011). What are the costs of atrial fibrillation?. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 13 Suppl 2, ii9-i12. doi:10.1093/europace/eur087
Recent progress in antithrombotic therapy for atrial fibrillation.
Velu, S., & Lip, G. Y. H. (2011). Recent progress in antithrombotic therapy for atrial fibrillation.. Journal of atherosclerosis and thrombosis, 18(4), 257-273. doi:10.5551/jat.7153
Short-term effects of screening for cardiovascular risk in the deaf community: a pilot study.
Patel, J. V., Gill, P. S., Chackathayil, J., Ojukwu, H., Stemman, P., Sheldon, L., . . . Hughes, E. A. (2011). Short-term effects of screening for cardiovascular risk in the deaf community: a pilot study.. Cardiology research and practice, 2011, 493546. doi:10.4061/2011/493546
Combined antiplatelet therapy and oral anticoagulation: is a balance between thromboembolism and bleeding possible?
Kuzniatsova, N., & Lip, G. Y. H. (2011). Combined antiplatelet therapy and oral anticoagulation: is a balance between thromboembolism and bleeding possible?. International journal of cardiology, 148(1), 1-3. doi:10.1016/j.ijcard.2010.12.098
Hemostatic cardiovascular risk factors, common carotid-intima medial thickness and peripheral arterial disease in South Asians and African Caribbeans: a substudy to the Ethnic-Echocardiographic Heart of England Screening (E-ECHOES) study.
Bennett, P. C., Gill, P. S., Silverman, S., Blann, A. D., Chackathayil, J., & Lip, G. Y. H. (2011). Hemostatic cardiovascular risk factors, common carotid-intima medial thickness and peripheral arterial disease in South Asians and African Caribbeans: a substudy to the Ethnic-Echocardiographic Heart of England Screening (E-ECHOES) study.. Journal of thrombosis and haemostasis : JTH, 9(4), 645-652. doi:10.1111/j.1538-7836.2011.04190.x
Lone atrial fibrillation: what is known and what is to come.
Potpara, T. S., & Lip, G. Y. H. (2011). Lone atrial fibrillation: what is known and what is to come.. International journal of clinical practice, 65(4), 446-457. doi:10.1111/j.1742-1241.2010.02618.x
Review article: proton pump inhibitors with clopidogrel--evidence for and against a clinically-important interaction.
Disney, B. R., Watson, R. D. S., Blann, A. D., Lip, G. Y. H., & Anderson, M. R. (2011). Review article: proton pump inhibitors with clopidogrel--evidence for and against a clinically-important interaction.. Alimentary pharmacology & therapeutics, 33(7), 758-767. doi:10.1111/j.1365-2036.2011.04585.x
What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?
Ahrens, I., Lip, G. Y. H., & Peter, K. (2011). What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?. Thrombosis and haemostasis, 105(4), 574-578. doi:10.1160/th10-12-0808
Severe Renal Impairment and Stroke Prevention in Atrial Fibrillation Implications for Thromboprophylaxis and Bleeding Risk
Marinigh, R., Lane, D. A., & Lip, G. Y. H. (2011). Severe Renal Impairment and Stroke Prevention in Atrial Fibrillation Implications for Thromboprophylaxis and Bleeding Risk. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 57(12), 1339-1348. doi:10.1016/j.jacc.2010.12.013
Apixaban in patients with atrial fibrillation.
Connolly, S. J., Eikelboom, J., Joyner, C., Diener, H. -C., Hart, R., Golitsyn, S., . . . AVERROES Steering Committee and Investigators. (2011). Apixaban in patients with atrial fibrillation.. The New England journal of medicine, 364(9), 806-817. doi:10.1056/nejmoa1007432
Ethnic differences in common carotid intima-media thickness, and the relationship to cardiovascular risk factors and peripheral arterial disease: the Ethnic-Echocardiographic Heart of England Screening Study.
Bennett, P. C., Gill, P. S., Silverman, S., Blann, A. D., & Lip, G. Y. H. (2011). Ethnic differences in common carotid intima-media thickness, and the relationship to cardiovascular risk factors and peripheral arterial disease: the Ethnic-Echocardiographic Heart of England Screening Study.. QJM : monthly journal of the Association of Physicians, 104(3), 245-254. doi:10.1093/qjmed/hcq187
Monocytes: Possible mediators of benefits and harms from physical activity?
Shantsila, E., & Lip, G. Y. H. (2011). Monocytes: Possible mediators of benefits and harms from physical activity?. THROMBOSIS AND HAEMOSTASIS, 105(3), 387-389. doi:10.1160/TH11-01-0009
Peri-operative management of ophthalmic patients taking antithrombotic therapy.
Lip, G. Y. H., Durrani, O. M., Roldan, V., Lip, P. L., Marin, F., & Reuser, T. Q. (2011). Peri-operative management of ophthalmic patients taking antithrombotic therapy.. International journal of clinical practice, 65(3), 361-371. doi:10.1111/j.1742-1241.2010.02538.x
Persistent Macrovascular and Microvascular Dysfunction in Patients With Malignant Hypertension
Shantsila, A., Dwivedi, G., Shantsila, E., Butt, M., Beevers, D. G., & Lip, G. Y. H. (2011). Persistent Macrovascular and Microvascular Dysfunction in Patients With Malignant Hypertension. HYPERTENSION, 57(3), 490-496. doi:10.1161/HYPERTENSIONAHA.110.166314
Atrial fibrillation (acute onset).
Lip, G. Y. H., & Apostolakis, S. (2011). Atrial fibrillation (acute onset).. BMJ clinical evidence, 2011, 0210.
The Risk of Thromboembolism in Heart Failure: Does It Merit Anticoagulation Therapy?
Shantsila, E., & Lip, G. Y. H. (2011). The Risk of Thromboembolism in Heart Failure: Does It Merit Anticoagulation Therapy?. AMERICAN JOURNAL OF CARDIOLOGY, 107(4), 558-560. doi:10.1016/j.amjcard.2010.10.029
Assessment of left atrial volume: a focus on echocardiographic methods and clinical implications.
Khoo, C. W., Krishnamoorthy, S., Lim, H. S., & Lip, G. Y. H. (2011). Assessment of left atrial volume: a focus on echocardiographic methods and clinical implications.. Clinical research in cardiology : official journal of the German Cardiac Society, 100(2), 97-105. doi:10.1007/s00392-010-0222-y
Chronic renal disease and stroke in atrial fibrillation: balancing the prevention of thromboembolism and bleeding risk.
Lip, G. Y. H. (2011). Chronic renal disease and stroke in atrial fibrillation: balancing the prevention of thromboembolism and bleeding risk.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 13(2), 145-148. doi:10.1093/europace/euq427
Optimal Antithrombotic Therapy in Patients Receiving Long-term Oral Anticoagulation Requiring Percutaneous Coronary Intervention "Triple Therapy" or "Triple Threat"
Tapp, L. D., Lip, G. Y. H., & Lane, D. A. (2011). Optimal Antithrombotic Therapy in Patients Receiving Long-term Oral Anticoagulation Requiring Percutaneous Coronary Intervention "Triple Therapy" or "Triple Threat". CHEST, 139(2), 240-243. doi:10.1378/chest.10-1102
Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy.
Lip, G. Y. H., Rasmussen, L. H., Olsson, S. B., Zetterstrand, S., Stahre, C., Bylock, A., . . . Steering Committee. (2011). Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy.. Thrombosis research, 127(2), 91-99. doi:10.1016/j.thromres.2010.11.012
Platelet reactivity in prolonged stress disorders-A link with cardiovascular disease?
Montoro-Garcia, S., Shantsila, E., & Lip, G. Y. H. (2011). Platelet reactivity in prolonged stress disorders-A link with cardiovascular disease?. PSYCHONEUROENDOCRINOLOGY, 36(2), 159-160. doi:10.1016/j.psyneuen.2010.08.010
Renin-angiotensin blockade in diabetic retinopathy.
Ghattas, A., Lip, P. -L., & Lip, G. Y. H. (2011). Renin-angiotensin blockade in diabetic retinopathy.. International journal of clinical practice, 65(2), 113-116. doi:10.1111/j.1742-1241.2010.02592.x
Author Response: Can Vascular Function Be Assessed by the Interpretation of Retinal Vascular Diameter Changes?
Heitmar, R., Blann, A., Cubbidge, R. P., Lip, G., & Gherghel, D. (2011). Author Response: Can Vascular Function Be Assessed by the Interpretation of Retinal Vascular Diameter Changes?. Investigative Opthalmology & Visual Science, 52(1), 636. doi:10.1167/iovs.10-6690
Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study.
Olesen, J. B., Lip, G. Y. H., Hansen, M. L., Hansen, P. R., Tolstrup, J. S., Lindhardsen, J., . . . Torp-Pedersen, C. (2011). Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study.. BMJ (Clinical research ed.), 342, d124. doi:10.1136/bmj.d124
Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation The HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) Score
Lip, G. Y. H., Frison, L., Halperin, J. L., & Lane, D. A. (2011). Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation The HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) Score. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 57(2), 173-180. doi:10.1016/j.jacc.2010.09.024
A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice
van Staa, T. P., Setakis, E., di Tanna, G. L., Lane, D. A., & Lip, G. Y. H. (2011). A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 9(1), 39-48. doi:10.1111/j.1538-7836.2010.04085.x
Antithrombotic therapy after percutaneous coronary intervention in anticoagulated patients: a fine balance between thrombosis and bleeding.
Ghattas, A., Shantsila, E., & Lip, G. Y. H. (2011). Antithrombotic therapy after percutaneous coronary intervention in anticoagulated patients: a fine balance between thrombosis and bleeding.. Therapeutic advances in cardiovascular disease, 5(1), 5-9. doi:10.1177/1753944710397225
Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers safe in pregnancy: a report of ninety-one pregnancies
Karthikeyan, V. J., Ferner, R. E., Baghdadi, S., Lane, D. A., Lip, G. Y. H., & Beevers, D. G. (2011). Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers safe in pregnancy: a report of ninety-one pregnancies. JOURNAL OF HYPERTENSION, 29(2), 396-399. doi:10.1097/HJH.0b013e328341885d
Bleeding and stroke risk in a real-world prospective primary prevention cohort of patients with atrial fibrillation.
Poli, D., Testa, S., Antonucci, E., Grifoni, E., Paoletti, O., & Lip, G. Y. H. (2011). Bleeding and stroke risk in a real-world prospective primary prevention cohort of patients with atrial fibrillation.. Chest, 140(4), 918-924. doi:10.1378/chest.10-3024
Can We IMPROVE Bleeding Risk Assessment for Acutely III, Hospitalized Medical Patients?
Tay, K. H., Lip, G. Y. H., & Lane, D. A. (2011). Can We IMPROVE Bleeding Risk Assessment for Acutely III, Hospitalized Medical Patients?. CHEST, 139(1), 10-13. doi:10.1378/chest.10-1127
Clinical and basic science articles from Thrombosis and Haemostasis.
Lip, G. Y. H., & Weber, C. (2011). Clinical and basic science articles from Thrombosis and Haemostasis.. Thrombosis and haemostasis, 105(1), 202-205. doi:10.1055/s-0037-1609004
Commencing 2011 with Thrombosis and Haemostasis – and looking to the future
Weber, C., & Lip, G. (2011). Commencing 2011 with Thrombosis and Haemostasis – and looking to the future. Thrombosis and Haemostasis, 105(01), 1-2. doi:10.1055/s-0037-1609003
Dronedarone as a new treatment option for atrial fibrillation patients: pharmacokinetics, pharmacodynamics and clinical practice.
Pamukcu, B., & Lip, G. Y. H. (2011). Dronedarone as a new treatment option for atrial fibrillation patients: pharmacokinetics, pharmacodynamics and clinical practice.. Expert opinion on pharmacotherapy, 12(1), 131-140. doi:10.1517/14656566.2011.540800
Implications of the CHA(2)DS(2)-VASc and HAS-BLED Scores for thromboprophylaxis in atrial fibrillation.
Lip, G. Y. H. (2011). Implications of the CHA(2)DS(2)-VASc and HAS-BLED Scores for thromboprophylaxis in atrial fibrillation.. The American journal of medicine, 124(2), 111-114. doi:10.1016/j.amjmed.2010.05.007
Lone atrial fibrillation: where are we now?
Potpara, T. S., & Lip, G. Y. (2011). Lone atrial fibrillation: where are we now?. Hospital practice (1995), 39(4), 17-31. doi:10.3810/hp.2011.10.919
Mitral annular calcification predicts cardiovascular morbidity and mortality in middle-aged patients with atrial fibrillation: the Belgrade Atrial Fibrillation Study.
Potpara, T. S., Vasiljevic, Z. M., Vujisic-Tesic, B. D., Marinkovic, J. M., Polovina, M. M., Stepanovic, J. M., . . . Lip, G. Y. H. (2011). Mitral annular calcification predicts cardiovascular morbidity and mortality in middle-aged patients with atrial fibrillation: the Belgrade Atrial Fibrillation Study.. Chest, 140(4), 902-910. doi:10.1378/chest.10-2963
New Oral Anti-Coagulants for Atrial Fibrillation: Will We Say Good Bye to Warfarin?
YH Lip, G. (2011). New Oral Anti-Coagulants for Atrial Fibrillation: Will We Say Good Bye to Warfarin?. Journal of Arrhythmia, 27(Supplement), SY06_4. doi:10.4020/jhrs.27.sy06_4
Prevention of Thromboembolism in Atrial Fibrillation Patients
Kuzniatsova, N., & Lip, G. Y. H. (2011). Prevention of Thromboembolism in Atrial Fibrillation Patients. European Cardiology Review, 7(1), 37. doi:10.15420/ecr.2011.7.1.37
Prognosis and guideline-adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: implications of undertreatment and overtreatment in real-life clinical practice; the Loire Valley Atrial Fibrillation Project.
Gorin, L., Fauchier, L., Nonin, E., Charbonnier, B., Babuty, D., & Lip, G. Y. H. (2011). Prognosis and guideline-adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: implications of undertreatment and overtreatment in real-life clinical practice; the Loire Valley Atrial Fibrillation Project.. Chest, 140(4), 911-917. doi:10.1378/chest.10-2436
Simplifying stroke risk stratification in atrial fibrillation patients: implications of the CHA<sub>2</sub>DS<sub>2</sub>-VASc risk stratification scores (vol 39, pg 533, 2010)
Pamukcu, B., Lip, G. Y. H., & Lane, D. A. (2011). Simplifying stroke risk stratification in atrial fibrillation patients: implications of the CHA<sub>2</sub>DS<sub>2</sub>-VASc risk stratification scores (vol 39, pg 533, 2010). AGE AND AGEING, 40(1), 141. doi:10.1093/ageing/afq128
Stroke Risk Stratification in a "Real-World" Elderly Anticoagulated Atrial Fibrillation Population
Poli, D., Lip, G. Y., Antonucci, E., Grifoni, E., & Lane, D. (2011). Stroke Risk Stratification in a "Real-World" Elderly Anticoagulated Atrial Fibrillation Population. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 22(1), 25-30. doi:10.1111/j.1540-8167.2010.01858.x
The 2010 European Society of Cardiology Guidelines on the management of atrial fibrillation: an evolution or revolution?
Lip, G. Y. H., Halperin, J. L., & Tse, H. -F. (2011). The 2010 European Society of Cardiology Guidelines on the management of atrial fibrillation: an evolution or revolution?. Chest, 139(4), 738-741. doi:10.1378/chest.10-2763
The improved but unfinished business of stroke risk stratification in atrial fibrillation.
Banerjee, A., Marín, F., & Lip, G. Y. H. (2011). The improved but unfinished business of stroke risk stratification in atrial fibrillation.. Revista espanola de cardiologia, 64(8), 639-641. doi:10.1016/j.recesp.2011.04.005
Thrombogenesis in lone atrial fibrillation: a role for soluble P-selectin?
Montoro-García, S., Marín, F., & Lip, G. Y. H. (2011). Thrombogenesis in lone atrial fibrillation: a role for soluble P-selectin?. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 13(1), 3-4. doi:10.1093/europace/euq376
What is the role of the cardiologist in future management of stroke prevention in atrial fibrillation?
Velu, S., & Lip, G. Y. H. (2011). What is the role of the cardiologist in future management of stroke prevention in atrial fibrillation?. Advances in therapy, 28(1), 1-12. doi:10.1007/s12325-010-0091-9
2010
Novel anticoagulants for stroke prevention in atrial fibrillation: current clinical evidence and future developments.
Schirmer, S. H., Baumhäkel, M., Neuberger, H. -R., Hohnloser, S. H., van Gelder, I. C., Lip, G. Y. H., & Böhm, M. (2010). Novel anticoagulants for stroke prevention in atrial fibrillation: current clinical evidence and future developments.. Journal of the American College of Cardiology, 56(25), 2067-2076. doi:10.1016/j.jacc.2010.09.017
Plasma indices of angiogenesis in rheumatoid disease: relationship to cardiovascular risk factors and cardiac function.
Bhatia, G. S., Sosin, M. D., Patel, J. V., Grindulis, K. A., Khattak, F. H., Davis, R. C., & Lip, G. Y. H. (2010). Plasma indices of angiogenesis in rheumatoid disease: relationship to cardiovascular risk factors and cardiac function.. International journal of cardiology, 145(3), e105-e108. doi:10.1016/j.ijcard.2008.12.168
Dabigatran in atrial fibrillation: balancing secondary stroke prevention against bleeding risk
Lane, D. A., & Lip, G. Y. H. (2010). Dabigatran in atrial fibrillation: balancing secondary stroke prevention against bleeding risk. LANCET NEUROLOGY, 9(12), 1140-1142. doi:10.1016/S1474-4422(10)70275-1
Dronedarone or amiodarone for rhythm control for atrial fibrillation: implications from the DIONYSOS study.
Pamukcu, B., & Lip, G. Y. (2010). Dronedarone or amiodarone for rhythm control for atrial fibrillation: implications from the DIONYSOS study.. Expert opinion on pharmacotherapy, 11(17), 2775-2778. doi:10.1517/14656566.2010.517196
Editors choice: recent highlights from the journal of human hypertension
Stowasser, M., & Lip, G. Y. H. (2010). Editors choice: recent highlights from the journal of human hypertension. Journal of Human Hypertension, 24(12), 775-778. doi:10.1038/jhh.2010.90
Identifying Patients at High Risk for Stroke Despite Anticoagulation A Comparison of Contemporary Stroke Risk Stratification Schemes in an Anticoagulated Atrial Fibrillation Cohort
Lip, G. Y. H., Frison, L., Halperin, J. L., & Lane, D. A. (2010). Identifying Patients at High Risk for Stroke Despite Anticoagulation A Comparison of Contemporary Stroke Risk Stratification Schemes in an Anticoagulated Atrial Fibrillation Cohort. STROKE, 41(12), 2731-2738. doi:10.1161/STROKEAHA.110.590257
New concepts and approaches to stroke prevention in the new European Society of Cardiology guidelines for the management of atrial fibrillation.
Kuzniatsova, N., & Lip, G. Y. H. (2010). New concepts and approaches to stroke prevention in the new European Society of Cardiology guidelines for the management of atrial fibrillation.. Expert review of cardiovascular therapy, 8(12), 1643-1647. doi:10.1586/erc.10.150
The assessment of stroke and bleeding risk in atrial fibrillation: where are we now?
Pamukcu, B., Lane, D. A., & Lip, G. Y. H. (2010). The assessment of stroke and bleeding risk in atrial fibrillation: where are we now?. Expert review of cardiovascular therapy, 8(12), 1703-1710. doi:10.1586/erc.10.153
Treatments for stroke prevention in atrial fibrillation: a network meta-analysis and indirect comparisons versus dabigatran etexilate.
Roskell, N. S., Lip, G. Y. H., Noack, H., Clemens, A., & Plumb, J. M. (2010). Treatments for stroke prevention in atrial fibrillation: a network meta-analysis and indirect comparisons versus dabigatran etexilate.. Thrombosis and haemostasis, 104(6), 1106-1115. doi:10.1160/th10-10-0642
Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation.
Ezekowitz, M. D., Wallentin, L., Connolly, S. J., Parekh, A., Chernick, M. R., Pogue, J., . . . RE-LY Steering Committee and Investigators. (2010). Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation.. Circulation, 122(22), 2246-2253. doi:10.1161/circulationaha.110.973735
How do we get better at identifying patients with atrial fibrillation who are at 'truly low risk' or 'truly high risk' of stroke?
Kuzniatsova, N., & Lip, G. Y. H. (2010). How do we get better at identifying patients with atrial fibrillation who are at 'truly low risk' or 'truly high risk' of stroke?. Journal of the neurological sciences, 298(1-2), 21-22. doi:10.1016/j.jns.2010.08.015
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation The Euro Head Survey
Pisters, R., Lane, D. A., Nieuwlaat, R., de Vos, C. B., Crijns, H. J. G. M., & Lip, G. Y. H. (2010). A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation The Euro Head Survey. CHEST, 138(5), 1093-1100. doi:10.1378/chest.10-0134
Anger rumination, social support, and cardiac symptoms in patients undergoing angiography.
Closa León, T., Nouwen, A., Sheffield, D., Jaumdally, R., & Lip, G. Y. H. (2010). Anger rumination, social support, and cardiac symptoms in patients undergoing angiography.. British journal of health psychology, 15(Pt 4), 841-857. doi:10.1348/135910710x491360
Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis
Shantsila, E., Kamphuisen, P. W., & Lip, G. Y. H. (2010). Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 8(11), 2358-2368. doi:10.1111/j.1538-7836.2010.04007.x
Continuous retinal vessel diameter measurements: the future in retinal vessel assessment?
Heitmar, R., Blann, A. D., Cubbidge, R. P., Lip, G. Y. H., & Gherghel, D. (2010). Continuous retinal vessel diameter measurements: the future in retinal vessel assessment?. Investigative ophthalmology & visual science, 51(11), 5833-5839. doi:10.1167/iovs.09-5136
Insights from the new European Society of Cardiology guidelines for the medical management of atrial fibrillation.
Pamukcu, B., & Lip, G. Y. H. (2010). Insights from the new European Society of Cardiology guidelines for the medical management of atrial fibrillation.. International journal of clinical practice, 64(12), 1587-1590. doi:10.1111/j.1742-1241.2010.02522.x
Malignant Hypertension: A Rare Problem or is it Underdiagnosed?
Shantsila, A., Shantsila, E., & Lip, G. Y. H. (2010). Malignant Hypertension: A Rare Problem or is it Underdiagnosed?. CURRENT VASCULAR PHARMACOLOGY, 8(6), 775-779. doi:10.2174/157016110793563834
Plasma haemoxygenase-1 in coronary artery disease. A comparison with angiogenin, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and vascular endothelial growth factor.
Idriss, N. K., Lip, G. Y. H., Balakrishnan, B., Jaumdally, R., Boos, C. J., & Blann, A. D. (2010). Plasma haemoxygenase-1 in coronary artery disease. A comparison with angiogenin, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and vascular endothelial growth factor.. Thrombosis and haemostasis, 104(5), 1029-1037. doi:10.1160/th09-11-0802
Response to Dr Kula: Asymptomatic hypoxia in a young pregnant lady--unusual presentation of atrial septal defect.
Krishnamoorthy, S., & Lip, G. Y. H. (2010). Response to Dr Kula: Asymptomatic hypoxia in a young pregnant lady--unusual presentation of atrial septal defect.. International journal of cardiology, 144(3), 428. doi:10.1016/j.ijcard.2009.03.047
Soluble Fms-Like Tyrosine Kinase-1-A Novel Marker for Atherosclerotic Progression? -
Pamukcu, B., Shantsila, E., & Lip, G. Y. H. (2010). Soluble Fms-Like Tyrosine Kinase-1-A Novel Marker for Atherosclerotic Progression? -. CIRCULATION JOURNAL, 74(10), 2064-2065. doi:10.1253/circj.CJ-10-0621
CHA<sub>2</sub>DS<sub>2</sub>-VASc Risk Scheme Not Ready for Clinical Use Response
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010). CHA<sub>2</sub>DS<sub>2</sub>-VASc Risk Scheme Not Ready for Clinical Use Response. CHEST, 138(4), 1020-1021. doi:10.1378/chest.10-0938
Complement activation, endothelial dysfunction, insulin resistance and chronic heart failure.
Bjerre, M., Kistorp, C., Hansen, T. K., Faber, J., Lip, G. Y. H., Hildebrandt, P., & Flyvbjerg, A. (2010). Complement activation, endothelial dysfunction, insulin resistance and chronic heart failure.. Scandinavian cardiovascular journal : SCJ, 44(5), 260-266. doi:10.3109/14017431.2010.484506
Current therapeutic strategies and future perspectives for the prevention of arterial thromboembolism: focus on atrial fibrillation.
Potpara, T. S., & Lip, G. Y. H. (2010). Current therapeutic strategies and future perspectives for the prevention of arterial thromboembolism: focus on atrial fibrillation.. Current pharmaceutical design, 16(31), 3455-3471. doi:10.2174/138161210793563400
Endothelial dysfunction: methods of assessment & implications for cardiovascular diseases.
Butt, M., Dwivedi, G., Blann, A., Khair, O., & Lip, G. Y. H. (2010). Endothelial dysfunction: methods of assessment & implications for cardiovascular diseases.. Current pharmaceutical design, 16(31), 3442-3454. doi:10.2174/138161210793563383
Omega-3 polyunsaturated acids and cardiovascular disease: notable ethnic differences or unfulfilled promise?
Patel, J. V., Tracey, I., Hughes, E. A., & Lip, G. Y. (2010). Omega-3 polyunsaturated acids and cardiovascular disease: notable ethnic differences or unfulfilled promise?. Journal of thrombosis and haemostasis : JTH, 8(10), 2095-2104. doi:10.1111/j.1538-7836.2010.03956.x
Percutaneous Coronary Intervention in Anticoagulated Patients and Balancing the Risk of Stroke and Bleeding To Interrupt or Not To Interrupt?
Wrigley, B. J., Shantsila, E., & Lip, G. Y. H. (2010). Percutaneous Coronary Intervention in Anticoagulated Patients and Balancing the Risk of Stroke and Bleeding To Interrupt or Not To Interrupt?. CHEST, 138(4), 771-774. doi:10.1378/chest.10-0789
Stroke prevention in atrial fibrillation patients
Marinigh, R., Lip, G. Y. H., & Lane, D. A. (2010). Stroke prevention in atrial fibrillation patients. EXPERT OPINION ON PHARMACOTHERAPY, 11(14), 2331-2350. doi:10.1517/14656566.2010.498819
Review: direct thrombin inhibitors are similar to LMWH and vitamin K antagonists for preventing VTE after hip or knee replacement.
Salazar, C. A. (2010). Review: direct thrombin inhibitors are similar to LMWH and vitamin K antagonists for preventing VTE after hip or knee replacement.. Annals of internal medicine, 153(6), JC3-JC8. doi:10.7326/0003-4819-153-6-201009210-02008
Quality of anticoagulation control in atrial fibrillation
Lane, D. A., & Lip, G. Y. H. (2010). Quality of anticoagulation control in atrial fibrillation. LANCET, 376(9745), 935-937. doi:10.1016/S0140-6736(10)61305-0
Age as a Risk Factor for Stroke in Atrial Fibrillation Patients Implications for Thromboprophylaxis
Marinigh, R., Lip, G. Y. H., Fiotti, N., Giansante, C., & Lane, D. A. (2010). Age as a Risk Factor for Stroke in Atrial Fibrillation Patients Implications for Thromboprophylaxis. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 56(11), 827-837. doi:10.1016/j.jacc.2010.05.028
The prognostic value of biomarkers after a premature myocardial infarction.
Pineda, J., Marín, F., Marco, P., Roldán, V., Valencia, J., Ruiz-Nodar, J. M., . . . Lip, G. Y. H. (2010). The prognostic value of biomarkers after a premature myocardial infarction.. International journal of cardiology, 143(3), 249-254. doi:10.1016/j.ijcard.2009.02.019
Atrial fibrillation and mortality: the impact of antithrombotic therapy
Lane, D. A., & Lip, G. Y. H. (2010). Atrial fibrillation and mortality: the impact of antithrombotic therapy. EUROPEAN HEART JOURNAL, 31(17), 2075-2076. doi:10.1093/eurheartj/ehp486
Does Warfarin for Stroke Thromboprophylaxis Protect Against MI in Atrial Fibrillation Patients?
Lip, G. Y. H., & Lane, D. A. (2010). Does Warfarin for Stroke Thromboprophylaxis Protect Against MI in Atrial Fibrillation Patients?. AMERICAN JOURNAL OF MEDICINE, 123(9), 785-789. doi:10.1016/j.amjmed.2010.01.031
Guidelines for antithrombotic therapy in atrial fibrillation: understanding the reasons for non-adherence and moving forwards with simplifying risk stratification for stroke and bleeding
Fauchier, L., & Lip, G. Y. H. (2010). Guidelines for antithrombotic therapy in atrial fibrillation: understanding the reasons for non-adherence and moving forwards with simplifying risk stratification for stroke and bleeding. Europace, 12(9), 1349. doi:10.1093/europace/euq311
Rhythm control agents and adverse events in patients with atrial fibrillation.
Marín, F., & Lip, G. Y. H. (2010). Rhythm control agents and adverse events in patients with atrial fibrillation.. International journal of clinical practice, 64(10), 1329-1331. doi:10.1111/j.1742-1241.2010.02473.x
Simplifying stroke risk stratification in atrial fibrillation patients: implications of the CHA<sub>2</sub>DS<sub>2</sub>-VASc risk stratification scores
Pamukcu, B., Lip, G. Y. H., & Lane, D. A. (2010). Simplifying stroke risk stratification in atrial fibrillation patients: implications of the CHA<sub>2</sub>DS<sub>2</sub>-VASc risk stratification scores. AGE AND AGEING, 39(5), 533-535. doi:10.1093/ageing/afq059
Statins and prophylaxis of venous thrombosis - a further link between arterial and venous thrombosis
Shantsila, A., & Lip, G. Y. H. (2010). Statins and prophylaxis of venous thrombosis - a further link between arterial and venous thrombosis. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 64(10), 1327-1328. doi:10.1111/j.1742-1241.2010.02461.x
Synergism between factor XII -4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction.
Hernández-Romero, D., Marín, F., Lee, K. W., Roldán, V., Caturla, J., Corral, J., . . . González-Conejero, R. (2010). Synergism between factor XII -4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction.. Thrombosis and haemostasis, 104(3), 650-652. doi:10.1160/th10-01-0022
The contribution of cardiovascular risk factors to peripheral arterial disease in South Asians and Blacks: a sub-study to the Ethnic-Echocardiographic Heart of England Screening (E-ECHOES) study.
Bennett, P. C., Lip, G. Y. H., Silverman, S., Blann, A. D., & Gill, P. S. (2010). The contribution of cardiovascular risk factors to peripheral arterial disease in South Asians and Blacks: a sub-study to the Ethnic-Echocardiographic Heart of England Screening (E-ECHOES) study.. QJM : monthly journal of the Association of Physicians, 103(9), 661-669. doi:10.1093/qjmed/hcq102
The role of monocytes in atherosclerotic coronary artery disease
Pamukcu, B., Lip, G. Y. H., Devitt, A., Griffiths, H., & Shantsila, E. (2010). The role of monocytes in atherosclerotic coronary artery disease. ANNALS OF MEDICINE, 42(6), 394-403. doi:10.3109/07853890.2010.497767
Asymptomatic hypoxia in a young pregnant lady--unusual presentation of atrial septal defect.
Krishnamoorthy, S., Butt, M., & Lip, G. Y. H. (2010). Asymptomatic hypoxia in a young pregnant lady--unusual presentation of atrial septal defect.. International journal of cardiology, 143(2), e34-e36. doi:10.1016/j.ijcard.2008.12.039
Circulating monocytes and atherogenesis: From animal experiments to human studies
Shantsila, E., Devitt, A., & Lip, G. Y. H. (2010). Circulating monocytes and atherogenesis: From animal experiments to human studies. THROMBOSIS AND HAEMOSTASIS, 104(2), 191-193. doi:10.1160/TH10-03-0176
Circulating progenitor cells in patients with atrial fibrillation and their relation with serum markers of inflammation and angiogenesis
Watson, T., Shantsila, E., Blann, A., & Lip, G. Y. H. (2010). Circulating progenitor cells in patients with atrial fibrillation and their relation with serum markers of inflammation and angiogenesis. THROMBOSIS AND HAEMOSTASIS, 104(2), 327-334. doi:10.1160/TH10-01-0024
The impact of new and emerging clinical data on treatment strategies for atrial fibrillation.
Prystowsky, E. N., Camm, J., Lip, G. Y. H., Allessie, M., Bergmann, J. -F., Breithardt, G., . . . Tamargo, J. (2010). The impact of new and emerging clinical data on treatment strategies for atrial fibrillation.. Journal of cardiovascular electrophysiology, 21(8), 946-958. doi:10.1111/j.1540-8167.2010.01770.x
Antithrombotic therapy in anticoagulated patients with atrial fibrillation presenting with acute coronary syndromes and/or undergoing percutaneous coronary intervention/stenting
Wrigley, B. J., Tapp, L. D., Shantsila, E., & Lip, G. Y. H. (2010). Antithrombotic therapy in anticoagulated patients with atrial fibrillation presenting with acute coronary syndromes and/or undergoing percutaneous coronary intervention/stenting. POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 120(7-8), 290-293. doi:10.20452/pamw.949
Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients
Kaireviciute, D., Blann, A. D., Balakrishnan, B., Lane, D. A., Patel, J. V., Uzdavinys, G., . . . Lip, G. Y. H. (2010). Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients. THROMBOSIS AND HAEMOSTASIS, 104(1), 122-127. doi:10.1160/TH09-12-0837
Levosimendan - a calcium sensitising agent with potential anti-arrhythmic properties.
Kowalczyk, M., Banach, M., Lip, G. Y. H., Kozłowski, D., Mikhailidis, D. P., & Rysz, J. (2010). Levosimendan - a calcium sensitising agent with potential anti-arrhythmic properties.. International journal of clinical practice, 64(8), 1148-1154. doi:10.1111/j.1742-1241.2010.02396.x
New oral anticoagulant drugs in cardiovascular disease.
Ahrens, I., Lip, G. Y. H., & Peter, K. (2010). New oral anticoagulant drugs in cardiovascular disease.. Thrombosis and haemostasis, 104(1), 49-60. doi:10.1160/th09-05-0327
Obstructive Sleep Apnea Is a Risk Factor for Stroke and Atrial Fibrillation <i>Response</i>
Pisters, R., Nieuwlaat, R., Lane, D. A., Crijns, H. J. G. M., & Lip, G. Y. H. (2010). Obstructive Sleep Apnea Is a Risk Factor for Stroke and Atrial Fibrillation <i>Response</i>. CHEST, 138(1), 239-240. doi:10.1378/chest.10-0545
Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
Lip, G. Y. H., Huber, K., Andreotti, F., Arnesen, H., Airaksinen, J. K., Cuisset, T., . . . Consensus Document of European Society of Cardiology Working Group on Thrombosis. (2010). Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).. European heart journal, 31(11), 1311-1318. doi:10.1093/eurheartj/ehq117
Guidelines for antithrombotic therapy in atrial fibrillation: understanding the reasons for non-adherence and moving forwards with simplifying risk stratification for stroke and bleeding.
Fauchier, L., & Lip, G. Y. H. (2010). Guidelines for antithrombotic therapy in atrial fibrillation: understanding the reasons for non-adherence and moving forwards with simplifying risk stratification for stroke and bleeding.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 12(6), 761-763. doi:10.1093/europace/euq102
Improving stroke risk stratification in atrial fibrillation.
Lip, G. Y. H., & Halperin, J. L. (2010). Improving stroke risk stratification in atrial fibrillation.. The American journal of medicine, 123(6), 484-488. doi:10.1016/j.amjmed.2009.12.013
Novel oral anticoagulants: the potential relegation of vitamin K antagonists in clinical practice
Wrigley, B. J., Lip, G. Y. H., & Shantsila, E. (2010). Novel oral anticoagulants: the potential relegation of vitamin K antagonists in clinical practice. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 64(7), 835-838. doi:10.1111/j.1742-1241.2010.02351.x
Peripheral artery disease: appreciating the asymptomatic - yet lethal - epidemic.
Jaipersad, A. S., Silverman, S. H., & Lip, G. Y. H. (2010). Peripheral artery disease: appreciating the asymptomatic - yet lethal - epidemic.. International journal of clinical practice, 64(7), 832-835. doi:10.1111/j.1742-1241.2010.02393.x
TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT)
Smith, D. E., Xuereb, C. B., Pattison, H. M., Lip, G. Y. H., & Lane, D. A. (2010). TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT). BMC CARDIOVASCULAR DISORDERS, 10. doi:10.1186/1471-2261-10-21
An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality.
Aliot, E., Breithardt, G., Brugada, J., Camm, J., Lip, G. Y. H., Vardas, P. E., . . . World Heart Federation. (2010). An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 12(5), 626-633. doi:10.1093/europace/euq109
Anticoagulation for Atrial Fibrillation Patients with CHADS<sub>2</sub> Score of 1
Lane, D. A., & Lip, G. Y. H. (2010). Anticoagulation for Atrial Fibrillation Patients with CHADS<sub>2</sub> Score of 1. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 21(5), 508-510. doi:10.1111/j.1540-8167.2009.01687.x
Impact of symptom control on health-related quality of life in atrial fibrillation patients: the psychologist's viewpoint
Smith, D., Lip, G. Y. H., & Lane, D. A. (2010). Impact of symptom control on health-related quality of life in atrial fibrillation patients: the psychologist's viewpoint. EUROPACE, 12(5), 608-610. doi:10.1093/europace/euq083
Inflammatory cytokines, endothelial markers and adhesion molecules in rheumatoid arthritis: effect of intensive anti-inflammatory treatment.
Foster, W., Carruthers, D., Lip, G. Y. H., & Blann, A. D. (2010). Inflammatory cytokines, endothelial markers and adhesion molecules in rheumatoid arthritis: effect of intensive anti-inflammatory treatment.. Journal of thrombosis and thrombolysis, 29(4), 437-442. doi:10.1007/s11239-009-0370-y
Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels.
Barbalic, M., Dupuis, J., Dehghan, A., Bis, J. C., Hoogeveen, R. C., Schnabel, R. B., . . . Benjamin, E. J. (2010). Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels.. Human molecular genetics, 19(9), 1863-1872. doi:10.1093/hmg/ddq061
Anti-platelet therapy: is it all over in peripheral artery disease?
Jaipersad, A. S., Silverman, S. H., & Lip, G. Y. H. (2010). Anti-platelet therapy: is it all over in peripheral artery disease?. Thrombosis and haemostasis, 103(4), 689-691. doi:10.1160/th10-01-0053
Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk' [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice.
Lip, G. Y. H. (2010). Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk' [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice.. Thrombosis and haemostasis, 103(4), 683-685. doi:10.1160/th10-01-0038
Assessment of endothelial dysfunction.
Freestone, B., Krishnamoorthy, S., & Lip, G. Y. H. (2010). Assessment of endothelial dysfunction.. Expert review of cardiovascular therapy, 8(4), 557-571. doi:10.1586/erc.09.184
Effects of atorvastatin on circulating CD34+/CD133+/ CD45- progenitor cells and indices of angiogenesis (vascular endothelial growth factor and the angiopoietins 1 and 2) in atherosclerotic vascular disease and diabetes mellitus.
Jaumdally, R. J., Goon, P. K. Y., Varma, C., Blann, A. D., & Lip, G. Y. H. (2010). Effects of atorvastatin on circulating CD34+/CD133+/ CD45- progenitor cells and indices of angiogenesis (vascular endothelial growth factor and the angiopoietins 1 and 2) in atherosclerotic vascular disease and diabetes mellitus.. Journal of internal medicine, 267(4), 385-393. doi:10.1111/j.1365-2796.2009.02151.x
Inflammation and microvascular and macrovascular endothelial dysfunction in rheumatoid arthritis: effect of treatment.
Foster, W., Carruthers, D., Lip, G. Y. H., & Blann, A. D. (2010). Inflammation and microvascular and macrovascular endothelial dysfunction in rheumatoid arthritis: effect of treatment.. The Journal of rheumatology, 37(4), 711-716. doi:10.3899/jrheum.090699
Lone atrial fibrillation: what do we know?
Kozlowski, D., Budrejko, S., Lip, G. Y. H., Rysz, J., Mikhailidis, D. P., Raczak, G., & Banach, M. (2010). Lone atrial fibrillation: what do we know?. Heart (British Cardiac Society), 96(7), 498-503. doi:10.1136/hrt.2009.176321
Relationship of circulating endothelial progenitor cells to the recurrence of atrial fibrillation after successful conversion and maintenance of sinus rhythm.
Siu, C. -W., Watson, T., Lai, W. -H., Lee, Y. -K., Chan, Y. -H., Ng, K. -M., . . . Tse, H. -F. (2010). Relationship of circulating endothelial progenitor cells to the recurrence of atrial fibrillation after successful conversion and maintenance of sinus rhythm.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 12(4), 517-521. doi:10.1093/europace/eup382
Relationship of indices of inflammation and thrombogenesis to arrhythmia burden in paroxysmal atrial fibrillation.
Watson, T., Arya, A., Sulke, N., & Lip, G. Y. H. (2010). Relationship of indices of inflammation and thrombogenesis to arrhythmia burden in paroxysmal atrial fibrillation.. Chest, 137(4), 869-876. doi:10.1378/chest.09-1426
Triglycerides and small dense low density lipoprotein in the discrimination of coronary heart disease risk in South Asian populations.
Patel, J. V., Caslake, M. J., Vyas, A., Cruickshank, J. K., Prabhakaran, D., Bhatnagar, D., . . . Durrington, P. N. (2010). Triglycerides and small dense low density lipoprotein in the discrimination of coronary heart disease risk in South Asian populations.. Atherosclerosis, 209(2), 579-584. doi:10.1016/j.atherosclerosis.2009.10.010
Plasma YKL-40 levels are elevated in patients with chronic heart failure.
Rathcke, C. N., Kistorp, C., Raymond, I., Hildebrandt, P., Gustafsson, F., Lip, G. Y. H., . . . Vestergaard, H. (2010). Plasma YKL-40 levels are elevated in patients with chronic heart failure.. Scandinavian cardiovascular journal : SCJ, 44(2), 92-99. doi:10.3109/14017430903402218
Role of Ticagrelor in Clopidogrel Nonresponders: Resistance Is Futile?
Tapp, L., Shantsila, E., & Lip, G. Y. H. (2010). Role of Ticagrelor in Clopidogrel Nonresponders: Resistance Is Futile?. CIRCULATION, 121(10), 1169-1171. doi:10.1161/CIR.0b013e3181d8d929
Advances in therapy for atrial fibrillation
Lane, D. A., & Lip, G. Y. H. (2010). Advances in therapy for atrial fibrillation. Therapy, 7(2), 103-105. doi:10.2217/thy.10.15
Apolipoproteins in the discrimination of atherosclerotic burden and cardiac function in patients with stable coronary artery disease.
Patel, J. V., Abraheem, A., Creamer, J., Gunning, M., Hughes, E. A., & Lip, G. Y. H. (2010). Apolipoproteins in the discrimination of atherosclerotic burden and cardiac function in patients with stable coronary artery disease.. European journal of heart failure, 12(3), 254-259. doi:10.1093/eurjhf/hfp202
Changing the scope of preventative and therapeutic approaches in atherothrombosis.
Peter, K., & Lip, G. Y. H. (2010). Changing the scope of preventative and therapeutic approaches in atherothrombosis.. Thrombosis and haemostasis, 103(3), 487-488. doi:10.1160/th10-01-0063
Comparison of sequential rosuvastatin doses in hypercholesterolaemia: a meta-analysis of randomised controlled trials.
Gray, J., Edwards, S. J., & Lip, G. Y. H. (2010). Comparison of sequential rosuvastatin doses in hypercholesterolaemia: a meta-analysis of randomised controlled trials.. Current medical research and opinion, 26(3), 537-547. doi:10.1185/03007990903513980
Coronary Atherosclerosis in Rheumatoid Arthritis: Could Endothelial Progenitor Cells Be the Missing Link?
Wrigley, B. J., Lip, G. Y. H., & Shantsila, E. (2010). Coronary Atherosclerosis in Rheumatoid Arthritis: Could Endothelial Progenitor Cells Be the Missing Link?. JOURNAL OF RHEUMATOLOGY, 37(3), 479-481. doi:10.3899/jrheum.091341
Insights from the dabigatran versus warfarin in patients with atrial fibrillation (RE-LY) trial.
Khoo, C. W., & Lip, G. Y. H. (2010). Insights from the dabigatran versus warfarin in patients with atrial fibrillation (RE-LY) trial.. Expert opinion on pharmacotherapy, 11(4), 685-687. doi:10.1517/14656560903530691
Monocytes in heart failure: relationship to a deteriorating immune overreaction or a desperate attempt for tissue repair?
Apostolakis, S., Lip, G. Y. H., & Shantsila, E. (2010). Monocytes in heart failure: relationship to a deteriorating immune overreaction or a desperate attempt for tissue repair?. CARDIOVASCULAR RESEARCH, 85(4), 649-660. doi:10.1093/cvr/cvp327
Endothelial progenitor cells: what use for the cardiologist?
Siddique, A., Shantsila, E., Lip, G. Y., & Varma, C. (2010). Endothelial progenitor cells: what use for the cardiologist?. Journal of angiogenesis research, 2, 6. doi:10.1186/2040-2384-2-6
Effects of atorvastatin 80 mg daily on indices of matrix remodelling in 'high-risk' patients with ischemic heart disease.
López-Cuenca, A., Marín, F., Roldán, V., Climent, V. E., Valdés, M., & Lip, G. Y. H. (2010). Effects of atorvastatin 80 mg daily on indices of matrix remodelling in 'high-risk' patients with ischemic heart disease.. International journal of cardiology, 139(1), 95-97. doi:10.1016/j.ijcard.2008.06.076
Obstructive sleep apnea and cardiovascular disease.
Butt, M., Dwivedi, G., Khair, O., & Lip, G. Y. H. (2010). Obstructive sleep apnea and cardiovascular disease.. International journal of cardiology, 139(1), 7-16. doi:10.1016/j.ijcard.2009.05.021
Aspirin-A Drug Whose Time Has Gone?
Tapp, L., Shantsila, E., & Lip, G. Y. H. (2010). Aspirin-A Drug Whose Time Has Gone?. AMERICAN JOURNAL OF CARDIOLOGY, 105(4), 577-578. doi:10.1016/j.amjcard.2009.10.026
Anticoagulation intensity for elderly atrial fibrillation patients: Should we use a conventional INR target (2.0 to 3.0) or a lower range?
Lane, D. A., & Lip, G. Y. H. (2010). Anticoagulation intensity for elderly atrial fibrillation patients: Should we use a conventional INR target (2.0 to 3.0) or a lower range?. THROMBOSIS AND HAEMOSTASIS, 103(2), 254-256. doi:10.1160/TH09-12-0843
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010). Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation. CHEST, 137(2), 263-272. doi:10.1378/chest.09-1584
The additive value of biomarkers to clinical risk scores in acute coronary syndrome. Are biomarkers really ready for real world usage?
Tello-Montoliu, A., Marín, F., Roldán, V., & Lip, G. Y. H. (2010). The additive value of biomarkers to clinical risk scores in acute coronary syndrome. Are biomarkers really ready for real world usage?. Heart (British Cardiac Society), 96(3), 227-228. doi:10.1136/hrt.2009.182105
The effects of exercise stress testing, diurnal variation and temporal decline on circulating progenitor cells
Watson, T., Shantsila, E., Karthikeyan, V. J., Jessani, S., Goon, P. K., & Lip, G. Y. H. (2010). The effects of exercise stress testing, diurnal variation and temporal decline on circulating progenitor cells. THROMBOSIS AND HAEMOSTASIS, 103(2), 419-425. doi:10.1160/TH09-06-0386
Peripheral Blood Monocyte Subset Assessment in Non-ST-Segment Elevation Myocardial Infarction Is Required Reply
Shantsila, E., & Lip, G. Y. H. (2010). Peripheral Blood Monocyte Subset Assessment in Non-ST-Segment Elevation Myocardial Infarction Is Required Reply. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 55(2), 170-171. doi:10.1016/j.jacc.2009.08.044
ATRIAL FIBRILLATION Blockade of the renin-angiotensin system in atrial fibrillation
Kuzniatsova, N., Shantsila, E., & Lip, G. Y. H. (2010). ATRIAL FIBRILLATION Blockade of the renin-angiotensin system in atrial fibrillation. NATURE REVIEWS CARDIOLOGY, 7(8), 428-430. doi:10.1038/nrcardio.2010.103
Bleeding after coronary stenting in patients on oral anticoagulation: who is guilty?
Rubboli, A., Schlitt, A., Airaksinen, J., & Lip, G. Y. H. (2010). Bleeding after coronary stenting in patients on oral anticoagulation: who is guilty?. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 5(6), 649-650. doi:10.4244/5i6a105
Dronedarone: NICE enough?
Khoo, C. W., Lim, H. S., & Lip, G. Y. H. (2010). Dronedarone: NICE enough?. Expert review of cardiovascular therapy, 8(8), 1049-1051. doi:10.1586/erc.10.83
Editor´s choice articles 2008–2009
Lip, G., Preissner, K., & Weber, C. (2010). Editor´s choice articles 2008–2009. Thrombosis and Haemostasis, 103(01), 3-6. doi:10.1055/s-0037-1608916
Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk.
López-Cuenca, A., Marín, F., Roldán, V., González-Conejero, R., Hernández-Romero, D., Valdés, M., & Lip, G. Y. H. (2010). Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk.. Annals of medicine, 42(8), 562-575. doi:10.3109/07853890.2010.507601
How to manage antithrombotic treatment during percutaneous coronary interventions in patients receiving long-term oral anticoagulation: to "bridge" or not to "bridge"?
Airaksinen, K. E. J., Schlitt, A., Rubboli, A., Karjalainen, P., & Lip, G. Y. H. (2010). How to manage antithrombotic treatment during percutaneous coronary interventions in patients receiving long-term oral anticoagulation: to "bridge" or not to "bridge"?. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 6(4), 520-526. doi:10.4244/eij30v6i4a86
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting.
Lip, G. Y. H., Huber, K., Andreotti, F., Arnesen, H., Airaksinen, K. J., Cuisset, T., . . . European Society of Cardiology Working Group on Thrombosis. (2010). Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting.. In Thrombosis and haemostasis Vol. 103 (pp. 13-28). doi:10.1160/th09-08-0580
Moving forward with a new editorial team for Thrombosis and Haemostasis.
Weber, C., & Lip, G. Y. H. (2010). Moving forward with a new editorial team for Thrombosis and Haemostasis.. Thrombosis and haemostasis, 103(1), 1-2. doi:10.1160/th10-04-0256
Thrombosis and cardiovascular disease: Exciting perspectives in cardiovascular prevention and therapy.
Peter, K., & Lip, G. Y. H. (2010). Thrombosis and cardiovascular disease: Exciting perspectives in cardiovascular prevention and therapy.. Thrombosis and haemostasis, 103(5), 875-876. doi:10.1160/th10-03-0205
Towards (cost)effective cardiovascular risk management: using new drugs vs. the better use of available ones
Shantsila, A., & Lip, G. Y. H. (2010). Towards (cost)effective cardiovascular risk management: using new drugs vs. the better use of available ones. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 64(2), 138-140. doi:10.1111/j.1742-1241.2009.02233.x
Underuse of oral anticoagulants in atrial fibrillation: a systematic review.
Ogilvie, I. M., Newton, N., Welner, S. A., Cowell, W., & Lip, G. Y. H. (2010). Underuse of oral anticoagulants in atrial fibrillation: a systematic review.. The American journal of medicine, 123(7), 638-645.e4. doi:10.1016/j.amjmed.2009.11.025
2009
A prospective survey of acute hospital admissions with atrial fibrillation in Karachi, Pakistan
Haq, U., & Lip, G. Y. H. (2009). A prospective survey of acute hospital admissions with atrial fibrillation in Karachi, Pakistan. Journal of the Royal College of Physicians of Edinburgh, 39(3), 200-203.
Antithrombotic therapy for heart failure in sinus rhythm
Subramaniam, V., Davis, R. C., Shantsila, E., & Lip, G. Y. H. (2009). Antithrombotic therapy for heart failure in sinus rhythm. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 23(6), 705-717. doi:10.1111/j.1472-8206.2009.00776.x
Assessment of endothelial (dys)function in atrial fibrillation.
Krishnamoorthy, S., Lim, S. H., & Lip, G. Y. H. (2009). Assessment of endothelial (dys)function in atrial fibrillation.. Annals of medicine, 41(8), 576-590. doi:10.1080/07853890903160726
Atrial fibrillation in primary aldosteronism.
Watson, T., Karthikeyan, V. J., Lip, G. Y. H., & Beevers, D. G. (2009). Atrial fibrillation in primary aldosteronism.. Journal of the renin-angiotensin-aldosterone system : JRAAS, 10(4), 190-194. doi:10.1177/1470320309342734
Balancing Thromboembolism and Bleeding Risks Insights From Anticoagulation for Prosthetic Heart Valves
Tay, K. -H., Lane, D. A., & Lip, G. Y. H. (2009). Balancing Thromboembolism and Bleeding Risks Insights From Anticoagulation for Prosthetic Heart Valves. CHEST, 136(6), 1451-1452. doi:10.1378/chest.09-1187
Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'.
Kirchhof, P., Bax, J., Blomstrom-Lundquist, C., Calkins, H., Camm, A. J., Cappato, R., . . . Breithardt, G. (2009). Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'.. European heart journal, 30(24), 2969-277c. doi:10.1093/eurheartj/ehp235
Evidence guided antiplatelet treatment: Time to move from bench to bedside
Apostolakis, S., Shantsila, E., & Lip, G. Y. H. (2009). Evidence guided antiplatelet treatment: Time to move from bench to bedside. THROMBOSIS RESEARCH, 124(6), 649-650. doi:10.1016/j.thromres.2009.04.020
Heparin-Induced Thrombocytopenia <i>Response</i>
Shantsila, E., & Lip, G. Y. H. (2009). Heparin-Induced Thrombocytopenia <i>Response</i>. CHEST, 136(6), 1704-1705. doi:10.1378/chest.09-1753
High-risk myocardial infarction patients appear to derive more mortality benefit from short door-to-balloon time than low-risk patients.
Kong, P. K., Connolly, D., Varma, C., Lip, G., Millane, T., Davis, R., & Ahmad, R. (2009). High-risk myocardial infarction patients appear to derive more mortality benefit from short door-to-balloon time than low-risk patients.. International journal of clinical practice, 63(12), 1693-1701. doi:10.1111/j.1742-1241.2009.02122.x
Impaired glucose tolerance and endothelial damage, as assessed by levels of von Willebrand factor and circulating endothelial cells, following acute myocardial infarction
Jessani, S. S., Lane, D. A., Shantsila, E., Watson, T., Millane, T. A., & Lip, G. Y. H. (2009). Impaired glucose tolerance and endothelial damage, as assessed by levels of von Willebrand factor and circulating endothelial cells, following acute myocardial infarction. ANNALS OF MEDICINE, 41(8), 608-618. doi:10.1080/07853890903159256
Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists.
Lip, G. Y. H., Rasmussen, L. H., Olsson, S. B., Jensen, E. C., Persson, A. L., Eriksson, U., . . . Steering Committee. (2009). Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists.. European heart journal, 30(23), 2897-2907. doi:10.1093/eurheartj/ehp318
Vernakalant hydrochloride for the treatment of atrial fibrillation.
Kozlowski, D., Budrejko, S., Lip, G. Y. H., Mikhailidis, D. P., Rysz, J., Raczak, G., & Banach, M. (2009). Vernakalant hydrochloride for the treatment of atrial fibrillation.. Expert opinion on investigational drugs, 18(12), 1929-1937. doi:10.1517/13543780903386246
Circulating levels of adiponectin, leptin, and tumour necrosis factor alpha in hypertension.
Patel, J. V., Lim, H. S., Dubb, K., Hughes, E. A., & Lip, G. Y. H. (2009). Circulating levels of adiponectin, leptin, and tumour necrosis factor alpha in hypertension.. Annals of medicine, 41(4), 291-300. doi:10.1080/07853890802672839
Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation"
Apostolakis, S., Shantsila, E., Lip, G. Y. H., & Lane, D. A. (2009). Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation". THROMBOSIS AND HAEMOSTASIS, 102(5), 914-915. doi:10.1160/TH09-08-0563
Improving Survival of Malignant Hypertension Patients Over 40 Years
Lane, D. A., Lip, G. Y. H., & Beevers, D. G. (2009). Improving Survival of Malignant Hypertension Patients Over 40 Years. AMERICAN JOURNAL OF HYPERTENSION, 22(11), 1199-1204. doi:10.1038/ajh.2009.153
Systemic inflammation as a driver of vascular calcification: a proof of concept
Shantsila, E., & Lip, G. Y. H. (2009). Systemic inflammation as a driver of vascular calcification: a proof of concept. JOURNAL OF INTERNAL MEDICINE, 266(5), 453-456. doi:10.1111/j.1365-2796.2009.02138.x
The role of monocytes in thrombotic disorders Insights from tissue factor, monocyte-platelet aggregates and novel mechanisms
Shantsila, E., & Lip, G. Y. H. (2009). The role of monocytes in thrombotic disorders Insights from tissue factor, monocyte-platelet aggregates and novel mechanisms. THROMBOSIS AND HAEMOSTASIS, 102(5), 916-924. doi:10.1160/TH09-01-0023
New Anticoagulants for the Prevention of Deep Venous Thrombosis Time to Consider Cost Effectiveness?
Apostolakis, S., Shantsila, E., & Lip, G. Y. H. (2009). New Anticoagulants for the Prevention of Deep Venous Thrombosis Time to Consider Cost Effectiveness?. PHARMACOECONOMICS, 27(10), 793-795. doi:10.2165/11313780-000000000-00000
Treatment of hypertension in peripheral arterial disease
Lane, D. A., & Lip, G. Y. H. (2009). Treatment of hypertension in peripheral arterial disease. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (4). doi:10.1002/14651858.CD003075.pub2
Can the WATCHMAN device truly PROTECT from stroke in atrial fibrillation?
Wrigley, B. J., & Lip, G. Y. H. (2009). Can the WATCHMAN device truly PROTECT from stroke in atrial fibrillation?. The Lancet. Neurology, 8(10), 877-878. doi:10.1016/s1474-4422(09)70244-3
Monocytes in Acute Coronary Syndromes
Shantsila, E., & Lip, G. Y. H. (2009). Monocytes in Acute Coronary Syndromes. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 29(10), 1433-1U66. doi:10.1161/ATVBAHA.108.180513
Pathophysiological insights into atrial fibrillation following cardiac surgery: implications for current pharmaceutical design.
Kaireviciute, D., Aidietis, A., & Lip, G. Y. H. (2009). Pathophysiological insights into atrial fibrillation following cardiac surgery: implications for current pharmaceutical design.. Current pharmaceutical design, 15(29), 3367-3383. doi:10.2174/138161209789105063
Response to Letter by De Silva et al
Gunarathne, A., Patel, J. V., Gammon, B., Gill, P. S., Hughes, E. A., & Lip, G. Y. H. (2009). Response to Letter by De Silva et al. Stroke, 40(10). doi:10.1161/strokeaha.109.560102
Review: combining 2 classes of blood pressure-lowering drugs has an approximately additive effect on systolic blood pressure.
Shantsila, A., & Lip, G. Y. H. (2009). Review: combining 2 classes of blood pressure-lowering drugs has an approximately additive effect on systolic blood pressure.. Evidence-based medicine, 14(5), 142. doi:10.1136/ebm.14.5.142
Vascular Imaging as a Cardiovascular Risk Stratification Tool in Systemic Lupus Erythematosus
Apostolakis, S., Shantsila, E., & Lip, G. Y. H. (2009). Vascular Imaging as a Cardiovascular Risk Stratification Tool in Systemic Lupus Erythematosus. JOURNAL OF RHEUMATOLOGY, 36(10), 2141-2143. doi:10.3899/jrheum.090640
Vascular damage in impaired glucose tolerance: an unappreciated phenomenon?
Jessani, S., Millane, T., & Lip, G. Y. H. (2009). Vascular damage in impaired glucose tolerance: an unappreciated phenomenon?. Current pharmaceutical design, 15(29), 3417-3432. doi:10.2174/138161209789105072
Rationale and study design of a cross sectional study documenting the prevalence of Heart Failure amongst the minority ethnic communities in the UK: the E-ECHOES Study (Ethnic--Echocardiographic Heart of England Screening Study).
Gill, P. S., Davis, R., Davies, M., Freemantle, N., & Lip, G. Y. (2009). Rationale and study design of a cross sectional study documenting the prevalence of Heart Failure amongst the minority ethnic communities in the UK: the E-ECHOES Study (Ethnic--Echocardiographic Heart of England Screening Study).. BMC cardiovascular disorders, 9, 47. doi:10.1186/1471-2261-9-47
Combination Anticoagulant and Antiplatelet Therapy in Atrial Fibrillation Patients
Lip, G. Y. H., & Lane, D. A. (2009). Combination Anticoagulant and Antiplatelet Therapy in Atrial Fibrillation Patients. REVISTA ESPANOLA DE CARDIOLOGIA, 62(9), 972-975. doi:10.1016/S0300-8932(09)72094-9
Premature coronary artery disease in young (age <45) subjects: interactions of lipid profile, thrombophilic and haemostatic markers.
Pineda, J., Marín, F., Marco, P., Roldán, V., Valencia, J., Ruiz-Nodar, J. M., . . . Lip, G. Y. H. (2009). Premature coronary artery disease in young (age <45) subjects: interactions of lipid profile, thrombophilic and haemostatic markers.. International journal of cardiology, 136(2), 222-225. doi:10.1016/j.ijcard.2008.04.020
Acute Management of Atrial Fibrillation: Response
Khoo, C. W., & Lip, G. Y. H. (2009). Acute Management of Atrial Fibrillation: Response. Chest, 136(2), 652. doi:10.1378/chest.09-0976
Angiopoietins and Preeclampsia: New Perspectives in the Quest for Markers
Apostolakis, S., Shantsila, E., & Lip, G. Y. H. (2009). Angiopoietins and Preeclampsia: New Perspectives in the Quest for Markers. AMERICAN JOURNAL OF HYPERTENSION, 22(8), 820. doi:10.1038/ajh.2009.108
Defibrillation testing in patients with atrial fibrillation.
Lim, H. S., & Lip, G. Y. H. (2009). Defibrillation testing in patients with atrial fibrillation.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 11(8), 1108-1109. doi:10.1093/europace/eup157
Novel antiarrhythmic drugs in atrial fibrillation: focus on tedisamil.
Krishnamoorthy, S., & Lip, G. Y. H. (2009). Novel antiarrhythmic drugs in atrial fibrillation: focus on tedisamil.. Expert opinion on investigational drugs, 18(8), 1191-1196. doi:10.1517/13543780903114150
The endothelium and thrombotic risk in heart failure
Shantsila, E., & Lip, G. Y. H. (2009). The endothelium and thrombotic risk in heart failure. THROMBOSIS AND HAEMOSTASIS, 102(2), 185-187. doi:10.1160/TH09-06-0344
Monocyte Diversity in Myocardial Infarction
Shantsila, E., & Lip, G. Y. H. (2009). Monocyte Diversity in Myocardial Infarction. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 54(2), 139-142. doi:10.1016/j.jacc.2009.03.047
Antithrombotic therapy use for patients with atrial fibrillation undergoing percutaneous coronary intervention: new data in an area of limited evidence.
Marín, F., Kirchhof, P., & Lip, G. Y. H. (2009). Antithrombotic therapy use for patients with atrial fibrillation undergoing percutaneous coronary intervention: new data in an area of limited evidence.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 11(7), 842-843. doi:10.1093/europace/eup161
Bleeding rates in elderly patients on vitamin K antagonist therapy for nonvalvular atrial fibrillation
Tay, K. -H., Lip, G. Y. H., & Lane, D. A. (2009). Bleeding rates in elderly patients on vitamin K antagonist therapy for nonvalvular atrial fibrillation. BLOOD COAGULATION & FIBRINOLYSIS, 20(5), 392-393. doi:10.1097/MBC.0b013e32832aec47
Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'.
Kirchhof, P., Bax, J., Blomstrom-Lundquist, C., Calkins, H., Camm, A. J., Cappato, R., . . . Breithardt, G. (2009). Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 11(7), 860-885. doi:10.1093/europace/eup124
Glycemic status underlies increased arterial stiffness and impaired endothelial function in migrant South Asian stroke survivors compared to European Caucasians: pathophysiological insights from the West Birmingham Stroke Project.
Gunarathne, A., Patel, J. V., Kausar, S., Gammon, B., Hughes, E. A., & Lip, G. Y. H. (2009). Glycemic status underlies increased arterial stiffness and impaired endothelial function in migrant South Asian stroke survivors compared to European Caucasians: pathophysiological insights from the West Birmingham Stroke Project.. Stroke, 40(7), 2298-2306. doi:10.1161/strokeaha.109.548388
How safe is the antiarrhythmic drug therapy in atrial fibrillation?
Krishnamoorthy, S., & Lip, G. Y. H. (2009). How safe is the antiarrhythmic drug therapy in atrial fibrillation?. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 11(7), 837-839. doi:10.1093/europace/eup170
Drug-eluting stents: a comprehensive appraisal.
Butt, M., Connolly, D., & Lip, G. Y. H. (2009). Drug-eluting stents: a comprehensive appraisal.. Future cardiology, 5(2), 141-157. doi:10.2217/14796678.5.2.141
Assessment of endothelial function: implications for hypertension and cardiovascular disorders.
Butt, M., Dwivedi, G., Khair, O., & Lip, G. Y. (2009). Assessment of endothelial function: implications for hypertension and cardiovascular disorders.. Expert review of cardiovascular therapy, 7(6), 561-563. doi:10.1586/erc.09.36
Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus.
Jaumdally, R. J., Lip, G. Y. H., Patel, J. V., MacFadyen, R. J., & Varma, C. (2009). Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus.. Journal of internal medicine, 265(6), 689-697. doi:10.1111/j.1365-2796.2009.02072.x
Fondaparinux: an overview.
Nadar, S. K., Goyal, D., Shantsila, E., Banerjee, P., & Lip, G. Y. H. (2009). Fondaparinux: an overview.. Expert review of cardiovascular therapy, 7(6), 577-585. doi:10.1586/erc.09.19
Heparin-Induced Thrombocytopenia A Contemporary Clinical Approach to Diagnosis and Management
Shantsila, E., Lip, G. Y. H., & Chong, B. H. (2009). Heparin-Induced Thrombocytopenia A Contemporary Clinical Approach to Diagnosis and Management. CHEST, 135(6), 1651-1664. doi:10.1378/chest.08-2830
Hypertension to heart failure: a pathophysiological spectrum relating blood pressure, drug treatments and stroke.
Subramaniam, V., & Lip, G. Y. H. (2009). Hypertension to heart failure: a pathophysiological spectrum relating blood pressure, drug treatments and stroke.. Expert review of cardiovascular therapy, 7(6), 703-713. doi:10.1586/erc.09.43
Ischemic stroke in South Asians: a review of the epidemiology, pathophysiology, and ethnicity-related clinical features.
Gunarathne, A., Patel, J. V., Gammon, B., Gill, P. S., Hughes, E. A., & Lip, G. Y. H. (2009). Ischemic stroke in South Asians: a review of the epidemiology, pathophysiology, and ethnicity-related clinical features.. Stroke, 40(6), e415-e423. doi:10.1161/strokeaha.108.535724
Performing repeated noninvasive bedside measures of volume response to intravenous furosemide in acute pulmonary edema: a feasibility assessment.
Ng Kam Chuen, M. J., Lip, G. Y. H., & Macfadyen, R. J. (2009). Performing repeated noninvasive bedside measures of volume response to intravenous furosemide in acute pulmonary edema: a feasibility assessment.. Cardiovascular therapeutics, 27(2), 89-95. doi:10.1111/j.1755-5922.2009.00080.x
Quality of life in older people with atrial fibrillation
Lane, D. A., & Lip, G. Y. H. (2009). Quality of life in older people with atrial fibrillation. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 25(1), 37-42. doi:10.1007/s10840-008-9318-y
Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone.
Krishnamoorthy, S., & Lip, G. Y. H. (2009). Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone.. Expert review of cardiovascular therapy, 7(5), 473-481. doi:10.1586/erc.09.14
Burden of atrial fibrillation.
Khoo, C. W., & Lip, G. Y. H. (2009). Burden of atrial fibrillation.. Current medical research and opinion, 25(5), 1261-1263. doi:10.1185/03007990902910443
Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients
Lane, D. A., & Lip, G. Y. H. (2009). Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients. THROMBOSIS AND HAEMOSTASIS, 101(5), 802-805. doi:10.1160/TH09-02-0106
Indications for the use of diagnostic implantable and external ECG loop recorders.
Task Force members., Brignole, M., Vardas, P., Hoffman, E., Huikuri, H., Moya, A., . . . EHRA Scientific Documents Committee. (2009). Indications for the use of diagnostic implantable and external ECG loop recorders.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 11(5), 671-687. doi:10.1093/europace/eup097
Mitral regurgitation reduces systemic coagulation activity in rheumatic heart disease: using fibrin D-dimer as a biomarker of thrombogenesis.
Tay, K. H., Khoo, C. W., & Lip, G. Y. H. (2009). Mitral regurgitation reduces systemic coagulation activity in rheumatic heart disease: using fibrin D-dimer as a biomarker of thrombogenesis.. The Journal of heart valve disease, 18(3), 276-277.
New antiplatelet drugs: beyond aspirin and clopidogrel
Siddique, A., Butt, M., Shantsila, E., & Lip, G. Y. H. (2009). New antiplatelet drugs: beyond aspirin and clopidogrel. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 63(5), 776-789. doi:10.1111/j.1742-1241.2009.02058.x
Plasma indices of endothelial and platelet activation in Rheumatoid Disease: relationship to cardiovascular co-morbidity.
Bhatia, G. S., Sosin, M. D., Patel, J. V., Grindulis, K. A., Khattak, F. H., Davis, R. C., & Lip, G. Y. H. (2009). Plasma indices of endothelial and platelet activation in Rheumatoid Disease: relationship to cardiovascular co-morbidity.. International journal of cardiology, 134(1), 97-103. doi:10.1016/j.ijcard.2008.01.038
Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study.
Du, X., Ninomiya, T., de Galan, B., Abadir, E., Chalmers, J., Pillai, A., . . . ADVANCE Collaborative Group. (2009). Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study.. European heart journal, 30(9), 1128-1135. doi:10.1093/eurheartj/ehp055
AZD6140 and bleeding: towards safer antiplatelet therapy?
Siddique, A., Shantsila, E., & Lip, G. Y. H. (2009). AZD6140 and bleeding: towards safer antiplatelet therapy?. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 63(4), 537-539. doi:10.1111/j.1742-1241.2008.01963.x
Clinical outcomes of acute stroke patients with atrial fibrillation.
Khoo, C. W., & Lip, G. Y. H. (2009). Clinical outcomes of acute stroke patients with atrial fibrillation.. Expert review of cardiovascular therapy, 7(4), 371-374. doi:10.1586/erc.09.11
Impact of chronic kidney disease on major bleeding complications and mortality in patients with indication for oral anticoagulation undergoing coronary stenting.
Manzano-Fernández, S., Marín, F., Pastor-Pérez, F. J., Caro, C., Cambronero, F., Lacunza, J., . . . Lip, G. Y. H. (2009). Impact of chronic kidney disease on major bleeding complications and mortality in patients with indication for oral anticoagulation undergoing coronary stenting.. Chest, 135(4), 983-990. doi:10.1378/chest.08-1425
Markers of thrombosis and hemostasis in acute coronary syndromes: relationship to increased heart rate and reduced heart-rate variability.
Hamaad, A., Sosin, M. D., Blann, A. D., Lip, G. Y. H., & MacFadyen, R. J. (2009). Markers of thrombosis and hemostasis in acute coronary syndromes: relationship to increased heart rate and reduced heart-rate variability.. Clinical cardiology, 32(4), 204-209. doi:10.1002/clc.20321
Novel oral anticoagulants
Khoo, C. W., Tay, K. -H., Shantsila, E., & Lip, G. Y. H. (2009). Novel oral anticoagulants. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 63(4), 630-641. doi:10.1111/j.1742-1241.2009.02011.x
Unraveling the paradoxical link between obesity and heart failure: the role of adipocytokines.
Patel, J. V., Tracey, I., Hughes, E. A., & Lip, G. Y. H. (2009). Unraveling the paradoxical link between obesity and heart failure: the role of adipocytokines.. Expert review of cardiovascular therapy, 7(4), 337-340. doi:10.1586/erc.09.12
Mechanisms of thrombogenesis in atrial fibrillation Reply
Lip, G. Y. H., & Shantsila, E. (2009). Mechanisms of thrombogenesis in atrial fibrillation Reply. LANCET, 373(9668), 1006-1007. doi:10.1016/S0140-6736(09)60605-X
Challenges facing anticoagulation among the elderly and frail
Tay, K. H., Lane, D. A., & Lip, G. Y. H. (2009). Challenges facing anticoagulation among the elderly and frail. AGE AND AGEING, 38(2), 140-142. doi:10.1093/ageing/afn295
Circulating endothelial cells and rheumatoid arthritis: relationship with plasma markers of endothelial damage/dysfunction
Foster, W., Shantsila, E., Carruthers, D., Lip, G. Y. H., & Blann, A. D. (2009). Circulating endothelial cells and rheumatoid arthritis: relationship with plasma markers of endothelial damage/dysfunction. RHEUMATOLOGY, 48(3), 285-288. doi:10.1093/rheumatology/ken486
Anticoagulation variability: is it the physician, patient or hospital?
Tay, K. H., Lip, G. Y. H., & Lane, D. A. (2009). Anticoagulation variability: is it the physician, patient or hospital?. Journal of internal medicine, 265(3), 303-306. doi:10.1111/j.1365-2796.2008.02069.x
Atrial fibrillation and stroke risk prevention in real-life clinical practice
Tay, K. H., Lip, G. Y. H., & Lane, D. A. (2009). Atrial fibrillation and stroke risk prevention in real-life clinical practice. THROMBOSIS AND HAEMOSTASIS, 101(3), 415-416. doi:10.1160/TH08-10-0645
Generalized obesity but not that characterized by raised waist-hip ratio is associated with increased perceived breathlessness during treadmill exercise testing.
Goyal, D., Logie, I. -M., Nadar, S. K., Lip, G. Y. H., & Macfadyen, R. J. (2009). Generalized obesity but not that characterized by raised waist-hip ratio is associated with increased perceived breathlessness during treadmill exercise testing.. Cardiovascular therapeutics, 27(1), 10-16. doi:10.1111/j.1755-5922.2008.00067.x
Illness perceptions, affective response, and health-related quality of life in patients with atrial fibrillation
Lane, D. A., Langman, C. M., Lip, G. Y. H., & Nouwen, A. (2009). Illness perceptions, affective response, and health-related quality of life in patients with atrial fibrillation. JOURNAL OF PSYCHOSOMATIC RESEARCH, 66(3), 203-210. doi:10.1016/j.jpsychores.2008.10.007
Rivaroxaban, a new oral factor Xa inhibitor, provides new data on anticoagulation
Siddique, A., Lip, G. Y. H., & Shantsila, E. (2009). Rivaroxaban, a new oral factor Xa inhibitor, provides new data on anticoagulation. Therapy, 6(2), 187-189. doi:10.2217/14750708.6.2.187
Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.
Chung, I., Choudhury, A., Patel, J., & Lip, G. Y. H. (2009). Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.. Annals of medicine, 41(1), 45-51. doi:10.1080/07853890802227089
Influence of electrical cardioversion on inflammation and indexes of structural remodeling, in persistent atrial fibrillation.
Climent, V., Marín, F., Mainar, L., Roldán, V., García, A., Martínez, J. G., & Lip, G. Y. H. (2009). Influence of electrical cardioversion on inflammation and indexes of structural remodeling, in persistent atrial fibrillation.. International journal of cardiology, 132(2), 227-232. doi:10.1016/j.ijcard.2007.11.044
A randomized trial of the addition of home-based exercise to specialist heart failure nurse care: the Birmingham Rehabilitation Uptake Maximisation study for patients with Congestive Heart Failure (BRUM-CHF) study.
Jolly, K., Taylor, R. S., Lip, G. Y. H., Davies, M., Davis, R., Mant, J., . . . Stevens, A. (2009). A randomized trial of the addition of home-based exercise to specialist heart failure nurse care: the Birmingham Rehabilitation Uptake Maximisation study for patients with Congestive Heart Failure (BRUM-CHF) study.. European journal of heart failure, 11(2), 205-213. doi:10.1093/eurjhf/hfn029
Atrial fibrillation following cardiac surgery: clinical features and preventative strategies.
Kaireviciute, D., Aidietis, A., & Lip, G. Y. H. (2009). Atrial fibrillation following cardiac surgery: clinical features and preventative strategies.. European heart journal, 30(4), 410-425. doi:10.1093/eurheartj/ehn609
Relationships between endothelial, inflammatory and angiogenesis markers in rheumatoid arthritis: implications for cardiovascular pathophysiology.
Foster, W., Carruthers, D., Lip, G. Y. H., & Blann, A. D. (2009). Relationships between endothelial, inflammatory and angiogenesis markers in rheumatoid arthritis: implications for cardiovascular pathophysiology.. Thrombosis research, 123(4), 659-664. doi:10.1016/j.thromres.2008.06.014
Response to letter by Haft: Using CHADS2 backwards plus echo criteria to identify stroke patients who have occult intermittent atrial fibrillation
Lip, G. Y. H. (2009). Response to letter by Haft: Using CHADS2 backwards plus echo criteria to identify stroke patients who have occult intermittent atrial fibrillation. American Heart Journal, 157(2), e11. doi:10.1016/j.ahj.2008.10.015
Response to the letter by Dr Jolobe: “Risk factors and stroke risk stratification for atrial fibrillation: Limitations and new possibilities”
Lip, G. Y. H. (2009). Response to the letter by Dr Jolobe: “Risk factors and stroke risk stratification for atrial fibrillation: Limitations and new possibilities”. American Heart Journal, 157(2), e7. doi:10.1016/j.ahj.2008.10.013
Variability of response to antiplatelet therapy: what should we do next?
Shantsila, E., & Lip, G. Y. H. (2009). Variability of response to antiplatelet therapy: what should we do next?. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 23(1), 19-22. doi:10.1111/j.1472-8206.2008.00674.x
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
Watson, T., Shantsila, E., & Lip, G. Y. H. (2009). Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited. LANCET, 373(9658), 155-166. doi:10.1016/S0140-6736(09)60040-4
Acute coronary syndromes: oral factor Xa inhibitors in acute coronary syndromes.
Tapp, L., Wrigley, B., & Lip, G. Y. H. (2009). Acute coronary syndromes: oral factor Xa inhibitors in acute coronary syndromes.. Nature reviews. Cardiology, 6(10), 619-620. doi:10.1038/nrcardio.2009.160
Acute management of atrial fibrillation.
Khoo, C. W., & Lip, G. Y. H. (2009). Acute management of atrial fibrillation.. Chest, 135(3), 849-859. doi:10.1378/chest.08-2183
Alcohol and Illicit Drug Use as Precipitants of Atrial Fibrillation in Young Adults: A Case Series and Literature Review
Krishnamoorthy, S., Lip, G. Y. H., & Lane, D. A. (2009). Alcohol and Illicit Drug Use as Precipitants of Atrial Fibrillation in Young Adults: A Case Series and Literature Review. AMERICAN JOURNAL OF MEDICINE, 122(9), 851-U83. doi:10.1016/j.amjmed.2009.02.012
Angiopoietins in arterial hypertension: a mechanism of adaptation or a target for treatment?
Shantsila, E., & Lip, G. Y. H. (2009). Angiopoietins in arterial hypertension: a mechanism of adaptation or a target for treatment?. JOURNAL OF HYPERTENSION, 27(8), 1524-1526. doi:10.1097/HJH.0b013e32832dd5c4
Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis.
Cambronero, F., Marín, F., Roldán, V., Hernández-Romero, D., Valdés, M., & Lip, G. Y. H. (2009). Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis.. European heart journal, 30(2), 139-151. doi:10.1093/eurheartj/ehn538
Can the NICE guidelines on the management of atrial fibrillation improve its management?
Khoo, C. W., & Lip, G. Y. H. (2009). Can the NICE guidelines on the management of atrial fibrillation improve its management?. Clinical medicine (London, England), 9(3), 207-209. doi:10.7861/clinmedicine.9-3-207
Circulating biomarkers of angiogenesis as indicators of left ventricular systolic dysfunction amongst patients with coronary artery disease.
Patel, J. V., Abraheem, A., Chackathayil, J., Gunning, M., Creamer, J., Hughes, E. A., & Lip, G. Y. H. (2009). Circulating biomarkers of angiogenesis as indicators of left ventricular systolic dysfunction amongst patients with coronary artery disease.. Journal of internal medicine, 265(5), 562-567. doi:10.1111/j.1365-2796.2008.02057.x
Circulating endothelial cells and circulating progenitor cells in breast cancer: relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index.
Goon, P. K. Y., Lip, G. Y. H., Stonelake, P. S., & Blann, A. D. (2009). Circulating endothelial cells and circulating progenitor cells in breast cancer: relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index.. Neoplasia (New York, N.Y.), 11(8), 771-779. doi:10.1593/neo.09490
Endothelial function and endothelial progenitors: possible mediators of the benefits from physical exercise?
Shantsila, E., & Lip, G. Y. H. (2009). Endothelial function and endothelial progenitors: possible mediators of the benefits from physical exercise?. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 16(4), 401-403. doi:10.1097/HJR.0b013e32832d3c76
Ethnicity and peripheral artery disease.
Bennett, P. C., Silverman, S., Gill, P. S., & Lip, G. Y. H. (2009). Ethnicity and peripheral artery disease.. QJM : monthly journal of the Association of Physicians, 102(1), 3-16. doi:10.1093/qjmed/hcn140
Face to face with basic and clinical research in Thrombosis and Haemostasis.
Preissner, K. T., & Lip, G. Y. H. (2009). Face to face with basic and clinical research in Thrombosis and Haemostasis.. Thrombosis and haemostasis, 101(1), 1. doi:10.1160/th08-12-0791
Left atrial remodelling in hypertrophic cardiomyopathy: relation with exercise capacity and biochemical markers of tissue strain and remodelling.
Saura, D., Marín, F., Climent, V., González, J., Roldán, V., Hernández-Romero, D., . . . Valdés, M. (2009). Left atrial remodelling in hypertrophic cardiomyopathy: relation with exercise capacity and biochemical markers of tissue strain and remodelling.. International journal of clinical practice, 63(10), 1465-1471. doi:10.1111/j.1742-1241.2009.02127.x
Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study.
Ip, J., Waldo, A. L., Lip, G. Y. H., Rothwell, P. M., Martin, D. T., Bersohn, M. M., . . . IMPACT Investigators. (2009). Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study.. American heart journal, 158(3), 364-370.e1. doi:10.1016/j.ahj.2009.07.002
Omega-3 polyunsaturated fatty acids: a necessity for a comprehensive secondary prevention strategy.
Patel, J. V., Tracey, I., Hughes, E. A., & Lip, G. Y. H. (2009). Omega-3 polyunsaturated fatty acids: a necessity for a comprehensive secondary prevention strategy.. Vascular health and risk management, 5, 801-810. doi:10.2147/vhrm.s4307
Peripheral arterial disease and Virchow's triad.
Bennett, P. C., Silverman, S. H., Gill, P. S., & Lip, G. Y. H. (2009). Peripheral arterial disease and Virchow's triad.. Thrombosis and haemostasis, 101(6), 1032-1040. doi:10.1160/th08-08-0518
Plasma metalloproteinase-9 in age-related macular degeneration.
Blann, A. D., & Lip, G. Y. H. (2009). Plasma metalloproteinase-9 in age-related macular degeneration.. Eye (London, England), 23(2), 494-495. doi:10.1038/eye.2008.71
Pro: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation"
Healey, J. S. (2009). Pro: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation". THROMBOSIS AND HAEMOSTASIS, 102(5), 912-913. doi:10.1160/TH09-06-0369
Renin-angiotensin-aldosterone system blockade in atrial fibrillation and left atrial remodelling.
Krishnamoorthy, S., & Lip, G. Y. H. (2009). Renin-angiotensin-aldosterone system blockade in atrial fibrillation and left atrial remodelling.. International journal of clinical practice, 63(7), 982-985. doi:10.1111/j.1742-1241.2009.02083.x
The Birmingham Rehabilitation Uptake Maximisation study (BRUM): a randomised controlled trial comparing home-based with centre-based cardiac rehabilitation.
Jolly, K., Lip, G. Y. H., Taylor, R. S., Raftery, J., Mant, J., Lane, D., . . . Stevens, A. (2009). The Birmingham Rehabilitation Uptake Maximisation study (BRUM): a randomised controlled trial comparing home-based with centre-based cardiac rehabilitation.. Heart (British Cardiac Society), 95(1), 36-42. doi:10.1136/hrt.2007.127209
Thrombosis prophylaxis in patients with ischaemic (cardioembolic) stroke. How long is long enough?
Lip, G. Y. H., & Krishnamoorthy, S. (2009). Thrombosis prophylaxis in patients with ischaemic (cardioembolic) stroke. How long is long enough?. Hamostaseologie, 29(1), 96-101.
2008
Is thrombogenesis related to residual platelet function in ischaemic heart disease?
Pastor-Pérez, F. J., Marín, F., Manzano-Fernández, S., & Lip, G. Y. H. (2008). Is thrombogenesis related to residual platelet function in ischaemic heart disease?. European heart journal, 29(24), 3065. doi:10.1093/eurheartj/ehn472
Bleeding risks with combination of oral anticoagulation plus antiplatelet therapy: Is clopidogrel any safer than aspirin when combined with warfarin?
Tay, K. H., Lane, D. A., & Lip, G. Y. H. (2008). Bleeding risks with combination of oral anticoagulation plus antiplatelet therapy: Is clopidogrel any safer than aspirin when combined with warfarin?. THROMBOSIS AND HAEMOSTASIS, 100(6), 955-957. doi:10.1160/TH08-10-0685
Circulating serum adiponectin levels in patients with coronary artery disease: relationship to atherosclerotic burden and cardiac function.
Patel, J. V., Abraheem, A., Dotsenko, O., Creamer, J., Gunning, M., Hughes, E. A., & Lip, G. Y. H. (2008). Circulating serum adiponectin levels in patients with coronary artery disease: relationship to atherosclerotic burden and cardiac function.. Journal of internal medicine, 264(6), 593-598. doi:10.1111/j.1365-2796.2008.02007.x
Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology.
Van de Werf, F., Bax, J., Betriu, A., Blomstrom-Lundqvist, C., Crea, F., Falk, V., . . . ESC Committee for Practice Guidelines (CPG). (2008). Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology.. European heart journal, 29(23), 2909-2945. doi:10.1093/eurheartj/ehn416
Predicting thrombotic events: Creating a complex approach for a complex condition
Shantsila, E., & Lip, G. Y. H. (2008). Predicting thrombotic events: Creating a complex approach for a complex condition. THROMBOSIS AND HAEMOSTASIS, 100(6), 962-964. doi:10.1160/TH08-10-0681
Radiofrequency catheter ablation of atrial fibrillation and thromboembolic risk.
Khoo, C. W., & Lip, G. Y. H. (2008). Radiofrequency catheter ablation of atrial fibrillation and thromboembolic risk.. European journal of neurology, 15(12), 1261-1262. doi:10.1111/j.1468-1331.2008.02342.x
The endothelium, arterial stiffness, and von Willebrand factor levels in hypertensive women: effects of ethnicity.
Butt, M., & Lip, G. Y. H. (2008). The endothelium, arterial stiffness, and von Willebrand factor levels in hypertensive women: effects of ethnicity.. American journal of hypertension, 21(12), 1275-1276. doi:10.1038/ajh.2008.303
The search for new anticoagulants: dabigatran etexilate
Siddique, A., Shantsila, E., & Lip, G. Y. H. (2008). The search for new anticoagulants: dabigatran etexilate. Therapy, 5(6), 793-796. doi:10.2217/14750708.5.6.793
What "drives" the link between the renin-angiotensin-aldosterone system and the prothrombotic state in hypertension?
Tay, K. -H., & Lip, G. Y. H. (2008). What "drives" the link between the renin-angiotensin-aldosterone system and the prothrombotic state in hypertension?. American journal of hypertension, 21(12), 1278-1279. doi:10.1038/ajh.2008.315
10 steps before you refer for: Atrial fibrillation
Heath, R., & Lip, G. Y. H. (2008). 10 steps before you refer for: Atrial fibrillation. British Journal of Cardiology, 15(6), 302-305.
Gender and the response to blood pressure-lowering treatment.
Lip, G. Y. H., & Butt, M. (2008). Gender and the response to blood pressure-lowering treatment.. European heart journal, 29(21), 2585-2586. doi:10.1093/eurheartj/ehn451
Hypertension, stroke and the impact of atrial fibrillation.
Krishnamoorthy, S., & Lip, G. Y. (2008). Hypertension, stroke and the impact of atrial fibrillation.. Expert review of cardiovascular therapy, 6(10), 1287-1289. doi:10.1586/14779072.6.10.1287
The relationship of circulating endothelial cells to plasma indices of endothelial damage/dysfunction and apoptosis in acute coronary syndromes: implications for prognosis.
Boos, C. J., Balakrishnan, B., Blann, A. D., & Lip, G. Y. H. (2008). The relationship of circulating endothelial cells to plasma indices of endothelial damage/dysfunction and apoptosis in acute coronary syndromes: implications for prognosis.. Journal of thrombosis and haemostasis : JTH, 6(11), 1841-1850. doi:10.1111/j.1538-7836.2008.03148.x
Reply
Gasparyan, A. Y., & Lip, G. Y. H. (2008). Reply. Journal of the American College of Cardiology, 52(15), 1277. doi:10.1016/j.jacc.2008.07.014
Factor VII -323 decanucleotide D/I polymorphism in atrial fibrillation: implications for the prothrombotic state and stroke risk.
Roldán, V., Marín, F., González-Conejero, R., García-Honrubia, A., Martí, S., Alfaro, A., . . . Vicente, V. (2008). Factor VII -323 decanucleotide D/I polymorphism in atrial fibrillation: implications for the prothrombotic state and stroke risk.. Annals of medicine, 40(7), 553-559. doi:10.1080/07853890802108412
Arterial stiffness: beyond pulse wave velocity and its measurement.
Lim, H. S., & Lip, G. Y. H. (2008). Arterial stiffness: beyond pulse wave velocity and its measurement.. Journal of human hypertension, 22(10), 656-658. doi:10.1038/jhh.2008.47
Response to letter to editor by Jolobe ‘Stroke risk might be specifically correlated with the burden of paroxysmal atrial fibrillation’
Lip, G. Y. H. (2008). Response to letter to editor by Jolobe ‘Stroke risk might be specifically correlated with the burden of paroxysmal atrial fibrillation’. Journal of Internal Medicine, 264(4), 402-403. doi:10.1111/j.1365-2796.2008.02009.x
Initiation and persistence of warfarin or aspirin as thromboprophylaxis in chronic atrial fibrillation in general practice.
Khoo, C. W., & Lip, G. Y. H. (2008). Initiation and persistence of warfarin or aspirin as thromboprophylaxis in chronic atrial fibrillation in general practice.. Journal of thrombosis and haemostasis : JTH, 6(10), 1622-1624. doi:10.1111/j.1538-7836.2008.03115.x
Effects of white European, African Caribbean and South Asian ethnicity on homocysteine levels in patients with systolic heart failure.
Sosin, M. D., Patel, J. V., Bhatia, G. S., Hughes, E. A., Davis, R. C., & Lip, G. Y. H. (2008). Effects of white European, African Caribbean and South Asian ethnicity on homocysteine levels in patients with systolic heart failure.. International journal of cardiology, 129(1), 69-75. doi:10.1016/j.ijcard.2007.04.112
Hemoxygenase-1 in cardiovascular disease.
Idriss, N. K., Blann, A. D., & Lip, G. Y. H. (2008). Hemoxygenase-1 in cardiovascular disease.. Journal of the American College of Cardiology, 52(12), 971-978. doi:10.1016/j.jacc.2008.06.019
Managing the anticoagulated patient with atrial fibrillation at high risk of stroke who needs coronary intervention.
Lip, G. Y. H. (2008). Managing the anticoagulated patient with atrial fibrillation at high risk of stroke who needs coronary intervention.. BMJ (Clinical research ed.), 337, a840. doi:10.1136/bmj.39533.570602.be
Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation.
Rubboli, A., Halperin, J. L., Airaksinen, K. E. J., Buerke, M., Eeckhout, E., Freedman, S. B., . . . Lip, G. Y. H. (2008). Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation.. Annals of medicine, 40(6), 428-436. doi:10.1080/07853890802089786
Elevated angiogenin levels in chronic heart failure.
Patel, J. V., Sosin, M., Gunarathne, A., Hussain, I., Davis, R. C., Hughes, E. A., & Lip, G. Y. H. (2008). Elevated angiogenin levels in chronic heart failure.. Annals of medicine, 40(6), 474-479. doi:10.1080/07853890802001419
Stroke prevention.
Lip, G. Y., & Kalra, L. (2008). Stroke prevention.. BMJ clinical evidence, 2008, 0207.
Apixaban, an oral, direct inhibitor of activated Factor Xa
Shantsila, E., & Lip, G. Y. H. (2008). Apixaban, an oral, direct inhibitor of activated Factor Xa. CURRENT OPINION IN INVESTIGATIONAL DRUGS, 9(9), 1020-1033. Retrieved from https://www.webofscience.com/
Beyond lipid-lowering therapy: does ezetimibe enhance the effects of statins on atherosclerosis?
Krishnamoorthy, S., & Lip, G. Y. H. (2008). Beyond lipid-lowering therapy: does ezetimibe enhance the effects of statins on atherosclerosis?. Therapy, 5(4), 487-489. doi:10.2217/14750708.5.4.487
Asymptomatic atrial fibrillation on device interrogation.
Lim, H. S., & Lip, G. Y. H. (2008). Asymptomatic atrial fibrillation on device interrogation.. Journal of cardiovascular electrophysiology, 19(8), 891-893. doi:10.1111/j.1540-8167.2008.01194.x
Candidate circulating biomarkers for the cardiovascular disease continuum.
Dotsenko, O., Chackathayil, J., Patel, J. V., Gill, P. S., & Lip, G. Y. H. (2008). Candidate circulating biomarkers for the cardiovascular disease continuum.. Current pharmaceutical design, 14(24), 2445-2461. doi:10.2174/138161208785777388
Endothelium and fibrinolysis in hypertension: important facets of a prothrombotic state?
Lip, G. Y. H., & Blann, A. D. (2008). Endothelium and fibrinolysis in hypertension: important facets of a prothrombotic state?. Hypertension (Dallas, Tex. : 1979), 52(2), 218-219. doi:10.1161/hypertensionaha.108.114876
Measurement of stiffness index by digital volume pulse analysis technique: clinical utility in cardiovascular disease risk stratification.
Gunarathne, A., Patel, J. V., Hughes, E. A., & Lip, G. Y. H. (2008). Measurement of stiffness index by digital volume pulse analysis technique: clinical utility in cardiovascular disease risk stratification.. American journal of hypertension, 21(8), 866-872. doi:10.1038/ajh.2008.207
Ventricular optimization of biventricular pacing: a systematic review.
Lim, S. H., Lip, G. Y. H., & Sanderson, J. E. (2008). Ventricular optimization of biventricular pacing: a systematic review.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 10(8), 901-906. doi:10.1093/europace/eun177
Imaging of the unstable plaque.
Tan, K. T., & Lip, G. Y. H. (2008). Imaging of the unstable plaque.. International journal of cardiology, 127(2), 157-165. doi:10.1016/j.ijcard.2007.11.054
Vital exhaustion and cardiovascular disease: Are circulating fibrinogen and D-dimer levels a plausible link?
Bennett, P. C., Lane, D. A., & Lip, G. Y. H. (2008). Vital exhaustion and cardiovascular disease: Are circulating fibrinogen and D-dimer levels a plausible link?. STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS, 11(4), 247-249. doi:10.1080/10253890701833029
Is soluble CD40 ligand a mediator of angiogenesis in patients with coronary artery disease?
Lim, H. S., Tayebjee, M. H., Tan, K. T., Patel, J. V., Macfadyen, R. J., & Lip, G. Y. H. (2008). Is soluble CD40 ligand a mediator of angiogenesis in patients with coronary artery disease?. Thrombosis research, 122(3), 307-313. doi:10.1016/j.thromres.2007.10.013
Beyond glucose levels in diabetic patients with coronary artery disease: Platelet activity and non-responsiveness to antiplatelet therapy
Shantsila, E., & Lip, G. Y. H. (2008). Beyond glucose levels in diabetic patients with coronary artery disease: Platelet activity and non-responsiveness to antiplatelet therapy. THROMBOSIS AND HAEMOSTASIS, 100(1), 7-8. doi:10.1160/TH08-06-0342
Interleukin-8 and atrial fibrillation.
Melenovsky, V., & Lip, G. Y. H. (2008). Interleukin-8 and atrial fibrillation.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 10(7), 784-785. doi:10.1093/europace/eun154
Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis.
Lip, G. Y. H. (2008). Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis.. Thrombosis and haemostasis, 100(1), 11-13. doi:10.1160/th08-05-0331
Risk factors and stroke risk stratification for atrial fibrillation: limitations and new possibilities.
Lip, G. Y. H. (2008). Risk factors and stroke risk stratification for atrial fibrillation: limitations and new possibilities.. American heart journal, 156(1), 1-3. doi:10.1016/j.ahj.2008.02.020
Stroke event rates in anticoagulated patients with paroxysmal atrial fibrillation.
Lip, G. Y. H., Frison, L., Grind, M., & SPORTIF Investigators. (2008). Stroke event rates in anticoagulated patients with paroxysmal atrial fibrillation.. Journal of internal medicine, 264(1), 50-61. doi:10.1111/j.1365-2796.2007.01909.x
Thrombosis and Haemostasis: volume 100 and going strong ...
Preissner, K. T., & Lip, G. Y. H. (2008). Thrombosis and Haemostasis: volume 100 and going strong .... Thrombosis and haemostasis, 100(1), 1-2. doi:10.1160/th08-06-0359
Soluble CD40 ligand and atrial fibrillation: relationship to platelet activation, and endothelial damage/dysfunction.
Blann, A. D., Choudhury, A., Freestone, B., Patel, J., & Lip, G. Y. H. (2008). Soluble CD40 ligand and atrial fibrillation: relationship to platelet activation, and endothelial damage/dysfunction.. International journal of cardiology, 127(1), 135-137. doi:10.1016/j.ijcard.2007.04.028
Identifying AF patients at risk of stroke: can prothrombotic indices improve things?
Watson, T., & Lip, G. Y. H. (2008). Identifying AF patients at risk of stroke: can prothrombotic indices improve things?. International journal of cardiology, 126(3), 299-301. doi:10.1016/j.ijcard.2007.08.092
Antithrombotic therapy use after percutaneous coronary intervention and stent implantation in patients taking chronic oral anticoagulation.
Ruiz-Nodar, J. M., Marín, F., & Lip, G. Y. H. (2008). Antithrombotic therapy use after percutaneous coronary intervention and stent implantation in patients taking chronic oral anticoagulation.. JACC. Cardiovascular interventions, 1(3), 329. doi:10.1016/j.jcin.2008.03.016
Circulating endothelial cells in health and disease: how do we best quantify them?
Shantsila, E., & Lip, G. Y. H. (2008). Circulating endothelial cells in health and disease: how do we best quantify them?. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 6(6), 1021-1024. doi:10.1111/j.1538-7836.2008.02985.x
Circulating matrix metalloproteinase-9 levels in atherosclerotic vascular disease: a possible measurement of systemic or specific disease pathophysiology?
Lim, H. S., & Lip, G. Y. H. (2008). Circulating matrix metalloproteinase-9 levels in atherosclerotic vascular disease: a possible measurement of systemic or specific disease pathophysiology?. Journal of internal medicine, 263(6), 620-622. doi:10.1111/j.1365-2796.2008.01937.x
Endothelial progenitor cells, endothelial dysfunction, inflammation, and oxidative stress in hypertension.
Watson, T., Goon, P. K. Y., & Lip, G. Y. H. (2008). Endothelial progenitor cells, endothelial dysfunction, inflammation, and oxidative stress in hypertension.. Antioxidants & redox signaling, 10(6), 1079-1088. doi:10.1089/ars.2007.1998
Obstructive sleep apnoea and metabolic syndrome: two sides of the same coin?
Dwivedi, G., Khair, O., & Lip, G. Y. H. (2008). Obstructive sleep apnoea and metabolic syndrome: two sides of the same coin?. Journal of human hypertension, 22(6), 377-379. doi:10.1038/jhh.2008.14
Platelet adhesion in congestive heart failure.
Chung, I., Choudhury, A., & Lip, G. Y. H. (2008). Platelet adhesion in congestive heart failure.. Thrombosis research, 121(6), 885-888. doi:10.1016/j.thromres.2007.07.011
Premature coronary artery disease: an inferred cardiovascular variant or a South Asian genetic disorder?
Patel, J. V., Dwivedi, S., Hughes, E. A., & Lip, G. Y. H. (2008). Premature coronary artery disease: an inferred cardiovascular variant or a South Asian genetic disorder?. Thrombosis and haemostasis, 99(6), 991-992. doi:10.1160/th08-05-0286
Statins and inflammation: Reciprocal effectors to endothelial progenitors?
Shantsila, E., Watson, T., & Lip, G. Y. H. (2008). Statins and inflammation: Reciprocal effectors to endothelial progenitors?. THROMBOSIS RESEARCH, 123(1), 1-4. doi:10.1016/j.thromres.2008.03.021
The role of aspirin in cardiovascular prevention: implications of aspirin resistance.
Gasparyan, A. Y., Watson, T., & Lip, G. Y. H. (2008). The role of aspirin in cardiovascular prevention: implications of aspirin resistance.. Journal of the American College of Cardiology, 51(19), 1829-1843. doi:10.1016/j.jacc.2007.11.080
Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
Freestone, B., Chong, A. Y., Nuttall, S., & Lip, G. Y. H. (2008). Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.. Thrombosis research, 122(1), 85-90. doi:10.1016/j.thromres.2007.09.008
Atrial fibrillation (acute onset).
Lip, G. Y. H., & Watson, T. (2008). Atrial fibrillation (acute onset).. BMJ clinical evidence, 2008, 0210.
Anticoagulation in atrial fibrillation: the trials and tribulations of keeping within therapeutic range.
Taggar, J. S., & Lip, G. Y. H. (2008). Anticoagulation in atrial fibrillation: the trials and tribulations of keeping within therapeutic range.. Current medical research and opinion, 24(5), 1455-1458. doi:10.1185/030079908x301875
Antithrombotic treatment in atrial fibrillation.
Lip, G. Y. H., & Boos, C. J. (2006). Antithrombotic treatment in atrial fibrillation.. Heart (British Cardiac Society), 92(2), 155-161. doi:10.1136/hrt.2005.066944
Circulating endothelial cells: from bench to clinical practice
Shantsila, E., Blann, A. D., & Lip, G. Y. H. (2008). Circulating endothelial cells: from bench to clinical practice. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 6(5), 865-868. doi:10.1111/j.1538-7836.2008.02918.x
Implantable cardioverter defibrillator following acute myocardial infarction: the '48-hour' and '40-day' rule.
Lim, H. S., Lip, G. Y. H., & Tse, H. -F. (2008). Implantable cardioverter defibrillator following acute myocardial infarction: the '48-hour' and '40-day' rule.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 10(5), 536-539. doi:10.1093/europace/eun070
The balance between stroke prevention and bleeding risk in atrial fibrillation: a delicate balance revisited.
Lip, G. Y. H. (2008). The balance between stroke prevention and bleeding risk in atrial fibrillation: a delicate balance revisited.. Stroke, 39(5), 1406-1408. doi:10.1161/strokeaha.107.506832
Atrial fibrillation (chronic).
Boos, C. J., Lane, D. A., & Lip, G. Y. H. (2008). Atrial fibrillation (chronic).. BMJ clinical evidence, 2008, 0217.
Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension.
Patel, J. V., Lim, H. S., Varughese, G. I., Hughes, E. A., & Lip, G. Y. H. (2008). Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension.. Annals of medicine, 40(3), 215-222. doi:10.1080/07853890701779586
Biomarkers of endothelial dysfunction are elevated and related to prognosis in chronic heart failure patients with diabetes but not in those without diabetes.
Kistorp, C., Chong, A. Y., Gustafsson, F., Galatius, S., Raymond, I., Faber, J., . . . Hildebrandt, P. (2008). Biomarkers of endothelial dysfunction are elevated and related to prognosis in chronic heart failure patients with diabetes but not in those without diabetes.. European journal of heart failure, 10(4), 380-387. doi:10.1016/j.ejheart.2008.02.012
Left ventricular ejection fraction: are the revised cut-off points for defining systolic dysfunction sufficiently evidence based?
Mahadevan, G., Davis, R. C., Frenneaux, M. P., Hobbs, F. D. R., Lip, G. Y. H., Sanderson, J. E., & Davies, M. K. (2008). Left ventricular ejection fraction: are the revised cut-off points for defining systolic dysfunction sufficiently evidence based?. Heart (British Cardiac Society), 94(4), 426-428. doi:10.1136/hrt.2007.123877
Mortality in patients with atrial fibrillation: improving or not?
Taggar, J. S., Marín, F., & Lip, G. Y. H. (2008). Mortality in patients with atrial fibrillation: improving or not?. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 10(4), 389-390. doi:10.1093/europace/eun054
Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?
Nieuwlaat, R., Dinh, T., Olsson, S. B., Camm, A. J., Capucci, A., Tieleman, R. G., . . . Euro Heart Survey Investigators. (2008). Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?. European heart journal, 29(7), 915-922. doi:10.1093/eurheartj/ehn101
Soluble P-selectin and vascular endothelial growth factor in steady state sickle cell disease: relationship to genotype.
Blann, A. D., Mohan, J. S., Bareford, D., & Lip, G. Y. H. (2008). Soluble P-selectin and vascular endothelial growth factor in steady state sickle cell disease: relationship to genotype.. Journal of thrombosis and thrombolysis, 25(2), 185-189. doi:10.1007/s11239-007-0177-7
The effects of coronary artery disease severity on time-dependent changes in platelet activation indices in stored whole blood.
Boos, C. J., Balakrishnan, B., & Lip, G. Y. H. (2008). The effects of coronary artery disease severity on time-dependent changes in platelet activation indices in stored whole blood.. Journal of thrombosis and thrombolysis, 25(2), 135-140. doi:10.1007/s11239-007-0034-8
Reproducibility and safety of the incremental shuttle walking test for cardiac rehabilitation.
Jolly, K., Taylor, R. S., Lip, G. Y. H., Singh, S., & BRUM Steering Committee. (2008). Reproducibility and safety of the incremental shuttle walking test for cardiac rehabilitation.. International journal of cardiology, 125(1), 144-145. doi:10.1016/j.ijcard.2007.01.037
Don't add aspirin for associated stable vascular disease in a patient with atrial fibrillation receiving anticoagulation.
Lip, G. Y. H. (2008). Don't add aspirin for associated stable vascular disease in a patient with atrial fibrillation receiving anticoagulation.. BMJ (Clinical research ed.), 336(7644), 614-615. doi:10.1136/bmj.39351.706586.ad
Soluble CD40L, platelet surface CD40L and total platelet CD40L in congestive heart failure: relationship to platelet volume, mass and granularity.
Chung, I., Choudhury, A., Patel, J., & Lip, G. Y. H. (2008). Soluble CD40L, platelet surface CD40L and total platelet CD40L in congestive heart failure: relationship to platelet volume, mass and granularity.. Journal of internal medicine, 263(3), 313-321. doi:10.1111/j.1365-2796.2007.01891.x
The effects of maximal treadmill graded exercise testing on haemorheological, haemodynamic and flow cytometry platelet markers in patients with systolic or diastolic heart failure.
Chung, I., Goyal, D., Macfadyen, R. J., & Lip, G. Y. H. (2008). The effects of maximal treadmill graded exercise testing on haemorheological, haemodynamic and flow cytometry platelet markers in patients with systolic or diastolic heart failure.. European journal of clinical investigation, 38(3), 150-158. doi:10.1111/j.1365-2362.2008.01909.x
Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
Ruiz-Nodar, J. M., Marín, F., Hurtado, J. A., Valencia, J., Pinar, E., Pineda, J., . . . Lip, G. Y. H. (2008). Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.. Journal of the American College of Cardiology, 51(8), 818-825. doi:10.1016/j.jacc.2007.11.035
Letter by Roldán et al regarding article, "Plasminogen activator inhibitor-1 as a predictor of postoperative atrial fibrillation after cardiopulmonary bypass".
Roldán, V., Marín, F., & Lip, G. Y. H. (2008). Letter by Roldán et al regarding article, "Plasminogen activator inhibitor-1 as a predictor of postoperative atrial fibrillation after cardiopulmonary bypass".. Circulation, 117(8), e169. doi:10.1161/circulationaha.107.746461
New insights on endothelial progenitor cell subpopulations and their angiogenic properties
Shantsila, E., Watson, T., Tse, H. -F., & Lip, G. Y. H. (2008). New insights on endothelial progenitor cell subpopulations and their angiogenic properties. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 51(6), 669-671. doi:10.1016/j.jacc.2007.09.057
Self-care and adherence to medication: a survey in the hypertension outpatient clinic.
Gohar, F., Greenfield, S. M., Beevers, D. G., Lip, G. Y. H., & Jolly, K. (2008). Self-care and adherence to medication: a survey in the hypertension outpatient clinic.. BMC complementary and alternative medicine, 8, 4. doi:10.1186/1472-6882-8-4
The effects of exercise stress testing on soluble E-selectin, von Willebrand factor, and circulating endothelial cells as indices of endothelial damage/dysfunction.
Boos, C. J., Balakrishnan, B., & Lip, G. Y. H. (2008). The effects of exercise stress testing on soluble E-selectin, von Willebrand factor, and circulating endothelial cells as indices of endothelial damage/dysfunction.. Annals of medicine, 40(1), 66-73. doi:10.1080/07853890701652833
Cardioversion and remodelline in atrial, fibrillation: Insights beyond the prothrombotic state
Shantsila, E., Watson, T., & Lip, G. Y. H. (2008). Cardioversion and remodelline in atrial, fibrillation: Insights beyond the prothrombotic state. THROMBOSIS RESEARCH, 121(4), 443-445. doi:10.1016/j.thromres.2007.08.019
Can patients with atrial fibrillation be optimally risk stratified for stroke and thromboembolism?
Taggar, J. S., Watson, T., & Lip, G. Y. H. (2008). Can patients with atrial fibrillation be optimally risk stratified for stroke and thromboembolism?. Stroke, 39(2), e24-e25. doi:10.1161/strokeaha.107.502369
Experiences of living with congestive heart failure: a qualitative study.
Thornhill, K., Lyons, A. C., Nouwen, A., & Lip, G. Y. H. (2008). Experiences of living with congestive heart failure: a qualitative study.. British journal of health psychology, 13(Pt 1), 155-175. doi:10.1348/135910706x170983
Increased 5-year mortality in the migrant South Asian stroke patients with diabetes mellitus in the United Kingdom: the West Birmingham Stroke Project.
Gunarathne, A., Patel, J. V., Potluri, R., Gammon, B., Jessani, S., Hughes, E. A., & Lip, G. Y. H. (2008). Increased 5-year mortality in the migrant South Asian stroke patients with diabetes mellitus in the United Kingdom: the West Birmingham Stroke Project.. International journal of clinical practice, 62(2), 197-201. doi:10.1111/j.1742-1241.2007.01580.x
Inflammation and atrial fibrillation: cause or effect?
Boos, C. J., & Lip, G. Y. H. (2008). Inflammation and atrial fibrillation: cause or effect?. Heart (British Cardiac Society), 94(2), 133-134. doi:10.1136/hrt.2007.119651
New approaches to therapy with omega-3 fatty acids.
Kakar, P., Watson, T., & Lip, G. Y. H. (2008). New approaches to therapy with omega-3 fatty acids.. Current atherosclerosis reports, 10(1), 79-87. doi:10.1007/s11883-008-0012-4
Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data.
Hughes, M., Lip, G. Y. H., & Guideline Development Group, National Clinical Guideline for Management of Atrial Fibrillation in Primary and Secondary Care, National Institute for Health and Clinical Excellence. (2008). Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data.. Thrombosis and haemostasis, 99(2), 295-304. doi:10.1160/th07-08-0508
Erratum to “Blood oxygen saturation during atrio-ventricular dissociation with wide-QRS complex tachycardias” [International Journal of Cardiology 107/1 (2006) 134–135]
Marinskis, G., Lip, G. Y. H., Adietis, A., Jurkuvėnas, P., Kairevičiūte, D., Ježov, V., . . . Laucevičius, A. (2008). Erratum to “Blood oxygen saturation during atrio-ventricular dissociation with wide-QRS complex tachycardias” [International Journal of Cardiology 107/1 (2006) 134–135]. International Journal of Cardiology, 123(2), 217. doi:10.1016/j.ijcard.2007.10.013
Anaemia as predictor of gastrointestinal bleeding in atrial fibrillation patients undergoing percutaneous coronary artery stenting.
Manzano-Fernández, S., Marin, F., Martinez, J. A. H., Cambronero, F., Valdés, M., Ruiz-Nodar, J. M., . . . Lip, G. Y. H. (2008). Anaemia as predictor of gastrointestinal bleeding in atrial fibrillation patients undergoing percutaneous coronary artery stenting.. QJM : monthly journal of the Association of Physicians, 101(9), 749-751. doi:10.1093/qjmed/hcn082
Anticoagulation for elderly patients with atrial fibrillation: not to be neglected.
Taggar, J. S., & Lip, G. Y. H. (2008). Anticoagulation for elderly patients with atrial fibrillation: not to be neglected.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 10(1), 1-2. doi:10.1093/europace/eum223
Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Singer, D. E., Albers, G. W., Dalen, J. E., Fang, M. C., Go, A. S., Halperin, J. L., . . . Manning, W. J. (2008). Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).. Chest, 133(6 Suppl), 546S-592S. doi:10.1378/chest.08-0678
Barriers to anticoagulation in patients with atrial fibrillation - Changing physician-related factors
Lane, D. A., & Lip, G. Y. H. (2008). Barriers to anticoagulation in patients with atrial fibrillation - Changing physician-related factors. STROKE, 39(1), 7-9. doi:10.1161/STROKEAHA.107.496554
Endothelial progenitor cells: from pathophysiology to clinical practice.
Goon, P. K. Y., Watson, T., Stonelake, P. S., & Lip, G. Y. H. (2008). Endothelial progenitor cells: from pathophysiology to clinical practice.. International journal of clinical practice, 62(1), 4-6. doi:10.1111/j.1742-1241.2007.01555.x
Ethnic differences in myocardial infarction in patients with hypertension: effects of diabetes mellitus.
Patel, J. V., Lim, H. S., Gunarathne, A., Tracey, I., Durrington, P. N., Hughes, E. A., & Lip, G. Y. H. (2008). Ethnic differences in myocardial infarction in patients with hypertension: effects of diabetes mellitus.. QJM : monthly journal of the Association of Physicians, 101(3), 231-236. doi:10.1093/qjmed/hcm151
Impact of mean arterial blood pressure on higher arterial stiffness indices in South Asians compared to white Europeans.
Gunarathne, A., Patel, J. V., Gammon, B., Hughes, E. A., & Lip, G. Y. H. (2008). Impact of mean arterial blood pressure on higher arterial stiffness indices in South Asians compared to white Europeans.. Journal of hypertension, 26(7), 1420-1426. doi:10.1097/hjh.0b013e3282ffb42a
Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting.
Manzano-Fernández, S., Pastor, F. J., Marín, F., Cambronero, F., Caro, C., Pascual-Figal, D. A., . . . Lip, G. Y. H. (2008). Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting.. Chest, 134(3), 559-567. doi:10.1378/chest.08-0350
Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure.
Freestone, B., Gustafsson, F., Chong, A. Y., Corell, P., Kistorp, C., Hildebrandt, P., & Lip, G. Y. H. (2008). Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure.. Chest, 133(5), 1203-1208. doi:10.1378/chest.07-2557
Measurement of C-reactive protein and natriuretic peptides for cardiovascular risk assessment: the need for age and gender-specific thresholds.
Dotsenko, O., Chackathayil, J., & Lip, G. Y. H. (2008). Measurement of C-reactive protein and natriuretic peptides for cardiovascular risk assessment: the need for age and gender-specific thresholds.. Journal of hypertension, 26(1), 11-13. doi:10.1097/hjh.0b013e3282f3320e
Risk predictors for lone atrial fibrillation.
Taggar, J. S., & Lip, G. Y. H. (2008). Risk predictors for lone atrial fibrillation.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 10(1), 6-8. doi:10.1093/europace/eum274
Secular trends in the cardiovascular risk profile and mortality of stroke admissions in an inner city, multiethnic population in the United Kingdom (1997-2005).
Gunarathne, A., Patel, J. V., Potluri, R., Gill, P. S., Hughes, E. A., & Lip, G. Y. H. (2008). Secular trends in the cardiovascular risk profile and mortality of stroke admissions in an inner city, multiethnic population in the United Kingdom (1997-2005).. Journal of human hypertension, 22(1), 18-23. doi:10.1038/sj.jhh.1002265
Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention.
Choudhury, A., Chung, I., Panja, N., Patel, J., & Lip, G. Y. H. (2008). Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention.. Chest, 134(3), 574-581. doi:10.1378/chest.07-2745
The endothelium and atrial fibrillation. The prothrombotic state revisited.
Freestone, B., & Lip, G. Y. H. (2008). The endothelium and atrial fibrillation. The prothrombotic state revisited.. Hamostaseologie, 28(4), 207-212. doi:10.1055/s-0037-1617102
The impact of statin use on atrial fibrillation.
Sánchez-Quiñones, J., Marín, F., Roldán, V., & Lip, G. Y. H. (2008). The impact of statin use on atrial fibrillation.. QJM : monthly journal of the Association of Physicians, 101(11), 845-861. doi:10.1093/qjmed/hcn101
The left atrium and diastolic dysfunction in hypertensive left ventricular hypertrophy: a consideration of size and function?
Dwivedi, G., & Lip, G. Y. H. (2008). The left atrium and diastolic dysfunction in hypertensive left ventricular hypertrophy: a consideration of size and function?. Journal of hypertension, 26(7), 1310-1312. doi:10.1097/hjh.0b013e328302ee20
2007
Atrial fibrillation: Rate control and digoxin.
Lip, G. Y. H., Rudolf, M., & Guideline development group for the NICE clinical guideline for the management of atrial fibrillation. (2007). Atrial fibrillation: Rate control and digoxin.. BMJ (Clinical research ed.), 335(7631), 1169-1170. doi:10.1136/bmj.39416.442731.be
Indices of angiogenesis, platelet activation, and endothelial damage/dysfunction in relation to ethnicity and coronary artery disease: differences in central versus peripheral levels.
Jaumdally, R. J., Varma, C., Blann, A. D., Macfadyen, R. J., & Lip, G. Y. H. (2007). Indices of angiogenesis, platelet activation, and endothelial damage/dysfunction in relation to ethnicity and coronary artery disease: differences in central versus peripheral levels.. Annals of medicine, 39(8), 628-633. doi:10.1080/07853890701636265
A comparison of plasma versus histologic indices of angiogenic markers in breast cancer.
Caine, G. J., Lip, G., Zanetto, U., Maheshwari, M., Stonelake, P. S., & Blann, A. D. (2007). A comparison of plasma versus histologic indices of angiogenic markers in breast cancer.. Applied immunohistochemistry & molecular morphology : AIMM, 15(4), 382-388. doi:10.1097/01.pai.0000213137.01536.ca
Comparative dose titration responses to the introduction of bisoprolol or carvedilol in stable chronic systolic heart failure.
Hamaad, A., Lip, G. Y. H., Nicholls, D., & MacFadyen, R. J. (2007). Comparative dose titration responses to the introduction of bisoprolol or carvedilol in stable chronic systolic heart failure.. Cardiovascular drugs and therapy, 21(6), 437-444. doi:10.1007/s10557-007-6055-x
Measuring soluble CD40 ligand:interleukin-10 ratio as a prognostic marker in acute myocardial infarction: yet another prognostic biomarker?
Jessani, S., & Lip, G. Y. H. (2007). Measuring soluble CD40 ligand:interleukin-10 ratio as a prognostic marker in acute myocardial infarction: yet another prognostic biomarker?. Thrombosis research, 121(3), 289-291. doi:10.1016/j.thromres.2007.05.011
PREFACE
Lip, G. Y. H., & Hall, J. E. (2007). PREFACE. Elsevier. doi:10.1016/b978-0-323-03961-1.50003-9
Plasma angiogenin levels in acute coronary syndromes: implications for prognosis.
Tello-Montoliu, A., Marín, F., Patel, J., Roldán, V., Mainar, L., Vicente, V., . . . Lip, G. Y. H. (2007). Plasma angiogenin levels in acute coronary syndromes: implications for prognosis.. European heart journal, 28(24), 3006-3011. doi:10.1093/eurheartj/ehm488
Widening access to cardiovascular healthcare: community screening among ethnic minorities in inner-city Britain - the Healthy Hearts Project
Patel, J. V., Gunarathne, A., Lane, D., Lim, H. S., Tracey, I., Panja, N. C., . . . Hughes, E. A. (2007). Widening access to cardiovascular healthcare: community screening among ethnic minorities in inner-city Britain - the Healthy Hearts Project. BMC HEALTH SERVICES RESEARCH, 7. doi:10.1186/1472-6963-7-192
Management of atrial fibrillation – Authors' reply
Lip, G. Y. H., & Tse, H. -F. (2007). Management of atrial fibrillation – Authors' reply. The Lancet, 370(9599), 1608. doi:10.1016/s0140-6736(07)61683-3
Atrial fibrillation and stroke prevention.
Lip, G. Y. H., & Lim, H. S. (2007). Atrial fibrillation and stroke prevention.. The Lancet. Neurology, 6(11), 981-993. doi:10.1016/s1474-4422(07)70264-8
Cardiac biomarkers: myths, facts and future horizons.
Dotsenko, O., Chackathayil, J., & Lip, G. Y. H. (2007). Cardiac biomarkers: myths, facts and future horizons.. Expert review of molecular diagnostics, 7(6), 693-697. doi:10.1586/14737159.7.6.693
Elevated lipoprotein (a) and apolipoprotein B to AI ratio in South Asian patients with ischaemic stroke.
Sharobeem, K. M., Patel, J. V., Ritch, A. E. S., Lip, G. Y. H., Gill, P. S., & Hughes, E. A. (2007). Elevated lipoprotein (a) and apolipoprotein B to AI ratio in South Asian patients with ischaemic stroke.. International journal of clinical practice, 61(11), 1824-1828. doi:10.1111/j.1742-1241.2007.01521.x
Post-stenting antithrombotic drug therapy in patients with atrial fibrillation.
Lip, G. Y. H. (2007). Post-stenting antithrombotic drug therapy in patients with atrial fibrillation.. The American journal of medicine, 120(11), 920-922. doi:10.1016/j.amjmed.2007.01.036
Stroke prevention in atrial fibrillation--things can only get better.
Lip, G. Y. H., & Watson, T. (2007). Stroke prevention in atrial fibrillation--things can only get better.. British journal of clinical pharmacology, 64(5), 575-577. doi:10.1111/j.1365-2125.2007.02953.x
Raised leptin concentrations among South Asian patients with chronic heart failure.
Patel, J. V., Sosin, M., Lim, H. S., Chung, I., Panja, N., Davis, R. C., . . . Lip, G. Y. H. (2007). Raised leptin concentrations among South Asian patients with chronic heart failure.. International journal of cardiology, 122(1), 34-40. doi:10.1016/j.ijcard.2006.11.013
Atherosclerotic renal artery stenosis--do we really know what to do?
Srivastava, S., & Lip, G. Y. H. (2007). Atherosclerotic renal artery stenosis--do we really know what to do?. Blood pressure, 16(5), 288-290. doi:10.1080/08037050701685567
Erratum: Cardioversion of atrial fibrillation (British Medical Journal (1996) 312, (112-115))
Lip, G. Y. H. (2007). Erratum: Cardioversion of atrial fibrillation (British Medical Journal (1996) 312, (112-115)). British Medical Journal, 335(7624), 805.
Combining antiplatelet drugs and oral anticoagulant therapy in atrial fibrillation: acute coronary syndromes and/or percutaneous coronary intervention/stenting revisited.
Watson, T., & Lip, G. Y. H. (2007). Combining antiplatelet drugs and oral anticoagulant therapy in atrial fibrillation: acute coronary syndromes and/or percutaneous coronary intervention/stenting revisited.. Stroke, 38(10), e107-e108. doi:10.1161/strokeaha.107.492488
Endothelial colony forming units: Are they a reliable marker of endothelial progenitor cell numbers?
Shantsila, E., Watson, T., Tse, H. F., & Lip, G. Y. H. (2007). Endothelial colony forming units: Are they a reliable marker of endothelial progenitor cell numbers?. ANNALS OF MEDICINE, 39(6), 474-479. doi:10.1080/07853890701329283
Peripheral artery disease and hypertension: the relation between ankle-brachial index and mortality.
Karthikeyan, V. J., & Lip, G. Y. H. (2007). Peripheral artery disease and hypertension: the relation between ankle-brachial index and mortality.. Journal of human hypertension, 21(10), 762-765. doi:10.1038/sj.jhh.1002219
Anticoagulation Issues
Prystowsky, E. N., Themistoclakis, S., Brachmann, J., Callans, D., Connolly, S., Lip, G. Y., & Waldo, A. L. (2007). Anticoagulation Issues. In Unknown Book (pp. 41-50). Wiley. doi:10.1002/9780470692646.ch6
A systematic review of the effects of acute psychological stress and physical activity on haemorheology, coagulation, fibrinolysis and platelet reactivity: Implications for the pathogenesis of acute coronary syndromes
Thrall, G., Lane, D., Carroll, D., & Lip, G. Y. H. (2007). A systematic review of the effects of acute psychological stress and physical activity on haemorheology, coagulation, fibrinolysis and platelet reactivity: Implications for the pathogenesis of acute coronary syndromes. THROMBOSIS RESEARCH, 120(6), 819-847. doi:10.1016/j.thromres.2007.01.004
Endotoxemia, inflammation, and atrial fibrillation.
Boos, C. J., Lip, G. Y. H., & Jilma, B. (2007). Endotoxemia, inflammation, and atrial fibrillation.. The American journal of cardiology, 100(6), 986-988. doi:10.1016/j.amjcard.2007.04.039
Circulating Markers of Endothelial Function
Blann, A. D., Foster, W., & Lip, G. Y. H. (2007). Circulating Markers of Endothelial Function. In Endothelial Biomedicine (pp. 1602-1611). Cambridge University Press. doi:10.1017/cbo9780511546198.174
Common carotid artery intima-media thickness and intracranial pulsatility index in non-ST-elevation acute coronary syndromes.
Tello-Montoliu, A., Moltó, J. M., López-Hernández, N., García-Medina, A., Roldán, V., Sogorb, F., . . . Marín, F. (2007). Common carotid artery intima-media thickness and intracranial pulsatility index in non-ST-elevation acute coronary syndromes.. Cerebrovascular diseases (Basel, Switzerland), 24(4), 338-342. doi:10.1159/000106979
Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias
Shantsila, E., Watson, T., & Lip, G. Y. H. (2007). Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias. EUROPACE, 9, 37-44. doi:10.1093/europace/eum169
Editorial [Hot Topic: The Clinical Management and Treatment of Hypertension, Its Pathophysiology and the Clinical Use of Antihypertensive Drugs (Executive Editor: Gregory Y.H. Lip)]
Lip, G. (2007). Editorial [Hot Topic: The Clinical Management and Treatment of Hypertension, Its Pathophysiology and the Clinical Use of Antihypertensive Drugs (Executive Editor: Gregory Y.H. Lip)]. Current Pharmaceutical Design, 13(25), 2538. doi:10.2174/138161207781663055
Endothelial progenitor cells, endothelial cell dysfunction and much more: observations from cardiac syndrome X.
Goon, P. K. Y., & Lip, G. Y. H. (2007). Endothelial progenitor cells, endothelial cell dysfunction and much more: observations from cardiac syndrome X.. Heart (British Cardiac Society), 93(9), 1020-1021. doi:10.1136/hrt.2006.112664
From diabetes to metabolic syndrome: a viewpoint on an evolving concept.
Lim, H. S., & Lip, G. Y. H. (2007). From diabetes to metabolic syndrome: a viewpoint on an evolving concept.. Current pharmaceutical design, 13(25), 2580-2583. doi:10.2174/138161207781663028
Hypertension in pregnancy: pathophysiology and management strategies.
Karthikeyan, V. J., & Lip, G. Y. H. (2007). Hypertension in pregnancy: pathophysiology and management strategies.. Current pharmaceutical design, 13(25), 2567-2579. doi:10.2174/138161207781663019
Hypertension, anti-hypertensive therapy and neoplasia.
Goon, P. K. Y., Stonelake, P. S., & Lip, G. Y. H. (2007). Hypertension, anti-hypertensive therapy and neoplasia.. Current pharmaceutical design, 13(25), 2539-2544. doi:10.2174/138161207781663073
Management of hypertension in relation to acute coronary syndromes and revascularisation.
Kühl, M., Lip, G. Y. H., & Varma, C. (2007). Management of hypertension in relation to acute coronary syndromes and revascularisation.. Current pharmaceutical design, 13(25), 2556-2566. doi:10.2174/138161207781663046
Matrix metalloproteinase-1 and its inhibitor, TIMP-1, in systolic heart failure: relation to functional data and prognosis.
Jordán, A., Roldán, V., García, M., Monmeneu, J., de Burgos, F. G., Lip, G. Y. H., & Marín, F. (2007). Matrix metalloproteinase-1 and its inhibitor, TIMP-1, in systolic heart failure: relation to functional data and prognosis.. Journal of internal medicine, 262(3), 385-392. doi:10.1111/j.1365-2796.2007.01823.x
The quest for circulating endothelial cell standardization: the peril of platelets.
Goon, P. K. Y., Watson, T., Stonelake, P. S., & Lip, G. Y. H. (2007). The quest for circulating endothelial cell standardization: the peril of platelets.. Cytometry. Part B, Clinical cytometry, 72(5), 416. doi:10.1002/cyto.b.20355
Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial.
Mant, J., Fitzmaurice, D. A., Hobbs, F. D. R., Jowett, S., Murray, E. T., Holder, R., . . . Lip, G. Y. H. (2007). Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial.. BMJ (Clinical research ed.), 335(7616), 380. doi:10.1136/bmj.39227.551713.ae
Platelet activation in acute, decompensated congestive heart failure.
Chung, I., Choudhury, A., & Lip, G. Y. H. (2007). Platelet activation in acute, decompensated congestive heart failure.. Thrombosis research, 120(5), 709-713. doi:10.1016/j.thromres.2007.01.003
Management of atrial fibrillation.
Lip, G. Y. H., & Tse, H. -F. (2007). Management of atrial fibrillation.. Lancet (London, England), 370(9587), 604-618. doi:10.1016/s0140-6736(07)61300-2
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.
Mant, J., Hobbs, F. D. R., Fletcher, K., Roalfe, A., Fitzmaurice, D., Lip, G. Y. H., . . . Midland Research Practices Network (MidReC). (2007). Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.. Lancet (London, England), 370(9586), 493-503. doi:10.1016/s0140-6736(07)61233-1
Fibrin D-dimer levels and thromboembolic events in patients with atrial fibrillation
Watson, T., Shantsila, E., & Lip, G. Y. H. (2007). Fibrin D-dimer levels and thromboembolic events in patients with atrial fibrillation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 120(1), 123-124. doi:10.1016/j.ijcard.2006.07.185
'DNA' may not mean 'did not participate': a qualitative study of reasons for non-adherence at home- and centre-based cardiac rehabilitation.
Jones, M., Jolly, K., Raftery, J., Lip, G. Y. H., Greenfield, S., & BRUM Steering Committee. (2007). 'DNA' may not mean 'did not participate': a qualitative study of reasons for non-adherence at home- and centre-based cardiac rehabilitation.. Family practice, 24(4), 343-357. doi:10.1093/fampra/cmm021
An analysis of factors that predict patient consent to take part in a randomized controlled trial.
Fletcher, K., Mant, J., Holder, R., Fitzmaurice, D., Lip, G. Y. H., & Hobbs, F. D. R. (2007). An analysis of factors that predict patient consent to take part in a randomized controlled trial.. Family practice, 24(4), 388-394. doi:10.1093/fampra/cmm019
Platelet adhesion in atrial fibrillation.
Choudhury, A., Chung, I., Blann, A., & Lip, G. Y. H. (2007). Platelet adhesion in atrial fibrillation.. Thrombosis research, 120(4), 623-629. doi:10.1016/j.thromres.2006.12.008
Compliance and the treatment of hypertension: where are we now?
Nadar, S. K., & Lip, G. Y. H. (2007). Compliance and the treatment of hypertension: where are we now?. Therapy, 4(4), 385-386. doi:10.2217/14750708.4.4.385
Thromboprophylaxis in acute ischaemic stroke: how can we PREVAIL?
Lim, H. S., & Lip, G. Y. H. (2007). Thromboprophylaxis in acute ischaemic stroke: how can we PREVAIL?. The Lancet. Neurology, 6(7), 578-579. doi:10.1016/s1474-4422(07)70159-x
New frontiers in cardiovascular disease: circulating endothelial cells and endothelial progenitor cells as cellular biomarkers.
Goon, P. K., Watson, T., & Lip, G. Y. H. (2007). New frontiers in cardiovascular disease: circulating endothelial cells and endothelial progenitor cells as cellular biomarkers.. Clinical laboratory, 53(5-6), 297-299.
Significant decrease in angiopoietin-1 and angiopoietin-2 after radical prostatectomy in prostate cancer patients.
Caine, G. J., Ryan, P., Lip, G. Y. H., & Blann, A. D. (2007). Significant decrease in angiopoietin-1 and angiopoietin-2 after radical prostatectomy in prostate cancer patients.. Cancer letters, 251(2), 296-301. doi:10.1016/j.canlet.2006.11.026
Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.
Chong, A. Y., Freestone, B., Lim, H. S., Kistorp, C., Gustafsson, F., Hildebrandt, P., & Lip, G. Y. H. (2007). Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.. International journal of cardiology, 119(1), 80-82. doi:10.1016/j.ijcard.2006.07.085
Circulating endothelial cells in obstructive sleep apnea: an important methodological lesson.
Goon, P. K. Y., Watson, T., & Lip, G. Y. H. (2007). Circulating endothelial cells in obstructive sleep apnea: an important methodological lesson.. American journal of respiratory and critical care medicine, 175(12), 1346. doi:10.1164/ajrccm.175.12.1346
Systemic and intracardiac vascular endothelial growth factor and angiopoietin-1 and -2 levels in coronary artery disease: effects of angioplasty.
Jaumdally, R. J., Varma, C., Blann, A. D., MacFadyen, R. J., & Lip, G. Y. H. (2007). Systemic and intracardiac vascular endothelial growth factor and angiopoietin-1 and -2 levels in coronary artery disease: effects of angioplasty.. Annals of medicine, 39(4), 298-305. doi:10.1080/07853890701298132
Management of atrial fibrillation.
Kakar, P., Boos, C. J., & Lip, G. Y. H. (2007). Management of atrial fibrillation.. Vascular health and risk management, 3(1), 109-116.
Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillation.
Lip, G. Y. H., Frison, L., & Grind, M. (2007). Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillation.. Journal of internal medicine, 261(6), 577-586. doi:10.1111/j.1365-2796.2007.01780.x
Cardioversion for atrial fibrillation: does inflammation matter?
Watson, T., Kakar, P., & Lip, G. Y. H. (2007). Cardioversion for atrial fibrillation: does inflammation matter?. The American journal of cardiology, 99(11), 1617-1618. doi:10.1016/j.amjcard.2006.12.089
Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer, C. G. C., Felmeden, D. C., Blann, A. D., & Lip, G. Y. H. (2007). Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.. American journal of hypertension, 20(6), 699-704. doi:10.1016/j.amjhyper.2007.01.004
Statin therapy in South-Asian patients: clinical implications beyond lipid lowering?
Jaumdally, J. R., Varma, C., & Lip, G. Y. H. (2007). Statin therapy in South-Asian patients: clinical implications beyond lipid lowering?. Expert opinion on pharmacotherapy, 8(9), 1235-1243. doi:10.1517/14656566.8.9.1235
Statins and intra-plaque angiogenesis in carotid artery disease.
Karthikeyan, V. J., & Lip, G. Y. H. (2007). Statins and intra-plaque angiogenesis in carotid artery disease.. Atherosclerosis, 192(2), 455-456. doi:10.1016/j.atherosclerosis.2007.01.018
Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm.
Choudhury, A., Chung, I., Blann, A. D., & Lip, G. Y. H. (2007). Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm.. Journal of the American College of Cardiology, 49(19), 1957-1964. doi:10.1016/j.jacc.2007.02.038
Antioxidant protection: yet another function of endothelial progenitor cells?
Shantsila, E., Watson, T., & Lip, G. Y. H. (2007). Antioxidant protection: yet another function of endothelial progenitor cells?. JOURNAL OF HUMAN HYPERTENSION, 21(5), 343-346. doi:10.1038/sj.jhh.1002166
Atrial fibrillation--the growing epidemic.
Lip, G. Y. H., Kakar, P., & Watson, T. (2007). Atrial fibrillation--the growing epidemic.. Heart (British Cardiac Society), 93(5), 542-543. doi:10.1136/hrt.2006.110791
Cardioversion of atrial fibrillation: from guidelines to contemporary clinical practice.
Lip, G. Y. H. (2007). Cardioversion of atrial fibrillation: from guidelines to contemporary clinical practice.. International journal of clinical practice, 61(5), 714-716. doi:10.1111/j.1742-1241.2007.01306.x
Hypertension: endothelial dysfunction, the prothrombotic state and antithrombotic therapy.
Kakar, P., & Lip, G. Y. H. (2007). Hypertension: endothelial dysfunction, the prothrombotic state and antithrombotic therapy.. Expert review of cardiovascular therapy, 5(3), 441-450. doi:10.1586/14779072.5.3.441
Oral anticoagulation in atrial fibrillation: A pan-European patient survey.
Lip, G. Y. H., Agnelli, G., Thach, A. A., Knight, E., Rost, D., & Tangelder, M. J. D. (2007). Oral anticoagulation in atrial fibrillation: A pan-European patient survey.. European journal of internal medicine, 18(3), 202-208. doi:10.1016/j.ejim.2006.11.005
Relationship between circulating endothelial cells and the predicted risk of cardiovascular events in acute coronary syndromes.
Boos, C. J., Soor, S. K., Kang, D., & Lip, G. Y. H. (2007). Relationship between circulating endothelial cells and the predicted risk of cardiovascular events in acute coronary syndromes.. European heart journal, 28(9), 1092-1101. doi:10.1093/eurheartj/ehm070
A cross-sectional study of hypertension in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation in the Aged (BAFTA) randomised controlled trial.
Hurley, V., Ireson, R., Fletcher, K., Lip, G. Y. H., Hobbs, F. D. R., Mant, J., & BAFTA Investigators. (2007). A cross-sectional study of hypertension in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation in the Aged (BAFTA) randomised controlled trial.. International journal of cardiology, 117(2), 152-156. doi:10.1016/j.ijcard.2006.04.061
Assessment of mean platelet volume in coronary artery disease - what does it mean?
Boos, C. J., & Lip, G. Y. H. (2007). Assessment of mean platelet volume in coronary artery disease - what does it mean?. Thrombosis research, 120(1), 11-13. doi:10.1016/j.thromres.2006.09.002
Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer.
Caine, G. J., Stonelake, P. S., Lip, G. Y. H., & Blann, A. D. (2007). Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer.. Cancer letters, 248(1), 131-136. doi:10.1016/j.canlet.2006.06.011
Effects of low osmolar contrast (iomeprol) on haemorheology and platelet activation in patients with coronary artery disease.
Jaumdally, R. J., Varma, C., MacFadyen, R. J., & Lip, G. Y. H. (2007). Effects of low osmolar contrast (iomeprol) on haemorheology and platelet activation in patients with coronary artery disease.. Journal of thrombosis and thrombolysis, 23(3), 189-194. doi:10.1007/s11239-006-9048-x
Coronary sinus blood sampling: an insight into local cardiac pathophysiology and treatment?
Jaumdally, R., Varma, C., Macfadyen, R. J., & Lip, G. Y. H. (2007). Coronary sinus blood sampling: an insight into local cardiac pathophysiology and treatment?. European heart journal, 28(8), 929-940. doi:10.1093/eurheartj/ehm015
Stroke prevention in atrial fibrillation: antiplatelet therapy revisited.
Lip, G. Y. H., & Watson, T. (2007). Stroke prevention in atrial fibrillation: antiplatelet therapy revisited.. European heart journal, 28(8), 926-928. doi:10.1093/eurheartj/ehm077
Effects of blood pressure on the prothrombotic risk in 1235 patients with non-valvular atrial fibrillation.
Varughese, G. I., Patel, J. V., Tomson, J., & Lip, G. Y. H. (2007). Effects of blood pressure on the prothrombotic risk in 1235 patients with non-valvular atrial fibrillation.. Heart (British Cardiac Society), 93(4), 495-499. doi:10.1136/hrt.2006.099374
Ethnic disparities in malignant hypertension: further observations.
Karthikeyan, V. J., Beevers, D. G., & Lip, G. Y. H. (2007). Ethnic disparities in malignant hypertension: further observations.. Journal of hypertension, 25(4), 895. doi:10.1097/hjh.0b013e32802ef31e
High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis.
Lip, G. Y. H., Patel, J. V., Hughes, E., & Hart, R. G. (2007). High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis.. Stroke, 38(4), 1229-1237. doi:10.1161/01.str.0000260090.90508.3e
In response [7]
Watson, T., Shantsila, E., & Lip, G. Y. H. (2007). In response [7]. Clinical Medicine, Journal of the Royal College of Physicians of London, 7(2), 199-200.
New insights into complement C3 and inflammation in hypertension.
Nadar, S. K., & Lip, G. Y. H. (2007). New insights into complement C3 and inflammation in hypertension.. Journal of human hypertension, 21(4), 261-263. doi:10.1038/sj.jhh.1002160
Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
Varughese, G. I., Patel, J. V., Tomson, J., Blann, A. D., Hughes, E. A., & Lip, G. Y. H. (2007). Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.. Journal of internal medicine, 261(4), 384-391. doi:10.1111/j.1365-2796.2007.01770.x
Should oral glucose tolerance testing be mandatory following acute myocardial infarction?
Jessani, S., Gangopadhyay, K., Patel, J. V., Lip, G. Y. H., & Millane, T. (2007). Should oral glucose tolerance testing be mandatory following acute myocardial infarction?. International journal of clinical practice, 61(4), 680-683. doi:10.1111/j.1742-1241.2007.01301.x
Standardization of circulating endothelial cell enumeration by the use of human umbilical vein endothelial cells
Goon, P. K. Y., Watson, T., Shantsila, E., Boos, C. J., & Lip, G. Y. H. (2007). Standardization of circulating endothelial cell enumeration by the use of human umbilical vein endothelial cells. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 5(4), 870-872. doi:10.1111/j.1538-7836.2007.02411.x
Home-based exercise rehabilitation in addition to specialist heart failure nurse care: design, rationale and recruitment to the Birmingham Rehabilitation Uptake Maximisation study for patients with congestive heart failure (BRUM-CHF): a randomised controlled trial.
Jolly, K., Tayor, R. S., Lip, G. Y. H., Greenfield, S. M., Davies, M. K., Davis, R. C., . . . Stevens, A. J. (2007). Home-based exercise rehabilitation in addition to specialist heart failure nurse care: design, rationale and recruitment to the Birmingham Rehabilitation Uptake Maximisation study for patients with congestive heart failure (BRUM-CHF): a randomised controlled trial.. BMC cardiovascular disorders, 7, 9. doi:10.1186/1471-2261-7-9
Circulating endothelial cells and von Willebrand factor as indices of endothelial damage/dysfunction in coronary artery disease: a comparison of central vs. peripheral levels and effects of coronary angioplasty.
Boos, C. J., Jaumdally, R. J., MacFadyen, R. J., Varma, C., & Lip, G. Y. H. (2007). Circulating endothelial cells and von Willebrand factor as indices of endothelial damage/dysfunction in coronary artery disease: a comparison of central vs. peripheral levels and effects of coronary angioplasty.. Journal of thrombosis and haemostasis : JTH, 5(3), 630-632. doi:10.1111/j.1538-7836.2007.02341.x
Drug evaluation: rivaroxaban, an oral, direct inhibitor of activated factor X.
Kakar, P., Watson, T., & Lip, G. Y. H. (2007). Drug evaluation: rivaroxaban, an oral, direct inhibitor of activated factor X.. Current opinion in investigational drugs (London, England : 2000), 8(3), 256-265.
Effect of hypertension on anticoagulated patients with atrial fibrillation.
Lip, G. Y. H., Frison, L., Grind, M., & SPORTIF Invetigators. (2007). Effect of hypertension on anticoagulated patients with atrial fibrillation.. European heart journal, 28(6), 752-759. doi:10.1093/eurheartj/ehl504
Is it the post-challenge hyperglycaemic spike or arterial stiffness we should be screening for?
Jessani, S., & Lip, G. Y. H. (2007). Is it the post-challenge hyperglycaemic spike or arterial stiffness we should be screening for?. International journal of clinical practice, 61(3), 356-358. doi:10.1111/j.1742-1241.2006.01209.x
Rivaroxaban.
Kakar, P., Watson, T., & Lip, G. Y. H. (2007). Rivaroxaban.. Drugs of today (Barcelona, Spain : 1998), 43(3), 129-136. doi:10.1358/dot.2007.43.3.1067345
Aspirin resistance: What, why and when?
Shantsita, E., Watson, T., & Lip, G. Y. H. (2007). Aspirin resistance: What, why and when?. THROMBOSIS RESEARCH, 119(5), 551-554. doi:10.1016/j.thromres.2006.08.009
Subclinical atherosclerosis and risk of atrial fibrillation: the rotterdam study.
Heeringa, J., van der Kuip, D. A. M., Hofman, A., Kors, J. A., van Rooij, F. J. A., Lip, G. Y. H., & Witteman, J. C. M. (2007). Subclinical atherosclerosis and risk of atrial fibrillation: the rotterdam study.. Archives of internal medicine, 167(4), 382-387. doi:10.1001/archinte.167.4.382
Assessment of platelet activation indices using the ADVIATM 120 amongst 'high-risk' patients with hypertension.
Boos, C. J., Beevers, G. D., & Lip, G. Y. H. (2007). Assessment of platelet activation indices using the ADVIATM 120 amongst 'high-risk' patients with hypertension.. Annals of medicine, 39(1), 72-78. doi:10.1080/07853890601040063
Endothelial progenitor cells in cardiovascular disorders
Shantsila, E., Watson, T., & Lip, G. Y. H. (2007). Endothelial progenitor cells in cardiovascular disorders. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 49(7), 741-752. doi:10.1016/j.jacc.2006.09.050
Viewpoint: the prothrombotic state in heart failure: a maladaptive inflammatory response?
Chong, A. -Y., & Lip, G. Y. H. (2007). Viewpoint: the prothrombotic state in heart failure: a maladaptive inflammatory response?. European journal of heart failure, 9(2), 124-128. doi:10.1016/j.ejheart.2006.05.009
Effects of omega-3 polyunsaturated fatty acids on metabolically active hormones in patients post-myocardial infarction.
Patel, J. V., Lee, K. W., Tomson, J., Dubb, K., Hughes, E. A., & Lip, G. Y. H. (2007). Effects of omega-3 polyunsaturated fatty acids on metabolically active hormones in patients post-myocardial infarction.. International journal of cardiology, 115(1), 42-45. doi:10.1016/j.ijcard.2006.04.004
Cross-cultural adaptation into Punjabi of the English version of the Hospital Anxiety and Depression Scale
Lane, D. A., Jajoo, J., Taylor, R. S., Lip, G. Y. H., & Jolly, K. (2007). Cross-cultural adaptation into Punjabi of the English version of the Hospital Anxiety and Depression Scale. BMC PSYCHIATRY, 7. doi:10.1186/1471-244X-7-5
South Asian or Afro-Caribbean ethnicity is not associated with altered 1 min heart rate recovery estimates in suspected coronary artery disease patients.
Goyal, D., Tayebjee, M., Lip, G. Y. H., & MacFadyen, R. J. (2007). South Asian or Afro-Caribbean ethnicity is not associated with altered 1 min heart rate recovery estimates in suspected coronary artery disease patients.. International journal of cardiology, 114(2), 261-264. doi:10.1016/j.ijcard.2005.11.065
A systematic review of the prothrombotic effects of an acute change in posture - A possible mechanism underlying the morning excess in cardiovascular events?
Thrall, G., Lane, D., Carroll, D., & Lip, G. Y. H. (2007). A systematic review of the prothrombotic effects of an acute change in posture - A possible mechanism underlying the morning excess in cardiovascular events?. CHEST, 132(4), 1337-1347. doi:10.1378/chest.06-2978
Acute management of atrial fibrillation with acute haemodynamic instability and in the postoperative setting.
Mann, C. J., Kendall, S., Lip, G. Y. H., & Guideline Development Group for the NICE clinical guideline for the management of atrial fibrillation. (2007). Acute management of atrial fibrillation with acute haemodynamic instability and in the postoperative setting.. In Heart (British Cardiac Society) Vol. 93 (pp. 45-47). doi:10.1136/hrt.2006.099929
Adiponectin and hypertension: a putative link between adipocyte function and atherosclerotic risk?
Patel, J. V., Lim, H. S., Hughes, E. A., & Lip, G. Y. H. (2007). Adiponectin and hypertension: a putative link between adipocyte function and atherosclerotic risk?. Journal of human hypertension, 21(1), 1-4. doi:10.1038/sj.jhh.1002078
Alpha 1-microglobulin: a further insight into inflammation in hypertension?
Karthikeyan, V. J., & Lip, G. Y. H. (2007). Alpha 1-microglobulin: a further insight into inflammation in hypertension?. American journal of hypertension, 20(9), 1022-1023. doi:10.1016/j.amjhyper.2007.03.001
Antihypertensive treatment, adiponectin and cardiovascular risk.
Karthikeyan, V. J., & Lip, G. Y. H. (2007). Antihypertensive treatment, adiponectin and cardiovascular risk.. Journal of human hypertension, 21(1), 8-11. doi:10.1038/sj.jhh.1002113
Antithrombotic Therapy in Hypertension
Lip, G. Y. H. (2007). Antithrombotic Therapy in Hypertension. In Comprehensive Hypertension (pp. 1101-1104). Elsevier. doi:10.1016/b978-0-323-03961-1.50092-1
Antithrombotic treatment in atrial fibrillation.
Kalra, L., Lip, G. Y. H., & Guideline Development Group for the NICE clinical guideline for the management of atrial fibrillation. (2007). Antithrombotic treatment in atrial fibrillation.. In Heart (British Cardiac Society) Vol. 93 (pp. 39-44). doi:10.1136/hrt.2006.099911
Assessment of endothelial damage/dysfunction: a focus on circulating endothelial cells.
Boos, C. J., Blann, A. D., & Lip, G. Y. H. (2007). Assessment of endothelial damage/dysfunction: a focus on circulating endothelial cells.. Methods in molecular medicine, 139, 211-224. doi:10.1007/978-1-59745-571-8_13
Circulating endothelial cells, arterial stiffness, and cardiovascular risk stratification in hypertension
Boos, C. J., Lane, D. A., Karpha, M., Beevers, D. G., Haynes, R., & Lip, G. Y. H. (2007). Circulating endothelial cells, arterial stiffness, and cardiovascular risk stratification in hypertension. CHEST, 132(5), 1540-1547. doi:10.1378/chest.07-0428
Comprehensive Hypertension
Comprehensive Hypertension (2007). . Elsevier. doi:10.1016/b978-0-323-03961-1.x5001-6
Coronary artery disease and ischemic stroke in atrial fibrillation.
Lip, G. Y. H. (2007). Coronary artery disease and ischemic stroke in atrial fibrillation.. Chest, 132(1), 8-10. doi:10.1378/chest.07-0500
Depression, anxiety, and quality of life in patients with atrial fibrillation
Thrall, G., Lip, G. Y. H., Carroll, D., & Lane, D. (2007). Depression, anxiety, and quality of life in patients with atrial fibrillation. CHEST, 132(4), 1259-1264. doi:10.1378/chest.07-0036
Effects of percutaneous coronary intervention on peripheral venous blood circulating endothelial cells and plasma indices of endothelial damage/dysfunction.
Boos, C. J., Balakrishnan, B., Jessani, S., Blann, A. D., & Lip, G. Y. H. (2007). Effects of percutaneous coronary intervention on peripheral venous blood circulating endothelial cells and plasma indices of endothelial damage/dysfunction.. Chest, 132(6), 1920-1926. doi:10.1378/chest.07-1693
Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy.
Choudhury, A., Chung, I., Blann, A. D., & Lip, G. Y. H. (2007). Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy.. Chest, 131(3), 809-815. doi:10.1378/chest.06-2039
Ethnic differences in cancer incidence and mortality: the Birmingham factory screening project
Lane, D. A., Lip, G. Y. H., & Beevers, D. G. (2007). Ethnic differences in cancer incidence and mortality: the Birmingham factory screening project. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 100(7), 423-431. doi:10.1093/qjmed/hcm041
Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer, C. G. C., Felmeden, D. C., Blann, A. D., & Lip, G. Y. H. (2007). Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.. In Journal of internal medicine Vol. 261 (pp. 82-90). doi:10.1111/j.1365-2796.2006.01735.x
Hypertension in the Context of Acute Myocardial Infarction and Percutaneous Coronary Interventions
Jaumdally, R., & Lip, G. Y. H. (2007). Hypertension in the Context of Acute Myocardial Infarction and Percutaneous Coronary Interventions. In Comprehensive Hypertension (pp. 747-751). Elsevier. doi:10.1016/b978-0-323-03961-1.50064-7
Identification, diagnosis and assessment of atrial fibrillation.
Dewar, R. I., Lip, G. Y. H., & Guidelines Development Group for the NICE clinical guideline for the management of atrial fibrillation. (2007). Identification, diagnosis and assessment of atrial fibrillation.. In Heart (British Cardiac Society) Vol. 93 (pp. 25-28). doi:10.1136/hrt.2006.099861
Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy.
Goon, P. K. Y., & Lip, G. Y. H. (2007). Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy.. Eye (London, England), 21(6), 838-839. doi:10.1038/sj.eye.6702650
Maintaining therapeutic anticoagulation - The importance of keeping "within range"
Lane, D. A., & Lip, G. Y. H. (2007). Maintaining therapeutic anticoagulation - The importance of keeping "within range". CHEST, 131(5), 1277-1279. doi:10.1378/chest.07-0273
Management of atrial fibrillation: An overview of the NICE guidance on AF management
Watson, T., Shanstila, E., & Lip, G. Y. H. (2007). Management of atrial fibrillation: An overview of the NICE guidance on AF management. British Journal of Cardiology, 14(1), 23-28.
Management of atrial fibrillation: the NICE guidelines.
Lip, G. Y. H., Rudolf, M., & Kakar, P. (2007). Management of atrial fibrillation: the NICE guidelines.. International journal of clinical practice, 61(1), 9-11. doi:10.1111/j.1742-1241.2006.01151.x
Matrix Metalloproteinases and the Extracellular Matrix
Tayebjee, M. H., & Lip, G. Y. H. (2007). Matrix Metalloproteinases and the Extracellular Matrix. In Comprehensive Hypertension (pp. 183-189). Elsevier. doi:10.1016/b978-0-323-03961-1.50020-9
Modern management of atrial fibrillation.
Watson, T., Shanstila, E., & Lip, G. Y. H. (2007). Modern management of atrial fibrillation.. Clinical medicine (London, England), 7(1), 28-34. doi:10.7861/clinmedicine.7-1-28
N-terminal pro-brain natriuretic peptide and coronary artery disease.
Karthikeyan, V. J., & Lip, G. Y. H. (2007). N-terminal pro-brain natriuretic peptide and coronary artery disease.. European journal of clinical investigation, 37(1), 1-7. doi:10.1111/j.1365-2362.2007.01750.x
Patient care pathway, implementation and audit criteria for patients with atrial fibrillation.
Davis, M., Rodgers, S., Rudolf, M., Hughes, M., Lip, G. Y. H., & Guideline Development Group for the NICE clinical guideline for the management of atrial fibrillation. (2007). Patient care pathway, implementation and audit criteria for patients with atrial fibrillation.. In Heart (British Cardiac Society) Vol. 93 (pp. 48-52). doi:10.1136/hrt.2006.099937
Physical fitness and the relationship between hypertension and markers of atherothrombosis.
Jessani, S., & Lip, G. Y. H. (2007). Physical fitness and the relationship between hypertension and markers of atherothrombosis.. American journal of hypertension, 20(6), 676-677. doi:10.1016/j.amjhyper.2007.02.003
Platelet activation in coronary artery disease: intracardiac vs peripheral venous levels and the effects of angioplasty.
Jaumdally, R. J., Varma, C., Blann, A. D., MacFadyen, R. J., & Lip, G. Y. H. (2007). Platelet activation in coronary artery disease: intracardiac vs peripheral venous levels and the effects of angioplasty.. Chest, 132(5), 1532-1539. doi:10.1378/chest.07-0389
Platelet and Coagulation Abnormalities
Varughese, G. I., & Lip, G. Y. H. (2007). Platelet and Coagulation Abnormalities. In Comprehensive Hypertension (pp. 223-227). Elsevier. doi:10.1016/b978-0-323-03961-1.50024-6
Rate control in the medical management of atrial fibrillation.
Camm, A. J., Savelieva, I., Lip, G. Y. H., & Guideline Development Group for the NICE clinical guideline for the management of atrial fibrillation. (2007). Rate control in the medical management of atrial fibrillation.. In Heart (British Cardiac Society) Vol. 93 (pp. 35-38). doi:10.1136/hrt.2006.099903
Relationship of soluble CD40 ligand to vascular endothelial growth factor, angiopoietins, and tissue factor in atrial fibrillation: a link among platelet activation, angiogenesis, and thrombosis?
Choudhury, A., Freestone, B., Patel, J., & Lip, G. Y. H. (2007). Relationship of soluble CD40 ligand to vascular endothelial growth factor, angiopoietins, and tissue factor in atrial fibrillation: a link among platelet activation, angiogenesis, and thrombosis?. Chest, 132(6), 1913-1919. doi:10.1378/chest.07-1565
Rhythm control and cardioversion.
Sulke, N., Sayers, F., Lip, G. Y. H., & Guideline Development Group for the NICE clinical guideline for the management of atrial fibrillation. (2007). Rhythm control and cardioversion.. In Heart (British Cardiac Society) Vol. 93 (pp. 29-34). doi:10.1136/hrt.2006.099879
Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review.
Hughes, M., Lip, G. Y. H., & Guideline Development Group for the NICE national clinical guideline for management of atrial fibrillation in primary and secondary care. (2007). Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review.. QJM : monthly journal of the Association of Physicians, 100(10), 599-607. doi:10.1093/qjmed/hcm076
Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation.
Freestone, B., Chong, A. Y., Nuttall, S., Blann, A. D., & Lip, G. Y. H. (2007). Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation.. Chest, 132(4), 1253-1258. doi:10.1378/chest.07-1185
Stroke risk stratification in atrial fibrillation: something to EXAMINE more closely.
Watson, T., Kakar, P., & Lip, G. Y. H. (2007). Stroke risk stratification in atrial fibrillation: something to EXAMINE more closely.. International journal of clinical practice, 61(1), 6-9. doi:10.1111/j.1742-1241.2006.01226.x
The Birmingham Rehabilitation Uptake Maximisation Study (BRUM). Home-based compared with hospital-based cardiac rehabilitation in a multi-ethnic population: cost-effectiveness and patient adherence
Jolly, K., Taylor, R., Lip, G. Y. H., Greenfield, S., Raftery, J., Mant, J., . . . Stevens, A. (2007). The Birmingham Rehabilitation Uptake Maximisation Study (BRUM). Home-based compared with hospital-based cardiac rehabilitation in a multi-ethnic population: cost-effectiveness and patient adherence. HEALTH TECHNOLOGY ASSESSMENT, 11(35), 1-+. doi:10.3310/hta11350
The JBS-2 guidelines on prevention of cardiovascular disease in clinical practice: an opportunity missed.
Jessani, S., Lip, G. Y. H., Barnett, A., & Millane, T. (2007). The JBS-2 guidelines on prevention of cardiovascular disease in clinical practice: an opportunity missed.. QJM : monthly journal of the Association of Physicians, 100(2), 121-124. doi:10.1093/qjmed/hcm002
The new NICE guideline on atrial fibrillation management.
Lip, G. Y. H., & Rudolf, M. (2007). The new NICE guideline on atrial fibrillation management.. In Heart (British Cardiac Society) Vol. 93 (pp. 23). doi:10.1136/hrt.2006.099952
2006
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation.
Nieuwlaat, R., Capucci, A., Lip, G. Y. H., Olsson, S. B., Prins, M. H., Nieman, F. H., . . . Euro Heart Survey Investigators. (2006). Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation.. European heart journal, 27(24), 3018-3026. doi:10.1093/eurheartj/ehl015
Management of atrial fibrillation.
Watson, T., & Lip, G. Y. H. (2006). Management of atrial fibrillation.. Herz, 31(9), 849-856. doi:10.1007/s00059-006-2932-5
Oxidative stress and hypertension.
Karthikeyan, V. J., & Lip, G. Y. H. (2006). Oxidative stress and hypertension.. International journal of clinical practice, 60(12), 1525-1527. doi:10.1111/j.1742-1241.2006.00963.x
Plasma haemostatic markers, endothelial function and ambulatory blood pressure changes with home versus hospital cardiac rehabilitation: the Birmingham Rehabilitation Uptake Maximisation Study.
Lee, K. W., Blann, A. D., Jolly, K., Lip, G. Y. H., & BRUM Investigators. (2006). Plasma haemostatic markers, endothelial function and ambulatory blood pressure changes with home versus hospital cardiac rehabilitation: the Birmingham Rehabilitation Uptake Maximisation Study.. Heart (British Cardiac Society), 92(12), 1732-1738. doi:10.1136/hrt.2006.092163
Platelet activation and cardiovascular outcomes in acute coronary syndromes.
Boos, C. J., & Lip, G. Y. H. (2006). Platelet activation and cardiovascular outcomes in acute coronary syndromes.. Journal of thrombosis and haemostasis : JTH, 4(12), 2542-2543. doi:10.1111/j.1538-7836.2006.02250.x
Stroke: ethnic differences do exist.
Kakar, P., Gunarathne, A., & Lip, G. Y. H. (2006). Stroke: ethnic differences do exist.. Expert review of neurotherapeutics, 6(12), 1769-1771. doi:10.1586/14737175.6.12.1769
Towards improving the clinical assessment and management of human hypertension: An overview from this Journal.
Kakar, P., & Lip, G. Y. H. (2006). Towards improving the clinical assessment and management of human hypertension: An overview from this Journal.. Journal of human hypertension, 20(12), 913-916. doi:10.1038/sj.jhh.1002083
Aortic elasticity, left ventricular geometry and diastolic dysfunction in hypertension.
Karthikeyan, V. J., & Lip, G. Y. H. (2006). Aortic elasticity, left ventricular geometry and diastolic dysfunction in hypertension.. International journal of clinical practice, 60(11), 1337-1340. doi:10.1111/j.1742-1241.2006.01030.x
Are guidelines on cardiovascular risk prevention comprehensive enough? Focus on the 2005 Joint British Societies? Guidelines
Jessani, S., & Lip, G. Y. H. (2006). Are guidelines on cardiovascular risk prevention comprehensive enough? Focus on the 2005 Joint British Societies? Guidelines. Therapy, 3(6), 687-690. doi:10.1586/14750708.3.6.687
Endotoxemia enhances circulating endothelial cells in humans.
Boos, C. J., Mayr, F. B., Lip, G. Y. H., & Jilma, B. (2006). Endotoxemia enhances circulating endothelial cells in humans.. Journal of thrombosis and haemostasis : JTH, 4(11), 2509-2511. doi:10.1111/j.1538-7836.2006.02172.x
Platelets and heart failure.
Chung, I., & Lip, G. Y. H. (2006). Platelets and heart failure.. European heart journal, 27(22), 2623-2631. doi:10.1093/eurheartj/ehl305
Towards understanding the aetiology and pathophysiology of human hypertension: where are we now?
Kakar, P., & Lip, G. Y. H. (2006). Towards understanding the aetiology and pathophysiology of human hypertension: where are we now?. Journal of human hypertension, 20(11), 833-836. doi:10.1038/sj.jhh.1002082
Circulating endothelial cells in cardiovascular disease.
Boos, C. J., Lip, G. Y. H., & Blann, A. D. (2006). Circulating endothelial cells in cardiovascular disease.. Journal of the American College of Cardiology, 48(8), 1538-1547. doi:10.1016/j.jacc.2006.02.078
Reply
Bhatia, G., Lip, G. Y. H., & Davis, R. C. (2006). Reply. Journal of the American College of Cardiology, 48(8), 1727. doi:10.1016/j.jacc.2006.07.028
Anticoagulation for stroke prevention - High effectiveness, more cost benefit?
Shantsila, E., Watson, T., & Lip, G. Y. H. (2006). Anticoagulation for stroke prevention - High effectiveness, more cost benefit?. PHARMACOECONOMICS, 24(10), 1035-1038. doi:10.2165/00019053-200624100-00010
Atrial fibrillation and stroke prevention.
Kakar, P., & Lip, G. Y. H. (2006). Atrial fibrillation and stroke prevention.. Expert review of neurotherapeutics, 6(10), 1523-1530. doi:10.1586/14737175.6.10.1523
C-reactive protein and lone atrial fibrillation: potential confounders.
Boos, C. J., & Lip, G. Y. H. (2006). C-reactive protein and lone atrial fibrillation: potential confounders.. The American journal of cardiology, 98(7), 991-992. doi:10.1016/j.amjcard.2006.05.005
Death or heart failure post acute myocardial infarction? The role of cardiac biomarkers.
Jessani, S., & Lip, G. Y. H. (2006). Death or heart failure post acute myocardial infarction? The role of cardiac biomarkers.. Journal of cardiac failure, 12(8), 641-643. doi:10.1016/j.cardfail.2006.07.004
Hypertension and breast cancer: an association revisited?
Goon, P. K. Y., Messerli, F. H., & Lip, G. Y. H. (2006). Hypertension and breast cancer: an association revisited?. Journal of human hypertension, 20(10), 722-724. doi:10.1038/sj.jhh.1002053
Oral omega n3-PUFA therapy (Omacor) has no impact on indices of heart rate variability in stable post myocardial infarction patients.
Hamaad, A., Kaeng Lee, W., Lip, G. Y. H., & MacFadyen, R. J. (2006). Oral omega n3-PUFA therapy (Omacor) has no impact on indices of heart rate variability in stable post myocardial infarction patients.. Cardiovascular drugs and therapy, 20(5), 359-364. doi:10.1007/s10557-006-0295-z
Proteomics, metabolomics and circulating endothelial progenitor cells in acute coronary syndromes.
Goon, P. K. Y., & Lip, G. Y. H. (2006). Proteomics, metabolomics and circulating endothelial progenitor cells in acute coronary syndromes.. Journal of thrombosis and thrombolysis, 22(2), 155-156. doi:10.1007/s11239-006-8983-x
Temporal and venepuncture-related decline in circulating endothelial cell capture from mixed venous blood
Boos, C. J., Lane, D. A., Kang, D., Goon, P. K. Y., Blann, A. D., & Lip, G. Y. H. (2006). Temporal and venepuncture-related decline in circulating endothelial cell capture from mixed venous blood. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 22(2), 125-131. doi:10.1007/s11239-006-8422-z
Role of metabolically active hormones in the insulin resistance associated with short-term glucocorticoid treatment.
Patel, J. V., Cummings, D. E., Girod, J. P., Mascarenhas, A. V., Hughes, E. A., Gupta, M., . . . Brotman, D. J. (2006). Role of metabolically active hormones in the insulin resistance associated with short-term glucocorticoid treatment.. Journal of negative results in biomedicine, 5, 14. doi:10.1186/1477-5751-5-14
The effects of direct current cardioversion for persistent atrial fibrillation on indices of endothelial damage/dysfunction.
Freestone, B., Chong, A. Y., Blann, A. D., & Lip, G. Y. H. (2006). The effects of direct current cardioversion for persistent atrial fibrillation on indices of endothelial damage/dysfunction.. Thrombosis research, 118(4), 479-485. doi:10.1016/j.thromres.2005.10.004
A longitudinal population-based study of prothrombotic factors in elderly subjects with atrial fibrillation: the Rotterdam Study 1990-1999.
Heeringa, J., Conway, D. S. G., van der Kuip, D. A. M., Hofman, A., Breteler, M. M. B., Lip, G. Y. H., & Witteman, J. C. M. (2006). A longitudinal population-based study of prothrombotic factors in elderly subjects with atrial fibrillation: the Rotterdam Study 1990-1999.. Journal of thrombosis and haemostasis : JTH, 4(9), 1944-1949. doi:10.1111/j.1538-7836.2006.02115.x
Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation
Lip, G. Y. H., Lane, D., Van Walraven, C., & Hart, R. G. (2006). Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation. STROKE, 37(9), 2294-2300. doi:10.1161/01.STR.0000236840.00467.84
Angiogenin: a review of the pathophysiology and potential clinical applications.
Tello-Montoliu, A., Patel, J. V., & Lip, G. Y. H. (2006). Angiogenin: a review of the pathophysiology and potential clinical applications.. Journal of thrombosis and haemostasis : JTH, 4(9), 1864-1874. doi:10.1111/j.1538-7836.2006.01995.x
Anticoagulation plus aspirin following acute myocardial infarction: yes or no ... and if the latter, why not?
Lip, G. Y. H., & Varma, C. (2006). Anticoagulation plus aspirin following acute myocardial infarction: yes or no ... and if the latter, why not?. Thrombosis research, 118(4), 429-432. doi:10.1016/j.thromres.2005.09.012
Blood pressure control in the setting of diabetes mellitus: new targets, new hope for improvement?
Varughese, G. I., Patel, J. V., & Lip, G. Y. H. (2006). Blood pressure control in the setting of diabetes mellitus: new targets, new hope for improvement?. Journal of human hypertension, 20(9), 635-637. doi:10.1038/sj.jhh.1002029
Blood pressure measurement in atrial fibrillation: goodbye mercury?
Watson, T., & Lip, G. Y. H. (2006). Blood pressure measurement in atrial fibrillation: goodbye mercury?. Journal of human hypertension, 20(9), 638-640. doi:10.1038/sj.jhh.1002031
Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients.
Nadar, S., Blann, A. D., & Lip, G. Y. H. (2006). Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients.. American journal of hypertension, 19(9), 970-978. doi:10.1016/j.amjhyper.2006.03.001
Prevention of cardiovascular disease in clinical practice: The Joint British Societies' (JBS 2) guidelines.
Jessani, S., Watson, T., Cappuccio, F. P., & Lip, G. Y. H. (2006). Prevention of cardiovascular disease in clinical practice: The Joint British Societies' (JBS 2) guidelines.. Journal of human hypertension, 20(9), 641-645. doi:10.1038/sj.jhh.1002058
Home-based cardiac rehabilitation compared with centre-based rehabilitation and usual care: a systematic review and meta-analysis.
Jolly, K., Taylor, R. S., Lip, G. Y. H., & Stevens, A. (2006). Home-based cardiac rehabilitation compared with centre-based rehabilitation and usual care: a systematic review and meta-analysis.. International journal of cardiology, 111(3), 343-351. doi:10.1016/j.ijcard.2005.11.002
Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes.
Lee, K. W., Blann, A. D., & Lip, G. Y. H. (2006). Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes.. International journal of cardiology, 111(2), 302-308. doi:10.1016/j.ijcard.2005.10.014
Anticoagulation for stroke prevention in atrial fibrillation: is gender important?
Lip, G. Y. H., Watson, T., & Shantsila, E. (2006). Anticoagulation for stroke prevention in atrial fibrillation: is gender important?. EUROPEAN HEART JOURNAL, 27(16), 1893-1894. doi:10.1093/eurheartj/ehl140
Arterial disease and venous thromboembolism: a modern paradigm?
Goon, P. K. Y., & Lip, G. Y. H. (2006). Arterial disease and venous thromboembolism: a modern paradigm?. Thrombosis and haemostasis, 96(2), 111-112. doi:10.1160/th06-07-0380
Atrial fibrillation post-cardiac surgery: changing perspectives
Shantsila, E., Watson, T., & Lip, G. Y. H. (2006). Atrial fibrillation post-cardiac surgery: changing perspectives. CURRENT MEDICAL RESEARCH AND OPINION, 22(8), 1437-1441. doi:10.1185/030079906X115658
Management of atrial fibrillation.
Lip, G. Y. H., & Tello-Montoliu, A. (2006). Management of atrial fibrillation.. Heart (British Cardiac Society), 92(8), 1177-1182. doi:10.1136/hrt.2005.071555
The pathophysiology of target organ damage in hypertension.
Karpha, M., & Lip, G. V. H. (2006). The pathophysiology of target organ damage in hypertension.. Minerva cardioangiologica, 54(4), 417-429.
Effects of omega-3 polyunsaturated fatty acids on plasma indices of thrombogenesis and inflammation in patients post-myocardial infarction.
Lee, K. W., Blann, A. D., & Lip, G. Y. H. (2006). Effects of omega-3 polyunsaturated fatty acids on plasma indices of thrombogenesis and inflammation in patients post-myocardial infarction.. Thrombosis research, 118(3), 305-312. doi:10.1016/j.thromres.2005.07.018
Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis.
Lip, G. Y. H., & Edwards, S. J. (2006). Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis.. Thrombosis research, 118(3), 321-333. doi:10.1016/j.thromres.2005.08.007
Ximelagatran: an eulogy.
Boos, C. J., & Lip, G. Y. H. (2006). Ximelagatran: an eulogy.. Thrombosis research, 118(3), 301-304. doi:10.1016/j.thromres.2006.02.012
Hypercalcemia and the cardiovascular system
Karthikeyan, V. J., Khan, J. M., & Lip, G. Y. H. (2006). Hypercalcemia and the cardiovascular system. Heart and Metabolism, (30).
Antithrombotic therapy: standard therapy in essential hypertension?
Lip, G. Y. H. (2006). Antithrombotic therapy: standard therapy in essential hypertension?. Progress in cardiovascular diseases, 49(1), 11-15. doi:10.1016/j.pcad.2006.03.004
Aspirin for prevention of stroke in atrial fibrillation.
Lip, G. Y. H. (2006). Aspirin for prevention of stroke in atrial fibrillation.. Stroke, 37(7), 1640. doi:10.1161/01.str.0000227301.55019.60
Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: a methodological comparison.
Goon, P. K. Y., Boos, C. J., Stonelake, P. S., Blann, A. D., & Lip, G. Y. H. (2006). Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: a methodological comparison.. Thrombosis and haemostasis, 96(1), 45-52. doi:10.1160/th06-04-0185
Endothelial progenitor cells in the vascular pathophysiology of hypertension: arterial stiffness, ageing and more.
Boos, C. J., Goon, P. K. Y., & Lip, G. Y. H. (2006). Endothelial progenitor cells in the vascular pathophysiology of hypertension: arterial stiffness, ageing and more.. Journal of human hypertension, 20(7), 475-477. doi:10.1038/sj.jhh.1001991
Therapy for atrial fibrillation: new challenges
Shantsila, E., Watson, T., & Lip, G. Y. H. (2006). Therapy for atrial fibrillation: new challenges. Therapy, 3(4), 445-448. doi:10.2217/14750708.3.4.445
Patient knowledge and perceptions of atrial fibrillation and anticoagulant therapy: Effects of an educational intervention programme The West Birmingham Atrial Fibrillation Project
Lane, D. A., Ponsford, J., Shelley, A., Sirpal, A., & Lip, G. Y. H. (2006). Patient knowledge and perceptions of atrial fibrillation and anticoagulant therapy: Effects of an educational intervention programme The West Birmingham Atrial Fibrillation Project. INTERNATIONAL JOURNAL OF CARDIOLOGY, 110(3), 354-358. doi:10.1016/j.ijcard.2005.07.031
Is an advanced age an additive risk factor to the prothrombotic or hypercoagulable state in atrial fibrillation?
Roldán, V., Marín, F., García, A., Tello-Montoliu, A., & Lip, G. Y. H. (2006). Is an advanced age an additive risk factor to the prothrombotic or hypercoagulable state in atrial fibrillation?. International journal of cardiology, 110(2), 265-266. doi:10.1016/j.ijcard.2005.08.057
Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers.
Brotman, D. J., Girod, J. P., Posch, A., Jani, J. T., Patel, J. V., Gupta, M., . . . Kickler, T. S. (2006). Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers.. Thrombosis research, 118(2), 247-252. doi:10.1016/j.thromres.2005.06.006
Failed reperfusion with thrombolysis--the effect of a local environment?
Varma, C., & Lip, G. Y. H. (2006). Failed reperfusion with thrombolysis--the effect of a local environment?. Thrombosis research, 118(2), 185-187. doi:10.1016/j.thromres.2005.07.016
Pharmacotherapy for atrial fibrillation: is rhythm control achievable?
Watson, T., Shantsila, E., & Lip, G. Y. H. (2006). Pharmacotherapy for atrial fibrillation: is rhythm control achievable?. EXPERT OPINION ON PHARMACOTHERAPY, 7(9), 1105-1107. doi:10.1517/14656566.7.9.1105
Platelet P-selectin and platelet mass, volume and component in sickle cell disease: relationship to genotype.
Mohan, J. S., Lip, G. Y. H., Bareford, D., & Blann, A. D. (2006). Platelet P-selectin and platelet mass, volume and component in sickle cell disease: relationship to genotype.. Thrombosis research, 117(6), 623-629. doi:10.1016/j.thromres.2005.05.010
Editorial [Hot Topic: Clinical Management and Treatment of Hypertension, Its Pathophysiology and the Clinical Use of Antihypertensive Drugs (Executive Editor: Gregory Y.H. Lip)]
Lip, G. (2006). Editorial [Hot Topic: Clinical Management and Treatment of Hypertension, Its Pathophysiology and the Clinical Use of Antihypertensive Drugs (Executive Editor: Gregory Y.H. Lip)]. Current Pharmaceutical Design, 12(13), 1555. doi:10.2174/138161206776843359
Is hypertension an inflammatory process?
Boos, C. J., & Lip, G. Y. H. (2006). Is hypertension an inflammatory process?. Current pharmaceutical design, 12(13), 1623-1635. doi:10.2174/138161206776843313
Novel concepts of statin therapy for cardiovascular risk reduction in hypertension.
Varughese, G. I., Patel, J. V., Lip, G. Y. H., & Varma, C. (2006). Novel concepts of statin therapy for cardiovascular risk reduction in hypertension.. Current pharmaceutical design, 12(13), 1593-1609. doi:10.2174/138161206776843304
Quality of life in patients with atrial fibrillation: a systematic review.
Thrall, G., Lane, D., Carroll, D., & Lip, G. Y. H. (2006). Quality of life in patients with atrial fibrillation: a systematic review.. The American journal of medicine, 119(5), 448.e1-448.19. doi:10.1016/j.amjmed.2005.10.057
Reactive oxygen species production by circulating monocytes: insights from pathophysiology to clinical hypertension.
Lim, H. S., Patel, J. V., & Lip, G. Y. H. (2006). Reactive oxygen species production by circulating monocytes: insights from pathophysiology to clinical hypertension.. Journal of human hypertension, 20(5), 307-309. doi:10.1038/sj.jhh.1001994
Target organ damage in hypertension: pathophysiology and implications for drug therapy.
Nadar, S. K., Tayebjee, M. H., Messerli, F., & Lip, G. Y. H. (2006). Target organ damage in hypertension: pathophysiology and implications for drug therapy.. Current pharmaceutical design, 12(13), 1581-1592. doi:10.2174/138161206776843368
The role of hyperglycaemia and the hypercoagulable state in the pathogenesis of cardiovascular events in diabetes mellitus: implications for hypertension management.
Lim, H. S., MacFadyen, R. J., Bakris, G., & Lip, G. Y. H. (2006). The role of hyperglycaemia and the hypercoagulable state in the pathogenesis of cardiovascular events in diabetes mellitus: implications for hypertension management.. Current pharmaceutical design, 12(13), 1567-1579. doi:10.2174/138161206776843322
Traditional risk factors for coronary atherosclerosis in Indo Asians: the need for a reappraisal.
Jaumdally, J. R., Lip, G. Y. H., & Varma, C. (2006). Traditional risk factors for coronary atherosclerosis in Indo Asians: the need for a reappraisal.. Current pharmaceutical design, 12(13), 1611-1621. doi:10.2174/138161206776843331
White blood cell count and hypertension.
Karthikeyan, V. J., & Lip, G. Y. H. (2006). White blood cell count and hypertension.. Journal of human hypertension, 20(5), 310-312. doi:10.1038/sj.jhh.1001980
Do the National Institute of Clinical Excellence guidelines apply to 'real world' use of Abciximab in percutaneous coronary intervention in a teaching hospital setting?
Khan, J. M., Watson, R. D. S., Varma, C., Millane, T., & Lip, G. Y. H. (2006). Do the National Institute of Clinical Excellence guidelines apply to 'real world' use of Abciximab in percutaneous coronary intervention in a teaching hospital setting?. International journal of clinical practice, 60(4), 498-499. doi:10.1111/j.1368-5031.2006.0827c.x
Does smoking status influence the effect of physical exercise on fibrinolytic function in healthy volunteers?
Tello-Montoliu, A., Roldán, V., Climent, V. E., Sogorb, F., Lip, G. Y. H., & Marín, F. (2006). Does smoking status influence the effect of physical exercise on fibrinolytic function in healthy volunteers?. Journal of thrombosis and thrombolysis, 21(2), 163-166. doi:10.1007/s11239-006-4384-4
Growth hormone therapy and the heart.
Climent, V. E., Picó, A., Sogorb, F., Aznar, S., Lip, G. Y. H., & Marín, F. (2006). Growth hormone therapy and the heart.. The American journal of cardiology, 97(7), 1097-1102. doi:10.1016/j.amjcard.2005.10.054
Is atrial fibrillation an inflammatory disorder?: reply
Boos, C. J. (n.d.). Is atrial fibrillation an inflammatory disorder?: reply. European Heart Journal, 27(7), 886. doi:10.1093/eurheartj/ehi781
Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study.
Heeringa, J., van der Kuip, D. A. M., Hofman, A., Kors, J. A., van Herpen, G., Stricker, B. H. C., . . . Witteman, J. C. M. (2006). Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study.. European heart journal, 27(8), 949-953. doi:10.1093/eurheartj/ehi825
The role of inflammation in atrial fibrillation: increasing evidence in support of a novel concept
Boos, C. J., & Lip, G. Y. H. (n.d.). The role of inflammation in atrial fibrillation: increasing evidence in support of a novel concept. International Journal of Clinical Practice, 60(4), 497-498. doi:10.1111/j.1368-5031.2006.0827b.x
Left ventricular systolic dysfunction in rheumatoid disease: an unrecognized burden?
Bhatia, G. S., Sosin, M. D., Patel, J. V., Grindulis, K. A., Khattak, F. H., Hughes, E. A., . . . Davis, R. C. (2006). Left ventricular systolic dysfunction in rheumatoid disease: an unrecognized burden?. Journal of the American College of Cardiology, 47(6), 1169-1174. doi:10.1016/j.jacc.2005.10.059
Viewpoint.
Lip, G. Y. H. (2006). Viewpoint.. Circulation, 113(9), f33-f34.
Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
Chong, A. Y., Freestone, B., Patel, J., Lim, H. S., Hughes, E., Blann, A. D., & Lip, G. Y. H. (2006). Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.. The American journal of cardiology, 97(5), 671-675. doi:10.1016/j.amjcard.2005.09.113
Increased circulating endothelial cells in acute heart failure: comparison with von Willebrand factor and soluble E-selectin.
Chong, A. Y., Lip, G. Y. H., Freestone, B., & Blann, A. D. (2006). Increased circulating endothelial cells in acute heart failure: comparison with von Willebrand factor and soluble E-selectin.. European journal of heart failure, 8(2), 167-172. doi:10.1016/j.ejheart.2005.06.010
Prevention of atrial fibrillation by angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers.
Boos, C. J., & Lip, G. Y. H. (2006). Prevention of atrial fibrillation by angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers.. Journal of the American College of Cardiology, 47(4), 889-890. doi:10.1016/j.jacc.2005.11.033
Sudden death is less common than might be expected in underprivileged ethnic minorities at high cardiovascular risk.
Hamaad, A., Ghattas, A., Hirani, F., Lip, G. Y. H., & MacFadyen, R. J. (2006). Sudden death is less common than might be expected in underprivileged ethnic minorities at high cardiovascular risk.. International journal of cardiology, 107(2), 235-240. doi:10.1016/j.ijcard.2005.03.020
Blood oxygen saturation during atrio-ventricular dissociation with wide-QRS complex tachycardias.
Marinskis, G., Lip, G. Y. H., Aidietis, A., Jurkuvenas, P., Kaireviciūte, D., Jezov, V., . . . Laucevicius, A. (2006). Blood oxygen saturation during atrio-ventricular dissociation with wide-QRS complex tachycardias.. International journal of cardiology, 107(1), 134-135. doi:10.1016/j.ijcard.2005.01.030
Assessment of hemostatic risk factors in predicting arterial thrombotic events.
Boos, C. J., & Lip, G. Y. H. (2006). Assessment of hemostatic risk factors in predicting arterial thrombotic events.. Arteriosclerosis, thrombosis, and vascular biology, 26(2), e18. doi:10.1161/01.atv.0000199298.80771.1f
Blood pressure control and prevention of stroke.
Karthikeyan, V. J., & Lip, G. Y. H. (2006). Blood pressure control and prevention of stroke.. Expert review of neurotherapeutics, 6(2), 203-212. doi:10.1586/14737175.6.2.203
Corrigendum to: ‘The adhesion molecule P-selectin and cardiovascular disease’ [Eur Heart J 2003;24:2166–2179]
Blann, A. D., Nadar, S. K., & Lip, G. Y. H. (2006). Corrigendum to: ‘The adhesion molecule P-selectin and cardiovascular disease’ [Eur Heart J 2003;24:2166–2179]. European Heart Journal, 27(4), 501. doi:10.1093/eurheartj/ehi764
Hemodynamic, hemostatic, and endothelial reactions to psychological and physical stress in coronary artery disease patients.
Bacon, S. L., Ring, C., Hee, F. L. S., Lip, G. Y. H., Blann, A. D., Lavoie, K. L., & Carroll, D. (2006). Hemodynamic, hemostatic, and endothelial reactions to psychological and physical stress in coronary artery disease patients.. Biological psychology, 71(2), 162-170. doi:10.1016/j.biopsycho.2005.03.003
New evidence of anti-inflammatory interventions in atrial fibrillation: reply
Boos, C. J. (n.d.). New evidence of anti-inflammatory interventions in atrial fibrillation: reply. European Heart Journal, 27(4), 501. doi:10.1093/eurheartj/ehi692
Pulse pressure and carotid atherosclerosis: an important link revisited?
Karthikeyan, V. J., & Lip, G. Y. H. (2006). Pulse pressure and carotid atherosclerosis: an important link revisited?. International journal of clinical practice, 60(2), 127-130. doi:10.1111/j.1742-1241.2006.00843b.x
Review: Angiotensin converting enzyme inhibitors and angiotensin receptor blockers prevent atrial fibrillation.
Karthikeyan, V. J., & Lip, G. Y. H. (2006). Review: Angiotensin converting enzyme inhibitors and angiotensin receptor blockers prevent atrial fibrillation.. Evidence-based medicine, 11(1), 15. doi:10.1136/ebm.11.1.15
Venous thromboembolism.
Blann, A. D., & Lip, G. Y. H. (2006). Venous thromboembolism.. BMJ (Clinical research ed.), 332(7535), 215-219. doi:10.1136/bmj.332.7535.215
Matrix metalloproteinases and hypertension: a link between left ventricular hypertrophy and diastolic dysfunction?
Karthikeyan, V. J., & Lip, G. Y. H. (2006). Matrix metalloproteinases and hypertension: a link between left ventricular hypertrophy and diastolic dysfunction?. The Tohoku journal of experimental medicine, 208(2), 93-97. doi:10.1620/tjem.208.93
Abnormal circulating neutrophil linked matrix metalloproteinase -9 in stable coronary artery disease.
Tayebjee, M. H., Lip, G. Y. H., Tan, K. T., & MacFadyen, R. J. (2006). Abnormal circulating neutrophil linked matrix metalloproteinase -9 in stable coronary artery disease.. Thrombosis and haemostasis, 95(1), 202-204. doi:10.1055/s-0037-1612586
Abnormal soluble CD40 ligand and C-reactive protein concentrations in hypertension: relationship to indices of angiogenesis.
Patel, J. V., Lim, H. S., Nadar, S., Tayebjee, M., Hughes, E. A., & Lip, G. Y. (2006). Abnormal soluble CD40 ligand and C-reactive protein concentrations in hypertension: relationship to indices of angiogenesis.. Journal of hypertension, 24(1), 117-121. doi:10.1097/01.hjh.0000198034.09010.bc
Alcohol and hypertension: an old relationship revisited.
Tomson, J., & Lip, G. Y. (2006). Alcohol and hypertension: an old relationship revisited.. Alcohol and alcoholism (Oxford, Oxfordshire), 41(1), 3-4. doi:10.1093/alcalc/agh223
Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention: the need for consensus and a management guideline.
Lip, G. Y. H., & Karpha, M. (2006). Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention: the need for consensus and a management guideline.. Chest, 130(6), 1823-1827. doi:10.1378/chest.130.6.1823
Anticoagulation control with vitamin K antagonists - How well are we doing?
Lane, D. A., Boos, C. J., & Lip, G. Y. H. (2006). Anticoagulation control with vitamin K antagonists - How well are we doing?. CHEST, 129(5), 1122-1124. doi:10.1378/chest.129.5.1122
Antithrombotic therapy for congestive heart failure.
Chung, I., & Lip, G. Y. H. (2006). Antithrombotic therapy for congestive heart failure.. International journal of clinical practice, 60(1), 36-47. doi:10.1111/j.1368-5031.2005.00676.x
Bleeding risk stratification models in deciding on anticoagulation in patients with atrial fibrillation - A useful complement to stroke risk stratification schema
Kakar, P., Lane, D., & Lip, G. Y. H. (2006). Bleeding risk stratification models in deciding on anticoagulation in patients with atrial fibrillation - A useful complement to stroke risk stratification schema. CHEST, 130(5), 1296-1299. doi:10.1378/chest.130.5.1296
Blood clotting, inflammation, and thrombosis in cardiovascular events: perspectives.
Boos, C. J., & Lip, G. Y. H. (2006). Blood clotting, inflammation, and thrombosis in cardiovascular events: perspectives.. Frontiers in bioscience : a journal and virtual library, 11, 328-336. doi:10.2741/1800
Cardioversion and the endothelium in atrial fibrillation.
Lip, G. Y. H., & Freestone, B. (2006). Cardioversion and the endothelium in atrial fibrillation.. Thrombosis research, 117(3), 231-233. doi:10.1016/j.thromres.2005.04.028
Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer.
Goon, P. K. Y., Lip, G. Y. H., Boos, C. J., Stonelake, P. S., & Blann, A. D. (2006). Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer.. Neoplasia (New York, N.Y.), 8(2), 79-88. doi:10.1593/neo.05592
Differences in the platelet reactivity response to mental stress in cardiac syndrome X patients compared to known coronary artery disease patients: concepts, explanations and methodological weaknesses.
Thrall, G., Lane, D., & Lip, G. Y. H. (2006). Differences in the platelet reactivity response to mental stress in cardiac syndrome X patients compared to known coronary artery disease patients: concepts, explanations and methodological weaknesses.. Thrombosis research, 117(3), 351-352. doi:10.1016/j.thromres.2005.06.018
Drug development and the importance of ethnicity: Lessons from heart failure management and implications for hypertension
Sosin, M. D., Bhatia, G. S., Lip, G. Y. H., & Davis, R. C. (2006). Drug development and the importance of ethnicity: Lessons from heart failure management and implications for hypertension (Vol. 3).
Is atrial fibrillation an inflammatory disorder?
Boos, C. J., Anderson, R. A., & Lip, G. Y. H. (2006). Is atrial fibrillation an inflammatory disorder?. European heart journal, 27(2), 136-149. doi:10.1093/eurheartj/ehi645
Platelet microparticles and platelet adhesion: therapeutic implications for the prevention and treatment of stroke.
Tan, K. T., & Lip, G. Y. H. (2006). Platelet microparticles and platelet adhesion: therapeutic implications for the prevention and treatment of stroke.. Current treatment options in cardiovascular medicine, 8(3), 251-258. doi:10.1007/s11936-006-0019-5
Reduction of Vessel Wall Inflammation in Hypertensive Patients: Is Physical Activity the Answer?
THRALL, G., & LIP, G. (2006). Reduction of Vessel Wall Inflammation in Hypertensive Patients: Is Physical Activity the Answer?. American Journal of Hypertension, 19(7), 676-677. doi:10.1016/j.amjhyper.2005.11.007
Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting.
Marín, F., Pascual, D. A., Roldán, V., Arribas, J. M., Ahumada, M., Tornel, P. L., . . . Valdés, M. (2006). Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting.. The American journal of cardiology, 97(1), 55-60. doi:10.1016/j.amjcard.2005.07.124
The endothelium, inflammation, and coagulation in sepsis.
Boos, C. J., Goon, P. K. Y., & Lip, G. Y. H. (2006). The endothelium, inflammation, and coagulation in sepsis.. Clinical pharmacology and therapeutics, 79(1), 20-22. doi:10.1016/j.clpt.2005.10.004
Thromboprophylaxis in atrial fibrillation: why, how, when and how can we do better?
Watson, T., & Lip, G. Y. H. (2006). Thromboprophylaxis in atrial fibrillation: why, how, when and how can we do better?. International journal of clinical practice, 60(3), 252-255. doi:10.1111/j.1368-5031.2006.0884b.x
Urotensin and cardiovascular risk among patients with end-stage renal disease: fact or fiction?
Boos, C. J., & Lip, G. Y. H. (2006). Urotensin and cardiovascular risk among patients with end-stage renal disease: fact or fiction?. American journal of hypertension, 19(5), 511-512. doi:10.1016/j.amjhyper.2005.11.013
Vasculoprotective effects of angiotensin receptor blockers: beyond the renin-angiotensin-aldosterone system?
Karthikeyan, V. J., & Lip, G. Y. H. (2006). Vasculoprotective effects of angiotensin receptor blockers: beyond the renin-angiotensin-aldosterone system?. Journal of hypertension, 24(9), 1715-1717. doi:10.1097/01.hjh.0000242394.30344.8f
Ximelagatran.
Choudhury, A., Goyal, D., & Lip, G. Y. H. (2006). Ximelagatran.. Drugs of today (Barcelona, Spain : 1998), 42(1), 3-19. doi:10.1358/dot.2006.42.1.893611
2005
Circulating endothelial cells in malignant disease.
Goon, P. K. Y., Boos, C. J., Stonelake, P. S., & Lip, G. Y. H. (2005). Circulating endothelial cells in malignant disease.. Future oncology (London, England), 1(6), 813-820. doi:10.2217/14796694.1.6.813
Diabetes mellitus and atrial fibrillation: perspectives on epidemiological and pathophysiological links.
Lip, G. Y. H., & Varughese, G. I. (2005). Diabetes mellitus and atrial fibrillation: perspectives on epidemiological and pathophysiological links.. International journal of cardiology, 105(3), 319-321. doi:10.1016/j.ijcard.2005.03.003
Biomarkers in atrial fibrillation: further observations on biologic plausibility, cause and effect.
Boos, C. J., & Lip, G. Y. H. (2005). Biomarkers in atrial fibrillation: further observations on biologic plausibility, cause and effect.. Journal of thrombosis and thrombolysis, 20(3), 189-190. doi:10.1007/s11239-005-3597-2
Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
Tan, K. T., Tayebjee, M. H., Lim, H. S., & Lip, G. Y. H. (2005). Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.. Diabetic medicine : a journal of the British Diabetic Association, 22(12), 1657-1662. doi:10.1111/j.1464-5491.2005.01707.x
How far can population epidemiology contribute to defining the relationship between hypertension and left ventricular systolic dysfunction?
MacFadyen, R. J., Goyal, D., & Lip, G. Y. H. (2005). How far can population epidemiology contribute to defining the relationship between hypertension and left ventricular systolic dysfunction?. Journal of human hypertension, 19(12), 919-922. doi:10.1038/sj.jhh.1001927
Serum adiponectin in coronary heart disease: ethnic differences and relation to coronary artery disease severity.
Lim, H. S., Tayebjee, M. H., Tan, K. T., Patel, J. V., Macfadyen, R. J., & Lip, G. Y. H. (2005). Serum adiponectin in coronary heart disease: ethnic differences and relation to coronary artery disease severity.. Heart (British Cardiac Society), 91(12), 1605-1606. doi:10.1136/hrt.2004.047803
The assessment of platelet activation in antiplatelet drug development.
Tan, K. T., & Lip, G. Y. H. (2005). The assessment of platelet activation in antiplatelet drug development.. Current medicinal chemistry, 12(26), 3117-3125. doi:10.2174/092986705774933399
The prothrombotic risk of diabetes mellitus in atrial fibrillation and heart failure.
Varughese, G. I., Patel, J. V., Tomson, J., & Lip, G. Y. H. (2005). The prothrombotic risk of diabetes mellitus in atrial fibrillation and heart failure.. Journal of thrombosis and haemostasis : JTH, 3(12), 2811-2813. doi:10.1111/j.1538-7836.2005.01694.x
What role do extracellular matrix changes contribute to the cardiovascular disease burden of diabetes mellitus?
Tayebjee, M. H., Lip, G. Y. H., & MacFadyen, R. J. (2005). What role do extracellular matrix changes contribute to the cardiovascular disease burden of diabetes mellitus?. Diabetic medicine : a journal of the British Diabetic Association, 22(12), 1628-1635. doi:10.1111/j.1464-5491.2005.01675.x
Circulating endothelial cells: markers of vascular dysfunction.
Goon, P. K. Y., Boos, C. J., & Lip, G. Y. H. (2005). Circulating endothelial cells: markers of vascular dysfunction.. Clinical laboratory, 51(9-10), 531-538.
Antihypertensive therapy in diabetes mellitus: insights from ALLHAT and the Blood Pressure-Lowering Treatment Trialists' Collaboration meta-analysis.
Varughese, G. I., & Lip, G. Y. H. (2005). Antihypertensive therapy in diabetes mellitus: insights from ALLHAT and the Blood Pressure-Lowering Treatment Trialists' Collaboration meta-analysis.. Journal of human hypertension, 19(11), 851-853. doi:10.1038/sj.jhh.1001926
Endothelial function and its assessment.
Felmeden, D. C., & Lip, G. Y. H. (2005). Endothelial function and its assessment.. Expert opinion on investigational drugs, 14(11), 1319-1336. doi:10.1517/13543784.14.11.1319
Ethnic differences in arterial responses, inflammation, and metabolic profiles: possible insights into ethnic differences in cardiovascular disease and stroke.
Lip, G. Y. H., & Boos, C. J. (2005). Ethnic differences in arterial responses, inflammation, and metabolic profiles: possible insights into ethnic differences in cardiovascular disease and stroke.. Arteriosclerosis, thrombosis, and vascular biology, 25(11), 2240-2242. doi:10.1161/01.atv.0000188507.89134.ef
Incremental shuttle walking is associated with activation of haemostatic and haemorheological markers in patients with coronary artery disease: the Birmingham rehabilitation uptake maximization study (BRUM).
Lee, K. W., Blann, A. D., Ingram, J., Jolly, K., Lip, G. Y. H., & BRUM Investigators. (2005). Incremental shuttle walking is associated with activation of haemostatic and haemorheological markers in patients with coronary artery disease: the Birmingham rehabilitation uptake maximization study (BRUM).. Heart (British Cardiac Society), 91(11), 1413-1417. doi:10.1136/hrt.2004.050005
Plasma markers of angiogenesis in pregnancy induced hypertension.
Nadar, S. K., Karalis, I., Al Yemeni, E., Blann, A. D., & Lip, G. Y. H. (2005). Plasma markers of angiogenesis in pregnancy induced hypertension.. Thrombosis and haemostasis, 94(5), 1071-1076. doi:10.1160/th05-03-0167
Plasma markers of endothelial damage/dysfunction, inflammation and thrombogenesis in relation to TIMI risk stratification in acute coronary syndromes.
Lee, K. W., Blann, A. D., & Lip, G. Y. H. (2005). Plasma markers of endothelial damage/dysfunction, inflammation and thrombogenesis in relation to TIMI risk stratification in acute coronary syndromes.. Thrombosis and haemostasis, 94(5), 1077-1083. doi:10.1160/th05-03-0179
Targeting the renin-angiotensin-aldosterone system in atrial fibrillation: from pathophysiology to clinical trials.
Boos, C. J., & Lip, G. Y. H. (2005). Targeting the renin-angiotensin-aldosterone system in atrial fibrillation: from pathophysiology to clinical trials.. Journal of human hypertension, 19(11), 855-859. doi:10.1038/sj.jhh.1001933
Rheumatoid disease and ischaemic heart disease: insights from pathophysiology and vascular biology.
Bhatia, G. S., Sosin, M. D., Khattak, F. H., Davis, R. C., & Lip, G. Y. H. (2005). Rheumatoid disease and ischaemic heart disease: insights from pathophysiology and vascular biology.. International journal of cardiology, 105(1), 1-10. doi:10.1016/j.ijcard.2004.12.064
Angiogenic factors in atrial fibrillation: a possible role in thrombogenesis?
Freestone, B., Chong, A. Y., Lim, H. S., Blann, A., & Lip, G. Y. H. (2005). Angiogenic factors in atrial fibrillation: a possible role in thrombogenesis?. Annals of medicine, 37(5), 365-372. doi:10.1080/07853890510037392
Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
Nadar, S. K., Blann, A., Beevers, D. G., & Lip, G. Y. H. (2005). Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].. Journal of internal medicine, 258(4), 336-343. doi:10.1111/j.1365-2796.2005.01550.x
Circulating endothelial cells in acute ischaemic stroke.
Nadar, S. K., Lip, G. Y. H., Lee, K. W., & Blann, A. D. (2005). Circulating endothelial cells in acute ischaemic stroke.. Thrombosis and haemostasis, 94(4), 707-712. doi:10.1160/th04-12-0795
Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease.
Freestone, B., Lip, G. Y. H., Chong, A. Y., Nadar, S., Lee, K. W., & Blann, A. D. (2005). Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease.. Thrombosis and haemostasis, 94(4), 702-706. doi:10.1160/th05-02-0093
Impaired tissue Doppler diastolic function in patients with coronary artery disease: relationship to endothelial damage/dysfunction and platelet activation.
Lee, K. W., Blann, A. D., & Lip, G. Y. H. (2005). Impaired tissue Doppler diastolic function in patients with coronary artery disease: relationship to endothelial damage/dysfunction and platelet activation.. American heart journal, 150(4), 756-766. doi:10.1016/j.ahj.2004.11.019
Is there an association between hypertension and the development of coronary collateral flow?
Tayebjee, M. H., Lip, G. Y. H., & Macfadyen, R. J. (2005). Is there an association between hypertension and the development of coronary collateral flow?. Journal of human hypertension, 19(10), 757-759. doi:10.1038/sj.jhh.1001906
Targeting the renin-angiotensin-aldosterone-system in atrial fibrillation: a shift from electrical to structural therapy?
Choudhury, A., Varughese, G. I., & Lip, G. Y. H. (2005). Targeting the renin-angiotensin-aldosterone-system in atrial fibrillation: a shift from electrical to structural therapy?. Expert opinion on pharmacotherapy, 6(13), 2193-2207. doi:10.1517/14656566.6.13.2193
Preventing stroke in atrial fibrillation: the SPORTIF programme.
Lip, G. Y. H. (2005). Preventing stroke in atrial fibrillation: the SPORTIF programme.. Pathophysiology of haemostasis and thrombosis, 34 Suppl 1, 25-30. doi:10.1159/000083081
Aspirin and endothelial function in hypertension.
Felmeden, D., Nadar, S. K., & Lip, G. Y. H. (2005). Aspirin and endothelial function in hypertension.. Journal of human hypertension, 19(9), 663-665. doi:10.1038/sj.jhh.1001880
Elevated platelet microparticles in stable coronary artery disease are unrelated to disease severity or to indices of inflammation.
Tan, K. T., Tayebjee, M. H., Macfadyen, R. J., Lip, G. Y. H., & Blann, A. D. (2005). Elevated platelet microparticles in stable coronary artery disease are unrelated to disease severity or to indices of inflammation.. Platelets, 16(6), 368-371. doi:10.1080/00207230500120401
Percutaneous coronary interventions for coronary artery disease: the long and short of optimizing medical therapy.
Jaumdally, R., Lip, G. Y. H., & Varma, C. (2005). Percutaneous coronary interventions for coronary artery disease: the long and short of optimizing medical therapy.. International journal of clinical practice, 59(9), 1070-1081. doi:10.1111/j.1742-1241.2005.00608.x
Platelet activation in pregnancy-induced hypertension.
Karalis, I., Nadar, S. K., Al Yemeni, E., Blann, A. D., & Lip, G. Y. H. (2005). Platelet activation in pregnancy-induced hypertension.. Thrombosis research, 116(5), 377-383. doi:10.1016/j.thromres.2005.01.009
The potential role of platelet microparticles in atherosclerosis.
Tan, K. T., & Lip, G. Y. H. (2005). The potential role of platelet microparticles in atherosclerosis.. Thrombosis and haemostasis, 94(3), 488-492. doi:10.1160/th05-03-0201
Blood pressure changes in acute haemorrhagic stroke.
Tomson, J., & Lip, G. Y. H. (2005). Blood pressure changes in acute haemorrhagic stroke.. Blood pressure monitoring, 10(4), 197-199. doi:10.1097/1.mbp.0000172707.59416.3e
Exercise and hypertension.
Choudhury, A., & Lip, G. Y. H. (2005). Exercise and hypertension.. Journal of human hypertension, 19(8), 585-587. doi:10.1038/sj.jhh.1001851
Interleukin-15 in hypertension: further insights into inflammation and vascular disease.
Lim, H. S., & Lip, G. Y. H. (2005). Interleukin-15 in hypertension: further insights into inflammation and vascular disease.. American journal of hypertension, 18(8), 1017-1018. doi:10.1016/j.amjhyper.2005.03.742
Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease.
Tayebjee, M. H., Lip, G. Y. H., Tan, K. T., Patel, J. V., Hughes, E. A., & MacFadyen, R. J. (2005). Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease.. The American journal of cardiology, 96(3), 339-345. doi:10.1016/j.amjcard.2005.03.072
The role of inflammation in atrial fibrillation.
Boos, C. J., & Lip, G. Y. H. (2005). The role of inflammation in atrial fibrillation.. International journal of clinical practice, 59(8), 870-872. doi:10.1111/j.1368-5031.2005.0599b.x
Ximelagatran in the clinic: practical management of patients.
Schulman, S., & Lip, G. Y. H. (2005). Ximelagatran in the clinic: practical management of patients.. Seminars in vascular medicine, 5(3), 301-307. doi:10.1055/s-2005-916170
Ximelagatran: a clinical perspective.
Boos, C. J., Hinton, A., & Lip, G. Y. H. (2005). Ximelagatran: a clinical perspective.. In European journal of internal medicine Vol. 16 (pp. 267-278). doi:10.1016/j.ejim.2005.02.005
Antiplatelet and anticoagulant therapy in patients with advanced heart failure.
Lip, G. Y. H., & Chung, I. (2005). Antiplatelet and anticoagulant therapy in patients with advanced heart failure.. Thrombosis research, 116(4), 275-277. doi:10.1016/j.thromres.2004.12.022
Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillation.
Roldán, V., Marín, F., García-Herola, A., & Lip, G. Y. H. (2005). Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillation.. Thrombosis research, 116(4), 321-325. doi:10.1016/j.thromres.2005.01.005
Relation of platelet activation to coronary angiographic severity and collateralization.
Tan, K. T., Tayebjee, M. H., Macfadyen, R. J., & Lip, G. Y. H. (2005). Relation of platelet activation to coronary angiographic severity and collateralization.. The American journal of cardiology, 96(2), 208-210. doi:10.1016/j.amjcard.2005.03.045
Elevated high-sensitive C-reactive protein, large arterial stiffness and atherosclerosis: a relationship between inflammation and hypertension?
Boos, C. J., & Lip, G. Y. H. (2005). Elevated high-sensitive C-reactive protein, large arterial stiffness and atherosclerosis: a relationship between inflammation and hypertension?. Journal of human hypertension, 19(7), 511-513. doi:10.1038/sj.jhh.1001858
The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment.
Mohan, J. S., Lip, P. L., Blann, A. D., Bareford, D., & Lip, G. Y. H. (2005). The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment.. The British journal of ophthalmology, 89(7), 815-819. doi:10.1136/bjo.2004.058164
Type 2 diabetes mellitus: a cardiovascular perspective.
Varughese, G. I., Tomson, J., & Lip, G. Y. H. (2005). Type 2 diabetes mellitus: a cardiovascular perspective.. International journal of clinical practice, 59(7), 798-816. doi:10.1111/j.1368-5031.2005.00571.x
Ximelagatran for stroke prevention in atrial fibrillation.
Boos, C. J., & Lip, G. Y. H. (2005). Ximelagatran for stroke prevention in atrial fibrillation.. Expert review of cardiovascular therapy, 3(4), 551-563. doi:10.1586/14779072.3.4.551
Peripheral arterial disease: a high risk - but neglected - disease population.
Tomson, J., & Lip, G. Y. H. (2005). Peripheral arterial disease: a high risk - but neglected - disease population.. BMC cardiovascular disorders, 5(1), 15. doi:10.1186/1471-2261-5-15
Effects of antiplatelet therapy and oral anticoagulation on indices of endothelial damage/dysfunction in patients with systolic heart failure in sinus rhythm.
Chong, A. Y., Chin, B. S. P., Blann, A. D., & Lip, G. Y. H. (2005). Effects of antiplatelet therapy and oral anticoagulation on indices of endothelial damage/dysfunction in patients with systolic heart failure in sinus rhythm.. Thrombosis research, 116(2), 181-183. doi:10.1016/j.thromres.2004.11.023
Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation.
Lip, G. Y. H., Pearce, L. A., Chin, B. S. P., Conway, D. S. G., & Hart, R. G. (2005). Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation.. Heart (British Cardiac Society), 91(6), 759-763. doi:10.1136/hrt.2004.036160
Effects of short-term glucocorticoids on cardiovascular biomarkers.
Brotman, D. J., Girod, J. P., Garcia, M. J., Patel, J. V., Gupta, M., Posch, A., . . . Reddy, S. (2005). Effects of short-term glucocorticoids on cardiovascular biomarkers.. The Journal of clinical endocrinology and metabolism, 90(6), 3202-3208. doi:10.1210/jc.2004-2379
Hypertension in patients with type-II diabetes: relation to urinary albumin excretion, endothelial function and inflammation.
Varughese, G. I., & Lip, G. Y. H. (2005). Hypertension in patients with type-II diabetes: relation to urinary albumin excretion, endothelial function and inflammation.. Journal of human hypertension, 19(6), 421-424. doi:10.1038/sj.jhh.1001833
Stroke prevention in atrial fibrillation: the case for ximelagatran
Lip, G. Y. H. (2005). Stroke prevention in atrial fibrillation: the case for ximelagatran. European Heart Journal Supplements, 7(suppl_E), E21-E25. doi:10.1093/eurheartj/sui032
Heterotopic heart transplantation.
Tayebjee, M. H., & Lip, G. Y. H. (2005). Heterotopic heart transplantation.. International journal of cardiology, 101(2), 311-312. doi:10.1016/j.ijcard.2004.01.024
Recruitment of ethnic minority patients to a cardiac rehabilitation trial: the Birmingham Rehabilitation Uptake Maximisation (BRUM) study [ISRCTN72884263].
Jolly, K., Lip, G. Y., Taylor, R. S., Mant, J. W., Lane, D. A., Lee, K. W., . . . BRUM Steering Committee. (2005). Recruitment of ethnic minority patients to a cardiac rehabilitation trial: the Birmingham Rehabilitation Uptake Maximisation (BRUM) study [ISRCTN72884263].. BMC medical research methodology, 5, 18. doi:10.1186/1471-2288-5-18
Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension.
Lim, H. S., Lip, G. Y. H., Beevers, D. G., & Blann, A. D. (2005). Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension.. European journal of clinical investigation, 35(5), 324-329. doi:10.1111/j.1365-2362.2005.01495.x
Short-term adjuvant atorvastatin improves frequency domain indices of heart rate variability in stable systolic heart failure.
Hamaad, A., Sosin, M., Lip, G. Y. H., & MacFadyen, R. J. (2005). Short-term adjuvant atorvastatin improves frequency domain indices of heart rate variability in stable systolic heart failure.. Cardiovascular drugs and therapy, 19(3), 183-187. doi:10.1007/s10557-005-2219-8
Vascular endothelial growth factor and angiogenesis in heart failure.
Lip, G. Y. H., & Chung, I. (2005). Vascular endothelial growth factor and angiogenesis in heart failure.. Journal of cardiac failure, 11(4), 285-287. doi:10.1016/j.cardfail.2005.02.002
Soluble vascular endothelial growth factor, soluble VEGF receptor Flt-1 and endothelial function in healthy smokers.
Schmidt-Lucke, C., Belgore, F., Reinhold, D., Ansorge, S., Klein, H. U., Schmidt-Lucke, J. A., & Lip, G. Y. H. (2005). Soluble vascular endothelial growth factor, soluble VEGF receptor Flt-1 and endothelial function in healthy smokers.. International journal of cardiology, 100(2), 207-212. doi:10.1016/j.ijcard.2004.05.046
Hormone replacement therapy and arterial blood pressure in postmenopausal women with hypertension.
Karalis, I., Beevers, G., Beevers, M., & Lip, G. (2005). Hormone replacement therapy and arterial blood pressure in postmenopausal women with hypertension.. Blood pressure, 14(1), 38-44. doi:10.1080/08037050510008788
Hormone replacement use and cardiovascular function and structure in postmenopausal women.
Tomson, J., Os, I., & Lip, G. Y. H. (2005). Hormone replacement use and cardiovascular function and structure in postmenopausal women.. Blood pressure, 14(1), 3-5. doi:10.1080/08037050510008841
Are there ethnic differences in the circadian variation in onset of acute myocardial infarction? A comparison of 3 ethnic groups in Birmingham, UK and Alicante, Spain.
López, F., Lee, K. W., Marín, F., Roldán, V., Sogorb, F., Caturla, J., & Lip, G. Y. H. (2005). Are there ethnic differences in the circadian variation in onset of acute myocardial infarction? A comparison of 3 ethnic groups in Birmingham, UK and Alicante, Spain.. International journal of cardiology, 100(1), 151-154. doi:10.1016/j.ijcard.2004.12.002
Comparison of brain natriuretic peptide and left ventricular diastolic function determined by tissue Doppler in patients with diabetes mellitus, patients with hypertension without diabetes, and in healthy subjects.
Lim, H. S., Patel, J. V., Nadar, S., Hughes, E. A., & Lip, G. Y. H. (2005). Comparison of brain natriuretic peptide and left ventricular diastolic function determined by tissue Doppler in patients with diabetes mellitus, patients with hypertension without diabetes, and in healthy subjects.. The American journal of cardiology, 95(7), 905-908. doi:10.1016/j.amjcard.2004.12.024
Depression, indirect clinical markers of cardiac disease
Lane, D., Ring, C., Lip, G. Y. H., & Carroll, D. (2005). Depression, indirect clinical markers of cardiac disease. HEART, 91(4), 531-532. doi:10.1136/hrt.2004.036392
How good is anticoagulation control in non-valvar atrial fibrillation? Observations on the elderly, ethnicity, patient perceptions, and understanding of AF thromboprophylaxis.
Choudhury, A., & Lip, G. Y. H. (2005). How good is anticoagulation control in non-valvar atrial fibrillation? Observations on the elderly, ethnicity, patient perceptions, and understanding of AF thromboprophylaxis.. Heart (British Cardiac Society), 91(4), 425-426. doi:10.1136/hrt.2004.052480
Matrix metalloproteinases in coronary artery disease: clinical and therapeutic implications and pathological significance.
Tayebjee, M. H., Lip, G. Y. H., & MacFadyen, R. J. (2005). Matrix metalloproteinases in coronary artery disease: clinical and therapeutic implications and pathological significance.. Current medicinal chemistry, 12(8), 917-925. doi:10.2174/0929867053507270
Plasma von Willebrand factor levels and surrogates of atherosclerosis.
Lip, G. Y. H., Foster, W., & Blann, A. D. (2005). Plasma von Willebrand factor levels and surrogates of atherosclerosis.. Journal of thrombosis and haemostasis : JTH, 3(4), 659-661. doi:10.1111/j.1538-7836.2005.01284.x
Relation of interleukin-6 levels and prothrombin fragment 1+2 to a point-based score for stroke risk in atrial fibrillation.
Roldán, V., Marín, F., Martínez, J. G., García-Herola, A., Sogorb, F., & Lip, G. Y. H. (2005). Relation of interleukin-6 levels and prothrombin fragment 1+2 to a point-based score for stroke risk in atrial fibrillation.. The American journal of cardiology, 95(7), 881-882. doi:10.1016/j.amjcard.2004.12.016
Statins in women: Is primary prevention beneficial?
Varughese, G. I., & Lip, G. Y. H. (2005). Statins in women: Is primary prevention beneficial?. Evidence-based Healthcare and Public Health, 9(2), 91-92. doi:10.1016/j.ehbc.2005.01.032
Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers.
Tan, K. T., Tayebjee, M. H., Lynd, C., Blann, A. D., & Lip, G. Y. H. (2005). Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers.. Annals of medicine, 37(1), 61-66. doi:10.1080/07853890410018943
Positive pressure ventilation in the management of acute and chronic cardiac failure: a systematic review and meta-analysis.
Nadar, S., Prasad, N., Taylor, R. S., & Lip, G. Y. H. (2005). Positive pressure ventilation in the management of acute and chronic cardiac failure: a systematic review and meta-analysis.. International journal of cardiology, 99(2), 171-185. doi:10.1016/j.ijcard.2004.03.047
Atrial fibrillation, the prothrombotic state, inflammation, and gender.
Conway, D. S. G., & Lip, G. Y. H. (2005). Atrial fibrillation, the prothrombotic state, inflammation, and gender.. The American journal of cardiology, 95(6), 819. doi:10.1016/j.amjcard.2004.11.017
Analysis of combination anti-angiogenesis therapy on markers of coagulation, platelet activation and angiogenesis in patients with advanced cancer.
Caine, G. J., Harris, A. L., Christodoulos, K., Lip, G. Y. H., & Blann, A. D. (2005). Analysis of combination anti-angiogenesis therapy on markers of coagulation, platelet activation and angiogenesis in patients with advanced cancer.. Cancer letters, 219(2), 163-167. doi:10.1016/j.canlet.2004.09.036
Ambulatory blood pressure monitoring in heart failure: a systematic review.
Goyal, D., Macfadyen, R. J., Watson, R. D., & Lip, G. Y. H. (2005). Ambulatory blood pressure monitoring in heart failure: a systematic review.. European journal of heart failure, 7(2), 149-156. doi:10.1016/j.ejheart.2004.05.010
Antithrombotic therapy in hypertension: a Cochrane Systematic review.
Felmeden, D. C., & Lip, G. Y. H. (2005). Antithrombotic therapy in hypertension: a Cochrane Systematic review.. Journal of human hypertension, 19(3), 185-196. doi:10.1038/sj.jhh.1001807
Goodbye mercury? Blood pressure measurement and its future.
Varughese, G. I., & Lip, G. Y. H. (2005). Goodbye mercury? Blood pressure measurement and its future.. Journal of the Royal Society of Medicine, 98(3), 89-90. doi:10.1177/014107680509800301
Soluble CD40L in peripheral artery disease. Relationship with disease severity, platelet markers and the effects of angioplasty.
Blann, A. D., Tan, K. T., Tayebjee, M. H., Davagnanam, I., Moss, M., & Lip, G. Y. H. (2005). Soluble CD40L in peripheral artery disease. Relationship with disease severity, platelet markers and the effects of angioplasty.. Thrombosis and haemostasis, 93(3), 578-583. doi:10.1160/th04-09-0586
The effect of multi-factorial intervention on plasma von Willebrand factor, soluble E-selectin and tissue factor in diabetes mellitus: implications for atherosclerotic vascular disease.
Lim, H. S., Chong, A. Y., Freestone, B., Blann, A. D., & Lip, G. Y. H. (2005). The effect of multi-factorial intervention on plasma von Willebrand factor, soluble E-selectin and tissue factor in diabetes mellitus: implications for atherosclerotic vascular disease.. Diabetic medicine : a journal of the British Diabetic Association, 22(3), 249-255. doi:10.1111/j.1464-5491.2004.01388.x
Exercise and the prothrombotic state: a paradox of cardiovascular prevention or an enhanced prothrombotic state?
Thrall, G., & Lip, G. Y. H. (2005). Exercise and the prothrombotic state: a paradox of cardiovascular prevention or an enhanced prothrombotic state?. Arteriosclerosis, thrombosis, and vascular biology, 25(2), 265-266. doi:10.1161/01.atv.0000154579.11213.da
Fondaparinux.
Tan, K. T., & Lip, G. Y. H. (2005). Fondaparinux.. Current pharmaceutical design, 11(4), 415-419. doi:10.2174/1381612053382089
Recent developments in atrial fibrillation.
Iqbal, M. B., Taneja, A. K., Lip, G. Y. H., & Flather, M. (2005). Recent developments in atrial fibrillation.. BMJ (Clinical research ed.), 330(7485), 238-243. doi:10.1136/bmj.330.7485.238
Psychological interventions for depression in heart failure.
Lane, D. A., Chong, A. Y., & Lip, G. Y. H. (2005). Psychological interventions for depression in heart failure.. The Cochrane database of systematic reviews, (1), CD003329. doi:10.1002/14651858.cd003329.pub2
Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes.
Lee, K. W., Lip, G. Y. H., Tayebjee, M., Foster, W., & Blann, A. D. (2005). Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes.. Blood, 105(2), 526-532. doi:10.1182/blood-2004-03-1106
Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2.
Tayebjee, M. H., Lip, G. Y. H., Blann, A. D., & Macfadyen, R. J. (2005). Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2.. Thrombosis research, 115(3), 205-210. doi:10.1016/j.thromres.2004.08.023
Haemoconcentration and the hypercoagulable state associated with mental stress.
Thrall, G., & Lip, G. Y. H. (2005). Haemoconcentration and the hypercoagulable state associated with mental stress.. Thrombosis research, 115(3), 171-173. doi:10.1016/j.thromres.2004.08.021
Blood pressure demographics: nature or nurture ... ... genes or environment?
Tomson, J., & Lip, G. Y. H. (2005). Blood pressure demographics: nature or nurture ... ... genes or environment?. BMC medicine, 3, 3. doi:10.1186/1741-7015-3-3
A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.
Marín, F., González-Conejero, R., Lee, K. W., Corral, J., Roldán, V., López, F., . . . Vicente, V. (2005). A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.. Journal of the American College of Cardiology, 45(1), 25-29. doi:10.1016/j.jacc.2004.09.051
A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.
Hobbs, F. D. R., Fitzmaurice, D. A., Mant, J., Murray, E., Jowett, S., Bryan, S., . . . Lip, G. (2005). A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.. Health technology assessment (Winchester, England), 9(40), iii-74. doi:10.3310/hta9400
Abnormal circulating levels of metalloprotease 9 and its tissue inhibitor 1 in angiographically proven peripheral arterial disease: relationship to disease severity.
Tayebjee, M. H., Tan, K. T., MacFadyen, R. J., & Lip, G. Y. H. (2005). Abnormal circulating levels of metalloprotease 9 and its tissue inhibitor 1 in angiographically proven peripheral arterial disease: relationship to disease severity.. Journal of internal medicine, 257(1), 110-116. doi:10.1111/j.1365-2796.2004.01431.x
Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis.
Lim, H. S., Lip, G. Y. H., & Blann, A. D. (2005). Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis.. Atherosclerosis, 180(1), 113-118. doi:10.1016/j.atherosclerosis.2004.11.004
Angiotensin II-mediated vascular inflammation: the balance between vascular endothelial growth factor and angiopoietins.
Lim, H. S., Felmeden, D., & Lip, G. Y. H. (2005). Angiotensin II-mediated vascular inflammation: the balance between vascular endothelial growth factor and angiopoietins.. Hypertension (Dallas, Tex. : 1979), 45(2), e3. doi:10.1161/01.hyp.0000151886.26341.4b
Anti-thrombotic therapy for atrial fibrillation and patients' preferences for treatment.
Lane, D., & Lip, G. Y. H. (2005). Anti-thrombotic therapy for atrial fibrillation and patients' preferences for treatment.. Age and ageing, 34(1), 1-3. doi:10.1093/ageing/afi008
Anticoagulation as thromboprophylaxis for atrial fibrillation: implications in the 'real world' and the need for risk stratification
Lane, D. A., & Lip, G. Y. H. (2005). Anticoagulation as thromboprophylaxis for atrial fibrillation: implications in the 'real world' and the need for risk stratification. BLOOD COAGULATION & FIBRINOLYSIS, 16(7), 461-464. doi:10.1097/01.mbc.0000184739.35347.13
Atrial fibrillation (recent onset).
Lip, G. Y. H. (2005). Atrial fibrillation (recent onset).. Clinical evidence, (14), 71-89.
Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension.
Tayebjee, M. H., Karalis, I., Nadar, S. K., Beevers, D. G., MacFadyen, R. J., & Lip, G. Y. H. (2005). Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension.. American journal of hypertension, 18(3), 325-329. doi:10.1016/j.amjhyper.2004.09.014
Echocardiographic changes in patients with malignant phase hypertension: the West Birmingham Malignant Hypertension Register.
Nadar, S., Beevers, D. G., & Lip, G. Y. H. (2005). Echocardiographic changes in patients with malignant phase hypertension: the West Birmingham Malignant Hypertension Register.. Journal of human hypertension, 19(1), 69-75. doi:10.1038/sj.jhh.1001773
Ethnic differences in cardiovascular and all-cause mortality in Birmingham, England: the Birmingham Factory Screening Project
Lane, D. A., Lip, G. Y. H., & Beevers, D. G. (2005). Ethnic differences in cardiovascular and all-cause mortality in Birmingham, England: the Birmingham Factory Screening Project. JOURNAL OF HYPERTENSION, 23(7), 1347-1353. doi:10.1097/01.hjh.0000173516.60610.b5
Hibernating myocardium in heart failure.
Bhatia, G., Sosin, M., Leahy, J. F., Connolly, D. L., Davis, R. C., & Lip, G. Y. H. (2005). Hibernating myocardium in heart failure.. Expert review of cardiovascular therapy, 3(1), 111-122. doi:10.1586/14779072.3.1.111
High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction.
Lee, K. W., Blann, A. D., & Lip, G. Y. H. (2005). High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction.. American journal of hypertension, 18(1), 104-115. doi:10.1016/j.amjhyper.2004.09.003
Is hypertension a prothrombotic state?
Varughese, G. I., & Lip, G. Y. H. (2005). Is hypertension a prothrombotic state?. Current hypertension reports, 7(3), 168-173. doi:10.1007/s11906-005-0005-4
Markers of inflammation in acute coronary syndromes: association with increased heart rate and reductions in heart rate variability.
Hamaad, A., Sosin, M., Blann, A. D., Patel, J., Lip, G. Y. H., & MacFadyen, R. J. (2005). Markers of inflammation in acute coronary syndromes: association with increased heart rate and reductions in heart rate variability.. Clinical cardiology, 28(12), 570-576. doi:10.1002/clc.4960281207
Plasma levels of tissue factor and soluble E-selectin in sickle cell disease: relationship to genotype and to inflammation.
Mohan, J. S., Lip, G. Y., Wright, J., Bareford, D., & Blann, A. D. (2005). Plasma levels of tissue factor and soluble E-selectin in sickle cell disease: relationship to genotype and to inflammation.. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 16(3), 209-214. doi:10.1097/01.mbc.0000164431.98169.8f
Platelet adhesion in hypertension: application of a novel assay of platelet adhesion.
Nadar, S. K., Caine, G. J., Blann, A. D., & Lip, G. Y. H. (2005). Platelet adhesion in hypertension: application of a novel assay of platelet adhesion.. Annals of medicine, 37(1), 55-60. doi:10.1080/07853890410018916-1
Rheumatoid disease and the heart: from epidemiology to echocardiography.
Bhatia, G. S., Sosin, M. D., Grindulis, K. A., Davis, R. C., & Lip, G. Y. H. (2005). Rheumatoid disease and the heart: from epidemiology to echocardiography.. Expert opinion on investigational drugs, 14(1), 65-76. doi:10.1517/13543784.14.1.65
Stroke prevention.
Lip, G. H., Rothwell, P., & Sudlow, C. (2005). Stroke prevention.. Clinical evidence, (14), 173-197.
Thrombotic complications and thromboprophylaxis in breast and gynaecological malignancies.
Goyal, D., Choudhury, A., & Lip, G. Y. H. (2005). Thrombotic complications and thromboprophylaxis in breast and gynaecological malignancies.. Current opinion in obstetrics & gynecology, 17(1), 13-20. doi:10.1097/00001703-200502000-00004
Tissue inhibitor of metalloproteinse-1 is a marker of diastolic dysfunction using tissue doppler in patients with type 2 diabetes and hypertension.
Tayebjee, M. H., Lim, H. S., Nadar, S., MacFadyen, R. J., & Lip, G. Y. H. (2005). Tissue inhibitor of metalloproteinse-1 is a marker of diastolic dysfunction using tissue doppler in patients with type 2 diabetes and hypertension.. European journal of clinical investigation, 35(1), 8-12. doi:10.1111/j.1365-2362.2005.01438.x
2004
Heart failure--the importance of ethnicity.
Sosin, M. D., Bhatia, G. S., Davis, R. C., & Lip, G. Y. H. (2004). Heart failure--the importance of ethnicity.. European journal of heart failure, 6(7), 831-843. doi:10.1016/j.ejheart.2003.11.019
Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention.
Lim, H. S., Blann, A. D., Chong, A. Y., Freestone, B., & Lip, G. Y. H. (2004). Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention.. Diabetes care, 27(12), 2918-2924. doi:10.2337/diacare.27.12.2918
Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
Lip, P. L., Chatterjee, S., Caine, G. J., Hope-Ross, M., Gibson, J., Blann, A. D., & Lip, G. Y. H. (2004). Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.. The British journal of ophthalmology, 88(12), 1543-1546. doi:10.1136/bjo.2004.048587
Platelet morphology, soluble P selectin and platelet P-selectin in acute ischaemic stroke. The West Birmingham Stroke Project.
Nadar, S. K., Lip, G. Y. H., & Blann, A. D. (2004). Platelet morphology, soluble P selectin and platelet P-selectin in acute ischaemic stroke. The West Birmingham Stroke Project.. Thrombosis and haemostasis, 92(6), 1342-1348. doi:10.1160/th04-07-0433
Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapy.
Nadar, S., Blann, A. D., & Lip, G. Y. H. (2004). Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapy.. Annals of medicine, 36(7), 552-557. doi:10.1080/07853890410017386
Impact of delays to cardiac surgery.
Gubner, R., & Rowe, W. (2004). Impact of delays to cardiac surgery.. Journal of the American College of Cardiology, 44(10), 2094. doi:10.1016/j.jacc.2004.08.022
Pushing the envelope too far?
Connolly, D. L., Lip, G. Y. H., & Lo, T. S. N. (2004). Pushing the envelope too far?. Journal of the American College of Cardiology, 44(10), 2094-2095. doi:10.1016/j.jacc.2004.08.021
Antihypertensive therapy and endothelial function.
Nadar, S., Blann, A. D., & Lip, G. Y. H. (2004). Antihypertensive therapy and endothelial function.. Current pharmaceutical design, 10(29), 3607-3614. doi:10.2174/1381612043382800
Drug development and the importance of ethnicity: lessons from heart failure management and implications for hypertension.
Sosin, M. D., Bhatia, G. S., Lip, G. Y. H., & Davis, R. C. (2004). Drug development and the importance of ethnicity: lessons from heart failure management and implications for hypertension.. Current pharmaceutical design, 10(29), 3569-3577. doi:10.2174/1381612043382783
Endothelial dysfunction: methods of assessment and application to hypertension.
Nadar, S., Blann, A. D., & Lip, G. Y. H. (2004). Endothelial dysfunction: methods of assessment and application to hypertension.. Current pharmaceutical design, 10(29), 3591-3605. doi:10.2174/1381612043382765
Plasma von Willebrand factor and the development of the metabolic syndrome in patients with hypertension.
Lim, H. S., Lip, G. Y. H., & Blann, A. D. (2004). Plasma von Willebrand factor and the development of the metabolic syndrome in patients with hypertension.. The Journal of clinical endocrinology and metabolism, 89(11), 5377-5381. doi:10.1210/jc.2004-0616
Preface
Lip, G. Y. H. (2004). Preface. Current Pharmaceutical Design, 10(29).
Ximelagatran: The future in anticoagulation practice? (Multiple letters) [1]
Murin, R. J. A., Hamaad, A., Tayebjee, M. H., & Lip, G. Y. H. (2004). Ximelagatran: The future in anticoagulation practice? (Multiple letters) [1]. British Journal of Cardiology, 11(6), 447-448.
Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes.
Lee, K. W., Lip, G. Y. H., & Blann, A. D. (2004). Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes.. Circulation, 110(16), 2355-2360. doi:10.1161/01.cir.0000138112.90641.7f
Heart rate variability estimates of autonomic tone: relationship to mapping pathological and procedural stress responses in coronary disease.
Hamaad, A., Lip, G. Y. H., & MacFadyen, R. J. (2004). Heart rate variability estimates of autonomic tone: relationship to mapping pathological and procedural stress responses in coronary disease.. Annals of medicine, 36(6), 448-461. doi:10.1080/07853890410015810
Acute coronary syndromes presenting solely with heart failure symptoms: are they under recognised?
Hamaad, A., Lip, G. Y. H., & MacFadyen, R. J. (2004). Acute coronary syndromes presenting solely with heart failure symptoms: are they under recognised?. European journal of heart failure, 6(6), 683-686. doi:10.1016/j.ejheart.2004.02.009
Genetic polymorphisms and thromoembolic risk in atrial fibrillation.
Marín, F., Roldán, V., Tello, A., & Lip, G. Y. H. (2004). Genetic polymorphisms and thromoembolic risk in atrial fibrillation.. Journal of thrombosis and thrombolysis, 18(2), 151-152. doi:10.1007/s11239-004-0211-y
Inflammation, arrhythmia burden and the thrombotic consequences of atrial fibrillation.
Conway, D. S. G., & Lip, G. Y. H. (2004). Inflammation, arrhythmia burden and the thrombotic consequences of atrial fibrillation.. European heart journal, 25(19), 1761. doi:10.1016/j.ehj.2004.08.001
Plasma and platelet-derived vascular endothelial growth factor and angiopoietin-1 in hypertension: effects of antihypertensive therapy.
Nadar, S. K., Blann, A. D., & Lip, G. Y. H. (2004). Plasma and platelet-derived vascular endothelial growth factor and angiopoietin-1 in hypertension: effects of antihypertensive therapy.. Journal of internal medicine, 256(4), 331-337. doi:10.1111/j.1365-2796.2004.01367.x
Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation.
Marín, F., Roldán, V., Climent, V. E., Ibáñez, A., García, A., Marco, P., . . . Lip, G. Y. H. (2004). Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation.. Heart (British Cardiac Society), 90(10), 1162-1166. doi:10.1136/hrt.2003.024521
Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide.
Chong, A. Y., Blann, A. D., Patel, J., Freestone, B., Hughes, E., & Lip, G. Y. H. (2004). Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide.. Circulation, 110(13), 1794-1798. doi:10.1161/01.cir.0000143073.60937.50
Which strategies should be used for the primary and secondary prevention of cardiovascular disease?
Tayebjee, M. H., & Lip, G. Y. H. (2004). Which strategies should be used for the primary and secondary prevention of cardiovascular disease?. Dialogues in Cardiovascular Medicine, 9(2), 93-100.
Diabetes mellitus, the renin-angiotensin-aldosterone system, and the heart.
Lim, H. S., MacFadyen, R. J., & Lip, G. Y. H. (2004). Diabetes mellitus, the renin-angiotensin-aldosterone system, and the heart.. Archives of internal medicine, 164(16), 1737-1748. doi:10.1001/archinte.164.16.1737
Compliance with pharmacological therapy in hypertension: can we do better, and how?
Thrall, G., Lip, G. Y. H., & Lane, D. (2004). Compliance with pharmacological therapy in hypertension: can we do better, and how?. Journal of human hypertension, 18(9), 595-597. doi:10.1038/sj.jhh.1001722
Ethnic differences in left ventricular size and the prevalence of left ventricular hypertrophy among hypertensive patients vary with electrocardiographic criteria.
Spencer, C. G. C., Beevers, D. G., & Lip, G. Y. H. (2004). Ethnic differences in left ventricular size and the prevalence of left ventricular hypertrophy among hypertensive patients vary with electrocardiographic criteria.. Journal of human hypertension, 18(9), 631-636. doi:10.1038/sj.jhh.1001713
Ethnic differences in patient perceptions of heart failure and treatment: the West Birmingham heart failure project.
Lip, G. Y. H., Khan, H., Bhatnagar, A., Brahmabhatt, N., Crook, P., Davies, M. K., & West Birmingham heart failure project. (2004). Ethnic differences in patient perceptions of heart failure and treatment: the West Birmingham heart failure project.. Heart (British Cardiac Society), 90(9), 1016-1019. doi:10.1136/hrt.2003.025742
Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.
Marín, F., Corral, J., Roldán, V., González-Conejero, R., del Rey, M. L., Sogorb, F., . . . Vicente, V. (2004). Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.. Journal of molecular and cellular cardiology, 37(3), 699-704. doi:10.1016/j.yjmcc.2004.06.001
Left ventricular systolic dysfunction and atrial fibrillation in older people in the community: the need for identification, as well as appropriate management.
Choudhury, A., & Lip, G. Y. H. (2004). Left ventricular systolic dysfunction and atrial fibrillation in older people in the community: the need for identification, as well as appropriate management.. Age and ageing, 33(5), 434-436. doi:10.1093/ageing/afh185
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Tayebjee, M. H., Nadar, S., Blann, A. D., Gareth Beevers, D., MacFadyen, R. J., & Lip, G. Y. H. (2004). Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).. American journal of hypertension, 17(9), 764-769. doi:10.1016/j.amjhyper.2004.05.019
New antiarrhythmic agents for atrial fibrillation
Choudhury, A., & Lip, G. Y. H. (2004). New antiarrhythmic agents for atrial fibrillation. Therapy, 1(1), 111-121. doi:10.2217/14750708.1.1.111
Platelet adhesion in breast cancer: development and application of a novel assay.
Caine, G. J., Nadar, S. K., Lip, G. Y. H., Stonelake, P. S., & Blann, A. D. (2004). Platelet adhesion in breast cancer: development and application of a novel assay.. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 15(6), 513-518. doi:10.1097/00001721-200408000-00012
Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation.
Conway, D. S. G., Buggins, P., Hughes, E., & Lip, G. Y. H. (2004). Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation.. American heart journal, 148(3), 462-466. doi:10.1016/j.ahj.2004.01.026
Predictive value of indexes of inflammation and hypercoagulability on success of cardioversion of persistent atrial fibrillation.
Conway, D. S. G., Buggins, P., Hughes, E., & Lip, G. Y. H. (2004). Predictive value of indexes of inflammation and hypercoagulability on success of cardioversion of persistent atrial fibrillation.. The American journal of cardiology, 94(4), 508-510. doi:10.1016/j.amjcard.2004.04.070
Effects of losartan versus hydrochlorothiazide on indices of endothelial damage/dysfunction, angiogenesis and tissue factor in essential hypertension.
Chung, N. A., Beevers, D. G., & Lip, G. (2004). Effects of losartan versus hydrochlorothiazide on indices of endothelial damage/dysfunction, angiogenesis and tissue factor in essential hypertension.. Blood pressure, 13(3), 183-189. doi:10.1080/08037050410033312
An 8-year follow-up study of acute admissions with heart failure in a multiethnic population.
Sosin, M. D., Bhatia, G. S., Zarifis, J., Davis, R. C., & Lip, G. Y. H. (2004). An 8-year follow-up study of acute admissions with heart failure in a multiethnic population.. European journal of heart failure, 6(5), 669-672. doi:10.1016/j.ejheart.2003.11.016
Clinical review: clinical management of atrial fibrillation - rate control versus rhythm control.
Lim, H. S., Hamaad, A., & Lip, G. Y. H. (2004). Clinical review: clinical management of atrial fibrillation - rate control versus rhythm control.. Critical care (London, England), 8(4), 271-279. doi:10.1186/cc2827
Diastolic heart failure: recognition, diagnosis and management.
Goyal, D., Choudhary, A., Lip, G. Y. H., & MacFadyen, R. J. (2004). Diastolic heart failure: recognition, diagnosis and management.. Expert opinion on pharmacotherapy, 5(8), 1745-1754. doi:10.1517/14656566.5.8.1745
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 in type 2 diabetes: effect of 1 year's cardiovascular risk reduction therapy.
Tayebjee, M. H., Lim, H. S., MacFadyen, R. J., & Lip, G. Y. H. (2004). Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 in type 2 diabetes: effect of 1 year's cardiovascular risk reduction therapy.. Diabetes care, 27(8), 2049-2051. doi:10.2337/diacare.27.8.2049
A randomised controlled trial and cost effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in the over 65s: (SAFE) [ISRCTN19633732].
Swancutt, D., Hobbs, R., Fitzmaurice, D., Mant, J., Murray, E., Jowett, S., . . . Lip, G. (2004). A randomised controlled trial and cost effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in the over 65s: (SAFE) [ISRCTN19633732].. BMC cardiovascular disorders, 4, 12. doi:10.1186/1471-2261-4-12
Is depression a risk factor for coronary heart disease?
Pickering, T. G., Davidson, K., & Shimbo, D. (2004). Is depression a risk factor for coronary heart disease?. Journal of the American College of Cardiology, 44(2), 472-473. doi:10.1016/j.jacc.2004.04.029
Is depression following acute myocardial infarction an independent risk for mortality?
Lane, D., Lip, G. Y. H., & Carroll, D. (2004). Is depression following acute myocardial infarction an independent risk for mortality?. AMERICAN JOURNAL OF CARDIOLOGY, 93(10), 1333-1334. doi:10.1016/j.amjcard.2004.01.001
Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Clagett, G. P., Sobel, M., Jackson, M. R., Lip, G. Y. H., Tangelder, M., & Verhaeghe, R. (2004). Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.. In Chest Vol. 126 (pp. 609S-626S). doi:10.1378/chest.126.3_suppl.609s
Meta-analysis finds exercise training is safe in people with heart failure and left ventricular dysfunction
Meta-analysis finds exercise training is safe in people with heart failure and left ventricular dysfunction (2004). Evidence-based Cardiovascular Medicine, 8(4), 327-328. doi:10.1016/j.ebcm.2004.09.021
Novel therapies for the prevention of stroke.
Boos, C. J., & Lip, G. Y. H. (2004). Novel therapies for the prevention of stroke.. Expert opinion on investigational drugs, 13(12), 1615-1630. doi:10.1517/13543784.13.12.1615
Salt intake and Helicobacter pylori infection.
Beevers, D. G., Lip, G. Y. H., & Blann, A. D. (2004). Salt intake and Helicobacter pylori infection.. Journal of hypertension, 22(8), 1475-1477. doi:10.1097/01.hjh.0000133736.77866.77
Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertensionRelationship to tissue Doppler indices of diastolic relaxation
TAYEBJEE, M., NADAR, S., MACFADYEN, R., & LIP, G. (2004). Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertensionRelationship to tissue Doppler indices of diastolic relaxation. American Journal of Hypertension, 17(9), 770-774. doi:10.1016/s0895-7061(04)00902-1
2003
Anxiety, depression, and prognosis after myocardial infarction - Is there a causal association?
Lane, D., Carroll, D., & Lip, G. Y. H. (2003). Anxiety, depression, and prognosis after myocardial infarction - Is there a causal association?. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 42(10), 1808-1810. doi:10.1016/j.jacc.2003.08.018
Heart failure: treatment and ethnic origin.
Sosin, M. D., Bhatia, G. S., Davis, R. C., Connolly, D. L., & Lip, G. Y. H. (2003). Heart failure: treatment and ethnic origin.. Lancet (London, England), 362(9387), 919-920. doi:10.1016/s0140-6736(03)14317-6
Home-based versus hospital-based cardiac rehabilitation after myocardial infarction or revascularisation: design and rationale of the Birmingham Rehabilitation Uptake Maximisation Study (BRUM): a randomised controlled trial [ISRCTN72884263]
Jolly, K., Lip, G. Y. H., Sandercock, J., Greenfield, S. M., Raftery, J. P., Mant, J., . . . Stevens, A. J. (2003). Home-based versus hospital-based cardiac rehabilitation after myocardial infarction or revascularisation: design and rationale of the Birmingham Rehabilitation Uptake Maximisation Study (BRUM): a randomised controlled trial [ISRCTN72884263]. BMC CARDIOVASCULAR DISORDERS, 3. doi:10.1186/1471-2261-3-10
Psychological interventions for depression in adolescent and adult congenital heart disease.
Lip, G. Y. H., Lane, D. A., Millane, T. A., & Tayebjee, M. H. (2003). Psychological interventions for depression in adolescent and adult congenital heart disease.. The Cochrane database of systematic reviews, (3), CD004394. doi:10.1002/14651858.cd004394
2002
In-hospital symptoms of depression do not predict mortality 3 years after myocardial infarction
Lane, D., Carroll, D., Ring, C., Beevers, D. G., & Lip, G. Y. H. (2002). In-hospital symptoms of depression do not predict mortality 3 years after myocardial infarction. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 31(6), 1179-1182. doi:10.1093/ije/31.6.1179
Quality of life in adults with congenital heart disease
Lane, D. A., Lip, G. Y. H., & Millane, T. A. (2002). Quality of life in adults with congenital heart disease. HEART, 88(1), 71-75. doi:10.1136/heart.88.1.71
Ethnic differences in blood pressure and the prevalence of hypertension in England
Lane, D., Beevers, D. G., & Lip, G. Y. H. (2002). Ethnic differences in blood pressure and the prevalence of hypertension in England. JOURNAL OF HUMAN HYPERTENSION, 16(4), 267-273. doi:10.1038/sj.jhh.1001371
The prevalence and persistence of depression and anxiety following myocardial infarction
Lane, D., Carroll, D., Ring, C., Beevers, D. G., & Lip, G. Y. H. (2002). The prevalence and persistence of depression and anxiety following myocardial infarction. BRITISH JOURNAL OF HEALTH PSYCHOLOGY, 7, 11-21. doi:10.1348/135910702169321
Cancer and ethnic minorities.
Caine, G. J., Beevers, D. G., & Lip, G. Y. H. (2002). Cancer and ethnic minorities.. The Lancet. Oncology, 3(1), 9. doi:10.1016/s1470-2045(01)00614-3
2001
Blood pressure in different ethnic groups.
Lane, D., & Lip, G. Y. (2001). Blood pressure in different ethnic groups.. The American journal of cardiology, 88(10), 1218-1219. doi:10.1016/s0002-9149(01)01963-4
Predictors of attendance at cardiac rehabilitation after myocardial infarction
Lane, D., Carroll, D., Ring, C., Beevers, D. G., & Lip, G. Y. H. (2001). Predictors of attendance at cardiac rehabilitation after myocardial infarction. JOURNAL OF PSYCHOSOMATIC RESEARCH, 51(3), 497-501. doi:10.1016/S0022-3999(01)00225-2
Ethnic differences in hypertension and blood pressure control in the UK
Lane, D. A., & Lip, G. Y. H. (2001). Ethnic differences in hypertension and blood pressure control in the UK. QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 94(7), 391-396. doi:10.1093/qjmed/94.7.391
Lone papilloedema
Lip, P. L., Burdon, M. A., Clarke, C. E., Beevers, D. G., & Lip, G. Y. H. (2001). Lone papilloedema. The Lancet, 357(9272), 1924. doi:10.1016/s0140-6736(00)05062-5
Cardiovascular and behavioral reactions to stress and cerebrovascular disease
Lane, D. A., Carroll, D., & Lip, G. Y. H. (2001). Cardiovascular and behavioral reactions to stress and cerebrovascular disease. STROKE, 32(8), 1718-1720. Retrieved from https://www.webofscience.com/
Laboratory investigation of platelets
Shantsila, E., Watson, T., & Lip, G. Y. H. (2001). Laboratory investigation of platelets. In Platelets in Hematologic and Cardiovascular Disorders (pp. 124-146). Cambridge University Press. doi:10.1017/cbo9780511545276.010
Mortality and quality of life 12 months after myocardial infarction: Effects of depression and anxiety
Lane, D., Carroll, D., Ring, C., Beevers, D. G., & Lip, G. Y. H. (2001). Mortality and quality of life 12 months after myocardial infarction: Effects of depression and anxiety. PSYCHOSOMATIC MEDICINE, 63(2), 221-230. doi:10.1097/00006842-200103000-00005
2000
Effects of depression and anxiety on mortality and quality-of-life 4 months after myocardial infarction
Lane, D., Carroll, D., Ring, C., Beevers, D. G., & Lip, G. Y. H. (2000). Effects of depression and anxiety on mortality and quality-of-life 4 months after myocardial infarction. JOURNAL OF PSYCHOSOMATIC RESEARCH, 49(4), 229-238. doi:10.1016/S0022-3999(00)00170-7
Do depression and anxiety predict recurrent coronary events 12 months after myocardial infarction?
Lane, D., Carroll, D., Ring, C., Beevers, D. G., & Lip, G. Y. H. (2000). Do depression and anxiety predict recurrent coronary events 12 months after myocardial infarction?. QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 93(11), 739-744. doi:10.1093/qjmed/93.11.739
1999
Psychology in coronary care
Lane, D., Carroll, D., & Lip, G. Y. H. (1999). Psychology in coronary care. QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 92(8), 425-431. doi:10.1093/qjmed/92.8.425
1998
Oxidative stress after thrombolysis.
Landray, M. J., Nuttall, S. L., Lydakis, C., Martin, U., Maxwell, S. R., & Lip, G. Y. (1998). Oxidative stress after thrombolysis.. Lancet (London, England), 352(9132), 960. doi:10.1016/s0140-6736(05)61514-0